data_2hjj_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2hjj _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.356 0 CA-C-O 120.257 -0.19 . . . . 0.0 113.007 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.561 ' HD3' ' O ' ' A' ' 57' ' ' PRO . 53.2 Cg_endo -76.07 174.85 12.13 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.443 2.095 . . . . 0.0 112.17 176.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.43 ' CE1' ' HA ' ' A' ' 54' ' ' ASN . 16.5 p90 -126.96 -175.13 3.33 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.089 -177.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.422 ' H ' ' HB2' ' A' ' 16' ' ' GLN . 40.6 p -122.27 170.36 9.99 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.891 178.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 25.0 ttt85 -59.33 -39.55 83.49 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.246 0.546 . . . . 0.0 110.16 175.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 32.2 mtm180 -66.38 -52.36 47.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.106 177.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.613 ' O ' HG23 ' A' ' 20' ' ' VAL . 57.8 mm-40 -56.07 -48.0 76.9 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.862 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.425 ' HB3' HD21 ' A' ' 39' ' ' LEU . . . -49.12 -51.06 34.29 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.994 177.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -54.65 -40.31 68.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.455 179.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.17 -25.97 63.7 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.706 0.289 . . . . 0.0 111.745 -176.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.613 HG23 ' O ' ' A' ' 16' ' ' GLN . 15.9 t -89.44 -19.47 7.43 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.734 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 -173.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.525 HG21 ' HB ' ' A' ' 27' ' ' ILE . 13.2 m -97.11 -27.89 14.37 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-N 113.826 -1.534 . . . . 0.0 108.619 -175.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.8 m -63.63 -37.89 89.06 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 114.356 -1.293 . . . . 0.0 108.963 168.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 34.1 m -75.88 -56.68 4.44 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.645 175.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.57 ' O ' HG13 ' A' ' 27' ' ' ILE . 65.1 m-85 -105.78 99.81 9.39 Favored 'General case' 0 N--CA 1.439 -1.019 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 -179.054 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 4.0 p -70.01 -4.6 21.64 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.216 -178.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.519 ' OD1' ' HB3' ' A' ' 24' ' ' TYR . 6.3 p-10 -82.25 -7.42 59.63 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.702 176.123 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.57 HG13 ' O ' ' A' ' 24' ' ' TYR . 1.8 mt -90.25 158.74 2.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 173.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -153.39 135.41 14.72 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.721 0.296 . . . . 0.0 111.317 178.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 7.0 tt -90.66 109.76 20.93 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -131.17 176.73 8.02 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.384 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.409 ' HB2' ' HG2' ' A' ' 38' ' ' ARG . 11.9 m-20 61.85 30.82 18.34 Favored 'General case' 0 N--CA 1.467 0.376 0 O-C-N 123.735 0.647 . . . . 0.0 110.908 -178.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.549 ' HA ' ' HB3' ' A' ' 37' ' ' PHE . 25.9 t0 -71.13 122.85 20.88 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.619 -175.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.511 ' HB3' ' HB2' ' A' ' 36' ' ' HIS . 35.0 tt0 -133.78 18.31 3.87 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.034 178.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 113.14 -91.99 0.6 Allowed Glycine 0 N--CA 1.45 -0.393 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.688 -177.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.6 t -100.63 -15.33 17.81 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 174.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.511 ' HB2' ' HB3' ' A' ' 33' ' ' GLN . 35.5 m170 -93.1 107.7 19.44 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.417 175.051 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.549 ' HB3' ' HA ' ' A' ' 32' ' ' ASP . 55.3 p90 -163.81 162.17 23.62 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.049 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.516 ' HB3' ' HA ' ' A' ' 53' ' ' TRP . 30.7 ptt180 -138.62 146.15 41.39 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.29 0.567 . . . . 0.0 111.814 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.425 HD21 ' HB3' ' A' ' 17' ' ' ALA . 97.0 mt -91.77 126.15 36.75 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.072 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.458 HG12 ' SD ' ' A' ' 48' ' ' MET . 28.7 t -96.31 109.71 23.35 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.948 178.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 91.1 t -81.01 114.54 22.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.536 175.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.451 ' HB3' ' HA2' ' A' ' 46' ' ' GLY . 10.7 mtt180 -106.02 173.02 6.49 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.216 178.134 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -95.65 -167.9 1.68 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.244 -0.434 . . . . 0.0 109.933 177.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 10.2 p -60.7 -26.81 67.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.58 -178.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -91.56 -27.39 18.23 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.337 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.451 ' HA2' ' HB3' ' A' ' 42' ' ' ARG . . . 108.39 19.6 8.75 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.526 -0.845 . . . . 0.0 112.836 -178.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.412 ' O ' ' HA ' ' A' ' 42' ' ' ARG . 79.3 mtt180 -78.64 143.95 35.87 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 176.142 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.458 ' SD ' HG12 ' A' ' 40' ' ' VAL . 14.3 mmt -66.22 114.28 5.2 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.245 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 43.8 t -103.33 -35.1 3.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 120.741 0.305 . . . . 0.0 110.536 178.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 68.4 t-105 -172.3 125.54 0.52 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.968 -174.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 12.3 ptp180 -120.03 125.23 47.82 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.92 0.39 . . . . 0.0 110.232 175.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -125.89 143.25 51.15 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.572 -178.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.656 ' HB2' ' HG2' ' A' ' 56' ' ' GLU . 96.9 m95 -72.13 -174.12 1.2 Allowed 'General case' 0 CA--C 1.513 -0.464 0 CA-C-O 122.079 0.942 . . . . 0.0 112.13 -177.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.43 ' HA ' ' CE1' ' A' ' 12' ' ' PHE . 18.9 t-20 -101.9 -43.43 5.8 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 113.825 -1.534 . . . . 0.0 110.879 -176.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -83.68 10.64 8.84 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.941 -173.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.656 ' HG2' ' HB2' ' A' ' 53' ' ' TRP . 12.8 mm-40 -75.83 131.12 77.04 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.192 178.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.561 ' O ' ' HD3' ' A' ' 11' ' ' PRO . 4.2 Cg_endo -46.74 -37.01 20.39 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 124.01 3.14 . . . . 0.0 113.304 -174.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.537 ' HB3' ' HB2' ' A' ' 61' ' ' GLU . 11.5 m-20 -140.14 63.25 1.48 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.727 0.298 . . . . 0.0 110.249 174.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.51 ' HB3' ' HB2' ' A' ' 56' ' ' GLU . . . -61.77 -38.31 87.52 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-O 121.352 0.596 . . . . 0.0 110.572 177.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -62.51 -23.68 65.09 Favored Glycine 0 C--O 1.221 -0.691 0 CA-C-N 115.389 -0.823 . . . . 0.0 113.112 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.537 ' HB2' ' HB3' ' A' ' 58' ' ' ASP . 2.5 tm-20 -58.14 -51.9 67.8 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.159 0.504 . . . . 0.0 110.21 -178.297 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -71.84 -39.34 59.71 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.678 -0.772 . . . . 0.0 111.847 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.514 ' O ' HG13 ' A' ' 67' ' ' ILE . 80.4 mt -61.73 -46.46 89.55 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.593 0.235 . . . . 0.0 110.97 179.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -65.44 -29.53 70.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.14 -179.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.488 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 25.3 ttm105 -66.03 -33.76 76.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.027 176.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -73.07 -46.56 50.91 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 119.979 -0.688 . . . . 0.0 109.739 172.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.514 HG13 ' O ' ' A' ' 63' ' ' LEU . 80.3 mt -55.46 -55.59 16.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.342 -178.094 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.647 ' O ' HG22 ' A' ' 69' ' ' THR . 26.0 mmm-85 54.93 27.79 9.65 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 123.119 0.262 . . . . 0.0 111.55 177.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.647 HG22 ' O ' ' A' ' 68' ' ' ARG . 9.8 t 61.29 16.69 7.57 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.222 1.409 . . . . 0.0 111.042 176.165 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 13.2 p -113.72 -66.14 1.12 Allowed 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.438 175.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.531 ' HA3' ' CE1' ' A' ' 24' ' ' TYR . . . 65.65 179.64 8.97 Favored Glycine 0 N--CA 1.445 -0.765 0 CA-C-N 115.208 -0.906 . . . . 0.0 113.117 179.091 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.404 ' O ' HG21 ' A' ' 72' ' ' ILE . 35.8 mm -91.77 5.9 5.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.808 0.813 . . . . 0.0 110.119 -179.044 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 22.5 tpt180 . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.259 177.84 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.605 ' HA3' ' O ' ' A' ' 57' ' ' PRO . . . . . . . . 0 N--CA 1.441 -0.997 0 N-CA-C 111.325 -0.71 . . . . 0.0 111.325 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -73.33 132.92 18.45 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 121.494 1.462 . . . . 0.0 110.66 174.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 34.8 p90 -104.97 -171.7 1.96 Allowed 'General case' 0 C--N 1.31 -1.137 0 CA-C-O 121.703 0.763 . . . . 0.0 112.452 -173.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.89 156.44 36.26 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.924 -1.035 . . . . 0.0 109.2 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 22.5 ttt85 -61.6 -49.27 77.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.057 0.456 . . . . 0.0 110.346 -179.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.414 HH11 ' HD2' ' A' ' 15' ' ' ARG . 30.7 mtp180 -52.22 -47.97 65.36 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.338 -0.847 . . . . 0.0 111.2 175.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.585 ' O ' HG22 ' A' ' 20' ' ' VAL . 13.4 mm100 -58.0 -48.73 79.15 Favored 'General case' 0 C--O 1.226 -0.173 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.374 176.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -55.45 -46.09 76.8 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.319 -179.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 27.2 mm-40 -56.79 -41.65 78.07 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.529 -178.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.17 -23.26 67.06 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-O 121.181 0.515 . . . . 0.0 111.55 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.585 HG22 ' O ' ' A' ' 16' ' ' GLN . 5.0 t -90.6 -20.98 6.74 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.803 0 N-CA-C 107.227 -1.398 . . . . 0.0 107.227 -175.52 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.2 m -83.8 -31.73 25.73 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 114.084 -1.416 . . . . 0.0 110.243 179.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 15.6 p -70.41 -32.29 69.85 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 173.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 16.7 m -79.91 -49.06 12.45 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.756 175.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.71 ' O ' HG13 ' A' ' 27' ' ' ILE . 33.6 m-85 -115.12 96.9 5.91 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 175.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 37.9 m -83.33 16.17 2.63 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.035 0.445 . . . . 0.0 111.628 -174.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.422 ' OD1' ' HB3' ' A' ' 24' ' ' TYR . 21.5 p-10 -91.29 -17.4 26.0 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 169.543 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.71 HG13 ' O ' ' A' ' 24' ' ' TYR . 2.5 mt -72.55 147.46 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 CA-C-N 115.182 -0.917 . . . . 0.0 108.542 175.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.511 ' O ' ' HA ' ' A' ' 39' ' ' LEU . 14.5 p -141.95 144.45 33.74 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.712 -175.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.5 tt -101.15 108.62 20.34 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -113.77 162.5 16.22 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.83 179.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.54 ' O ' ' HA ' ' A' ' 37' ' ' PHE . 3.2 m-20 57.26 70.72 0.63 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.999 -1.001 . . . . 0.0 112.062 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -77.18 75.58 3.74 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.147 174.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.5 ' HB2' ' HB2' ' A' ' 36' ' ' HIS . 16.2 mm-40 -103.61 21.21 16.53 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.133 0.492 . . . . 0.0 109.981 -179.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.72 -93.06 1.64 Allowed Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 121.08 -0.581 . . . . 0.0 112.296 178.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 27.2 t -75.4 -29.55 59.84 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.397 0.617 . . . . 0.0 109.883 178.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.5 ' HB2' ' HB2' ' A' ' 33' ' ' GLN . 26.8 m-70 -101.84 107.54 18.75 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.79 177.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.54 ' HA ' ' O ' ' A' ' 31' ' ' ASP . 45.9 p90 -148.62 146.66 28.31 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 173.54 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 37.5 ptt85 -127.92 152.1 48.28 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.316 0.579 . . . . 0.0 112.314 -173.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.511 ' HA ' ' O ' ' A' ' 28' ' ' THR . 86.2 mt -108.88 132.6 53.88 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.891 175.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.431 ' HB ' ' OG1' ' A' ' 28' ' ' THR . 41.2 t -114.53 118.81 59.72 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.717 -179.032 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 93.5 t -89.46 114.83 28.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.654 176.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.453 ' HA ' ' O ' ' A' ' 47' ' ' ARG . 49.2 mtp180 -104.15 164.2 11.88 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.932 177.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.413 ' CG ' ' H ' ' A' ' 45' ' ' GLU . 1.7 p-10 -102.9 -166.04 1.23 Allowed 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 110.325 -0.25 . . . . 0.0 110.325 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 25.6 p -66.62 -22.96 66.11 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 120.92 0.39 . . . . 0.0 111.893 179.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.413 ' H ' ' CG ' ' A' ' 43' ' ' ASP . 8.6 tp10 -86.98 -21.61 26.07 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.239 0.543 . . . . 0.0 109.574 178.159 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 101.17 5.23 53.11 Favored Glycine 0 N--CA 1.444 -0.808 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.08 179.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.453 ' O ' ' HA ' ' A' ' 42' ' ' ARG . 88.0 mtt180 -72.23 146.87 47.0 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 -178.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -74.06 103.09 4.4 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 176.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 57.4 t -77.96 -40.67 26.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.991 179.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 76.1 t-105 -164.17 142.13 7.08 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.819 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' A' ' 51' ' ' ARG . 14.9 ptt-85 -141.78 138.68 32.44 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 177.477 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -143.97 156.47 44.42 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.354 -177.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 92.8 m95 -88.52 -161.6 0.76 Allowed 'General case' 0 N--CA 1.447 -0.615 0 CA-C-O 121.423 0.63 . . . . 0.0 110.474 -179.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -106.23 -33.93 7.66 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.274 -176.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -81.45 3.53 24.32 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 -173.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.508 ' HB2' ' HB3' ' A' ' 59' ' ' ALA . 37.1 mt-10 -80.19 129.22 70.58 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.463 -178.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.605 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 31.3 Cg_exo -62.16 -10.37 17.94 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 123.396 2.731 . . . . 0.0 114.009 -172.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.517 ' HA ' ' CA ' ' A' ' 10' ' ' GLY . 24.0 p-10 -143.01 34.02 1.36 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.761 0.315 . . . . 0.0 110.794 177.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.508 ' HB3' ' HB2' ' A' ' 56' ' ' GLU . . . -55.75 -40.96 73.25 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.994 -178.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -62.8 -39.33 97.85 Favored Glycine 0 N--CA 1.443 -0.878 0 CA-C-N 115.826 -0.624 . . . . 0.0 112.381 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -66.02 -23.1 66.49 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.886 0.343 . . . . 0.0 111.721 -177.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -75.5 -49.23 9.39 Favored Glycine 0 C--O 1.24 0.477 0 C-N-CA 120.286 -0.959 . . . . 0.0 111.085 175.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.427 ' O ' HG13 ' A' ' 67' ' ' ILE . 50.0 mt -63.24 -43.35 98.29 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.273 0.559 . . . . 0.0 109.833 177.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 8.8 m-20 -69.16 -20.43 64.02 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.189 178.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 6.8 tmm_? -65.93 -41.36 91.48 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 173.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.428 ' CE1' ' HA2' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -67.97 -42.9 80.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.425 175.018 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.427 HG13 ' O ' ' A' ' 63' ' ' LEU . 62.9 mt -67.74 -26.75 35.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.257 -178.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -59.9 -33.37 71.76 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.138 -178.257 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.471 ' O ' ' HB2' ' A' ' 70' ' ' SER . 4.5 t -101.73 66.48 1.06 Allowed 'General case' 0 N--CA 1.442 -0.838 0 CA-C-O 121.825 0.822 . . . . 0.0 109.526 179.015 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.471 ' HB2' ' O ' ' A' ' 69' ' ' THR . 63.2 m 80.37 -51.7 0.35 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 114.211 -1.359 . . . . 0.0 112.808 171.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.428 ' HA2' ' CE1' ' A' ' 66' ' ' TYR . . . 79.15 -174.04 55.29 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.633 -0.794 . . . . 0.0 111.271 -170.596 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.487 ' O ' HG23 ' A' ' 72' ' ' ILE . 47.5 mm -101.35 7.0 9.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-O 121.896 0.855 . . . . 0.0 110.341 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.534 ' HB3' ' CE2' ' A' ' 24' ' ' TYR . 14.6 ptm180 . . . . . 0 N--CA 1.474 0.726 0 CA-C-N 115.423 -0.808 . . . . 0.0 113.103 -178.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.411 ' HA3' ' HD3' ' A' ' 11' ' ' PRO . . . . . . . . 0 N--CA 1.463 0.473 0 N-CA-C 113.966 0.346 . . . . 0.0 113.966 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.411 ' HD3' ' HA3' ' A' ' 10' ' ' GLY . 7.7 Cg_exo -70.53 139.09 36.79 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.775 2.317 . . . . 0.0 111.053 176.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -104.9 -175.15 2.71 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.493 0.663 . . . . 0.0 112.134 -173.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.7 m -126.05 164.22 21.33 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-N 114.342 -1.299 . . . . 0.0 109.742 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.542 ' HA ' ' CZ ' ' A' ' 37' ' ' PHE . 48.3 ttt85 -51.49 -55.78 17.0 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 122.64 0.376 . . . . 0.0 111.351 -179.038 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 43.5 mtp180 -56.53 -45.57 81.08 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.464 177.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.563 ' O ' HG21 ' A' ' 20' ' ' VAL . 1.9 mp0 -59.2 -46.92 87.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.943 -179.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.47 ' HB3' HD12 ' A' ' 39' ' ' LEU . . . -57.44 -44.18 84.5 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 121.086 0.47 . . . . 0.0 111.17 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 58.2 mt-30 -55.28 -41.75 72.69 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.024 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.49 -23.96 66.33 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.739 -178.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.563 HG21 ' O ' ' A' ' 16' ' ' GLN . 10.4 t -90.83 -19.76 7.07 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.687 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 -172.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.513 HG23 ' HB ' ' A' ' 27' ' ' ILE . 10.8 m -95.86 -28.79 14.54 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 114.055 -1.429 . . . . 0.0 108.417 -176.036 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 54.8 m -63.45 -36.63 84.4 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 114.083 -1.417 . . . . 0.0 108.939 167.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.558 HG23 HH11 ' A' ' 73' ' ' ARG . 90.8 m -76.21 -54.4 6.85 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.376 175.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.554 ' O ' HG13 ' A' ' 27' ' ' ILE . 51.1 m-85 -110.64 102.7 11.25 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-O 121.087 0.47 . . . . 0.0 109.796 179.144 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 6.1 p -75.62 2.17 12.56 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.376 -177.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.441 ' OD1' ' HB3' ' A' ' 24' ' ' TYR . 6.1 p-10 -87.71 -8.3 56.25 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.572 173.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.554 HG13 ' O ' ' A' ' 24' ' ' TYR . 2.9 mt -83.08 150.27 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 172.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.41 ' O ' ' HA ' ' A' ' 39' ' ' LEU . 1.1 p -141.43 135.94 30.85 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 120.912 -0.315 . . . . 0.0 110.785 -178.011 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 5.0 tt -94.64 107.16 19.16 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -178.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -119.07 164.66 15.18 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.753 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.466 ' HB2' ' HG2' ' A' ' 38' ' ' ARG . 90.5 m-20 56.71 42.39 26.92 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.6 0.715 . . . . 0.0 110.462 -175.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -74.6 103.38 4.89 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.913 -177.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -103.43 -19.73 14.31 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 173.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 126.03 -80.54 0.36 Allowed Glycine 0 N--CA 1.449 -0.469 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.405 -177.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.8 t -72.21 -35.6 68.94 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.262 0.553 . . . . 0.0 109.623 174.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 40.0 m80 -109.34 139.26 44.51 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.783 178.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.542 ' CZ ' ' HA ' ' A' ' 14' ' ' ARG . 55.6 p90 -174.23 164.04 3.91 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 176.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.466 ' HG2' ' HB2' ' A' ' 31' ' ' ASP . 29.3 ptt85 -128.68 144.83 51.25 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.205 0.526 . . . . 0.0 111.191 177.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.47 HD12 ' HB3' ' A' ' 17' ' ' ALA . 86.0 mt -99.18 127.1 45.1 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.934 176.322 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 27.5 t -103.7 119.93 53.05 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.529 177.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.411 HG13 ' CD2' ' A' ' 66' ' ' TYR . 16.3 t -91.19 108.76 20.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.214 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 33.9 mtt85 -105.19 168.15 9.26 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.038 -177.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.608 ' OD1' ' HG2' ' A' ' 47' ' ' ARG . 7.6 p-10 -104.02 -164.57 1.07 Allowed 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.616 179.182 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -66.17 -17.11 64.51 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -91.98 -24.32 19.28 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.477 0.656 . . . . 0.0 109.821 179.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 99.32 7.78 53.93 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.745 -0.741 . . . . 0.0 111.575 -179.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.608 ' HG2' ' OD1' ' A' ' 43' ' ' ASP . 15.9 ptt180 -78.35 150.46 33.21 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 177.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 23.3 ptp -79.12 116.86 19.67 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.309 0.576 . . . . 0.0 110.01 178.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 41.4 t -98.26 -31.94 3.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-O 121.478 0.656 . . . . 0.0 109.322 176.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 75.2 t-105 -155.11 155.76 34.59 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.53 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 16.7 ptt180 -158.5 142.66 15.67 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 175.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -150.55 147.92 28.04 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.214 -179.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.534 ' HB2' ' HG2' ' A' ' 56' ' ' GLU . 65.0 m95 -80.92 -176.73 6.05 Favored 'General case' 0 CA--C 1.509 -0.627 0 CA-C-O 122.15 0.976 . . . . 0.0 111.371 177.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -82.82 -31.54 28.06 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 113.465 -1.698 . . . . 0.0 110.079 -178.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -97.04 8.65 44.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.58 -0.737 . . . . 0.0 112.325 -173.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.534 ' HG2' ' HB2' ' A' ' 53' ' ' TRP . 38.9 mm-40 -71.02 128.14 90.9 Favored Pre-proline 0 C--N 1.328 -0.354 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 179.118 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -49.28 -37.45 40.04 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 124.074 3.182 . . . . 0.0 113.904 -173.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -131.15 43.82 3.04 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.143 0.497 . . . . 0.0 110.248 178.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.519 ' HB3' ' HB2' ' A' ' 56' ' ' GLU . . . -51.4 -45.36 62.48 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.545 -177.234 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -59.04 -38.63 93.25 Favored Glycine 0 N--CA 1.446 -0.646 0 CA-C-N 115.433 -0.803 . . . . 0.0 113.163 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 22.1 tp10 -60.06 -38.78 83.84 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.873 0.337 . . . . 0.0 110.996 -175.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -68.84 -43.54 73.79 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.33 -0.938 . . . . 0.0 111.021 177.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.445 ' O ' HG13 ' A' ' 67' ' ' ILE . 57.5 mt -58.52 -47.6 83.61 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.324 -0.438 . . . . 0.0 109.867 176.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -59.72 -33.34 71.5 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.698 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.414 HH11 ' HD2' ' A' ' 65' ' ' ARG . 9.5 tpp85 -70.07 -29.58 66.61 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.059 -175.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.411 ' CD2' HG13 ' A' ' 41' ' ' VAL . 80.0 t80 -87.45 -42.58 12.7 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.177 -0.609 . . . . 0.0 110.546 172.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.641 HG21 ' H ' ' A' ' 69' ' ' THR . 86.1 mt -57.04 -59.89 2.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.884 -179.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.52 ' O ' HG23 ' A' ' 69' ' ' THR . 57.1 mtm-85 51.85 30.28 6.9 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.242 0.544 . . . . 0.0 111.213 177.339 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.641 ' H ' HG21 ' A' ' 67' ' ' ILE . 13.2 t 61.55 21.12 11.83 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 126.102 1.761 . . . . 0.0 111.736 174.369 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 55.3 p -112.57 -62.18 1.62 Allowed 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.233 171.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 65.26 -175.83 14.02 Favored Glycine 0 N--CA 1.446 -0.69 0 CA-C-N 115.152 -0.931 . . . . 0.0 112.721 177.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.434 HG21 ' O ' ' A' ' 72' ' ' ILE . 40.9 mm -101.34 5.82 10.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-O 121.876 0.846 . . . . 0.0 109.35 178.486 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.558 HH11 HG23 ' A' ' 23' ' ' THR . 51.3 ttt180 . . . . . 0 C--N 1.33 -0.24 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.376 179.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.574 ' HA2' ' HA ' ' A' ' 58' ' ' ASP . . . . . . . . 0 CA--C 1.523 0.559 0 N-CA-C 113.554 0.181 . . . . 0.0 113.554 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -81.31 170.85 14.38 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 123.371 2.714 . . . . 0.0 112.29 177.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 15.2 p90 -122.27 -173.85 2.77 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.015 0.436 . . . . 0.0 111.48 -176.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.402 ' H ' ' HB2' ' A' ' 16' ' ' GLN . 62.5 p -125.16 179.64 4.97 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.896 178.416 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 29.3 ttt180 -63.99 -41.32 97.55 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 174.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 25.7 ttm180 -58.72 -53.43 58.48 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.625 177.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.578 ' O ' HG21 ' A' ' 20' ' ' VAL . 2.0 mp0 -60.78 -48.61 81.02 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.541 178.192 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -50.26 -54.59 20.17 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.534 179.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -57.79 -36.77 72.64 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.191 -0.458 . . . . 0.0 112.11 -179.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.66 -29.48 70.05 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.027 0.441 . . . . 0.0 111.565 -179.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.578 HG21 ' O ' ' A' ' 16' ' ' GLN . 11.5 t -88.95 -25.31 5.77 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.827 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 -173.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.406 HG22 ' HB ' ' A' ' 27' ' ' ILE . 9.7 m -83.14 -33.51 26.25 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-N 113.909 -1.496 . . . . 0.0 110.994 -179.49 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.1 t -70.44 -25.34 63.16 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 173.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 33.6 m -76.0 -56.99 4.15 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.682 169.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.662 ' CE1' ' HA3' ' A' ' 71' ' ' GLY . 34.1 m-85 -113.14 105.72 13.79 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.282 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 31.5 m -86.71 11.6 12.65 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.59 0.709 . . . . 0.0 110.23 -176.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.554 ' OD1' ' HB ' ' A' ' 72' ' ' ILE . 7.5 p-10 -88.73 -6.98 57.06 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.917 -1.038 . . . . 0.0 108.748 170.44 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.617 HG13 ' O ' ' A' ' 24' ' ' TYR . 3.6 mt -82.45 142.32 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 172.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.0 p -136.05 130.13 33.0 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.748 -0.381 . . . . 0.0 111.095 -174.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.52 ' HA ' HD22 ' A' ' 39' ' ' LEU . 5.4 tt -86.08 117.3 24.83 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.335 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 70.7 mt-10 -123.4 173.3 8.08 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.295 -178.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.472 ' O ' ' HA ' ' A' ' 37' ' ' PHE . 0.4 OUTLIER 55.56 63.62 2.01 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.703 -1.135 . . . . 0.0 111.364 176.747 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -80.8 97.45 7.35 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.022 -179.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -106.94 -10.56 15.94 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 171.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 111.92 -81.97 0.3 Allowed Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.895 -0.669 . . . . 0.0 111.601 -177.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.7 m -76.74 -18.64 58.36 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.32 0.581 . . . . 0.0 110.18 177.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 38.3 m-70 -115.84 137.72 51.83 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.949 176.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.472 ' HA ' ' O ' ' A' ' 31' ' ' ASP . 48.6 p90 -167.17 156.94 10.84 Favored 'General case' 0 C--N 1.328 -0.337 0 O-C-N 123.824 0.703 . . . . 0.0 109.334 175.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 22.4 ptt180 -128.97 158.13 39.71 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.705 0.288 . . . . 0.0 111.056 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.52 HD22 ' HA ' ' A' ' 29' ' ' LEU . 75.0 mt -113.73 125.02 53.65 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.235 0.541 . . . . 0.0 109.978 174.077 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.497 HG23 ' CB ' ' A' ' 51' ' ' ARG . 61.9 t -103.37 123.97 57.25 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.823 177.03 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.433 HG11 ' CD1' ' A' ' 66' ' ' TYR . 3.1 t -93.92 111.0 24.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -104.47 168.24 9.22 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.963 -178.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -97.16 -166.72 1.43 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.637 0.256 . . . . 0.0 110.316 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 12.4 p -70.15 -17.18 63.17 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 111.99 0.366 . . . . 0.0 111.99 -176.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.411 ' HB3' ' HG2' ' A' ' 47' ' ' ARG . 23.5 tt0 -93.11 -22.69 18.95 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.002 0.43 . . . . 0.0 109.92 179.149 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 105.81 14.01 22.32 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.807 -0.711 . . . . 0.0 111.769 -178.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.411 ' HG2' ' HB3' ' A' ' 45' ' ' GLU . 14.9 mmt180 -76.74 124.93 28.41 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 178.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -69.09 106.07 2.67 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.133 0.492 . . . . 0.0 109.984 176.183 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 41.2 t -92.55 -33.11 5.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.444 -177.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 69.1 t-105 -156.4 149.17 23.84 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.893 -175.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.497 ' CB ' HG23 ' A' ' 40' ' ' VAL . 14.5 ptp180 -146.69 143.48 28.77 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 172.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -143.56 147.44 34.44 Favored 'General case' 0 C--N 1.319 -0.717 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 82.8 m95 -82.37 -171.26 3.35 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-O 121.594 0.711 . . . . 0.0 110.637 178.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -98.72 -16.78 18.85 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 114.417 -1.265 . . . . 0.0 110.294 -176.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -104.26 4.17 33.48 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.622 -177.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.532 ' HB2' ' HB1' ' A' ' 59' ' ' ALA . 20.7 mm-40 -61.26 131.93 92.4 Favored Pre-proline 0 C--O 1.235 0.316 0 CA-C-N 116.641 -0.254 . . . . 0.0 110.525 178.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_exo -40.01 -47.65 3.9 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 124.264 3.309 . . . . 0.0 113.243 -176.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.574 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . 5.0 t0 -140.22 70.03 1.36 Allowed 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 171.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.532 ' HB1' ' HB2' ' A' ' 56' ' ' GLU . . . -55.47 -35.98 66.09 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.823 178.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -58.16 -43.1 95.49 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.416 -0.811 . . . . 0.0 112.5 178.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.645 ' O ' ' HG3' ' A' ' 65' ' ' ARG . 5.3 tm-20 -58.65 -39.71 81.36 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.696 0.248 . . . . 0.0 111.003 -177.289 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.633 ' O ' ' HB2' ' A' ' 65' ' ' ARG . . . -76.4 -40.61 27.7 Favored Glycine 0 C--N 1.331 0.264 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.126 -178.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.486 ' O ' HG13 ' A' ' 67' ' ' ILE . 77.3 mt -66.26 -40.55 90.25 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 177.152 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -65.6 -26.42 67.83 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.822 177.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.645 ' HG3' ' O ' ' A' ' 61' ' ' GLU . 87.7 mtt180 -58.26 -48.91 78.93 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 121.112 0.482 . . . . 0.0 109.804 171.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.433 ' CD1' HG11 ' A' ' 41' ' ' VAL . 29.3 t80 -69.44 -48.36 61.13 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.378 178.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.486 HG13 ' O ' ' A' ' 63' ' ' LEU . 80.3 mt -56.86 -58.07 7.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.848 -178.211 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.477 ' O ' HG22 ' A' ' 69' ' ' THR . 13.7 mtm180 57.42 28.2 15.06 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-O 121.045 0.45 . . . . 0.0 110.611 178.003 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.477 HG22 ' O ' ' A' ' 68' ' ' ARG . 11.5 t 52.51 22.76 2.26 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.266 1.427 . . . . 0.0 112.001 -177.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 17.0 t -108.25 -64.73 1.19 Allowed 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 172.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.662 ' HA3' ' CE1' ' A' ' 24' ' ' TYR . . . 75.38 166.93 20.38 Favored Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.998 176.182 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.554 ' HB ' ' OD1' ' A' ' 26' ' ' ASN . 40.8 mm -87.74 -11.19 10.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 120.664 0.269 . . . . 0.0 111.164 -179.203 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 7.9 ttm180 . . . . . 0 N--CA 1.468 0.445 0 CA-C-O 120.931 0.396 . . . . 0.0 111.899 -178.323 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.41 ' HA3' ' HD3' ' A' ' 11' ' ' PRO . . . . . . . . 0 CA--C 1.516 0.127 0 CA-C-O 120.147 -0.252 . . . . 0.0 113.201 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.41 ' HD3' ' HA3' ' A' ' 10' ' ' GLY . 20.8 Cg_exo -64.75 153.05 79.71 Favored 'Trans proline' 0 C--O 1.234 0.314 0 C-N-CA 122.88 2.387 . . . . 0.0 111.704 177.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 16.8 p90 -120.32 -171.69 2.21 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.053 -176.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 46.1 p -125.02 171.65 10.07 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.84 179.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.474 ' O ' ' HG3' ' A' ' 18' ' ' GLN . 43.1 ttt180 -55.8 -45.86 78.15 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.651 0.739 . . . . 0.0 109.773 174.385 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -63.5 -50.27 70.29 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.765 -1.107 . . . . 0.0 111.772 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.578 ' O ' HG22 ' A' ' 20' ' ' VAL . 1.5 mp0 -58.78 -44.59 90.71 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.692 -0.231 . . . . 0.0 110.689 179.188 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -52.29 -49.0 65.03 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.256 178.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.474 ' HG3' ' O ' ' A' ' 14' ' ' ARG . 98.3 mt-30 -56.04 -45.1 79.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.374 -178.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.12 -31.15 70.86 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.079 -176.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.578 HG22 ' O ' ' A' ' 16' ' ' GLN . 8.2 t -87.55 -24.31 6.33 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.881 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 -171.278 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.521 HG21 ' HB ' ' A' ' 27' ' ' ILE . 10.3 m -86.4 -30.94 21.73 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 113.597 -1.638 . . . . 0.0 110.698 -178.389 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.6 p -68.56 -28.25 66.8 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 170.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 20.7 m -76.95 -56.79 4.28 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.089 172.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.609 ' HB3' ' OD1' ' A' ' 26' ' ' ASN . 79.0 m-85 -109.59 103.41 12.27 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 121.259 0.552 . . . . 0.0 109.948 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 6.0 p -71.72 -3.9 24.51 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.492 -0.776 . . . . 0.0 112.134 -178.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.609 ' OD1' ' HB3' ' A' ' 24' ' ' TYR . 25.6 p-10 -80.05 -16.68 54.54 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 174.405 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.552 HG13 ' O ' ' A' ' 24' ' ' TYR . 2.4 mt -76.72 146.63 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 173.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.526 ' OG1' ' HB ' ' A' ' 40' ' ' VAL . 1.6 p -141.59 123.26 15.16 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.013 0.435 . . . . 0.0 111.007 -177.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.451 ' CD2' ' HB3' ' A' ' 32' ' ' ASP . 6.5 tt -80.69 99.73 8.34 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 178.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 52.7 mm-40 -118.81 166.96 12.16 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.561 -177.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 58.97 34.63 23.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.347 -175.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.521 ' HA ' ' HB3' ' A' ' 37' ' ' PHE . 5.7 p-10 -68.03 99.8 0.91 Allowed 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.274 -0.876 . . . . 0.0 111.514 -178.152 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -104.97 9.21 34.61 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.018 176.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 125.06 -94.37 0.46 Allowed Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.409 -177.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.3 t -101.45 -13.38 17.97 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 173.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 13.9 m-70 -94.27 111.69 23.45 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.298 174.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.521 ' HB3' ' HA ' ' A' ' 32' ' ' ASP . 47.4 p90 -163.83 171.56 15.3 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -179.239 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.495 ' HA ' ' HA ' ' A' ' 53' ' ' TRP . 16.6 ptt-85 -130.79 144.63 51.58 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.083 0.468 . . . . 0.0 110.539 175.153 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.447 HD23 ' HA ' ' A' ' 29' ' ' LEU . 95.1 mt -95.33 117.12 29.75 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.532 176.346 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.526 ' HB ' ' OG1' ' A' ' 28' ' ' THR . 38.3 t -92.14 119.99 40.57 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.832 178.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.473 HG13 ' CD1' ' A' ' 66' ' ' TYR . 4.9 t -92.2 116.45 33.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 178.336 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 59.2 mtm180 -99.32 166.74 11.06 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.435 -178.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.62 ' OD1' ' HG2' ' A' ' 47' ' ' ARG . 9.7 p-10 -100.28 -166.71 1.36 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.23 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.83 -17.94 64.99 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.792 -179.185 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -89.32 -29.03 19.45 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -179.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 102.42 16.69 21.91 Favored Glycine 0 N--CA 1.444 -0.821 0 CA-C-N 115.276 -0.874 . . . . 0.0 112.309 -178.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.62 ' HG2' ' OD1' ' A' ' 43' ' ' ASP . 25.4 ptt180 -93.69 153.1 18.54 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 178.392 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.413 ' HG2' HG13 ' A' ' 40' ' ' VAL . 49.4 mtt -73.33 113.38 10.34 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.397 -178.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.44 HG23 ' HB3' ' A' ' 43' ' ' ASP . 46.1 t -97.84 -33.21 4.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 121.105 0.479 . . . . 0.0 110.264 178.114 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 74.0 t-105 -157.02 154.64 29.91 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.087 -177.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.426 ' HB2' ' HD2' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -151.13 140.46 21.38 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 174.366 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -141.51 143.75 33.96 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 177.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.503 ' HB2' ' HG2' ' A' ' 56' ' ' GLU . 69.2 m95 -80.23 -173.82 4.21 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 121.721 0.772 . . . . 0.0 111.069 -179.122 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -90.22 -28.32 18.93 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 114.008 -1.451 . . . . 0.0 110.089 -175.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 13.5 p90 -101.55 15.85 27.57 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.21 -0.904 . . . . 0.0 112.075 -173.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.505 ' HB2' ' HB2' ' A' ' 59' ' ' ALA . 19.3 mm-40 -77.87 135.23 63.62 Favored Pre-proline 0 C--N 1.323 -0.571 0 C-N-CA 121.232 -0.187 . . . . 0.0 110.828 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_exo -38.77 -46.67 2.66 Favored 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 124.637 3.558 . . . . 0.0 113.966 -173.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -145.33 67.8 1.23 Allowed 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 172.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.505 ' HB2' ' HB2' ' A' ' 56' ' ' GLU . . . -56.2 -36.12 68.06 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 115.263 -0.881 . . . . 0.0 111.232 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -57.0 -36.23 72.8 Favored Glycine 0 N--CA 1.447 -0.633 0 CA-C-N 115.486 -0.779 . . . . 0.0 113.78 -178.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.409 ' CD ' HH21 ' A' ' 65' ' ' ARG . 1.2 tm-20 -56.73 -49.15 76.07 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 117.211 0.505 . . . . 0.0 110.83 -176.472 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -70.21 -43.26 64.23 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.341 -177.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.546 ' O ' HG13 ' A' ' 67' ' ' ILE . 52.6 mt -66.39 -52.3 48.22 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.866 -0.167 . . . . 0.0 110.766 -178.418 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.666 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 87.9 m-20 -58.72 -40.76 84.65 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.717 -179.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.409 HH21 ' CD ' ' A' ' 61' ' ' GLU . 19.0 ttm180 -51.63 -50.99 59.2 Favored 'General case' 0 C--O 1.233 0.192 0 O-C-N 123.643 0.589 . . . . 0.0 110.446 178.504 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.473 ' CD1' HG13 ' A' ' 41' ' ' VAL . 44.5 t80 -63.36 -43.25 98.2 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.352 179.07 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.546 HG13 ' O ' ' A' ' 63' ' ' LEU . 87.4 mt -57.6 -31.49 39.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.927 -0.579 . . . . 0.0 112.329 -177.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.666 ' HG2' ' O ' ' A' ' 64' ' ' ASN . 10.7 mmm180 -65.02 -62.08 1.77 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.972 0.415 . . . . 0.0 111.257 -175.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 17.7 p -81.57 -26.21 35.18 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.327 -177.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 24.7 m -125.91 31.14 5.53 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -169.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.15 116.41 9.05 Favored Glycine 0 CA--C 1.522 0.528 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.099 170.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.48 ' O ' HG23 ' A' ' 72' ' ' ILE . 37.5 mm -93.99 2.6 9.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-O 121.029 0.442 . . . . 0.0 111.339 -171.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 45.0 ptt85 . . . . . 0 C--N 1.328 -0.34 0 O-C-N 121.976 -0.453 . . . . 0.0 111.691 -175.598 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.538 ' HA3' ' HA ' ' A' ' 58' ' ' ASP . . . . . . . . 0 N--CA 1.442 -0.907 0 N-CA-C 111.52 -0.632 . . . . 0.0 111.52 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.402 ' HD3' ' O ' ' A' ' 57' ' ' PRO . 6.0 Cg_exo -76.45 131.67 12.86 Favored 'Trans proline' 0 N--CA 1.45 -1.034 0 C-N-CA 121.776 1.651 . . . . 0.0 111.031 173.264 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 19.8 p90 -98.39 -169.54 1.82 Allowed 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.73 -173.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.419 ' HB ' ' OE1' ' A' ' 16' ' ' GLN . 0.2 OUTLIER -122.82 156.51 34.4 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.401 179.425 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 32.1 ttt85 -56.4 -46.19 80.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.331 0.586 . . . . 0.0 110.477 178.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 26.2 ttm180 -53.07 -59.29 4.73 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.981 -1.008 . . . . 0.0 110.842 176.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.625 ' O ' HG22 ' A' ' 20' ' ' VAL . 15.9 mp0 -57.4 -44.09 84.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.456 -179.19 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.458 ' HB3' HD11 ' A' ' 39' ' ' LEU . . . -53.54 -45.83 69.96 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 121.248 0.547 . . . . 0.0 111.114 179.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -59.91 -36.84 77.83 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.912 179.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.74 -24.43 64.45 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.017 177.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.625 HG22 ' O ' ' A' ' 16' ' ' GLN . 2.9 t -83.97 -18.68 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 -178.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.516 HG21 ' HB ' ' A' ' 27' ' ' ILE . 0.0 OUTLIER -90.89 -32.15 16.13 Favored 'General case' 0 CA--C 1.506 -0.734 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 177.581 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 76.4 m -56.65 -34.42 67.31 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 113.623 -1.626 . . . . 0.0 109.46 168.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.557 HG22 HH11 ' A' ' 73' ' ' ARG . 59.8 m -87.51 -49.31 7.28 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.399 -0.818 . . . . 0.0 111.684 177.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.641 ' HB3' ' OD1' ' A' ' 26' ' ' ASN . 63.7 m-85 -118.71 109.7 16.41 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 121.018 0.437 . . . . 0.0 110.352 -178.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 11.8 p -78.72 0.59 26.12 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.663 -177.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.641 ' OD1' ' HB3' ' A' ' 24' ' ' TYR . 25.0 p-10 -82.76 -19.79 37.17 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 175.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.516 ' HB ' HG21 ' A' ' 21' ' ' THR . 1.1 mt -77.68 151.32 5.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 177.155 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.553 ' OG1' ' HB ' ' A' ' 40' ' ' VAL . 19.7 p -138.33 128.08 25.15 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.904 0.383 . . . . 0.0 111.119 179.589 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.517 ' HA ' HD21 ' A' ' 39' ' ' LEU . 6.5 tt -86.63 103.24 14.92 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 175.474 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.407 ' O ' ' HB3' ' A' ' 31' ' ' ASP . 53.2 mt-10 -121.74 174.12 7.03 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.929 -176.214 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.407 ' HB3' ' O ' ' A' ' 30' ' ' GLU . 12.4 t70 77.48 -62.9 0.37 Allowed 'General case' 0 N--CA 1.466 0.341 0 O-C-N 124.28 0.987 . . . . 0.0 110.242 -176.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.482 ' HA ' ' HB3' ' A' ' 37' ' ' PHE . 54.1 t0 38.7 78.56 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.554 -1.203 . . . . 0.0 112.99 -177.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -105.01 37.01 2.27 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 170.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.2 -102.13 2.75 Favored Glycine 0 N--CA 1.448 -0.558 0 CA-C-N 115.142 -0.936 . . . . 0.0 112.126 179.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.3 m -82.84 -15.05 53.07 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.229 0.538 . . . . 0.0 110.547 177.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 55.6 m170 -108.33 109.51 20.85 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.901 177.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.482 ' HB3' ' HA ' ' A' ' 32' ' ' ASP . 53.3 p90 -152.92 169.45 22.81 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 177.133 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.453 ' HA ' ' HA ' ' A' ' 53' ' ' TRP . 25.6 ptt-85 -128.45 147.98 50.69 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.181 -0.608 . . . . 0.0 111.556 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.539 ' HA ' ' O ' ' A' ' 28' ' ' THR . 90.5 mt -107.0 117.66 34.65 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.403 173.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.553 ' HB ' ' OG1' ' A' ' 28' ' ' THR . 53.0 t -95.11 119.02 42.6 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.135 178.34 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.457 ' HB ' ' HB3' ' A' ' 50' ' ' TRP . 61.4 t -88.79 110.88 21.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 121.106 0.479 . . . . 0.0 109.888 177.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.415 ' HA ' ' O ' ' A' ' 47' ' ' ARG . 33.4 mtm180 -98.77 176.66 5.54 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.214 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -94.76 -171.14 2.39 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 173.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.1 t -60.76 -24.08 65.48 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.64 -176.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -91.59 -31.59 15.84 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.924 0.393 . . . . 0.0 110.663 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 120.73 10.36 7.07 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.929 -177.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.415 ' O ' ' HA ' ' A' ' 42' ' ' ARG . 28.9 mmm180 -74.54 133.59 42.26 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 177.49 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.438 ' SD ' HG11 ' A' ' 40' ' ' VAL . 50.8 mtt -79.96 104.06 10.27 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.065 0.46 . . . . 0.0 110.622 -174.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 35.0 t -90.18 -31.62 5.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.339 -177.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.457 ' HB3' ' HB ' ' A' ' 41' ' ' VAL . 76.6 t-105 -151.65 161.12 43.2 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.774 -176.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 4.3 ptp180 -159.24 132.81 7.29 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 176.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -138.62 141.72 39.12 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.698 -0.228 . . . . 0.0 110.742 -178.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.575 ' HB2' ' HG3' ' A' ' 56' ' ' GLU . 84.1 m95 -83.44 -166.05 1.27 Allowed 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 121.54 0.686 . . . . 0.0 110.226 178.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.417 HD21 ' C ' ' A' ' 54' ' ' ASN . 0.2 OUTLIER -99.51 -33.05 10.82 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.86 -178.501 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -88.98 10.17 22.45 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.893 -173.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.575 ' HG3' ' HB2' ' A' ' 53' ' ' TRP . 26.5 mt-10 -82.29 131.89 54.62 Favored Pre-proline 0 C--N 1.325 -0.489 0 C-N-CA 120.971 -0.292 . . . . 0.0 110.976 -177.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.402 ' O ' ' HD3' ' A' ' 11' ' ' PRO . 44.3 Cg_exo -36.17 -53.71 0.95 Allowed 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 124.816 3.677 . . . . 0.0 114.109 -173.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.538 ' HA ' ' HA3' ' A' ' 10' ' ' GLY . 3.3 t70 -137.37 67.02 1.44 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.104 0.478 . . . . 0.0 110.129 174.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.0 -33.76 65.17 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.201 176.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -61.4 -33.74 85.74 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 121.223 -0.513 . . . . 0.0 113.284 -178.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -64.61 -34.97 79.51 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.586 0.232 . . . . 0.0 110.944 -178.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -69.84 -45.74 56.34 Favored Glycine 0 C--O 1.236 0.25 0 C-N-CA 120.396 -0.907 . . . . 0.0 111.201 178.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 43.3 mt -61.97 -43.44 98.84 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.381 -0.41 . . . . 0.0 109.932 177.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -61.26 -38.33 86.32 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.073 177.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 23.3 tpt85 -56.09 -38.95 71.41 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.356 177.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.513 ' O ' HG21 ' A' ' 69' ' ' THR . 46.2 t80 -79.04 -49.42 12.71 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.229 177.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 94.6 mt -56.51 -30.5 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -177.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.426 HH11 ' HD2' ' A' ' 68' ' ' ARG . 33.2 ttm180 -59.0 -30.27 67.87 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.433 -179.571 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.513 HG21 ' O ' ' A' ' 66' ' ' TYR . 10.0 t -91.84 62.35 4.33 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 122.003 0.906 . . . . 0.0 110.058 179.141 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 25.3 t 84.35 -37.41 0.06 Allowed 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 114.363 -1.29 . . . . 0.0 112.718 167.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 76.59 164.35 18.83 Favored Glycine 0 CA--C 1.522 0.526 0 C-N-CA 120.285 -0.96 . . . . 0.0 111.977 -174.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.488 ' O ' HG23 ' A' ' 72' ' ' ILE . 46.2 mm -101.07 6.0 10.0 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-O 121.79 0.805 . . . . 0.0 111.025 -175.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.557 HH11 HG22 ' A' ' 23' ' ' THR . 21.2 ttt180 . . . . . 0 C--N 1.324 -0.506 0 O-C-N 121.257 -0.902 . . . . 0.0 110.881 178.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.417 ' HA3' ' HD3' ' A' ' 11' ' ' PRO . . . . . . . . 0 CA--C 1.519 0.332 0 CA-C-O 119.936 -0.369 . . . . 0.0 112.94 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.417 ' HD3' ' HA3' ' A' ' 10' ' ' GLY . 16.5 Cg_exo -66.65 142.13 63.01 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.655 2.236 . . . . 0.0 111.812 175.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 42.9 p90 -112.39 151.46 29.78 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.707 0.765 . . . . 0.0 112.521 -174.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.628 ' HB ' ' HG2' ' A' ' 16' ' ' GLN . 0.3 OUTLIER -76.94 156.34 32.07 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 114.422 -1.263 . . . . 0.0 110.788 178.66 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 25.8 ttt180 -61.32 -46.73 89.05 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.796 0.331 . . . . 0.0 110.578 -178.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 84.3 mtt-85 -61.29 -36.75 80.94 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.368 176.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.628 ' HG2' ' HB ' ' A' ' 13' ' ' THR . 76.3 mm-40 -61.75 -48.84 78.91 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 178.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.49 ' HB1' HD22 ' A' ' 39' ' ' LEU . . . -53.58 -44.12 69.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.943 178.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.42 ' HA ' ' OE1' ' A' ' 18' ' ' GLN . 14.7 mm-40 -58.82 -38.05 77.78 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.778 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.402 ' HA ' HG21 ' A' ' 22' ' ' THR . . . -72.68 -25.28 61.2 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.448 -178.34 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.606 HG22 ' O ' ' A' ' 16' ' ' GLN . 10.6 t -87.18 -30.07 5.75 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.96 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 -173.392 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 23.4 m -79.51 -32.3 42.35 Favored 'General case' 0 N--CA 1.435 -1.217 0 CA-C-N 113.478 -1.692 . . . . 0.0 110.935 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.402 HG21 ' HA ' ' A' ' 19' ' ' ALA . 6.5 t -73.33 -23.31 60.23 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 174.237 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 26.9 m -78.93 -57.23 3.85 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.368 171.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.597 ' O ' HG13 ' A' ' 27' ' ' ILE . 38.5 m-85 -107.9 96.34 6.31 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 178.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 4.6 p -65.4 -5.16 6.83 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.516 -179.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.541 ' OD1' ' HB3' ' A' ' 24' ' ' TYR . 28.2 p-10 -79.02 -16.89 56.24 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 173.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.597 HG13 ' O ' ' A' ' 24' ' ' TYR . 2.6 mt -80.24 150.71 4.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 171.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 6.6 p -143.91 124.71 14.21 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.003 178.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.531 ' HA ' HD23 ' A' ' 39' ' ' LEU . 5.8 tt -81.87 98.43 8.51 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 176.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -119.48 169.37 10.1 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.129 -0.942 . . . . 0.0 109.659 -174.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.0 t70 62.28 26.07 15.6 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.287 0.565 . . . . 0.0 109.982 176.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.531 ' HA ' ' HB3' ' A' ' 37' ' ' PHE . 17.8 t70 -68.28 119.9 13.57 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.152 -173.377 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -146.57 52.6 1.11 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.42 177.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.25 -101.56 2.22 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.462 177.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.9 m -91.43 -3.02 57.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.312 0.577 . . . . 0.0 110.367 178.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 47.8 m80 -115.84 108.09 15.86 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.739 177.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.531 ' HB3' ' HA ' ' A' ' 32' ' ' ASP . 53.5 p90 -160.94 160.81 31.27 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.036 178.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 68.3 mtm180 -134.03 138.01 45.09 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.26 0.552 . . . . 0.0 111.696 -178.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.531 HD23 ' HA ' ' A' ' 29' ' ' LEU . 91.1 mt -92.66 114.27 26.77 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.303 173.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 31.5 t -94.8 111.57 25.77 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.958 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.409 HG13 ' CD1' ' A' ' 66' ' ' TYR . 39.0 t -85.19 117.62 30.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 178.115 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.464 ' O ' ' HB2' ' A' ' 26' ' ' ASN . 63.2 mtp180 -110.35 161.45 15.63 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.258 -177.453 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.476 ' HB3' ' CG ' ' A' ' 47' ' ' ARG . 7.7 t70 -92.56 177.83 6.0 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.572 -177.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.453 ' H ' ' CG ' ' A' ' 43' ' ' ASP . 7.0 p -61.28 -22.36 64.78 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 122.59 0.356 . . . . 0.0 111.862 -177.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -88.84 -9.74 50.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.427 0.632 . . . . 0.0 109.967 178.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 93.79 4.62 63.42 Favored Glycine 0 N--CA 1.451 -0.305 0 CA-C-N 115.767 -0.652 . . . . 0.0 112.994 177.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.476 ' CG ' ' HB3' ' A' ' 43' ' ' ASP . 14.1 ptt180 -73.74 140.75 46.16 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 110.321 -0.252 . . . . 0.0 110.321 177.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 69.1 mtm -71.88 122.16 20.3 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 178.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 20.3 t -107.2 -29.84 2.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.611 -178.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 73.7 t-105 -157.99 151.54 23.57 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.573 -175.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 11.2 ptp180 -152.67 132.87 13.54 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 173.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -134.27 149.71 50.95 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.561 -0.291 . . . . 0.0 111.058 -178.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.848 ' HB2' ' HG3' ' A' ' 56' ' ' GLU . 86.5 m95 -75.74 -170.11 1.23 Allowed 'General case' 0 CA--C 1.514 -0.434 0 CA-C-O 121.905 0.859 . . . . 0.0 111.498 177.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -101.52 -37.76 8.27 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 114.223 -1.353 . . . . 0.0 110.74 178.144 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -88.02 3.69 47.88 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.052 -173.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.848 ' HG3' ' HB2' ' A' ' 53' ' ' TRP . 35.7 mt-10 -74.43 128.91 85.05 Favored Pre-proline 0 N--CA 1.452 -0.372 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.179 178.039 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 56' ' ' GLU . 32.5 Cg_exo -59.25 -14.44 24.34 Favored 'Trans proline' 0 N--CA 1.475 0.414 0 C-N-CA 123.293 2.662 . . . . 0.0 113.668 -175.159 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -133.6 24.95 4.06 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.756 -0.202 . . . . 0.0 111.46 -177.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.535 ' HB1' ' HB2' ' A' ' 56' ' ' GLU . . . -58.66 -48.08 82.28 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.015 0.436 . . . . 0.0 111.209 -174.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -65.14 -28.51 73.63 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.926 -179.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -68.02 -40.79 82.89 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.623 0.249 . . . . 0.0 110.532 -177.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -66.99 -39.77 93.27 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.51 -0.852 . . . . 0.0 111.291 178.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.446 ' O ' HG13 ' A' ' 67' ' ' ILE . 68.9 mt -63.91 -48.85 74.95 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.387 -0.407 . . . . 0.0 110.779 177.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.51 ' O ' ' HG3' ' A' ' 68' ' ' ARG . 96.0 m-20 -61.55 -36.71 81.37 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.748 0.309 . . . . 0.0 110.66 178.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 65' ' ' ARG . 20.4 ttt85 -53.59 -42.2 67.37 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.499 176.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.409 ' CD1' HG13 ' A' ' 41' ' ' VAL . 43.3 t80 -72.57 -50.5 25.1 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.382 175.207 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.446 HG13 ' O ' ' A' ' 63' ' ' LEU . 97.1 mt -48.38 -47.67 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 -176.116 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.51 ' HG3' ' O ' ' A' ' 64' ' ' ASN . 15.5 mtp180 -56.78 -54.08 50.48 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -173.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.6 t -90.96 10.97 24.34 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 120.691 -0.404 . . . . 0.0 111.175 -174.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 17.1 m -120.44 -61.83 1.53 Allowed 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.208 -0.597 . . . . 0.0 111.12 177.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 43.55 74.48 0.2 Allowed Glycine 0 CA--C 1.525 0.701 0 CA-C-N 115.281 -0.872 . . . . 0.0 113.41 -173.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.477 ' O ' HG23 ' A' ' 72' ' ' ILE . 30.2 mm -89.2 6.9 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-O 121.355 0.597 . . . . 0.0 110.973 -174.306 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 35.0 ptt180 . . . . . 0 C--N 1.329 -0.298 0 O-C-N 122.068 -0.395 . . . . 0.0 111.814 -175.433 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.456 ' HA2' ' HA ' ' A' ' 58' ' ' ASP . . . . . . . . 0 CA--C 1.519 0.293 0 CA-C-O 120.132 -0.26 . . . . 0.0 112.979 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.446 ' HD3' ' HA3' ' A' ' 10' ' ' GLY . 6.1 Cg_exo -72.03 162.23 42.44 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.597 2.198 . . . . 0.0 111.2 178.36 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -123.75 151.54 43.13 Favored 'General case' 0 CA--C 1.505 -0.783 0 CA-C-O 121.756 0.789 . . . . 0.0 112.096 -176.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -91.8 165.64 13.16 Favored 'General case' 0 N--CA 1.433 -1.275 0 CA-C-N 113.993 -1.458 . . . . 0.0 109.431 176.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.404 ' O ' ' HG3' ' A' ' 18' ' ' GLN . 47.8 ttt180 -61.97 -51.04 69.68 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 120.737 0.303 . . . . 0.0 110.693 -177.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 37.2 ttp180 -54.4 -40.17 67.98 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.481 177.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.601 ' O ' HG22 ' A' ' 20' ' ' VAL . 85.6 mm-40 -62.97 -47.86 81.36 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.305 177.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.71 -42.88 84.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.301 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.404 ' HG3' ' O ' ' A' ' 14' ' ' ARG . 24.4 mt-30 -61.04 -44.4 97.46 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.856 -178.506 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.1 -37.8 86.48 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.195 0.521 . . . . 0.0 111.202 -179.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.601 HG22 ' O ' ' A' ' 16' ' ' GLN . 10.2 t -77.8 -22.87 13.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.405 -175.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.408 HG21 ' HB ' ' A' ' 27' ' ' ILE . 0.0 OUTLIER -83.35 -33.23 25.89 Favored 'General case' 0 CA--C 1.516 -0.362 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.481 176.168 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.3 p -68.04 -19.68 64.91 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 174.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.3 m -89.74 -53.46 4.5 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.211 171.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.611 ' O ' HG13 ' A' ' 27' ' ' ILE . 47.3 m-85 -113.92 102.26 10.04 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 177.488 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 11.6 p -80.78 5.0 17.16 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.96 0.41 . . . . 0.0 111.469 -178.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.515 ' HB3' HG21 ' A' ' 72' ' ' ILE . 25.7 p-10 -82.34 -21.64 35.9 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 171.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.611 HG13 ' O ' ' A' ' 24' ' ' TYR . 1.0 OUTLIER -74.69 147.46 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 170.991 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.48 ' O ' ' HA ' ' A' ' 39' ' ' LEU . 2.5 p -142.05 134.51 28.06 Favored 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 120.571 -0.452 . . . . 0.0 110.881 -176.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.523 HD23 ' HB3' ' A' ' 32' ' ' ASP . 1.5 tt -90.29 97.17 11.03 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.67 0.747 . . . . 0.0 109.367 -179.087 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.45 ' HB2' ' HG3' ' A' ' 38' ' ' ARG . 14.5 mm-40 -104.05 161.96 13.56 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 114.482 -1.236 . . . . 0.0 109.481 -174.313 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.461 ' HB2' ' HG2' ' A' ' 38' ' ' ARG . 1.0 OUTLIER 56.25 30.72 17.16 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 123.541 0.526 . . . . 0.0 111.692 179.411 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.523 ' HB3' HD23 ' A' ' 29' ' ' LEU . 16.2 p-10 -71.35 90.58 0.95 Allowed 'General case' 0 N--CA 1.446 -0.674 0 CA-C-O 122.045 0.926 . . . . 0.0 111.385 -176.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 14.4 tm0? -111.77 -15.49 13.39 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.649 -1.16 . . . . 0.0 109.442 178.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 113.41 -79.02 0.26 Allowed Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.468 -175.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 11.7 m -63.17 -33.0 74.52 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.442 0.639 . . . . 0.0 109.732 175.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 68.2 m170 -115.61 141.62 47.82 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.929 173.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 55.6 p90 -176.31 145.13 0.58 Allowed 'General case' 0 C--N 1.326 -0.432 0 O-C-N 124.077 0.861 . . . . 0.0 109.318 169.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.461 ' HG2' ' HB2' ' A' ' 31' ' ' ASP . 16.1 ptt180 -132.75 150.2 52.19 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.87 0.367 . . . . 0.0 111.145 -178.244 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.48 ' HA ' ' O ' ' A' ' 28' ' ' THR . 84.0 mt -103.31 115.75 31.15 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 174.123 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.447 HG23 ' HB3' ' A' ' 51' ' ' ARG . 48.6 t -99.33 115.39 39.94 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.836 177.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.467 HG13 ' CD1' ' A' ' 66' ' ' TYR . 50.2 t -82.92 104.64 11.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 175.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.48 ' O ' ' HB2' ' A' ' 26' ' ' ASN . 50.3 mtt180 -102.16 163.74 12.07 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.592 0.711 . . . . 0.0 111.27 -177.38 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.678 ' HB3' ' HB2' ' A' ' 47' ' ' ARG . 4.3 t70 -89.45 176.08 7.05 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 114.514 -1.221 . . . . 0.0 109.444 177.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.437 ' H ' ' CG ' ' A' ' 43' ' ' ASP . 0.3 OUTLIER -67.35 -18.99 65.37 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 120.855 0.36 . . . . 0.0 111.298 -174.741 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -93.37 -0.2 56.65 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 121.46 0.647 . . . . 0.0 110.044 175.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 89.14 8.46 68.76 Favored Glycine 0 N--CA 1.452 -0.275 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.431 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.678 ' HB2' ' HB3' ' A' ' 43' ' ' ASP . 39.4 mtt180 -61.03 132.97 55.53 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 122.278 0.231 . . . . 0.0 110.775 177.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 10.0 mmt -75.65 97.36 3.78 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.2 t -84.45 -38.83 13.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.033 0.444 . . . . 0.0 110.551 -175.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 69.8 t-105 -166.17 153.8 10.16 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.711 -178.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.447 ' HB3' HG23 ' A' ' 40' ' ' VAL . 9.0 ptt180 -152.14 148.02 27.14 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.034 0.445 . . . . 0.0 111.14 177.025 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -148.79 143.09 26.13 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.17 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.439 ' HA ' ' HA ' ' A' ' 38' ' ' ARG . 72.0 m95 -87.98 -171.34 3.36 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 122.208 1.004 . . . . 0.0 111.539 -178.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -82.28 -35.63 27.84 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 113.481 -1.69 . . . . 0.0 109.83 178.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 32.2 p90 -87.98 17.88 4.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.65 -178.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.51 ' HB2' ' HB3' ' A' ' 59' ' ' ALA . 11.8 mm-40 -85.23 116.75 66.83 Favored Pre-proline 0 C--N 1.327 -0.401 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 175.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.423 ' HD2' ' HA ' ' A' ' 56' ' ' GLU . 3.6 Cg_endo -46.34 -39.92 21.95 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 124.269 3.312 . . . . 0.0 114.163 -172.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.456 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . 4.6 t0 -138.1 55.89 1.75 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.088 0.47 . . . . 0.0 110.14 178.324 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.51 ' HB3' ' HB2' ' A' ' 56' ' ' GLU . . . -56.4 -39.89 73.76 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.277 -179.452 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -59.45 -33.0 74.37 Favored Glycine 0 N--CA 1.45 -0.387 0 CA-C-N 115.384 -0.825 . . . . 0.0 114.071 -177.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.449 ' HB2' ' OD1' ' A' ' 58' ' ' ASP . 35.7 tt0 -62.52 -43.07 99.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 117.608 0.704 . . . . 0.0 110.96 -176.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -73.28 -41.2 47.01 Favored Glycine 0 C--O 1.237 0.288 0 C-N-CA 120.539 -0.838 . . . . 0.0 111.557 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 72.6 mt -64.73 -51.97 59.56 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.547 -0.326 . . . . 0.0 110.851 -179.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.448 ' HA ' ' HB ' ' A' ' 67' ' ' ILE . 93.2 m-20 -60.56 -32.64 71.71 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.608 0.242 . . . . 0.0 111.006 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 11.2 tpt180 -55.45 -50.75 69.03 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.262 176.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.467 ' CD1' HG13 ' A' ' 41' ' ' VAL . 38.9 t80 -72.53 -43.27 63.75 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.447 179.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.53 HG21 ' CZ ' ' A' ' 24' ' ' TYR . 59.9 mt -49.61 -44.84 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-N 115.617 -0.72 . . . . 0.0 112.262 -178.507 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 61.9 ttt180 -68.37 -53.77 21.73 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -175.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 8.8 t -76.34 -35.65 58.65 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 112.37 0.508 . . . . 0.0 112.37 -169.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 25.1 m -90.21 -50.84 5.75 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.69 -177.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 48.25 85.14 0.02 OUTLIER Glycine 0 CA--C 1.525 0.667 0 CA-C-N 115.515 -0.766 . . . . 0.0 114.632 179.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.515 HG21 ' HB3' ' A' ' 26' ' ' ASN . 1.8 mp -80.74 5.37 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 CA-C-O 122.369 1.08 . . . . 0.0 109.63 177.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.502 ' HB3' ' CE2' ' A' ' 24' ' ' TYR . 52.3 ptt85 . . . . . 0 N--CA 1.468 0.47 0 CA-C-N 114.833 -1.076 . . . . 0.0 112.036 178.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.509 ' HA3' ' O ' ' A' ' 57' ' ' PRO . . . . . . . . 0 N--CA 1.441 -0.998 0 N-CA-C 110.991 -0.844 . . . . 0.0 110.991 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -75.7 130.39 12.54 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 121.623 1.548 . . . . 0.0 110.958 172.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -102.58 -178.46 3.69 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 121.806 0.812 . . . . 0.0 111.923 -172.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.98 151.49 32.28 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 114.705 -1.134 . . . . 0.0 108.988 176.308 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.54 ' O ' ' HG3' ' A' ' 18' ' ' GLN . 43.7 ttt-85 -59.36 -48.98 79.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.033 0.444 . . . . 0.0 109.944 -178.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 72.5 mtp85 -56.7 -45.69 81.66 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.241 177.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.515 ' O ' HG22 ' A' ' 20' ' ' VAL . 12.4 mm100 -63.31 -39.87 95.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.489 179.255 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.402 ' HB2' HD23 ' A' ' 39' ' ' LEU . . . -62.06 -43.38 98.96 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.685 177.03 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.54 ' HG3' ' O ' ' A' ' 14' ' ' ARG . 28.0 mt-30 -51.71 -44.37 63.16 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.022 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.79 -27.04 68.91 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.107 -179.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.515 HG22 ' O ' ' A' ' 16' ' ' GLN . 14.1 t -92.46 -16.13 7.92 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.752 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 -172.619 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 12.0 m -93.31 -31.42 14.69 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-N 113.972 -1.467 . . . . 0.0 107.588 -176.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 99.0 m -61.65 -38.1 86.46 Favored 'General case' 0 N--CA 1.436 -1.175 0 CA-C-N 113.628 -1.624 . . . . 0.0 109.299 166.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.533 HG21 ' HE ' ' A' ' 73' ' ' ARG . 36.7 m -75.03 -53.86 8.18 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.992 177.139 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.675 ' O ' HG13 ' A' ' 27' ' ' ILE . 89.9 m-85 -117.45 96.88 5.6 Favored 'General case' 0 N--CA 1.44 -0.975 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 178.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 48.3 m -76.12 5.72 6.37 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.865 0.364 . . . . 0.0 111.506 -177.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.546 ' ND2' ' HB3' ' A' ' 24' ' ' TYR . 0.1 OUTLIER -76.84 -16.43 59.42 Favored 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 108.598 -0.889 . . . . 0.0 108.598 167.803 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.675 HG13 ' O ' ' A' ' 24' ' ' TYR . 2.2 mt -84.4 151.45 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 171.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.558 ' OG1' ' HB ' ' A' ' 40' ' ' VAL . 11.1 p -138.14 117.41 12.73 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 119.954 -0.698 . . . . 0.0 111.068 178.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.527 ' HA ' HD21 ' A' ' 39' ' ' LEU . 4.8 tt -83.23 99.03 9.71 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 174.239 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.507 ' HG2' ' HB ' ' A' ' 28' ' ' THR . 74.2 mm-40 -132.9 -173.55 3.22 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.957 -173.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.7 t70 69.53 17.25 8.01 Favored 'General case' 0 CA--C 1.531 0.214 0 O-C-N 124.072 0.857 . . . . 0.0 110.505 177.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -57.59 95.54 0.02 OUTLIER 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.659 178.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -122.79 10.11 9.56 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.206 0.527 . . . . 0.0 110.206 -178.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 119.31 -88.98 0.45 Allowed Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.583 178.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 9.8 t -89.36 -17.04 29.63 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 120.702 0.286 . . . . 0.0 110.569 -176.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 30.1 p80 -124.41 145.79 49.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.153 0.501 . . . . 0.0 111.424 178.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -166.67 167.91 14.87 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.298 -1.319 . . . . 0.0 107.608 174.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.404 ' HB3' ' HA ' ' A' ' 53' ' ' TRP . 30.9 ptt180 -153.0 156.29 38.54 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.115 0.484 . . . . 0.0 112.076 -175.285 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.527 HD21 ' HA ' ' A' ' 29' ' ' LEU . 89.2 mt -102.03 117.95 35.89 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.961 178.22 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.558 ' HB ' ' OG1' ' A' ' 28' ' ' THR . 37.7 t -100.89 113.91 38.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 116.278 -0.419 . . . . 0.0 109.983 178.54 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 46.5 t -90.04 122.4 41.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.022 0.439 . . . . 0.0 110.051 178.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 57.9 mtp180 -105.06 163.88 12.22 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.476 -178.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -88.66 -171.74 3.45 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 177.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.1 p -62.31 -22.26 65.92 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.918 -176.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -91.71 -31.46 15.8 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.891 0.377 . . . . 0.0 110.54 179.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 119.6 10.0 8.08 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.418 -0.896 . . . . 0.0 112.541 -177.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 92.4 mtt180 -82.57 127.56 33.47 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 177.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.13 118.62 10.13 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.264 0.554 . . . . 0.0 110.785 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 41.9 t -97.23 -35.78 5.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.07 -179.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 68.8 t-105 -158.14 119.32 3.49 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.177 -178.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.459 ' HB3' HG13 ' A' ' 40' ' ' VAL . 36.4 ptt180 -112.68 129.02 56.54 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.817 174.089 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -122.76 142.09 51.1 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.555 -177.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.513 ' HB2' ' HG3' ' A' ' 56' ' ' GLU . 95.0 m95 -79.36 -169.13 1.76 Allowed 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 121.709 0.766 . . . . 0.0 110.923 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -101.32 -30.41 11.5 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 114.701 -1.136 . . . . 0.0 110.932 -176.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 40.6 p90 -90.29 3.69 52.89 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.557 -174.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.513 ' HG3' ' HB2' ' A' ' 53' ' ' TRP . 40.0 mt-10 -75.42 132.51 75.72 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 120.752 0.31 . . . . 0.0 110.275 179.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.509 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 39.8 Cg_endo -66.5 -11.65 32.54 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 123.225 2.617 . . . . 0.0 113.394 -173.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -137.57 28.39 2.72 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.648 -0.251 . . . . 0.0 110.561 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.554 ' O ' ' HG ' ' A' ' 63' ' ' LEU . . . -53.03 -49.61 65.93 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.847 -176.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -69.82 -30.45 70.39 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.653 -178.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -70.53 -34.06 71.85 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.841 0.321 . . . . 0.0 110.279 -175.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.472 ' O ' ' HB3' ' A' ' 65' ' ' ARG . . . -74.24 -39.22 44.67 Favored Glycine 0 C--O 1.238 0.354 0 C-N-CA 120.382 -0.913 . . . . 0.0 111.583 177.158 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.554 ' HG ' ' O ' ' A' ' 59' ' ' ALA . 70.2 mt -67.51 -45.31 76.15 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.539 -0.33 . . . . 0.0 110.513 178.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -61.25 -32.34 72.14 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.557 176.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.472 ' HB3' ' O ' ' A' ' 62' ' ' GLY . 0.4 OUTLIER -57.32 -44.83 84.53 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.301 -0.409 . . . . 0.0 109.922 175.473 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 14.1 t80 -67.11 -53.19 33.16 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.079 176.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 97.3 mt -50.92 -51.37 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.847 -178.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 45.9 ttm105 -55.99 -32.41 63.92 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.274 -173.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 5.1 t -111.38 15.01 21.53 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.449 -0.501 . . . . 0.0 111.705 -174.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 16.2 m -134.66 -54.98 0.83 Allowed 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.849 -0.341 . . . . 0.0 111.15 -179.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.515 ' HA2' ' CE1' ' A' ' 24' ' ' TYR . . . 47.15 75.82 0.17 Allowed Glycine 0 CA--C 1.527 0.812 0 CA-C-N 115.552 -0.749 . . . . 0.0 114.114 -177.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.46 HG23 ' HB3' ' A' ' 26' ' ' ASN . 1.8 mp -72.94 -20.65 19.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-N 117.132 0.466 . . . . 0.0 111.912 -174.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.533 ' HE ' HG21 ' A' ' 23' ' ' THR . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.261 0 CA-C-O 121.237 0.541 . . . . 0.0 111.525 -178.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.54 ' HA2' ' HA ' ' A' ' 58' ' ' ASP . . . . . . . . 0 CA--C 1.52 0.358 0 N-CA-C 114.584 0.594 . . . . 0.0 114.584 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.441 ' HD3' ' HA3' ' A' ' 10' ' ' GLY . 6.6 Cg_exo -72.16 144.2 41.53 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 123.159 2.573 . . . . 0.0 112.515 -177.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -112.12 -173.3 2.22 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.143 -178.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.435 ' OG1' ' HG2' ' A' ' 16' ' ' GLN . 28.8 p -125.07 176.31 6.77 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 175.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 22.8 ttt180 -61.67 -46.7 88.6 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.488 0.661 . . . . 0.0 109.489 175.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 36.1 mmt180 -55.02 -48.79 72.91 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.558 -1.201 . . . . 0.0 110.675 178.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.6 ' O ' HG23 ' A' ' 20' ' ' VAL . 15.7 mm100 -62.7 -49.15 76.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.211 178.193 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -52.76 -49.26 65.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.684 179.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -55.65 -41.82 74.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.312 -179.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.44 -29.11 70.45 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.982 -179.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.6 HG23 ' O ' ' A' ' 16' ' ' GLN . 3.3 t -91.33 -26.05 5.17 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.958 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 -171.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 16.2 m -79.55 -32.97 42.2 Favored 'General case' 0 N--CA 1.437 -1.117 0 CA-C-N 113.95 -1.477 . . . . 0.0 110.655 179.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.8 p -73.54 -26.08 60.69 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 121.082 0.467 . . . . 0.0 109.742 172.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.445 HG21 ' HD2' ' A' ' 73' ' ' ARG . 89.8 m -76.2 -55.09 5.9 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.783 172.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.599 ' O ' HG13 ' A' ' 27' ' ' ILE . 70.1 m-85 -116.63 101.53 8.68 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 175.61 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 45.0 m -82.16 17.39 1.65 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.207 0.527 . . . . 0.0 111.747 -176.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.529 ' OD1' ' HB3' ' A' ' 24' ' ' TYR . 25.1 p-10 -87.91 -20.37 26.04 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 167.238 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.599 HG13 ' O ' ' A' ' 24' ' ' TYR . 2.4 mt -73.57 146.92 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 171.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -149.46 130.3 14.23 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 120.225 -0.59 . . . . 0.0 111.566 -179.094 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.519 ' HA ' HD22 ' A' ' 39' ' ' LEU . 5.9 tt -79.3 103.12 9.01 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.229 178.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -112.76 166.41 11.39 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.497 -176.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.6 t70 66.39 46.37 1.96 Allowed 'General case' 0 N--CA 1.465 0.304 0 O-C-N 123.65 0.594 . . . . 0.0 110.542 176.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -64.95 99.93 0.38 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.454 -179.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 21.8 tt0 -129.63 57.56 1.67 Allowed 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.494 0.664 . . . . 0.0 109.422 175.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 74.52 -112.81 3.85 Favored Glycine 0 N--CA 1.45 -0.372 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.741 -178.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 30.2 t -87.67 -1.5 57.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.092 0.472 . . . . 0.0 110.119 177.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -101.44 124.85 47.77 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 176.164 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -173.8 170.49 3.94 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 178.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 30.1 ptt-85 -145.18 145.39 31.33 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.217 0.532 . . . . 0.0 111.433 178.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.519 HD22 ' HA ' ' A' ' 29' ' ' LEU . 93.9 mt -90.67 110.75 21.91 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.284 177.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 84.2 t -89.93 115.05 28.72 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.049 173.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.5 t -91.82 108.73 20.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.455 ' O ' ' HB2' ' A' ' 26' ' ' ASN . 60.3 mtt85 -95.93 170.21 9.45 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.868 -178.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -96.65 -171.19 2.21 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.974 0.416 . . . . 0.0 110.002 179.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.46 -19.99 66.17 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.687 -176.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -91.08 -28.67 17.78 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.24 0.543 . . . . 0.0 109.944 177.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 114.18 12.19 11.28 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.798 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.418 ' O ' ' HA ' ' A' ' 42' ' ' ARG . 40.5 mtt-85 -80.33 137.67 36.61 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.081 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -76.72 96.87 4.32 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.42 0.629 . . . . 0.0 110.599 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 15.8 t -83.54 -31.27 8.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.523 -177.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.433 ' CD1' HD22 ' A' ' 63' ' ' LEU . 75.4 t-105 -150.38 159.15 44.67 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.261 -177.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 27.5 ptt-85 -158.4 131.4 7.3 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 178.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -140.94 140.75 34.49 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 110.463 -0.199 . . . . 0.0 110.463 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.619 ' HB2' ' HG3' ' A' ' 56' ' ' GLU . 72.4 m95 -77.27 -173.89 3.02 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-O 121.764 0.793 . . . . 0.0 110.752 -179.177 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -94.18 -26.37 16.71 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 114.254 -1.339 . . . . 0.0 109.837 -178.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -98.33 6.16 47.58 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.802 -174.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.619 ' HG3' ' HB2' ' A' ' 53' ' ' TRP . 38.2 mt-10 -76.45 129.97 78.37 Favored Pre-proline 0 C--N 1.326 -0.43 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.195 178.618 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 56' ' ' GLU . 31.7 Cg_exo -59.2 -20.07 52.99 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 123.431 2.754 . . . . 0.0 113.136 -175.155 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.54 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . 13.2 m-20 -133.6 37.92 3.28 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.541 179.599 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -54.95 -50.18 69.54 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 120.925 0.393 . . . . 0.0 111.141 -178.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -63.33 -30.28 77.07 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.789 179.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.4 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 23.5 tp10 -60.79 -42.18 97.07 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.784 0.325 . . . . 0.0 110.367 -178.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.465 ' O ' ' HB3' ' A' ' 65' ' ' ARG . . . -77.05 -38.64 29.62 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.093 179.354 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.519 ' O ' HG13 ' A' ' 67' ' ' ILE . 85.5 mt -63.17 -52.76 61.08 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.723 0.297 . . . . 0.0 110.357 179.492 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -61.99 -32.13 72.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.632 178.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.465 ' HB3' ' O ' ' A' ' 62' ' ' GLY . 7.0 tpt85 -54.29 -46.74 72.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.669 177.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -74.86 -44.14 50.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.985 178.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.519 HG13 ' O ' ' A' ' 63' ' ' LEU . 89.5 mt -52.65 -44.57 46.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-O 120.897 0.379 . . . . 0.0 111.083 -179.119 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 23.6 ttt180 -58.83 -24.24 61.73 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.432 -0.803 . . . . 0.0 112.425 -176.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 11.3 t -118.1 22.21 12.33 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.402 0.62 . . . . 0.0 111.601 -175.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 29.2 p -144.91 -55.44 0.32 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.349 178.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 44.98 78.13 0.08 OUTLIER Glycine 0 CA--C 1.52 0.353 0 CA-C-N 115.325 -0.852 . . . . 0.0 113.333 -177.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.7 mp -72.46 -19.93 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-N 117.196 0.498 . . . . 0.0 111.642 -174.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.445 ' HD2' HG21 ' A' ' 23' ' ' THR . 72.2 ttt180 . . . . . 0 CA--C 1.515 -0.398 0 CA-C-O 121.259 0.552 . . . . 0.0 111.273 -175.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.506 ' HA2' ' HA ' ' A' ' 58' ' ' ASP . . . . . . . . 0 CA--C 1.519 0.301 0 CA-C-O 120.086 -0.286 . . . . 0.0 113.689 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -72.49 165.2 33.39 Favored 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 122.873 2.382 . . . . 0.0 111.82 179.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -132.74 169.58 16.49 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.741 0.781 . . . . 0.0 111.997 -176.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.5 m -112.85 166.86 10.99 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 114.441 -1.254 . . . . 0.0 110.048 -176.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 45.5 ttt-85 -62.36 -47.56 83.67 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.683 0.277 . . . . 0.0 110.877 -175.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.418 HH11 ' HD3' ' A' ' 15' ' ' ARG . 27.0 ttm-85 -53.08 -47.13 68.77 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.612 174.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.593 ' O ' HG22 ' A' ' 20' ' ' VAL . 77.6 mt-30 -59.98 -47.83 84.22 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.657 178.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -55.28 -47.98 74.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.165 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 56.9 mm-40 -59.25 -36.16 74.97 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.934 -179.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.1 -29.32 68.23 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.036 0.446 . . . . 0.0 111.415 -178.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.593 HG22 ' O ' ' A' ' 16' ' ' GLN . 11.1 t -89.83 -27.42 5.18 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.826 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 -172.068 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.475 HG22 ' HB ' ' A' ' 27' ' ' ILE . 15.6 m -83.64 -27.47 29.09 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-N 113.795 -1.548 . . . . 0.0 111.119 -179.273 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.2 p -73.4 -30.68 63.42 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 171.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 34.7 m -77.09 -47.03 21.59 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.275 173.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.622 ' O ' HG13 ' A' ' 27' ' ' ILE . 40.0 m-85 -114.54 96.35 5.71 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 177.656 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 37.8 p -64.9 -7.61 12.09 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 111.906 0.335 . . . . 0.0 111.906 -179.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.57 ' OD1' ' HB3' ' A' ' 24' ' ' TYR . 5.4 p-10 -78.81 -11.49 59.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.999 0.428 . . . . 0.0 110.192 177.137 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.622 HG13 ' O ' ' A' ' 24' ' ' TYR . 2.5 mt -83.08 146.59 6.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 174.21 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.514 ' OG1' ' HB ' ' A' ' 40' ' ' VAL . 10.3 p -133.12 120.23 20.98 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.398 -0.521 . . . . 0.0 110.786 -177.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.534 HD21 ' HB2' ' A' ' 32' ' ' ASP . 2.8 tt -88.36 105.15 17.39 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 -179.171 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.22 161.85 18.35 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.71 -176.242 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 61.26 30.56 19.24 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.032 -177.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.534 ' HB2' HD21 ' A' ' 29' ' ' LEU . 32.7 t0 -73.98 95.97 2.58 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.004 -178.194 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -115.29 1.96 13.9 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.564 178.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 119.88 -85.22 0.38 Allowed Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.463 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.1 t -89.32 -1.14 57.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.997 0.427 . . . . 0.0 110.496 -178.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 12.3 m170 -132.66 135.72 46.02 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 173.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.457 ' HB2' HD22 ' A' ' 29' ' ' LEU . 43.2 p90 -174.66 156.83 2.43 Favored 'General case' 0 C--O 1.234 0.285 0 O-C-N 123.858 0.724 . . . . 0.0 109.558 178.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 15.1 ptt180 -136.08 153.03 51.44 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.937 0.399 . . . . 0.0 111.513 176.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.506 HD22 ' HA ' ' A' ' 29' ' ' LEU . 71.5 mt -108.66 125.76 52.23 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.171 0.51 . . . . 0.0 110.558 177.049 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.514 ' HB ' ' OG1' ' A' ' 28' ' ' THR . 45.1 t -100.13 114.83 39.87 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.351 171.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 16.9 t -87.6 114.99 27.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.412 ' HA ' ' O ' ' A' ' 47' ' ' ARG . 3.8 mtt85 -101.24 160.87 14.04 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.398 0.618 . . . . 0.0 111.402 -176.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.421 ' CG ' ' N ' ' A' ' 44' ' ' THR . 4.1 t70 -91.57 178.23 5.99 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.487 -1.233 . . . . 0.0 109.979 -178.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.421 ' N ' ' CG ' ' A' ' 43' ' ' ASP . 19.1 p -59.01 -22.39 60.59 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 123.201 0.6 . . . . 0.0 111.718 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -92.63 -5.07 52.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.138 0.494 . . . . 0.0 110.536 178.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 89.29 9.49 67.11 Favored Glycine 0 N--CA 1.453 -0.173 0 C-N-CA 120.807 -0.711 . . . . 0.0 111.946 -177.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.412 ' O ' ' HA ' ' A' ' 42' ' ' ARG . 38.0 mtp180 -70.96 130.66 42.17 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 122.533 0.333 . . . . 0.0 110.364 179.359 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.15 90.52 2.54 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.599 0.714 . . . . 0.0 110.283 176.037 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 24.7 t -75.16 -38.45 41.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.621 -176.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 75.5 t-105 -150.14 152.61 34.98 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.248 -175.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.428 HH11 ' HD3' ' A' ' 51' ' ' ARG . 13.7 ptt-85 -150.14 137.19 19.46 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 177.145 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -145.97 146.54 31.06 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.407 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.437 ' HB2' ' HG3' ' A' ' 56' ' ' GLU . 96.5 m95 -80.44 -171.23 2.94 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-O 121.387 0.613 . . . . 0.0 109.587 175.199 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -99.81 -21.34 15.79 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.551 -176.226 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -100.46 11.73 38.81 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.58 -174.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.437 ' HG3' ' HB2' ' A' ' 53' ' ' TRP . 42.7 mt-10 -80.88 135.8 51.57 Favored Pre-proline 0 C--N 1.329 -0.308 0 C-N-CA 121.025 -0.27 . . . . 0.0 110.432 179.419 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -36.78 -47.23 1.39 Allowed 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 125.071 3.847 . . . . 0.0 114.31 -172.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.506 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . 4.2 t70 -144.58 63.35 1.31 Allowed 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 176.424 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.405 ' HB2' ' HB2' ' A' ' 56' ' ' GLU . . . -58.69 -31.55 68.33 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.041 179.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -61.7 -34.07 87.33 Favored Glycine 0 N--CA 1.447 -0.604 0 CA-C-N 115.582 -0.735 . . . . 0.0 113.56 -178.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.509 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 2.1 tm-20 -57.34 -50.47 72.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 117.074 0.437 . . . . 0.0 110.351 -177.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -67.56 -43.25 86.69 Favored Glycine 0 C--O 1.237 0.334 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.287 -177.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.465 ' O ' HG13 ' A' ' 67' ' ' ILE . 53.2 mt -60.34 -55.61 31.58 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 110.331 -0.248 . . . . 0.0 110.331 178.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.544 ' HA ' ' HB ' ' A' ' 67' ' ' ILE . 94.4 m-20 -62.69 -31.46 72.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.933 -179.02 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.509 ' HB2' ' O ' ' A' ' 61' ' ' GLU . 7.1 tpt180 -52.86 -46.06 67.68 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.362 0.601 . . . . 0.0 109.66 177.315 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 75.8 t80 -81.35 -41.82 21.44 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.986 178.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.544 ' HB ' ' HA ' ' A' ' 64' ' ' ASN . 95.2 mt -55.37 -48.88 76.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -178.415 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 59.9 ttt-85 -63.42 -48.98 75.56 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.376 -176.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 38.7 p -79.4 -41.12 28.44 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.035 -0.53 . . . . 0.0 112.179 -172.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.433 ' O ' HD13 ' A' ' 72' ' ' ILE . 3.3 m -127.85 20.19 6.53 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 112.681 0.622 . . . . 0.0 112.681 -166.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -48.33 134.24 19.15 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 121.346 -0.454 . . . . 0.0 113.927 178.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.478 ' HB ' ' OD1' ' A' ' 26' ' ' ASN . 2.5 mp -89.2 7.68 3.44 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 C-N-CA 123.258 0.623 . . . . 0.0 109.935 -176.722 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.615 ' HB3' ' CE1' ' A' ' 24' ' ' TYR . 30.7 ptt180 . . . . . 0 N--CA 1.484 1.265 0 N-CA-C 115.135 1.531 . . . . 0.0 115.135 -173.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.437 ' HA2' ' HA ' ' A' ' 58' ' ' ASP . . . . . . . . 0 CA--C 1.518 0.251 0 CA-C-O 120.04 -0.311 . . . . 0.0 113.157 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.498 ' HD3' ' O ' ' A' ' 57' ' ' PRO . 19.4 Cg_exo -66.69 169.22 14.89 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.716 2.277 . . . . 0.0 111.856 176.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.481 ' CD2' ' HB1' ' A' ' 17' ' ' ALA . 41.2 p90 -140.33 165.27 27.86 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.189 -179.053 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.8 p -103.72 178.17 4.63 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.27 -178.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.559 ' HA ' ' CZ ' ' A' ' 37' ' ' PHE . 47.2 ttt180 -60.8 -54.85 40.19 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.212 178.22 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 57.9 mtt-85 -62.84 -37.31 86.3 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.683 -178.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.571 ' O ' HG21 ' A' ' 20' ' ' VAL . 77.5 mm-40 -62.97 -53.07 59.76 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.222 177.495 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.481 ' HB1' ' CD2' ' A' ' 12' ' ' PHE . . . -52.85 -44.27 66.66 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.492 178.156 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -58.8 -39.2 80.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.767 -178.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.02 -27.29 65.55 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-O 121.392 0.615 . . . . 0.0 110.945 179.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.571 HG21 ' O ' ' A' ' 16' ' ' GLN . 3.6 t -76.71 -25.71 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 -179.169 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.476 HG21 ' HB ' ' A' ' 27' ' ' ILE . 0.0 OUTLIER -80.61 -28.01 37.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.841 175.542 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.9 p -75.99 -14.52 60.23 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.434 0.635 . . . . 0.0 109.552 173.17 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 18.9 m -92.4 -50.18 5.77 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.753 170.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.585 ' O ' HG13 ' A' ' 27' ' ' ILE . 48.3 m-85 -118.85 105.31 11.38 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 177.273 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 17.7 p -76.94 -1.76 30.23 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.079 0.466 . . . . 0.0 111.093 -179.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.572 ' OD1' ' HB3' ' A' ' 24' ' ' TYR . 6.1 p-10 -81.6 -9.84 59.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.649 175.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.585 HG13 ' O ' ' A' ' 24' ' ' TYR . 1.8 mt -86.03 155.62 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 174.235 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.508 ' OG1' ' HB ' ' A' ' 40' ' ' VAL . 1.2 p -142.35 123.27 14.42 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.888 0.375 . . . . 0.0 111.251 -179.529 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.428 ' HA ' HD22 ' A' ' 39' ' ' LEU . 6.1 tt -88.44 105.78 17.83 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 178.697 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -126.79 169.09 13.56 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.524 179.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.542 ' HB2' ' HG2' ' A' ' 38' ' ' ARG . 1.1 m-20 66.06 37.67 5.14 Favored 'General case' 0 C--N 1.329 -0.309 0 O-C-N 123.528 0.517 . . . . 0.0 110.761 179.572 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.473 ' HA ' ' HB3' ' A' ' 37' ' ' PHE . 11.3 p-10 -67.6 102.56 1.19 Allowed 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 121.878 0.847 . . . . 0.0 110.334 179.216 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -116.93 30.31 7.41 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.435 -177.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 96.44 -106.41 3.36 Favored Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.807 -179.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.6 m -81.94 -1.87 49.47 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.911 0.386 . . . . 0.0 110.784 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.41 ' HA ' ' OD1' ' A' ' 54' ' ' ASN . 20.7 m-70 -129.37 143.42 50.83 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.652 179.504 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.559 ' CZ ' ' HA ' ' A' ' 14' ' ' ARG . 36.8 p90 -173.95 170.96 3.76 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 -178.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.542 ' HG2' ' HB2' ' A' ' 31' ' ' ASP . 16.5 ptt180 -127.33 152.61 47.24 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.133 0.492 . . . . 0.0 111.004 179.03 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.458 HD11 ' HB2' ' A' ' 17' ' ' ALA . 96.3 mt -111.56 115.78 29.75 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.713 173.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.528 HG13 ' HB3' ' A' ' 51' ' ' ARG . 3.1 t -92.2 113.79 28.07 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.152 178.253 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.8 t -87.12 111.51 21.85 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.7 mtp180 -100.42 164.02 12.11 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.23 -178.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.541 ' HB2' ' CG2' ' A' ' 49' ' ' VAL . 10.1 t70 -97.38 -169.2 1.81 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.605 -175.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.456 ' H ' ' CG ' ' A' ' 43' ' ' ASP . 40.3 p -67.91 -21.81 65.11 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.064 0.459 . . . . 0.0 110.727 -178.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -84.74 -10.58 57.12 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.665 0.745 . . . . 0.0 109.224 178.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 86.36 3.04 84.85 Favored Glycine 0 N--CA 1.444 -0.797 0 CA-C-N 115.289 -0.869 . . . . 0.0 112.75 -179.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 8.9 ptp180 -82.72 147.91 28.19 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 117.103 0.451 . . . . 0.0 110.212 177.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 21.2 ptt? -75.06 123.23 24.81 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.321 0.582 . . . . 0.0 110.749 -179.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.541 ' CG2' ' HB2' ' A' ' 43' ' ' ASP . 6.5 t -103.31 -33.93 3.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.085 -177.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 75.0 t-105 -152.23 152.0 31.66 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.494 -178.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.528 ' HB3' HG13 ' A' ' 40' ' ' VAL . 1.9 ppt_? -150.97 139.88 20.92 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 178.392 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -150.59 157.76 43.36 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.054 179.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.504 ' HA ' ' HA ' ' A' ' 38' ' ' ARG . 69.1 m95 -88.31 -164.67 1.15 Allowed 'General case' 0 N--CA 1.444 -0.764 0 CA-C-O 121.081 0.467 . . . . 0.0 110.229 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.41 ' OD1' ' HA ' ' A' ' 36' ' ' HIS . 0.4 OUTLIER -104.18 -21.93 13.47 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.301 -175.012 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -95.28 0.93 54.3 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -171.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.508 ' HB2' ' HB1' ' A' ' 59' ' ' ALA . 48.4 mt-10 -74.14 141.57 77.91 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 116.808 -0.178 . . . . 0.0 110.526 -179.147 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.498 ' O ' ' HD3' ' A' ' 11' ' ' PRO . 80.4 Cg_exo -45.95 -38.78 18.94 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 123.956 3.104 . . . . 0.0 114.163 -172.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.437 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . 9.1 m-20 -136.21 48.44 2.16 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 177.606 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.512 ' O ' ' HG ' ' A' ' 63' ' ' LEU . . . -56.77 -48.43 77.89 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.723 -0.672 . . . . 0.0 111.292 -175.311 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.4 ' HA2' HD12 ' A' ' 63' ' ' LEU . . . -70.77 -25.65 75.38 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.45 -178.416 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.59 -33.25 66.6 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 -177.082 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.539 ' O ' ' HB2' ' A' ' 65' ' ' ARG . . . -71.81 -41.02 56.99 Favored Glycine 0 C--O 1.239 0.459 0 C-N-CA 120.684 -0.77 . . . . 0.0 111.273 176.223 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.512 ' HG ' ' O ' ' A' ' 59' ' ' ALA . 55.1 mt -58.24 -44.48 88.3 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.112 0.482 . . . . 0.0 109.711 175.461 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.543 ' HA ' ' HB ' ' A' ' 67' ' ' ILE . 33.2 m-80 -73.32 -18.42 61.19 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.756 -0.657 . . . . 0.0 111.636 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.539 ' HB2' ' O ' ' A' ' 62' ' ' GLY . 9.7 mmt180 -60.76 -47.88 84.3 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 172.041 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 83.8 t80 -67.99 -47.27 68.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.434 176.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.543 ' HB ' ' HA ' ' A' ' 64' ' ' ASN . 97.0 mt -59.16 -39.87 79.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -177.301 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 47.1 ttt180 -54.54 -43.2 71.75 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.633 0.254 . . . . 0.0 111.253 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.3 t -98.7 -9.99 23.82 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.746 0.308 . . . . 0.0 111.484 -177.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 33.1 t -159.09 66.72 0.41 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.331 0.586 . . . . 0.0 111.328 -177.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -89.29 127.61 8.77 Favored Glycine 0 N--CA 1.447 -0.619 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 171.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.516 ' HB ' ' OD1' ' A' ' 26' ' ' ASN . 2.0 mp -83.82 -0.85 5.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 CA-C-O 121.433 0.635 . . . . 0.0 110.714 -172.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.526 ' HB3' ' CE1' ' A' ' 24' ' ' TYR . 4.7 ptm180 . . . . . 0 N--CA 1.47 0.571 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -176.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.405 ' HA3' ' HD3' ' A' ' 11' ' ' PRO . . . . . . . . 0 N--CA 1.453 -0.215 0 CA-C-O 119.957 -0.357 . . . . 0.0 112.506 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.405 ' HD3' ' HA3' ' A' ' 10' ' ' GLY . 2.8 Cg_exo -74.96 175.1 11.67 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 122.696 2.264 . . . . 0.0 111.872 178.475 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.452 ' HE1' ' HE2' ' A' ' 37' ' ' PHE . 51.3 p90 -128.19 161.5 29.15 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.386 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 43.0 p -102.08 170.31 8.2 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.677 178.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 32.6 ttt85 -59.22 -44.0 92.31 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.09 0.472 . . . . 0.0 109.814 176.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.42 HH11 ' HD2' ' A' ' 15' ' ' ARG . 4.8 tpp180 -65.5 -45.07 85.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.1 179.505 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.659 ' O ' HG22 ' A' ' 20' ' ' VAL . 2.1 mp0 -62.36 -48.13 81.14 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.911 178.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -51.76 -53.48 39.17 Favored 'General case' 0 C--N 1.328 -0.359 0 O-C-N 123.339 0.399 . . . . 0.0 111.56 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.852 ' HA ' HE21 ' A' ' 18' ' ' GLN . 0.0 OUTLIER -56.59 -42.57 78.9 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.826 -177.121 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.96 -28.41 70.06 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.491 -179.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.659 HG22 ' O ' ' A' ' 16' ' ' GLN . 15.4 t -90.77 -15.14 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -172.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.37 -29.04 37.87 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.26 174.066 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -80.24 -15.75 56.29 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-O 121.132 0.492 . . . . 0.0 109.758 172.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 7.0 m -85.78 -55.12 4.12 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.759 171.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.549 ' O ' HG13 ' A' ' 27' ' ' ILE . 34.3 m-85 -117.67 105.95 12.56 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 174.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -76.7 -2.2 31.68 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 120.962 -0.295 . . . . 0.0 111.309 -176.03 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.53 ' OD1' ' HB3' ' A' ' 24' ' ' TYR . 24.7 p-10 -75.87 -17.4 59.82 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 174.582 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.549 HG13 ' O ' ' A' ' 24' ' ' TYR . 4.2 mt -76.04 148.12 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 174.277 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 6.7 p -144.1 132.33 21.87 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 117.842 0.292 . . . . 0.0 111.05 -179.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.509 ' HA ' HD22 ' A' ' 39' ' ' LEU . 3.8 tt -86.53 105.65 16.97 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 176.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -118.93 163.74 16.47 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.329 -178.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 63.8 30.64 14.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.034 175.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.471 ' HA ' ' HB3' ' A' ' 37' ' ' PHE . 17.8 t0 -65.56 107.87 1.85 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.487 -178.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -129.09 34.57 4.41 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.264 -0.88 . . . . 0.0 108.662 179.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 85.24 -95.48 1.98 Allowed Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.638 -178.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 17.4 p -80.39 -30.09 37.78 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.332 0.587 . . . . 0.0 110.453 178.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 9.0 m-70 -92.87 121.57 34.37 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.769 177.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.471 ' HB3' ' HA ' ' A' ' 32' ' ' ASP . 38.2 p90 -170.33 157.05 5.95 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 176.155 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.428 ' NH1' ' HD3' ' A' ' 51' ' ' ARG . 38.3 ptt180 -139.72 150.09 44.42 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.216 0.531 . . . . 0.0 111.709 179.176 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.509 HD22 ' HA ' ' A' ' 29' ' ' LEU . 94.4 mt -98.27 124.09 42.69 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.941 177.085 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 46.7 t -101.8 121.24 52.51 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-N 115.329 -0.851 . . . . 0.0 109.716 177.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 15.4 t -99.03 115.01 38.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-O 121.04 0.448 . . . . 0.0 110.02 -179.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.513 ' HD2' ' O ' ' A' ' 46' ' ' GLY . 56.0 mtm180 -100.31 167.12 10.62 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.259 179.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -88.84 -169.49 2.55 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.781 0.324 . . . . 0.0 110.47 -178.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.474 HG21 HD12 ' A' ' 72' ' ' ILE . 0.5 OUTLIER -61.53 -26.75 68.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.827 -178.528 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 18.5 tp10 -86.41 -31.47 21.42 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 120.95 0.405 . . . . 0.0 110.247 179.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.513 ' O ' ' HD2' ' A' ' 42' ' ' ARG . . . 112.7 20.99 6.23 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.394 -176.108 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 89.0 mtm180 -87.81 129.32 35.23 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 176.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 12.5 ptt? -62.79 112.54 2.58 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.125 0.488 . . . . 0.0 110.909 176.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.405 HG11 ' CE1' ' A' ' 66' ' ' TYR . 40.1 t -99.84 -36.65 5.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.498 179.462 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.526 ' CD1' HD22 ' A' ' 63' ' ' LEU . 58.2 t-105 -157.27 156.68 32.87 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.851 -174.404 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.428 ' HD3' ' NH1' ' A' ' 38' ' ' ARG . 7.6 ptp85 -155.79 143.32 19.47 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.139 -178.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -146.93 143.46 28.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.632 -0.258 . . . . 0.0 110.413 179.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 70.2 m95 -82.75 -168.03 1.87 Allowed 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 121.808 0.813 . . . . 0.0 111.439 -177.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -93.54 -35.24 13.02 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.152 -1.386 . . . . 0.0 110.622 -179.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 26.6 p90 -83.67 12.01 6.46 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.481 -178.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.511 ' HB2' ' HB3' ' A' ' 59' ' ' ALA . 10.2 mm-40 -82.1 124.07 79.09 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.37 177.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -45.73 -50.95 8.85 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 124.303 3.335 . . . . 0.0 113.193 -175.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -126.96 57.65 1.45 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.082 0.468 . . . . 0.0 109.887 176.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.511 ' HB3' ' HB2' ' A' ' 56' ' ' GLU . . . -54.48 -45.46 73.2 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.428 -178.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -63.2 -32.36 83.89 Favored Glycine 0 N--CA 1.441 -1.026 0 CA-C-N 115.135 -0.939 . . . . 0.0 112.779 -177.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.414 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 18.0 tp10 -59.66 -41.94 91.71 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.969 0.384 . . . . 0.0 110.623 -176.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -73.62 -43.19 37.3 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.456 -0.878 . . . . 0.0 112.007 179.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.526 HD22 ' CD1' ' A' ' 50' ' ' TRP . 65.7 mt -66.27 -46.98 75.2 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.681 0.277 . . . . 0.0 110.43 -179.308 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.432 ' HA ' HD13 ' A' ' 67' ' ' ILE . 87.2 m-20 -65.75 -25.51 67.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.477 178.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.414 ' HB2' ' O ' ' A' ' 61' ' ' GLU . 42.4 ttp180 -63.84 -45.25 90.38 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 178.152 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.405 ' CE1' HG11 ' A' ' 49' ' ' VAL . 85.3 t80 -69.47 -42.63 74.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.953 0.406 . . . . 0.0 110.219 175.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.432 HD13 ' HA ' ' A' ' 64' ' ' ASN . 97.0 mt -55.09 -37.57 43.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.476 177.15 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 47.1 ttt180 -60.27 -46.75 88.73 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.84 -178.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 16.9 p -87.57 -17.68 31.45 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -172.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 24.7 m -108.46 -50.17 3.07 Favored 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.447 -176.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 47.7 81.92 0.04 OUTLIER Glycine 0 CA--C 1.522 0.519 0 CA-C-N 115.868 -0.605 . . . . 0.0 112.948 -174.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.474 HD12 HG21 ' A' ' 44' ' ' THR . 35.2 mm -90.88 6.58 4.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-O 121.697 0.76 . . . . 0.0 110.304 -173.515 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.458 ' HB3' ' CE2' ' A' ' 24' ' ' TYR . 15.0 ptt180 . . . . . 0 N--CA 1.471 0.577 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.767 179.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.449 ' HA3' ' HD3' ' A' ' 11' ' ' PRO . . . . . . . . 0 CA--C 1.522 0.49 0 CA-C-O 120.14 -0.255 . . . . 0.0 113.626 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.449 ' HD3' ' HA3' ' A' ' 10' ' ' GLY . 14.4 Cg_exo -67.86 142.49 57.53 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.778 2.319 . . . . 0.0 111.841 176.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.524 ' CD2' ' HB2' ' A' ' 17' ' ' ALA . 12.9 p90 -108.79 -171.8 1.92 Allowed 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.804 -175.474 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.445 ' OG1' ' HG2' ' A' ' 16' ' ' GLN . 21.5 p -125.49 175.71 7.33 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 172.807 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.487 ' O ' ' HG3' ' A' ' 18' ' ' GLN . 67.9 mtm180 -65.4 -43.94 89.05 Favored 'General case' 0 C--O 1.22 -0.462 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.128 175.129 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -54.93 -50.77 68.02 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 178.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.473 ' O ' HG21 ' A' ' 20' ' ' VAL . 65.0 mm-40 -60.81 -52.78 63.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.072 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.524 ' HB2' ' CD2' ' A' ' 12' ' ' PHE . . . -56.71 -46.45 81.24 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.304 -179.156 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.487 ' HG3' ' O ' ' A' ' 14' ' ' ARG . 91.9 mt-30 -58.95 -38.52 79.24 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.492 -176.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.52 -26.06 68.26 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-O 121.205 0.526 . . . . 0.0 111.535 178.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.473 HG21 ' O ' ' A' ' 16' ' ' GLN . 3.2 t -85.49 -22.88 7.29 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.903 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 -175.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 17.8 m -85.69 -33.73 21.46 Favored 'General case' 0 N--CA 1.434 -1.267 0 CA-C-N 113.315 -1.766 . . . . 0.0 110.814 -178.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.0 p -67.48 -29.35 68.77 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 173.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 23.3 m -80.73 -53.46 6.49 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.305 173.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.625 ' O ' HG13 ' A' ' 27' ' ' ILE . 62.3 m-85 -106.49 98.94 8.55 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 178.572 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 37.3 p -69.51 -3.8 16.18 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.225 -0.443 . . . . 0.0 112.142 -178.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.612 ' OD1' ' HB3' ' A' ' 24' ' ' TYR . 24.1 p-10 -82.48 -14.18 55.45 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.986 0.422 . . . . 0.0 109.877 176.141 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.625 HG13 ' O ' ' A' ' 24' ' ' TYR . 1.2 mt -81.12 146.17 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 N-CA-C 108.372 -0.974 . . . . 0.0 108.372 173.396 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.482 ' O ' ' HA ' ' A' ' 39' ' ' LEU . 3.0 p -144.12 136.42 26.62 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.853 -0.339 . . . . 0.0 111.204 -179.238 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.483 HD12 ' HG2' ' A' ' 14' ' ' ARG . 5.1 tt -95.71 105.12 17.08 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 177.277 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -115.84 166.59 11.79 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.224 -178.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.468 ' HB2' ' HG2' ' A' ' 38' ' ' ARG . 0.3 OUTLIER 60.95 31.59 19.96 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.256 177.493 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -70.77 102.47 2.34 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 121.612 0.72 . . . . 0.0 111.184 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 19.5 tm0? -100.53 -30.73 11.63 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.038 175.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 146.11 -80.02 0.22 Allowed Glycine 0 N--CA 1.445 -0.731 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 -175.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 44.5 p -82.12 -31.41 30.66 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 172.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 60.4 m80 -96.72 126.1 41.64 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.269 177.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.445 ' HB2' HD21 ' A' ' 29' ' ' LEU . 49.7 p90 -168.21 147.19 4.53 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.485 -0.779 . . . . 0.0 109.032 177.241 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.468 ' HG2' ' HB2' ' A' ' 31' ' ' ASP . 49.2 ptt85 -129.59 149.23 51.44 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.843 0.354 . . . . 0.0 110.785 -176.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.529 ' O ' ' HA ' ' A' ' 51' ' ' ARG . 75.9 mt -106.26 144.42 32.98 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.139 0.495 . . . . 0.0 110.188 178.434 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.558 HG11 ' HB3' ' A' ' 51' ' ' ARG . 38.2 t -123.48 110.04 24.97 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.066 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.316 174.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.2 t -88.84 104.37 14.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 173.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 67.2 mtt85 -94.98 171.2 8.9 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.325 -177.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -96.73 -169.73 1.94 Allowed 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 175.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.97 -17.28 62.66 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.548 -175.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.446 ' OE1' ' HD3' ' A' ' 47' ' ' ARG . 37.9 tt0 -89.18 -24.73 22.1 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 176.347 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 105.0 18.55 12.07 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.329 178.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.446 ' HD3' ' OE1' ' A' ' 45' ' ' GLU . 41.6 mtm-85 -85.65 142.07 29.33 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 177.452 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 11.0 ptp -77.86 105.38 9.01 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.46 0.648 . . . . 0.0 111.104 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.2 t -87.7 -36.22 9.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.69 177.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.495 ' CZ2' ' HB2' ' A' ' 52' ' ' ALA . 31.4 t90 -137.62 123.27 19.82 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 177.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.558 ' HB3' HG11 ' A' ' 40' ' ' VAL . 0.0 OUTLIER -149.47 120.1 7.5 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.518 0.675 . . . . 0.0 110.006 172.706 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.495 ' HB2' ' CZ2' ' A' ' 50' ' ' TRP . . . -155.3 174.38 15.3 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.322 -174.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 78.9 m95 -93.9 -158.95 0.66 Allowed 'General case' 0 N--CA 1.445 -0.698 0 CA-C-O 121.258 0.551 . . . . 0.0 110.799 -174.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -110.09 -32.41 7.02 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.619 -0.718 . . . . 0.0 111.25 -175.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -79.34 34.73 0.26 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.982 -175.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.524 ' HB2' ' HB1' ' A' ' 59' ' ' ALA . 51.1 mt-10 -111.04 135.19 20.87 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.058 179.633 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -51.69 -32.83 46.88 Favored 'Trans proline' 0 N--CA 1.477 0.513 0 C-N-CA 123.879 3.052 . . . . 0.0 114.375 -170.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.444 ' HB2' ' HB3' ' A' ' 61' ' ' GLU . 2.3 p30 -136.36 44.18 2.43 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.017 0.436 . . . . 0.0 110.617 179.419 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.524 ' HB1' ' HB2' ' A' ' 56' ' ' GLU . . . -58.74 -41.35 86.25 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.904 -178.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.436 ' HA2' HD11 ' A' ' 63' ' ' LEU . . . -69.2 -27.52 73.67 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.588 178.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.444 ' HB3' ' HB2' ' A' ' 58' ' ' ASP . 31.2 tt0 -73.46 -34.63 65.48 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.581 ' HA2' ' HD3' ' A' ' 65' ' ' ARG . . . -63.49 -41.27 99.32 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.71 -0.757 . . . . 0.0 111.487 173.747 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.461 ' O ' HG13 ' A' ' 67' ' ' ILE . 6.6 mt -64.1 -41.08 97.41 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 110.31 -0.255 . . . . 0.0 110.31 175.141 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -56.17 -33.95 65.73 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.146 0.498 . . . . 0.0 110.497 173.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.581 ' HD3' ' HA2' ' A' ' 62' ' ' GLY . 45.6 mtp85 -71.31 -28.67 64.27 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.153 179.46 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.55 ' O ' HG22 ' A' ' 69' ' ' THR . 36.9 t80 -76.24 -51.62 11.69 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.49 -0.484 . . . . 0.0 109.795 171.658 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.461 HG13 ' O ' ' A' ' 63' ' ' LEU . 46.2 mt -62.05 -13.19 9.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.172 -178.612 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 8.8 tpt180 -49.36 -32.87 12.2 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.632 172.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.55 HG22 ' O ' ' A' ' 66' ' ' TYR . 12.1 t -92.96 29.29 1.86 Allowed 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 121.322 0.582 . . . . 0.0 110.291 -177.312 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 7.9 t 80.22 -27.05 0.15 Allowed 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.967 0.907 . . . . 0.0 111.351 176.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.12 -172.27 51.17 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.468 -0.873 . . . . 0.0 111.894 -177.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.492 ' O ' HG21 ' A' ' 72' ' ' ILE . 32.3 mm -101.02 7.73 9.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 121.768 0.794 . . . . 0.0 110.626 -174.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.402 ' HB3' ' CE2' ' A' ' 24' ' ' TYR . 37.1 ptt180 . . . . . 0 N--CA 1.474 0.765 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.64 178.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.525 ' HA2' ' HA ' ' A' ' 58' ' ' ASP . . . . . . . . 0 N--CA 1.45 -0.397 0 CA-C-O 120.147 -0.252 . . . . 0.0 112.778 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -72.7 168.56 24.18 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.956 2.437 . . . . 0.0 111.856 177.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -125.74 -170.61 2.21 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.379 -176.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.404 ' H ' ' HB2' ' A' ' 16' ' ' GLN . 41.6 p -125.4 173.41 8.89 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.149 178.579 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 4.4 tmt_? -58.42 -43.91 88.86 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.548 0.689 . . . . 0.0 109.261 172.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 41.5 ttm105 -60.77 -54.13 48.96 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.525 -1.216 . . . . 0.0 111.306 178.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.62 ' O ' HG22 ' A' ' 20' ' ' VAL . 73.5 mm-40 -56.71 -49.86 73.88 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.918 179.538 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.445 ' HB1' HD23 ' A' ' 39' ' ' LEU . . . -48.84 -51.9 27.06 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.576 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.423 HE21 HD13 ' A' ' 29' ' ' LEU . 55.4 mm-40 -58.68 -38.0 77.27 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.664 -177.69 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.98 -27.87 66.1 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.969 0.414 . . . . 0.0 111.446 -178.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.62 HG22 ' O ' ' A' ' 16' ' ' GLN . 18.7 t -89.16 -18.9 7.68 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.816 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 -172.432 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 21.1 m -93.41 -31.25 14.69 Favored 'General case' 0 N--CA 1.432 -1.328 0 CA-C-N 114.004 -1.453 . . . . 0.0 108.149 -175.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 52.9 m -61.4 -36.58 80.7 Favored 'General case' 0 N--CA 1.435 -1.187 0 CA-C-N 113.93 -1.486 . . . . 0.0 109.047 168.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 25.9 m -78.97 -51.4 9.67 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.592 177.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.624 ' O ' HG13 ' A' ' 27' ' ' ILE . 47.6 m-85 -113.37 94.81 5.04 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 177.228 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 13.7 m -73.25 1.53 9.22 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.987 0.423 . . . . 0.0 111.204 -176.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.551 ' OD1' ' HB3' ' A' ' 24' ' ' TYR . 4.4 p-10 -78.55 -18.08 55.2 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 172.323 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.624 HG13 ' O ' ' A' ' 24' ' ' TYR . 2.0 mt -79.72 152.18 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 170.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.472 ' O ' ' HA ' ' A' ' 39' ' ' LEU . 17.2 p -141.0 123.64 16.04 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.91 -178.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.533 ' HA ' HD21 ' A' ' 39' ' ' LEU . 6.7 tt -83.85 95.68 8.55 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 176.114 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -114.95 171.31 7.73 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.628 -175.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.468 ' OD2' ' HZ3' ' A' ' 53' ' ' TRP . 38.3 t70 66.39 18.34 10.84 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 123.652 0.595 . . . . 0.0 110.639 177.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.544 ' HA ' ' HB3' ' A' ' 37' ' ' PHE . 7.6 p-10 -64.78 95.97 0.17 Allowed 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 121.826 0.822 . . . . 0.0 110.752 -179.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.429 ' NE2' ' HE1' ' A' ' 36' ' ' HIS . 45.1 mt-30 -128.13 45.17 2.8 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.133 -0.939 . . . . 0.0 109.471 -179.328 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.25 -88.24 1.44 Allowed Glycine 0 N--CA 1.444 -0.815 0 CA-C-N 114.55 -1.205 . . . . 0.0 112.6 176.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 49.0 m -81.63 -14.4 56.75 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -173.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.429 ' HE1' ' NE2' ' A' ' 33' ' ' GLN . 25.7 p80 -136.74 148.95 47.57 Favored 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 119.912 -0.715 . . . . 0.0 110.953 176.669 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.544 ' HB3' ' HA ' ' A' ' 32' ' ' ASP . 45.1 p90 -170.0 161.44 8.74 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.79 -1.095 . . . . 0.0 108.474 178.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 32.9 ptt180 -144.05 155.57 44.04 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.052 0.453 . . . . 0.0 112.119 -178.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.533 HD21 ' HA ' ' A' ' 29' ' ' LEU . 95.8 mt -103.18 112.38 25.21 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.285 176.651 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 47.8 t -94.21 122.38 45.63 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.944 175.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.501 HG11 ' CD2' ' A' ' 66' ' ' TYR . 80.4 t -90.09 115.28 29.26 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 178.201 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.513 ' HA ' ' O ' ' A' ' 47' ' ' ARG . 59.1 mtp180 -110.52 161.04 16.09 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.37 -176.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -95.56 -165.81 1.35 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.18 -178.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 17.6 p -63.46 -27.23 69.14 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.859 0.361 . . . . 0.0 111.427 -177.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -82.87 -33.82 26.9 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.217 0.532 . . . . 0.0 109.788 177.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 110.28 18.49 8.62 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.817 -0.706 . . . . 0.0 111.584 -175.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.513 ' O ' ' HA ' ' A' ' 42' ' ' ARG . 52.0 mtt180 -80.53 145.57 31.74 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 179.101 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.404 ' N ' ' SD ' ' A' ' 48' ' ' MET . 1.8 mpt? -72.49 108.46 5.57 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 177.42 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 42.6 t -95.14 -31.03 4.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.459 0.647 . . . . 0.0 109.592 177.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.445 ' CD1' HD22 ' A' ' 63' ' ' LEU . 69.3 t-105 -159.12 157.87 31.79 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.35 -178.352 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 15.3 ptt180 -160.66 138.73 9.77 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.887 0.375 . . . . 0.0 110.114 178.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -143.12 145.76 33.13 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.043 178.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.528 ' HB2' ' OE1' ' A' ' 56' ' ' GLU . 42.4 m95 -84.71 -160.44 0.48 Allowed 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 176.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -107.55 0.86 22.95 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.928 -174.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 22.9 p90 -117.56 2.98 12.42 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -173.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.528 ' OE1' ' HB2' ' A' ' 53' ' ' TRP . 3.1 mp0 -66.16 132.18 94.49 Favored Pre-proline 0 C--O 1.237 0.398 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.119 173.13 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -46.65 -32.62 12.09 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 123.86 3.04 . . . . 0.0 113.358 -176.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.525 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . 4.4 t0 -146.29 62.9 1.22 Allowed 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 174.389 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.515 ' HB3' ' HB2' ' A' ' 56' ' ' GLU . . . -58.17 -35.51 71.68 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-O 121.286 0.565 . . . . 0.0 111.011 -179.054 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -59.01 -37.75 91.98 Favored Glycine 0 N--CA 1.446 -0.673 0 CA-C-N 115.281 -0.872 . . . . 0.0 113.554 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -60.5 -38.72 85.23 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 117.386 0.593 . . . . 0.0 111.182 -174.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.518 ' O ' ' HB3' ' A' ' 65' ' ' ARG . . . -72.32 -44.49 42.6 Favored Glycine 0 C--O 1.237 0.308 0 C-N-CA 120.823 -0.703 . . . . 0.0 111.99 179.078 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.445 HD22 ' CD1' ' A' ' 50' ' ' TRP . 65.6 mt -62.36 -50.24 72.36 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.705 0.288 . . . . 0.0 110.244 178.21 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -63.43 -28.33 69.9 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.923 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.518 ' HB3' ' O ' ' A' ' 62' ' ' GLY . 10.9 ttt180 -57.02 -51.0 71.0 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.009 175.293 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.501 ' CD2' HG11 ' A' ' 41' ' ' VAL . 77.5 t80 -72.06 -38.8 69.39 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.622 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.402 HG13 ' O ' ' A' ' 63' ' ' LEU . 96.4 mt -57.21 -43.97 82.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.007 0.432 . . . . 0.0 110.896 177.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 5.9 ttp85 -65.76 -41.85 91.61 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.89 -179.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 30.9 p -79.3 -44.7 21.15 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -176.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.417 ' O ' HD13 ' A' ' 72' ' ' ILE . 31.0 m -147.68 56.48 1.09 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.618 -173.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -64.46 130.51 37.61 Favored Glycine 0 CA--C 1.52 0.4 0 C-N-CA 120.284 -0.96 . . . . 0.0 111.9 173.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.524 ' HB ' ' OD1' ' A' ' 26' ' ' ASN . 1.9 mp -81.29 2.31 2.77 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 CA-C-O 121.66 0.743 . . . . 0.0 111.059 -174.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 15.5 ttt180 . . . . . 0 N--CA 1.469 0.524 0 O-C-N 121.644 -0.66 . . . . 0.0 111.639 177.917 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.441 ' HA2' ' OD1' ' A' ' 58' ' ' ASP . . . . . . . . 0 CA--C 1.519 0.311 0 CA-C-O 120.239 -0.2 . . . . 0.0 113.499 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -70.69 153.48 64.64 Favored 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 122.662 2.242 . . . . 0.0 111.577 178.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 16.4 p90 -115.98 -175.93 2.84 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.773 0.797 . . . . 0.0 112.134 -174.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -125.68 159.35 32.47 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-N 114.862 -1.063 . . . . 0.0 109.344 179.774 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.417 HH11 ' HD2' ' A' ' 14' ' ' ARG . 24.5 ttt85 -57.63 -48.46 79.37 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 120.895 0.379 . . . . 0.0 110.424 -179.774 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 21.4 tpp180 -46.22 -55.78 6.66 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.041 175.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.674 ' O ' HG22 ' A' ' 20' ' ' VAL . 2.1 mp0 -62.04 -49.45 75.94 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.857 179.22 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.407 ' HB3' HD12 ' A' ' 39' ' ' LEU . . . -53.29 -49.19 67.49 Favored 'General case' 0 N--CA 1.464 0.225 0 O-C-N 123.279 0.362 . . . . 0.0 111.557 -177.511 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -58.82 -40.14 83.27 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.433 -178.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.44 -24.26 66.42 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.856 179.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.674 HG22 ' O ' ' A' ' 16' ' ' GLN . 15.3 t -88.49 -22.75 6.58 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.794 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 -174.679 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.535 HG22 ' HB ' ' A' ' 27' ' ' ILE . 11.0 m -86.73 -31.03 21.19 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-N 113.768 -1.56 . . . . 0.0 110.575 -178.035 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.5 p -68.5 -31.34 70.53 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 170.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 41.0 m -75.67 -50.92 13.97 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.34 174.067 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.557 ' HB2' HG13 ' A' ' 27' ' ' ILE . 61.6 m-85 -113.16 102.26 10.21 Favored 'General case' 0 N--CA 1.447 -0.594 0 O-C-N 121.883 -0.511 . . . . 0.0 109.97 177.54 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 76.0 p -67.2 -9.25 38.33 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.06 -0.518 . . . . 0.0 112.056 -179.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.546 ' OD1' ' HB3' ' A' ' 24' ' ' TYR . 24.8 p-10 -79.01 -12.25 60.03 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.995 0.426 . . . . 0.0 110.035 177.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.557 HG13 ' HB2' ' A' ' 24' ' ' TYR . 2.2 mt -83.8 147.12 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 173.793 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.572 ' OG1' ' HB ' ' A' ' 40' ' ' VAL . 1.4 p -139.81 127.88 22.32 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 120.477 -0.489 . . . . 0.0 111.26 -179.07 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.487 ' HA ' HD21 ' A' ' 39' ' ' LEU . 5.6 tt -83.48 102.92 12.43 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 177.203 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -113.68 159.06 20.1 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.765 -175.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.8 t70 59.84 47.69 9.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.735 -179.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -72.27 96.54 1.85 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.976 -175.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -112.97 24.13 12.68 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.866 175.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 77.8 -79.99 1.38 Allowed Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.705 -0.68 . . . . 0.0 112.241 179.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 38.8 m -82.97 -16.69 46.26 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.077 0.465 . . . . 0.0 110.672 179.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 24.8 m170 -119.43 137.92 53.45 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 174.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -170.62 156.47 5.34 Favored 'General case' 0 C--N 1.323 -0.583 0 O-C-N 123.518 0.511 . . . . 0.0 109.769 177.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 11.9 ptt180 -128.53 153.28 47.35 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.136 176.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.54 ' O ' ' HA ' ' A' ' 51' ' ' ARG . 91.6 mt -111.21 132.54 54.25 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.177 0.513 . . . . 0.0 110.223 178.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.572 ' HB ' ' OG1' ' A' ' 28' ' ' THR . 38.6 t -108.99 109.23 27.56 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.624 176.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.475 HG13 ' CD2' ' A' ' 66' ' ' TYR . 10.9 t -85.1 118.44 32.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 173.267 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.402 ' O ' ' HB2' ' A' ' 26' ' ' ASN . 16.5 mtp180 -113.21 158.79 20.02 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 -178.097 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -89.77 -168.7 2.21 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 177.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 9.2 t -71.42 -14.32 62.12 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.099 -177.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -93.15 -16.02 25.36 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.34 0.591 . . . . 0.0 109.592 177.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 95.51 13.04 52.71 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.963 177.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 15.5 mtp180 -79.32 127.94 32.71 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 178.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.7 102.79 2.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.223 0.535 . . . . 0.0 111.213 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 43.9 t -86.72 -40.39 14.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.349 -0.842 . . . . 0.0 110.286 -179.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.586 ' CH2' ' HB1' ' A' ' 52' ' ' ALA . 22.6 t90 -135.48 106.57 6.7 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -178.719 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.54 ' HA ' ' O ' ' A' ' 39' ' ' LEU . 29.9 ptt180 -130.95 109.19 10.36 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 173.673 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.586 ' HB1' ' CH2' ' A' ' 50' ' ' TRP . . . -149.33 166.44 28.98 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.796 -177.456 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 44.1 m95 -85.53 -162.8 0.76 Allowed 'General case' 0 N--CA 1.445 -0.705 0 CA-C-O 121.468 0.651 . . . . 0.0 111.162 -175.139 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 61.8 t30 -105.17 -20.39 13.52 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.816 -176.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -83.45 14.67 3.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.15 0.5 . . . . 0.0 111.305 -178.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.509 ' HB2' ' HB2' ' A' ' 59' ' ' ALA . 9.4 mm-40 -80.33 129.57 68.85 Favored Pre-proline 0 C--N 1.325 -0.459 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 174.532 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -44.89 -39.1 13.85 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.867 3.045 . . . . 0.0 114.067 -172.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.441 ' OD1' ' HA2' ' A' ' 10' ' ' GLY . 12.7 t0 -142.11 59.02 1.47 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 178.021 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.509 ' HB2' ' HB2' ' A' ' 56' ' ' GLU . . . -56.38 -35.25 67.52 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.204 -179.636 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -62.22 -37.46 94.58 Favored Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.698 -0.683 . . . . 0.0 113.51 -177.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -59.75 -50.94 71.86 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 117.176 0.488 . . . . 0.0 110.384 -175.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -59.46 -43.05 97.8 Favored Glycine 0 CA--C 1.52 0.374 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.098 178.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 17.7 mt -59.31 -48.54 81.25 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.691 0.281 . . . . 0.0 111.074 176.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.441 ' N ' HD21 ' A' ' 64' ' ' ASN . 0.9 OUTLIER -65.05 -34.94 79.63 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.444 -178.948 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 14.2 ttm180 -63.63 -32.55 74.07 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.978 -178.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.475 ' CD2' HG13 ' A' ' 41' ' ' VAL . 68.6 t80 -82.45 -45.69 14.44 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 120.028 -0.669 . . . . 0.0 110.448 176.107 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 86.8 mt -55.22 -42.55 66.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.19 -178.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 56.8 ttp180 -55.87 -36.93 68.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.524 -178.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 13.6 t -105.34 25.56 10.5 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.179 0.514 . . . . 0.0 111.553 -173.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 54.0 m -149.59 -55.59 0.18 Allowed 'General case' 0 C--N 1.324 -0.534 0 O-C-N 122.126 -0.359 . . . . 0.0 111.266 177.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 45.03 75.64 0.16 Allowed Glycine 0 CA--C 1.524 0.632 0 CA-C-N 115.51 -0.768 . . . . 0.0 113.227 -175.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.452 HG22 ' HB3' ' A' ' 26' ' ' ASN . 45.9 mm -79.86 6.41 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-O 121.62 0.724 . . . . 0.0 111.118 -172.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 . . . . . 0 N--CA 1.469 0.495 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.193 178.848 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.441 ' HA3' ' HD3' ' A' ' 11' ' ' PRO . . . . . . . . 0 CA--C 1.518 0.277 0 CA-C-O 120.117 -0.268 . . . . 0.0 113.404 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.441 ' HD3' ' HA3' ' A' ' 10' ' ' GLY . 17.7 Cg_exo -66.87 170.85 12.0 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.915 2.41 . . . . 0.0 112.531 178.44 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -136.25 -173.48 3.41 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.084 -177.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 27.5 p -122.21 178.17 5.04 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.227 175.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.629 ' O ' ' HG2' ' A' ' 18' ' ' GLN . 36.4 ttt-85 -63.0 -46.99 85.08 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 176.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 70.6 mtp180 -57.01 -48.36 78.67 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.133 178.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.566 ' O ' HG22 ' A' ' 20' ' ' VAL . 81.2 mm-40 -60.4 -46.9 88.33 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 178.548 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.461 ' HB3' HD12 ' A' ' 39' ' ' LEU . . . -52.32 -47.1 66.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.565 177.576 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.629 ' HG2' ' O ' ' A' ' 14' ' ' ARG . 16.4 mm100 -55.07 -48.06 74.03 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.504 -178.55 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.67 -28.53 69.99 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -175.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.566 HG22 ' O ' ' A' ' 16' ' ' GLN . 11.3 t -86.91 -25.57 6.18 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.787 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 -171.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.512 HG22 ' HB ' ' A' ' 27' ' ' ILE . 17.7 m -86.36 -31.25 21.61 Favored 'General case' 0 N--CA 1.435 -1.222 0 CA-C-N 113.735 -1.575 . . . . 0.0 111.211 -177.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.7 p -69.16 -29.01 66.93 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 172.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 19.5 m -77.34 -56.0 4.92 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.222 171.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.636 ' HB3' ' OD1' ' A' ' 26' ' ' ASN . 58.0 m-85 -105.13 98.07 7.83 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 -179.811 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.9 p -70.24 1.12 5.18 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 120.728 0.299 . . . . 0.0 111.759 178.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.636 ' OD1' ' HB3' ' A' ' 24' ' ' TYR . 4.5 p-10 -83.26 -10.87 58.3 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 174.205 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.621 HG13 ' O ' ' A' ' 24' ' ' TYR . 1.7 mt -85.25 138.02 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 173.058 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.494 ' OG1' ' HB ' ' A' ' 40' ' ' VAL . 2.3 p -130.62 126.43 36.62 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 120.641 -0.424 . . . . 0.0 111.043 -176.318 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 5.4 tt -91.26 108.05 19.62 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -122.97 167.9 13.0 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.719 178.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.56 ' HB2' HH11 ' A' ' 38' ' ' ARG . 0.7 OUTLIER 62.59 67.66 0.7 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.618 -177.88 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -81.38 100.25 9.14 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.657 -175.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -114.08 6.96 16.58 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.534 0.683 . . . . 0.0 109.553 174.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.62 -79.71 1.28 Allowed Glycine 0 N--CA 1.45 -0.419 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.948 -179.112 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 17.1 m -86.36 -18.63 31.38 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.156 0.503 . . . . 0.0 110.359 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 29.7 m170 -114.25 132.07 56.27 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.73 173.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.478 ' HA ' ' O ' ' A' ' 31' ' ' ASP . 52.9 p90 -164.59 157.37 16.89 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 178.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.567 ' HA ' ' HA ' ' A' ' 53' ' ' TRP . 27.0 ptt-85 -124.47 142.42 51.34 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 119.567 -0.853 . . . . 0.0 111.31 177.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.48 ' HA ' ' O ' ' A' ' 28' ' ' THR . 63.0 mt -104.05 134.74 46.81 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.589 176.133 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.53 HG12 ' HB3' ' A' ' 51' ' ' ARG . 40.6 t -112.83 116.41 52.53 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.959 175.408 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.533 ' HB ' ' HB3' ' A' ' 50' ' ' TRP . 97.1 t -86.36 107.97 17.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.239 173.727 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' A' ' 42' ' ' ARG . 14.7 mtp180 -101.48 156.57 17.39 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.543 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.808 ' HA ' ' HH ' ' A' ' 66' ' ' TYR . 1.9 p-10 -88.91 -171.06 3.14 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 120.793 0.33 . . . . 0.0 110.947 -175.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 12.2 t -64.1 -22.53 66.97 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.878 -177.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -87.14 -31.52 20.36 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 178.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 114.01 14.07 9.56 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.339 -179.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 72.3 mtp180 -91.01 140.98 29.33 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 179.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 22.3 ptt? -74.91 118.79 18.26 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.227 0.537 . . . . 0.0 111.459 -177.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 34.0 t -101.6 -32.41 3.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.002 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.533 ' HB3' ' HB ' ' A' ' 41' ' ' VAL . 49.3 t90 -144.77 136.58 25.74 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.973 -1.012 . . . . 0.0 108.542 -179.76 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.577 ' HD2' ' O ' ' A' ' 51' ' ' ARG . 0.0 OUTLIER -158.01 119.99 3.67 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 121.448 0.642 . . . . 0.0 110.354 174.772 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.494 ' HB2' ' CZ2' ' A' ' 50' ' ' TRP . . . -151.83 171.3 17.95 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.091 -177.747 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.567 ' HA ' ' HA ' ' A' ' 38' ' ' ARG . 87.7 m95 -80.26 -95.25 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -172.333 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -162.1 -35.8 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.123 0.487 . . . . 0.0 110.607 -176.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -84.67 14.86 4.23 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.396 -177.027 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.515 ' OE2' ' HB2' ' A' ' 53' ' ' TRP . 1.9 mm-40 -66.52 128.02 93.64 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.1 -178.008 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_exo -38.19 -49.6 2.25 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 124.338 3.359 . . . . 0.0 113.541 -176.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -138.92 69.16 1.37 Allowed 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 172.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.503 ' HB1' ' HB2' ' A' ' 56' ' ' GLU . . . -57.75 -33.86 68.92 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.898 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -55.16 -41.84 79.85 Favored Glycine 0 N--CA 1.446 -0.694 0 CA-C-N 115.241 -0.89 . . . . 0.0 112.963 178.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.602 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 9.0 tp10 -49.02 -54.76 14.37 Favored 'General case' 0 C--O 1.223 -0.332 0 CA-C-N 116.974 0.387 . . . . 0.0 111.059 -178.143 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.493 ' HA3' ' CD1' ' A' ' 50' ' ' TRP . . . -65.22 -40.94 97.03 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.777 -178.157 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.461 HD22 ' CZ3' ' A' ' 50' ' ' TRP . 49.3 mt -62.82 -51.04 68.61 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.609 0.242 . . . . 0.0 110.943 179.669 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 51.8 m-80 -69.15 -24.78 64.12 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.941 0.4 . . . . 0.0 110.28 179.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.602 ' HB2' ' O ' ' A' ' 61' ' ' GLU . 12.6 ttt85 -61.91 -37.64 85.41 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.961 177.277 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.808 ' HH ' ' HA ' ' A' ' 43' ' ' ASP . 91.4 t80 -82.32 -47.92 11.79 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.992 176.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.427 HG13 ' O ' ' A' ' 63' ' ' LEU . 72.2 mt -56.52 -21.85 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 CA-C-O 120.992 0.425 . . . . 0.0 111.404 179.718 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 49.6 ttp180 -50.24 -34.04 21.69 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.455 175.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.445 ' O ' ' HB2' ' A' ' 70' ' ' SER . 6.9 t -102.89 61.85 0.8 Allowed 'General case' 0 N--CA 1.443 -0.779 0 CA-C-O 122.062 0.934 . . . . 0.0 109.217 179.464 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.445 ' HB2' ' O ' ' A' ' 69' ' ' THR . 63.2 m 78.18 -51.63 0.49 Allowed 'General case' 0 C--O 1.236 0.356 0 CA-C-N 114.224 -1.353 . . . . 0.0 112.978 172.491 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.06 175.71 51.16 Favored Glycine 0 CA--C 1.52 0.38 0 N-CA-C 111.585 -0.606 . . . . 0.0 111.585 -172.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.568 ' HB ' ' OD1' ' A' ' 26' ' ' ASN . 1.1 mp -83.29 -5.62 9.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.458 0.647 . . . . 0.0 111.061 -177.313 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 23.7 ptt180 . . . . . 0 C--N 1.327 -0.398 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.408 175.811 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.567 ' HA3' ' O ' ' A' ' 57' ' ' PRO . . . . . . . . 0 N--CA 1.445 -0.766 0 N-CA-C 111.776 -0.53 . . . . 0.0 111.776 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.543 ' HG3' ' HA ' ' A' ' 57' ' ' PRO . 3.4 Cg_exo -78.86 133.67 11.46 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 121.547 1.498 . . . . 0.0 111.659 175.526 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 26.7 p90 -100.89 -170.78 1.9 Allowed 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.525 -0.762 . . . . 0.0 111.139 -178.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.427 ' OG1' ' HG2' ' A' ' 16' ' ' GLN . 21.2 p -125.73 172.53 9.73 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 176.24 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.523 ' O ' ' HG3' ' A' ' 18' ' ' GLN . 1.9 tmt_? -61.03 -49.1 78.76 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 174.365 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 13.7 ttp85 -52.56 -52.57 54.31 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.823 -1.08 . . . . 0.0 111.376 176.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.612 ' O ' HG22 ' A' ' 20' ' ' VAL . 15.6 mm100 -59.27 -47.34 85.75 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.587 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -52.11 -48.31 64.86 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.719 179.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.523 ' HG3' ' O ' ' A' ' 14' ' ' ARG . 44.9 mt-30 -54.94 -48.58 72.99 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.446 -179.321 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.98 -35.14 76.02 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.181 0.515 . . . . 0.0 111.175 -178.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.612 HG22 ' O ' ' A' ' 16' ' ' GLN . 16.4 t -82.29 -13.14 12.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.756 -175.08 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.423 HG23 ' HB ' ' A' ' 27' ' ' ILE . 0.0 OUTLIER -91.87 -34.72 14.41 Favored 'General case' 0 CA--C 1.507 -0.674 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 176.349 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 22.1 m -56.24 -30.87 62.96 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 114.294 -1.321 . . . . 0.0 109.665 167.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.401 ' O ' ' HA ' ' A' ' 73' ' ' ARG . 28.0 m -89.38 -46.99 8.32 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.794 178.257 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.621 ' O ' HG13 ' A' ' 27' ' ' ILE . 36.9 m-85 -122.29 104.81 9.69 Favored 'General case' 0 N--CA 1.447 -0.611 0 O-C-N 121.767 -0.583 . . . . 0.0 109.481 177.639 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 7.2 p -77.09 -6.07 51.4 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -177.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.438 ' ND2' ' HB3' ' A' ' 24' ' ' TYR . 6.4 p30 -71.71 -19.36 62.06 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 173.466 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.621 HG13 ' O ' ' A' ' 24' ' ' TYR . 1.9 mt -77.01 138.95 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 CA-C-N 115.258 -0.883 . . . . 0.0 108.622 177.433 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.536 ' OG1' ' HB ' ' A' ' 40' ' ' VAL . 1.3 p -137.0 146.4 45.28 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 121.18 -0.208 . . . . 0.0 110.534 -175.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.482 ' HA ' HD22 ' A' ' 39' ' ' LEU . 4.5 tt -100.31 122.98 43.96 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.962 0.411 . . . . 0.0 110.193 -176.32 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.506 ' HB2' ' HG3' ' A' ' 38' ' ' ARG . 24.0 mt-10 -116.82 155.15 29.47 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.679 175.63 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 59.92 52.88 5.01 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.205 171.728 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.432 ' OD2' HD23 ' A' ' 29' ' ' LEU . 2.0 m-20 -62.3 83.51 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.762 178.551 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -119.46 71.31 0.87 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.333 0.587 . . . . 0.0 111.088 -177.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 66.11 -106.88 1.73 Allowed Glycine 0 N--CA 1.445 -0.73 0 CA-C-N 115.094 -0.957 . . . . 0.0 112.966 174.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 39.7 t -85.49 -14.24 46.63 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 111.667 0.247 . . . . 0.0 111.667 -175.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 34.4 p-80 -129.7 143.02 50.62 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.071 -0.651 . . . . 0.0 111.598 -177.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -163.88 179.35 7.11 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 179.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.506 ' HG3' ' HB2' ' A' ' 30' ' ' GLU . 13.6 ptt180 -127.41 154.26 45.25 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.015 -0.674 . . . . 0.0 110.866 176.072 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.482 HD22 ' HA ' ' A' ' 29' ' ' LEU . 95.5 mt -115.93 136.15 53.3 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.024 0.44 . . . . 0.0 110.392 178.336 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.536 ' HB ' ' OG1' ' A' ' 28' ' ' THR . 21.4 t -107.21 120.85 59.23 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.556 178.319 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 63.5 t -89.28 122.63 40.84 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 173.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 24.8 mtp85 -111.39 159.61 17.85 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.344 0.593 . . . . 0.0 110.558 -178.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.403 ' CG ' ' H ' ' A' ' 44' ' ' THR . 6.5 t70 -90.97 176.83 6.46 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.295 178.736 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.403 ' H ' ' CG ' ' A' ' 43' ' ' ASP . 17.8 p -68.96 -15.69 63.55 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.757 0.313 . . . . 0.0 111.303 -177.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -83.88 -17.08 42.04 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.491 0.662 . . . . 0.0 109.363 172.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 91.14 11.04 61.78 Favored Glycine 0 N--CA 1.447 -0.61 0 CA-C-N 115.291 -0.868 . . . . 0.0 112.517 -178.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 31.8 ptt85 -81.19 138.22 35.84 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 175.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 14.4 ptm -61.22 127.47 31.69 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.049 0.452 . . . . 0.0 110.839 177.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 13.5 t -102.68 -39.11 5.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.86 177.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 75.6 t-105 -166.54 121.69 1.16 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.991 -175.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 4.8 ptp85 -120.39 125.14 47.23 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 174.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -134.67 157.59 46.25 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.155 -176.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.531 ' HB2' ' HG3' ' A' ' 56' ' ' GLU . 81.7 m95 -85.6 -174.45 5.17 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 122.203 1.001 . . . . 0.0 111.988 -177.392 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.451 HD21 ' C ' ' A' ' 54' ' ' ASN . 0.2 OUTLIER -96.34 -33.52 11.91 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 113.692 -1.595 . . . . 0.0 110.158 -176.59 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 17.8 p90 -85.84 10.56 13.42 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.625 -174.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.531 ' HG3' ' HB2' ' A' ' 53' ' ' TRP . 25.5 mt-10 -88.19 128.59 52.96 Favored Pre-proline 0 C--N 1.322 -0.593 0 C-N-CA 121.007 -0.277 . . . . 0.0 110.406 -178.651 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.567 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 21.9 Cg_exo -65.14 -5.22 10.56 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.46 2.774 . . . . 0.0 114.094 -171.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -141.03 25.93 2.07 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.365 0.126 . . . . 0.0 111.132 -179.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.535 ' O ' ' HG ' ' A' ' 63' ' ' LEU . . . -57.06 -46.6 82.33 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.166 0.508 . . . . 0.0 110.997 -176.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -74.0 -22.05 78.41 Favored Glycine 0 N--CA 1.443 -0.843 0 CA-C-N 115.775 -0.648 . . . . 0.0 113.303 -176.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -70.87 -33.43 70.6 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 117.182 0.491 . . . . 0.0 109.905 -177.023 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.513 ' O ' ' HB3' ' A' ' 65' ' ' ARG . . . -79.43 -38.27 21.77 Favored Glycine 0 N--CA 1.45 -0.399 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 175.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.535 ' HG ' ' O ' ' A' ' 59' ' ' ALA . 92.4 mt -61.77 -44.73 96.31 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.381 -0.409 . . . . 0.0 110.024 176.581 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.55 ' HA ' ' HB ' ' A' ' 67' ' ' ILE . 90.4 m-20 -62.96 -33.59 75.7 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.896 177.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.513 ' HB3' ' O ' ' A' ' 62' ' ' GLY . 9.5 tpt180 -54.39 -40.4 68.15 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.833 0.349 . . . . 0.0 110.439 173.72 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -77.33 -48.56 17.03 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.905 0.384 . . . . 0.0 110.545 174.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.55 ' HB ' ' HA ' ' A' ' 64' ' ' ASN . 84.2 mt -52.83 -56.15 8.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -174.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -71.86 -32.89 67.95 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.705 0.288 . . . . 0.0 111.656 -169.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.03 28.71 7.98 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -176.079 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 62.4 m -148.77 -53.75 0.18 Allowed 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 172.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 53.84 89.13 0.01 OUTLIER Glycine 0 CA--C 1.522 0.529 0 CA-C-N 115.422 -0.808 . . . . 0.0 114.373 176.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.445 ' O ' HG21 ' A' ' 72' ' ' ILE . 38.2 mm -86.37 7.02 2.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.749 0.785 . . . . 0.0 109.89 178.612 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.401 ' HA ' ' O ' ' A' ' 23' ' ' THR . 4.6 ptm180 . . . . . 0 N--CA 1.466 0.327 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.646 -178.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.467 ' HA3' ' HD3' ' A' ' 11' ' ' PRO . . . . . . . . 0 CA--C 1.522 0.527 0 N-CA-C 114.812 0.685 . . . . 0.0 114.812 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.527 ' HG3' ' HA ' ' A' ' 57' ' ' PRO . 1.3 Cg_endo -80.53 142.64 14.71 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 122.852 2.368 . . . . 0.0 112.409 -179.216 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.44 ' CZ ' ' HA ' ' A' ' 54' ' ' ASN . 9.8 p90 -111.46 -171.39 1.83 Allowed 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.002 -179.275 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.42 ' OG1' ' HG2' ' A' ' 16' ' ' GLN . 16.7 p -124.61 179.94 4.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.186 178.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.411 ' O ' ' HG3' ' A' ' 18' ' ' GLN . 5.6 ttm180 -65.8 -53.58 38.37 Favored 'General case' 0 N--CA 1.427 -1.591 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.705 -178.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.425 HH11 ' HD2' ' A' ' 15' ' ' ARG . 20.6 ptt85 -62.37 -36.46 82.34 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.204 178.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.615 ' O ' HG22 ' A' ' 20' ' ' VAL . 15.7 mm100 -62.31 -48.18 81.0 Favored 'General case' 0 CA--C 1.519 -0.246 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 176.516 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.419 ' HB2' HD13 ' A' ' 39' ' ' LEU . . . -55.0 -47.9 74.05 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.99 175.602 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.411 ' HG3' ' O ' ' A' ' 14' ' ' ARG . 99.1 mt-30 -57.59 -42.54 83.36 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.401 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.446 ' O ' ' HB ' ' A' ' 22' ' ' THR . . . -62.59 -34.59 77.29 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.985 178.31 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.615 HG22 ' O ' ' A' ' 16' ' ' GLN . 24.3 t -79.18 -16.33 13.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.808 0.337 . . . . 0.0 110.362 -178.034 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.458 HG22 ' HB ' ' A' ' 27' ' ' ILE . 0.0 OUTLIER -92.24 -26.42 18.18 Favored 'General case' 0 CA--C 1.503 -0.83 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 177.624 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.446 ' HB ' ' O ' ' A' ' 19' ' ' ALA . 98.0 m -61.12 -32.97 72.65 Favored 'General case' 0 N--CA 1.437 -1.122 0 CA-C-N 113.612 -1.631 . . . . 0.0 109.419 167.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.8 m -87.45 -50.66 6.4 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.968 178.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.634 ' O ' HG13 ' A' ' 27' ' ' ILE . 35.0 m-85 -116.64 102.37 9.39 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 -179.469 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 15.6 p -81.21 5.34 17.3 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.942 0.401 . . . . 0.0 111.419 -177.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.522 ' OD1' ' HB3' ' A' ' 24' ' ' TYR . 25.5 p-10 -83.53 -17.31 42.28 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 172.221 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.634 HG13 ' O ' ' A' ' 24' ' ' TYR . 1.1 mt -78.22 148.48 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 N-CA-C 108.183 -1.044 . . . . 0.0 108.183 173.5 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.496 ' O ' ' HA ' ' A' ' 39' ' ' LEU . 1.7 p -141.68 133.94 27.91 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.498 -0.481 . . . . 0.0 111.465 -178.029 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.497 ' HA ' HD21 ' A' ' 39' ' ' LEU . 6.5 tt -87.88 100.6 13.0 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 179.623 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -115.75 166.5 11.87 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.848 -174.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 60.6 37.22 19.49 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 123.388 0.43 . . . . 0.0 111.462 171.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -74.95 125.11 28.19 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.135 0.493 . . . . 0.0 111.305 -175.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -126.69 25.2 6.45 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.526 173.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.0 -90.87 1.6 Allowed Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.038 -177.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.0 t -78.27 -7.13 56.83 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.262 0.553 . . . . 0.0 110.863 -178.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 57.2 m80 -131.42 138.56 49.13 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.408 ' O ' ' HA ' ' A' ' 53' ' ' TRP . 52.8 p90 -168.81 166.39 11.49 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.306 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.485 ' HA ' ' HA ' ' A' ' 53' ' ' TRP . 70.2 mtm180 -128.28 132.98 48.69 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.497 HD21 ' HA ' ' A' ' 29' ' ' LEU . 64.4 mt -95.45 107.65 19.81 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.348 0.594 . . . . 0.0 109.661 174.244 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 60.7 t -89.48 116.87 31.71 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.896 177.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.45 HG22 HG21 ' A' ' 27' ' ' ILE . 25.4 t -89.4 110.58 21.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 178.057 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 33.7 mtt85 -97.03 171.82 8.24 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.806 -178.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.4 ' CG ' ' H ' ' A' ' 45' ' ' GLU . 1.3 p-10 -104.17 -168.91 1.55 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.602 -178.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.1 p -63.01 -22.74 67.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.108 -179.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.4 ' H ' ' CG ' ' A' ' 43' ' ' ASP . 9.9 tp10 -89.81 -28.56 19.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.057 0.456 . . . . 0.0 110.073 178.42 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 107.19 19.36 9.51 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.055 -178.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 51.0 mtp180 -89.79 143.99 26.34 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 178.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.8 113.74 8.17 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.227 0.537 . . . . 0.0 110.709 178.391 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 58.0 t -98.83 -33.46 4.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.135 178.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 73.3 t-105 -153.0 157.44 40.55 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.989 -176.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.409 HH11 ' HD2' ' A' ' 51' ' ' ARG . 20.6 ptt85 -156.93 146.19 20.33 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 177.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -152.95 153.42 32.95 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 177.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.613 ' HB2' ' OE1' ' A' ' 56' ' ' GLU . 80.4 m95 -77.39 -92.66 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.05 0.452 . . . . 0.0 110.857 -179.048 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.44 ' HA ' ' CZ ' ' A' ' 12' ' ' PHE . 6.6 t30 -175.58 -37.78 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.385 -177.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -86.0 -15.04 42.72 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -169.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.613 ' OE1' ' HB2' ' A' ' 53' ' ' TRP . 2.4 mp0 -62.88 137.16 96.8 Favored Pre-proline 0 C--N 1.327 -0.408 0 N-CA-C 110.321 -0.251 . . . . 0.0 110.321 -179.236 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.527 ' HA ' ' HG3' ' A' ' 11' ' ' PRO . 43.2 Cg_endo -68.59 5.35 1.31 Allowed 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.879 2.386 . . . . 0.0 112.917 -177.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -138.6 12.24 2.73 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.465 177.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.508 ' HB3' ' HB2' ' A' ' 56' ' ' GLU . . . -62.31 -43.35 99.02 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-O 121.239 0.542 . . . . 0.0 110.738 -172.773 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -68.03 -29.72 73.63 Favored Glycine 0 N--CA 1.442 -0.936 0 CA-C-N 115.346 -0.843 . . . . 0.0 112.301 179.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -72.44 -29.51 63.76 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 120.494 -0.483 . . . . 0.0 109.719 -178.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -68.57 -41.87 82.8 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.573 -0.822 . . . . 0.0 111.077 176.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 57.7 mt -64.16 -47.8 78.46 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.906 0.384 . . . . 0.0 110.143 176.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 9.5 m-20 -61.9 -29.2 70.05 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.953 177.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 36.0 ttm180 -65.73 -37.99 87.94 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.191 179.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -70.39 -50.3 40.17 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 174.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 99.0 mt -53.83 -35.97 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.068 179.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 50.0 ttt180 -49.72 -32.44 13.5 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -176.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 41.0 p -56.26 -38.37 71.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.038 0.447 . . . . 0.0 111.147 -178.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 37.2 t 167.32 -38.13 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 114.914 -1.039 . . . . 0.0 108.997 -174.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 84.12 147.34 8.05 Favored Glycine 0 N--CA 1.447 -0.628 0 CA-C-N 115.416 -0.811 . . . . 0.0 112.264 -178.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.433 ' O ' HG23 ' A' ' 72' ' ' ILE . 38.9 mm -83.29 6.7 1.69 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-O 121.672 0.749 . . . . 0.0 110.161 -178.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.481 ' HB3' ' CE2' ' A' ' 24' ' ' TYR . 16.1 ptt-85 . . . . . 0 N--CA 1.466 0.359 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.74 178.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.527 ' HA2' ' HA ' ' A' ' 58' ' ' ASP . . . . . . . . 0 N--CA 1.451 -0.304 0 CA-C-O 119.795 -0.447 . . . . 0.0 113.024 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -67.59 154.66 72.87 Favored 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 122.512 2.141 . . . . 0.0 112.396 177.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.467 ' CD2' ' HB3' ' A' ' 17' ' ' ALA . 15.9 p90 -126.79 -172.14 2.57 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.968 -176.682 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.507 ' OG1' ' HG2' ' A' ' 16' ' ' GLN . 31.9 p -125.47 176.13 7.03 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 172.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.499 ' HG2' HD11 ' A' ' 29' ' ' LEU . 45.1 mtm180 -65.38 -43.83 89.45 Favored 'General case' 0 C--O 1.219 -0.52 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.332 173.53 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 16.7 mtp180 -56.94 -46.97 81.71 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.933 179.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.556 ' O ' HG23 ' A' ' 20' ' ' VAL . 10.6 mm100 -64.37 -49.89 69.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.962 178.499 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.467 ' HB3' ' CD2' ' A' ' 12' ' ' PHE . . . -56.24 -49.05 75.26 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.768 179.339 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.433 ' HG2' ' O ' ' A' ' 14' ' ' ARG . 15.2 mm100 -55.28 -38.6 68.83 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.432 -178.54 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.11 -25.67 66.32 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.656 178.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 16' ' ' GLN . 31.3 t -91.61 -16.88 7.85 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.721 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 -173.731 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.511 HG21 ' HB ' ' A' ' 27' ' ' ILE . 6.2 m -93.74 -27.02 16.74 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-N 113.839 -1.528 . . . . 0.0 107.612 -177.623 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.9 m -65.07 -35.55 81.51 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 113.636 -1.62 . . . . 0.0 108.943 165.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 41.6 m -74.57 -55.93 5.38 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.559 177.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.644 ' HB3' ' OD1' ' A' ' 26' ' ' ASN . 63.9 m-85 -114.21 104.13 11.79 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-O 121.097 0.475 . . . . 0.0 109.839 178.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.3 p -69.72 -6.52 32.37 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.309 -179.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.644 ' OD1' ' HB3' ' A' ' 24' ' ' TYR . 7.6 p-10 -79.5 -8.83 59.42 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.167 0.508 . . . . 0.0 109.723 175.459 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.531 HG13 ' HB2' ' A' ' 24' ' ' TYR . 4.2 mt -88.19 157.42 3.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 172.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -153.37 130.82 11.36 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.639 -0.424 . . . . 0.0 111.298 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.504 ' HA ' HD21 ' A' ' 39' ' ' LEU . 6.5 tt -90.01 111.11 22.09 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -178.334 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -123.97 170.94 10.12 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.141 -178.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.8 t70 61.85 30.17 18.13 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.432 -0.803 . . . . 0.0 110.061 -178.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -63.18 99.33 0.17 Allowed 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.505 -177.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -112.74 -6.98 13.83 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.242 176.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.419 ' HA2' ' NH1' ' A' ' 14' ' ' ARG . . . 129.74 -102.42 0.55 Allowed Glycine 0 N--CA 1.448 -0.518 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.036 -177.399 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 37.2 m -79.3 -19.68 49.87 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 172.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -93.13 120.38 33.37 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.715 173.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.431 ' HE2' ' HE2' ' A' ' 12' ' ' PHE . 35.6 p90 -174.8 165.93 3.66 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 176.007 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.414 HH11 ' HD3' ' A' ' 38' ' ' ARG . 13.8 ptt180 -142.17 142.95 32.75 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.093 0.473 . . . . 0.0 110.774 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.504 HD21 ' HA ' ' A' ' 29' ' ' LEU . 82.0 mt -95.68 121.65 37.61 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.193 0.52 . . . . 0.0 110.375 179.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 41.4 t -98.46 115.14 37.98 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.632 178.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.0 t -96.69 118.63 43.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 121.122 0.487 . . . . 0.0 110.11 -177.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.465 ' HA ' ' O ' ' A' ' 47' ' ' ARG . 39.1 mtm105 -103.08 168.8 8.95 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.485 -178.466 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.454 ' CG ' ' H ' ' A' ' 45' ' ' GLU . 0.5 OUTLIER -96.09 -167.91 1.66 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.037 -0.528 . . . . 0.0 109.986 178.505 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 23.2 p -64.01 -26.17 68.45 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.317 -178.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.518 ' HB3' ' HD2' ' A' ' 47' ' ' ARG . 9.1 tp10 -95.84 -13.0 24.37 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 121.18 0.515 . . . . 0.0 110.433 -177.044 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 104.63 15.28 21.24 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.575 179.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.518 ' HD2' ' HB3' ' A' ' 45' ' ' GLU . 0.0 OUTLIER -78.0 128.54 34.04 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 178.448 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 63.1 mtm -74.27 99.89 3.58 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 177.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 23.7 t -86.92 -33.45 6.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.641 -174.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.419 ' CD1' HD23 ' A' ' 63' ' ' LEU . 75.5 t-105 -153.72 150.78 28.89 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.486 -173.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 16.0 ptt180 -156.09 141.24 17.42 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 174.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -142.92 153.49 43.14 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.415 -178.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.467 ' HB2' ' HG2' ' A' ' 56' ' ' GLU . 98.0 m95 -75.62 -167.41 0.68 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.643 0.735 . . . . 0.0 111.73 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -103.98 -40.88 6.04 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.746 -1.115 . . . . 0.0 111.413 -177.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 13.8 p90 -83.24 10.27 8.82 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.82 -174.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.53 ' HB2' ' HB2' ' A' ' 59' ' ' ALA . 11.9 mm-40 -77.55 131.75 70.56 Favored Pre-proline 0 C--N 1.324 -0.538 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 177.676 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 56' ' ' GLU . 52.1 Cg_exo -55.39 -21.26 28.99 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 123.493 2.795 . . . . 0.0 113.217 -176.487 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.527 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . 4.2 p30 -136.86 38.34 2.59 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.77 0.319 . . . . 0.0 110.621 177.476 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.53 ' HB2' ' HB2' ' A' ' 56' ' ' GLU . . . -55.0 -52.75 62.16 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 121.22 0.533 . . . . 0.0 111.36 -174.344 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.4 ' HA2' HD11 ' A' ' 63' ' ' LEU . . . -67.7 -28.62 73.51 Favored Glycine 0 N--CA 1.44 -1.091 0 CA-C-N 115.422 -0.808 . . . . 0.0 112.729 -178.024 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -68.15 -35.88 78.77 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 117.139 0.469 . . . . 0.0 110.407 -176.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -68.49 -42.46 81.38 Favored Glycine 0 CA--C 1.519 0.299 0 C-N-CA 120.645 -0.788 . . . . 0.0 111.305 175.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.463 ' O ' HG13 ' A' ' 67' ' ' ILE . 49.7 mt -61.05 -47.47 86.21 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.994 -0.372 . . . . 0.0 109.994 176.014 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.497 ' HA ' ' HB ' ' A' ' 67' ' ' ILE . 94.0 m-20 -63.57 -29.29 70.57 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.791 177.679 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 6.4 ttt180 -58.93 -39.66 82.25 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 177.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -76.88 -46.59 24.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.505 173.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.497 ' HB ' ' HA ' ' A' ' 64' ' ' ASN . 93.7 mt -53.41 -46.16 58.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.681 -178.378 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 47.6 ttt85 -57.69 -36.56 72.12 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.948 -176.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.5 p -105.4 20.81 18.26 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -176.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 15.0 m -139.16 -57.31 0.6 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.688 0.28 . . . . 0.0 110.841 178.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 40.1 77.71 0.07 OUTLIER Glycine 0 CA--C 1.521 0.461 0 CA-C-N 115.189 -0.914 . . . . 0.0 113.512 -175.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.509 ' HB ' ' OD1' ' A' ' 26' ' ' ASN . 37.8 mm -82.55 5.73 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 CA-C-O 121.465 0.65 . . . . 0.0 111.317 -171.383 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 30.7 ttt-85 . . . . . 0 C--N 1.328 -0.36 0 CA-C-O 121.072 0.463 . . . . 0.0 111.839 -179.498 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.356 0 CA-C-O 120.257 -0.19 . . . . 0.0 113.007 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.561 ' HD3' ' O ' ' A' ' 57' ' ' PRO . 53.2 Cg_endo -76.07 174.85 12.13 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.443 2.095 . . . . 0.0 112.17 176.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.43 ' CE1' ' HA ' ' A' ' 54' ' ' ASN . 16.5 p90 -126.96 -175.13 3.33 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.089 -177.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.422 ' H ' ' HB2' ' A' ' 16' ' ' GLN . 40.6 p -122.27 170.36 9.99 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.891 178.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 25.0 ttt85 -59.33 -39.55 83.49 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.246 0.546 . . . . 0.0 110.16 175.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 32.2 mtm180 -66.38 -52.36 47.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.106 177.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.613 ' O ' HG23 ' A' ' 20' ' ' VAL . 57.8 mm-40 -56.07 -48.0 76.9 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.862 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.425 ' HB3' HD21 ' A' ' 39' ' ' LEU . . . -49.12 -51.06 34.29 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.994 177.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -54.65 -40.31 68.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.455 179.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.17 -25.97 63.7 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.706 0.289 . . . . 0.0 111.745 -176.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.613 HG23 ' O ' ' A' ' 16' ' ' GLN . 15.9 t -89.44 -19.47 7.43 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.734 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 -173.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.525 HG21 ' HB ' ' A' ' 27' ' ' ILE . 13.2 m -97.11 -27.89 14.37 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-N 113.826 -1.534 . . . . 0.0 108.619 -175.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.8 m -63.63 -37.89 89.06 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 114.356 -1.293 . . . . 0.0 108.963 168.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 34.1 m -75.88 -56.68 4.44 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.645 175.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.57 ' O ' HG13 ' A' ' 27' ' ' ILE . 65.1 m-85 -105.78 99.81 9.39 Favored 'General case' 0 N--CA 1.439 -1.019 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 -179.054 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 4.0 p -70.01 -4.6 21.64 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.216 -178.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.519 ' OD1' ' HB3' ' A' ' 24' ' ' TYR . 6.3 p-10 -82.25 -7.42 59.63 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.702 176.123 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.57 HG13 ' O ' ' A' ' 24' ' ' TYR . 1.8 mt -90.25 158.74 2.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 173.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -153.39 135.41 14.72 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.721 0.296 . . . . 0.0 111.317 178.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 7.0 tt -90.66 109.76 20.93 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -131.17 176.73 8.02 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.384 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.409 ' HB2' ' HG2' ' A' ' 38' ' ' ARG . 11.9 m-20 61.85 30.82 18.34 Favored 'General case' 0 N--CA 1.467 0.376 0 O-C-N 123.735 0.647 . . . . 0.0 110.908 -178.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.549 ' HA ' ' HB3' ' A' ' 37' ' ' PHE . 25.9 t0 -71.13 122.85 20.88 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.619 -175.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.511 ' HB3' ' HB2' ' A' ' 36' ' ' HIS . 35.0 tt0 -133.78 18.31 3.87 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.034 178.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 113.14 -91.99 0.6 Allowed Glycine 0 N--CA 1.45 -0.393 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.688 -177.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.6 t -100.63 -15.33 17.81 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 174.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.511 ' HB2' ' HB3' ' A' ' 33' ' ' GLN . 35.5 m170 -93.1 107.7 19.44 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.417 175.051 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.549 ' HB3' ' HA ' ' A' ' 32' ' ' ASP . 55.3 p90 -163.81 162.17 23.62 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.049 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.516 ' HB3' ' HA ' ' A' ' 53' ' ' TRP . 30.7 ptt180 -138.62 146.15 41.39 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.29 0.567 . . . . 0.0 111.814 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.425 HD21 ' HB3' ' A' ' 17' ' ' ALA . 97.0 mt -91.77 126.15 36.75 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.072 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.458 HG12 ' SD ' ' A' ' 48' ' ' MET . 28.7 t -96.31 109.71 23.35 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.948 178.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 91.1 t -81.01 114.54 22.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.536 175.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.451 ' HB3' ' HA2' ' A' ' 46' ' ' GLY . 10.7 mtt180 -106.02 173.02 6.49 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.216 178.134 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -95.65 -167.9 1.68 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.244 -0.434 . . . . 0.0 109.933 177.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 10.2 p -60.7 -26.81 67.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.58 -178.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -91.56 -27.39 18.23 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.337 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.451 ' HA2' ' HB3' ' A' ' 42' ' ' ARG . . . 108.39 19.6 8.75 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.526 -0.845 . . . . 0.0 112.836 -178.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.412 ' O ' ' HA ' ' A' ' 42' ' ' ARG . 79.3 mtt180 -78.64 143.95 35.87 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 176.142 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.458 ' SD ' HG12 ' A' ' 40' ' ' VAL . 14.3 mmt -66.22 114.28 5.2 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.245 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 43.8 t -103.33 -35.1 3.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 120.741 0.305 . . . . 0.0 110.536 178.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 68.4 t-105 -172.3 125.54 0.52 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.968 -174.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 12.3 ptp180 -120.03 125.23 47.82 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.92 0.39 . . . . 0.0 110.232 175.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -125.89 143.25 51.15 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.572 -178.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.656 ' HB2' ' HG2' ' A' ' 56' ' ' GLU . 96.9 m95 -72.13 -174.12 1.2 Allowed 'General case' 0 CA--C 1.513 -0.464 0 CA-C-O 122.079 0.942 . . . . 0.0 112.13 -177.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.43 ' HA ' ' CE1' ' A' ' 12' ' ' PHE . 18.9 t-20 -101.9 -43.43 5.8 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 113.825 -1.534 . . . . 0.0 110.879 -176.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -83.68 10.64 8.84 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.941 -173.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.656 ' HG2' ' HB2' ' A' ' 53' ' ' TRP . 12.8 mm-40 -75.83 131.12 77.04 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.192 178.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.561 ' O ' ' HD3' ' A' ' 11' ' ' PRO . 4.2 Cg_endo -46.74 -37.01 20.39 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 124.01 3.14 . . . . 0.0 113.304 -174.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.537 ' HB3' ' HB2' ' A' ' 61' ' ' GLU . 11.5 m-20 -140.14 63.25 1.48 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.727 0.298 . . . . 0.0 110.249 174.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.51 ' HB3' ' HB2' ' A' ' 56' ' ' GLU . . . -61.77 -38.31 87.52 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-O 121.352 0.596 . . . . 0.0 110.572 177.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -62.51 -23.68 65.09 Favored Glycine 0 C--O 1.221 -0.691 0 CA-C-N 115.389 -0.823 . . . . 0.0 113.112 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.537 ' HB2' ' HB3' ' A' ' 58' ' ' ASP . 2.5 tm-20 -58.14 -51.9 67.8 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.159 0.504 . . . . 0.0 110.21 -178.297 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -71.84 -39.34 59.71 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.678 -0.772 . . . . 0.0 111.847 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.514 ' O ' HG13 ' A' ' 67' ' ' ILE . 80.4 mt -61.73 -46.46 89.55 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.593 0.235 . . . . 0.0 110.97 179.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -65.44 -29.53 70.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.14 -179.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.488 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 25.3 ttm105 -66.03 -33.76 76.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.027 176.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -73.07 -46.56 50.91 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 119.979 -0.688 . . . . 0.0 109.739 172.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.514 HG13 ' O ' ' A' ' 63' ' ' LEU . 80.3 mt -55.46 -55.59 16.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.342 -178.094 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.647 ' O ' HG22 ' A' ' 69' ' ' THR . 26.0 mmm-85 54.93 27.79 9.65 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 123.119 0.262 . . . . 0.0 111.55 177.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.647 HG22 ' O ' ' A' ' 68' ' ' ARG . 9.8 t 61.29 16.69 7.57 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.222 1.409 . . . . 0.0 111.042 176.165 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 13.2 p -113.72 -66.14 1.12 Allowed 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.438 175.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.531 ' HA3' ' CE1' ' A' ' 24' ' ' TYR . . . 65.65 179.64 8.97 Favored Glycine 0 N--CA 1.445 -0.765 0 CA-C-N 115.208 -0.906 . . . . 0.0 113.117 179.091 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.404 ' O ' HG21 ' A' ' 72' ' ' ILE . 35.8 mm -91.77 5.9 5.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.808 0.813 . . . . 0.0 110.119 -179.044 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 22.5 tpt180 -60.21 -84.35 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.259 177.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 11.1 m -91.69 -33.43 15.06 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.5 t70 . . . . . 0 N--CA 1.473 0.701 0 O-C-N 124.649 1.218 . . . . 0.0 112.767 178.955 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.605 ' HA3' ' O ' ' A' ' 57' ' ' PRO . . . . . . . . 0 N--CA 1.441 -0.997 0 N-CA-C 111.325 -0.71 . . . . 0.0 111.325 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -73.33 132.92 18.45 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 121.494 1.462 . . . . 0.0 110.66 174.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 34.8 p90 -104.97 -171.7 1.96 Allowed 'General case' 0 C--N 1.31 -1.137 0 CA-C-O 121.703 0.763 . . . . 0.0 112.452 -173.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.89 156.44 36.26 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.924 -1.035 . . . . 0.0 109.2 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 22.5 ttt85 -61.6 -49.27 77.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.057 0.456 . . . . 0.0 110.346 -179.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.414 HH11 ' HD2' ' A' ' 15' ' ' ARG . 30.7 mtp180 -52.22 -47.97 65.36 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.338 -0.847 . . . . 0.0 111.2 175.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.585 ' O ' HG22 ' A' ' 20' ' ' VAL . 13.4 mm100 -58.0 -48.73 79.15 Favored 'General case' 0 C--O 1.226 -0.173 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.374 176.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -55.45 -46.09 76.8 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.319 -179.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 27.2 mm-40 -56.79 -41.65 78.07 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.529 -178.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.17 -23.26 67.06 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-O 121.181 0.515 . . . . 0.0 111.55 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.585 HG22 ' O ' ' A' ' 16' ' ' GLN . 5.0 t -90.6 -20.98 6.74 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.803 0 N-CA-C 107.227 -1.398 . . . . 0.0 107.227 -175.52 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.2 m -83.8 -31.73 25.73 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 114.084 -1.416 . . . . 0.0 110.243 179.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 15.6 p -70.41 -32.29 69.85 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 173.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 16.7 m -79.91 -49.06 12.45 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.756 175.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.71 ' O ' HG13 ' A' ' 27' ' ' ILE . 33.6 m-85 -115.12 96.9 5.91 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 175.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 37.9 m -83.33 16.17 2.63 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.035 0.445 . . . . 0.0 111.628 -174.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.422 ' OD1' ' HB3' ' A' ' 24' ' ' TYR . 21.5 p-10 -91.29 -17.4 26.0 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 169.543 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.71 HG13 ' O ' ' A' ' 24' ' ' TYR . 2.5 mt -72.55 147.46 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 CA-C-N 115.182 -0.917 . . . . 0.0 108.542 175.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.511 ' O ' ' HA ' ' A' ' 39' ' ' LEU . 14.5 p -141.95 144.45 33.74 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.712 -175.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.5 tt -101.15 108.62 20.34 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -113.77 162.5 16.22 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.83 179.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.54 ' O ' ' HA ' ' A' ' 37' ' ' PHE . 3.2 m-20 57.26 70.72 0.63 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.999 -1.001 . . . . 0.0 112.062 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -77.18 75.58 3.74 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.147 174.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.5 ' HB2' ' HB2' ' A' ' 36' ' ' HIS . 16.2 mm-40 -103.61 21.21 16.53 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.133 0.492 . . . . 0.0 109.981 -179.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.72 -93.06 1.64 Allowed Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 121.08 -0.581 . . . . 0.0 112.296 178.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 27.2 t -75.4 -29.55 59.84 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.397 0.617 . . . . 0.0 109.883 178.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.5 ' HB2' ' HB2' ' A' ' 33' ' ' GLN . 26.8 m-70 -101.84 107.54 18.75 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.79 177.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.54 ' HA ' ' O ' ' A' ' 31' ' ' ASP . 45.9 p90 -148.62 146.66 28.31 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 173.54 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 37.5 ptt85 -127.92 152.1 48.28 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.316 0.579 . . . . 0.0 112.314 -173.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.511 ' HA ' ' O ' ' A' ' 28' ' ' THR . 86.2 mt -108.88 132.6 53.88 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.891 175.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.431 ' HB ' ' OG1' ' A' ' 28' ' ' THR . 41.2 t -114.53 118.81 59.72 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.717 -179.032 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 93.5 t -89.46 114.83 28.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.654 176.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.453 ' HA ' ' O ' ' A' ' 47' ' ' ARG . 49.2 mtp180 -104.15 164.2 11.88 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.932 177.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.413 ' CG ' ' H ' ' A' ' 45' ' ' GLU . 1.7 p-10 -102.9 -166.04 1.23 Allowed 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 110.325 -0.25 . . . . 0.0 110.325 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 25.6 p -66.62 -22.96 66.11 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 120.92 0.39 . . . . 0.0 111.893 179.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.413 ' H ' ' CG ' ' A' ' 43' ' ' ASP . 8.6 tp10 -86.98 -21.61 26.07 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.239 0.543 . . . . 0.0 109.574 178.159 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 101.17 5.23 53.11 Favored Glycine 0 N--CA 1.444 -0.808 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.08 179.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.453 ' O ' ' HA ' ' A' ' 42' ' ' ARG . 88.0 mtt180 -72.23 146.87 47.0 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 -178.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -74.06 103.09 4.4 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 176.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 57.4 t -77.96 -40.67 26.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.991 179.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 76.1 t-105 -164.17 142.13 7.08 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.819 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' A' ' 51' ' ' ARG . 14.9 ptt-85 -141.78 138.68 32.44 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 177.477 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -143.97 156.47 44.42 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.354 -177.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 92.8 m95 -88.52 -161.6 0.76 Allowed 'General case' 0 N--CA 1.447 -0.615 0 CA-C-O 121.423 0.63 . . . . 0.0 110.474 -179.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -106.23 -33.93 7.66 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.274 -176.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -81.45 3.53 24.32 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 -173.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.508 ' HB2' ' HB3' ' A' ' 59' ' ' ALA . 37.1 mt-10 -80.19 129.22 70.58 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.463 -178.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.605 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 31.3 Cg_exo -62.16 -10.37 17.94 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 123.396 2.731 . . . . 0.0 114.009 -172.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.517 ' HA ' ' CA ' ' A' ' 10' ' ' GLY . 24.0 p-10 -143.01 34.02 1.36 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.761 0.315 . . . . 0.0 110.794 177.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.508 ' HB3' ' HB2' ' A' ' 56' ' ' GLU . . . -55.75 -40.96 73.25 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.994 -178.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -62.8 -39.33 97.85 Favored Glycine 0 N--CA 1.443 -0.878 0 CA-C-N 115.826 -0.624 . . . . 0.0 112.381 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -66.02 -23.1 66.49 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.886 0.343 . . . . 0.0 111.721 -177.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -75.5 -49.23 9.39 Favored Glycine 0 C--O 1.24 0.477 0 C-N-CA 120.286 -0.959 . . . . 0.0 111.085 175.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.427 ' O ' HG13 ' A' ' 67' ' ' ILE . 50.0 mt -63.24 -43.35 98.29 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.273 0.559 . . . . 0.0 109.833 177.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 8.8 m-20 -69.16 -20.43 64.02 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.189 178.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 6.8 tmm_? -65.93 -41.36 91.48 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 173.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.428 ' CE1' ' HA2' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -67.97 -42.9 80.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.425 175.018 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.427 HG13 ' O ' ' A' ' 63' ' ' LEU . 62.9 mt -67.74 -26.75 35.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.257 -178.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -59.9 -33.37 71.76 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.138 -178.257 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.471 ' O ' ' HB2' ' A' ' 70' ' ' SER . 4.5 t -101.73 66.48 1.06 Allowed 'General case' 0 N--CA 1.442 -0.838 0 CA-C-O 121.825 0.822 . . . . 0.0 109.526 179.015 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.471 ' HB2' ' O ' ' A' ' 69' ' ' THR . 63.2 m 80.37 -51.7 0.35 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 114.211 -1.359 . . . . 0.0 112.808 171.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.428 ' HA2' ' CE1' ' A' ' 66' ' ' TYR . . . 79.15 -174.04 55.29 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.633 -0.794 . . . . 0.0 111.271 -170.596 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.487 ' O ' HG23 ' A' ' 72' ' ' ILE . 47.5 mm -101.35 7.0 9.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-O 121.896 0.855 . . . . 0.0 110.341 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.534 ' HB3' ' CE2' ' A' ' 24' ' ' TYR . 14.6 ptm180 -55.43 -11.02 0.72 Allowed 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.423 -0.808 . . . . 0.0 113.103 -178.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 2.8 m -61.3 -10.03 6.3 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.955 0.407 . . . . 0.0 110.439 176.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 9.1 t0 . . . . . 0 CA--C 1.515 -0.393 0 CA-C-O 121.3 0.571 . . . . 0.0 109.75 -178.959 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.411 ' HA3' ' HD3' ' A' ' 11' ' ' PRO . . . . . . . . 0 N--CA 1.463 0.473 0 N-CA-C 113.966 0.346 . . . . 0.0 113.966 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.411 ' HD3' ' HA3' ' A' ' 10' ' ' GLY . 7.7 Cg_exo -70.53 139.09 36.79 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.775 2.317 . . . . 0.0 111.053 176.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -104.9 -175.15 2.71 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.493 0.663 . . . . 0.0 112.134 -173.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.7 m -126.05 164.22 21.33 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-N 114.342 -1.299 . . . . 0.0 109.742 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.542 ' HA ' ' CZ ' ' A' ' 37' ' ' PHE . 48.3 ttt85 -51.49 -55.78 17.0 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 122.64 0.376 . . . . 0.0 111.351 -179.038 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 43.5 mtp180 -56.53 -45.57 81.08 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.464 177.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.563 ' O ' HG21 ' A' ' 20' ' ' VAL . 1.9 mp0 -59.2 -46.92 87.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.943 -179.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.47 ' HB3' HD12 ' A' ' 39' ' ' LEU . . . -57.44 -44.18 84.5 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 121.086 0.47 . . . . 0.0 111.17 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 58.2 mt-30 -55.28 -41.75 72.69 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.024 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.49 -23.96 66.33 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.739 -178.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.563 HG21 ' O ' ' A' ' 16' ' ' GLN . 10.4 t -90.83 -19.76 7.07 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.687 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 -172.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.513 HG23 ' HB ' ' A' ' 27' ' ' ILE . 10.8 m -95.86 -28.79 14.54 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 114.055 -1.429 . . . . 0.0 108.417 -176.036 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 54.8 m -63.45 -36.63 84.4 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 114.083 -1.417 . . . . 0.0 108.939 167.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.558 HG23 HH11 ' A' ' 73' ' ' ARG . 90.8 m -76.21 -54.4 6.85 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.376 175.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.554 ' O ' HG13 ' A' ' 27' ' ' ILE . 51.1 m-85 -110.64 102.7 11.25 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-O 121.087 0.47 . . . . 0.0 109.796 179.144 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 6.1 p -75.62 2.17 12.56 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.376 -177.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.441 ' OD1' ' HB3' ' A' ' 24' ' ' TYR . 6.1 p-10 -87.71 -8.3 56.25 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.572 173.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.554 HG13 ' O ' ' A' ' 24' ' ' TYR . 2.9 mt -83.08 150.27 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 172.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.41 ' O ' ' HA ' ' A' ' 39' ' ' LEU . 1.1 p -141.43 135.94 30.85 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 120.912 -0.315 . . . . 0.0 110.785 -178.011 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 5.0 tt -94.64 107.16 19.16 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -178.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -119.07 164.66 15.18 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.753 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.466 ' HB2' ' HG2' ' A' ' 38' ' ' ARG . 90.5 m-20 56.71 42.39 26.92 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.6 0.715 . . . . 0.0 110.462 -175.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -74.6 103.38 4.89 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.913 -177.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -103.43 -19.73 14.31 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 173.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 126.03 -80.54 0.36 Allowed Glycine 0 N--CA 1.449 -0.469 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.405 -177.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.8 t -72.21 -35.6 68.94 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.262 0.553 . . . . 0.0 109.623 174.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 40.0 m80 -109.34 139.26 44.51 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.783 178.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.542 ' CZ ' ' HA ' ' A' ' 14' ' ' ARG . 55.6 p90 -174.23 164.04 3.91 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 176.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.466 ' HG2' ' HB2' ' A' ' 31' ' ' ASP . 29.3 ptt85 -128.68 144.83 51.25 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.205 0.526 . . . . 0.0 111.191 177.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.47 HD12 ' HB3' ' A' ' 17' ' ' ALA . 86.0 mt -99.18 127.1 45.1 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.934 176.322 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 27.5 t -103.7 119.93 53.05 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.529 177.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.411 HG13 ' CD2' ' A' ' 66' ' ' TYR . 16.3 t -91.19 108.76 20.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.214 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 33.9 mtt85 -105.19 168.15 9.26 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.038 -177.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.608 ' OD1' ' HG2' ' A' ' 47' ' ' ARG . 7.6 p-10 -104.02 -164.57 1.07 Allowed 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.616 179.182 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -66.17 -17.11 64.51 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -91.98 -24.32 19.28 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.477 0.656 . . . . 0.0 109.821 179.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 99.32 7.78 53.93 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.745 -0.741 . . . . 0.0 111.575 -179.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.608 ' HG2' ' OD1' ' A' ' 43' ' ' ASP . 15.9 ptt180 -78.35 150.46 33.21 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 177.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 23.3 ptp -79.12 116.86 19.67 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.309 0.576 . . . . 0.0 110.01 178.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 41.4 t -98.26 -31.94 3.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-O 121.478 0.656 . . . . 0.0 109.322 176.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 75.2 t-105 -155.11 155.76 34.59 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.53 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 16.7 ptt180 -158.5 142.66 15.67 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 175.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -150.55 147.92 28.04 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.214 -179.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.534 ' HB2' ' HG2' ' A' ' 56' ' ' GLU . 65.0 m95 -80.92 -176.73 6.05 Favored 'General case' 0 CA--C 1.509 -0.627 0 CA-C-O 122.15 0.976 . . . . 0.0 111.371 177.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -82.82 -31.54 28.06 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 113.465 -1.698 . . . . 0.0 110.079 -178.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -97.04 8.65 44.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.58 -0.737 . . . . 0.0 112.325 -173.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.534 ' HG2' ' HB2' ' A' ' 53' ' ' TRP . 38.9 mm-40 -71.02 128.14 90.9 Favored Pre-proline 0 C--N 1.328 -0.354 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 179.118 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -49.28 -37.45 40.04 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 124.074 3.182 . . . . 0.0 113.904 -173.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -131.15 43.82 3.04 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.143 0.497 . . . . 0.0 110.248 178.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.519 ' HB3' ' HB2' ' A' ' 56' ' ' GLU . . . -51.4 -45.36 62.48 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.545 -177.234 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -59.04 -38.63 93.25 Favored Glycine 0 N--CA 1.446 -0.646 0 CA-C-N 115.433 -0.803 . . . . 0.0 113.163 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 22.1 tp10 -60.06 -38.78 83.84 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.873 0.337 . . . . 0.0 110.996 -175.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -68.84 -43.54 73.79 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.33 -0.938 . . . . 0.0 111.021 177.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.445 ' O ' HG13 ' A' ' 67' ' ' ILE . 57.5 mt -58.52 -47.6 83.61 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.324 -0.438 . . . . 0.0 109.867 176.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -59.72 -33.34 71.5 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.698 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.414 HH11 ' HD2' ' A' ' 65' ' ' ARG . 9.5 tpp85 -70.07 -29.58 66.61 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.059 -175.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.411 ' CD2' HG13 ' A' ' 41' ' ' VAL . 80.0 t80 -87.45 -42.58 12.7 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.177 -0.609 . . . . 0.0 110.546 172.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.641 HG21 ' H ' ' A' ' 69' ' ' THR . 86.1 mt -57.04 -59.89 2.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.884 -179.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.52 ' O ' HG23 ' A' ' 69' ' ' THR . 57.1 mtm-85 51.85 30.28 6.9 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.242 0.544 . . . . 0.0 111.213 177.339 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.641 ' H ' HG21 ' A' ' 67' ' ' ILE . 13.2 t 61.55 21.12 11.83 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 126.102 1.761 . . . . 0.0 111.736 174.369 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 55.3 p -112.57 -62.18 1.62 Allowed 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.233 171.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 65.26 -175.83 14.02 Favored Glycine 0 N--CA 1.446 -0.69 0 CA-C-N 115.152 -0.931 . . . . 0.0 112.721 177.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.434 HG21 ' O ' ' A' ' 72' ' ' ILE . 40.9 mm -101.34 5.82 10.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-O 121.876 0.846 . . . . 0.0 109.35 178.486 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.558 HH11 HG23 ' A' ' 23' ' ' THR . 51.3 ttt180 -58.6 -70.4 0.15 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.376 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 10.0 t -97.06 4.14 51.51 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 178.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 32.9 t0 . . . . . 0 N--CA 1.466 0.35 0 CA-C-N 114.304 -1.316 . . . . 0.0 111.543 -176.868 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.574 ' HA2' ' HA ' ' A' ' 58' ' ' ASP . . . . . . . . 0 CA--C 1.523 0.559 0 N-CA-C 113.554 0.181 . . . . 0.0 113.554 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -81.31 170.85 14.38 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 123.371 2.714 . . . . 0.0 112.29 177.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 15.2 p90 -122.27 -173.85 2.77 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.015 0.436 . . . . 0.0 111.48 -176.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.402 ' H ' ' HB2' ' A' ' 16' ' ' GLN . 62.5 p -125.16 179.64 4.97 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.896 178.416 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 29.3 ttt180 -63.99 -41.32 97.55 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 174.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 25.7 ttm180 -58.72 -53.43 58.48 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.625 177.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.578 ' O ' HG21 ' A' ' 20' ' ' VAL . 2.0 mp0 -60.78 -48.61 81.02 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.541 178.192 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -50.26 -54.59 20.17 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.534 179.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -57.79 -36.77 72.64 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.191 -0.458 . . . . 0.0 112.11 -179.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.66 -29.48 70.05 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.027 0.441 . . . . 0.0 111.565 -179.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.578 HG21 ' O ' ' A' ' 16' ' ' GLN . 11.5 t -88.95 -25.31 5.77 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.827 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 -173.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.406 HG22 ' HB ' ' A' ' 27' ' ' ILE . 9.7 m -83.14 -33.51 26.25 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-N 113.909 -1.496 . . . . 0.0 110.994 -179.49 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.1 t -70.44 -25.34 63.16 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 173.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 33.6 m -76.0 -56.99 4.15 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.682 169.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.662 ' CE1' ' HA3' ' A' ' 71' ' ' GLY . 34.1 m-85 -113.14 105.72 13.79 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.282 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 31.5 m -86.71 11.6 12.65 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.59 0.709 . . . . 0.0 110.23 -176.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.554 ' OD1' ' HB ' ' A' ' 72' ' ' ILE . 7.5 p-10 -88.73 -6.98 57.06 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.917 -1.038 . . . . 0.0 108.748 170.44 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.617 HG13 ' O ' ' A' ' 24' ' ' TYR . 3.6 mt -82.45 142.32 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 172.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.0 p -136.05 130.13 33.0 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.748 -0.381 . . . . 0.0 111.095 -174.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.52 ' HA ' HD22 ' A' ' 39' ' ' LEU . 5.4 tt -86.08 117.3 24.83 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.335 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 70.7 mt-10 -123.4 173.3 8.08 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.295 -178.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.472 ' O ' ' HA ' ' A' ' 37' ' ' PHE . 0.4 OUTLIER 55.56 63.62 2.01 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.703 -1.135 . . . . 0.0 111.364 176.747 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -80.8 97.45 7.35 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.022 -179.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -106.94 -10.56 15.94 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 171.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 111.92 -81.97 0.3 Allowed Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.895 -0.669 . . . . 0.0 111.601 -177.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.7 m -76.74 -18.64 58.36 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.32 0.581 . . . . 0.0 110.18 177.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 38.3 m-70 -115.84 137.72 51.83 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.949 176.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.472 ' HA ' ' O ' ' A' ' 31' ' ' ASP . 48.6 p90 -167.17 156.94 10.84 Favored 'General case' 0 C--N 1.328 -0.337 0 O-C-N 123.824 0.703 . . . . 0.0 109.334 175.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 22.4 ptt180 -128.97 158.13 39.71 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.705 0.288 . . . . 0.0 111.056 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.52 HD22 ' HA ' ' A' ' 29' ' ' LEU . 75.0 mt -113.73 125.02 53.65 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.235 0.541 . . . . 0.0 109.978 174.077 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.497 HG23 ' CB ' ' A' ' 51' ' ' ARG . 61.9 t -103.37 123.97 57.25 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.823 177.03 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.433 HG11 ' CD1' ' A' ' 66' ' ' TYR . 3.1 t -93.92 111.0 24.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -104.47 168.24 9.22 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.963 -178.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -97.16 -166.72 1.43 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.637 0.256 . . . . 0.0 110.316 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 12.4 p -70.15 -17.18 63.17 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 111.99 0.366 . . . . 0.0 111.99 -176.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.411 ' HB3' ' HG2' ' A' ' 47' ' ' ARG . 23.5 tt0 -93.11 -22.69 18.95 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.002 0.43 . . . . 0.0 109.92 179.149 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 105.81 14.01 22.32 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.807 -0.711 . . . . 0.0 111.769 -178.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.411 ' HG2' ' HB3' ' A' ' 45' ' ' GLU . 14.9 mmt180 -76.74 124.93 28.41 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 178.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -69.09 106.07 2.67 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.133 0.492 . . . . 0.0 109.984 176.183 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 41.2 t -92.55 -33.11 5.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.444 -177.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 69.1 t-105 -156.4 149.17 23.84 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.893 -175.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.497 ' CB ' HG23 ' A' ' 40' ' ' VAL . 14.5 ptp180 -146.69 143.48 28.77 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 172.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -143.56 147.44 34.44 Favored 'General case' 0 C--N 1.319 -0.717 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 82.8 m95 -82.37 -171.26 3.35 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-O 121.594 0.711 . . . . 0.0 110.637 178.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -98.72 -16.78 18.85 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 114.417 -1.265 . . . . 0.0 110.294 -176.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -104.26 4.17 33.48 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.622 -177.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.532 ' HB2' ' HB1' ' A' ' 59' ' ' ALA . 20.7 mm-40 -61.26 131.93 92.4 Favored Pre-proline 0 C--O 1.235 0.316 0 CA-C-N 116.641 -0.254 . . . . 0.0 110.525 178.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_exo -40.01 -47.65 3.9 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 124.264 3.309 . . . . 0.0 113.243 -176.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.574 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . 5.0 t0 -140.22 70.03 1.36 Allowed 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 171.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.532 ' HB1' ' HB2' ' A' ' 56' ' ' GLU . . . -55.47 -35.98 66.09 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.823 178.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -58.16 -43.1 95.49 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.416 -0.811 . . . . 0.0 112.5 178.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.645 ' O ' ' HG3' ' A' ' 65' ' ' ARG . 5.3 tm-20 -58.65 -39.71 81.36 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.696 0.248 . . . . 0.0 111.003 -177.289 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.633 ' O ' ' HB2' ' A' ' 65' ' ' ARG . . . -76.4 -40.61 27.7 Favored Glycine 0 C--N 1.331 0.264 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.126 -178.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.486 ' O ' HG13 ' A' ' 67' ' ' ILE . 77.3 mt -66.26 -40.55 90.25 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 177.152 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -65.6 -26.42 67.83 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.822 177.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.645 ' HG3' ' O ' ' A' ' 61' ' ' GLU . 87.7 mtt180 -58.26 -48.91 78.93 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 121.112 0.482 . . . . 0.0 109.804 171.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.433 ' CD1' HG11 ' A' ' 41' ' ' VAL . 29.3 t80 -69.44 -48.36 61.13 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.378 178.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.486 HG13 ' O ' ' A' ' 63' ' ' LEU . 80.3 mt -56.86 -58.07 7.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.848 -178.211 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.477 ' O ' HG22 ' A' ' 69' ' ' THR . 13.7 mtm180 57.42 28.2 15.06 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-O 121.045 0.45 . . . . 0.0 110.611 178.003 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.477 HG22 ' O ' ' A' ' 68' ' ' ARG . 11.5 t 52.51 22.76 2.26 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.266 1.427 . . . . 0.0 112.001 -177.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 17.0 t -108.25 -64.73 1.19 Allowed 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 172.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.662 ' HA3' ' CE1' ' A' ' 24' ' ' TYR . . . 75.38 166.93 20.38 Favored Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.998 176.182 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.554 ' HB ' ' OD1' ' A' ' 26' ' ' ASN . 40.8 mm -87.74 -11.19 10.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 120.664 0.269 . . . . 0.0 111.164 -179.203 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 7.9 ttm180 -49.81 -74.16 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.931 0.396 . . . . 0.0 111.899 -178.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.8 m -83.32 2.15 37.61 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.76 0.791 . . . . 0.0 109.472 -177.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.518 ' HB3' ' HA ' ' A' ' 72' ' ' ILE . 17.2 t70 . . . . . 0 C--N 1.325 -0.486 0 CA-C-N 115.091 -0.958 . . . . 0.0 110.282 -178.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.41 ' HA3' ' HD3' ' A' ' 11' ' ' PRO . . . . . . . . 0 CA--C 1.516 0.127 0 CA-C-O 120.147 -0.252 . . . . 0.0 113.201 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.41 ' HD3' ' HA3' ' A' ' 10' ' ' GLY . 20.8 Cg_exo -64.75 153.05 79.71 Favored 'Trans proline' 0 C--O 1.234 0.314 0 C-N-CA 122.88 2.387 . . . . 0.0 111.704 177.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 16.8 p90 -120.32 -171.69 2.21 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.053 -176.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 46.1 p -125.02 171.65 10.07 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.84 179.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.474 ' O ' ' HG3' ' A' ' 18' ' ' GLN . 43.1 ttt180 -55.8 -45.86 78.15 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.651 0.739 . . . . 0.0 109.773 174.385 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -63.5 -50.27 70.29 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.765 -1.107 . . . . 0.0 111.772 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.578 ' O ' HG22 ' A' ' 20' ' ' VAL . 1.5 mp0 -58.78 -44.59 90.71 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.692 -0.231 . . . . 0.0 110.689 179.188 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -52.29 -49.0 65.03 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.256 178.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.474 ' HG3' ' O ' ' A' ' 14' ' ' ARG . 98.3 mt-30 -56.04 -45.1 79.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.374 -178.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.12 -31.15 70.86 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.079 -176.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.578 HG22 ' O ' ' A' ' 16' ' ' GLN . 8.2 t -87.55 -24.31 6.33 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.881 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 -171.278 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.521 HG21 ' HB ' ' A' ' 27' ' ' ILE . 10.3 m -86.4 -30.94 21.73 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 113.597 -1.638 . . . . 0.0 110.698 -178.389 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.6 p -68.56 -28.25 66.8 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 170.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 20.7 m -76.95 -56.79 4.28 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.089 172.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.609 ' HB3' ' OD1' ' A' ' 26' ' ' ASN . 79.0 m-85 -109.59 103.41 12.27 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 121.259 0.552 . . . . 0.0 109.948 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 6.0 p -71.72 -3.9 24.51 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.492 -0.776 . . . . 0.0 112.134 -178.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.609 ' OD1' ' HB3' ' A' ' 24' ' ' TYR . 25.6 p-10 -80.05 -16.68 54.54 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 174.405 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.552 HG13 ' O ' ' A' ' 24' ' ' TYR . 2.4 mt -76.72 146.63 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 173.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.526 ' OG1' ' HB ' ' A' ' 40' ' ' VAL . 1.6 p -141.59 123.26 15.16 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.013 0.435 . . . . 0.0 111.007 -177.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.451 ' CD2' ' HB3' ' A' ' 32' ' ' ASP . 6.5 tt -80.69 99.73 8.34 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 178.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 52.7 mm-40 -118.81 166.96 12.16 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.561 -177.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 58.97 34.63 23.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.347 -175.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.521 ' HA ' ' HB3' ' A' ' 37' ' ' PHE . 5.7 p-10 -68.03 99.8 0.91 Allowed 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.274 -0.876 . . . . 0.0 111.514 -178.152 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -104.97 9.21 34.61 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.018 176.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 125.06 -94.37 0.46 Allowed Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.409 -177.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.3 t -101.45 -13.38 17.97 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 173.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 13.9 m-70 -94.27 111.69 23.45 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.298 174.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.521 ' HB3' ' HA ' ' A' ' 32' ' ' ASP . 47.4 p90 -163.83 171.56 15.3 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -179.239 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.495 ' HA ' ' HA ' ' A' ' 53' ' ' TRP . 16.6 ptt-85 -130.79 144.63 51.58 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.083 0.468 . . . . 0.0 110.539 175.153 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.447 HD23 ' HA ' ' A' ' 29' ' ' LEU . 95.1 mt -95.33 117.12 29.75 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.532 176.346 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.526 ' HB ' ' OG1' ' A' ' 28' ' ' THR . 38.3 t -92.14 119.99 40.57 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.832 178.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.473 HG13 ' CD1' ' A' ' 66' ' ' TYR . 4.9 t -92.2 116.45 33.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 178.336 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 59.2 mtm180 -99.32 166.74 11.06 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.435 -178.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.62 ' OD1' ' HG2' ' A' ' 47' ' ' ARG . 9.7 p-10 -100.28 -166.71 1.36 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.23 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.83 -17.94 64.99 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.792 -179.185 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -89.32 -29.03 19.45 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -179.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 102.42 16.69 21.91 Favored Glycine 0 N--CA 1.444 -0.821 0 CA-C-N 115.276 -0.874 . . . . 0.0 112.309 -178.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.62 ' HG2' ' OD1' ' A' ' 43' ' ' ASP . 25.4 ptt180 -93.69 153.1 18.54 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 178.392 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.413 ' HG2' HG13 ' A' ' 40' ' ' VAL . 49.4 mtt -73.33 113.38 10.34 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.397 -178.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.44 HG23 ' HB3' ' A' ' 43' ' ' ASP . 46.1 t -97.84 -33.21 4.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 121.105 0.479 . . . . 0.0 110.264 178.114 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 74.0 t-105 -157.02 154.64 29.91 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.087 -177.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.426 ' HB2' ' HD2' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -151.13 140.46 21.38 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 174.366 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -141.51 143.75 33.96 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 177.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.503 ' HB2' ' HG2' ' A' ' 56' ' ' GLU . 69.2 m95 -80.23 -173.82 4.21 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 121.721 0.772 . . . . 0.0 111.069 -179.122 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -90.22 -28.32 18.93 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 114.008 -1.451 . . . . 0.0 110.089 -175.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 13.5 p90 -101.55 15.85 27.57 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.21 -0.904 . . . . 0.0 112.075 -173.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.505 ' HB2' ' HB2' ' A' ' 59' ' ' ALA . 19.3 mm-40 -77.87 135.23 63.62 Favored Pre-proline 0 C--N 1.323 -0.571 0 C-N-CA 121.232 -0.187 . . . . 0.0 110.828 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_exo -38.77 -46.67 2.66 Favored 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 124.637 3.558 . . . . 0.0 113.966 -173.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -145.33 67.8 1.23 Allowed 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 172.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.505 ' HB2' ' HB2' ' A' ' 56' ' ' GLU . . . -56.2 -36.12 68.06 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 115.263 -0.881 . . . . 0.0 111.232 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -57.0 -36.23 72.8 Favored Glycine 0 N--CA 1.447 -0.633 0 CA-C-N 115.486 -0.779 . . . . 0.0 113.78 -178.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.409 ' CD ' HH21 ' A' ' 65' ' ' ARG . 1.2 tm-20 -56.73 -49.15 76.07 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 117.211 0.505 . . . . 0.0 110.83 -176.472 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -70.21 -43.26 64.23 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.341 -177.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.546 ' O ' HG13 ' A' ' 67' ' ' ILE . 52.6 mt -66.39 -52.3 48.22 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.866 -0.167 . . . . 0.0 110.766 -178.418 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.666 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 87.9 m-20 -58.72 -40.76 84.65 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.717 -179.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.409 HH21 ' CD ' ' A' ' 61' ' ' GLU . 19.0 ttm180 -51.63 -50.99 59.2 Favored 'General case' 0 C--O 1.233 0.192 0 O-C-N 123.643 0.589 . . . . 0.0 110.446 178.504 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.473 ' CD1' HG13 ' A' ' 41' ' ' VAL . 44.5 t80 -63.36 -43.25 98.2 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.352 179.07 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.546 HG13 ' O ' ' A' ' 63' ' ' LEU . 87.4 mt -57.6 -31.49 39.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.927 -0.579 . . . . 0.0 112.329 -177.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.666 ' HG2' ' O ' ' A' ' 64' ' ' ASN . 10.7 mmm180 -65.02 -62.08 1.77 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.972 0.415 . . . . 0.0 111.257 -175.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 17.7 p -81.57 -26.21 35.18 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.327 -177.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 24.7 m -125.91 31.14 5.53 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -169.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.15 116.41 9.05 Favored Glycine 0 CA--C 1.522 0.528 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.099 170.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.48 ' O ' HG23 ' A' ' 72' ' ' ILE . 37.5 mm -93.99 2.6 9.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-O 121.029 0.442 . . . . 0.0 111.339 -171.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.42 ' HG3' ' N ' ' A' ' 74' ' ' THR . 45.0 ptt85 -68.63 -39.85 80.57 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 121.976 -0.453 . . . . 0.0 111.691 -175.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.42 ' N ' ' HG3' ' A' ' 73' ' ' ARG . 9.2 t -84.17 -2.63 57.18 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 178.439 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.34 0.188 0 O-C-N 124.894 1.371 . . . . 0.0 113.167 -179.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.538 ' HA3' ' HA ' ' A' ' 58' ' ' ASP . . . . . . . . 0 N--CA 1.442 -0.907 0 N-CA-C 111.52 -0.632 . . . . 0.0 111.52 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.402 ' HD3' ' O ' ' A' ' 57' ' ' PRO . 6.0 Cg_exo -76.45 131.67 12.86 Favored 'Trans proline' 0 N--CA 1.45 -1.034 0 C-N-CA 121.776 1.651 . . . . 0.0 111.031 173.264 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 19.8 p90 -98.39 -169.54 1.82 Allowed 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.73 -173.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.419 ' HB ' ' OE1' ' A' ' 16' ' ' GLN . 0.2 OUTLIER -122.82 156.51 34.4 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.401 179.425 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 32.1 ttt85 -56.4 -46.19 80.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.331 0.586 . . . . 0.0 110.477 178.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 26.2 ttm180 -53.07 -59.29 4.73 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.981 -1.008 . . . . 0.0 110.842 176.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.625 ' O ' HG22 ' A' ' 20' ' ' VAL . 15.9 mp0 -57.4 -44.09 84.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.456 -179.19 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.458 ' HB3' HD11 ' A' ' 39' ' ' LEU . . . -53.54 -45.83 69.96 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 121.248 0.547 . . . . 0.0 111.114 179.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -59.91 -36.84 77.83 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.912 179.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.74 -24.43 64.45 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.017 177.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.625 HG22 ' O ' ' A' ' 16' ' ' GLN . 2.9 t -83.97 -18.68 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 -178.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.516 HG21 ' HB ' ' A' ' 27' ' ' ILE . 0.0 OUTLIER -90.89 -32.15 16.13 Favored 'General case' 0 CA--C 1.506 -0.734 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 177.581 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 76.4 m -56.65 -34.42 67.31 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 113.623 -1.626 . . . . 0.0 109.46 168.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.557 HG22 HH11 ' A' ' 73' ' ' ARG . 59.8 m -87.51 -49.31 7.28 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.399 -0.818 . . . . 0.0 111.684 177.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.641 ' HB3' ' OD1' ' A' ' 26' ' ' ASN . 63.7 m-85 -118.71 109.7 16.41 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 121.018 0.437 . . . . 0.0 110.352 -178.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 11.8 p -78.72 0.59 26.12 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.663 -177.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.641 ' OD1' ' HB3' ' A' ' 24' ' ' TYR . 25.0 p-10 -82.76 -19.79 37.17 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 175.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.516 ' HB ' HG21 ' A' ' 21' ' ' THR . 1.1 mt -77.68 151.32 5.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 177.155 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.553 ' OG1' ' HB ' ' A' ' 40' ' ' VAL . 19.7 p -138.33 128.08 25.15 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.904 0.383 . . . . 0.0 111.119 179.589 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.517 ' HA ' HD21 ' A' ' 39' ' ' LEU . 6.5 tt -86.63 103.24 14.92 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 175.474 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.407 ' O ' ' HB3' ' A' ' 31' ' ' ASP . 53.2 mt-10 -121.74 174.12 7.03 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.929 -176.214 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.407 ' HB3' ' O ' ' A' ' 30' ' ' GLU . 12.4 t70 77.48 -62.9 0.37 Allowed 'General case' 0 N--CA 1.466 0.341 0 O-C-N 124.28 0.987 . . . . 0.0 110.242 -176.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.482 ' HA ' ' HB3' ' A' ' 37' ' ' PHE . 54.1 t0 38.7 78.56 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.554 -1.203 . . . . 0.0 112.99 -177.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -105.01 37.01 2.27 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 170.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.2 -102.13 2.75 Favored Glycine 0 N--CA 1.448 -0.558 0 CA-C-N 115.142 -0.936 . . . . 0.0 112.126 179.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.3 m -82.84 -15.05 53.07 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.229 0.538 . . . . 0.0 110.547 177.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 55.6 m170 -108.33 109.51 20.85 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.901 177.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.482 ' HB3' ' HA ' ' A' ' 32' ' ' ASP . 53.3 p90 -152.92 169.45 22.81 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 177.133 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.453 ' HA ' ' HA ' ' A' ' 53' ' ' TRP . 25.6 ptt-85 -128.45 147.98 50.69 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.181 -0.608 . . . . 0.0 111.556 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.539 ' HA ' ' O ' ' A' ' 28' ' ' THR . 90.5 mt -107.0 117.66 34.65 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.403 173.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.553 ' HB ' ' OG1' ' A' ' 28' ' ' THR . 53.0 t -95.11 119.02 42.6 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.135 178.34 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.457 ' HB ' ' HB3' ' A' ' 50' ' ' TRP . 61.4 t -88.79 110.88 21.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 121.106 0.479 . . . . 0.0 109.888 177.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.415 ' HA ' ' O ' ' A' ' 47' ' ' ARG . 33.4 mtm180 -98.77 176.66 5.54 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.214 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -94.76 -171.14 2.39 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 173.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.1 t -60.76 -24.08 65.48 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.64 -176.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -91.59 -31.59 15.84 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.924 0.393 . . . . 0.0 110.663 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 120.73 10.36 7.07 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.929 -177.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.415 ' O ' ' HA ' ' A' ' 42' ' ' ARG . 28.9 mmm180 -74.54 133.59 42.26 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 177.49 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.438 ' SD ' HG11 ' A' ' 40' ' ' VAL . 50.8 mtt -79.96 104.06 10.27 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.065 0.46 . . . . 0.0 110.622 -174.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 35.0 t -90.18 -31.62 5.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.339 -177.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.457 ' HB3' ' HB ' ' A' ' 41' ' ' VAL . 76.6 t-105 -151.65 161.12 43.2 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.774 -176.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 4.3 ptp180 -159.24 132.81 7.29 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 176.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -138.62 141.72 39.12 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.698 -0.228 . . . . 0.0 110.742 -178.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.575 ' HB2' ' HG3' ' A' ' 56' ' ' GLU . 84.1 m95 -83.44 -166.05 1.27 Allowed 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 121.54 0.686 . . . . 0.0 110.226 178.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.417 HD21 ' C ' ' A' ' 54' ' ' ASN . 0.2 OUTLIER -99.51 -33.05 10.82 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.86 -178.501 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -88.98 10.17 22.45 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.893 -173.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.575 ' HG3' ' HB2' ' A' ' 53' ' ' TRP . 26.5 mt-10 -82.29 131.89 54.62 Favored Pre-proline 0 C--N 1.325 -0.489 0 C-N-CA 120.971 -0.292 . . . . 0.0 110.976 -177.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.402 ' O ' ' HD3' ' A' ' 11' ' ' PRO . 44.3 Cg_exo -36.17 -53.71 0.95 Allowed 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 124.816 3.677 . . . . 0.0 114.109 -173.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.538 ' HA ' ' HA3' ' A' ' 10' ' ' GLY . 3.3 t70 -137.37 67.02 1.44 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.104 0.478 . . . . 0.0 110.129 174.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.0 -33.76 65.17 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.201 176.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -61.4 -33.74 85.74 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 121.223 -0.513 . . . . 0.0 113.284 -178.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -64.61 -34.97 79.51 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.586 0.232 . . . . 0.0 110.944 -178.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -69.84 -45.74 56.34 Favored Glycine 0 C--O 1.236 0.25 0 C-N-CA 120.396 -0.907 . . . . 0.0 111.201 178.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 43.3 mt -61.97 -43.44 98.84 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.381 -0.41 . . . . 0.0 109.932 177.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -61.26 -38.33 86.32 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.073 177.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 23.3 tpt85 -56.09 -38.95 71.41 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.356 177.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.513 ' O ' HG21 ' A' ' 69' ' ' THR . 46.2 t80 -79.04 -49.42 12.71 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.229 177.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 94.6 mt -56.51 -30.5 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -177.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.426 HH11 ' HD2' ' A' ' 68' ' ' ARG . 33.2 ttm180 -59.0 -30.27 67.87 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.433 -179.571 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.513 HG21 ' O ' ' A' ' 66' ' ' TYR . 10.0 t -91.84 62.35 4.33 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 122.003 0.906 . . . . 0.0 110.058 179.141 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 25.3 t 84.35 -37.41 0.06 Allowed 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 114.363 -1.29 . . . . 0.0 112.718 167.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 76.59 164.35 18.83 Favored Glycine 0 CA--C 1.522 0.526 0 C-N-CA 120.285 -0.96 . . . . 0.0 111.977 -174.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.488 ' O ' HG23 ' A' ' 72' ' ' ILE . 46.2 mm -101.07 6.0 10.0 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-O 121.79 0.805 . . . . 0.0 111.025 -175.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.557 HH11 HG22 ' A' ' 23' ' ' THR . 21.2 ttt180 -71.35 -29.82 65.43 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 121.257 -0.902 . . . . 0.0 110.881 178.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 2.9 m -79.1 11.69 2.65 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.109 178.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 12.1 t70 . . . . . 0 C--O 1.233 0.231 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.028 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.417 ' HA3' ' HD3' ' A' ' 11' ' ' PRO . . . . . . . . 0 CA--C 1.519 0.332 0 CA-C-O 119.936 -0.369 . . . . 0.0 112.94 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.417 ' HD3' ' HA3' ' A' ' 10' ' ' GLY . 16.5 Cg_exo -66.65 142.13 63.01 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.655 2.236 . . . . 0.0 111.812 175.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 42.9 p90 -112.39 151.46 29.78 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.707 0.765 . . . . 0.0 112.521 -174.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.628 ' HB ' ' HG2' ' A' ' 16' ' ' GLN . 0.3 OUTLIER -76.94 156.34 32.07 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 114.422 -1.263 . . . . 0.0 110.788 178.66 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 25.8 ttt180 -61.32 -46.73 89.05 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.796 0.331 . . . . 0.0 110.578 -178.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 84.3 mtt-85 -61.29 -36.75 80.94 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.368 176.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.628 ' HG2' ' HB ' ' A' ' 13' ' ' THR . 76.3 mm-40 -61.75 -48.84 78.91 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 178.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.49 ' HB1' HD22 ' A' ' 39' ' ' LEU . . . -53.58 -44.12 69.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.943 178.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.42 ' HA ' ' OE1' ' A' ' 18' ' ' GLN . 14.7 mm-40 -58.82 -38.05 77.78 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.778 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.402 ' HA ' HG21 ' A' ' 22' ' ' THR . . . -72.68 -25.28 61.2 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.448 -178.34 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.606 HG22 ' O ' ' A' ' 16' ' ' GLN . 10.6 t -87.18 -30.07 5.75 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.96 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 -173.392 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 23.4 m -79.51 -32.3 42.35 Favored 'General case' 0 N--CA 1.435 -1.217 0 CA-C-N 113.478 -1.692 . . . . 0.0 110.935 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.402 HG21 ' HA ' ' A' ' 19' ' ' ALA . 6.5 t -73.33 -23.31 60.23 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 174.237 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 26.9 m -78.93 -57.23 3.85 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.368 171.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.597 ' O ' HG13 ' A' ' 27' ' ' ILE . 38.5 m-85 -107.9 96.34 6.31 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 178.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 4.6 p -65.4 -5.16 6.83 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.516 -179.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.541 ' OD1' ' HB3' ' A' ' 24' ' ' TYR . 28.2 p-10 -79.02 -16.89 56.24 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 173.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.597 HG13 ' O ' ' A' ' 24' ' ' TYR . 2.6 mt -80.24 150.71 4.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 171.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 6.6 p -143.91 124.71 14.21 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.003 178.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.531 ' HA ' HD23 ' A' ' 39' ' ' LEU . 5.8 tt -81.87 98.43 8.51 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 176.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -119.48 169.37 10.1 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.129 -0.942 . . . . 0.0 109.659 -174.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.0 t70 62.28 26.07 15.6 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.287 0.565 . . . . 0.0 109.982 176.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.531 ' HA ' ' HB3' ' A' ' 37' ' ' PHE . 17.8 t70 -68.28 119.9 13.57 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.152 -173.377 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -146.57 52.6 1.11 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.42 177.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.25 -101.56 2.22 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.462 177.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.9 m -91.43 -3.02 57.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.312 0.577 . . . . 0.0 110.367 178.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 47.8 m80 -115.84 108.09 15.86 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.739 177.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.531 ' HB3' ' HA ' ' A' ' 32' ' ' ASP . 53.5 p90 -160.94 160.81 31.27 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.036 178.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 68.3 mtm180 -134.03 138.01 45.09 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.26 0.552 . . . . 0.0 111.696 -178.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.531 HD23 ' HA ' ' A' ' 29' ' ' LEU . 91.1 mt -92.66 114.27 26.77 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.303 173.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 31.5 t -94.8 111.57 25.77 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.958 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.409 HG13 ' CD1' ' A' ' 66' ' ' TYR . 39.0 t -85.19 117.62 30.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 178.115 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.464 ' O ' ' HB2' ' A' ' 26' ' ' ASN . 63.2 mtp180 -110.35 161.45 15.63 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.258 -177.453 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.476 ' HB3' ' CG ' ' A' ' 47' ' ' ARG . 7.7 t70 -92.56 177.83 6.0 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.572 -177.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.453 ' H ' ' CG ' ' A' ' 43' ' ' ASP . 7.0 p -61.28 -22.36 64.78 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 122.59 0.356 . . . . 0.0 111.862 -177.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -88.84 -9.74 50.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.427 0.632 . . . . 0.0 109.967 178.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 93.79 4.62 63.42 Favored Glycine 0 N--CA 1.451 -0.305 0 CA-C-N 115.767 -0.652 . . . . 0.0 112.994 177.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.476 ' CG ' ' HB3' ' A' ' 43' ' ' ASP . 14.1 ptt180 -73.74 140.75 46.16 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 110.321 -0.252 . . . . 0.0 110.321 177.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 69.1 mtm -71.88 122.16 20.3 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 178.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 20.3 t -107.2 -29.84 2.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.611 -178.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 73.7 t-105 -157.99 151.54 23.57 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.573 -175.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 11.2 ptp180 -152.67 132.87 13.54 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 173.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -134.27 149.71 50.95 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.561 -0.291 . . . . 0.0 111.058 -178.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.848 ' HB2' ' HG3' ' A' ' 56' ' ' GLU . 86.5 m95 -75.74 -170.11 1.23 Allowed 'General case' 0 CA--C 1.514 -0.434 0 CA-C-O 121.905 0.859 . . . . 0.0 111.498 177.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -101.52 -37.76 8.27 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 114.223 -1.353 . . . . 0.0 110.74 178.144 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -88.02 3.69 47.88 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.052 -173.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.848 ' HG3' ' HB2' ' A' ' 53' ' ' TRP . 35.7 mt-10 -74.43 128.91 85.05 Favored Pre-proline 0 N--CA 1.452 -0.372 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.179 178.039 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 56' ' ' GLU . 32.5 Cg_exo -59.25 -14.44 24.34 Favored 'Trans proline' 0 N--CA 1.475 0.414 0 C-N-CA 123.293 2.662 . . . . 0.0 113.668 -175.159 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -133.6 24.95 4.06 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.756 -0.202 . . . . 0.0 111.46 -177.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.535 ' HB1' ' HB2' ' A' ' 56' ' ' GLU . . . -58.66 -48.08 82.28 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.015 0.436 . . . . 0.0 111.209 -174.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -65.14 -28.51 73.63 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.926 -179.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -68.02 -40.79 82.89 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.623 0.249 . . . . 0.0 110.532 -177.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -66.99 -39.77 93.27 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.51 -0.852 . . . . 0.0 111.291 178.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.446 ' O ' HG13 ' A' ' 67' ' ' ILE . 68.9 mt -63.91 -48.85 74.95 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.387 -0.407 . . . . 0.0 110.779 177.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.51 ' O ' ' HG3' ' A' ' 68' ' ' ARG . 96.0 m-20 -61.55 -36.71 81.37 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.748 0.309 . . . . 0.0 110.66 178.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 65' ' ' ARG . 20.4 ttt85 -53.59 -42.2 67.37 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.499 176.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.409 ' CD1' HG13 ' A' ' 41' ' ' VAL . 43.3 t80 -72.57 -50.5 25.1 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.382 175.207 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.446 HG13 ' O ' ' A' ' 63' ' ' LEU . 97.1 mt -48.38 -47.67 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 -176.116 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.51 ' HG3' ' O ' ' A' ' 64' ' ' ASN . 15.5 mtp180 -56.78 -54.08 50.48 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -173.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.6 t -90.96 10.97 24.34 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 120.691 -0.404 . . . . 0.0 111.175 -174.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 17.1 m -120.44 -61.83 1.53 Allowed 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.208 -0.597 . . . . 0.0 111.12 177.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 43.55 74.48 0.2 Allowed Glycine 0 CA--C 1.525 0.701 0 CA-C-N 115.281 -0.872 . . . . 0.0 113.41 -173.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.477 ' O ' HG23 ' A' ' 72' ' ' ILE . 30.2 mm -89.2 6.9 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-O 121.355 0.597 . . . . 0.0 110.973 -174.306 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 35.0 ptt180 -64.2 -35.03 79.47 Favored 'General case' 0 C--N 1.329 -0.298 0 O-C-N 122.068 -0.395 . . . . 0.0 111.814 -175.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 15.3 t -77.65 -5.6 50.93 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 177.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 17.6 t0 . . . . . 0 CA--C 1.518 -0.266 0 CA-C-O 122.299 1.047 . . . . 0.0 111.679 -172.992 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.456 ' HA2' ' HA ' ' A' ' 58' ' ' ASP . . . . . . . . 0 CA--C 1.519 0.293 0 CA-C-O 120.132 -0.26 . . . . 0.0 112.979 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.446 ' HD3' ' HA3' ' A' ' 10' ' ' GLY . 6.1 Cg_exo -72.03 162.23 42.44 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.597 2.198 . . . . 0.0 111.2 178.36 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -123.75 151.54 43.13 Favored 'General case' 0 CA--C 1.505 -0.783 0 CA-C-O 121.756 0.789 . . . . 0.0 112.096 -176.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -91.8 165.64 13.16 Favored 'General case' 0 N--CA 1.433 -1.275 0 CA-C-N 113.993 -1.458 . . . . 0.0 109.431 176.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.404 ' O ' ' HG3' ' A' ' 18' ' ' GLN . 47.8 ttt180 -61.97 -51.04 69.68 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 120.737 0.303 . . . . 0.0 110.693 -177.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 37.2 ttp180 -54.4 -40.17 67.98 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.481 177.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.601 ' O ' HG22 ' A' ' 20' ' ' VAL . 85.6 mm-40 -62.97 -47.86 81.36 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.305 177.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.71 -42.88 84.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.301 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.404 ' HG3' ' O ' ' A' ' 14' ' ' ARG . 24.4 mt-30 -61.04 -44.4 97.46 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.856 -178.506 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.1 -37.8 86.48 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.195 0.521 . . . . 0.0 111.202 -179.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.601 HG22 ' O ' ' A' ' 16' ' ' GLN . 10.2 t -77.8 -22.87 13.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.405 -175.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.408 HG21 ' HB ' ' A' ' 27' ' ' ILE . 0.0 OUTLIER -83.35 -33.23 25.89 Favored 'General case' 0 CA--C 1.516 -0.362 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.481 176.168 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.3 p -68.04 -19.68 64.91 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 174.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.3 m -89.74 -53.46 4.5 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.211 171.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.611 ' O ' HG13 ' A' ' 27' ' ' ILE . 47.3 m-85 -113.92 102.26 10.04 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 177.488 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 11.6 p -80.78 5.0 17.16 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.96 0.41 . . . . 0.0 111.469 -178.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.515 ' HB3' HG21 ' A' ' 72' ' ' ILE . 25.7 p-10 -82.34 -21.64 35.9 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 171.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.611 HG13 ' O ' ' A' ' 24' ' ' TYR . 1.0 OUTLIER -74.69 147.46 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 170.991 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.48 ' O ' ' HA ' ' A' ' 39' ' ' LEU . 2.5 p -142.05 134.51 28.06 Favored 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 120.571 -0.452 . . . . 0.0 110.881 -176.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.523 HD23 ' HB3' ' A' ' 32' ' ' ASP . 1.5 tt -90.29 97.17 11.03 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.67 0.747 . . . . 0.0 109.367 -179.087 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.45 ' HB2' ' HG3' ' A' ' 38' ' ' ARG . 14.5 mm-40 -104.05 161.96 13.56 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 114.482 -1.236 . . . . 0.0 109.481 -174.313 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.461 ' HB2' ' HG2' ' A' ' 38' ' ' ARG . 1.0 OUTLIER 56.25 30.72 17.16 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 123.541 0.526 . . . . 0.0 111.692 179.411 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.523 ' HB3' HD23 ' A' ' 29' ' ' LEU . 16.2 p-10 -71.35 90.58 0.95 Allowed 'General case' 0 N--CA 1.446 -0.674 0 CA-C-O 122.045 0.926 . . . . 0.0 111.385 -176.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 14.4 tm0? -111.77 -15.49 13.39 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.649 -1.16 . . . . 0.0 109.442 178.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 113.41 -79.02 0.26 Allowed Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.468 -175.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 11.7 m -63.17 -33.0 74.52 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.442 0.639 . . . . 0.0 109.732 175.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 68.2 m170 -115.61 141.62 47.82 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.929 173.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 55.6 p90 -176.31 145.13 0.58 Allowed 'General case' 0 C--N 1.326 -0.432 0 O-C-N 124.077 0.861 . . . . 0.0 109.318 169.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.461 ' HG2' ' HB2' ' A' ' 31' ' ' ASP . 16.1 ptt180 -132.75 150.2 52.19 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.87 0.367 . . . . 0.0 111.145 -178.244 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.48 ' HA ' ' O ' ' A' ' 28' ' ' THR . 84.0 mt -103.31 115.75 31.15 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 174.123 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.447 HG23 ' HB3' ' A' ' 51' ' ' ARG . 48.6 t -99.33 115.39 39.94 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.836 177.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.467 HG13 ' CD1' ' A' ' 66' ' ' TYR . 50.2 t -82.92 104.64 11.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 175.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.48 ' O ' ' HB2' ' A' ' 26' ' ' ASN . 50.3 mtt180 -102.16 163.74 12.07 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.592 0.711 . . . . 0.0 111.27 -177.38 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.678 ' HB3' ' HB2' ' A' ' 47' ' ' ARG . 4.3 t70 -89.45 176.08 7.05 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 114.514 -1.221 . . . . 0.0 109.444 177.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.437 ' H ' ' CG ' ' A' ' 43' ' ' ASP . 0.3 OUTLIER -67.35 -18.99 65.37 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 120.855 0.36 . . . . 0.0 111.298 -174.741 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -93.37 -0.2 56.65 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 121.46 0.647 . . . . 0.0 110.044 175.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 89.14 8.46 68.76 Favored Glycine 0 N--CA 1.452 -0.275 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.431 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.678 ' HB2' ' HB3' ' A' ' 43' ' ' ASP . 39.4 mtt180 -61.03 132.97 55.53 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 122.278 0.231 . . . . 0.0 110.775 177.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 10.0 mmt -75.65 97.36 3.78 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.2 t -84.45 -38.83 13.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.033 0.444 . . . . 0.0 110.551 -175.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 69.8 t-105 -166.17 153.8 10.16 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.711 -178.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.447 ' HB3' HG23 ' A' ' 40' ' ' VAL . 9.0 ptt180 -152.14 148.02 27.14 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.034 0.445 . . . . 0.0 111.14 177.025 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -148.79 143.09 26.13 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.17 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.439 ' HA ' ' HA ' ' A' ' 38' ' ' ARG . 72.0 m95 -87.98 -171.34 3.36 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 122.208 1.004 . . . . 0.0 111.539 -178.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -82.28 -35.63 27.84 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 113.481 -1.69 . . . . 0.0 109.83 178.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 32.2 p90 -87.98 17.88 4.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.65 -178.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.51 ' HB2' ' HB3' ' A' ' 59' ' ' ALA . 11.8 mm-40 -85.23 116.75 66.83 Favored Pre-proline 0 C--N 1.327 -0.401 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 175.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.423 ' HD2' ' HA ' ' A' ' 56' ' ' GLU . 3.6 Cg_endo -46.34 -39.92 21.95 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 124.269 3.312 . . . . 0.0 114.163 -172.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.456 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . 4.6 t0 -138.1 55.89 1.75 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.088 0.47 . . . . 0.0 110.14 178.324 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.51 ' HB3' ' HB2' ' A' ' 56' ' ' GLU . . . -56.4 -39.89 73.76 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.277 -179.452 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -59.45 -33.0 74.37 Favored Glycine 0 N--CA 1.45 -0.387 0 CA-C-N 115.384 -0.825 . . . . 0.0 114.071 -177.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.449 ' HB2' ' OD1' ' A' ' 58' ' ' ASP . 35.7 tt0 -62.52 -43.07 99.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 117.608 0.704 . . . . 0.0 110.96 -176.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -73.28 -41.2 47.01 Favored Glycine 0 C--O 1.237 0.288 0 C-N-CA 120.539 -0.838 . . . . 0.0 111.557 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 72.6 mt -64.73 -51.97 59.56 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.547 -0.326 . . . . 0.0 110.851 -179.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.448 ' HA ' ' HB ' ' A' ' 67' ' ' ILE . 93.2 m-20 -60.56 -32.64 71.71 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.608 0.242 . . . . 0.0 111.006 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 11.2 tpt180 -55.45 -50.75 69.03 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.262 176.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.467 ' CD1' HG13 ' A' ' 41' ' ' VAL . 38.9 t80 -72.53 -43.27 63.75 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.447 179.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.53 HG21 ' CZ ' ' A' ' 24' ' ' TYR . 59.9 mt -49.61 -44.84 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-N 115.617 -0.72 . . . . 0.0 112.262 -178.507 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 61.9 ttt180 -68.37 -53.77 21.73 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -175.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 8.8 t -76.34 -35.65 58.65 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 112.37 0.508 . . . . 0.0 112.37 -169.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 25.1 m -90.21 -50.84 5.75 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.69 -177.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 48.25 85.14 0.02 OUTLIER Glycine 0 CA--C 1.525 0.667 0 CA-C-N 115.515 -0.766 . . . . 0.0 114.632 179.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.515 HG21 ' HB3' ' A' ' 26' ' ' ASN . 1.8 mp -80.74 5.37 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 CA-C-O 122.369 1.08 . . . . 0.0 109.63 177.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.502 ' HB3' ' CE2' ' A' ' 24' ' ' TYR . 52.3 ptt85 -57.89 -16.92 13.58 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 114.833 -1.076 . . . . 0.0 112.036 178.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 7.2 t -75.26 9.26 2.16 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.272 0.558 . . . . 0.0 109.961 176.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.424 ' H ' ' C ' ' A' ' 73' ' ' ARG . 4.8 t70 . . . . . 0 N--CA 1.467 0.408 0 CA-C-N 114.886 -1.052 . . . . 0.0 112.543 169.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.509 ' HA3' ' O ' ' A' ' 57' ' ' PRO . . . . . . . . 0 N--CA 1.441 -0.998 0 N-CA-C 110.991 -0.844 . . . . 0.0 110.991 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -75.7 130.39 12.54 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 121.623 1.548 . . . . 0.0 110.958 172.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -102.58 -178.46 3.69 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 121.806 0.812 . . . . 0.0 111.923 -172.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.98 151.49 32.28 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 114.705 -1.134 . . . . 0.0 108.988 176.308 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.54 ' O ' ' HG3' ' A' ' 18' ' ' GLN . 43.7 ttt-85 -59.36 -48.98 79.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.033 0.444 . . . . 0.0 109.944 -178.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 72.5 mtp85 -56.7 -45.69 81.66 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.241 177.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.515 ' O ' HG22 ' A' ' 20' ' ' VAL . 12.4 mm100 -63.31 -39.87 95.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.489 179.255 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.402 ' HB2' HD23 ' A' ' 39' ' ' LEU . . . -62.06 -43.38 98.96 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.685 177.03 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.54 ' HG3' ' O ' ' A' ' 14' ' ' ARG . 28.0 mt-30 -51.71 -44.37 63.16 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.022 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.79 -27.04 68.91 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.107 -179.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.515 HG22 ' O ' ' A' ' 16' ' ' GLN . 14.1 t -92.46 -16.13 7.92 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.752 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 -172.619 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 12.0 m -93.31 -31.42 14.69 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-N 113.972 -1.467 . . . . 0.0 107.588 -176.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 99.0 m -61.65 -38.1 86.46 Favored 'General case' 0 N--CA 1.436 -1.175 0 CA-C-N 113.628 -1.624 . . . . 0.0 109.299 166.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.533 HG21 ' HE ' ' A' ' 73' ' ' ARG . 36.7 m -75.03 -53.86 8.18 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.992 177.139 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.675 ' O ' HG13 ' A' ' 27' ' ' ILE . 89.9 m-85 -117.45 96.88 5.6 Favored 'General case' 0 N--CA 1.44 -0.975 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 178.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 48.3 m -76.12 5.72 6.37 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.865 0.364 . . . . 0.0 111.506 -177.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.546 ' ND2' ' HB3' ' A' ' 24' ' ' TYR . 0.1 OUTLIER -76.84 -16.43 59.42 Favored 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 108.598 -0.889 . . . . 0.0 108.598 167.803 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.675 HG13 ' O ' ' A' ' 24' ' ' TYR . 2.2 mt -84.4 151.45 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 171.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.558 ' OG1' ' HB ' ' A' ' 40' ' ' VAL . 11.1 p -138.14 117.41 12.73 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 119.954 -0.698 . . . . 0.0 111.068 178.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.527 ' HA ' HD21 ' A' ' 39' ' ' LEU . 4.8 tt -83.23 99.03 9.71 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 174.239 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.507 ' HG2' ' HB ' ' A' ' 28' ' ' THR . 74.2 mm-40 -132.9 -173.55 3.22 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.957 -173.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.7 t70 69.53 17.25 8.01 Favored 'General case' 0 CA--C 1.531 0.214 0 O-C-N 124.072 0.857 . . . . 0.0 110.505 177.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -57.59 95.54 0.02 OUTLIER 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.659 178.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -122.79 10.11 9.56 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.206 0.527 . . . . 0.0 110.206 -178.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 119.31 -88.98 0.45 Allowed Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.583 178.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 9.8 t -89.36 -17.04 29.63 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 120.702 0.286 . . . . 0.0 110.569 -176.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 30.1 p80 -124.41 145.79 49.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.153 0.501 . . . . 0.0 111.424 178.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -166.67 167.91 14.87 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.298 -1.319 . . . . 0.0 107.608 174.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.404 ' HB3' ' HA ' ' A' ' 53' ' ' TRP . 30.9 ptt180 -153.0 156.29 38.54 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.115 0.484 . . . . 0.0 112.076 -175.285 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.527 HD21 ' HA ' ' A' ' 29' ' ' LEU . 89.2 mt -102.03 117.95 35.89 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.961 178.22 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.558 ' HB ' ' OG1' ' A' ' 28' ' ' THR . 37.7 t -100.89 113.91 38.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 116.278 -0.419 . . . . 0.0 109.983 178.54 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 46.5 t -90.04 122.4 41.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.022 0.439 . . . . 0.0 110.051 178.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 57.9 mtp180 -105.06 163.88 12.22 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.476 -178.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -88.66 -171.74 3.45 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 177.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.1 p -62.31 -22.26 65.92 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.918 -176.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -91.71 -31.46 15.8 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.891 0.377 . . . . 0.0 110.54 179.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 119.6 10.0 8.08 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.418 -0.896 . . . . 0.0 112.541 -177.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 92.4 mtt180 -82.57 127.56 33.47 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 177.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.13 118.62 10.13 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.264 0.554 . . . . 0.0 110.785 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 41.9 t -97.23 -35.78 5.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.07 -179.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 68.8 t-105 -158.14 119.32 3.49 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.177 -178.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.459 ' HB3' HG13 ' A' ' 40' ' ' VAL . 36.4 ptt180 -112.68 129.02 56.54 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.817 174.089 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -122.76 142.09 51.1 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.555 -177.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.513 ' HB2' ' HG3' ' A' ' 56' ' ' GLU . 95.0 m95 -79.36 -169.13 1.76 Allowed 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 121.709 0.766 . . . . 0.0 110.923 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -101.32 -30.41 11.5 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 114.701 -1.136 . . . . 0.0 110.932 -176.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 40.6 p90 -90.29 3.69 52.89 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.557 -174.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.513 ' HG3' ' HB2' ' A' ' 53' ' ' TRP . 40.0 mt-10 -75.42 132.51 75.72 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 120.752 0.31 . . . . 0.0 110.275 179.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.509 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 39.8 Cg_endo -66.5 -11.65 32.54 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 123.225 2.617 . . . . 0.0 113.394 -173.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -137.57 28.39 2.72 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.648 -0.251 . . . . 0.0 110.561 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.554 ' O ' ' HG ' ' A' ' 63' ' ' LEU . . . -53.03 -49.61 65.93 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.847 -176.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -69.82 -30.45 70.39 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.653 -178.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -70.53 -34.06 71.85 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.841 0.321 . . . . 0.0 110.279 -175.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.472 ' O ' ' HB3' ' A' ' 65' ' ' ARG . . . -74.24 -39.22 44.67 Favored Glycine 0 C--O 1.238 0.354 0 C-N-CA 120.382 -0.913 . . . . 0.0 111.583 177.158 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.554 ' HG ' ' O ' ' A' ' 59' ' ' ALA . 70.2 mt -67.51 -45.31 76.15 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.539 -0.33 . . . . 0.0 110.513 178.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -61.25 -32.34 72.14 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.557 176.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.472 ' HB3' ' O ' ' A' ' 62' ' ' GLY . 0.4 OUTLIER -57.32 -44.83 84.53 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.301 -0.409 . . . . 0.0 109.922 175.473 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 14.1 t80 -67.11 -53.19 33.16 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.079 176.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 97.3 mt -50.92 -51.37 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.847 -178.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 45.9 ttm105 -55.99 -32.41 63.92 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.274 -173.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 5.1 t -111.38 15.01 21.53 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.449 -0.501 . . . . 0.0 111.705 -174.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 16.2 m -134.66 -54.98 0.83 Allowed 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.849 -0.341 . . . . 0.0 111.15 -179.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.515 ' HA2' ' CE1' ' A' ' 24' ' ' TYR . . . 47.15 75.82 0.17 Allowed Glycine 0 CA--C 1.527 0.812 0 CA-C-N 115.552 -0.749 . . . . 0.0 114.114 -177.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.46 HG23 ' HB3' ' A' ' 26' ' ' ASN . 1.8 mp -72.94 -20.65 19.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-N 117.132 0.466 . . . . 0.0 111.912 -174.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.533 ' HE ' HG21 ' A' ' 23' ' ' THR . 0.0 OUTLIER -57.78 -65.39 0.64 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.237 0.541 . . . . 0.0 111.525 -178.403 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 2.8 t -72.6 -0.8 13.91 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.355 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 35.0 t70 . . . . . 0 N--CA 1.47 0.53 0 CA-C-N 113.719 -1.582 . . . . 0.0 112.644 174.026 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.54 ' HA2' ' HA ' ' A' ' 58' ' ' ASP . . . . . . . . 0 CA--C 1.52 0.358 0 N-CA-C 114.584 0.594 . . . . 0.0 114.584 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.441 ' HD3' ' HA3' ' A' ' 10' ' ' GLY . 6.6 Cg_exo -72.16 144.2 41.53 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 123.159 2.573 . . . . 0.0 112.515 -177.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -112.12 -173.3 2.22 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.143 -178.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.435 ' OG1' ' HG2' ' A' ' 16' ' ' GLN . 28.8 p -125.07 176.31 6.77 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 175.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 22.8 ttt180 -61.67 -46.7 88.6 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.488 0.661 . . . . 0.0 109.489 175.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 36.1 mmt180 -55.02 -48.79 72.91 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.558 -1.201 . . . . 0.0 110.675 178.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.6 ' O ' HG23 ' A' ' 20' ' ' VAL . 15.7 mm100 -62.7 -49.15 76.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.211 178.193 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -52.76 -49.26 65.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.684 179.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -55.65 -41.82 74.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.312 -179.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.44 -29.11 70.45 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.982 -179.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.6 HG23 ' O ' ' A' ' 16' ' ' GLN . 3.3 t -91.33 -26.05 5.17 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.958 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 -171.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 16.2 m -79.55 -32.97 42.2 Favored 'General case' 0 N--CA 1.437 -1.117 0 CA-C-N 113.95 -1.477 . . . . 0.0 110.655 179.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.8 p -73.54 -26.08 60.69 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 121.082 0.467 . . . . 0.0 109.742 172.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.445 HG21 ' HD2' ' A' ' 73' ' ' ARG . 89.8 m -76.2 -55.09 5.9 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.783 172.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.599 ' O ' HG13 ' A' ' 27' ' ' ILE . 70.1 m-85 -116.63 101.53 8.68 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 175.61 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 45.0 m -82.16 17.39 1.65 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.207 0.527 . . . . 0.0 111.747 -176.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.529 ' OD1' ' HB3' ' A' ' 24' ' ' TYR . 25.1 p-10 -87.91 -20.37 26.04 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 167.238 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.599 HG13 ' O ' ' A' ' 24' ' ' TYR . 2.4 mt -73.57 146.92 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 171.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -149.46 130.3 14.23 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 120.225 -0.59 . . . . 0.0 111.566 -179.094 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.519 ' HA ' HD22 ' A' ' 39' ' ' LEU . 5.9 tt -79.3 103.12 9.01 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.229 178.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -112.76 166.41 11.39 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.497 -176.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.6 t70 66.39 46.37 1.96 Allowed 'General case' 0 N--CA 1.465 0.304 0 O-C-N 123.65 0.594 . . . . 0.0 110.542 176.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -64.95 99.93 0.38 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.454 -179.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 21.8 tt0 -129.63 57.56 1.67 Allowed 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.494 0.664 . . . . 0.0 109.422 175.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 74.52 -112.81 3.85 Favored Glycine 0 N--CA 1.45 -0.372 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.741 -178.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 30.2 t -87.67 -1.5 57.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.092 0.472 . . . . 0.0 110.119 177.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -101.44 124.85 47.77 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 176.164 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -173.8 170.49 3.94 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 178.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 30.1 ptt-85 -145.18 145.39 31.33 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.217 0.532 . . . . 0.0 111.433 178.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.519 HD22 ' HA ' ' A' ' 29' ' ' LEU . 93.9 mt -90.67 110.75 21.91 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.284 177.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 84.2 t -89.93 115.05 28.72 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.049 173.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.5 t -91.82 108.73 20.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.455 ' O ' ' HB2' ' A' ' 26' ' ' ASN . 60.3 mtt85 -95.93 170.21 9.45 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.868 -178.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -96.65 -171.19 2.21 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.974 0.416 . . . . 0.0 110.002 179.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.46 -19.99 66.17 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.687 -176.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -91.08 -28.67 17.78 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.24 0.543 . . . . 0.0 109.944 177.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 114.18 12.19 11.28 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.798 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.418 ' O ' ' HA ' ' A' ' 42' ' ' ARG . 40.5 mtt-85 -80.33 137.67 36.61 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.081 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -76.72 96.87 4.32 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.42 0.629 . . . . 0.0 110.599 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 15.8 t -83.54 -31.27 8.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.523 -177.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.433 ' CD1' HD22 ' A' ' 63' ' ' LEU . 75.4 t-105 -150.38 159.15 44.67 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.261 -177.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 27.5 ptt-85 -158.4 131.4 7.3 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 178.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -140.94 140.75 34.49 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 110.463 -0.199 . . . . 0.0 110.463 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.619 ' HB2' ' HG3' ' A' ' 56' ' ' GLU . 72.4 m95 -77.27 -173.89 3.02 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-O 121.764 0.793 . . . . 0.0 110.752 -179.177 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -94.18 -26.37 16.71 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 114.254 -1.339 . . . . 0.0 109.837 -178.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -98.33 6.16 47.58 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.802 -174.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.619 ' HG3' ' HB2' ' A' ' 53' ' ' TRP . 38.2 mt-10 -76.45 129.97 78.37 Favored Pre-proline 0 C--N 1.326 -0.43 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.195 178.618 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 56' ' ' GLU . 31.7 Cg_exo -59.2 -20.07 52.99 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 123.431 2.754 . . . . 0.0 113.136 -175.155 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.54 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . 13.2 m-20 -133.6 37.92 3.28 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.541 179.599 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -54.95 -50.18 69.54 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 120.925 0.393 . . . . 0.0 111.141 -178.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -63.33 -30.28 77.07 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.789 179.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.4 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 23.5 tp10 -60.79 -42.18 97.07 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.784 0.325 . . . . 0.0 110.367 -178.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.465 ' O ' ' HB3' ' A' ' 65' ' ' ARG . . . -77.05 -38.64 29.62 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.093 179.354 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.519 ' O ' HG13 ' A' ' 67' ' ' ILE . 85.5 mt -63.17 -52.76 61.08 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.723 0.297 . . . . 0.0 110.357 179.492 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -61.99 -32.13 72.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.632 178.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.465 ' HB3' ' O ' ' A' ' 62' ' ' GLY . 7.0 tpt85 -54.29 -46.74 72.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.669 177.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -74.86 -44.14 50.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.985 178.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.519 HG13 ' O ' ' A' ' 63' ' ' LEU . 89.5 mt -52.65 -44.57 46.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-O 120.897 0.379 . . . . 0.0 111.083 -179.119 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 23.6 ttt180 -58.83 -24.24 61.73 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.432 -0.803 . . . . 0.0 112.425 -176.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 11.3 t -118.1 22.21 12.33 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.402 0.62 . . . . 0.0 111.601 -175.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 29.2 p -144.91 -55.44 0.32 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.349 178.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 44.98 78.13 0.08 OUTLIER Glycine 0 CA--C 1.52 0.353 0 CA-C-N 115.325 -0.852 . . . . 0.0 113.333 -177.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.7 mp -72.46 -19.93 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-N 117.196 0.498 . . . . 0.0 111.642 -174.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.497 ' C ' ' H ' ' A' ' 75' ' ' ASP . 72.2 ttt180 -64.33 -49.63 70.94 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-O 121.259 0.552 . . . . 0.0 111.273 -175.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 14.1 t -80.72 17.41 1.15 Allowed 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.247 -178.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.497 ' H ' ' C ' ' A' ' 73' ' ' ARG . 21.9 t70 . . . . . 0 C--O 1.231 0.122 0 CA-C-N 114.395 -1.275 . . . . 0.0 112.104 -178.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.506 ' HA2' ' HA ' ' A' ' 58' ' ' ASP . . . . . . . . 0 CA--C 1.519 0.301 0 CA-C-O 120.086 -0.286 . . . . 0.0 113.689 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -72.49 165.2 33.39 Favored 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 122.873 2.382 . . . . 0.0 111.82 179.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -132.74 169.58 16.49 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.741 0.781 . . . . 0.0 111.997 -176.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.5 m -112.85 166.86 10.99 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 114.441 -1.254 . . . . 0.0 110.048 -176.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 45.5 ttt-85 -62.36 -47.56 83.67 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.683 0.277 . . . . 0.0 110.877 -175.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.418 HH11 ' HD3' ' A' ' 15' ' ' ARG . 27.0 ttm-85 -53.08 -47.13 68.77 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.612 174.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.593 ' O ' HG22 ' A' ' 20' ' ' VAL . 77.6 mt-30 -59.98 -47.83 84.22 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.657 178.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -55.28 -47.98 74.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.165 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 56.9 mm-40 -59.25 -36.16 74.97 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.934 -179.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.1 -29.32 68.23 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.036 0.446 . . . . 0.0 111.415 -178.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.593 HG22 ' O ' ' A' ' 16' ' ' GLN . 11.1 t -89.83 -27.42 5.18 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.826 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 -172.068 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.475 HG22 ' HB ' ' A' ' 27' ' ' ILE . 15.6 m -83.64 -27.47 29.09 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-N 113.795 -1.548 . . . . 0.0 111.119 -179.273 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.2 p -73.4 -30.68 63.42 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 171.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 34.7 m -77.09 -47.03 21.59 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.275 173.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.622 ' O ' HG13 ' A' ' 27' ' ' ILE . 40.0 m-85 -114.54 96.35 5.71 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 177.656 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 37.8 p -64.9 -7.61 12.09 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 111.906 0.335 . . . . 0.0 111.906 -179.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.57 ' OD1' ' HB3' ' A' ' 24' ' ' TYR . 5.4 p-10 -78.81 -11.49 59.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.999 0.428 . . . . 0.0 110.192 177.137 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.622 HG13 ' O ' ' A' ' 24' ' ' TYR . 2.5 mt -83.08 146.59 6.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 174.21 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.514 ' OG1' ' HB ' ' A' ' 40' ' ' VAL . 10.3 p -133.12 120.23 20.98 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.398 -0.521 . . . . 0.0 110.786 -177.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.534 HD21 ' HB2' ' A' ' 32' ' ' ASP . 2.8 tt -88.36 105.15 17.39 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 -179.171 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.22 161.85 18.35 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.71 -176.242 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 61.26 30.56 19.24 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.032 -177.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.534 ' HB2' HD21 ' A' ' 29' ' ' LEU . 32.7 t0 -73.98 95.97 2.58 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.004 -178.194 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -115.29 1.96 13.9 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.564 178.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 119.88 -85.22 0.38 Allowed Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.463 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.1 t -89.32 -1.14 57.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.997 0.427 . . . . 0.0 110.496 -178.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 12.3 m170 -132.66 135.72 46.02 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 173.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.457 ' HB2' HD22 ' A' ' 29' ' ' LEU . 43.2 p90 -174.66 156.83 2.43 Favored 'General case' 0 C--O 1.234 0.285 0 O-C-N 123.858 0.724 . . . . 0.0 109.558 178.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 15.1 ptt180 -136.08 153.03 51.44 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.937 0.399 . . . . 0.0 111.513 176.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.506 HD22 ' HA ' ' A' ' 29' ' ' LEU . 71.5 mt -108.66 125.76 52.23 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.171 0.51 . . . . 0.0 110.558 177.049 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.514 ' HB ' ' OG1' ' A' ' 28' ' ' THR . 45.1 t -100.13 114.83 39.87 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.351 171.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 16.9 t -87.6 114.99 27.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.412 ' HA ' ' O ' ' A' ' 47' ' ' ARG . 3.8 mtt85 -101.24 160.87 14.04 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.398 0.618 . . . . 0.0 111.402 -176.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.421 ' CG ' ' N ' ' A' ' 44' ' ' THR . 4.1 t70 -91.57 178.23 5.99 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.487 -1.233 . . . . 0.0 109.979 -178.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.421 ' N ' ' CG ' ' A' ' 43' ' ' ASP . 19.1 p -59.01 -22.39 60.59 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 123.201 0.6 . . . . 0.0 111.718 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -92.63 -5.07 52.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.138 0.494 . . . . 0.0 110.536 178.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 89.29 9.49 67.11 Favored Glycine 0 N--CA 1.453 -0.173 0 C-N-CA 120.807 -0.711 . . . . 0.0 111.946 -177.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.412 ' O ' ' HA ' ' A' ' 42' ' ' ARG . 38.0 mtp180 -70.96 130.66 42.17 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 122.533 0.333 . . . . 0.0 110.364 179.359 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.15 90.52 2.54 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.599 0.714 . . . . 0.0 110.283 176.037 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 24.7 t -75.16 -38.45 41.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.621 -176.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 75.5 t-105 -150.14 152.61 34.98 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.248 -175.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.428 HH11 ' HD3' ' A' ' 51' ' ' ARG . 13.7 ptt-85 -150.14 137.19 19.46 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 177.145 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -145.97 146.54 31.06 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.407 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.437 ' HB2' ' HG3' ' A' ' 56' ' ' GLU . 96.5 m95 -80.44 -171.23 2.94 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-O 121.387 0.613 . . . . 0.0 109.587 175.199 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -99.81 -21.34 15.79 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.551 -176.226 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -100.46 11.73 38.81 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.58 -174.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.437 ' HG3' ' HB2' ' A' ' 53' ' ' TRP . 42.7 mt-10 -80.88 135.8 51.57 Favored Pre-proline 0 C--N 1.329 -0.308 0 C-N-CA 121.025 -0.27 . . . . 0.0 110.432 179.419 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -36.78 -47.23 1.39 Allowed 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 125.071 3.847 . . . . 0.0 114.31 -172.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.506 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . 4.2 t70 -144.58 63.35 1.31 Allowed 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 176.424 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.405 ' HB2' ' HB2' ' A' ' 56' ' ' GLU . . . -58.69 -31.55 68.33 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.041 179.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -61.7 -34.07 87.33 Favored Glycine 0 N--CA 1.447 -0.604 0 CA-C-N 115.582 -0.735 . . . . 0.0 113.56 -178.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.509 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 2.1 tm-20 -57.34 -50.47 72.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 117.074 0.437 . . . . 0.0 110.351 -177.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -67.56 -43.25 86.69 Favored Glycine 0 C--O 1.237 0.334 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.287 -177.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.465 ' O ' HG13 ' A' ' 67' ' ' ILE . 53.2 mt -60.34 -55.61 31.58 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 110.331 -0.248 . . . . 0.0 110.331 178.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.544 ' HA ' ' HB ' ' A' ' 67' ' ' ILE . 94.4 m-20 -62.69 -31.46 72.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.933 -179.02 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.509 ' HB2' ' O ' ' A' ' 61' ' ' GLU . 7.1 tpt180 -52.86 -46.06 67.68 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.362 0.601 . . . . 0.0 109.66 177.315 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 75.8 t80 -81.35 -41.82 21.44 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.986 178.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.544 ' HB ' ' HA ' ' A' ' 64' ' ' ASN . 95.2 mt -55.37 -48.88 76.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -178.415 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 59.9 ttt-85 -63.42 -48.98 75.56 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.376 -176.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 38.7 p -79.4 -41.12 28.44 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.035 -0.53 . . . . 0.0 112.179 -172.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.433 ' O ' HD13 ' A' ' 72' ' ' ILE . 3.3 m -127.85 20.19 6.53 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 112.681 0.622 . . . . 0.0 112.681 -166.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -48.33 134.24 19.15 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 121.346 -0.454 . . . . 0.0 113.927 178.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.478 ' HB ' ' OD1' ' A' ' 26' ' ' ASN . 2.5 mp -89.2 7.68 3.44 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 C-N-CA 123.258 0.623 . . . . 0.0 109.935 -176.722 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.615 ' HB3' ' CE1' ' A' ' 24' ' ' TYR . 30.7 ptt180 -48.79 -6.25 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 115.135 1.531 . . . . 0.0 115.135 -173.004 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.417 ' N ' ' O ' ' A' ' 72' ' ' ILE . 10.1 t -68.87 5.73 1.06 Allowed 'General case' 0 C--N 1.321 -0.641 0 O-C-N 122.017 -0.427 . . . . 0.0 110.223 173.491 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.472 ' H ' ' C ' ' A' ' 73' ' ' ARG . 12.5 p-10 . . . . . 0 N--CA 1.45 -0.473 0 CA-C-O 122.476 1.131 . . . . 0.0 109.52 176.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.437 ' HA2' ' HA ' ' A' ' 58' ' ' ASP . . . . . . . . 0 CA--C 1.518 0.251 0 CA-C-O 120.04 -0.311 . . . . 0.0 113.157 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.498 ' HD3' ' O ' ' A' ' 57' ' ' PRO . 19.4 Cg_exo -66.69 169.22 14.89 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.716 2.277 . . . . 0.0 111.856 176.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.481 ' CD2' ' HB1' ' A' ' 17' ' ' ALA . 41.2 p90 -140.33 165.27 27.86 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.189 -179.053 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.8 p -103.72 178.17 4.63 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.27 -178.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.559 ' HA ' ' CZ ' ' A' ' 37' ' ' PHE . 47.2 ttt180 -60.8 -54.85 40.19 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.212 178.22 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 57.9 mtt-85 -62.84 -37.31 86.3 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.683 -178.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.571 ' O ' HG21 ' A' ' 20' ' ' VAL . 77.5 mm-40 -62.97 -53.07 59.76 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.222 177.495 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.481 ' HB1' ' CD2' ' A' ' 12' ' ' PHE . . . -52.85 -44.27 66.66 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.492 178.156 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -58.8 -39.2 80.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.767 -178.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.02 -27.29 65.55 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-O 121.392 0.615 . . . . 0.0 110.945 179.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.571 HG21 ' O ' ' A' ' 16' ' ' GLN . 3.6 t -76.71 -25.71 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 -179.169 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.476 HG21 ' HB ' ' A' ' 27' ' ' ILE . 0.0 OUTLIER -80.61 -28.01 37.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.841 175.542 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.9 p -75.99 -14.52 60.23 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.434 0.635 . . . . 0.0 109.552 173.17 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 18.9 m -92.4 -50.18 5.77 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.753 170.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.585 ' O ' HG13 ' A' ' 27' ' ' ILE . 48.3 m-85 -118.85 105.31 11.38 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 177.273 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 17.7 p -76.94 -1.76 30.23 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.079 0.466 . . . . 0.0 111.093 -179.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.572 ' OD1' ' HB3' ' A' ' 24' ' ' TYR . 6.1 p-10 -81.6 -9.84 59.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.649 175.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.585 HG13 ' O ' ' A' ' 24' ' ' TYR . 1.8 mt -86.03 155.62 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 174.235 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.508 ' OG1' ' HB ' ' A' ' 40' ' ' VAL . 1.2 p -142.35 123.27 14.42 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.888 0.375 . . . . 0.0 111.251 -179.529 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.428 ' HA ' HD22 ' A' ' 39' ' ' LEU . 6.1 tt -88.44 105.78 17.83 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 178.697 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -126.79 169.09 13.56 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.524 179.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.542 ' HB2' ' HG2' ' A' ' 38' ' ' ARG . 1.1 m-20 66.06 37.67 5.14 Favored 'General case' 0 C--N 1.329 -0.309 0 O-C-N 123.528 0.517 . . . . 0.0 110.761 179.572 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.473 ' HA ' ' HB3' ' A' ' 37' ' ' PHE . 11.3 p-10 -67.6 102.56 1.19 Allowed 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 121.878 0.847 . . . . 0.0 110.334 179.216 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -116.93 30.31 7.41 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.435 -177.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 96.44 -106.41 3.36 Favored Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.807 -179.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.6 m -81.94 -1.87 49.47 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.911 0.386 . . . . 0.0 110.784 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.41 ' HA ' ' OD1' ' A' ' 54' ' ' ASN . 20.7 m-70 -129.37 143.42 50.83 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.652 179.504 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.559 ' CZ ' ' HA ' ' A' ' 14' ' ' ARG . 36.8 p90 -173.95 170.96 3.76 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 -178.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.542 ' HG2' ' HB2' ' A' ' 31' ' ' ASP . 16.5 ptt180 -127.33 152.61 47.24 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.133 0.492 . . . . 0.0 111.004 179.03 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.458 HD11 ' HB2' ' A' ' 17' ' ' ALA . 96.3 mt -111.56 115.78 29.75 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.713 173.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.528 HG13 ' HB3' ' A' ' 51' ' ' ARG . 3.1 t -92.2 113.79 28.07 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.152 178.253 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.8 t -87.12 111.51 21.85 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.7 mtp180 -100.42 164.02 12.11 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.23 -178.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.541 ' HB2' ' CG2' ' A' ' 49' ' ' VAL . 10.1 t70 -97.38 -169.2 1.81 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.605 -175.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.456 ' H ' ' CG ' ' A' ' 43' ' ' ASP . 40.3 p -67.91 -21.81 65.11 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.064 0.459 . . . . 0.0 110.727 -178.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -84.74 -10.58 57.12 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.665 0.745 . . . . 0.0 109.224 178.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 86.36 3.04 84.85 Favored Glycine 0 N--CA 1.444 -0.797 0 CA-C-N 115.289 -0.869 . . . . 0.0 112.75 -179.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 8.9 ptp180 -82.72 147.91 28.19 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 117.103 0.451 . . . . 0.0 110.212 177.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 21.2 ptt? -75.06 123.23 24.81 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.321 0.582 . . . . 0.0 110.749 -179.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.541 ' CG2' ' HB2' ' A' ' 43' ' ' ASP . 6.5 t -103.31 -33.93 3.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.085 -177.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 75.0 t-105 -152.23 152.0 31.66 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.494 -178.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.528 ' HB3' HG13 ' A' ' 40' ' ' VAL . 1.9 ppt_? -150.97 139.88 20.92 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 178.392 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -150.59 157.76 43.36 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.054 179.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.504 ' HA ' ' HA ' ' A' ' 38' ' ' ARG . 69.1 m95 -88.31 -164.67 1.15 Allowed 'General case' 0 N--CA 1.444 -0.764 0 CA-C-O 121.081 0.467 . . . . 0.0 110.229 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.41 ' OD1' ' HA ' ' A' ' 36' ' ' HIS . 0.4 OUTLIER -104.18 -21.93 13.47 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.301 -175.012 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -95.28 0.93 54.3 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -171.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.508 ' HB2' ' HB1' ' A' ' 59' ' ' ALA . 48.4 mt-10 -74.14 141.57 77.91 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 116.808 -0.178 . . . . 0.0 110.526 -179.147 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.498 ' O ' ' HD3' ' A' ' 11' ' ' PRO . 80.4 Cg_exo -45.95 -38.78 18.94 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 123.956 3.104 . . . . 0.0 114.163 -172.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.437 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . 9.1 m-20 -136.21 48.44 2.16 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 177.606 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.512 ' O ' ' HG ' ' A' ' 63' ' ' LEU . . . -56.77 -48.43 77.89 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.723 -0.672 . . . . 0.0 111.292 -175.311 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.4 ' HA2' HD12 ' A' ' 63' ' ' LEU . . . -70.77 -25.65 75.38 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.45 -178.416 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.59 -33.25 66.6 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 -177.082 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.539 ' O ' ' HB2' ' A' ' 65' ' ' ARG . . . -71.81 -41.02 56.99 Favored Glycine 0 C--O 1.239 0.459 0 C-N-CA 120.684 -0.77 . . . . 0.0 111.273 176.223 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.512 ' HG ' ' O ' ' A' ' 59' ' ' ALA . 55.1 mt -58.24 -44.48 88.3 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.112 0.482 . . . . 0.0 109.711 175.461 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.543 ' HA ' ' HB ' ' A' ' 67' ' ' ILE . 33.2 m-80 -73.32 -18.42 61.19 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.756 -0.657 . . . . 0.0 111.636 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.539 ' HB2' ' O ' ' A' ' 62' ' ' GLY . 9.7 mmt180 -60.76 -47.88 84.3 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 172.041 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 83.8 t80 -67.99 -47.27 68.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.434 176.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.543 ' HB ' ' HA ' ' A' ' 64' ' ' ASN . 97.0 mt -59.16 -39.87 79.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -177.301 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 47.1 ttt180 -54.54 -43.2 71.75 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.633 0.254 . . . . 0.0 111.253 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.3 t -98.7 -9.99 23.82 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.746 0.308 . . . . 0.0 111.484 -177.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 33.1 t -159.09 66.72 0.41 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.331 0.586 . . . . 0.0 111.328 -177.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -89.29 127.61 8.77 Favored Glycine 0 N--CA 1.447 -0.619 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 171.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.516 ' HB ' ' OD1' ' A' ' 26' ' ' ASN . 2.0 mp -83.82 -0.85 5.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 CA-C-O 121.433 0.635 . . . . 0.0 110.714 -172.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.526 ' HB3' ' CE1' ' A' ' 24' ' ' TYR . 4.7 ptm180 -64.17 -7.71 9.93 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -176.063 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.1 m -59.26 -10.18 2.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.88 0.848 . . . . 0.0 109.253 172.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.405 ' H ' ' C ' ' A' ' 73' ' ' ARG . 17.5 t0 . . . . . 0 N--CA 1.449 -0.494 0 CA-C-N 114.402 -1.272 . . . . 0.0 109.252 171.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.405 ' HA3' ' HD3' ' A' ' 11' ' ' PRO . . . . . . . . 0 N--CA 1.453 -0.215 0 CA-C-O 119.957 -0.357 . . . . 0.0 112.506 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.405 ' HD3' ' HA3' ' A' ' 10' ' ' GLY . 2.8 Cg_exo -74.96 175.1 11.67 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 122.696 2.264 . . . . 0.0 111.872 178.475 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.452 ' HE1' ' HE2' ' A' ' 37' ' ' PHE . 51.3 p90 -128.19 161.5 29.15 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.386 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 43.0 p -102.08 170.31 8.2 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.677 178.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 32.6 ttt85 -59.22 -44.0 92.31 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.09 0.472 . . . . 0.0 109.814 176.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.42 HH11 ' HD2' ' A' ' 15' ' ' ARG . 4.8 tpp180 -65.5 -45.07 85.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.1 179.505 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.659 ' O ' HG22 ' A' ' 20' ' ' VAL . 2.1 mp0 -62.36 -48.13 81.14 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.911 178.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -51.76 -53.48 39.17 Favored 'General case' 0 C--N 1.328 -0.359 0 O-C-N 123.339 0.399 . . . . 0.0 111.56 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.852 ' HA ' HE21 ' A' ' 18' ' ' GLN . 0.0 OUTLIER -56.59 -42.57 78.9 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.826 -177.121 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.96 -28.41 70.06 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.491 -179.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.659 HG22 ' O ' ' A' ' 16' ' ' GLN . 15.4 t -90.77 -15.14 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -172.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.37 -29.04 37.87 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.26 174.066 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -80.24 -15.75 56.29 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-O 121.132 0.492 . . . . 0.0 109.758 172.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 7.0 m -85.78 -55.12 4.12 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.759 171.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.549 ' O ' HG13 ' A' ' 27' ' ' ILE . 34.3 m-85 -117.67 105.95 12.56 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 174.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -76.7 -2.2 31.68 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 120.962 -0.295 . . . . 0.0 111.309 -176.03 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.53 ' OD1' ' HB3' ' A' ' 24' ' ' TYR . 24.7 p-10 -75.87 -17.4 59.82 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 174.582 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.549 HG13 ' O ' ' A' ' 24' ' ' TYR . 4.2 mt -76.04 148.12 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 174.277 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 6.7 p -144.1 132.33 21.87 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 117.842 0.292 . . . . 0.0 111.05 -179.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.509 ' HA ' HD22 ' A' ' 39' ' ' LEU . 3.8 tt -86.53 105.65 16.97 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 176.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -118.93 163.74 16.47 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.329 -178.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 63.8 30.64 14.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.034 175.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.471 ' HA ' ' HB3' ' A' ' 37' ' ' PHE . 17.8 t0 -65.56 107.87 1.85 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.487 -178.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -129.09 34.57 4.41 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.264 -0.88 . . . . 0.0 108.662 179.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 85.24 -95.48 1.98 Allowed Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.638 -178.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 17.4 p -80.39 -30.09 37.78 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.332 0.587 . . . . 0.0 110.453 178.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 9.0 m-70 -92.87 121.57 34.37 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.769 177.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.471 ' HB3' ' HA ' ' A' ' 32' ' ' ASP . 38.2 p90 -170.33 157.05 5.95 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 176.155 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.428 ' NH1' ' HD3' ' A' ' 51' ' ' ARG . 38.3 ptt180 -139.72 150.09 44.42 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.216 0.531 . . . . 0.0 111.709 179.176 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.509 HD22 ' HA ' ' A' ' 29' ' ' LEU . 94.4 mt -98.27 124.09 42.69 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.941 177.085 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 46.7 t -101.8 121.24 52.51 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-N 115.329 -0.851 . . . . 0.0 109.716 177.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 15.4 t -99.03 115.01 38.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-O 121.04 0.448 . . . . 0.0 110.02 -179.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.513 ' HD2' ' O ' ' A' ' 46' ' ' GLY . 56.0 mtm180 -100.31 167.12 10.62 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.259 179.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -88.84 -169.49 2.55 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.781 0.324 . . . . 0.0 110.47 -178.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.474 HG21 HD12 ' A' ' 72' ' ' ILE . 0.5 OUTLIER -61.53 -26.75 68.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.827 -178.528 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 18.5 tp10 -86.41 -31.47 21.42 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 120.95 0.405 . . . . 0.0 110.247 179.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.513 ' O ' ' HD2' ' A' ' 42' ' ' ARG . . . 112.7 20.99 6.23 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.394 -176.108 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 89.0 mtm180 -87.81 129.32 35.23 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 176.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 12.5 ptt? -62.79 112.54 2.58 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.125 0.488 . . . . 0.0 110.909 176.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.405 HG11 ' CE1' ' A' ' 66' ' ' TYR . 40.1 t -99.84 -36.65 5.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.498 179.462 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.526 ' CD1' HD22 ' A' ' 63' ' ' LEU . 58.2 t-105 -157.27 156.68 32.87 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.851 -174.404 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.428 ' HD3' ' NH1' ' A' ' 38' ' ' ARG . 7.6 ptp85 -155.79 143.32 19.47 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.139 -178.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -146.93 143.46 28.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.632 -0.258 . . . . 0.0 110.413 179.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 70.2 m95 -82.75 -168.03 1.87 Allowed 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 121.808 0.813 . . . . 0.0 111.439 -177.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -93.54 -35.24 13.02 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.152 -1.386 . . . . 0.0 110.622 -179.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 26.6 p90 -83.67 12.01 6.46 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.481 -178.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.511 ' HB2' ' HB3' ' A' ' 59' ' ' ALA . 10.2 mm-40 -82.1 124.07 79.09 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.37 177.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -45.73 -50.95 8.85 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 124.303 3.335 . . . . 0.0 113.193 -175.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -126.96 57.65 1.45 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.082 0.468 . . . . 0.0 109.887 176.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.511 ' HB3' ' HB2' ' A' ' 56' ' ' GLU . . . -54.48 -45.46 73.2 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.428 -178.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -63.2 -32.36 83.89 Favored Glycine 0 N--CA 1.441 -1.026 0 CA-C-N 115.135 -0.939 . . . . 0.0 112.779 -177.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.414 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 18.0 tp10 -59.66 -41.94 91.71 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.969 0.384 . . . . 0.0 110.623 -176.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -73.62 -43.19 37.3 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.456 -0.878 . . . . 0.0 112.007 179.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.526 HD22 ' CD1' ' A' ' 50' ' ' TRP . 65.7 mt -66.27 -46.98 75.2 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.681 0.277 . . . . 0.0 110.43 -179.308 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.432 ' HA ' HD13 ' A' ' 67' ' ' ILE . 87.2 m-20 -65.75 -25.51 67.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.477 178.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.414 ' HB2' ' O ' ' A' ' 61' ' ' GLU . 42.4 ttp180 -63.84 -45.25 90.38 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 178.152 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.405 ' CE1' HG11 ' A' ' 49' ' ' VAL . 85.3 t80 -69.47 -42.63 74.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.953 0.406 . . . . 0.0 110.219 175.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.432 HD13 ' HA ' ' A' ' 64' ' ' ASN . 97.0 mt -55.09 -37.57 43.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.476 177.15 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 47.1 ttt180 -60.27 -46.75 88.73 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.84 -178.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 16.9 p -87.57 -17.68 31.45 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -172.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 24.7 m -108.46 -50.17 3.07 Favored 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.447 -176.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 47.7 81.92 0.04 OUTLIER Glycine 0 CA--C 1.522 0.519 0 CA-C-N 115.868 -0.605 . . . . 0.0 112.948 -174.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.474 HD12 HG21 ' A' ' 44' ' ' THR . 35.2 mm -90.88 6.58 4.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-O 121.697 0.76 . . . . 0.0 110.304 -173.515 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.458 ' HB3' ' CE2' ' A' ' 24' ' ' TYR . 15.0 ptt180 -64.1 -1.94 1.79 Allowed 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.767 179.395 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 8.9 t -71.25 6.53 1.65 Allowed 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.266 177.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.444 ' H ' ' C ' ' A' ' 73' ' ' ARG . 1.1 p-10 . . . . . 0 N--CA 1.45 -0.437 0 CA-C-O 122.878 1.323 . . . . 0.0 109.977 178.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.449 ' HA3' ' HD3' ' A' ' 11' ' ' PRO . . . . . . . . 0 CA--C 1.522 0.49 0 CA-C-O 120.14 -0.255 . . . . 0.0 113.626 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.449 ' HD3' ' HA3' ' A' ' 10' ' ' GLY . 14.4 Cg_exo -67.86 142.49 57.53 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.778 2.319 . . . . 0.0 111.841 176.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.524 ' CD2' ' HB2' ' A' ' 17' ' ' ALA . 12.9 p90 -108.79 -171.8 1.92 Allowed 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.804 -175.474 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.445 ' OG1' ' HG2' ' A' ' 16' ' ' GLN . 21.5 p -125.49 175.71 7.33 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 172.807 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.487 ' O ' ' HG3' ' A' ' 18' ' ' GLN . 67.9 mtm180 -65.4 -43.94 89.05 Favored 'General case' 0 C--O 1.22 -0.462 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.128 175.129 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -54.93 -50.77 68.02 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 178.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.473 ' O ' HG21 ' A' ' 20' ' ' VAL . 65.0 mm-40 -60.81 -52.78 63.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.072 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.524 ' HB2' ' CD2' ' A' ' 12' ' ' PHE . . . -56.71 -46.45 81.24 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.304 -179.156 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.487 ' HG3' ' O ' ' A' ' 14' ' ' ARG . 91.9 mt-30 -58.95 -38.52 79.24 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.492 -176.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.52 -26.06 68.26 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-O 121.205 0.526 . . . . 0.0 111.535 178.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.473 HG21 ' O ' ' A' ' 16' ' ' GLN . 3.2 t -85.49 -22.88 7.29 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.903 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 -175.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 17.8 m -85.69 -33.73 21.46 Favored 'General case' 0 N--CA 1.434 -1.267 0 CA-C-N 113.315 -1.766 . . . . 0.0 110.814 -178.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.0 p -67.48 -29.35 68.77 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 173.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 23.3 m -80.73 -53.46 6.49 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.305 173.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.625 ' O ' HG13 ' A' ' 27' ' ' ILE . 62.3 m-85 -106.49 98.94 8.55 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 178.572 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 37.3 p -69.51 -3.8 16.18 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.225 -0.443 . . . . 0.0 112.142 -178.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.612 ' OD1' ' HB3' ' A' ' 24' ' ' TYR . 24.1 p-10 -82.48 -14.18 55.45 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.986 0.422 . . . . 0.0 109.877 176.141 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.625 HG13 ' O ' ' A' ' 24' ' ' TYR . 1.2 mt -81.12 146.17 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 N-CA-C 108.372 -0.974 . . . . 0.0 108.372 173.396 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.482 ' O ' ' HA ' ' A' ' 39' ' ' LEU . 3.0 p -144.12 136.42 26.62 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.853 -0.339 . . . . 0.0 111.204 -179.238 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.483 HD12 ' HG2' ' A' ' 14' ' ' ARG . 5.1 tt -95.71 105.12 17.08 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 177.277 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -115.84 166.59 11.79 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.224 -178.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.468 ' HB2' ' HG2' ' A' ' 38' ' ' ARG . 0.3 OUTLIER 60.95 31.59 19.96 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.256 177.493 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -70.77 102.47 2.34 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 121.612 0.72 . . . . 0.0 111.184 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 19.5 tm0? -100.53 -30.73 11.63 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.038 175.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 146.11 -80.02 0.22 Allowed Glycine 0 N--CA 1.445 -0.731 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 -175.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 44.5 p -82.12 -31.41 30.66 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 172.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 60.4 m80 -96.72 126.1 41.64 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.269 177.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.445 ' HB2' HD21 ' A' ' 29' ' ' LEU . 49.7 p90 -168.21 147.19 4.53 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.485 -0.779 . . . . 0.0 109.032 177.241 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.468 ' HG2' ' HB2' ' A' ' 31' ' ' ASP . 49.2 ptt85 -129.59 149.23 51.44 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.843 0.354 . . . . 0.0 110.785 -176.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.529 ' O ' ' HA ' ' A' ' 51' ' ' ARG . 75.9 mt -106.26 144.42 32.98 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.139 0.495 . . . . 0.0 110.188 178.434 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.558 HG11 ' HB3' ' A' ' 51' ' ' ARG . 38.2 t -123.48 110.04 24.97 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.066 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.316 174.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.2 t -88.84 104.37 14.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 173.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 67.2 mtt85 -94.98 171.2 8.9 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.325 -177.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -96.73 -169.73 1.94 Allowed 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 175.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.97 -17.28 62.66 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.548 -175.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.446 ' OE1' ' HD3' ' A' ' 47' ' ' ARG . 37.9 tt0 -89.18 -24.73 22.1 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 176.347 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 105.0 18.55 12.07 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.329 178.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.446 ' HD3' ' OE1' ' A' ' 45' ' ' GLU . 41.6 mtm-85 -85.65 142.07 29.33 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 177.452 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 11.0 ptp -77.86 105.38 9.01 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.46 0.648 . . . . 0.0 111.104 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.2 t -87.7 -36.22 9.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.69 177.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.495 ' CZ2' ' HB2' ' A' ' 52' ' ' ALA . 31.4 t90 -137.62 123.27 19.82 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 177.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.558 ' HB3' HG11 ' A' ' 40' ' ' VAL . 0.0 OUTLIER -149.47 120.1 7.5 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.518 0.675 . . . . 0.0 110.006 172.706 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.495 ' HB2' ' CZ2' ' A' ' 50' ' ' TRP . . . -155.3 174.38 15.3 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.322 -174.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 78.9 m95 -93.9 -158.95 0.66 Allowed 'General case' 0 N--CA 1.445 -0.698 0 CA-C-O 121.258 0.551 . . . . 0.0 110.799 -174.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -110.09 -32.41 7.02 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.619 -0.718 . . . . 0.0 111.25 -175.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -79.34 34.73 0.26 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.982 -175.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.524 ' HB2' ' HB1' ' A' ' 59' ' ' ALA . 51.1 mt-10 -111.04 135.19 20.87 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.058 179.633 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -51.69 -32.83 46.88 Favored 'Trans proline' 0 N--CA 1.477 0.513 0 C-N-CA 123.879 3.052 . . . . 0.0 114.375 -170.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.444 ' HB2' ' HB3' ' A' ' 61' ' ' GLU . 2.3 p30 -136.36 44.18 2.43 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.017 0.436 . . . . 0.0 110.617 179.419 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.524 ' HB1' ' HB2' ' A' ' 56' ' ' GLU . . . -58.74 -41.35 86.25 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.904 -178.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.436 ' HA2' HD11 ' A' ' 63' ' ' LEU . . . -69.2 -27.52 73.67 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.588 178.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.444 ' HB3' ' HB2' ' A' ' 58' ' ' ASP . 31.2 tt0 -73.46 -34.63 65.48 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.581 ' HA2' ' HD3' ' A' ' 65' ' ' ARG . . . -63.49 -41.27 99.32 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.71 -0.757 . . . . 0.0 111.487 173.747 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.461 ' O ' HG13 ' A' ' 67' ' ' ILE . 6.6 mt -64.1 -41.08 97.41 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 110.31 -0.255 . . . . 0.0 110.31 175.141 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -56.17 -33.95 65.73 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.146 0.498 . . . . 0.0 110.497 173.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.581 ' HD3' ' HA2' ' A' ' 62' ' ' GLY . 45.6 mtp85 -71.31 -28.67 64.27 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.153 179.46 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.55 ' O ' HG22 ' A' ' 69' ' ' THR . 36.9 t80 -76.24 -51.62 11.69 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.49 -0.484 . . . . 0.0 109.795 171.658 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.461 HG13 ' O ' ' A' ' 63' ' ' LEU . 46.2 mt -62.05 -13.19 9.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.172 -178.612 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 8.8 tpt180 -49.36 -32.87 12.2 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.632 172.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.55 HG22 ' O ' ' A' ' 66' ' ' TYR . 12.1 t -92.96 29.29 1.86 Allowed 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 121.322 0.582 . . . . 0.0 110.291 -177.312 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 7.9 t 80.22 -27.05 0.15 Allowed 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.967 0.907 . . . . 0.0 111.351 176.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.12 -172.27 51.17 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.468 -0.873 . . . . 0.0 111.894 -177.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.492 ' O ' HG21 ' A' ' 72' ' ' ILE . 32.3 mm -101.02 7.73 9.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 121.768 0.794 . . . . 0.0 110.626 -174.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.452 ' C ' ' H ' ' A' ' 75' ' ' ASP . 37.1 ptt180 -50.17 -21.24 1.24 Allowed 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.64 178.571 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 10.0 t -63.88 -1.49 1.44 Allowed 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 120.772 0.32 . . . . 0.0 110.569 176.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.452 ' H ' ' C ' ' A' ' 73' ' ' ARG . 19.9 t70 . . . . . 0 C--N 1.331 -0.238 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.428 177.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.525 ' HA2' ' HA ' ' A' ' 58' ' ' ASP . . . . . . . . 0 N--CA 1.45 -0.397 0 CA-C-O 120.147 -0.252 . . . . 0.0 112.778 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -72.7 168.56 24.18 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.956 2.437 . . . . 0.0 111.856 177.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -125.74 -170.61 2.21 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.379 -176.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.404 ' H ' ' HB2' ' A' ' 16' ' ' GLN . 41.6 p -125.4 173.41 8.89 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.149 178.579 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 4.4 tmt_? -58.42 -43.91 88.86 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.548 0.689 . . . . 0.0 109.261 172.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 41.5 ttm105 -60.77 -54.13 48.96 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.525 -1.216 . . . . 0.0 111.306 178.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.62 ' O ' HG22 ' A' ' 20' ' ' VAL . 73.5 mm-40 -56.71 -49.86 73.88 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.918 179.538 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.445 ' HB1' HD23 ' A' ' 39' ' ' LEU . . . -48.84 -51.9 27.06 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.576 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.423 HE21 HD13 ' A' ' 29' ' ' LEU . 55.4 mm-40 -58.68 -38.0 77.27 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.664 -177.69 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.98 -27.87 66.1 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.969 0.414 . . . . 0.0 111.446 -178.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.62 HG22 ' O ' ' A' ' 16' ' ' GLN . 18.7 t -89.16 -18.9 7.68 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.816 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 -172.432 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 21.1 m -93.41 -31.25 14.69 Favored 'General case' 0 N--CA 1.432 -1.328 0 CA-C-N 114.004 -1.453 . . . . 0.0 108.149 -175.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 52.9 m -61.4 -36.58 80.7 Favored 'General case' 0 N--CA 1.435 -1.187 0 CA-C-N 113.93 -1.486 . . . . 0.0 109.047 168.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 25.9 m -78.97 -51.4 9.67 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.592 177.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.624 ' O ' HG13 ' A' ' 27' ' ' ILE . 47.6 m-85 -113.37 94.81 5.04 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 177.228 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 13.7 m -73.25 1.53 9.22 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.987 0.423 . . . . 0.0 111.204 -176.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.551 ' OD1' ' HB3' ' A' ' 24' ' ' TYR . 4.4 p-10 -78.55 -18.08 55.2 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 172.323 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.624 HG13 ' O ' ' A' ' 24' ' ' TYR . 2.0 mt -79.72 152.18 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 170.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.472 ' O ' ' HA ' ' A' ' 39' ' ' LEU . 17.2 p -141.0 123.64 16.04 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.91 -178.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.533 ' HA ' HD21 ' A' ' 39' ' ' LEU . 6.7 tt -83.85 95.68 8.55 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 176.114 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -114.95 171.31 7.73 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.628 -175.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.468 ' OD2' ' HZ3' ' A' ' 53' ' ' TRP . 38.3 t70 66.39 18.34 10.84 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 123.652 0.595 . . . . 0.0 110.639 177.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.544 ' HA ' ' HB3' ' A' ' 37' ' ' PHE . 7.6 p-10 -64.78 95.97 0.17 Allowed 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 121.826 0.822 . . . . 0.0 110.752 -179.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.429 ' NE2' ' HE1' ' A' ' 36' ' ' HIS . 45.1 mt-30 -128.13 45.17 2.8 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.133 -0.939 . . . . 0.0 109.471 -179.328 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.25 -88.24 1.44 Allowed Glycine 0 N--CA 1.444 -0.815 0 CA-C-N 114.55 -1.205 . . . . 0.0 112.6 176.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 49.0 m -81.63 -14.4 56.75 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -173.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.429 ' HE1' ' NE2' ' A' ' 33' ' ' GLN . 25.7 p80 -136.74 148.95 47.57 Favored 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 119.912 -0.715 . . . . 0.0 110.953 176.669 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.544 ' HB3' ' HA ' ' A' ' 32' ' ' ASP . 45.1 p90 -170.0 161.44 8.74 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.79 -1.095 . . . . 0.0 108.474 178.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 32.9 ptt180 -144.05 155.57 44.04 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.052 0.453 . . . . 0.0 112.119 -178.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.533 HD21 ' HA ' ' A' ' 29' ' ' LEU . 95.8 mt -103.18 112.38 25.21 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.285 176.651 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 47.8 t -94.21 122.38 45.63 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.944 175.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.501 HG11 ' CD2' ' A' ' 66' ' ' TYR . 80.4 t -90.09 115.28 29.26 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 178.201 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.513 ' HA ' ' O ' ' A' ' 47' ' ' ARG . 59.1 mtp180 -110.52 161.04 16.09 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.37 -176.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -95.56 -165.81 1.35 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.18 -178.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 17.6 p -63.46 -27.23 69.14 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.859 0.361 . . . . 0.0 111.427 -177.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -82.87 -33.82 26.9 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.217 0.532 . . . . 0.0 109.788 177.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 110.28 18.49 8.62 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.817 -0.706 . . . . 0.0 111.584 -175.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.513 ' O ' ' HA ' ' A' ' 42' ' ' ARG . 52.0 mtt180 -80.53 145.57 31.74 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 179.101 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.404 ' N ' ' SD ' ' A' ' 48' ' ' MET . 1.8 mpt? -72.49 108.46 5.57 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 177.42 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 42.6 t -95.14 -31.03 4.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.459 0.647 . . . . 0.0 109.592 177.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.445 ' CD1' HD22 ' A' ' 63' ' ' LEU . 69.3 t-105 -159.12 157.87 31.79 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.35 -178.352 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 15.3 ptt180 -160.66 138.73 9.77 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.887 0.375 . . . . 0.0 110.114 178.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -143.12 145.76 33.13 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.043 178.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.528 ' HB2' ' OE1' ' A' ' 56' ' ' GLU . 42.4 m95 -84.71 -160.44 0.48 Allowed 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 176.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -107.55 0.86 22.95 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.928 -174.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 22.9 p90 -117.56 2.98 12.42 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -173.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.528 ' OE1' ' HB2' ' A' ' 53' ' ' TRP . 3.1 mp0 -66.16 132.18 94.49 Favored Pre-proline 0 C--O 1.237 0.398 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.119 173.13 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -46.65 -32.62 12.09 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 123.86 3.04 . . . . 0.0 113.358 -176.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.525 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . 4.4 t0 -146.29 62.9 1.22 Allowed 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 174.389 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.515 ' HB3' ' HB2' ' A' ' 56' ' ' GLU . . . -58.17 -35.51 71.68 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-O 121.286 0.565 . . . . 0.0 111.011 -179.054 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -59.01 -37.75 91.98 Favored Glycine 0 N--CA 1.446 -0.673 0 CA-C-N 115.281 -0.872 . . . . 0.0 113.554 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -60.5 -38.72 85.23 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 117.386 0.593 . . . . 0.0 111.182 -174.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.518 ' O ' ' HB3' ' A' ' 65' ' ' ARG . . . -72.32 -44.49 42.6 Favored Glycine 0 C--O 1.237 0.308 0 C-N-CA 120.823 -0.703 . . . . 0.0 111.99 179.078 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.445 HD22 ' CD1' ' A' ' 50' ' ' TRP . 65.6 mt -62.36 -50.24 72.36 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.705 0.288 . . . . 0.0 110.244 178.21 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -63.43 -28.33 69.9 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.923 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.518 ' HB3' ' O ' ' A' ' 62' ' ' GLY . 10.9 ttt180 -57.02 -51.0 71.0 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.009 175.293 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.501 ' CD2' HG11 ' A' ' 41' ' ' VAL . 77.5 t80 -72.06 -38.8 69.39 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.622 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.402 HG13 ' O ' ' A' ' 63' ' ' LEU . 96.4 mt -57.21 -43.97 82.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.007 0.432 . . . . 0.0 110.896 177.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 5.9 ttp85 -65.76 -41.85 91.61 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.89 -179.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 30.9 p -79.3 -44.7 21.15 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -176.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.417 ' O ' HD13 ' A' ' 72' ' ' ILE . 31.0 m -147.68 56.48 1.09 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.618 -173.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -64.46 130.51 37.61 Favored Glycine 0 CA--C 1.52 0.4 0 C-N-CA 120.284 -0.96 . . . . 0.0 111.9 173.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.524 ' HB ' ' OD1' ' A' ' 26' ' ' ASN . 1.9 mp -81.29 2.31 2.77 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 CA-C-O 121.66 0.743 . . . . 0.0 111.059 -174.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 15.5 ttt180 -57.48 -18.51 19.0 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 121.644 -0.66 . . . . 0.0 111.639 177.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 8.9 m -55.43 -15.42 2.66 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 121.378 0.608 . . . . 0.0 110.282 172.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 17.0 t70 . . . . . 0 CA--C 1.508 -0.652 0 CA-C-O 122.404 1.097 . . . . 0.0 110.144 178.676 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.441 ' HA2' ' OD1' ' A' ' 58' ' ' ASP . . . . . . . . 0 CA--C 1.519 0.311 0 CA-C-O 120.239 -0.2 . . . . 0.0 113.499 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -70.69 153.48 64.64 Favored 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 122.662 2.242 . . . . 0.0 111.577 178.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 16.4 p90 -115.98 -175.93 2.84 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.773 0.797 . . . . 0.0 112.134 -174.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -125.68 159.35 32.47 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-N 114.862 -1.063 . . . . 0.0 109.344 179.774 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.417 HH11 ' HD2' ' A' ' 14' ' ' ARG . 24.5 ttt85 -57.63 -48.46 79.37 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 120.895 0.379 . . . . 0.0 110.424 -179.774 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 21.4 tpp180 -46.22 -55.78 6.66 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.041 175.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.674 ' O ' HG22 ' A' ' 20' ' ' VAL . 2.1 mp0 -62.04 -49.45 75.94 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.857 179.22 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.407 ' HB3' HD12 ' A' ' 39' ' ' LEU . . . -53.29 -49.19 67.49 Favored 'General case' 0 N--CA 1.464 0.225 0 O-C-N 123.279 0.362 . . . . 0.0 111.557 -177.511 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -58.82 -40.14 83.27 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.433 -178.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.44 -24.26 66.42 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.856 179.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.674 HG22 ' O ' ' A' ' 16' ' ' GLN . 15.3 t -88.49 -22.75 6.58 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.794 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 -174.679 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.535 HG22 ' HB ' ' A' ' 27' ' ' ILE . 11.0 m -86.73 -31.03 21.19 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-N 113.768 -1.56 . . . . 0.0 110.575 -178.035 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.5 p -68.5 -31.34 70.53 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 170.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 41.0 m -75.67 -50.92 13.97 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.34 174.067 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.557 ' HB2' HG13 ' A' ' 27' ' ' ILE . 61.6 m-85 -113.16 102.26 10.21 Favored 'General case' 0 N--CA 1.447 -0.594 0 O-C-N 121.883 -0.511 . . . . 0.0 109.97 177.54 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 76.0 p -67.2 -9.25 38.33 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.06 -0.518 . . . . 0.0 112.056 -179.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.546 ' OD1' ' HB3' ' A' ' 24' ' ' TYR . 24.8 p-10 -79.01 -12.25 60.03 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.995 0.426 . . . . 0.0 110.035 177.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.557 HG13 ' HB2' ' A' ' 24' ' ' TYR . 2.2 mt -83.8 147.12 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 173.793 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.572 ' OG1' ' HB ' ' A' ' 40' ' ' VAL . 1.4 p -139.81 127.88 22.32 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 120.477 -0.489 . . . . 0.0 111.26 -179.07 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.487 ' HA ' HD21 ' A' ' 39' ' ' LEU . 5.6 tt -83.48 102.92 12.43 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 177.203 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -113.68 159.06 20.1 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.765 -175.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.8 t70 59.84 47.69 9.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.735 -179.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -72.27 96.54 1.85 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.976 -175.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -112.97 24.13 12.68 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.866 175.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 77.8 -79.99 1.38 Allowed Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.705 -0.68 . . . . 0.0 112.241 179.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 38.8 m -82.97 -16.69 46.26 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.077 0.465 . . . . 0.0 110.672 179.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 24.8 m170 -119.43 137.92 53.45 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 174.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -170.62 156.47 5.34 Favored 'General case' 0 C--N 1.323 -0.583 0 O-C-N 123.518 0.511 . . . . 0.0 109.769 177.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 11.9 ptt180 -128.53 153.28 47.35 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.136 176.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.54 ' O ' ' HA ' ' A' ' 51' ' ' ARG . 91.6 mt -111.21 132.54 54.25 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.177 0.513 . . . . 0.0 110.223 178.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.572 ' HB ' ' OG1' ' A' ' 28' ' ' THR . 38.6 t -108.99 109.23 27.56 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.624 176.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.475 HG13 ' CD2' ' A' ' 66' ' ' TYR . 10.9 t -85.1 118.44 32.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 173.267 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.402 ' O ' ' HB2' ' A' ' 26' ' ' ASN . 16.5 mtp180 -113.21 158.79 20.02 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 -178.097 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -89.77 -168.7 2.21 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 177.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 9.2 t -71.42 -14.32 62.12 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.099 -177.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -93.15 -16.02 25.36 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.34 0.591 . . . . 0.0 109.592 177.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 95.51 13.04 52.71 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.963 177.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 15.5 mtp180 -79.32 127.94 32.71 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 178.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.7 102.79 2.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.223 0.535 . . . . 0.0 111.213 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 43.9 t -86.72 -40.39 14.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.349 -0.842 . . . . 0.0 110.286 -179.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.586 ' CH2' ' HB1' ' A' ' 52' ' ' ALA . 22.6 t90 -135.48 106.57 6.7 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -178.719 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.54 ' HA ' ' O ' ' A' ' 39' ' ' LEU . 29.9 ptt180 -130.95 109.19 10.36 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 173.673 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.586 ' HB1' ' CH2' ' A' ' 50' ' ' TRP . . . -149.33 166.44 28.98 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.796 -177.456 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 44.1 m95 -85.53 -162.8 0.76 Allowed 'General case' 0 N--CA 1.445 -0.705 0 CA-C-O 121.468 0.651 . . . . 0.0 111.162 -175.139 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 61.8 t30 -105.17 -20.39 13.52 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.816 -176.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -83.45 14.67 3.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.15 0.5 . . . . 0.0 111.305 -178.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.509 ' HB2' ' HB2' ' A' ' 59' ' ' ALA . 9.4 mm-40 -80.33 129.57 68.85 Favored Pre-proline 0 C--N 1.325 -0.459 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 174.532 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -44.89 -39.1 13.85 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.867 3.045 . . . . 0.0 114.067 -172.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.441 ' OD1' ' HA2' ' A' ' 10' ' ' GLY . 12.7 t0 -142.11 59.02 1.47 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 178.021 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.509 ' HB2' ' HB2' ' A' ' 56' ' ' GLU . . . -56.38 -35.25 67.52 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.204 -179.636 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -62.22 -37.46 94.58 Favored Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.698 -0.683 . . . . 0.0 113.51 -177.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -59.75 -50.94 71.86 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 117.176 0.488 . . . . 0.0 110.384 -175.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -59.46 -43.05 97.8 Favored Glycine 0 CA--C 1.52 0.374 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.098 178.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 17.7 mt -59.31 -48.54 81.25 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.691 0.281 . . . . 0.0 111.074 176.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.441 ' N ' HD21 ' A' ' 64' ' ' ASN . 0.9 OUTLIER -65.05 -34.94 79.63 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.444 -178.948 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 14.2 ttm180 -63.63 -32.55 74.07 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.978 -178.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.475 ' CD2' HG13 ' A' ' 41' ' ' VAL . 68.6 t80 -82.45 -45.69 14.44 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 120.028 -0.669 . . . . 0.0 110.448 176.107 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 86.8 mt -55.22 -42.55 66.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.19 -178.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 56.8 ttp180 -55.87 -36.93 68.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.524 -178.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 13.6 t -105.34 25.56 10.5 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.179 0.514 . . . . 0.0 111.553 -173.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 54.0 m -149.59 -55.59 0.18 Allowed 'General case' 0 C--N 1.324 -0.534 0 O-C-N 122.126 -0.359 . . . . 0.0 111.266 177.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 45.03 75.64 0.16 Allowed Glycine 0 CA--C 1.524 0.632 0 CA-C-N 115.51 -0.768 . . . . 0.0 113.227 -175.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.452 HG22 ' HB3' ' A' ' 26' ' ' ASN . 45.9 mm -79.86 6.41 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-O 121.62 0.724 . . . . 0.0 111.118 -172.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.478 ' C ' ' H ' ' A' ' 75' ' ' ASP . 9.3 ptm180 -69.31 -2.82 11.73 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.193 178.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.4 t -72.26 8.48 1.31 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.971 175.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.478 ' H ' ' C ' ' A' ' 73' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.445 -0.675 0 CA-C-O 123.061 1.41 . . . . 0.0 110.896 -177.305 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.441 ' HA3' ' HD3' ' A' ' 11' ' ' PRO . . . . . . . . 0 CA--C 1.518 0.277 0 CA-C-O 120.117 -0.268 . . . . 0.0 113.404 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.441 ' HD3' ' HA3' ' A' ' 10' ' ' GLY . 17.7 Cg_exo -66.87 170.85 12.0 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.915 2.41 . . . . 0.0 112.531 178.44 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -136.25 -173.48 3.41 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.084 -177.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 27.5 p -122.21 178.17 5.04 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.227 175.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.629 ' O ' ' HG2' ' A' ' 18' ' ' GLN . 36.4 ttt-85 -63.0 -46.99 85.08 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 176.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 70.6 mtp180 -57.01 -48.36 78.67 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.133 178.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.566 ' O ' HG22 ' A' ' 20' ' ' VAL . 81.2 mm-40 -60.4 -46.9 88.33 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 178.548 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.461 ' HB3' HD12 ' A' ' 39' ' ' LEU . . . -52.32 -47.1 66.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.565 177.576 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.629 ' HG2' ' O ' ' A' ' 14' ' ' ARG . 16.4 mm100 -55.07 -48.06 74.03 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.504 -178.55 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.67 -28.53 69.99 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -175.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.566 HG22 ' O ' ' A' ' 16' ' ' GLN . 11.3 t -86.91 -25.57 6.18 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.787 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 -171.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.512 HG22 ' HB ' ' A' ' 27' ' ' ILE . 17.7 m -86.36 -31.25 21.61 Favored 'General case' 0 N--CA 1.435 -1.222 0 CA-C-N 113.735 -1.575 . . . . 0.0 111.211 -177.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.7 p -69.16 -29.01 66.93 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 172.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 19.5 m -77.34 -56.0 4.92 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.222 171.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.636 ' HB3' ' OD1' ' A' ' 26' ' ' ASN . 58.0 m-85 -105.13 98.07 7.83 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 -179.811 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.9 p -70.24 1.12 5.18 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 120.728 0.299 . . . . 0.0 111.759 178.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.636 ' OD1' ' HB3' ' A' ' 24' ' ' TYR . 4.5 p-10 -83.26 -10.87 58.3 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 174.205 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.621 HG13 ' O ' ' A' ' 24' ' ' TYR . 1.7 mt -85.25 138.02 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 173.058 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.494 ' OG1' ' HB ' ' A' ' 40' ' ' VAL . 2.3 p -130.62 126.43 36.62 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 120.641 -0.424 . . . . 0.0 111.043 -176.318 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 5.4 tt -91.26 108.05 19.62 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -122.97 167.9 13.0 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.719 178.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.56 ' HB2' HH11 ' A' ' 38' ' ' ARG . 0.7 OUTLIER 62.59 67.66 0.7 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.618 -177.88 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -81.38 100.25 9.14 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.657 -175.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -114.08 6.96 16.58 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.534 0.683 . . . . 0.0 109.553 174.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.62 -79.71 1.28 Allowed Glycine 0 N--CA 1.45 -0.419 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.948 -179.112 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 17.1 m -86.36 -18.63 31.38 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.156 0.503 . . . . 0.0 110.359 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 29.7 m170 -114.25 132.07 56.27 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.73 173.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.478 ' HA ' ' O ' ' A' ' 31' ' ' ASP . 52.9 p90 -164.59 157.37 16.89 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 178.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.567 ' HA ' ' HA ' ' A' ' 53' ' ' TRP . 27.0 ptt-85 -124.47 142.42 51.34 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 119.567 -0.853 . . . . 0.0 111.31 177.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.48 ' HA ' ' O ' ' A' ' 28' ' ' THR . 63.0 mt -104.05 134.74 46.81 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.589 176.133 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.53 HG12 ' HB3' ' A' ' 51' ' ' ARG . 40.6 t -112.83 116.41 52.53 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.959 175.408 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.533 ' HB ' ' HB3' ' A' ' 50' ' ' TRP . 97.1 t -86.36 107.97 17.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.239 173.727 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' A' ' 42' ' ' ARG . 14.7 mtp180 -101.48 156.57 17.39 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.543 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.808 ' HA ' ' HH ' ' A' ' 66' ' ' TYR . 1.9 p-10 -88.91 -171.06 3.14 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 120.793 0.33 . . . . 0.0 110.947 -175.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 12.2 t -64.1 -22.53 66.97 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.878 -177.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -87.14 -31.52 20.36 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 178.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 114.01 14.07 9.56 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.339 -179.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 72.3 mtp180 -91.01 140.98 29.33 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 179.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 22.3 ptt? -74.91 118.79 18.26 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.227 0.537 . . . . 0.0 111.459 -177.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 34.0 t -101.6 -32.41 3.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.002 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.533 ' HB3' ' HB ' ' A' ' 41' ' ' VAL . 49.3 t90 -144.77 136.58 25.74 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.973 -1.012 . . . . 0.0 108.542 -179.76 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.577 ' HD2' ' O ' ' A' ' 51' ' ' ARG . 0.0 OUTLIER -158.01 119.99 3.67 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 121.448 0.642 . . . . 0.0 110.354 174.772 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.494 ' HB2' ' CZ2' ' A' ' 50' ' ' TRP . . . -151.83 171.3 17.95 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.091 -177.747 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.567 ' HA ' ' HA ' ' A' ' 38' ' ' ARG . 87.7 m95 -80.26 -95.25 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -172.333 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -162.1 -35.8 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.123 0.487 . . . . 0.0 110.607 -176.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -84.67 14.86 4.23 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.396 -177.027 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.515 ' OE2' ' HB2' ' A' ' 53' ' ' TRP . 1.9 mm-40 -66.52 128.02 93.64 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.1 -178.008 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_exo -38.19 -49.6 2.25 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 124.338 3.359 . . . . 0.0 113.541 -176.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -138.92 69.16 1.37 Allowed 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 172.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.503 ' HB1' ' HB2' ' A' ' 56' ' ' GLU . . . -57.75 -33.86 68.92 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.898 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -55.16 -41.84 79.85 Favored Glycine 0 N--CA 1.446 -0.694 0 CA-C-N 115.241 -0.89 . . . . 0.0 112.963 178.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.602 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 9.0 tp10 -49.02 -54.76 14.37 Favored 'General case' 0 C--O 1.223 -0.332 0 CA-C-N 116.974 0.387 . . . . 0.0 111.059 -178.143 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.493 ' HA3' ' CD1' ' A' ' 50' ' ' TRP . . . -65.22 -40.94 97.03 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.777 -178.157 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.461 HD22 ' CZ3' ' A' ' 50' ' ' TRP . 49.3 mt -62.82 -51.04 68.61 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.609 0.242 . . . . 0.0 110.943 179.669 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 51.8 m-80 -69.15 -24.78 64.12 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.941 0.4 . . . . 0.0 110.28 179.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.602 ' HB2' ' O ' ' A' ' 61' ' ' GLU . 12.6 ttt85 -61.91 -37.64 85.41 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.961 177.277 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.808 ' HH ' ' HA ' ' A' ' 43' ' ' ASP . 91.4 t80 -82.32 -47.92 11.79 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.992 176.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.427 HG13 ' O ' ' A' ' 63' ' ' LEU . 72.2 mt -56.52 -21.85 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 CA-C-O 120.992 0.425 . . . . 0.0 111.404 179.718 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 49.6 ttp180 -50.24 -34.04 21.69 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.455 175.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.445 ' O ' ' HB2' ' A' ' 70' ' ' SER . 6.9 t -102.89 61.85 0.8 Allowed 'General case' 0 N--CA 1.443 -0.779 0 CA-C-O 122.062 0.934 . . . . 0.0 109.217 179.464 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.445 ' HB2' ' O ' ' A' ' 69' ' ' THR . 63.2 m 78.18 -51.63 0.49 Allowed 'General case' 0 C--O 1.236 0.356 0 CA-C-N 114.224 -1.353 . . . . 0.0 112.978 172.491 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.06 175.71 51.16 Favored Glycine 0 CA--C 1.52 0.38 0 N-CA-C 111.585 -0.606 . . . . 0.0 111.585 -172.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.568 ' HB ' ' OD1' ' A' ' 26' ' ' ASN . 1.1 mp -83.29 -5.62 9.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.458 0.647 . . . . 0.0 111.061 -177.313 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 23.7 ptt180 -59.34 -20.94 58.65 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.408 175.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.6 m -68.66 -1.54 7.12 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.058 177.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.7 t0 . . . . . 0 C--N 1.326 -0.415 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 177.654 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.567 ' HA3' ' O ' ' A' ' 57' ' ' PRO . . . . . . . . 0 N--CA 1.445 -0.766 0 N-CA-C 111.776 -0.53 . . . . 0.0 111.776 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.543 ' HG3' ' HA ' ' A' ' 57' ' ' PRO . 3.4 Cg_exo -78.86 133.67 11.46 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 121.547 1.498 . . . . 0.0 111.659 175.526 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 26.7 p90 -100.89 -170.78 1.9 Allowed 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.525 -0.762 . . . . 0.0 111.139 -178.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.427 ' OG1' ' HG2' ' A' ' 16' ' ' GLN . 21.2 p -125.73 172.53 9.73 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 176.24 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.523 ' O ' ' HG3' ' A' ' 18' ' ' GLN . 1.9 tmt_? -61.03 -49.1 78.76 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 174.365 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 13.7 ttp85 -52.56 -52.57 54.31 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.823 -1.08 . . . . 0.0 111.376 176.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.612 ' O ' HG22 ' A' ' 20' ' ' VAL . 15.6 mm100 -59.27 -47.34 85.75 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.587 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -52.11 -48.31 64.86 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.719 179.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.523 ' HG3' ' O ' ' A' ' 14' ' ' ARG . 44.9 mt-30 -54.94 -48.58 72.99 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.446 -179.321 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.98 -35.14 76.02 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.181 0.515 . . . . 0.0 111.175 -178.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.612 HG22 ' O ' ' A' ' 16' ' ' GLN . 16.4 t -82.29 -13.14 12.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.756 -175.08 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.423 HG23 ' HB ' ' A' ' 27' ' ' ILE . 0.0 OUTLIER -91.87 -34.72 14.41 Favored 'General case' 0 CA--C 1.507 -0.674 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 176.349 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 22.1 m -56.24 -30.87 62.96 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 114.294 -1.321 . . . . 0.0 109.665 167.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.401 ' O ' ' HA ' ' A' ' 73' ' ' ARG . 28.0 m -89.38 -46.99 8.32 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.794 178.257 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.621 ' O ' HG13 ' A' ' 27' ' ' ILE . 36.9 m-85 -122.29 104.81 9.69 Favored 'General case' 0 N--CA 1.447 -0.611 0 O-C-N 121.767 -0.583 . . . . 0.0 109.481 177.639 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 7.2 p -77.09 -6.07 51.4 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -177.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.438 ' ND2' ' HB3' ' A' ' 24' ' ' TYR . 6.4 p30 -71.71 -19.36 62.06 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 173.466 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.621 HG13 ' O ' ' A' ' 24' ' ' TYR . 1.9 mt -77.01 138.95 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 CA-C-N 115.258 -0.883 . . . . 0.0 108.622 177.433 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.536 ' OG1' ' HB ' ' A' ' 40' ' ' VAL . 1.3 p -137.0 146.4 45.28 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 121.18 -0.208 . . . . 0.0 110.534 -175.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.482 ' HA ' HD22 ' A' ' 39' ' ' LEU . 4.5 tt -100.31 122.98 43.96 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.962 0.411 . . . . 0.0 110.193 -176.32 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.506 ' HB2' ' HG3' ' A' ' 38' ' ' ARG . 24.0 mt-10 -116.82 155.15 29.47 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.679 175.63 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 59.92 52.88 5.01 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.205 171.728 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.432 ' OD2' HD23 ' A' ' 29' ' ' LEU . 2.0 m-20 -62.3 83.51 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.762 178.551 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -119.46 71.31 0.87 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.333 0.587 . . . . 0.0 111.088 -177.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 66.11 -106.88 1.73 Allowed Glycine 0 N--CA 1.445 -0.73 0 CA-C-N 115.094 -0.957 . . . . 0.0 112.966 174.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 39.7 t -85.49 -14.24 46.63 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 111.667 0.247 . . . . 0.0 111.667 -175.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 34.4 p-80 -129.7 143.02 50.62 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.071 -0.651 . . . . 0.0 111.598 -177.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -163.88 179.35 7.11 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 179.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.506 ' HG3' ' HB2' ' A' ' 30' ' ' GLU . 13.6 ptt180 -127.41 154.26 45.25 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.015 -0.674 . . . . 0.0 110.866 176.072 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.482 HD22 ' HA ' ' A' ' 29' ' ' LEU . 95.5 mt -115.93 136.15 53.3 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.024 0.44 . . . . 0.0 110.392 178.336 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.536 ' HB ' ' OG1' ' A' ' 28' ' ' THR . 21.4 t -107.21 120.85 59.23 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.556 178.319 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 63.5 t -89.28 122.63 40.84 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 173.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 24.8 mtp85 -111.39 159.61 17.85 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.344 0.593 . . . . 0.0 110.558 -178.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.403 ' CG ' ' H ' ' A' ' 44' ' ' THR . 6.5 t70 -90.97 176.83 6.46 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.295 178.736 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.403 ' H ' ' CG ' ' A' ' 43' ' ' ASP . 17.8 p -68.96 -15.69 63.55 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.757 0.313 . . . . 0.0 111.303 -177.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -83.88 -17.08 42.04 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.491 0.662 . . . . 0.0 109.363 172.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 91.14 11.04 61.78 Favored Glycine 0 N--CA 1.447 -0.61 0 CA-C-N 115.291 -0.868 . . . . 0.0 112.517 -178.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 31.8 ptt85 -81.19 138.22 35.84 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 175.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 14.4 ptm -61.22 127.47 31.69 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.049 0.452 . . . . 0.0 110.839 177.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 13.5 t -102.68 -39.11 5.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.86 177.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 75.6 t-105 -166.54 121.69 1.16 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.991 -175.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 4.8 ptp85 -120.39 125.14 47.23 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 174.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -134.67 157.59 46.25 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.155 -176.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.531 ' HB2' ' HG3' ' A' ' 56' ' ' GLU . 81.7 m95 -85.6 -174.45 5.17 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 122.203 1.001 . . . . 0.0 111.988 -177.392 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.451 HD21 ' C ' ' A' ' 54' ' ' ASN . 0.2 OUTLIER -96.34 -33.52 11.91 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 113.692 -1.595 . . . . 0.0 110.158 -176.59 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 17.8 p90 -85.84 10.56 13.42 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.625 -174.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.531 ' HG3' ' HB2' ' A' ' 53' ' ' TRP . 25.5 mt-10 -88.19 128.59 52.96 Favored Pre-proline 0 C--N 1.322 -0.593 0 C-N-CA 121.007 -0.277 . . . . 0.0 110.406 -178.651 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.567 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 21.9 Cg_exo -65.14 -5.22 10.56 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.46 2.774 . . . . 0.0 114.094 -171.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -141.03 25.93 2.07 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.365 0.126 . . . . 0.0 111.132 -179.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.535 ' O ' ' HG ' ' A' ' 63' ' ' LEU . . . -57.06 -46.6 82.33 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.166 0.508 . . . . 0.0 110.997 -176.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -74.0 -22.05 78.41 Favored Glycine 0 N--CA 1.443 -0.843 0 CA-C-N 115.775 -0.648 . . . . 0.0 113.303 -176.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -70.87 -33.43 70.6 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 117.182 0.491 . . . . 0.0 109.905 -177.023 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.513 ' O ' ' HB3' ' A' ' 65' ' ' ARG . . . -79.43 -38.27 21.77 Favored Glycine 0 N--CA 1.45 -0.399 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 175.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.535 ' HG ' ' O ' ' A' ' 59' ' ' ALA . 92.4 mt -61.77 -44.73 96.31 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.381 -0.409 . . . . 0.0 110.024 176.581 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.55 ' HA ' ' HB ' ' A' ' 67' ' ' ILE . 90.4 m-20 -62.96 -33.59 75.7 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.896 177.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.513 ' HB3' ' O ' ' A' ' 62' ' ' GLY . 9.5 tpt180 -54.39 -40.4 68.15 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.833 0.349 . . . . 0.0 110.439 173.72 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -77.33 -48.56 17.03 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.905 0.384 . . . . 0.0 110.545 174.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.55 ' HB ' ' HA ' ' A' ' 64' ' ' ASN . 84.2 mt -52.83 -56.15 8.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -174.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -71.86 -32.89 67.95 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.705 0.288 . . . . 0.0 111.656 -169.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.03 28.71 7.98 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -176.079 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 62.4 m -148.77 -53.75 0.18 Allowed 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 172.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 53.84 89.13 0.01 OUTLIER Glycine 0 CA--C 1.522 0.529 0 CA-C-N 115.422 -0.808 . . . . 0.0 114.373 176.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.445 ' O ' HG21 ' A' ' 72' ' ' ILE . 38.2 mm -86.37 7.02 2.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.749 0.785 . . . . 0.0 109.89 178.612 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.44 ' C ' ' H ' ' A' ' 75' ' ' ASP . 4.6 ptm180 -63.95 -13.5 46.42 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.646 -178.59 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 14.3 t -75.52 5.69 5.62 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 174.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.44 ' H ' ' C ' ' A' ' 73' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.466 0.342 0 C-N-CA 124.939 1.295 . . . . 0.0 112.499 176.501 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.467 ' HA3' ' HD3' ' A' ' 11' ' ' PRO . . . . . . . . 0 CA--C 1.522 0.527 0 N-CA-C 114.812 0.685 . . . . 0.0 114.812 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.527 ' HG3' ' HA ' ' A' ' 57' ' ' PRO . 1.3 Cg_endo -80.53 142.64 14.71 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 122.852 2.368 . . . . 0.0 112.409 -179.216 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.44 ' CZ ' ' HA ' ' A' ' 54' ' ' ASN . 9.8 p90 -111.46 -171.39 1.83 Allowed 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.002 -179.275 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.42 ' OG1' ' HG2' ' A' ' 16' ' ' GLN . 16.7 p -124.61 179.94 4.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.186 178.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.411 ' O ' ' HG3' ' A' ' 18' ' ' GLN . 5.6 ttm180 -65.8 -53.58 38.37 Favored 'General case' 0 N--CA 1.427 -1.591 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.705 -178.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.425 HH11 ' HD2' ' A' ' 15' ' ' ARG . 20.6 ptt85 -62.37 -36.46 82.34 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.204 178.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.615 ' O ' HG22 ' A' ' 20' ' ' VAL . 15.7 mm100 -62.31 -48.18 81.0 Favored 'General case' 0 CA--C 1.519 -0.246 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 176.516 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.419 ' HB2' HD13 ' A' ' 39' ' ' LEU . . . -55.0 -47.9 74.05 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.99 175.602 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.411 ' HG3' ' O ' ' A' ' 14' ' ' ARG . 99.1 mt-30 -57.59 -42.54 83.36 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.401 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.446 ' O ' ' HB ' ' A' ' 22' ' ' THR . . . -62.59 -34.59 77.29 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.985 178.31 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.615 HG22 ' O ' ' A' ' 16' ' ' GLN . 24.3 t -79.18 -16.33 13.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.808 0.337 . . . . 0.0 110.362 -178.034 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.458 HG22 ' HB ' ' A' ' 27' ' ' ILE . 0.0 OUTLIER -92.24 -26.42 18.18 Favored 'General case' 0 CA--C 1.503 -0.83 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 177.624 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.446 ' HB ' ' O ' ' A' ' 19' ' ' ALA . 98.0 m -61.12 -32.97 72.65 Favored 'General case' 0 N--CA 1.437 -1.122 0 CA-C-N 113.612 -1.631 . . . . 0.0 109.419 167.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.8 m -87.45 -50.66 6.4 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.968 178.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.634 ' O ' HG13 ' A' ' 27' ' ' ILE . 35.0 m-85 -116.64 102.37 9.39 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 -179.469 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 15.6 p -81.21 5.34 17.3 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.942 0.401 . . . . 0.0 111.419 -177.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.522 ' OD1' ' HB3' ' A' ' 24' ' ' TYR . 25.5 p-10 -83.53 -17.31 42.28 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 172.221 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.634 HG13 ' O ' ' A' ' 24' ' ' TYR . 1.1 mt -78.22 148.48 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 N-CA-C 108.183 -1.044 . . . . 0.0 108.183 173.5 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.496 ' O ' ' HA ' ' A' ' 39' ' ' LEU . 1.7 p -141.68 133.94 27.91 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.498 -0.481 . . . . 0.0 111.465 -178.029 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.497 ' HA ' HD21 ' A' ' 39' ' ' LEU . 6.5 tt -87.88 100.6 13.0 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 179.623 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -115.75 166.5 11.87 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.848 -174.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 60.6 37.22 19.49 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 123.388 0.43 . . . . 0.0 111.462 171.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -74.95 125.11 28.19 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.135 0.493 . . . . 0.0 111.305 -175.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -126.69 25.2 6.45 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.526 173.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.0 -90.87 1.6 Allowed Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.038 -177.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.0 t -78.27 -7.13 56.83 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.262 0.553 . . . . 0.0 110.863 -178.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 57.2 m80 -131.42 138.56 49.13 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.408 ' O ' ' HA ' ' A' ' 53' ' ' TRP . 52.8 p90 -168.81 166.39 11.49 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.306 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.485 ' HA ' ' HA ' ' A' ' 53' ' ' TRP . 70.2 mtm180 -128.28 132.98 48.69 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.497 HD21 ' HA ' ' A' ' 29' ' ' LEU . 64.4 mt -95.45 107.65 19.81 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.348 0.594 . . . . 0.0 109.661 174.244 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 60.7 t -89.48 116.87 31.71 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.896 177.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.45 HG22 HG21 ' A' ' 27' ' ' ILE . 25.4 t -89.4 110.58 21.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 178.057 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 33.7 mtt85 -97.03 171.82 8.24 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.806 -178.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.4 ' CG ' ' H ' ' A' ' 45' ' ' GLU . 1.3 p-10 -104.17 -168.91 1.55 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.602 -178.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.1 p -63.01 -22.74 67.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.108 -179.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.4 ' H ' ' CG ' ' A' ' 43' ' ' ASP . 9.9 tp10 -89.81 -28.56 19.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.057 0.456 . . . . 0.0 110.073 178.42 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 107.19 19.36 9.51 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.055 -178.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 51.0 mtp180 -89.79 143.99 26.34 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 178.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.8 113.74 8.17 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.227 0.537 . . . . 0.0 110.709 178.391 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 58.0 t -98.83 -33.46 4.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.135 178.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 73.3 t-105 -153.0 157.44 40.55 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.989 -176.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.409 HH11 ' HD2' ' A' ' 51' ' ' ARG . 20.6 ptt85 -156.93 146.19 20.33 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 177.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -152.95 153.42 32.95 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 177.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.613 ' HB2' ' OE1' ' A' ' 56' ' ' GLU . 80.4 m95 -77.39 -92.66 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.05 0.452 . . . . 0.0 110.857 -179.048 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.44 ' HA ' ' CZ ' ' A' ' 12' ' ' PHE . 6.6 t30 -175.58 -37.78 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.385 -177.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -86.0 -15.04 42.72 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -169.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.613 ' OE1' ' HB2' ' A' ' 53' ' ' TRP . 2.4 mp0 -62.88 137.16 96.8 Favored Pre-proline 0 C--N 1.327 -0.408 0 N-CA-C 110.321 -0.251 . . . . 0.0 110.321 -179.236 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.527 ' HA ' ' HG3' ' A' ' 11' ' ' PRO . 43.2 Cg_endo -68.59 5.35 1.31 Allowed 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.879 2.386 . . . . 0.0 112.917 -177.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -138.6 12.24 2.73 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.465 177.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.508 ' HB3' ' HB2' ' A' ' 56' ' ' GLU . . . -62.31 -43.35 99.02 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-O 121.239 0.542 . . . . 0.0 110.738 -172.773 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -68.03 -29.72 73.63 Favored Glycine 0 N--CA 1.442 -0.936 0 CA-C-N 115.346 -0.843 . . . . 0.0 112.301 179.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -72.44 -29.51 63.76 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 120.494 -0.483 . . . . 0.0 109.719 -178.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -68.57 -41.87 82.8 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.573 -0.822 . . . . 0.0 111.077 176.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 57.7 mt -64.16 -47.8 78.46 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.906 0.384 . . . . 0.0 110.143 176.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 9.5 m-20 -61.9 -29.2 70.05 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.953 177.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 36.0 ttm180 -65.73 -37.99 87.94 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.191 179.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -70.39 -50.3 40.17 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 174.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 99.0 mt -53.83 -35.97 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.068 179.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 50.0 ttt180 -49.72 -32.44 13.5 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -176.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 41.0 p -56.26 -38.37 71.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.038 0.447 . . . . 0.0 111.147 -178.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 37.2 t 167.32 -38.13 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 114.914 -1.039 . . . . 0.0 108.997 -174.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 84.12 147.34 8.05 Favored Glycine 0 N--CA 1.447 -0.628 0 CA-C-N 115.416 -0.811 . . . . 0.0 112.264 -178.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.433 ' O ' HG23 ' A' ' 72' ' ' ILE . 38.9 mm -83.29 6.7 1.69 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-O 121.672 0.749 . . . . 0.0 110.161 -178.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.481 ' HB3' ' CE2' ' A' ' 24' ' ' TYR . 16.1 ptt-85 -62.86 -24.28 67.72 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.74 178.061 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 20.0 m -60.95 -20.69 62.59 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.433 0.635 . . . . 0.0 109.548 173.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 29.5 t0 . . . . . 0 CA--C 1.517 -0.309 0 CA-C-N 114.036 -1.438 . . . . 0.0 112.914 -175.621 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.527 ' HA2' ' HA ' ' A' ' 58' ' ' ASP . . . . . . . . 0 N--CA 1.451 -0.304 0 CA-C-O 119.795 -0.447 . . . . 0.0 113.024 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -67.59 154.66 72.87 Favored 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 122.512 2.141 . . . . 0.0 112.396 177.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.467 ' CD2' ' HB3' ' A' ' 17' ' ' ALA . 15.9 p90 -126.79 -172.14 2.57 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.968 -176.682 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.507 ' OG1' ' HG2' ' A' ' 16' ' ' GLN . 31.9 p -125.47 176.13 7.03 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 172.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.499 ' HG2' HD11 ' A' ' 29' ' ' LEU . 45.1 mtm180 -65.38 -43.83 89.45 Favored 'General case' 0 C--O 1.219 -0.52 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.332 173.53 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 16.7 mtp180 -56.94 -46.97 81.71 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.933 179.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.556 ' O ' HG23 ' A' ' 20' ' ' VAL . 10.6 mm100 -64.37 -49.89 69.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.962 178.499 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.467 ' HB3' ' CD2' ' A' ' 12' ' ' PHE . . . -56.24 -49.05 75.26 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.768 179.339 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.433 ' HG2' ' O ' ' A' ' 14' ' ' ARG . 15.2 mm100 -55.28 -38.6 68.83 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.432 -178.54 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.11 -25.67 66.32 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.656 178.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 16' ' ' GLN . 31.3 t -91.61 -16.88 7.85 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.721 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 -173.731 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.511 HG21 ' HB ' ' A' ' 27' ' ' ILE . 6.2 m -93.74 -27.02 16.74 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-N 113.839 -1.528 . . . . 0.0 107.612 -177.623 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.9 m -65.07 -35.55 81.51 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 113.636 -1.62 . . . . 0.0 108.943 165.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 41.6 m -74.57 -55.93 5.38 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.559 177.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.644 ' HB3' ' OD1' ' A' ' 26' ' ' ASN . 63.9 m-85 -114.21 104.13 11.79 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-O 121.097 0.475 . . . . 0.0 109.839 178.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.3 p -69.72 -6.52 32.37 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.309 -179.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.644 ' OD1' ' HB3' ' A' ' 24' ' ' TYR . 7.6 p-10 -79.5 -8.83 59.42 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.167 0.508 . . . . 0.0 109.723 175.459 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.531 HG13 ' HB2' ' A' ' 24' ' ' TYR . 4.2 mt -88.19 157.42 3.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 172.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -153.37 130.82 11.36 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.639 -0.424 . . . . 0.0 111.298 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.504 ' HA ' HD21 ' A' ' 39' ' ' LEU . 6.5 tt -90.01 111.11 22.09 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -178.334 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -123.97 170.94 10.12 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.141 -178.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.8 t70 61.85 30.17 18.13 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.432 -0.803 . . . . 0.0 110.061 -178.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -63.18 99.33 0.17 Allowed 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.505 -177.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -112.74 -6.98 13.83 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.242 176.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.419 ' HA2' ' NH1' ' A' ' 14' ' ' ARG . . . 129.74 -102.42 0.55 Allowed Glycine 0 N--CA 1.448 -0.518 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.036 -177.399 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 37.2 m -79.3 -19.68 49.87 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 172.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -93.13 120.38 33.37 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.715 173.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.431 ' HE2' ' HE2' ' A' ' 12' ' ' PHE . 35.6 p90 -174.8 165.93 3.66 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 176.007 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.414 HH11 ' HD3' ' A' ' 38' ' ' ARG . 13.8 ptt180 -142.17 142.95 32.75 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.093 0.473 . . . . 0.0 110.774 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.504 HD21 ' HA ' ' A' ' 29' ' ' LEU . 82.0 mt -95.68 121.65 37.61 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.193 0.52 . . . . 0.0 110.375 179.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 41.4 t -98.46 115.14 37.98 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.632 178.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.0 t -96.69 118.63 43.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 121.122 0.487 . . . . 0.0 110.11 -177.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.465 ' HA ' ' O ' ' A' ' 47' ' ' ARG . 39.1 mtm105 -103.08 168.8 8.95 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.485 -178.466 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.454 ' CG ' ' H ' ' A' ' 45' ' ' GLU . 0.5 OUTLIER -96.09 -167.91 1.66 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.037 -0.528 . . . . 0.0 109.986 178.505 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 23.2 p -64.01 -26.17 68.45 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.317 -178.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.518 ' HB3' ' HD2' ' A' ' 47' ' ' ARG . 9.1 tp10 -95.84 -13.0 24.37 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 121.18 0.515 . . . . 0.0 110.433 -177.044 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 104.63 15.28 21.24 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.575 179.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.518 ' HD2' ' HB3' ' A' ' 45' ' ' GLU . 0.0 OUTLIER -78.0 128.54 34.04 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 178.448 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 63.1 mtm -74.27 99.89 3.58 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 177.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 23.7 t -86.92 -33.45 6.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.641 -174.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.419 ' CD1' HD23 ' A' ' 63' ' ' LEU . 75.5 t-105 -153.72 150.78 28.89 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.486 -173.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 16.0 ptt180 -156.09 141.24 17.42 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 174.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -142.92 153.49 43.14 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.415 -178.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.467 ' HB2' ' HG2' ' A' ' 56' ' ' GLU . 98.0 m95 -75.62 -167.41 0.68 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.643 0.735 . . . . 0.0 111.73 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -103.98 -40.88 6.04 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.746 -1.115 . . . . 0.0 111.413 -177.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 13.8 p90 -83.24 10.27 8.82 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.82 -174.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.53 ' HB2' ' HB2' ' A' ' 59' ' ' ALA . 11.9 mm-40 -77.55 131.75 70.56 Favored Pre-proline 0 C--N 1.324 -0.538 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 177.676 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 56' ' ' GLU . 52.1 Cg_exo -55.39 -21.26 28.99 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 123.493 2.795 . . . . 0.0 113.217 -176.487 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.527 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . 4.2 p30 -136.86 38.34 2.59 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.77 0.319 . . . . 0.0 110.621 177.476 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.53 ' HB2' ' HB2' ' A' ' 56' ' ' GLU . . . -55.0 -52.75 62.16 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 121.22 0.533 . . . . 0.0 111.36 -174.344 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.4 ' HA2' HD11 ' A' ' 63' ' ' LEU . . . -67.7 -28.62 73.51 Favored Glycine 0 N--CA 1.44 -1.091 0 CA-C-N 115.422 -0.808 . . . . 0.0 112.729 -178.024 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -68.15 -35.88 78.77 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 117.139 0.469 . . . . 0.0 110.407 -176.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -68.49 -42.46 81.38 Favored Glycine 0 CA--C 1.519 0.299 0 C-N-CA 120.645 -0.788 . . . . 0.0 111.305 175.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.463 ' O ' HG13 ' A' ' 67' ' ' ILE . 49.7 mt -61.05 -47.47 86.21 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.994 -0.372 . . . . 0.0 109.994 176.014 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.497 ' HA ' ' HB ' ' A' ' 67' ' ' ILE . 94.0 m-20 -63.57 -29.29 70.57 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.791 177.679 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 6.4 ttt180 -58.93 -39.66 82.25 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 177.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -76.88 -46.59 24.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.505 173.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.497 ' HB ' ' HA ' ' A' ' 64' ' ' ASN . 93.7 mt -53.41 -46.16 58.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.681 -178.378 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 47.6 ttt85 -57.69 -36.56 72.12 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.948 -176.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.5 p -105.4 20.81 18.26 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -176.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 15.0 m -139.16 -57.31 0.6 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.688 0.28 . . . . 0.0 110.841 178.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 40.1 77.71 0.07 OUTLIER Glycine 0 CA--C 1.521 0.461 0 CA-C-N 115.189 -0.914 . . . . 0.0 113.512 -175.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.509 ' HB ' ' OD1' ' A' ' 26' ' ' ASN . 37.8 mm -82.55 5.73 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 CA-C-O 121.465 0.65 . . . . 0.0 111.317 -171.383 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.448 ' C ' ' H ' ' A' ' 75' ' ' ASP . 30.7 ttt-85 -75.84 -65.95 0.84 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.072 0.463 . . . . 0.0 111.839 -179.498 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 61.5 m -66.04 -8.32 22.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.127 -178.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.448 ' H ' ' C ' ' A' ' 73' ' ' ARG . 16.4 t70 . . . . . 0 C--N 1.326 -0.418 0 CA-C-N 114.29 -1.323 . . . . 0.0 111.705 -170.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.356 0 CA-C-O 120.257 -0.19 . . . . 0.0 113.007 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.575 ' HD3' ' O ' ' A' ' 57' ' ' PRO . 53.2 Cg_endo -76.07 174.85 12.13 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.443 2.095 . . . . 0.0 112.17 176.818 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.439 ' CE1' ' HA ' ' A' ' 54' ' ' ASN . 16.5 p90 -126.96 -175.13 3.33 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.089 -177.693 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.517 ' H ' ' HB2' ' A' ' 16' ' ' GLN . 40.6 p -122.27 170.36 9.99 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.891 178.649 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 25.0 ttt85 -59.33 -39.55 83.49 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.246 0.546 . . . . 0.0 110.16 175.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 32.2 mtm180 -66.38 -52.36 47.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.106 177.444 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.623 ' O ' HG23 ' A' ' 20' ' ' VAL . 57.8 mm-40 -56.07 -48.0 76.9 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.862 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.427 ' HB1' HD21 ' A' ' 39' ' ' LEU . . . -49.12 -51.06 34.29 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.994 177.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -54.65 -40.31 68.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.455 179.285 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.17 -25.97 63.7 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.706 0.289 . . . . 0.0 111.745 -176.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.623 HG23 ' O ' ' A' ' 16' ' ' GLN . 15.9 t -89.44 -19.47 7.43 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.734 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 -173.63 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.525 HG23 ' HB ' ' A' ' 27' ' ' ILE . 13.2 m -97.11 -27.89 14.37 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-N 113.826 -1.534 . . . . 0.0 108.619 -175.543 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.8 m -63.63 -37.89 89.06 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 114.356 -1.293 . . . . 0.0 108.963 168.058 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 34.1 m -75.88 -56.68 4.44 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.645 175.6 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.572 ' O ' HG13 ' A' ' 27' ' ' ILE . 65.1 m-85 -105.78 99.81 9.39 Favored 'General case' 0 N--CA 1.439 -1.019 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 -179.054 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 4.0 p -70.01 -4.6 21.64 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.216 -178.552 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.531 ' OD1' ' HB3' ' A' ' 24' ' ' TYR . 6.3 p-10 -82.25 -7.42 59.63 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.702 176.123 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.572 HG13 ' O ' ' A' ' 24' ' ' TYR . 1.8 mt -90.25 158.74 2.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 173.43 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -153.39 135.41 14.72 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.721 0.296 . . . . 0.0 111.317 178.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.401 ' HA ' HD23 ' A' ' 39' ' ' LEU . 7.0 tt -90.66 109.76 20.93 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -131.17 176.73 8.02 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.384 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.446 ' HB2' ' HG2' ' A' ' 38' ' ' ARG . 11.9 m-20 61.85 30.82 18.34 Favored 'General case' 0 N--CA 1.467 0.376 0 O-C-N 123.735 0.647 . . . . 0.0 110.908 -178.804 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.585 ' HA ' ' HB3' ' A' ' 37' ' ' PHE . 25.9 t0 -71.13 122.85 20.88 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.619 -175.651 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.541 ' HB3' ' HB2' ' A' ' 36' ' ' HIS . 35.0 tt0 -133.78 18.31 3.87 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.034 178.596 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 113.14 -91.99 0.6 Allowed Glycine 0 N--CA 1.45 -0.393 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.688 -177.507 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.6 t -100.63 -15.33 17.81 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 174.64 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.541 ' HB2' ' HB3' ' A' ' 33' ' ' GLN . 35.5 m170 -93.1 107.7 19.44 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.417 175.051 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.585 ' HB3' ' HA ' ' A' ' 32' ' ' ASP . 55.3 p90 -163.81 162.17 23.62 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.049 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.544 ' HB3' ' HA ' ' A' ' 53' ' ' TRP . 30.7 ptt180 -138.62 146.15 41.39 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.29 0.567 . . . . 0.0 111.814 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.427 HD21 ' HB1' ' A' ' 17' ' ' ALA . 97.0 mt -91.77 126.15 36.75 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.072 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.466 HG11 ' SD ' ' A' ' 48' ' ' MET . 28.7 t -96.31 109.71 23.35 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.948 178.737 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 91.1 t -81.01 114.54 22.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.536 175.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.463 ' HB3' ' HA2' ' A' ' 46' ' ' GLY . 10.7 mtt180 -106.02 173.02 6.49 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.216 178.134 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.438 ' CG ' ' H ' ' A' ' 45' ' ' GLU . 1.0 OUTLIER -95.65 -167.9 1.68 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.244 -0.434 . . . . 0.0 109.933 177.647 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 10.2 p -60.7 -26.81 67.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.58 -178.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.438 ' H ' ' CG ' ' A' ' 43' ' ' ASP . 36.1 tt0 -91.56 -27.39 18.23 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.337 -179.555 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.463 ' HA2' ' HB3' ' A' ' 42' ' ' ARG . . . 108.39 19.6 8.75 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.526 -0.845 . . . . 0.0 112.836 -178.696 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.429 ' O ' ' HA ' ' A' ' 42' ' ' ARG . 79.3 mtt180 -78.64 143.95 35.87 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 176.142 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.466 ' SD ' HG11 ' A' ' 40' ' ' VAL . 14.3 mmt -66.22 114.28 5.2 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.245 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 43.8 t -103.33 -35.1 3.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 120.741 0.305 . . . . 0.0 110.536 178.001 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 68.4 t-105 -172.3 125.54 0.52 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.968 -174.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 12.3 ptp180 -120.03 125.23 47.82 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.92 0.39 . . . . 0.0 110.232 175.529 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -125.89 143.25 51.15 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.572 -178.568 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.698 ' HB2' ' HG2' ' A' ' 56' ' ' GLU . 96.9 m95 -72.13 -174.12 1.2 Allowed 'General case' 0 CA--C 1.513 -0.464 0 CA-C-O 122.079 0.942 . . . . 0.0 112.13 -177.594 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.439 ' HA ' ' CE1' ' A' ' 12' ' ' PHE . 18.9 t-20 -101.9 -43.43 5.8 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 113.825 -1.534 . . . . 0.0 110.879 -176.606 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -83.68 10.64 8.84 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.941 -173.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.698 ' HG2' ' HB2' ' A' ' 53' ' ' TRP . 12.8 mm-40 -75.83 131.12 77.04 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.192 178.713 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.575 ' O ' ' HD3' ' A' ' 11' ' ' PRO . 4.2 Cg_endo -46.74 -37.01 20.39 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 124.01 3.14 . . . . 0.0 113.304 -174.834 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.566 ' HB3' ' HB2' ' A' ' 61' ' ' GLU . 11.5 m-20 -140.14 63.25 1.48 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.727 0.298 . . . . 0.0 110.249 174.668 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.539 ' HB2' ' HB2' ' A' ' 56' ' ' GLU . . . -61.77 -38.31 87.52 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-O 121.352 0.596 . . . . 0.0 110.572 177.704 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -62.51 -23.68 65.09 Favored Glycine 0 C--O 1.221 -0.691 0 CA-C-N 115.389 -0.823 . . . . 0.0 113.112 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.566 ' HB2' ' HB3' ' A' ' 58' ' ' ASP . 2.5 tm-20 -58.14 -51.9 67.8 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.159 0.504 . . . . 0.0 110.21 -178.297 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -71.84 -39.34 59.71 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.678 -0.772 . . . . 0.0 111.847 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.511 ' O ' HG13 ' A' ' 67' ' ' ILE . 80.4 mt -61.73 -46.46 89.55 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.593 0.235 . . . . 0.0 110.97 179.409 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -65.44 -29.53 70.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.14 -179.308 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.509 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 25.3 ttm105 -66.03 -33.76 76.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.027 176.522 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -73.07 -46.56 50.91 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 119.979 -0.688 . . . . 0.0 109.739 172.515 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.511 HG13 ' O ' ' A' ' 63' ' ' LEU . 80.3 mt -55.46 -55.59 16.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.342 -178.094 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.607 ' O ' HG22 ' A' ' 69' ' ' THR . 26.0 mmm-85 54.93 27.79 9.65 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 123.119 0.262 . . . . 0.0 111.55 177.516 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.607 HG22 ' O ' ' A' ' 68' ' ' ARG . 9.8 t 61.29 16.69 7.57 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.222 1.409 . . . . 0.0 111.042 176.165 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 13.2 p -113.72 -66.14 1.12 Allowed 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.438 175.498 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.535 ' HA3' ' CE1' ' A' ' 24' ' ' TYR . . . 65.65 179.64 8.97 Favored Glycine 0 N--CA 1.445 -0.765 0 CA-C-N 115.208 -0.906 . . . . 0.0 113.117 179.091 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.453 ' O ' HG22 ' A' ' 72' ' ' ILE . 35.8 mm -91.77 5.9 5.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.808 0.813 . . . . 0.0 110.119 -179.044 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 22.5 tpt180 . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.259 177.84 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.613 ' HA3' ' O ' ' A' ' 57' ' ' PRO . . . . . . . . 0 N--CA 1.441 -0.997 0 N-CA-C 111.325 -0.71 . . . . 0.0 111.325 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -73.33 132.92 18.45 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 121.494 1.462 . . . . 0.0 110.66 174.394 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 34.8 p90 -104.97 -171.7 1.96 Allowed 'General case' 0 C--N 1.31 -1.137 0 CA-C-O 121.703 0.763 . . . . 0.0 112.452 -173.651 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.89 156.44 36.26 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.924 -1.035 . . . . 0.0 109.2 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 22.5 ttt85 -61.6 -49.27 77.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.057 0.456 . . . . 0.0 110.346 -179.039 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.419 HH11 ' HD2' ' A' ' 15' ' ' ARG . 30.7 mtp180 -52.22 -47.97 65.36 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.338 -0.847 . . . . 0.0 111.2 175.63 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.595 ' O ' HG23 ' A' ' 20' ' ' VAL . 84.1 mm-40 -58.0 -48.73 79.15 Favored 'General case' 0 C--O 1.226 -0.173 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.374 176.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -55.45 -46.09 76.8 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.319 -179.344 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 27.2 mm-40 -56.79 -41.65 78.07 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.529 -178.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.17 -23.26 67.06 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-O 121.181 0.515 . . . . 0.0 111.55 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.595 HG23 ' O ' ' A' ' 16' ' ' GLN . 5.0 t -90.6 -20.98 6.74 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.803 0 N-CA-C 107.227 -1.398 . . . . 0.0 107.227 -175.52 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.2 m -83.8 -31.73 25.73 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 114.084 -1.416 . . . . 0.0 110.243 179.446 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 15.6 p -70.41 -32.29 69.85 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 173.183 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 16.7 m -79.91 -49.06 12.45 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.756 175.792 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.707 ' O ' HG13 ' A' ' 27' ' ' ILE . 33.6 m-85 -115.12 96.9 5.91 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 175.322 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 37.9 m -83.33 16.17 2.63 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.035 0.445 . . . . 0.0 111.628 -174.285 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.44 ' OD1' ' HB3' ' A' ' 24' ' ' TYR . 21.5 p-10 -91.29 -17.4 26.0 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 169.543 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.707 HG13 ' O ' ' A' ' 24' ' ' TYR . 2.5 mt -72.55 147.46 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 CA-C-N 115.182 -0.917 . . . . 0.0 108.542 175.689 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.518 ' O ' ' HA ' ' A' ' 39' ' ' LEU . 14.5 p -141.95 144.45 33.74 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.712 -175.635 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.5 tt -101.15 108.62 20.34 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -113.77 162.5 16.22 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.83 179.054 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.578 ' O ' ' HA ' ' A' ' 37' ' ' PHE . 3.2 m-20 57.26 70.72 0.63 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.999 -1.001 . . . . 0.0 112.062 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -77.18 75.58 3.74 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.147 174.146 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.529 ' HB2' ' HB2' ' A' ' 36' ' ' HIS . 16.2 mm-40 -103.61 21.21 16.53 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.133 0.492 . . . . 0.0 109.981 -179.659 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.72 -93.06 1.64 Allowed Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 121.08 -0.581 . . . . 0.0 112.296 178.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 27.2 t -75.4 -29.55 59.84 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.397 0.617 . . . . 0.0 109.883 178.064 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.529 ' HB2' ' HB2' ' A' ' 33' ' ' GLN . 26.8 m-70 -101.84 107.54 18.75 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.79 177.6 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.578 ' HA ' ' O ' ' A' ' 31' ' ' ASP . 45.9 p90 -148.62 146.66 28.31 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 173.54 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 37.5 ptt85 -127.92 152.1 48.28 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.316 0.579 . . . . 0.0 112.314 -173.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.518 ' HA ' ' O ' ' A' ' 28' ' ' THR . 86.2 mt -108.88 132.6 53.88 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.891 175.851 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.439 ' HB ' ' OG1' ' A' ' 28' ' ' THR . 41.2 t -114.53 118.81 59.72 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.717 -179.032 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 93.5 t -89.46 114.83 28.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.654 176.515 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.469 ' HA ' ' O ' ' A' ' 47' ' ' ARG . 49.2 mtp180 -104.15 164.2 11.88 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.932 177.657 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.452 ' CG ' ' H ' ' A' ' 45' ' ' GLU . 1.7 p-10 -102.9 -166.04 1.23 Allowed 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 110.325 -0.25 . . . . 0.0 110.325 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 25.6 p -66.62 -22.96 66.11 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 120.92 0.39 . . . . 0.0 111.893 179.353 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.452 ' H ' ' CG ' ' A' ' 43' ' ' ASP . 8.6 tp10 -86.98 -21.61 26.07 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.239 0.543 . . . . 0.0 109.574 178.159 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 101.17 5.23 53.11 Favored Glycine 0 N--CA 1.444 -0.808 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.08 179.409 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.469 ' O ' ' HA ' ' A' ' 42' ' ' ARG . 88.0 mtt180 -72.23 146.87 47.0 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 -178.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -74.06 103.09 4.4 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 176.317 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 57.4 t -77.96 -40.67 26.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.991 179.602 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 76.1 t-105 -164.17 142.13 7.08 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.819 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.417 HH11 ' HD3' ' A' ' 51' ' ' ARG . 14.9 ptt-85 -141.78 138.68 32.44 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 177.477 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -143.97 156.47 44.42 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.354 -177.416 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 92.8 m95 -88.52 -161.6 0.76 Allowed 'General case' 0 N--CA 1.447 -0.615 0 CA-C-O 121.423 0.63 . . . . 0.0 110.474 -179.297 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -106.23 -33.93 7.66 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.274 -176.364 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -81.45 3.53 24.32 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 -173.577 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.523 ' HB2' ' HB2' ' A' ' 59' ' ' ALA . 37.1 mt-10 -80.19 129.22 70.58 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.463 -178.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.613 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 31.3 Cg_exo -62.16 -10.37 17.94 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 123.396 2.731 . . . . 0.0 114.009 -172.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.519 ' HA ' ' CA ' ' A' ' 10' ' ' GLY . 24.0 p-10 -143.01 34.02 1.36 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.761 0.315 . . . . 0.0 110.794 177.92 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.523 ' HB2' ' HB2' ' A' ' 56' ' ' GLU . . . -55.75 -40.96 73.25 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.994 -178.839 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -62.8 -39.33 97.85 Favored Glycine 0 N--CA 1.443 -0.878 0 CA-C-N 115.826 -0.624 . . . . 0.0 112.381 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -66.02 -23.1 66.49 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.886 0.343 . . . . 0.0 111.721 -177.321 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -75.5 -49.23 9.39 Favored Glycine 0 C--O 1.24 0.477 0 C-N-CA 120.286 -0.959 . . . . 0.0 111.085 175.035 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.427 ' O ' HG13 ' A' ' 67' ' ' ILE . 50.0 mt -63.24 -43.35 98.29 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.273 0.559 . . . . 0.0 109.833 177.625 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 8.8 m-20 -69.16 -20.43 64.02 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.189 178.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 6.8 tmm_? -65.93 -41.36 91.48 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 173.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.438 ' CE1' ' HA2' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -67.97 -42.9 80.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.425 175.018 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.427 HG13 ' O ' ' A' ' 63' ' ' LEU . 62.9 mt -67.74 -26.75 35.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.257 -178.837 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -59.9 -33.37 71.76 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.138 -178.257 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.449 ' O ' ' HB2' ' A' ' 70' ' ' SER . 4.5 t -101.73 66.48 1.06 Allowed 'General case' 0 N--CA 1.442 -0.838 0 CA-C-O 121.825 0.822 . . . . 0.0 109.526 179.015 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.449 ' HB2' ' O ' ' A' ' 69' ' ' THR . 63.2 m 80.37 -51.7 0.35 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 114.211 -1.359 . . . . 0.0 112.808 171.849 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.438 ' HA2' ' CE1' ' A' ' 66' ' ' TYR . . . 79.15 -174.04 55.29 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.633 -0.794 . . . . 0.0 111.271 -170.596 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.487 ' O ' HG22 ' A' ' 72' ' ' ILE . 47.5 mm -101.35 7.0 9.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-O 121.896 0.855 . . . . 0.0 110.341 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.54 ' HB3' ' CE2' ' A' ' 24' ' ' TYR . 14.6 ptm180 . . . . . 0 N--CA 1.474 0.726 0 CA-C-N 115.423 -0.808 . . . . 0.0 113.103 -178.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.425 ' HA3' ' HD3' ' A' ' 11' ' ' PRO . . . . . . . . 0 N--CA 1.463 0.473 0 N-CA-C 113.966 0.346 . . . . 0.0 113.966 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.425 ' HD3' ' HA3' ' A' ' 10' ' ' GLY . 7.7 Cg_exo -70.53 139.09 36.79 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.775 2.317 . . . . 0.0 111.053 176.411 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -104.9 -175.15 2.71 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.493 0.663 . . . . 0.0 112.134 -173.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.46 ' H ' ' HB2' ' A' ' 16' ' ' GLN . 1.7 m -126.05 164.22 21.33 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-N 114.342 -1.299 . . . . 0.0 109.742 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.543 ' HA ' ' CZ ' ' A' ' 37' ' ' PHE . 48.3 ttt85 -51.49 -55.78 17.0 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 122.64 0.376 . . . . 0.0 111.351 -179.038 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 43.5 mtp180 -56.53 -45.57 81.08 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.464 177.453 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.572 ' O ' HG23 ' A' ' 20' ' ' VAL . 1.9 mp0 -59.2 -46.92 87.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.943 -179.69 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.505 ' HB1' HD11 ' A' ' 39' ' ' LEU . . . -57.44 -44.18 84.5 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 121.086 0.47 . . . . 0.0 111.17 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 58.2 mt-30 -55.28 -41.75 72.69 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.024 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.49 -23.96 66.33 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.739 -178.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.572 HG23 ' O ' ' A' ' 16' ' ' GLN . 10.4 t -90.83 -19.76 7.07 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.687 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 -172.877 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.526 HG23 ' HB ' ' A' ' 27' ' ' ILE . 10.8 m -95.86 -28.79 14.54 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 114.055 -1.429 . . . . 0.0 108.417 -176.036 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 54.8 m -63.45 -36.63 84.4 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 114.083 -1.417 . . . . 0.0 108.939 167.097 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.585 HG23 HH11 ' A' ' 73' ' ' ARG . 90.8 m -76.21 -54.4 6.85 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.376 175.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.569 ' HB2' HG13 ' A' ' 27' ' ' ILE . 51.1 m-85 -110.64 102.7 11.25 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-O 121.087 0.47 . . . . 0.0 109.796 179.144 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 6.1 p -75.62 2.17 12.56 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.376 -177.517 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.453 ' OD1' ' HB3' ' A' ' 24' ' ' TYR . 6.1 p-10 -87.71 -8.3 56.25 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.572 173.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.569 HG13 ' HB2' ' A' ' 24' ' ' TYR . 2.9 mt -83.08 150.27 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 172.55 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.409 ' O ' ' HA ' ' A' ' 39' ' ' LEU . 1.1 p -141.43 135.94 30.85 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 120.912 -0.315 . . . . 0.0 110.785 -178.011 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 5.0 tt -94.64 107.16 19.16 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -178.032 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -119.07 164.66 15.18 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.753 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.482 ' HB2' ' HG2' ' A' ' 38' ' ' ARG . 90.5 m-20 56.71 42.39 26.92 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.6 0.715 . . . . 0.0 110.462 -175.841 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -74.6 103.38 4.89 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.913 -177.448 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -103.43 -19.73 14.31 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 173.397 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 126.03 -80.54 0.36 Allowed Glycine 0 N--CA 1.449 -0.469 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.405 -177.293 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.8 t -72.21 -35.6 68.94 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.262 0.553 . . . . 0.0 109.623 174.735 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 40.0 m80 -109.34 139.26 44.51 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.783 178.745 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.543 ' CZ ' ' HA ' ' A' ' 14' ' ' ARG . 55.6 p90 -174.23 164.04 3.91 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 176.748 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.482 ' HG2' ' HB2' ' A' ' 31' ' ' ASP . 29.3 ptt85 -128.68 144.83 51.25 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.205 0.526 . . . . 0.0 111.191 177.539 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.505 HD11 ' HB1' ' A' ' 17' ' ' ALA . 86.0 mt -99.18 127.1 45.1 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.934 176.322 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 27.5 t -103.7 119.93 53.05 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.529 177.041 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.409 HG11 ' CD2' ' A' ' 66' ' ' TYR . 16.3 t -91.19 108.76 20.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.214 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 33.9 mtt85 -105.19 168.15 9.26 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.038 -177.578 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.628 ' OD1' ' HG2' ' A' ' 47' ' ' ARG . 7.6 p-10 -104.02 -164.57 1.07 Allowed 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.616 179.182 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -66.17 -17.11 64.51 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -91.98 -24.32 19.28 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.477 0.656 . . . . 0.0 109.821 179.263 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 99.32 7.78 53.93 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.745 -0.741 . . . . 0.0 111.575 -179.062 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.628 ' HG2' ' OD1' ' A' ' 43' ' ' ASP . 15.9 ptt180 -78.35 150.46 33.21 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 177.565 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 23.3 ptp -79.12 116.86 19.67 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.309 0.576 . . . . 0.0 110.01 178.699 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 41.4 t -98.26 -31.94 3.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-O 121.478 0.656 . . . . 0.0 109.322 176.614 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 75.2 t-105 -155.11 155.76 34.59 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.53 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 16.7 ptt180 -158.5 142.66 15.67 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 175.618 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -150.55 147.92 28.04 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.214 -179.4 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.561 ' HB2' ' HG2' ' A' ' 56' ' ' GLU . 65.0 m95 -80.92 -176.73 6.05 Favored 'General case' 0 CA--C 1.509 -0.627 0 CA-C-O 122.15 0.976 . . . . 0.0 111.371 177.788 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -82.82 -31.54 28.06 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 113.465 -1.698 . . . . 0.0 110.079 -178.776 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -97.04 8.65 44.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.58 -0.737 . . . . 0.0 112.325 -173.407 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.664 ' HB2' ' HB2' ' A' ' 59' ' ' ALA . 38.9 mm-40 -71.02 128.14 90.9 Favored Pre-proline 0 C--N 1.328 -0.354 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 179.118 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -49.28 -37.45 40.04 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 124.074 3.182 . . . . 0.0 113.904 -173.276 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -131.15 43.82 3.04 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.143 0.497 . . . . 0.0 110.248 178.667 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.664 ' HB2' ' HB2' ' A' ' 56' ' ' GLU . . . -51.4 -45.36 62.48 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.545 -177.234 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -59.04 -38.63 93.25 Favored Glycine 0 N--CA 1.446 -0.646 0 CA-C-N 115.433 -0.803 . . . . 0.0 113.163 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 22.1 tp10 -60.06 -38.78 83.84 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.873 0.337 . . . . 0.0 110.996 -175.414 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -68.84 -43.54 73.79 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.33 -0.938 . . . . 0.0 111.021 177.399 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.438 ' O ' HG13 ' A' ' 67' ' ' ILE . 57.5 mt -58.52 -47.6 83.61 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.324 -0.438 . . . . 0.0 109.867 176.866 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 64.7 m-20 -59.72 -33.34 71.5 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.698 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.419 HH11 ' HD2' ' A' ' 65' ' ' ARG . 9.5 tpp85 -70.07 -29.58 66.61 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.059 -175.718 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.409 ' CD2' HG11 ' A' ' 41' ' ' VAL . 80.0 t80 -87.45 -42.58 12.7 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.177 -0.609 . . . . 0.0 110.546 172.515 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.696 HG22 ' H ' ' A' ' 69' ' ' THR . 86.1 mt -57.04 -59.89 2.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.884 -179.411 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.516 ' O ' HG22 ' A' ' 69' ' ' THR . 57.1 mtm-85 51.85 30.28 6.9 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.242 0.544 . . . . 0.0 111.213 177.339 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.696 ' H ' HG22 ' A' ' 67' ' ' ILE . 13.2 t 61.55 21.12 11.83 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 126.102 1.761 . . . . 0.0 111.736 174.369 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 55.3 p -112.57 -62.18 1.62 Allowed 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.233 171.146 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 65.26 -175.83 14.02 Favored Glycine 0 N--CA 1.446 -0.69 0 CA-C-N 115.152 -0.931 . . . . 0.0 112.721 177.01 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.455 ' O ' HG22 ' A' ' 72' ' ' ILE . 40.9 mm -101.34 5.82 10.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-O 121.876 0.846 . . . . 0.0 109.35 178.486 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.585 HH11 HG23 ' A' ' 23' ' ' THR . 51.3 ttt180 . . . . . 0 C--N 1.33 -0.24 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.376 179.713 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.612 ' HA2' ' HA ' ' A' ' 58' ' ' ASP . . . . . . . . 0 CA--C 1.523 0.559 0 N-CA-C 113.554 0.181 . . . . 0.0 113.554 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.474 ' HD3' ' HA3' ' A' ' 10' ' ' GLY . 3.3 Cg_exo -81.31 170.85 14.38 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 123.371 2.714 . . . . 0.0 112.29 177.246 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 15.2 p90 -122.27 -173.85 2.77 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.015 0.436 . . . . 0.0 111.48 -176.505 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.48 ' H ' ' HB2' ' A' ' 16' ' ' GLN . 62.5 p -125.16 179.64 4.97 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.896 178.416 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 29.3 ttt180 -63.99 -41.32 97.55 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 174.71 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 25.7 ttm180 -58.72 -53.43 58.48 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.625 177.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.584 ' O ' HG23 ' A' ' 20' ' ' VAL . 2.0 mp0 -60.78 -48.61 81.02 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.541 178.192 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -50.26 -54.59 20.17 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.534 179.462 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -57.79 -36.77 72.64 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.191 -0.458 . . . . 0.0 112.11 -179.366 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.66 -29.48 70.05 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.027 0.441 . . . . 0.0 111.565 -179.164 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.584 HG23 ' O ' ' A' ' 16' ' ' GLN . 11.5 t -88.95 -25.31 5.77 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.827 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 -173.567 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.418 HG23 ' HB ' ' A' ' 27' ' ' ILE . 9.7 m -83.14 -33.51 26.25 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-N 113.909 -1.496 . . . . 0.0 110.994 -179.49 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.1 t -70.44 -25.34 63.16 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 173.126 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 33.6 m -76.0 -56.99 4.15 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.682 169.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.675 ' CE1' ' HA3' ' A' ' 71' ' ' GLY . 34.1 m-85 -113.14 105.72 13.79 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.282 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 31.5 m -86.71 11.6 12.65 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.59 0.709 . . . . 0.0 110.23 -176.476 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.559 ' OD1' ' HB3' ' A' ' 24' ' ' TYR . 7.5 p-10 -88.73 -6.98 57.06 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.917 -1.038 . . . . 0.0 108.748 170.44 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.613 HG13 ' O ' ' A' ' 24' ' ' TYR . 3.6 mt -82.45 142.32 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 172.721 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.0 p -136.05 130.13 33.0 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.748 -0.381 . . . . 0.0 111.095 -174.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.546 ' HA ' HD23 ' A' ' 39' ' ' LEU . 5.4 tt -86.08 117.3 24.83 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.335 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 70.7 mt-10 -123.4 173.3 8.08 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.295 -178.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.493 ' O ' ' HA ' ' A' ' 37' ' ' PHE . 0.4 OUTLIER 55.56 63.62 2.01 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.703 -1.135 . . . . 0.0 111.364 176.747 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -80.8 97.45 7.35 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.022 -179.07 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -106.94 -10.56 15.94 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 171.019 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 111.92 -81.97 0.3 Allowed Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.895 -0.669 . . . . 0.0 111.601 -177.279 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.7 m -76.74 -18.64 58.36 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.32 0.581 . . . . 0.0 110.18 177.375 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 38.3 m-70 -115.84 137.72 51.83 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.949 176.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.493 ' HA ' ' O ' ' A' ' 31' ' ' ASP . 48.6 p90 -167.17 156.94 10.84 Favored 'General case' 0 C--N 1.328 -0.337 0 O-C-N 123.824 0.703 . . . . 0.0 109.334 175.342 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 22.4 ptt180 -128.97 158.13 39.71 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.705 0.288 . . . . 0.0 111.056 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.546 HD23 ' HA ' ' A' ' 29' ' ' LEU . 75.0 mt -113.73 125.02 53.65 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.235 0.541 . . . . 0.0 109.978 174.077 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.51 HG22 ' CB ' ' A' ' 51' ' ' ARG . 61.9 t -103.37 123.97 57.25 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.823 177.03 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.452 HG11 ' CD1' ' A' ' 66' ' ' TYR . 3.1 t -93.92 111.0 24.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -104.47 168.24 9.22 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.963 -178.064 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -97.16 -166.72 1.43 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.637 0.256 . . . . 0.0 110.316 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 12.4 p -70.15 -17.18 63.17 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 111.99 0.366 . . . . 0.0 111.99 -176.148 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.434 ' HB3' ' HG2' ' A' ' 47' ' ' ARG . 23.5 tt0 -93.11 -22.69 18.95 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.002 0.43 . . . . 0.0 109.92 179.149 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 105.81 14.01 22.32 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.807 -0.711 . . . . 0.0 111.769 -178.043 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.434 ' HG2' ' HB3' ' A' ' 45' ' ' GLU . 14.9 mmt180 -76.74 124.93 28.41 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 178.535 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -69.09 106.07 2.67 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.133 0.492 . . . . 0.0 109.984 176.183 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 41.2 t -92.55 -33.11 5.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.444 -177.779 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 69.1 t-105 -156.4 149.17 23.84 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.893 -175.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.51 ' CB ' HG22 ' A' ' 40' ' ' VAL . 14.5 ptp180 -146.69 143.48 28.77 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 172.758 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -143.56 147.44 34.44 Favored 'General case' 0 C--N 1.319 -0.717 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 82.8 m95 -82.37 -171.26 3.35 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-O 121.594 0.711 . . . . 0.0 110.637 178.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -98.72 -16.78 18.85 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 114.417 -1.265 . . . . 0.0 110.294 -176.341 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -104.26 4.17 33.48 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.622 -177.111 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.58 ' HB2' ' HB2' ' A' ' 59' ' ' ALA . 20.7 mm-40 -61.26 131.93 92.4 Favored Pre-proline 0 C--O 1.235 0.316 0 CA-C-N 116.641 -0.254 . . . . 0.0 110.525 178.757 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_exo -40.01 -47.65 3.9 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 124.264 3.309 . . . . 0.0 113.243 -176.077 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.612 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . 5.0 t0 -140.22 70.03 1.36 Allowed 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 171.74 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.58 ' HB2' ' HB2' ' A' ' 56' ' ' GLU . . . -55.47 -35.98 66.09 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.823 178.786 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -58.16 -43.1 95.49 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.416 -0.811 . . . . 0.0 112.5 178.533 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.654 ' O ' ' HG3' ' A' ' 65' ' ' ARG . 5.3 tm-20 -58.65 -39.71 81.36 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.696 0.248 . . . . 0.0 111.003 -177.289 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.63 ' O ' ' HB2' ' A' ' 65' ' ' ARG . . . -76.4 -40.61 27.7 Favored Glycine 0 C--N 1.331 0.264 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.126 -178.849 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.484 ' O ' HG13 ' A' ' 67' ' ' ILE . 77.3 mt -66.26 -40.55 90.25 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 177.152 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -65.6 -26.42 67.83 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.822 177.056 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.654 ' HG3' ' O ' ' A' ' 61' ' ' GLU . 87.7 mtt180 -58.26 -48.91 78.93 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 121.112 0.482 . . . . 0.0 109.804 171.503 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.452 ' CD1' HG11 ' A' ' 41' ' ' VAL . 29.3 t80 -69.44 -48.36 61.13 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.378 178.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.484 HG13 ' O ' ' A' ' 63' ' ' LEU . 80.3 mt -56.86 -58.07 7.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.848 -178.211 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.454 ' O ' HG22 ' A' ' 69' ' ' THR . 13.7 mtm180 57.42 28.2 15.06 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-O 121.045 0.45 . . . . 0.0 110.611 178.003 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.454 HG22 ' O ' ' A' ' 68' ' ' ARG . 11.5 t 52.51 22.76 2.26 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.266 1.427 . . . . 0.0 112.001 -177.521 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 17.0 t -108.25 -64.73 1.19 Allowed 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 172.352 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.675 ' HA3' ' CE1' ' A' ' 24' ' ' TYR . . . 75.38 166.93 20.38 Favored Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.998 176.182 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.559 ' HB ' ' OD1' ' A' ' 26' ' ' ASN . 40.8 mm -87.74 -11.19 10.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 120.664 0.269 . . . . 0.0 111.164 -179.203 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.406 HH11 ' HD3' ' A' ' 73' ' ' ARG . 7.9 ttm180 . . . . . 0 N--CA 1.468 0.445 0 CA-C-O 120.931 0.396 . . . . 0.0 111.899 -178.323 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.421 ' HA3' ' HD3' ' A' ' 11' ' ' PRO . . . . . . . . 0 CA--C 1.516 0.127 0 CA-C-O 120.147 -0.252 . . . . 0.0 113.201 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.421 ' HD3' ' HA3' ' A' ' 10' ' ' GLY . 20.8 Cg_exo -64.75 153.05 79.71 Favored 'Trans proline' 0 C--O 1.234 0.314 0 C-N-CA 122.88 2.387 . . . . 0.0 111.704 177.633 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 16.8 p90 -120.32 -171.69 2.21 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.053 -176.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.484 ' H ' ' HB2' ' A' ' 16' ' ' GLN . 46.1 p -125.02 171.65 10.07 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.84 179.225 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.479 ' O ' ' HG3' ' A' ' 18' ' ' GLN . 43.1 ttt180 -55.8 -45.86 78.15 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.651 0.739 . . . . 0.0 109.773 174.385 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -63.5 -50.27 70.29 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.765 -1.107 . . . . 0.0 111.772 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.586 ' O ' HG23 ' A' ' 20' ' ' VAL . 1.5 mp0 -58.78 -44.59 90.71 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.692 -0.231 . . . . 0.0 110.689 179.188 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -52.29 -49.0 65.03 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.256 178.245 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.479 ' HG3' ' O ' ' A' ' 14' ' ' ARG . 98.3 mt-30 -56.04 -45.1 79.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.374 -178.887 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.12 -31.15 70.86 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.079 -176.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.586 HG23 ' O ' ' A' ' 16' ' ' GLN . 8.2 t -87.55 -24.31 6.33 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.881 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 -171.278 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.52 HG23 ' HB ' ' A' ' 27' ' ' ILE . 10.3 m -86.4 -30.94 21.73 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 113.597 -1.638 . . . . 0.0 110.698 -178.389 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.6 p -68.56 -28.25 66.8 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 170.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 20.7 m -76.95 -56.79 4.28 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.089 172.738 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.627 ' HB3' ' OD1' ' A' ' 26' ' ' ASN . 79.0 m-85 -109.59 103.41 12.27 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 121.259 0.552 . . . . 0.0 109.948 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 6.0 p -71.72 -3.9 24.51 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.492 -0.776 . . . . 0.0 112.134 -178.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.627 ' OD1' ' HB3' ' A' ' 24' ' ' TYR . 25.6 p-10 -80.05 -16.68 54.54 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 174.405 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.548 HG13 ' O ' ' A' ' 24' ' ' TYR . 2.4 mt -76.72 146.63 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 173.793 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.535 ' OG1' ' HB ' ' A' ' 40' ' ' VAL . 1.6 p -141.59 123.26 15.16 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.013 0.435 . . . . 0.0 111.007 -177.798 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.465 ' CD2' ' HB3' ' A' ' 32' ' ' ASP . 6.5 tt -80.69 99.73 8.34 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 178.742 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 52.7 mm-40 -118.81 166.96 12.16 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.561 -177.119 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 58.97 34.63 23.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.347 -175.539 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.55 ' HA ' ' HB3' ' A' ' 37' ' ' PHE . 5.7 p-10 -68.03 99.8 0.91 Allowed 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.274 -0.876 . . . . 0.0 111.514 -178.152 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -104.97 9.21 34.61 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.018 176.548 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 125.06 -94.37 0.46 Allowed Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.409 -177.712 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.3 t -101.45 -13.38 17.97 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 173.304 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 13.9 m-70 -94.27 111.69 23.45 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.298 174.301 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.55 ' HB3' ' HA ' ' A' ' 32' ' ' ASP . 47.4 p90 -163.83 171.56 15.3 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -179.239 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.527 ' HA ' ' HA ' ' A' ' 53' ' ' TRP . 16.6 ptt-85 -130.79 144.63 51.58 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.083 0.468 . . . . 0.0 110.539 175.153 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.463 HD23 ' HA ' ' A' ' 29' ' ' LEU . 95.1 mt -95.33 117.12 29.75 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.532 176.346 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.535 ' HB ' ' OG1' ' A' ' 28' ' ' THR . 38.3 t -92.14 119.99 40.57 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.832 178.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.462 HG11 ' CD1' ' A' ' 66' ' ' TYR . 4.9 t -92.2 116.45 33.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 178.336 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 59.2 mtm180 -99.32 166.74 11.06 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.435 -178.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.639 ' OD1' ' HG2' ' A' ' 47' ' ' ARG . 9.7 p-10 -100.28 -166.71 1.36 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.23 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.83 -17.94 64.99 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.792 -179.185 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -89.32 -29.03 19.45 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -179.225 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 102.42 16.69 21.91 Favored Glycine 0 N--CA 1.444 -0.821 0 CA-C-N 115.276 -0.874 . . . . 0.0 112.309 -178.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.639 ' HG2' ' OD1' ' A' ' 43' ' ' ASP . 25.4 ptt180 -93.69 153.1 18.54 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 178.392 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 49.4 mtt -73.33 113.38 10.34 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.397 -178.522 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.455 HG21 ' HB3' ' A' ' 43' ' ' ASP . 46.1 t -97.84 -33.21 4.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 121.105 0.479 . . . . 0.0 110.264 178.114 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 74.0 t-105 -157.02 154.64 29.91 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.087 -177.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.412 ' HB2' ' HD2' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -151.13 140.46 21.38 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 174.366 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -141.51 143.75 33.96 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 177.401 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.531 ' HB2' ' HG2' ' A' ' 56' ' ' GLU . 69.2 m95 -80.23 -173.82 4.21 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 121.721 0.772 . . . . 0.0 111.069 -179.122 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -90.22 -28.32 18.93 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 114.008 -1.451 . . . . 0.0 110.089 -175.227 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 13.5 p90 -101.55 15.85 27.57 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.21 -0.904 . . . . 0.0 112.075 -173.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.531 ' HG2' ' HB2' ' A' ' 53' ' ' TRP . 19.3 mm-40 -77.87 135.23 63.62 Favored Pre-proline 0 C--N 1.323 -0.571 0 C-N-CA 121.232 -0.187 . . . . 0.0 110.828 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_exo -38.77 -46.67 2.66 Favored 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 124.637 3.558 . . . . 0.0 113.966 -173.417 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -145.33 67.8 1.23 Allowed 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 172.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.53 ' HB2' ' HB2' ' A' ' 56' ' ' GLU . . . -56.2 -36.12 68.06 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 115.263 -0.881 . . . . 0.0 111.232 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -57.0 -36.23 72.8 Favored Glycine 0 N--CA 1.447 -0.633 0 CA-C-N 115.486 -0.779 . . . . 0.0 113.78 -178.559 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.416 ' CD ' HH21 ' A' ' 65' ' ' ARG . 1.2 tm-20 -56.73 -49.15 76.07 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 117.211 0.505 . . . . 0.0 110.83 -176.472 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -70.21 -43.26 64.23 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.341 -177.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.546 ' O ' HG13 ' A' ' 67' ' ' ILE . 52.6 mt -66.39 -52.3 48.22 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.866 -0.167 . . . . 0.0 110.766 -178.418 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.666 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 87.9 m-20 -58.72 -40.76 84.65 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.717 -179.481 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.416 HH21 ' CD ' ' A' ' 61' ' ' GLU . 19.0 ttm180 -51.63 -50.99 59.2 Favored 'General case' 0 C--O 1.233 0.192 0 O-C-N 123.643 0.589 . . . . 0.0 110.446 178.504 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.462 ' CD1' HG11 ' A' ' 41' ' ' VAL . 44.5 t80 -63.36 -43.25 98.2 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.352 179.07 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.546 HG13 ' O ' ' A' ' 63' ' ' LEU . 87.4 mt -57.6 -31.49 39.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.927 -0.579 . . . . 0.0 112.329 -177.498 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.666 ' HG2' ' O ' ' A' ' 64' ' ' ASN . 10.7 mmm180 -65.02 -62.08 1.77 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.972 0.415 . . . . 0.0 111.257 -175.852 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 17.7 p -81.57 -26.21 35.18 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.327 -177.192 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 24.7 m -125.91 31.14 5.53 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -169.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.15 116.41 9.05 Favored Glycine 0 CA--C 1.522 0.528 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.099 170.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.455 ' O ' HG22 ' A' ' 72' ' ' ILE . 37.5 mm -93.99 2.6 9.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-O 121.029 0.442 . . . . 0.0 111.339 -171.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 45.0 ptt85 . . . . . 0 C--N 1.328 -0.34 0 O-C-N 121.976 -0.453 . . . . 0.0 111.691 -175.598 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.571 ' HA3' ' HA ' ' A' ' 58' ' ' ASP . . . . . . . . 0 N--CA 1.442 -0.907 0 N-CA-C 111.52 -0.632 . . . . 0.0 111.52 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -76.45 131.67 12.86 Favored 'Trans proline' 0 N--CA 1.45 -1.034 0 C-N-CA 121.776 1.651 . . . . 0.0 111.031 173.264 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 19.8 p90 -98.39 -169.54 1.82 Allowed 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.73 -173.093 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.424 ' HB ' ' OE1' ' A' ' 16' ' ' GLN . 0.2 OUTLIER -122.82 156.51 34.4 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.401 179.425 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 32.1 ttt85 -56.4 -46.19 80.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.331 0.586 . . . . 0.0 110.477 178.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 26.2 ttm180 -53.07 -59.29 4.73 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.981 -1.008 . . . . 0.0 110.842 176.237 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.629 ' O ' HG23 ' A' ' 20' ' ' VAL . 15.9 mp0 -57.4 -44.09 84.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.456 -179.19 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.482 ' HB1' HD11 ' A' ' 39' ' ' LEU . . . -53.54 -45.83 69.96 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 121.248 0.547 . . . . 0.0 111.114 179.542 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -59.91 -36.84 77.83 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.912 179.097 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.74 -24.43 64.45 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.017 177.625 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.629 HG23 ' O ' ' A' ' 16' ' ' GLN . 2.9 t -83.97 -18.68 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 -178.847 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.623 HG23 ' HB ' ' A' ' 27' ' ' ILE . 0.0 OUTLIER -90.89 -32.15 16.13 Favored 'General case' 0 CA--C 1.506 -0.734 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 177.581 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 76.4 m -56.65 -34.42 67.31 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 113.623 -1.626 . . . . 0.0 109.46 168.432 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.583 HG23 HH11 ' A' ' 73' ' ' ARG . 59.8 m -87.51 -49.31 7.28 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.399 -0.818 . . . . 0.0 111.684 177.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.658 ' HB3' ' OD1' ' A' ' 26' ' ' ASN . 63.7 m-85 -118.71 109.7 16.41 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 121.018 0.437 . . . . 0.0 110.352 -178.828 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 11.8 p -78.72 0.59 26.12 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.663 -177.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.658 ' OD1' ' HB3' ' A' ' 24' ' ' TYR . 25.0 p-10 -82.76 -19.79 37.17 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 175.473 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.623 ' HB ' HG23 ' A' ' 21' ' ' THR . 1.1 mt -77.68 151.32 5.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 177.155 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.562 ' OG1' ' HB ' ' A' ' 40' ' ' VAL . 19.7 p -138.33 128.08 25.15 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.904 0.383 . . . . 0.0 111.119 179.589 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.533 ' HA ' HD23 ' A' ' 39' ' ' LEU . 6.5 tt -86.63 103.24 14.92 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 175.474 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.421 ' O ' ' HB3' ' A' ' 31' ' ' ASP . 53.2 mt-10 -121.74 174.12 7.03 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.929 -176.214 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.421 ' HB3' ' O ' ' A' ' 30' ' ' GLU . 12.4 t70 77.48 -62.9 0.37 Allowed 'General case' 0 N--CA 1.466 0.341 0 O-C-N 124.28 0.987 . . . . 0.0 110.242 -176.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.517 ' HA ' ' HB3' ' A' ' 37' ' ' PHE . 54.1 t0 38.7 78.56 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.554 -1.203 . . . . 0.0 112.99 -177.592 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -105.01 37.01 2.27 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 170.459 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.2 -102.13 2.75 Favored Glycine 0 N--CA 1.448 -0.558 0 CA-C-N 115.142 -0.936 . . . . 0.0 112.126 179.496 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.3 m -82.84 -15.05 53.07 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.229 0.538 . . . . 0.0 110.547 177.681 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 55.6 m170 -108.33 109.51 20.85 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.901 177.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.517 ' HB3' ' HA ' ' A' ' 32' ' ' ASP . 53.3 p90 -152.92 169.45 22.81 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 177.133 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.471 ' HA ' ' HA ' ' A' ' 53' ' ' TRP . 25.6 ptt-85 -128.45 147.98 50.69 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.181 -0.608 . . . . 0.0 111.556 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.537 ' HA ' ' O ' ' A' ' 28' ' ' THR . 90.5 mt -107.0 117.66 34.65 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.403 173.809 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.562 ' HB ' ' OG1' ' A' ' 28' ' ' THR . 53.0 t -95.11 119.02 42.6 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.135 178.34 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.476 ' HB ' ' HB3' ' A' ' 50' ' ' TRP . 61.4 t -88.79 110.88 21.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 121.106 0.479 . . . . 0.0 109.888 177.828 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.432 ' HA ' ' O ' ' A' ' 47' ' ' ARG . 33.4 mtm180 -98.77 176.66 5.54 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.214 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -94.76 -171.14 2.39 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 173.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.1 t -60.76 -24.08 65.48 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.64 -176.704 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -91.59 -31.59 15.84 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.924 0.393 . . . . 0.0 110.663 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 120.73 10.36 7.07 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.929 -177.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.432 ' O ' ' HA ' ' A' ' 42' ' ' ARG . 28.9 mmm180 -74.54 133.59 42.26 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 177.49 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.448 ' SD ' HG11 ' A' ' 40' ' ' VAL . 50.8 mtt -79.96 104.06 10.27 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.065 0.46 . . . . 0.0 110.622 -174.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 35.0 t -90.18 -31.62 5.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.339 -177.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.476 ' HB3' ' HB ' ' A' ' 41' ' ' VAL . 76.6 t-105 -151.65 161.12 43.2 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.774 -176.632 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 4.3 ptp180 -159.24 132.81 7.29 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 176.505 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -138.62 141.72 39.12 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.698 -0.228 . . . . 0.0 110.742 -178.319 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.596 ' HB2' ' HG3' ' A' ' 56' ' ' GLU . 84.1 m95 -83.44 -166.05 1.27 Allowed 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 121.54 0.686 . . . . 0.0 110.226 178.654 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.422 HD22 ' C ' ' A' ' 54' ' ' ASN . 0.2 OUTLIER -99.51 -33.05 10.82 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.86 -178.501 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -88.98 10.17 22.45 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.893 -173.548 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.596 ' HG3' ' HB2' ' A' ' 53' ' ' TRP . 26.5 mt-10 -82.29 131.89 54.62 Favored Pre-proline 0 C--N 1.325 -0.489 0 C-N-CA 120.971 -0.292 . . . . 0.0 110.976 -177.811 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_exo -36.17 -53.71 0.95 Allowed 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 124.816 3.677 . . . . 0.0 114.109 -173.799 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.571 ' HA ' ' HA3' ' A' ' 10' ' ' GLY . 3.3 t70 -137.37 67.02 1.44 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.104 0.478 . . . . 0.0 110.129 174.573 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.0 -33.76 65.17 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.201 176.474 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -61.4 -33.74 85.74 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 121.223 -0.513 . . . . 0.0 113.284 -178.516 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -64.61 -34.97 79.51 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.586 0.232 . . . . 0.0 110.944 -178.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -69.84 -45.74 56.34 Favored Glycine 0 C--O 1.236 0.25 0 C-N-CA 120.396 -0.907 . . . . 0.0 111.201 178.5 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 43.3 mt -61.97 -43.44 98.84 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.381 -0.41 . . . . 0.0 109.932 177.258 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -61.26 -38.33 86.32 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.073 177.489 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 23.3 tpt85 -56.09 -38.95 71.41 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.356 177.334 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.503 ' O ' HG22 ' A' ' 69' ' ' THR . 46.2 t80 -79.04 -49.42 12.71 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.229 177.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 94.6 mt -56.51 -30.5 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -177.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.431 HH11 ' HD2' ' A' ' 68' ' ' ARG . 33.2 ttm180 -59.0 -30.27 67.87 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.433 -179.571 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.503 HG22 ' O ' ' A' ' 66' ' ' TYR . 10.0 t -91.84 62.35 4.33 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 122.003 0.906 . . . . 0.0 110.058 179.141 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.405 ' HB3' ' O ' ' A' ' 69' ' ' THR . 25.3 t 84.35 -37.41 0.06 Allowed 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 114.363 -1.29 . . . . 0.0 112.718 167.873 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 76.59 164.35 18.83 Favored Glycine 0 CA--C 1.522 0.526 0 C-N-CA 120.285 -0.96 . . . . 0.0 111.977 -174.58 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.483 ' O ' HG22 ' A' ' 72' ' ' ILE . 46.2 mm -101.07 6.0 10.0 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-O 121.79 0.805 . . . . 0.0 111.025 -175.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.583 HH11 HG23 ' A' ' 23' ' ' THR . 21.2 ttt180 . . . . . 0 C--N 1.324 -0.506 0 O-C-N 121.257 -0.902 . . . . 0.0 110.881 178.636 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.427 ' HA3' ' HD3' ' A' ' 11' ' ' PRO . . . . . . . . 0 CA--C 1.519 0.332 0 CA-C-O 119.936 -0.369 . . . . 0.0 112.94 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.442 ' HG3' ' HA ' ' A' ' 57' ' ' PRO . 16.5 Cg_exo -66.65 142.13 63.01 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.655 2.236 . . . . 0.0 111.812 175.683 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.439 ' HE1' ' HB1' ' A' ' 59' ' ' ALA . 42.9 p90 -112.39 151.46 29.78 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.707 0.765 . . . . 0.0 112.521 -174.755 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.654 ' HB ' ' HG2' ' A' ' 16' ' ' GLN . 0.3 OUTLIER -76.94 156.34 32.07 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 114.422 -1.263 . . . . 0.0 110.788 178.66 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 25.8 ttt180 -61.32 -46.73 89.05 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.796 0.331 . . . . 0.0 110.578 -178.65 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 84.3 mtt-85 -61.29 -36.75 80.94 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.368 176.698 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.654 ' HG2' ' HB ' ' A' ' 13' ' ' THR . 76.3 mm-40 -61.75 -48.84 78.91 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 178.44 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.499 ' HB1' HD21 ' A' ' 39' ' ' LEU . . . -53.58 -44.12 69.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.943 178.88 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.407 ' HA ' ' OE1' ' A' ' 18' ' ' GLN . 14.7 mm-40 -58.82 -38.05 77.78 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.778 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.43 ' HA ' HG22 ' A' ' 22' ' ' THR . . . -72.68 -25.28 61.2 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.448 -178.34 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.618 HG23 ' O ' ' A' ' 16' ' ' GLN . 10.6 t -87.18 -30.07 5.75 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.96 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 -173.392 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 23.4 m -79.51 -32.3 42.35 Favored 'General case' 0 N--CA 1.435 -1.217 0 CA-C-N 113.478 -1.692 . . . . 0.0 110.935 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.43 HG22 ' HA ' ' A' ' 19' ' ' ALA . 6.5 t -73.33 -23.31 60.23 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 174.237 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 26.9 m -78.93 -57.23 3.85 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.368 171.687 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.603 ' HB2' HG13 ' A' ' 27' ' ' ILE . 38.5 m-85 -107.9 96.34 6.31 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 178.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 4.6 p -65.4 -5.16 6.83 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.516 -179.09 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.558 ' OD1' ' HB3' ' A' ' 24' ' ' TYR . 28.2 p-10 -79.02 -16.89 56.24 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 173.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.603 HG13 ' HB2' ' A' ' 24' ' ' TYR . 2.6 mt -80.24 150.71 4.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 171.438 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 6.6 p -143.91 124.71 14.21 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.003 178.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.558 ' HA ' HD23 ' A' ' 39' ' ' LEU . 5.8 tt -81.87 98.43 8.51 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 176.546 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -119.48 169.37 10.1 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.129 -0.942 . . . . 0.0 109.659 -174.403 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.0 t70 62.28 26.07 15.6 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.287 0.565 . . . . 0.0 109.982 176.59 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.563 ' HA ' ' HB3' ' A' ' 37' ' ' PHE . 17.8 t70 -68.28 119.9 13.57 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.152 -173.377 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -146.57 52.6 1.11 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.42 177.25 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.25 -101.56 2.22 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.462 177.077 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.9 m -91.43 -3.02 57.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.312 0.577 . . . . 0.0 110.367 178.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 47.8 m80 -115.84 108.09 15.86 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.739 177.256 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.563 ' HB3' ' HA ' ' A' ' 32' ' ' ASP . 53.5 p90 -160.94 160.81 31.27 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.036 178.764 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 68.3 mtm180 -134.03 138.01 45.09 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.26 0.552 . . . . 0.0 111.696 -178.131 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.558 HD23 ' HA ' ' A' ' 29' ' ' LEU . 91.1 mt -92.66 114.27 26.77 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.303 173.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 31.5 t -94.8 111.57 25.77 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.958 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.416 HG11 ' CD1' ' A' ' 66' ' ' TYR . 39.0 t -85.19 117.62 30.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 178.115 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.467 ' O ' ' HB2' ' A' ' 26' ' ' ASN . 63.2 mtp180 -110.35 161.45 15.63 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.258 -177.453 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.489 ' HB3' ' HG3' ' A' ' 47' ' ' ARG . 7.7 t70 -92.56 177.83 6.0 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.572 -177.758 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.427 ' N ' ' CG ' ' A' ' 43' ' ' ASP . 7.0 p -61.28 -22.36 64.78 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 122.59 0.356 . . . . 0.0 111.862 -177.559 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -88.84 -9.74 50.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.427 0.632 . . . . 0.0 109.967 178.193 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 93.79 4.62 63.42 Favored Glycine 0 N--CA 1.451 -0.305 0 CA-C-N 115.767 -0.652 . . . . 0.0 112.994 177.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.489 ' HG3' ' HB3' ' A' ' 43' ' ' ASP . 14.1 ptt180 -73.74 140.75 46.16 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 110.321 -0.252 . . . . 0.0 110.321 177.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 69.1 mtm -71.88 122.16 20.3 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 178.149 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 20.3 t -107.2 -29.84 2.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.611 -178.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.403 ' HB3' ' HB ' ' A' ' 41' ' ' VAL . 73.7 t-105 -157.99 151.54 23.57 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.573 -175.728 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 11.2 ptp180 -152.67 132.87 13.54 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 173.124 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -134.27 149.71 50.95 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.561 -0.291 . . . . 0.0 111.058 -178.299 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.884 ' HB2' ' HG3' ' A' ' 56' ' ' GLU . 86.5 m95 -75.74 -170.11 1.23 Allowed 'General case' 0 CA--C 1.514 -0.434 0 CA-C-O 121.905 0.859 . . . . 0.0 111.498 177.724 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -101.52 -37.76 8.27 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 114.223 -1.353 . . . . 0.0 110.74 178.144 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -88.02 3.69 47.88 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.052 -173.686 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.884 ' HG3' ' HB2' ' A' ' 53' ' ' TRP . 35.7 mt-10 -74.43 128.91 85.05 Favored Pre-proline 0 N--CA 1.452 -0.372 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.179 178.039 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.442 ' HA ' ' HG3' ' A' ' 11' ' ' PRO . 32.5 Cg_exo -59.25 -14.44 24.34 Favored 'Trans proline' 0 N--CA 1.475 0.414 0 C-N-CA 123.293 2.662 . . . . 0.0 113.668 -175.159 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -133.6 24.95 4.06 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.756 -0.202 . . . . 0.0 111.46 -177.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.599 ' HB2' ' HB2' ' A' ' 56' ' ' GLU . . . -58.66 -48.08 82.28 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.015 0.436 . . . . 0.0 111.209 -174.858 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -65.14 -28.51 73.63 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.926 -179.128 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -68.02 -40.79 82.89 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.623 0.249 . . . . 0.0 110.532 -177.677 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -66.99 -39.77 93.27 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.51 -0.852 . . . . 0.0 111.291 178.403 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.443 ' O ' HG13 ' A' ' 67' ' ' ILE . 68.9 mt -63.91 -48.85 74.95 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.387 -0.407 . . . . 0.0 110.779 177.855 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.506 ' O ' ' HG3' ' A' ' 68' ' ' ARG . 96.0 m-20 -61.55 -36.71 81.37 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.748 0.309 . . . . 0.0 110.66 178.656 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.418 HH11 ' HD2' ' A' ' 65' ' ' ARG . 20.4 ttt85 -53.59 -42.2 67.37 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.499 176.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.416 ' CD1' HG11 ' A' ' 41' ' ' VAL . 43.3 t80 -72.57 -50.5 25.1 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.382 175.207 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.443 HG13 ' O ' ' A' ' 63' ' ' LEU . 97.1 mt -48.38 -47.67 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 -176.116 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.506 ' HG3' ' O ' ' A' ' 64' ' ' ASN . 15.5 mtp180 -56.78 -54.08 50.48 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -173.759 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.6 t -90.96 10.97 24.34 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 120.691 -0.404 . . . . 0.0 111.175 -174.813 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 17.1 m -120.44 -61.83 1.53 Allowed 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.208 -0.597 . . . . 0.0 111.12 177.408 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 43.55 74.48 0.2 Allowed Glycine 0 CA--C 1.525 0.701 0 CA-C-N 115.281 -0.872 . . . . 0.0 113.41 -173.846 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.465 ' O ' HG22 ' A' ' 72' ' ' ILE . 30.2 mm -89.2 6.9 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-O 121.355 0.597 . . . . 0.0 110.973 -174.306 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 35.0 ptt180 . . . . . 0 C--N 1.329 -0.298 0 O-C-N 122.068 -0.395 . . . . 0.0 111.814 -175.433 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.48 ' HA2' ' HA ' ' A' ' 58' ' ' ASP . . . . . . . . 0 CA--C 1.519 0.293 0 CA-C-O 120.132 -0.26 . . . . 0.0 112.979 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.453 ' HD3' ' HA3' ' A' ' 10' ' ' GLY . 6.1 Cg_exo -72.03 162.23 42.44 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.597 2.198 . . . . 0.0 111.2 178.36 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -123.75 151.54 43.13 Favored 'General case' 0 CA--C 1.505 -0.783 0 CA-C-O 121.756 0.789 . . . . 0.0 112.096 -176.244 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -91.8 165.64 13.16 Favored 'General case' 0 N--CA 1.433 -1.275 0 CA-C-N 113.993 -1.458 . . . . 0.0 109.431 176.789 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.401 ' O ' ' HG3' ' A' ' 18' ' ' GLN . 47.8 ttt180 -61.97 -51.04 69.68 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 120.737 0.303 . . . . 0.0 110.693 -177.581 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 37.2 ttp180 -54.4 -40.17 67.98 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.481 177.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.609 ' O ' HG23 ' A' ' 20' ' ' VAL . 85.6 mm-40 -62.97 -47.86 81.36 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.305 177.5 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.71 -42.88 84.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.301 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.401 ' HG3' ' O ' ' A' ' 14' ' ' ARG . 97.9 mt-30 -61.04 -44.4 97.46 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.856 -178.506 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.1 -37.8 86.48 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.195 0.521 . . . . 0.0 111.202 -179.407 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.609 HG23 ' O ' ' A' ' 16' ' ' GLN . 10.2 t -77.8 -22.87 13.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.405 -175.613 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.474 HG23 ' HB ' ' A' ' 27' ' ' ILE . 0.0 OUTLIER -83.35 -33.23 25.89 Favored 'General case' 0 CA--C 1.516 -0.362 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.481 176.168 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.3 p -68.04 -19.68 64.91 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 174.126 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.3 m -89.74 -53.46 4.5 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.211 171.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.618 ' O ' HG13 ' A' ' 27' ' ' ILE . 47.3 m-85 -113.92 102.26 10.04 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 177.488 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 11.6 p -80.78 5.0 17.16 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.96 0.41 . . . . 0.0 111.469 -178.018 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.525 ' OD1' ' HB3' ' A' ' 24' ' ' TYR . 25.7 p-10 -82.34 -21.64 35.9 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 171.432 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.618 HG13 ' O ' ' A' ' 24' ' ' TYR . 1.0 OUTLIER -74.69 147.46 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 170.991 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.479 ' O ' ' HA ' ' A' ' 39' ' ' LEU . 2.5 p -142.05 134.51 28.06 Favored 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 120.571 -0.452 . . . . 0.0 110.881 -176.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.591 HD22 ' HB3' ' A' ' 32' ' ' ASP . 1.5 tt -90.29 97.17 11.03 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.67 0.747 . . . . 0.0 109.367 -179.087 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.478 ' HB2' ' HG3' ' A' ' 38' ' ' ARG . 14.5 mm-40 -104.05 161.96 13.56 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 114.482 -1.236 . . . . 0.0 109.481 -174.313 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.482 ' HB2' ' HG2' ' A' ' 38' ' ' ARG . 1.0 OUTLIER 56.25 30.72 17.16 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 123.541 0.526 . . . . 0.0 111.692 179.411 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.591 ' HB3' HD22 ' A' ' 29' ' ' LEU . 16.2 p-10 -71.35 90.58 0.95 Allowed 'General case' 0 N--CA 1.446 -0.674 0 CA-C-O 122.045 0.926 . . . . 0.0 111.385 -176.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 14.4 tm0? -111.77 -15.49 13.39 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.649 -1.16 . . . . 0.0 109.442 178.028 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 113.41 -79.02 0.26 Allowed Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.468 -175.409 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 11.7 m -63.17 -33.0 74.52 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.442 0.639 . . . . 0.0 109.732 175.784 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 68.2 m170 -115.61 141.62 47.82 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.929 173.775 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 55.6 p90 -176.31 145.13 0.58 Allowed 'General case' 0 C--N 1.326 -0.432 0 O-C-N 124.077 0.861 . . . . 0.0 109.318 169.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.482 ' HG2' ' HB2' ' A' ' 31' ' ' ASP . 16.1 ptt180 -132.75 150.2 52.19 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.87 0.367 . . . . 0.0 111.145 -178.244 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.479 ' HA ' ' O ' ' A' ' 28' ' ' THR . 84.0 mt -103.31 115.75 31.15 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 174.123 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.473 HG22 ' HB3' ' A' ' 51' ' ' ARG . 48.6 t -99.33 115.39 39.94 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.836 177.812 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.476 HG11 ' CD1' ' A' ' 66' ' ' TYR . 50.2 t -82.92 104.64 11.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 175.85 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.487 ' O ' ' HB2' ' A' ' 26' ' ' ASN . 50.3 mtt180 -102.16 163.74 12.07 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.592 0.711 . . . . 0.0 111.27 -177.38 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.702 ' HB3' ' HB2' ' A' ' 47' ' ' ARG . 4.3 t70 -89.45 176.08 7.05 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 114.514 -1.221 . . . . 0.0 109.444 177.867 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.414 ' N ' ' CG ' ' A' ' 43' ' ' ASP . 0.3 OUTLIER -67.35 -18.99 65.37 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 120.855 0.36 . . . . 0.0 111.298 -174.741 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -93.37 -0.2 56.65 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 121.46 0.647 . . . . 0.0 110.044 175.451 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 89.14 8.46 68.76 Favored Glycine 0 N--CA 1.452 -0.275 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.431 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.702 ' HB2' ' HB3' ' A' ' 43' ' ' ASP . 39.4 mtt180 -61.03 132.97 55.53 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 122.278 0.231 . . . . 0.0 110.775 177.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 10.0 mmt -75.65 97.36 3.78 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.31 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.2 t -84.45 -38.83 13.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.033 0.444 . . . . 0.0 110.551 -175.652 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 69.8 t-105 -166.17 153.8 10.16 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.711 -178.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.473 ' HB3' HG22 ' A' ' 40' ' ' VAL . 9.0 ptt180 -152.14 148.02 27.14 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.034 0.445 . . . . 0.0 111.14 177.025 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -148.79 143.09 26.13 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.17 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.468 ' H ' ' HG3' ' A' ' 56' ' ' GLU . 72.0 m95 -87.98 -171.34 3.36 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 122.208 1.004 . . . . 0.0 111.539 -178.775 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -82.28 -35.63 27.84 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 113.481 -1.69 . . . . 0.0 109.83 178.535 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 32.2 p90 -87.98 17.88 4.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.65 -178.004 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.586 ' HB2' ' HB2' ' A' ' 59' ' ' ALA . 11.8 mm-40 -85.23 116.75 66.83 Favored Pre-proline 0 C--N 1.327 -0.401 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 175.753 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.445 ' HD2' ' HA ' ' A' ' 56' ' ' GLU . 3.6 Cg_endo -46.34 -39.92 21.95 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 124.269 3.312 . . . . 0.0 114.163 -172.487 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.48 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . 4.6 t0 -138.1 55.89 1.75 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.088 0.47 . . . . 0.0 110.14 178.324 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.586 ' HB2' ' HB2' ' A' ' 56' ' ' GLU . . . -56.4 -39.89 73.76 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.277 -179.452 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -59.45 -33.0 74.37 Favored Glycine 0 N--CA 1.45 -0.387 0 CA-C-N 115.384 -0.825 . . . . 0.0 114.071 -177.168 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.468 ' HB2' ' OD1' ' A' ' 58' ' ' ASP . 35.7 tt0 -62.52 -43.07 99.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 117.608 0.704 . . . . 0.0 110.96 -176.421 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -73.28 -41.2 47.01 Favored Glycine 0 C--O 1.237 0.288 0 C-N-CA 120.539 -0.838 . . . . 0.0 111.557 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 72.6 mt -64.73 -51.97 59.56 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.547 -0.326 . . . . 0.0 110.851 -179.461 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.452 ' HA ' ' HB ' ' A' ' 67' ' ' ILE . 93.2 m-20 -60.56 -32.64 71.71 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.608 0.242 . . . . 0.0 111.006 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 11.2 tpt180 -55.45 -50.75 69.03 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.262 176.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.476 ' CD1' HG11 ' A' ' 41' ' ' VAL . 38.9 t80 -72.53 -43.27 63.75 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.447 179.356 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.538 HG23 ' CZ ' ' A' ' 24' ' ' TYR . 59.9 mt -49.61 -44.84 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-N 115.617 -0.72 . . . . 0.0 112.262 -178.507 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 61.9 ttt180 -68.37 -53.77 21.73 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -175.727 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 8.8 t -76.34 -35.65 58.65 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 112.37 0.508 . . . . 0.0 112.37 -169.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 25.1 m -90.21 -50.84 5.75 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.69 -177.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 48.25 85.14 0.02 OUTLIER Glycine 0 CA--C 1.525 0.667 0 CA-C-N 115.515 -0.766 . . . . 0.0 114.632 179.466 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.516 HG21 ' HB3' ' A' ' 26' ' ' ASN . 1.8 mp -80.74 5.37 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 CA-C-O 122.369 1.08 . . . . 0.0 109.63 177.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.499 ' HB3' ' CE2' ' A' ' 24' ' ' TYR . 52.3 ptt85 . . . . . 0 N--CA 1.468 0.47 0 CA-C-N 114.833 -1.076 . . . . 0.0 112.036 178.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.525 ' HA3' ' O ' ' A' ' 57' ' ' PRO . . . . . . . . 0 N--CA 1.441 -0.998 0 N-CA-C 110.991 -0.844 . . . . 0.0 110.991 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -75.7 130.39 12.54 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 121.623 1.548 . . . . 0.0 110.958 172.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -102.58 -178.46 3.69 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 121.806 0.812 . . . . 0.0 111.923 -172.39 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.98 151.49 32.28 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 114.705 -1.134 . . . . 0.0 108.988 176.308 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.544 ' O ' ' HG3' ' A' ' 18' ' ' GLN . 43.7 ttt-85 -59.36 -48.98 79.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.033 0.444 . . . . 0.0 109.944 -178.684 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 72.5 mtp85 -56.7 -45.69 81.66 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.241 177.589 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.519 ' O ' HG23 ' A' ' 20' ' ' VAL . 73.7 mm-40 -63.31 -39.87 95.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.489 179.255 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.456 ' HB1' HD21 ' A' ' 39' ' ' LEU . . . -62.06 -43.38 98.96 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.685 177.03 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.544 ' HG3' ' O ' ' A' ' 14' ' ' ARG . 79.7 mt-30 -51.71 -44.37 63.16 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.022 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.79 -27.04 68.91 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.107 -179.259 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.519 HG23 ' O ' ' A' ' 16' ' ' GLN . 14.1 t -92.46 -16.13 7.92 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.752 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 -172.619 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 12.0 m -93.31 -31.42 14.69 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-N 113.972 -1.467 . . . . 0.0 107.588 -176.72 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 99.0 m -61.65 -38.1 86.46 Favored 'General case' 0 N--CA 1.436 -1.175 0 CA-C-N 113.628 -1.624 . . . . 0.0 109.299 166.709 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.575 HG23 ' HE ' ' A' ' 73' ' ' ARG . 36.7 m -75.03 -53.86 8.18 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.992 177.139 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.67 ' O ' HG13 ' A' ' 27' ' ' ILE . 89.9 m-85 -117.45 96.88 5.6 Favored 'General case' 0 N--CA 1.44 -0.975 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 178.548 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 48.3 m -76.12 5.72 6.37 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.865 0.364 . . . . 0.0 111.506 -177.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.473 ' HB3' HG21 ' A' ' 72' ' ' ILE . 11.9 p-10 -76.84 -16.43 59.42 Favored 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 108.598 -0.889 . . . . 0.0 108.598 167.803 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.67 HG13 ' O ' ' A' ' 24' ' ' TYR . 2.2 mt -84.4 151.45 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 171.371 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.564 ' OG1' ' HB ' ' A' ' 40' ' ' VAL . 11.1 p -138.14 117.41 12.73 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 119.954 -0.698 . . . . 0.0 111.068 178.713 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.593 ' HA ' HD23 ' A' ' 39' ' ' LEU . 4.8 tt -83.23 99.03 9.71 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 174.239 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.532 ' HG2' ' HB ' ' A' ' 28' ' ' THR . 74.2 mm-40 -132.9 -173.55 3.22 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.957 -173.697 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.7 t70 69.53 17.25 8.01 Favored 'General case' 0 CA--C 1.531 0.214 0 O-C-N 124.072 0.857 . . . . 0.0 110.505 177.509 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -57.59 95.54 0.02 OUTLIER 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.659 178.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 33.0 tp60 -122.79 10.11 9.56 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.206 0.527 . . . . 0.0 110.206 -178.141 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 119.31 -88.98 0.45 Allowed Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.583 178.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 9.8 t -89.36 -17.04 29.63 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 120.702 0.286 . . . . 0.0 110.569 -176.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 30.1 p80 -124.41 145.79 49.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.153 0.501 . . . . 0.0 111.424 178.291 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -166.67 167.91 14.87 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.298 -1.319 . . . . 0.0 107.608 174.809 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.429 ' HB3' ' HA ' ' A' ' 53' ' ' TRP . 30.9 ptt180 -153.0 156.29 38.54 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.115 0.484 . . . . 0.0 112.076 -175.285 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.593 HD23 ' HA ' ' A' ' 29' ' ' LEU . 89.2 mt -102.03 117.95 35.89 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.961 178.22 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.564 ' HB ' ' OG1' ' A' ' 28' ' ' THR . 37.7 t -100.89 113.91 38.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 116.278 -0.419 . . . . 0.0 109.983 178.54 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 46.5 t -90.04 122.4 41.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.022 0.439 . . . . 0.0 110.051 178.152 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 57.9 mtp180 -105.06 163.88 12.22 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.476 -178.441 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -88.66 -171.74 3.45 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 177.697 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.1 p -62.31 -22.26 65.92 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.918 -176.544 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -91.71 -31.46 15.8 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.891 0.377 . . . . 0.0 110.54 179.092 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 119.6 10.0 8.08 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.418 -0.896 . . . . 0.0 112.541 -177.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 92.4 mtt180 -82.57 127.56 33.47 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 177.589 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.13 118.62 10.13 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.264 0.554 . . . . 0.0 110.785 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 41.9 t -97.23 -35.78 5.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.07 -179.368 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 68.8 t-105 -158.14 119.32 3.49 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.177 -178.191 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.473 ' HB3' HG13 ' A' ' 40' ' ' VAL . 36.4 ptt180 -112.68 129.02 56.54 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.817 174.089 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -122.76 142.09 51.1 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.555 -177.065 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.547 ' HB2' ' HG3' ' A' ' 56' ' ' GLU . 95.0 m95 -79.36 -169.13 1.76 Allowed 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 121.709 0.766 . . . . 0.0 110.923 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -101.32 -30.41 11.5 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 114.701 -1.136 . . . . 0.0 110.932 -176.694 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 40.6 p90 -90.29 3.69 52.89 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.557 -174.611 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.547 ' HG3' ' HB2' ' A' ' 53' ' ' TRP . 40.0 mt-10 -75.42 132.51 75.72 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 120.752 0.31 . . . . 0.0 110.275 179.476 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.525 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 39.8 Cg_endo -66.5 -11.65 32.54 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 123.225 2.617 . . . . 0.0 113.394 -173.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -137.57 28.39 2.72 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.648 -0.251 . . . . 0.0 110.561 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.563 ' O ' ' HG ' ' A' ' 63' ' ' LEU . . . -53.03 -49.61 65.93 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.847 -176.787 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -69.82 -30.45 70.39 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.653 -178.53 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -70.53 -34.06 71.85 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.841 0.321 . . . . 0.0 110.279 -175.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.484 ' O ' ' HB3' ' A' ' 65' ' ' ARG . . . -74.24 -39.22 44.67 Favored Glycine 0 C--O 1.238 0.354 0 C-N-CA 120.382 -0.913 . . . . 0.0 111.583 177.158 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.563 ' HG ' ' O ' ' A' ' 59' ' ' ALA . 70.2 mt -67.51 -45.31 76.15 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.539 -0.33 . . . . 0.0 110.513 178.594 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -61.25 -32.34 72.14 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.557 176.556 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.484 ' HB3' ' O ' ' A' ' 62' ' ' GLY . 0.4 OUTLIER -57.32 -44.83 84.53 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.301 -0.409 . . . . 0.0 109.922 175.473 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 14.1 t80 -67.11 -53.19 33.16 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.079 176.232 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 97.3 mt -50.92 -51.37 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.847 -178.398 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 45.9 ttm105 -55.99 -32.41 63.92 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.274 -173.72 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 5.1 t -111.38 15.01 21.53 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.449 -0.501 . . . . 0.0 111.705 -174.415 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 16.2 m -134.66 -54.98 0.83 Allowed 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.849 -0.341 . . . . 0.0 111.15 -179.278 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.52 ' HA2' ' CE1' ' A' ' 24' ' ' TYR . . . 47.15 75.82 0.17 Allowed Glycine 0 CA--C 1.527 0.812 0 CA-C-N 115.552 -0.749 . . . . 0.0 114.114 -177.601 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.473 HG21 ' HB3' ' A' ' 26' ' ' ASN . 1.8 mp -72.94 -20.65 19.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-N 117.132 0.466 . . . . 0.0 111.912 -174.707 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.575 ' HE ' HG23 ' A' ' 23' ' ' THR . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.261 0 CA-C-O 121.237 0.541 . . . . 0.0 111.525 -178.403 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.56 ' HA2' ' HA ' ' A' ' 58' ' ' ASP . . . . . . . . 0 CA--C 1.52 0.358 0 N-CA-C 114.584 0.594 . . . . 0.0 114.584 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.466 ' HD3' ' HA3' ' A' ' 10' ' ' GLY . 6.6 Cg_exo -72.16 144.2 41.53 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 123.159 2.573 . . . . 0.0 112.515 -177.478 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -112.12 -173.3 2.22 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.143 -178.736 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.447 ' OG1' ' HG2' ' A' ' 16' ' ' GLN . 28.8 p -125.07 176.31 6.77 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 175.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.412 HH11 ' HD2' ' A' ' 14' ' ' ARG . 22.8 ttt180 -61.67 -46.7 88.6 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.488 0.661 . . . . 0.0 109.489 175.655 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 36.1 mmt180 -55.02 -48.79 72.91 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.558 -1.201 . . . . 0.0 110.675 178.303 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.61 ' O ' HG23 ' A' ' 20' ' ' VAL . 84.9 mm-40 -62.7 -49.15 76.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.211 178.193 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -52.76 -49.26 65.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.684 179.261 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.405 ' HG2' ' O ' ' A' ' 14' ' ' ARG . 15.2 mm100 -55.65 -41.82 74.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.312 -179.37 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.44 -29.11 70.45 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.982 -179.273 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.61 HG23 ' O ' ' A' ' 16' ' ' GLN . 3.3 t -91.33 -26.05 5.17 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.958 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 -171.889 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 16.2 m -79.55 -32.97 42.2 Favored 'General case' 0 N--CA 1.437 -1.117 0 CA-C-N 113.95 -1.477 . . . . 0.0 110.655 179.702 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.8 p -73.54 -26.08 60.69 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 121.082 0.467 . . . . 0.0 109.742 172.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.534 HG23 ' HD2' ' A' ' 73' ' ' ARG . 89.8 m -76.2 -55.09 5.9 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.783 172.689 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.606 ' O ' HG13 ' A' ' 27' ' ' ILE . 70.1 m-85 -116.63 101.53 8.68 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 175.61 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 45.0 m -82.16 17.39 1.65 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.207 0.527 . . . . 0.0 111.747 -176.566 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.547 ' OD1' ' HB3' ' A' ' 24' ' ' TYR . 25.1 p-10 -87.91 -20.37 26.04 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 167.238 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.606 HG13 ' O ' ' A' ' 24' ' ' TYR . 2.4 mt -73.57 146.92 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 171.763 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -149.46 130.3 14.23 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 120.225 -0.59 . . . . 0.0 111.566 -179.094 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.528 ' HA ' HD23 ' A' ' 39' ' ' LEU . 5.9 tt -79.3 103.12 9.01 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.229 178.778 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -112.76 166.41 11.39 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.497 -176.548 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.6 t70 66.39 46.37 1.96 Allowed 'General case' 0 N--CA 1.465 0.304 0 O-C-N 123.65 0.594 . . . . 0.0 110.542 176.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -64.95 99.93 0.38 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.454 -179.354 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 21.8 tt0 -129.63 57.56 1.67 Allowed 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.494 0.664 . . . . 0.0 109.422 175.485 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 74.52 -112.81 3.85 Favored Glycine 0 N--CA 1.45 -0.372 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.741 -178.362 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 30.2 t -87.67 -1.5 57.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.092 0.472 . . . . 0.0 110.119 177.279 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -101.44 124.85 47.77 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 176.164 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -173.8 170.49 3.94 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 178.477 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 30.1 ptt-85 -145.18 145.39 31.33 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.217 0.532 . . . . 0.0 111.433 178.293 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.528 HD23 ' HA ' ' A' ' 29' ' ' LEU . 93.9 mt -90.67 110.75 21.91 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.284 177.642 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 84.2 t -89.93 115.05 28.72 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.049 173.774 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.5 t -91.82 108.73 20.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.453 ' O ' ' HB2' ' A' ' 26' ' ' ASN . 60.3 mtt85 -95.93 170.21 9.45 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.868 -178.488 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.438 ' CG ' ' H ' ' A' ' 45' ' ' GLU . 1.2 p-10 -96.65 -171.19 2.21 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.974 0.416 . . . . 0.0 110.002 179.54 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.46 -19.99 66.17 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.687 -176.868 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.438 ' H ' ' CG ' ' A' ' 43' ' ' ASP . 9.5 tp10 -91.08 -28.67 17.78 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.24 0.543 . . . . 0.0 109.944 177.663 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 114.18 12.19 11.28 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.798 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.445 ' O ' ' HA ' ' A' ' 42' ' ' ARG . 40.5 mtt-85 -80.33 137.67 36.61 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.081 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -76.72 96.87 4.32 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.42 0.629 . . . . 0.0 110.599 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 15.8 t -83.54 -31.27 8.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.523 -177.721 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.442 ' CD1' HD23 ' A' ' 63' ' ' LEU . 75.4 t-105 -150.38 159.15 44.67 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.261 -177.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 27.5 ptt-85 -158.4 131.4 7.3 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 178.5 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -140.94 140.75 34.49 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 110.463 -0.199 . . . . 0.0 110.463 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.635 ' HB2' ' HG3' ' A' ' 56' ' ' GLU . 72.4 m95 -77.27 -173.89 3.02 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-O 121.764 0.793 . . . . 0.0 110.752 -179.177 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -94.18 -26.37 16.71 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 114.254 -1.339 . . . . 0.0 109.837 -178.534 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -98.33 6.16 47.58 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.802 -174.066 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.635 ' HG3' ' HB2' ' A' ' 53' ' ' TRP . 38.2 mt-10 -76.45 129.97 78.37 Favored Pre-proline 0 C--N 1.326 -0.43 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.195 178.618 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.428 ' HA ' ' HG3' ' A' ' 11' ' ' PRO . 31.7 Cg_exo -59.2 -20.07 52.99 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 123.431 2.754 . . . . 0.0 113.136 -175.155 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.56 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . 13.2 m-20 -133.6 37.92 3.28 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.541 179.599 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.407 ' O ' ' HG ' ' A' ' 63' ' ' LEU . . . -54.95 -50.18 69.54 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 120.925 0.393 . . . . 0.0 111.141 -178.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -63.33 -30.28 77.07 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.789 179.525 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.42 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 23.5 tp10 -60.79 -42.18 97.07 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.784 0.325 . . . . 0.0 110.367 -178.826 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.477 ' O ' ' HB3' ' A' ' 65' ' ' ARG . . . -77.05 -38.64 29.62 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.093 179.354 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.519 ' O ' HG13 ' A' ' 67' ' ' ILE . 85.5 mt -63.17 -52.76 61.08 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.723 0.297 . . . . 0.0 110.357 179.492 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -61.99 -32.13 72.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.632 178.428 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.477 ' HB3' ' O ' ' A' ' 62' ' ' GLY . 7.0 tpt85 -54.29 -46.74 72.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.669 177.384 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -74.86 -44.14 50.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.985 178.116 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.519 HG13 ' O ' ' A' ' 63' ' ' LEU . 89.5 mt -52.65 -44.57 46.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-O 120.897 0.379 . . . . 0.0 111.083 -179.119 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 23.6 ttt180 -58.83 -24.24 61.73 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.432 -0.803 . . . . 0.0 112.425 -176.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 11.3 t -118.1 22.21 12.33 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.402 0.62 . . . . 0.0 111.601 -175.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 29.2 p -144.91 -55.44 0.32 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.349 178.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 44.98 78.13 0.08 OUTLIER Glycine 0 CA--C 1.52 0.353 0 CA-C-N 115.325 -0.852 . . . . 0.0 113.333 -177.105 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.7 mp -72.46 -19.93 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-N 117.196 0.498 . . . . 0.0 111.642 -174.18 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.534 ' HD2' HG23 ' A' ' 23' ' ' THR . 72.2 ttt180 . . . . . 0 CA--C 1.515 -0.398 0 CA-C-O 121.259 0.552 . . . . 0.0 111.273 -175.796 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.537 ' HA2' ' HA ' ' A' ' 58' ' ' ASP . . . . . . . . 0 CA--C 1.519 0.301 0 CA-C-O 120.086 -0.286 . . . . 0.0 113.689 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -72.49 165.2 33.39 Favored 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 122.873 2.382 . . . . 0.0 111.82 179.176 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -132.74 169.58 16.49 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.741 0.781 . . . . 0.0 111.997 -176.732 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.5 m -112.85 166.86 10.99 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 114.441 -1.254 . . . . 0.0 110.048 -176.663 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 45.5 ttt-85 -62.36 -47.56 83.67 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.683 0.277 . . . . 0.0 110.877 -175.515 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.428 HH11 ' HD3' ' A' ' 15' ' ' ARG . 27.0 ttm-85 -53.08 -47.13 68.77 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.612 174.76 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.605 ' O ' HG23 ' A' ' 20' ' ' VAL . 77.6 mt-30 -59.98 -47.83 84.22 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.657 178.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.404 ' HB1' HD21 ' A' ' 39' ' ' LEU . . . -55.28 -47.98 74.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.165 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 56.9 mm-40 -59.25 -36.16 74.97 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.934 -179.428 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.1 -29.32 68.23 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.036 0.446 . . . . 0.0 111.415 -178.229 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.605 HG23 ' O ' ' A' ' 16' ' ' GLN . 11.1 t -89.83 -27.42 5.18 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.826 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 -172.068 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.477 HG23 ' HB ' ' A' ' 27' ' ' ILE . 15.6 m -83.64 -27.47 29.09 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-N 113.795 -1.548 . . . . 0.0 111.119 -179.273 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.2 p -73.4 -30.68 63.42 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 171.73 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 34.7 m -77.09 -47.03 21.59 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.275 173.694 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.636 ' HB2' HG13 ' A' ' 27' ' ' ILE . 40.0 m-85 -114.54 96.35 5.71 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 177.656 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 37.8 p -64.9 -7.61 12.09 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 111.906 0.335 . . . . 0.0 111.906 -179.549 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.586 ' OD1' ' HB3' ' A' ' 24' ' ' TYR . 5.4 p-10 -78.81 -11.49 59.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.999 0.428 . . . . 0.0 110.192 177.137 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.636 HG13 ' HB2' ' A' ' 24' ' ' TYR . 2.5 mt -83.08 146.59 6.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 174.21 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.525 ' OG1' ' HB ' ' A' ' 40' ' ' VAL . 10.3 p -133.12 120.23 20.98 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.398 -0.521 . . . . 0.0 110.786 -177.81 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.561 HD22 ' HB2' ' A' ' 32' ' ' ASP . 2.8 tt -88.36 105.15 17.39 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 -179.171 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.22 161.85 18.35 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.71 -176.242 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 61.26 30.56 19.24 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.032 -177.627 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.561 ' HB2' HD22 ' A' ' 29' ' ' LEU . 32.7 t0 -73.98 95.97 2.58 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.004 -178.194 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -115.29 1.96 13.9 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.564 178.138 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 119.88 -85.22 0.38 Allowed Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.463 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.1 t -89.32 -1.14 57.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.997 0.427 . . . . 0.0 110.496 -178.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 12.3 m170 -132.66 135.72 46.02 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 173.001 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.436 ' HB3' ' HA ' ' A' ' 32' ' ' ASP . 43.2 p90 -174.66 156.83 2.43 Favored 'General case' 0 C--O 1.234 0.285 0 O-C-N 123.858 0.724 . . . . 0.0 109.558 178.869 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 15.1 ptt180 -136.08 153.03 51.44 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.937 0.399 . . . . 0.0 111.513 176.541 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.526 HD23 ' HA ' ' A' ' 29' ' ' LEU . 71.5 mt -108.66 125.76 52.23 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.171 0.51 . . . . 0.0 110.558 177.049 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.525 ' HB ' ' OG1' ' A' ' 28' ' ' THR . 45.1 t -100.13 114.83 39.87 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.351 171.762 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 16.9 t -87.6 114.99 27.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.243 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.421 ' HA ' ' O ' ' A' ' 47' ' ' ARG . 3.8 mtt85 -101.24 160.87 14.04 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.398 0.618 . . . . 0.0 111.402 -176.883 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.421 ' CG ' ' N ' ' A' ' 44' ' ' THR . 4.1 t70 -91.57 178.23 5.99 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.487 -1.233 . . . . 0.0 109.979 -178.823 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.421 ' N ' ' CG ' ' A' ' 43' ' ' ASP . 19.1 p -59.01 -22.39 60.59 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 123.201 0.6 . . . . 0.0 111.718 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -92.63 -5.07 52.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.138 0.494 . . . . 0.0 110.536 178.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 89.29 9.49 67.11 Favored Glycine 0 N--CA 1.453 -0.173 0 C-N-CA 120.807 -0.711 . . . . 0.0 111.946 -177.043 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.421 ' O ' ' HA ' ' A' ' 42' ' ' ARG . 38.0 mtp180 -70.96 130.66 42.17 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 122.533 0.333 . . . . 0.0 110.364 179.359 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.15 90.52 2.54 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.599 0.714 . . . . 0.0 110.283 176.037 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 24.7 t -75.16 -38.45 41.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.621 -176.662 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 75.5 t-105 -150.14 152.61 34.98 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.248 -175.857 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 13.7 ptt-85 -150.14 137.19 19.46 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 177.145 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -145.97 146.54 31.06 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.407 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.463 ' HB2' ' HG3' ' A' ' 56' ' ' GLU . 96.5 m95 -80.44 -171.23 2.94 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-O 121.387 0.613 . . . . 0.0 109.587 175.199 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -99.81 -21.34 15.79 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.551 -176.226 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -100.46 11.73 38.81 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.58 -174.538 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.463 ' HG3' ' HB2' ' A' ' 53' ' ' TRP . 42.7 mt-10 -80.88 135.8 51.57 Favored Pre-proline 0 C--N 1.329 -0.308 0 C-N-CA 121.025 -0.27 . . . . 0.0 110.432 179.419 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -36.78 -47.23 1.39 Allowed 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 125.071 3.847 . . . . 0.0 114.31 -172.608 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.537 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . 4.2 t70 -144.58 63.35 1.31 Allowed 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 176.424 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.436 ' HB2' ' HB2' ' A' ' 56' ' ' GLU . . . -58.69 -31.55 68.33 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.041 179.714 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -61.7 -34.07 87.33 Favored Glycine 0 N--CA 1.447 -0.604 0 CA-C-N 115.582 -0.735 . . . . 0.0 113.56 -178.558 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.52 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 2.1 tm-20 -57.34 -50.47 72.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 117.074 0.437 . . . . 0.0 110.351 -177.61 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -67.56 -43.25 86.69 Favored Glycine 0 C--O 1.237 0.334 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.287 -177.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.458 ' O ' HG13 ' A' ' 67' ' ' ILE . 53.2 mt -60.34 -55.61 31.58 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 110.331 -0.248 . . . . 0.0 110.331 178.62 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.569 ' HA ' ' HB ' ' A' ' 67' ' ' ILE . 94.4 m-20 -62.69 -31.46 72.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.933 -179.02 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.52 ' HB2' ' O ' ' A' ' 61' ' ' GLU . 7.1 tpt180 -52.86 -46.06 67.68 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.362 0.601 . . . . 0.0 109.66 177.315 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 75.8 t80 -81.35 -41.82 21.44 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.986 178.447 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.569 ' HB ' ' HA ' ' A' ' 64' ' ' ASN . 95.2 mt -55.37 -48.88 76.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -178.415 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 59.9 ttt-85 -63.42 -48.98 75.56 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.376 -176.352 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 38.7 p -79.4 -41.12 28.44 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.035 -0.53 . . . . 0.0 112.179 -172.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.436 ' O ' HD12 ' A' ' 72' ' ' ILE . 3.3 m -127.85 20.19 6.53 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 112.681 0.622 . . . . 0.0 112.681 -166.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -48.33 134.24 19.15 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 121.346 -0.454 . . . . 0.0 113.927 178.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.478 ' HB ' ' OD1' ' A' ' 26' ' ' ASN . 2.5 mp -89.2 7.68 3.44 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 C-N-CA 123.258 0.623 . . . . 0.0 109.935 -176.722 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.633 ' HB3' ' CE1' ' A' ' 24' ' ' TYR . 30.7 ptt180 . . . . . 0 N--CA 1.484 1.265 0 N-CA-C 115.135 1.531 . . . . 0.0 115.135 -173.004 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.464 ' HA2' ' HA ' ' A' ' 58' ' ' ASP . . . . . . . . 0 CA--C 1.518 0.251 0 CA-C-O 120.04 -0.311 . . . . 0.0 113.157 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.489 ' HD3' ' O ' ' A' ' 57' ' ' PRO . 19.4 Cg_exo -66.69 169.22 14.89 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.716 2.277 . . . . 0.0 111.856 176.732 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.488 ' CD2' ' HB2' ' A' ' 17' ' ' ALA . 41.2 p90 -140.33 165.27 27.86 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.189 -179.053 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.8 p -103.72 178.17 4.63 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.27 -178.35 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.563 ' HA ' ' CZ ' ' A' ' 37' ' ' PHE . 47.2 ttt180 -60.8 -54.85 40.19 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.212 178.22 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 57.9 mtt-85 -62.84 -37.31 86.3 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.683 -178.082 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.581 ' O ' HG23 ' A' ' 20' ' ' VAL . 77.5 mm-40 -62.97 -53.07 59.76 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.222 177.495 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.488 ' HB2' ' CD2' ' A' ' 12' ' ' PHE . . . -52.85 -44.27 66.66 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.492 178.156 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -58.8 -39.2 80.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.767 -178.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.02 -27.29 65.55 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-O 121.392 0.615 . . . . 0.0 110.945 179.684 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.581 HG23 ' O ' ' A' ' 16' ' ' GLN . 3.6 t -76.71 -25.71 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 -179.169 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.545 HG23 ' HB ' ' A' ' 27' ' ' ILE . 0.0 OUTLIER -80.61 -28.01 37.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.841 175.542 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.9 p -75.99 -14.52 60.23 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.434 0.635 . . . . 0.0 109.552 173.17 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 18.9 m -92.4 -50.18 5.77 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.753 170.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.587 ' HB3' ' OD1' ' A' ' 26' ' ' ASN . 48.3 m-85 -118.85 105.31 11.38 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 177.273 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 17.7 p -76.94 -1.76 30.23 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.079 0.466 . . . . 0.0 111.093 -179.63 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.587 ' OD1' ' HB3' ' A' ' 24' ' ' TYR . 6.1 p-10 -81.6 -9.84 59.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.649 175.897 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.584 HG13 ' O ' ' A' ' 24' ' ' TYR . 1.8 mt -86.03 155.62 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 174.235 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.517 ' OG1' ' HB ' ' A' ' 40' ' ' VAL . 1.2 p -142.35 123.27 14.42 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.888 0.375 . . . . 0.0 111.251 -179.529 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.45 ' HA ' HD23 ' A' ' 39' ' ' LEU . 6.1 tt -88.44 105.78 17.83 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 178.697 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -126.79 169.09 13.56 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.524 179.243 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.549 ' HB2' ' HG2' ' A' ' 38' ' ' ARG . 1.1 m-20 66.06 37.67 5.14 Favored 'General case' 0 C--N 1.329 -0.309 0 O-C-N 123.528 0.517 . . . . 0.0 110.761 179.572 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.502 ' HA ' ' HB3' ' A' ' 37' ' ' PHE . 11.3 p-10 -67.6 102.56 1.19 Allowed 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 121.878 0.847 . . . . 0.0 110.334 179.216 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -116.93 30.31 7.41 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.435 -177.553 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 96.44 -106.41 3.36 Favored Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.807 -179.388 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.6 m -81.94 -1.87 49.47 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.911 0.386 . . . . 0.0 110.784 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.42 ' HA ' ' OD1' ' A' ' 54' ' ' ASN . 20.7 m-70 -129.37 143.42 50.83 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.652 179.504 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.563 ' CZ ' ' HA ' ' A' ' 14' ' ' ARG . 36.8 p90 -173.95 170.96 3.76 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 -178.683 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.549 ' HG2' ' HB2' ' A' ' 31' ' ' ASP . 16.5 ptt180 -127.33 152.61 47.24 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.133 0.492 . . . . 0.0 111.004 179.03 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.47 HD11 ' HB1' ' A' ' 17' ' ' ALA . 96.3 mt -111.56 115.78 29.75 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.713 173.779 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.558 HG13 ' HB3' ' A' ' 51' ' ' ARG . 3.1 t -92.2 113.79 28.07 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.152 178.253 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.406 HG11 ' CD2' ' A' ' 66' ' ' TYR . 21.8 t -87.12 111.51 21.85 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.428 HH11 HG21 ' A' ' 28' ' ' THR . 23.7 mtp180 -100.42 164.02 12.11 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.23 -178.423 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.558 ' HB2' ' CG2' ' A' ' 49' ' ' VAL . 10.1 t70 -97.38 -169.2 1.81 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.605 -175.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.417 ' H ' ' CG ' ' A' ' 43' ' ' ASP . 40.3 p -67.91 -21.81 65.11 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.064 0.459 . . . . 0.0 110.727 -178.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -84.74 -10.58 57.12 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.665 0.745 . . . . 0.0 109.224 178.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 86.36 3.04 84.85 Favored Glycine 0 N--CA 1.444 -0.797 0 CA-C-N 115.289 -0.869 . . . . 0.0 112.75 -179.376 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 8.9 ptp180 -82.72 147.91 28.19 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 117.103 0.451 . . . . 0.0 110.212 177.277 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 21.2 ptt? -75.06 123.23 24.81 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.321 0.582 . . . . 0.0 110.749 -179.173 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.558 ' CG2' ' HB2' ' A' ' 43' ' ' ASP . 6.5 t -103.31 -33.93 3.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.085 -177.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 75.0 t-105 -152.23 152.0 31.66 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.494 -178.387 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.558 ' HB3' HG13 ' A' ' 40' ' ' VAL . 1.9 ppt_? -150.97 139.88 20.92 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 178.392 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -150.59 157.76 43.36 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.054 179.213 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.521 ' HA ' ' HA ' ' A' ' 38' ' ' ARG . 69.1 m95 -88.31 -164.67 1.15 Allowed 'General case' 0 N--CA 1.444 -0.764 0 CA-C-O 121.081 0.467 . . . . 0.0 110.229 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.42 ' OD1' ' HA ' ' A' ' 36' ' ' HIS . 0.4 OUTLIER -104.18 -21.93 13.47 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.301 -175.012 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -95.28 0.93 54.3 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -171.111 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.585 ' HB2' ' HB2' ' A' ' 59' ' ' ALA . 48.4 mt-10 -74.14 141.57 77.91 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 116.808 -0.178 . . . . 0.0 110.526 -179.147 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.489 ' O ' ' HD3' ' A' ' 11' ' ' PRO . 80.4 Cg_exo -45.95 -38.78 18.94 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 123.956 3.104 . . . . 0.0 114.163 -172.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.464 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . 9.1 m-20 -136.21 48.44 2.16 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 177.606 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.585 ' HB2' ' HB2' ' A' ' 56' ' ' GLU . . . -56.77 -48.43 77.89 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.723 -0.672 . . . . 0.0 111.292 -175.311 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.405 ' HA2' HD12 ' A' ' 63' ' ' LEU . . . -70.77 -25.65 75.38 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.45 -178.416 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.59 -33.25 66.6 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 -177.082 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.55 ' O ' ' HB2' ' A' ' 65' ' ' ARG . . . -71.81 -41.02 56.99 Favored Glycine 0 C--O 1.239 0.459 0 C-N-CA 120.684 -0.77 . . . . 0.0 111.273 176.223 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.515 ' HG ' ' O ' ' A' ' 59' ' ' ALA . 55.1 mt -58.24 -44.48 88.3 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.112 0.482 . . . . 0.0 109.711 175.461 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.569 ' HA ' ' HB ' ' A' ' 67' ' ' ILE . 33.2 m-80 -73.32 -18.42 61.19 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.756 -0.657 . . . . 0.0 111.636 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.55 ' HB2' ' O ' ' A' ' 62' ' ' GLY . 9.7 mmt180 -60.76 -47.88 84.3 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 172.041 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.406 ' CD2' HG11 ' A' ' 41' ' ' VAL . 83.8 t80 -67.99 -47.27 68.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.434 176.213 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.569 ' HB ' ' HA ' ' A' ' 64' ' ' ASN . 97.0 mt -59.16 -39.87 79.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -177.301 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 47.1 ttt180 -54.54 -43.2 71.75 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.633 0.254 . . . . 0.0 111.253 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.3 t -98.7 -9.99 23.82 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.746 0.308 . . . . 0.0 111.484 -177.119 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 33.1 t -159.09 66.72 0.41 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.331 0.586 . . . . 0.0 111.328 -177.377 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -89.29 127.61 8.77 Favored Glycine 0 N--CA 1.447 -0.619 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 171.015 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.521 ' HB ' ' OD1' ' A' ' 26' ' ' ASN . 2.0 mp -83.82 -0.85 5.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 CA-C-O 121.433 0.635 . . . . 0.0 110.714 -172.834 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.523 ' HB3' ' CE1' ' A' ' 24' ' ' TYR . 4.7 ptm180 . . . . . 0 N--CA 1.47 0.571 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -176.063 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.409 ' HA3' ' HD3' ' A' ' 11' ' ' PRO . . . . . . . . 0 N--CA 1.453 -0.215 0 CA-C-O 119.957 -0.357 . . . . 0.0 112.506 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.409 ' HD3' ' HA3' ' A' ' 10' ' ' GLY . 2.8 Cg_exo -74.96 175.1 11.67 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 122.696 2.264 . . . . 0.0 111.872 178.475 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.453 ' HE1' ' HE2' ' A' ' 37' ' ' PHE . 51.3 p90 -128.19 161.5 29.15 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.386 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 43.0 p -102.08 170.31 8.2 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.677 178.182 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 32.6 ttt85 -59.22 -44.0 92.31 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.09 0.472 . . . . 0.0 109.814 176.269 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.435 HH11 ' HD2' ' A' ' 15' ' ' ARG . 4.8 tpp180 -65.5 -45.07 85.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.1 179.505 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.669 ' O ' HG23 ' A' ' 20' ' ' VAL . 0.9 OUTLIER -62.36 -48.13 81.14 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.911 178.961 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.411 ' HB2' ' CD1' ' A' ' 12' ' ' PHE . . . -51.76 -53.48 39.17 Favored 'General case' 0 C--N 1.328 -0.359 0 O-C-N 123.339 0.399 . . . . 0.0 111.56 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 18.7 mm-40 -56.59 -42.57 78.9 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.826 -177.121 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.96 -28.41 70.06 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.491 -179.269 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.669 HG23 ' O ' ' A' ' 16' ' ' GLN . 15.4 t -90.77 -15.14 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -172.723 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.37 -29.04 37.87 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.26 174.066 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -80.24 -15.75 56.29 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-O 121.132 0.492 . . . . 0.0 109.758 172.688 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 7.0 m -85.78 -55.12 4.12 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.759 171.305 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.547 ' HB3' ' OD1' ' A' ' 26' ' ' ASN . 34.3 m-85 -117.67 105.95 12.56 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 174.924 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -76.7 -2.2 31.68 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 120.962 -0.295 . . . . 0.0 111.309 -176.03 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.547 ' OD1' ' HB3' ' A' ' 24' ' ' TYR . 24.7 p-10 -75.87 -17.4 59.82 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 174.582 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.544 HG13 ' O ' ' A' ' 24' ' ' TYR . 4.2 mt -76.04 148.12 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 174.277 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 6.7 p -144.1 132.33 21.87 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 117.842 0.292 . . . . 0.0 111.05 -179.494 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.527 ' HA ' HD23 ' A' ' 39' ' ' LEU . 3.8 tt -86.53 105.65 16.97 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 176.929 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -118.93 163.74 16.47 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.329 -178.016 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 63.8 30.64 14.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.034 175.484 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.503 ' HA ' ' HB3' ' A' ' 37' ' ' PHE . 17.8 t0 -65.56 107.87 1.85 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.487 -178.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.418 ' HB3' ' HB2' ' A' ' 36' ' ' HIS . 60.9 tt0 -129.09 34.57 4.41 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.264 -0.88 . . . . 0.0 108.662 179.068 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 85.24 -95.48 1.98 Allowed Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.638 -178.315 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 17.4 p -80.39 -30.09 37.78 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.332 0.587 . . . . 0.0 110.453 178.378 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.418 ' HB2' ' HB3' ' A' ' 33' ' ' GLN . 9.0 m-70 -92.87 121.57 34.37 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.769 177.523 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.503 ' HB3' ' HA ' ' A' ' 32' ' ' ASP . 38.2 p90 -170.33 157.05 5.95 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 176.155 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.447 ' NH1' ' HD3' ' A' ' 51' ' ' ARG . 38.3 ptt180 -139.72 150.09 44.42 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.216 0.531 . . . . 0.0 111.709 179.176 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.527 HD23 ' HA ' ' A' ' 29' ' ' LEU . 94.4 mt -98.27 124.09 42.69 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.941 177.085 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 46.7 t -101.8 121.24 52.51 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-N 115.329 -0.851 . . . . 0.0 109.716 177.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.402 HG23 HD22 ' A' ' 63' ' ' LEU . 15.4 t -99.03 115.01 38.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-O 121.04 0.448 . . . . 0.0 110.02 -179.51 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.521 ' HD2' ' O ' ' A' ' 46' ' ' GLY . 56.0 mtm180 -100.31 167.12 10.62 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.259 179.699 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -88.84 -169.49 2.55 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.781 0.324 . . . . 0.0 110.47 -178.66 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.485 HG23 HD12 ' A' ' 72' ' ' ILE . 0.5 OUTLIER -61.53 -26.75 68.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.827 -178.528 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 18.5 tp10 -86.41 -31.47 21.42 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 120.95 0.405 . . . . 0.0 110.247 179.55 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.521 ' O ' ' HD2' ' A' ' 42' ' ' ARG . . . 112.7 20.99 6.23 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.394 -176.108 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 89.0 mtm180 -87.81 129.32 35.23 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 176.616 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 12.5 ptt? -62.79 112.54 2.58 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.125 0.488 . . . . 0.0 110.909 176.458 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.403 HG11 ' CE1' ' A' ' 66' ' ' TYR . 40.1 t -99.84 -36.65 5.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.498 179.462 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.526 ' CD1' HD23 ' A' ' 63' ' ' LEU . 58.2 t-105 -157.27 156.68 32.87 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.851 -174.404 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.447 ' HD3' ' NH1' ' A' ' 38' ' ' ARG . 7.6 ptp85 -155.79 143.32 19.47 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.139 -178.883 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -146.93 143.46 28.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.632 -0.258 . . . . 0.0 110.413 179.333 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 70.2 m95 -82.75 -168.03 1.87 Allowed 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 121.808 0.813 . . . . 0.0 111.439 -177.289 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -93.54 -35.24 13.02 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.152 -1.386 . . . . 0.0 110.622 -179.483 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 26.6 p90 -83.67 12.01 6.46 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.481 -178.369 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.664 ' HB2' ' HB2' ' A' ' 59' ' ' ALA . 10.2 mm-40 -82.1 124.07 79.09 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.37 177.779 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -45.73 -50.95 8.85 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 124.303 3.335 . . . . 0.0 113.193 -175.171 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -126.96 57.65 1.45 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.082 0.468 . . . . 0.0 109.887 176.078 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.664 ' HB2' ' HB2' ' A' ' 56' ' ' GLU . . . -54.48 -45.46 73.2 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.428 -178.864 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -63.2 -32.36 83.89 Favored Glycine 0 N--CA 1.441 -1.026 0 CA-C-N 115.135 -0.939 . . . . 0.0 112.779 -177.439 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.428 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 18.0 tp10 -59.66 -41.94 91.71 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.969 0.384 . . . . 0.0 110.623 -176.556 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -73.62 -43.19 37.3 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.456 -0.878 . . . . 0.0 112.007 179.658 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.526 HD23 ' CD1' ' A' ' 50' ' ' TRP . 65.7 mt -66.27 -46.98 75.2 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.681 0.277 . . . . 0.0 110.43 -179.308 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.472 ' HA ' HD12 ' A' ' 67' ' ' ILE . 87.2 m-20 -65.75 -25.51 67.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.477 178.781 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.428 ' HB2' ' O ' ' A' ' 61' ' ' GLU . 42.4 ttp180 -63.84 -45.25 90.38 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 178.152 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.403 ' CE1' HG11 ' A' ' 49' ' ' VAL . 85.3 t80 -69.47 -42.63 74.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.953 0.406 . . . . 0.0 110.219 175.826 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.472 HD12 ' HA ' ' A' ' 64' ' ' ASN . 97.0 mt -55.09 -37.57 43.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.476 177.15 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 47.1 ttt180 -60.27 -46.75 88.73 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.84 -178.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 16.9 p -87.57 -17.68 31.45 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -172.772 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 24.7 m -108.46 -50.17 3.07 Favored 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.447 -176.491 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 47.7 81.92 0.04 OUTLIER Glycine 0 CA--C 1.522 0.519 0 CA-C-N 115.868 -0.605 . . . . 0.0 112.948 -174.704 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.485 HD12 HG23 ' A' ' 44' ' ' THR . 35.2 mm -90.88 6.58 4.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-O 121.697 0.76 . . . . 0.0 110.304 -173.515 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.461 ' HB3' ' CE2' ' A' ' 24' ' ' TYR . 15.0 ptt180 . . . . . 0 N--CA 1.471 0.577 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.767 179.395 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.461 ' HA3' ' HD3' ' A' ' 11' ' ' PRO . . . . . . . . 0 CA--C 1.522 0.49 0 CA-C-O 120.14 -0.255 . . . . 0.0 113.626 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.461 ' HD3' ' HA3' ' A' ' 10' ' ' GLY . 14.4 Cg_exo -67.86 142.49 57.53 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.778 2.319 . . . . 0.0 111.841 176.936 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.535 ' CD2' ' HB2' ' A' ' 17' ' ' ALA . 12.9 p90 -108.79 -171.8 1.92 Allowed 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.804 -175.474 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.455 ' OG1' ' HG2' ' A' ' 16' ' ' GLN . 21.5 p -125.49 175.71 7.33 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 172.807 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.498 ' HG2' HD11 ' A' ' 29' ' ' LEU . 67.9 mtm180 -65.4 -43.94 89.05 Favored 'General case' 0 C--O 1.22 -0.462 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.128 175.129 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -54.93 -50.77 68.02 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 178.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.488 ' O ' HG23 ' A' ' 20' ' ' VAL . 65.0 mm-40 -60.81 -52.78 63.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.072 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.535 ' HB2' ' CD2' ' A' ' 12' ' ' PHE . . . -56.71 -46.45 81.24 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.304 -179.156 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.475 ' HG3' ' O ' ' A' ' 14' ' ' ARG . 91.9 mt-30 -58.95 -38.52 79.24 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.492 -176.787 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.52 -26.06 68.26 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-O 121.205 0.526 . . . . 0.0 111.535 178.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 16' ' ' GLN . 3.2 t -85.49 -22.88 7.29 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.903 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 -175.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 17.8 m -85.69 -33.73 21.46 Favored 'General case' 0 N--CA 1.434 -1.267 0 CA-C-N 113.315 -1.766 . . . . 0.0 110.814 -178.061 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.0 p -67.48 -29.35 68.77 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 173.012 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 23.3 m -80.73 -53.46 6.49 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.305 173.178 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.631 ' O ' HG13 ' A' ' 27' ' ' ILE . 62.3 m-85 -106.49 98.94 8.55 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 178.572 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 37.3 p -69.51 -3.8 16.18 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.225 -0.443 . . . . 0.0 112.142 -178.019 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.627 ' OD1' ' HB3' ' A' ' 24' ' ' TYR . 24.1 p-10 -82.48 -14.18 55.45 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.986 0.422 . . . . 0.0 109.877 176.141 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.631 HG13 ' O ' ' A' ' 24' ' ' TYR . 1.2 mt -81.12 146.17 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 N-CA-C 108.372 -0.974 . . . . 0.0 108.372 173.396 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.482 ' O ' ' HA ' ' A' ' 39' ' ' LEU . 3.0 p -144.12 136.42 26.62 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.853 -0.339 . . . . 0.0 111.204 -179.238 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.498 HD11 ' HG2' ' A' ' 14' ' ' ARG . 5.1 tt -95.71 105.12 17.08 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 177.277 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -115.84 166.59 11.79 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.224 -178.555 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.504 ' HB2' ' HG2' ' A' ' 38' ' ' ARG . 0.3 OUTLIER 60.95 31.59 19.96 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.256 177.493 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -70.77 102.47 2.34 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 121.612 0.72 . . . . 0.0 111.184 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 19.5 tm0? -100.53 -30.73 11.63 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.038 175.246 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 146.11 -80.02 0.22 Allowed Glycine 0 N--CA 1.445 -0.731 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 -175.647 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 44.5 p -82.12 -31.41 30.66 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 172.642 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 60.4 m80 -96.72 126.1 41.64 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.269 177.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.453 ' HB2' HD21 ' A' ' 29' ' ' LEU . 49.7 p90 -168.21 147.19 4.53 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.485 -0.779 . . . . 0.0 109.032 177.241 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.504 ' HG2' ' HB2' ' A' ' 31' ' ' ASP . 49.2 ptt85 -129.59 149.23 51.44 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.843 0.354 . . . . 0.0 110.785 -176.938 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.564 ' O ' ' HA ' ' A' ' 51' ' ' ARG . 75.9 mt -106.26 144.42 32.98 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.139 0.495 . . . . 0.0 110.188 178.434 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.575 HG13 ' HB3' ' A' ' 51' ' ' ARG . 38.2 t -123.48 110.04 24.97 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.066 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.316 174.845 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.2 t -88.84 104.37 14.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 173.445 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.403 ' HA ' ' O ' ' A' ' 47' ' ' ARG . 67.2 mtt85 -94.98 171.2 8.9 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.325 -177.822 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.427 ' CG ' ' H ' ' A' ' 45' ' ' GLU . 1.5 p-10 -96.73 -169.73 1.94 Allowed 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 175.667 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.97 -17.28 62.66 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.548 -175.925 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.444 ' OE1' ' HD3' ' A' ' 47' ' ' ARG . 37.9 tt0 -89.18 -24.73 22.1 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 176.347 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 105.0 18.55 12.07 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.329 178.521 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.444 ' HD3' ' OE1' ' A' ' 45' ' ' GLU . 41.6 mtm-85 -85.65 142.07 29.33 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 177.452 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 11.0 ptp -77.86 105.38 9.01 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.46 0.648 . . . . 0.0 111.104 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.2 t -87.7 -36.22 9.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.69 177.46 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.518 ' CZ2' ' HB3' ' A' ' 52' ' ' ALA . 31.4 t90 -137.62 123.27 19.82 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 177.661 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.575 ' HB3' HG13 ' A' ' 40' ' ' VAL . 0.0 OUTLIER -149.47 120.1 7.5 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.518 0.675 . . . . 0.0 110.006 172.706 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.518 ' HB3' ' CZ2' ' A' ' 50' ' ' TRP . . . -155.3 174.38 15.3 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.322 -174.883 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 78.9 m95 -93.9 -158.95 0.66 Allowed 'General case' 0 N--CA 1.445 -0.698 0 CA-C-O 121.258 0.551 . . . . 0.0 110.799 -174.226 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -110.09 -32.41 7.02 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.619 -0.718 . . . . 0.0 111.25 -175.461 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -79.34 34.73 0.26 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.982 -175.452 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.557 ' HB2' ' HB2' ' A' ' 59' ' ' ALA . 51.1 mt-10 -111.04 135.19 20.87 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.058 179.633 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -51.69 -32.83 46.88 Favored 'Trans proline' 0 N--CA 1.477 0.513 0 C-N-CA 123.879 3.052 . . . . 0.0 114.375 -170.15 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.47 ' HB2' ' HB3' ' A' ' 61' ' ' GLU . 2.3 p30 -136.36 44.18 2.43 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.017 0.436 . . . . 0.0 110.617 179.419 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.557 ' HB2' ' HB2' ' A' ' 56' ' ' GLU . . . -58.74 -41.35 86.25 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.904 -178.649 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.44 ' HA2' HD12 ' A' ' 63' ' ' LEU . . . -69.2 -27.52 73.67 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.588 178.846 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.47 ' HB3' ' HB2' ' A' ' 58' ' ' ASP . 31.2 tt0 -73.46 -34.63 65.48 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.592 ' HA2' ' HD3' ' A' ' 65' ' ' ARG . . . -63.49 -41.27 99.32 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.71 -0.757 . . . . 0.0 111.487 173.747 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.46 ' O ' HG13 ' A' ' 67' ' ' ILE . 6.6 mt -64.1 -41.08 97.41 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 110.31 -0.255 . . . . 0.0 110.31 175.141 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -56.17 -33.95 65.73 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.146 0.498 . . . . 0.0 110.497 173.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.592 ' HD3' ' HA2' ' A' ' 62' ' ' GLY . 45.6 mtp85 -71.31 -28.67 64.27 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.153 179.46 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.562 ' O ' HG22 ' A' ' 69' ' ' THR . 36.9 t80 -76.24 -51.62 11.69 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.49 -0.484 . . . . 0.0 109.795 171.658 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.46 HG13 ' O ' ' A' ' 63' ' ' LEU . 46.2 mt -62.05 -13.19 9.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.172 -178.612 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 8.8 tpt180 -49.36 -32.87 12.2 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.632 172.555 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.562 HG22 ' O ' ' A' ' 66' ' ' TYR . 12.1 t -92.96 29.29 1.86 Allowed 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 121.322 0.582 . . . . 0.0 110.291 -177.312 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 7.9 t 80.22 -27.05 0.15 Allowed 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.967 0.907 . . . . 0.0 111.351 176.434 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.12 -172.27 51.17 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.468 -0.873 . . . . 0.0 111.894 -177.697 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.481 ' O ' HG22 ' A' ' 72' ' ' ILE . 32.3 mm -101.02 7.73 9.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 121.768 0.794 . . . . 0.0 110.626 -174.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 . . . . . 0 N--CA 1.474 0.765 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.64 178.571 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.559 ' HA2' ' HA ' ' A' ' 58' ' ' ASP . . . . . . . . 0 N--CA 1.45 -0.397 0 CA-C-O 120.147 -0.252 . . . . 0.0 112.778 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.405 ' HD3' ' HA3' ' A' ' 10' ' ' GLY . 8.0 Cg_exo -72.7 168.56 24.18 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.956 2.437 . . . . 0.0 111.856 177.004 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -125.74 -170.61 2.21 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.379 -176.597 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.473 ' H ' ' HB2' ' A' ' 16' ' ' GLN . 41.6 p -125.4 173.41 8.89 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.149 178.579 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 4.4 tmt_? -58.42 -43.91 88.86 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.548 0.689 . . . . 0.0 109.261 172.855 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 41.5 ttm105 -60.77 -54.13 48.96 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.525 -1.216 . . . . 0.0 111.306 178.877 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.634 ' O ' HG23 ' A' ' 20' ' ' VAL . 73.5 mm-40 -56.71 -49.86 73.88 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.918 179.538 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.457 ' HB1' HD21 ' A' ' 39' ' ' LEU . . . -48.84 -51.9 27.06 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.576 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 9.1 mm100 -58.68 -38.0 77.27 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.664 -177.69 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.98 -27.87 66.1 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.969 0.414 . . . . 0.0 111.446 -178.531 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.634 HG23 ' O ' ' A' ' 16' ' ' GLN . 18.7 t -89.16 -18.9 7.68 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.816 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 -172.432 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 21.1 m -93.41 -31.25 14.69 Favored 'General case' 0 N--CA 1.432 -1.328 0 CA-C-N 114.004 -1.453 . . . . 0.0 108.149 -175.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 52.9 m -61.4 -36.58 80.7 Favored 'General case' 0 N--CA 1.435 -1.187 0 CA-C-N 113.93 -1.486 . . . . 0.0 109.047 168.503 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 25.9 m -78.97 -51.4 9.67 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.592 177.403 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.63 ' O ' HG13 ' A' ' 27' ' ' ILE . 47.6 m-85 -113.37 94.81 5.04 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 177.228 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 13.7 m -73.25 1.53 9.22 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.987 0.423 . . . . 0.0 111.204 -176.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.567 ' OD1' ' HB3' ' A' ' 24' ' ' TYR . 4.4 p-10 -78.55 -18.08 55.2 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 172.323 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.63 HG13 ' O ' ' A' ' 24' ' ' TYR . 2.0 mt -79.72 152.18 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 170.9 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.474 ' O ' ' HA ' ' A' ' 39' ' ' LEU . 17.2 p -141.0 123.64 16.04 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.91 -178.68 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.56 ' HA ' HD23 ' A' ' 39' ' ' LEU . 6.7 tt -83.85 95.68 8.55 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 176.114 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -114.95 171.31 7.73 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.628 -175.024 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.468 ' OD2' ' HZ3' ' A' ' 53' ' ' TRP . 38.3 t70 66.39 18.34 10.84 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 123.652 0.595 . . . . 0.0 110.639 177.929 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.568 ' HA ' ' HB3' ' A' ' 37' ' ' PHE . 7.6 p-10 -64.78 95.97 0.17 Allowed 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 121.826 0.822 . . . . 0.0 110.752 -179.793 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -128.13 45.17 2.8 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.133 -0.939 . . . . 0.0 109.471 -179.328 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.25 -88.24 1.44 Allowed Glycine 0 N--CA 1.444 -0.815 0 CA-C-N 114.55 -1.205 . . . . 0.0 112.6 176.558 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 49.0 m -81.63 -14.4 56.75 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -173.654 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 25.7 p80 -136.74 148.95 47.57 Favored 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 119.912 -0.715 . . . . 0.0 110.953 176.669 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.568 ' HB3' ' HA ' ' A' ' 32' ' ' ASP . 45.1 p90 -170.0 161.44 8.74 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.79 -1.095 . . . . 0.0 108.474 178.708 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.421 ' HG2' ' HB3' ' A' ' 31' ' ' ASP . 32.9 ptt180 -144.05 155.57 44.04 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.052 0.453 . . . . 0.0 112.119 -178.86 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.56 HD23 ' HA ' ' A' ' 29' ' ' LEU . 95.8 mt -103.18 112.38 25.21 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.285 176.651 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 47.8 t -94.21 122.38 45.63 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.944 175.846 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.507 HG11 ' CD2' ' A' ' 66' ' ' TYR . 80.4 t -90.09 115.28 29.26 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 178.201 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.536 ' HA ' ' O ' ' A' ' 47' ' ' ARG . 59.1 mtp180 -110.52 161.04 16.09 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.37 -176.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -95.56 -165.81 1.35 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.18 -178.28 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 17.6 p -63.46 -27.23 69.14 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.859 0.361 . . . . 0.0 111.427 -177.228 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -82.87 -33.82 26.9 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.217 0.532 . . . . 0.0 109.788 177.511 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 110.28 18.49 8.62 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.817 -0.706 . . . . 0.0 111.584 -175.263 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.536 ' O ' ' HA ' ' A' ' 42' ' ' ARG . 52.0 mtt180 -80.53 145.57 31.74 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 179.101 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.404 ' N ' ' SD ' ' A' ' 48' ' ' MET . 1.8 mpt? -72.49 108.46 5.57 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 177.42 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 42.6 t -95.14 -31.03 4.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.459 0.647 . . . . 0.0 109.592 177.18 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.457 ' CD1' HD23 ' A' ' 63' ' ' LEU . 69.3 t-105 -159.12 157.87 31.79 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.35 -178.352 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 15.3 ptt180 -160.66 138.73 9.77 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.887 0.375 . . . . 0.0 110.114 178.864 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -143.12 145.76 33.13 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.043 178.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.537 ' HB2' ' OE1' ' A' ' 56' ' ' GLU . 42.4 m95 -84.71 -160.44 0.48 Allowed 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 176.736 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -107.55 0.86 22.95 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.928 -174.684 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 22.9 p90 -117.56 2.98 12.42 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -173.632 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.569 ' HB2' ' HB2' ' A' ' 59' ' ' ALA . 3.1 mp0 -66.16 132.18 94.49 Favored Pre-proline 0 C--O 1.237 0.398 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.119 173.13 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -46.65 -32.62 12.09 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 123.86 3.04 . . . . 0.0 113.358 -176.717 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.559 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . 4.4 t0 -146.29 62.9 1.22 Allowed 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 174.389 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.569 ' HB2' ' HB2' ' A' ' 56' ' ' GLU . . . -58.17 -35.51 71.68 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-O 121.286 0.565 . . . . 0.0 111.011 -179.054 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -59.01 -37.75 91.98 Favored Glycine 0 N--CA 1.446 -0.673 0 CA-C-N 115.281 -0.872 . . . . 0.0 113.554 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -60.5 -38.72 85.23 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 117.386 0.593 . . . . 0.0 111.182 -174.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.527 ' O ' ' HB3' ' A' ' 65' ' ' ARG . . . -72.32 -44.49 42.6 Favored Glycine 0 C--O 1.237 0.308 0 C-N-CA 120.823 -0.703 . . . . 0.0 111.99 179.078 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.457 HD23 ' CD1' ' A' ' 50' ' ' TRP . 65.6 mt -62.36 -50.24 72.36 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.705 0.288 . . . . 0.0 110.244 178.21 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.414 ' HA ' ' HB ' ' A' ' 67' ' ' ILE . 92.8 m-20 -63.43 -28.33 69.9 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.923 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.527 ' HB3' ' O ' ' A' ' 62' ' ' GLY . 10.9 ttt180 -57.02 -51.0 71.0 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.009 175.293 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.507 ' CD2' HG11 ' A' ' 41' ' ' VAL . 77.5 t80 -72.06 -38.8 69.39 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.622 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.414 ' HB ' ' HA ' ' A' ' 64' ' ' ASN . 96.4 mt -57.21 -43.97 82.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.007 0.432 . . . . 0.0 110.896 177.868 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 5.9 ttp85 -65.76 -41.85 91.61 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.89 -179.444 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 30.9 p -79.3 -44.7 21.15 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -176.7 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.427 ' O ' HD12 ' A' ' 72' ' ' ILE . 31.0 m -147.68 56.48 1.09 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.618 -173.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -64.46 130.51 37.61 Favored Glycine 0 CA--C 1.52 0.4 0 C-N-CA 120.284 -0.96 . . . . 0.0 111.9 173.205 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.533 ' HB ' ' OD1' ' A' ' 26' ' ' ASN . 1.9 mp -81.29 2.31 2.77 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 CA-C-O 121.66 0.743 . . . . 0.0 111.059 -174.758 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 15.5 ttt180 . . . . . 0 N--CA 1.469 0.524 0 O-C-N 121.644 -0.66 . . . . 0.0 111.639 177.917 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.446 ' HA2' ' OD1' ' A' ' 58' ' ' ASP . . . . . . . . 0 CA--C 1.519 0.311 0 CA-C-O 120.239 -0.2 . . . . 0.0 113.499 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -70.69 153.48 64.64 Favored 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 122.662 2.242 . . . . 0.0 111.577 178.539 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 16.4 p90 -115.98 -175.93 2.84 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.773 0.797 . . . . 0.0 112.134 -174.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -125.68 159.35 32.47 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-N 114.862 -1.063 . . . . 0.0 109.344 179.774 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.424 HH11 ' HD2' ' A' ' 14' ' ' ARG . 24.5 ttt85 -57.63 -48.46 79.37 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 120.895 0.379 . . . . 0.0 110.424 -179.774 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 21.4 tpp180 -46.22 -55.78 6.66 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.041 175.417 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.685 ' O ' HG23 ' A' ' 20' ' ' VAL . 1.7 mp0 -62.04 -49.45 75.94 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.857 179.22 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -53.29 -49.19 67.49 Favored 'General case' 0 N--CA 1.464 0.225 0 O-C-N 123.279 0.362 . . . . 0.0 111.557 -177.511 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -58.82 -40.14 83.27 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.433 -178.745 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.44 -24.26 66.42 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.856 179.327 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.685 HG23 ' O ' ' A' ' 16' ' ' GLN . 15.3 t -88.49 -22.75 6.58 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.794 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 -174.679 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.534 HG23 ' HB ' ' A' ' 27' ' ' ILE . 11.0 m -86.73 -31.03 21.19 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-N 113.768 -1.56 . . . . 0.0 110.575 -178.035 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.5 p -68.5 -31.34 70.53 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 170.163 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 41.0 m -75.67 -50.92 13.97 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.34 174.067 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.599 ' HB2' HG13 ' A' ' 27' ' ' ILE . 61.6 m-85 -113.16 102.26 10.21 Favored 'General case' 0 N--CA 1.447 -0.594 0 O-C-N 121.883 -0.511 . . . . 0.0 109.97 177.54 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 76.0 p -67.2 -9.25 38.33 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.06 -0.518 . . . . 0.0 112.056 -179.351 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.56 ' OD1' ' HB3' ' A' ' 24' ' ' TYR . 24.8 p-10 -79.01 -12.25 60.03 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.995 0.426 . . . . 0.0 110.035 177.929 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.599 HG13 ' HB2' ' A' ' 24' ' ' TYR . 2.2 mt -83.8 147.12 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 173.793 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.583 ' OG1' ' HB ' ' A' ' 40' ' ' VAL . 1.4 p -139.81 127.88 22.32 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 120.477 -0.489 . . . . 0.0 111.26 -179.07 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.521 ' HA ' HD23 ' A' ' 39' ' ' LEU . 5.6 tt -83.48 102.92 12.43 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 177.203 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -113.68 159.06 20.1 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.765 -175.632 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.8 t70 59.84 47.69 9.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.735 -179.682 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -72.27 96.54 1.85 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.976 -175.461 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -112.97 24.13 12.68 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.866 175.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 77.8 -79.99 1.38 Allowed Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.705 -0.68 . . . . 0.0 112.241 179.459 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 38.8 m -82.97 -16.69 46.26 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.077 0.465 . . . . 0.0 110.672 179.567 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 24.8 m170 -119.43 137.92 53.45 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 174.291 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -170.62 156.47 5.34 Favored 'General case' 0 C--N 1.323 -0.583 0 O-C-N 123.518 0.511 . . . . 0.0 109.769 177.803 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 11.9 ptt180 -128.53 153.28 47.35 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.136 176.17 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.546 ' O ' ' HA ' ' A' ' 51' ' ' ARG . 91.6 mt -111.21 132.54 54.25 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.177 0.513 . . . . 0.0 110.223 178.902 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.583 ' HB ' ' OG1' ' A' ' 28' ' ' THR . 38.6 t -108.99 109.23 27.56 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.624 176.849 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.468 HG11 ' CD2' ' A' ' 66' ' ' TYR . 10.9 t -85.1 118.44 32.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 173.267 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.407 ' O ' ' HB2' ' A' ' 26' ' ' ASN . 16.5 mtp180 -113.21 158.79 20.02 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 -178.097 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.448 ' CG ' ' H ' ' A' ' 45' ' ' GLU . 2.6 p-10 -89.77 -168.7 2.21 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 177.379 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 9.2 t -71.42 -14.32 62.12 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.099 -177.855 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.448 ' H ' ' CG ' ' A' ' 43' ' ' ASP . 32.5 tt0 -93.15 -16.02 25.36 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.34 0.591 . . . . 0.0 109.592 177.122 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 95.51 13.04 52.71 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.963 177.584 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 15.5 mtp180 -79.32 127.94 32.71 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 178.657 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.7 102.79 2.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.223 0.535 . . . . 0.0 111.213 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 43.9 t -86.72 -40.39 14.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.349 -0.842 . . . . 0.0 110.286 -179.155 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.598 ' CH2' ' HB3' ' A' ' 52' ' ' ALA . 22.6 t90 -135.48 106.57 6.7 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -178.719 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.546 ' HA ' ' O ' ' A' ' 39' ' ' LEU . 29.9 ptt180 -130.95 109.19 10.36 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 173.673 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.598 ' HB3' ' CH2' ' A' ' 50' ' ' TRP . . . -149.33 166.44 28.98 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.796 -177.456 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 44.1 m95 -85.53 -162.8 0.76 Allowed 'General case' 0 N--CA 1.445 -0.705 0 CA-C-O 121.468 0.651 . . . . 0.0 111.162 -175.139 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 61.8 t30 -105.17 -20.39 13.52 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.816 -176.035 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -83.45 14.67 3.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.15 0.5 . . . . 0.0 111.305 -178.017 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.54 ' HB2' ' HB2' ' A' ' 59' ' ' ALA . 9.4 mm-40 -80.33 129.57 68.85 Favored Pre-proline 0 C--N 1.325 -0.459 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 174.532 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -44.89 -39.1 13.85 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.867 3.045 . . . . 0.0 114.067 -172.39 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.446 ' OD1' ' HA2' ' A' ' 10' ' ' GLY . 12.7 t0 -142.11 59.02 1.47 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 178.021 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.54 ' HB2' ' HB2' ' A' ' 56' ' ' GLU . . . -56.38 -35.25 67.52 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.204 -179.636 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -62.22 -37.46 94.58 Favored Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.698 -0.683 . . . . 0.0 113.51 -177.908 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.404 ' CD ' HH21 ' A' ' 65' ' ' ARG . 1.4 tm-20 -59.75 -50.94 71.86 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 117.176 0.488 . . . . 0.0 110.384 -175.958 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -59.46 -43.05 97.8 Favored Glycine 0 CA--C 1.52 0.374 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.098 178.673 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 17.7 mt -59.31 -48.54 81.25 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.691 0.281 . . . . 0.0 111.074 176.869 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -65.05 -34.94 79.63 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.444 -178.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.404 HH21 ' CD ' ' A' ' 61' ' ' GLU . 14.2 ttm180 -63.63 -32.55 74.07 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.978 -178.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.468 ' CD2' HG11 ' A' ' 41' ' ' VAL . 68.6 t80 -82.45 -45.69 14.44 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 120.028 -0.669 . . . . 0.0 110.448 176.107 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 86.8 mt -55.22 -42.55 66.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.19 -178.567 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 56.8 ttp180 -55.87 -36.93 68.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.524 -178.664 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 13.6 t -105.34 25.56 10.5 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.179 0.514 . . . . 0.0 111.553 -173.842 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 54.0 m -149.59 -55.59 0.18 Allowed 'General case' 0 C--N 1.324 -0.534 0 O-C-N 122.126 -0.359 . . . . 0.0 111.266 177.075 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 45.03 75.64 0.16 Allowed Glycine 0 CA--C 1.524 0.632 0 CA-C-N 115.51 -0.768 . . . . 0.0 113.227 -175.082 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.475 HG21 ' HB3' ' A' ' 26' ' ' ASN . 45.9 mm -79.86 6.41 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-O 121.62 0.724 . . . . 0.0 111.118 -172.895 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 . . . . . 0 N--CA 1.469 0.495 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.193 178.848 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.447 ' HA3' ' HD3' ' A' ' 11' ' ' PRO . . . . . . . . 0 CA--C 1.518 0.277 0 CA-C-O 120.117 -0.268 . . . . 0.0 113.404 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.447 ' HD3' ' HA3' ' A' ' 10' ' ' GLY . 17.7 Cg_exo -66.87 170.85 12.0 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.915 2.41 . . . . 0.0 112.531 178.44 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -136.25 -173.48 3.41 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.084 -177.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.435 ' H ' ' HB2' ' A' ' 16' ' ' GLN . 27.5 p -122.21 178.17 5.04 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.227 175.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.639 ' O ' ' HG2' ' A' ' 18' ' ' GLN . 36.4 ttt-85 -63.0 -46.99 85.08 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 176.695 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 70.6 mtp180 -57.01 -48.36 78.67 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.133 178.342 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.58 ' O ' HG23 ' A' ' 20' ' ' VAL . 81.2 mm-40 -60.4 -46.9 88.33 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 178.548 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.434 ' HB1' HD11 ' A' ' 39' ' ' LEU . . . -52.32 -47.1 66.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.565 177.576 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.639 ' HG2' ' O ' ' A' ' 14' ' ' ARG . 86.7 mm-40 -55.07 -48.06 74.03 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.504 -178.55 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.67 -28.53 69.99 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -175.664 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.58 HG23 ' O ' ' A' ' 16' ' ' GLN . 11.3 t -86.91 -25.57 6.18 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.787 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 -171.947 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.516 HG23 ' HB ' ' A' ' 27' ' ' ILE . 17.7 m -86.36 -31.25 21.61 Favored 'General case' 0 N--CA 1.435 -1.222 0 CA-C-N 113.735 -1.575 . . . . 0.0 111.211 -177.803 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.7 p -69.16 -29.01 66.93 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 172.263 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 19.5 m -77.34 -56.0 4.92 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.222 171.655 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.646 ' HB3' ' OD1' ' A' ' 26' ' ' ASN . 58.0 m-85 -105.13 98.07 7.83 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 -179.811 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.9 p -70.24 1.12 5.18 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 120.728 0.299 . . . . 0.0 111.759 178.68 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.646 ' OD1' ' HB3' ' A' ' 24' ' ' TYR . 4.5 p-10 -83.26 -10.87 58.3 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 174.205 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.622 HG13 ' O ' ' A' ' 24' ' ' TYR . 1.7 mt -85.25 138.02 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 173.058 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.503 ' OG1' ' HB ' ' A' ' 40' ' ' VAL . 2.3 p -130.62 126.43 36.62 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 120.641 -0.424 . . . . 0.0 111.043 -176.318 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.416 ' HA ' HD23 ' A' ' 39' ' ' LEU . 5.4 tt -91.26 108.05 19.62 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -122.97 167.9 13.0 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.719 178.767 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.571 ' HB2' HH11 ' A' ' 38' ' ' ARG . 0.7 OUTLIER 62.59 67.66 0.7 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.618 -177.88 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -81.38 100.25 9.14 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.657 -175.273 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -114.08 6.96 16.58 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.534 0.683 . . . . 0.0 109.553 174.261 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.62 -79.71 1.28 Allowed Glycine 0 N--CA 1.45 -0.419 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.948 -179.112 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 17.1 m -86.36 -18.63 31.38 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.156 0.503 . . . . 0.0 110.359 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 29.7 m170 -114.25 132.07 56.27 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.73 173.12 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.501 ' HA ' ' O ' ' A' ' 31' ' ' ASP . 52.9 p90 -164.59 157.37 16.89 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 178.812 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.607 ' HA ' ' HA ' ' A' ' 53' ' ' TRP . 27.0 ptt-85 -124.47 142.42 51.34 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 119.567 -0.853 . . . . 0.0 111.31 177.766 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.506 ' O ' ' HA ' ' A' ' 51' ' ' ARG . 63.0 mt -104.05 134.74 46.81 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.589 176.133 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.541 HG13 ' HB3' ' A' ' 51' ' ' ARG . 40.6 t -112.83 116.41 52.53 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.959 175.408 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.552 ' HB ' ' HB3' ' A' ' 50' ' ' TRP . 97.1 t -86.36 107.97 17.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.239 173.727 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.43 HH11 ' HD2' ' A' ' 42' ' ' ARG . 14.7 mtp180 -101.48 156.57 17.39 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.543 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.443 ' HA ' ' OH ' ' A' ' 66' ' ' TYR . 1.9 p-10 -88.91 -171.06 3.14 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 120.793 0.33 . . . . 0.0 110.947 -175.605 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 12.2 t -64.1 -22.53 66.97 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.878 -177.287 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -87.14 -31.52 20.36 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 178.478 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 114.01 14.07 9.56 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.339 -179.579 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 72.3 mtp180 -91.01 140.98 29.33 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 179.348 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 22.3 ptt? -74.91 118.79 18.26 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.227 0.537 . . . . 0.0 111.459 -177.201 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 34.0 t -101.6 -32.41 3.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.002 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.552 ' HB3' ' HB ' ' A' ' 41' ' ' VAL . 49.3 t90 -144.77 136.58 25.74 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.973 -1.012 . . . . 0.0 108.542 -179.76 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.573 ' O ' ' HD2' ' A' ' 51' ' ' ARG . 0.0 OUTLIER -158.01 119.99 3.67 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 121.448 0.642 . . . . 0.0 110.354 174.772 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.519 ' HB3' ' CZ2' ' A' ' 50' ' ' TRP . . . -151.83 171.3 17.95 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.091 -177.747 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.607 ' HA ' ' HA ' ' A' ' 38' ' ' ARG . 87.7 m95 -80.26 -95.25 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -172.333 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -162.1 -35.8 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.123 0.487 . . . . 0.0 110.607 -176.249 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -84.67 14.86 4.23 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.396 -177.027 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.526 ' HB2' ' HB2' ' A' ' 59' ' ' ALA . 1.9 mm-40 -66.52 128.02 93.64 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.1 -178.008 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_exo -38.19 -49.6 2.25 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 124.338 3.359 . . . . 0.0 113.541 -176.214 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -138.92 69.16 1.37 Allowed 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 172.191 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.526 ' HB2' ' HB2' ' A' ' 56' ' ' GLU . . . -57.75 -33.86 68.92 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.898 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -55.16 -41.84 79.85 Favored Glycine 0 N--CA 1.446 -0.694 0 CA-C-N 115.241 -0.89 . . . . 0.0 112.963 178.542 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.616 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 9.0 tp10 -49.02 -54.76 14.37 Favored 'General case' 0 C--O 1.223 -0.332 0 CA-C-N 116.974 0.387 . . . . 0.0 111.059 -178.143 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.498 ' HA3' ' CD1' ' A' ' 50' ' ' TRP . . . -65.22 -40.94 97.03 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.777 -178.157 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.478 HD23 HG21 ' A' ' 41' ' ' VAL . 49.3 mt -62.82 -51.04 68.61 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.609 0.242 . . . . 0.0 110.943 179.669 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 51.8 m-80 -69.15 -24.78 64.12 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.941 0.4 . . . . 0.0 110.28 179.775 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.616 ' HB2' ' O ' ' A' ' 61' ' ' GLU . 12.6 ttt85 -61.91 -37.64 85.41 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.961 177.277 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.443 ' OH ' ' HA ' ' A' ' 43' ' ' ASP . 91.4 t80 -82.32 -47.92 11.79 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.992 176.753 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.422 HG13 ' O ' ' A' ' 63' ' ' LEU . 72.2 mt -56.52 -21.85 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 CA-C-O 120.992 0.425 . . . . 0.0 111.404 179.718 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 49.6 ttp180 -50.24 -34.04 21.69 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.455 175.214 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.417 ' O ' ' HB2' ' A' ' 70' ' ' SER . 6.9 t -102.89 61.85 0.8 Allowed 'General case' 0 N--CA 1.443 -0.779 0 CA-C-O 122.062 0.934 . . . . 0.0 109.217 179.464 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.417 ' HB2' ' O ' ' A' ' 69' ' ' THR . 63.2 m 78.18 -51.63 0.49 Allowed 'General case' 0 C--O 1.236 0.356 0 CA-C-N 114.224 -1.353 . . . . 0.0 112.978 172.491 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.06 175.71 51.16 Favored Glycine 0 CA--C 1.52 0.38 0 N-CA-C 111.585 -0.606 . . . . 0.0 111.585 -172.248 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.592 ' HB ' ' OD1' ' A' ' 26' ' ' ASN . 1.1 mp -83.29 -5.62 9.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.458 0.647 . . . . 0.0 111.061 -177.313 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 23.7 ptt180 . . . . . 0 C--N 1.327 -0.398 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.408 175.811 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.578 ' HA3' ' O ' ' A' ' 57' ' ' PRO . . . . . . . . 0 N--CA 1.445 -0.766 0 N-CA-C 111.776 -0.53 . . . . 0.0 111.776 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.583 ' HG3' ' HA ' ' A' ' 57' ' ' PRO . 3.4 Cg_exo -78.86 133.67 11.46 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 121.547 1.498 . . . . 0.0 111.659 175.526 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 26.7 p90 -100.89 -170.78 1.9 Allowed 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.525 -0.762 . . . . 0.0 111.139 -178.12 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.438 ' OG1' ' HG2' ' A' ' 16' ' ' GLN . 21.2 p -125.73 172.53 9.73 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 176.24 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.529 ' O ' ' HG3' ' A' ' 18' ' ' GLN . 1.9 tmt_? -61.03 -49.1 78.76 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 174.365 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' A' ' 15' ' ' ARG . 13.7 ttp85 -52.56 -52.57 54.31 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.823 -1.08 . . . . 0.0 111.376 176.428 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.617 ' O ' HG23 ' A' ' 20' ' ' VAL . 15.6 mm100 -59.27 -47.34 85.75 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.587 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -52.11 -48.31 64.86 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.719 179.214 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.529 ' HG3' ' O ' ' A' ' 14' ' ' ARG . 44.9 mt-30 -54.94 -48.58 72.99 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.446 -179.321 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.98 -35.14 76.02 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.181 0.515 . . . . 0.0 111.175 -178.673 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.617 HG23 ' O ' ' A' ' 16' ' ' GLN . 16.4 t -82.29 -13.14 12.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.756 -175.08 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.472 HG23 ' HB ' ' A' ' 27' ' ' ILE . 0.0 OUTLIER -91.87 -34.72 14.41 Favored 'General case' 0 CA--C 1.507 -0.674 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 176.349 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 22.1 m -56.24 -30.87 62.96 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 114.294 -1.321 . . . . 0.0 109.665 167.39 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.406 ' O ' ' HA ' ' A' ' 73' ' ' ARG . 28.0 m -89.38 -46.99 8.32 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.794 178.257 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.625 ' O ' HG13 ' A' ' 27' ' ' ILE . 36.9 m-85 -122.29 104.81 9.69 Favored 'General case' 0 N--CA 1.447 -0.611 0 O-C-N 121.767 -0.583 . . . . 0.0 109.481 177.639 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 7.2 p -77.09 -6.07 51.4 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -177.216 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.454 ' ND2' ' HB3' ' A' ' 24' ' ' TYR . 6.4 p30 -71.71 -19.36 62.06 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 173.466 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.625 HG13 ' O ' ' A' ' 24' ' ' TYR . 1.9 mt -77.01 138.95 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 CA-C-N 115.258 -0.883 . . . . 0.0 108.622 177.433 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.545 ' OG1' ' HB ' ' A' ' 40' ' ' VAL . 1.3 p -137.0 146.4 45.28 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 121.18 -0.208 . . . . 0.0 110.534 -175.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.493 ' HA ' HD23 ' A' ' 39' ' ' LEU . 4.5 tt -100.31 122.98 43.96 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.962 0.411 . . . . 0.0 110.193 -176.32 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.551 ' HB2' ' HG3' ' A' ' 38' ' ' ARG . 24.0 mt-10 -116.82 155.15 29.47 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.679 175.63 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 59.92 52.88 5.01 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.205 171.728 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.454 ' OD2' HD22 ' A' ' 29' ' ' LEU . 2.0 m-20 -62.3 83.51 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.762 178.551 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -119.46 71.31 0.87 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.333 0.587 . . . . 0.0 111.088 -177.657 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 66.11 -106.88 1.73 Allowed Glycine 0 N--CA 1.445 -0.73 0 CA-C-N 115.094 -0.957 . . . . 0.0 112.966 174.69 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 39.7 t -85.49 -14.24 46.63 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 111.667 0.247 . . . . 0.0 111.667 -175.558 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 34.4 p-80 -129.7 143.02 50.62 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.071 -0.651 . . . . 0.0 111.598 -177.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -163.88 179.35 7.11 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 179.481 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.551 ' HG3' ' HB2' ' A' ' 30' ' ' GLU . 13.6 ptt180 -127.41 154.26 45.25 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.015 -0.674 . . . . 0.0 110.866 176.072 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.493 HD23 ' HA ' ' A' ' 29' ' ' LEU . 95.5 mt -115.93 136.15 53.3 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.024 0.44 . . . . 0.0 110.392 178.336 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.545 ' HB ' ' OG1' ' A' ' 28' ' ' THR . 21.4 t -107.21 120.85 59.23 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.556 178.319 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 63.5 t -89.28 122.63 40.84 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 173.019 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 42' ' ' ARG . 24.8 mtp85 -111.39 159.61 17.85 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.344 0.593 . . . . 0.0 110.558 -178.741 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -90.97 176.83 6.46 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.295 178.736 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 17.8 p -68.96 -15.69 63.55 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.757 0.313 . . . . 0.0 111.303 -177.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -83.88 -17.08 42.04 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.491 0.662 . . . . 0.0 109.363 172.792 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 91.14 11.04 61.78 Favored Glycine 0 N--CA 1.447 -0.61 0 CA-C-N 115.291 -0.868 . . . . 0.0 112.517 -178.643 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 31.8 ptt85 -81.19 138.22 35.84 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 175.505 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 14.4 ptm -61.22 127.47 31.69 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.049 0.452 . . . . 0.0 110.839 177.625 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 13.5 t -102.68 -39.11 5.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.86 177.768 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 75.6 t-105 -166.54 121.69 1.16 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.991 -175.645 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.407 ' HB3' HG22 ' A' ' 40' ' ' VAL . 4.8 ptp85 -120.39 125.14 47.23 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 174.158 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -134.67 157.59 46.25 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.155 -176.818 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.563 ' HB2' ' HG3' ' A' ' 56' ' ' GLU . 81.7 m95 -85.6 -174.45 5.17 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 122.203 1.001 . . . . 0.0 111.988 -177.392 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.461 HD22 ' C ' ' A' ' 54' ' ' ASN . 0.2 OUTLIER -96.34 -33.52 11.91 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 113.692 -1.595 . . . . 0.0 110.158 -176.59 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 17.8 p90 -85.84 10.56 13.42 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.625 -174.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.563 ' HG3' ' HB2' ' A' ' 53' ' ' TRP . 25.5 mt-10 -88.19 128.59 52.96 Favored Pre-proline 0 C--N 1.322 -0.593 0 C-N-CA 121.007 -0.277 . . . . 0.0 110.406 -178.651 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.583 ' HA ' ' HG3' ' A' ' 11' ' ' PRO . 21.9 Cg_exo -65.14 -5.22 10.56 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.46 2.774 . . . . 0.0 114.094 -171.893 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -141.03 25.93 2.07 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.365 0.126 . . . . 0.0 111.132 -179.161 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.544 ' O ' ' HG ' ' A' ' 63' ' ' LEU . . . -57.06 -46.6 82.33 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.166 0.508 . . . . 0.0 110.997 -176.888 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -74.0 -22.05 78.41 Favored Glycine 0 N--CA 1.443 -0.843 0 CA-C-N 115.775 -0.648 . . . . 0.0 113.303 -176.307 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -70.87 -33.43 70.6 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 117.182 0.491 . . . . 0.0 109.905 -177.023 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.52 ' O ' ' HB3' ' A' ' 65' ' ' ARG . . . -79.43 -38.27 21.77 Favored Glycine 0 N--CA 1.45 -0.399 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 175.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.544 ' HG ' ' O ' ' A' ' 59' ' ' ALA . 92.4 mt -61.77 -44.73 96.31 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.381 -0.409 . . . . 0.0 110.024 176.581 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.558 ' HA ' ' HB ' ' A' ' 67' ' ' ILE . 90.4 m-20 -62.96 -33.59 75.7 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.896 177.788 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.52 ' HB3' ' O ' ' A' ' 62' ' ' GLY . 9.5 tpt180 -54.39 -40.4 68.15 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.833 0.349 . . . . 0.0 110.439 173.72 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -77.33 -48.56 17.03 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.905 0.384 . . . . 0.0 110.545 174.581 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.558 ' HB ' ' HA ' ' A' ' 64' ' ' ASN . 84.2 mt -52.83 -56.15 8.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -174.936 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -71.86 -32.89 67.95 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.705 0.288 . . . . 0.0 111.656 -169.549 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.03 28.71 7.98 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -176.079 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 62.4 m -148.77 -53.75 0.18 Allowed 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 172.33 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 53.84 89.13 0.01 OUTLIER Glycine 0 CA--C 1.522 0.529 0 CA-C-N 115.422 -0.808 . . . . 0.0 114.373 176.381 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.451 ' O ' HG22 ' A' ' 72' ' ' ILE . 38.2 mm -86.37 7.02 2.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.749 0.785 . . . . 0.0 109.89 178.612 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.406 ' HA ' ' O ' ' A' ' 23' ' ' THR . 4.6 ptm180 . . . . . 0 N--CA 1.466 0.327 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.646 -178.59 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.482 ' HA3' ' HD3' ' A' ' 11' ' ' PRO . . . . . . . . 0 CA--C 1.522 0.527 0 N-CA-C 114.812 0.685 . . . . 0.0 114.812 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.514 ' HG3' ' HA ' ' A' ' 57' ' ' PRO . 1.3 Cg_endo -80.53 142.64 14.71 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 122.852 2.368 . . . . 0.0 112.409 -179.216 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.445 ' CZ ' ' HA ' ' A' ' 54' ' ' ASN . 9.8 p90 -111.46 -171.39 1.83 Allowed 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.002 -179.275 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.436 ' OG1' ' HG2' ' A' ' 16' ' ' GLN . 16.7 p -124.61 179.94 4.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.186 178.868 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.409 ' O ' ' HG3' ' A' ' 18' ' ' GLN . 5.6 ttm180 -65.8 -53.58 38.37 Favored 'General case' 0 N--CA 1.427 -1.591 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.705 -178.887 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.429 HH11 ' HD2' ' A' ' 15' ' ' ARG . 20.6 ptt85 -62.37 -36.46 82.34 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.204 178.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.618 ' O ' HG23 ' A' ' 20' ' ' VAL . 87.7 mm-40 -62.31 -48.18 81.0 Favored 'General case' 0 CA--C 1.519 -0.246 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 176.516 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -55.0 -47.9 74.05 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.99 175.602 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.409 ' HG3' ' O ' ' A' ' 14' ' ' ARG . 99.1 mt-30 -57.59 -42.54 83.36 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.401 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.454 ' O ' ' HB ' ' A' ' 22' ' ' THR . . . -62.59 -34.59 77.29 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.985 178.31 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.618 HG23 ' O ' ' A' ' 16' ' ' GLN . 24.3 t -79.18 -16.33 13.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.808 0.337 . . . . 0.0 110.362 -178.034 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.555 HG23 ' HB ' ' A' ' 27' ' ' ILE . 0.0 OUTLIER -92.24 -26.42 18.18 Favored 'General case' 0 CA--C 1.503 -0.83 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 177.624 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.454 ' HB ' ' O ' ' A' ' 19' ' ' ALA . 98.0 m -61.12 -32.97 72.65 Favored 'General case' 0 N--CA 1.437 -1.122 0 CA-C-N 113.612 -1.631 . . . . 0.0 109.419 167.859 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.8 m -87.45 -50.66 6.4 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.968 178.264 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.637 ' O ' HG13 ' A' ' 27' ' ' ILE . 35.0 m-85 -116.64 102.37 9.39 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 -179.469 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 15.6 p -81.21 5.34 17.3 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.942 0.401 . . . . 0.0 111.419 -177.638 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.538 ' OD1' ' HB3' ' A' ' 24' ' ' TYR . 25.5 p-10 -83.53 -17.31 42.28 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 172.221 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.637 HG13 ' O ' ' A' ' 24' ' ' TYR . 1.1 mt -78.22 148.48 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 N-CA-C 108.183 -1.044 . . . . 0.0 108.183 173.5 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.504 ' O ' ' HA ' ' A' ' 39' ' ' LEU . 1.7 p -141.68 133.94 27.91 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.498 -0.481 . . . . 0.0 111.465 -178.029 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.518 ' HA ' HD23 ' A' ' 39' ' ' LEU . 6.5 tt -87.88 100.6 13.0 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 179.623 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -115.75 166.5 11.87 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.848 -174.87 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 60.6 37.22 19.49 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 123.388 0.43 . . . . 0.0 111.462 171.871 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -74.95 125.11 28.19 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.135 0.493 . . . . 0.0 111.305 -175.278 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -126.69 25.2 6.45 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.526 173.204 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.0 -90.87 1.6 Allowed Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.038 -177.794 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.0 t -78.27 -7.13 56.83 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.262 0.553 . . . . 0.0 110.863 -178.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 57.2 m80 -131.42 138.56 49.13 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.647 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.41 ' O ' ' HA ' ' A' ' 53' ' ' TRP . 52.8 p90 -168.81 166.39 11.49 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.306 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.502 ' HA ' ' HA ' ' A' ' 53' ' ' TRP . 70.2 mtm180 -128.28 132.98 48.69 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.518 HD23 ' HA ' ' A' ' 29' ' ' LEU . 64.4 mt -95.45 107.65 19.81 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.348 0.594 . . . . 0.0 109.661 174.244 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 60.7 t -89.48 116.87 31.71 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.896 177.826 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.465 HG22 HG23 ' A' ' 27' ' ' ILE . 25.4 t -89.4 110.58 21.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 178.057 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.415 ' HA ' ' O ' ' A' ' 47' ' ' ARG . 33.7 mtt85 -97.03 171.82 8.24 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.806 -178.685 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.437 ' CG ' ' H ' ' A' ' 45' ' ' GLU . 1.3 p-10 -104.17 -168.91 1.55 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.602 -178.752 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.1 p -63.01 -22.74 67.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.108 -179.202 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.437 ' H ' ' CG ' ' A' ' 43' ' ' ASP . 9.9 tp10 -89.81 -28.56 19.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.057 0.456 . . . . 0.0 110.073 178.42 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 107.19 19.36 9.51 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.055 -178.151 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.415 ' O ' ' HA ' ' A' ' 42' ' ' ARG . 51.0 mtp180 -89.79 143.99 26.34 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 178.227 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.8 113.74 8.17 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.227 0.537 . . . . 0.0 110.709 178.391 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 58.0 t -98.83 -33.46 4.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.135 178.459 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 73.3 t-105 -153.0 157.44 40.55 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.989 -176.361 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.417 HH11 ' HD2' ' A' ' 51' ' ' ARG . 20.6 ptt85 -156.93 146.19 20.33 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 177.917 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -152.95 153.42 32.95 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 177.388 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.633 ' HB2' ' OE1' ' A' ' 56' ' ' GLU . 80.4 m95 -77.39 -92.66 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.05 0.452 . . . . 0.0 110.857 -179.048 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.445 ' HA ' ' CZ ' ' A' ' 12' ' ' PHE . 26.7 t-20 -175.58 -37.78 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.385 -177.889 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -86.0 -15.04 42.72 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -169.136 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.633 ' OE1' ' HB2' ' A' ' 53' ' ' TRP . 2.4 mp0 -62.88 137.16 96.8 Favored Pre-proline 0 C--N 1.327 -0.408 0 N-CA-C 110.321 -0.251 . . . . 0.0 110.321 -179.236 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.514 ' HA ' ' HG3' ' A' ' 11' ' ' PRO . 43.2 Cg_endo -68.59 5.35 1.31 Allowed 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.879 2.386 . . . . 0.0 112.917 -177.916 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -138.6 12.24 2.73 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.465 177.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.52 ' HB2' ' HB2' ' A' ' 56' ' ' GLU . . . -62.31 -43.35 99.02 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-O 121.239 0.542 . . . . 0.0 110.738 -172.773 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -68.03 -29.72 73.63 Favored Glycine 0 N--CA 1.442 -0.936 0 CA-C-N 115.346 -0.843 . . . . 0.0 112.301 179.215 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -72.44 -29.51 63.76 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 120.494 -0.483 . . . . 0.0 109.719 -178.421 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -68.57 -41.87 82.8 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.573 -0.822 . . . . 0.0 111.077 176.818 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 57.7 mt -64.16 -47.8 78.46 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.906 0.384 . . . . 0.0 110.143 176.363 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 9.5 m-20 -61.9 -29.2 70.05 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.953 177.067 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 36.0 ttm180 -65.73 -37.99 87.94 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.191 179.41 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -70.39 -50.3 40.17 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 174.203 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 99.0 mt -53.83 -35.97 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.068 179.097 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 50.0 ttt180 -49.72 -32.44 13.5 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -176.548 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.408 ' O ' ' HB2' ' A' ' 70' ' ' SER . 41.0 p -56.26 -38.37 71.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.038 0.447 . . . . 0.0 111.147 -178.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.408 ' HB2' ' O ' ' A' ' 69' ' ' THR . 37.2 t 167.32 -38.13 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 114.914 -1.039 . . . . 0.0 108.997 -174.838 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 84.12 147.34 8.05 Favored Glycine 0 N--CA 1.447 -0.628 0 CA-C-N 115.416 -0.811 . . . . 0.0 112.264 -178.59 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.466 ' O ' HG22 ' A' ' 72' ' ' ILE . 38.9 mm -83.29 6.7 1.69 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-O 121.672 0.749 . . . . 0.0 110.161 -178.991 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.476 ' HB3' ' CE2' ' A' ' 24' ' ' TYR . 16.1 ptt-85 . . . . . 0 N--CA 1.466 0.359 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.74 178.061 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.555 ' HA2' ' HA ' ' A' ' 58' ' ' ASP . . . . . . . . 0 N--CA 1.451 -0.304 0 CA-C-O 119.795 -0.447 . . . . 0.0 113.024 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -67.59 154.66 72.87 Favored 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 122.512 2.141 . . . . 0.0 112.396 177.662 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.479 ' CD2' ' HB2' ' A' ' 17' ' ' ALA . 15.9 p90 -126.79 -172.14 2.57 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.968 -176.682 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.52 ' OG1' ' HG2' ' A' ' 16' ' ' GLN . 31.9 p -125.47 176.13 7.03 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 172.933 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.524 ' HG2' HD11 ' A' ' 29' ' ' LEU . 45.1 mtm180 -65.38 -43.83 89.45 Favored 'General case' 0 C--O 1.219 -0.52 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.332 173.53 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 16.7 mtp180 -56.94 -46.97 81.71 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.933 179.174 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.554 ' O ' HG23 ' A' ' 20' ' ' VAL . 10.6 mm100 -64.37 -49.89 69.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.962 178.499 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.479 ' HB2' ' CD2' ' A' ' 12' ' ' PHE . . . -56.24 -49.05 75.26 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.768 179.339 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.443 ' HG2' ' O ' ' A' ' 14' ' ' ARG . 15.2 mm100 -55.28 -38.6 68.83 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.432 -178.54 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.11 -25.67 66.32 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.656 178.885 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 16' ' ' GLN . 31.3 t -91.61 -16.88 7.85 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.721 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 -173.731 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.537 HG23 ' HB ' ' A' ' 27' ' ' ILE . 6.2 m -93.74 -27.02 16.74 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-N 113.839 -1.528 . . . . 0.0 107.612 -177.623 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.9 m -65.07 -35.55 81.51 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 113.636 -1.62 . . . . 0.0 108.943 165.097 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 41.6 m -74.57 -55.93 5.38 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.559 177.073 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.66 ' HB3' ' OD1' ' A' ' 26' ' ' ASN . 63.9 m-85 -114.21 104.13 11.79 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-O 121.097 0.475 . . . . 0.0 109.839 178.71 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.3 p -69.72 -6.52 32.37 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.309 -179.629 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.66 ' OD1' ' HB3' ' A' ' 24' ' ' TYR . 7.6 p-10 -79.5 -8.83 59.42 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.167 0.508 . . . . 0.0 109.723 175.459 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.561 HG13 ' HB2' ' A' ' 24' ' ' TYR . 4.2 mt -88.19 157.42 3.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 172.834 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -153.37 130.82 11.36 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.639 -0.424 . . . . 0.0 111.298 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.526 ' HA ' HD23 ' A' ' 39' ' ' LEU . 6.5 tt -90.01 111.11 22.09 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -178.334 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -123.97 170.94 10.12 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.141 -178.552 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.8 t70 61.85 30.17 18.13 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.432 -0.803 . . . . 0.0 110.061 -178.319 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -63.18 99.33 0.17 Allowed 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.505 -177.835 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -112.74 -6.98 13.83 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.242 176.461 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.419 ' HA2' ' NH1' ' A' ' 14' ' ' ARG . . . 129.74 -102.42 0.55 Allowed Glycine 0 N--CA 1.448 -0.518 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.036 -177.399 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 37.2 m -79.3 -19.68 49.87 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 172.309 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -93.13 120.38 33.37 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.715 173.352 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.429 ' HE2' ' HE2' ' A' ' 12' ' ' PHE . 35.6 p90 -174.8 165.93 3.66 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 176.007 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.427 HH11 ' HD3' ' A' ' 38' ' ' ARG . 13.8 ptt180 -142.17 142.95 32.75 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.093 0.473 . . . . 0.0 110.774 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.526 HD23 ' HA ' ' A' ' 29' ' ' LEU . 82.0 mt -95.68 121.65 37.61 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.193 0.52 . . . . 0.0 110.375 179.819 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 41.4 t -98.46 115.14 37.98 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.632 178.021 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.0 t -96.69 118.63 43.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 121.122 0.487 . . . . 0.0 110.11 -177.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.478 ' HA ' ' O ' ' A' ' 47' ' ' ARG . 39.1 mtm105 -103.08 168.8 8.95 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.485 -178.466 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.475 ' CG ' ' H ' ' A' ' 45' ' ' GLU . 0.5 OUTLIER -96.09 -167.91 1.66 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.037 -0.528 . . . . 0.0 109.986 178.505 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 23.2 p -64.01 -26.17 68.45 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.317 -178.581 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.554 ' HB3' ' HD2' ' A' ' 47' ' ' ARG . 9.1 tp10 -95.84 -13.0 24.37 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 121.18 0.515 . . . . 0.0 110.433 -177.044 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 104.63 15.28 21.24 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.575 179.278 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.554 ' HD2' ' HB3' ' A' ' 45' ' ' GLU . 0.0 OUTLIER -78.0 128.54 34.04 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 178.448 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 63.1 mtm -74.27 99.89 3.58 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 177.019 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 23.7 t -86.92 -33.45 6.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.641 -174.741 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.424 ' CD1' HD23 ' A' ' 63' ' ' LEU . 75.5 t-105 -153.72 150.78 28.89 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.486 -173.838 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 16.0 ptt180 -156.09 141.24 17.42 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 174.811 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -142.92 153.49 43.14 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.415 -178.702 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.515 ' HB2' ' HG2' ' A' ' 56' ' ' GLU . 98.0 m95 -75.62 -167.41 0.68 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.643 0.735 . . . . 0.0 111.73 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -103.98 -40.88 6.04 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.746 -1.115 . . . . 0.0 111.413 -177.755 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 13.8 p90 -83.24 10.27 8.82 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.82 -174.319 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.642 ' HB2' ' HB2' ' A' ' 59' ' ' ALA . 11.9 mm-40 -77.55 131.75 70.56 Favored Pre-proline 0 C--N 1.324 -0.538 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 177.676 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 56' ' ' GLU . 52.1 Cg_exo -55.39 -21.26 28.99 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 123.493 2.795 . . . . 0.0 113.217 -176.487 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.555 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . 4.2 p30 -136.86 38.34 2.59 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.77 0.319 . . . . 0.0 110.621 177.476 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.642 ' HB2' ' HB2' ' A' ' 56' ' ' GLU . . . -55.0 -52.75 62.16 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 121.22 0.533 . . . . 0.0 111.36 -174.344 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.424 ' HA2' HD12 ' A' ' 63' ' ' LEU . . . -67.7 -28.62 73.51 Favored Glycine 0 N--CA 1.44 -1.091 0 CA-C-N 115.422 -0.808 . . . . 0.0 112.729 -178.024 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -68.15 -35.88 78.77 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 117.139 0.469 . . . . 0.0 110.407 -176.605 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -68.49 -42.46 81.38 Favored Glycine 0 CA--C 1.519 0.299 0 C-N-CA 120.645 -0.788 . . . . 0.0 111.305 175.072 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.462 ' O ' HG13 ' A' ' 67' ' ' ILE . 49.7 mt -61.05 -47.47 86.21 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.994 -0.372 . . . . 0.0 109.994 176.014 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.508 ' HA ' ' HB ' ' A' ' 67' ' ' ILE . 94.0 m-20 -63.57 -29.29 70.57 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.791 177.679 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 6.4 ttt180 -58.93 -39.66 82.25 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 177.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -76.88 -46.59 24.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.505 173.897 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.508 ' HB ' ' HA ' ' A' ' 64' ' ' ASN . 93.7 mt -53.41 -46.16 58.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.681 -178.378 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 47.6 ttt85 -57.69 -36.56 72.12 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.948 -176.759 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.5 p -105.4 20.81 18.26 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -176.148 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 15.0 m -139.16 -57.31 0.6 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.688 0.28 . . . . 0.0 110.841 178.545 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 40.1 77.71 0.07 OUTLIER Glycine 0 CA--C 1.521 0.461 0 CA-C-N 115.189 -0.914 . . . . 0.0 113.512 -175.673 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.513 ' HB ' ' OD1' ' A' ' 26' ' ' ASN . 37.8 mm -82.55 5.73 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 CA-C-O 121.465 0.65 . . . . 0.0 111.317 -171.383 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 30.7 ttt-85 . . . . . 0 C--N 1.328 -0.36 0 CA-C-O 121.072 0.463 . . . . 0.0 111.839 -179.498 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.356 0 CA-C-O 120.257 -0.19 . . . . 0.0 113.007 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.575 ' HD3' ' O ' ' A' ' 57' ' ' PRO . 53.2 Cg_endo -76.07 174.85 12.13 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.443 2.095 . . . . 0.0 112.17 176.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.439 ' CE1' ' HA ' ' A' ' 54' ' ' ASN . 16.5 p90 -126.96 -175.13 3.33 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.089 -177.693 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.517 ' H ' ' HB2' ' A' ' 16' ' ' GLN . 40.6 p -122.27 170.36 9.99 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.891 178.649 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 25.0 ttt85 -59.33 -39.55 83.49 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.246 0.546 . . . . 0.0 110.16 175.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 32.2 mtm180 -66.38 -52.36 47.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.106 177.444 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.623 ' O ' HG23 ' A' ' 20' ' ' VAL . 57.8 mm-40 -56.07 -48.0 76.9 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.862 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.427 ' HB1' HD21 ' A' ' 39' ' ' LEU . . . -49.12 -51.06 34.29 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.994 177.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -54.65 -40.31 68.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.455 179.285 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.17 -25.97 63.7 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.706 0.289 . . . . 0.0 111.745 -176.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.623 HG23 ' O ' ' A' ' 16' ' ' GLN . 15.9 t -89.44 -19.47 7.43 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.734 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 -173.63 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.525 HG23 ' HB ' ' A' ' 27' ' ' ILE . 13.2 m -97.11 -27.89 14.37 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-N 113.826 -1.534 . . . . 0.0 108.619 -175.543 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.8 m -63.63 -37.89 89.06 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 114.356 -1.293 . . . . 0.0 108.963 168.058 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 34.1 m -75.88 -56.68 4.44 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.645 175.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.572 ' O ' HG13 ' A' ' 27' ' ' ILE . 65.1 m-85 -105.78 99.81 9.39 Favored 'General case' 0 N--CA 1.439 -1.019 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 -179.054 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 4.0 p -70.01 -4.6 21.64 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.216 -178.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.531 ' OD1' ' HB3' ' A' ' 24' ' ' TYR . 6.3 p-10 -82.25 -7.42 59.63 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.702 176.123 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.572 HG13 ' O ' ' A' ' 24' ' ' TYR . 1.8 mt -90.25 158.74 2.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 173.43 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -153.39 135.41 14.72 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.721 0.296 . . . . 0.0 111.317 178.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.401 ' HA ' HD23 ' A' ' 39' ' ' LEU . 7.0 tt -90.66 109.76 20.93 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -131.17 176.73 8.02 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.384 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.446 ' HB2' ' HG2' ' A' ' 38' ' ' ARG . 11.9 m-20 61.85 30.82 18.34 Favored 'General case' 0 N--CA 1.467 0.376 0 O-C-N 123.735 0.647 . . . . 0.0 110.908 -178.804 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.585 ' HA ' ' HB3' ' A' ' 37' ' ' PHE . 25.9 t0 -71.13 122.85 20.88 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.619 -175.651 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.541 ' HB3' ' HB2' ' A' ' 36' ' ' HIS . 35.0 tt0 -133.78 18.31 3.87 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.034 178.596 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 113.14 -91.99 0.6 Allowed Glycine 0 N--CA 1.45 -0.393 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.688 -177.507 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.6 t -100.63 -15.33 17.81 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 174.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.541 ' HB2' ' HB3' ' A' ' 33' ' ' GLN . 35.5 m170 -93.1 107.7 19.44 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.417 175.051 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.585 ' HB3' ' HA ' ' A' ' 32' ' ' ASP . 55.3 p90 -163.81 162.17 23.62 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.049 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.544 ' HB3' ' HA ' ' A' ' 53' ' ' TRP . 30.7 ptt180 -138.62 146.15 41.39 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.29 0.567 . . . . 0.0 111.814 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.427 HD21 ' HB1' ' A' ' 17' ' ' ALA . 97.0 mt -91.77 126.15 36.75 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.072 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.466 HG11 ' SD ' ' A' ' 48' ' ' MET . 28.7 t -96.31 109.71 23.35 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.948 178.737 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 91.1 t -81.01 114.54 22.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.536 175.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.463 ' HB3' ' HA2' ' A' ' 46' ' ' GLY . 10.7 mtt180 -106.02 173.02 6.49 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.216 178.134 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.438 ' CG ' ' H ' ' A' ' 45' ' ' GLU . 1.0 OUTLIER -95.65 -167.9 1.68 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.244 -0.434 . . . . 0.0 109.933 177.647 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 10.2 p -60.7 -26.81 67.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.58 -178.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.438 ' H ' ' CG ' ' A' ' 43' ' ' ASP . 36.1 tt0 -91.56 -27.39 18.23 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.337 -179.555 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.463 ' HA2' ' HB3' ' A' ' 42' ' ' ARG . . . 108.39 19.6 8.75 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.526 -0.845 . . . . 0.0 112.836 -178.696 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.429 ' O ' ' HA ' ' A' ' 42' ' ' ARG . 79.3 mtt180 -78.64 143.95 35.87 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 176.142 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.466 ' SD ' HG11 ' A' ' 40' ' ' VAL . 14.3 mmt -66.22 114.28 5.2 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.245 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 43.8 t -103.33 -35.1 3.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 120.741 0.305 . . . . 0.0 110.536 178.001 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 68.4 t-105 -172.3 125.54 0.52 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.968 -174.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 12.3 ptp180 -120.03 125.23 47.82 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.92 0.39 . . . . 0.0 110.232 175.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -125.89 143.25 51.15 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.572 -178.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.698 ' HB2' ' HG2' ' A' ' 56' ' ' GLU . 96.9 m95 -72.13 -174.12 1.2 Allowed 'General case' 0 CA--C 1.513 -0.464 0 CA-C-O 122.079 0.942 . . . . 0.0 112.13 -177.594 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.439 ' HA ' ' CE1' ' A' ' 12' ' ' PHE . 18.9 t-20 -101.9 -43.43 5.8 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 113.825 -1.534 . . . . 0.0 110.879 -176.606 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -83.68 10.64 8.84 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.941 -173.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.698 ' HG2' ' HB2' ' A' ' 53' ' ' TRP . 12.8 mm-40 -75.83 131.12 77.04 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.192 178.713 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.575 ' O ' ' HD3' ' A' ' 11' ' ' PRO . 4.2 Cg_endo -46.74 -37.01 20.39 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 124.01 3.14 . . . . 0.0 113.304 -174.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.566 ' HB3' ' HB2' ' A' ' 61' ' ' GLU . 11.5 m-20 -140.14 63.25 1.48 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.727 0.298 . . . . 0.0 110.249 174.668 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.539 ' HB2' ' HB2' ' A' ' 56' ' ' GLU . . . -61.77 -38.31 87.52 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-O 121.352 0.596 . . . . 0.0 110.572 177.704 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -62.51 -23.68 65.09 Favored Glycine 0 C--O 1.221 -0.691 0 CA-C-N 115.389 -0.823 . . . . 0.0 113.112 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.566 ' HB2' ' HB3' ' A' ' 58' ' ' ASP . 2.5 tm-20 -58.14 -51.9 67.8 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.159 0.504 . . . . 0.0 110.21 -178.297 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -71.84 -39.34 59.71 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.678 -0.772 . . . . 0.0 111.847 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.511 ' O ' HG13 ' A' ' 67' ' ' ILE . 80.4 mt -61.73 -46.46 89.55 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.593 0.235 . . . . 0.0 110.97 179.409 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -65.44 -29.53 70.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.14 -179.308 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.509 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 25.3 ttm105 -66.03 -33.76 76.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.027 176.522 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -73.07 -46.56 50.91 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 119.979 -0.688 . . . . 0.0 109.739 172.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.511 HG13 ' O ' ' A' ' 63' ' ' LEU . 80.3 mt -55.46 -55.59 16.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.342 -178.094 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.607 ' O ' HG22 ' A' ' 69' ' ' THR . 26.0 mmm-85 54.93 27.79 9.65 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 123.119 0.262 . . . . 0.0 111.55 177.516 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.607 HG22 ' O ' ' A' ' 68' ' ' ARG . 9.8 t 61.29 16.69 7.57 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.222 1.409 . . . . 0.0 111.042 176.165 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 13.2 p -113.72 -66.14 1.12 Allowed 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.438 175.498 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.535 ' HA3' ' CE1' ' A' ' 24' ' ' TYR . . . 65.65 179.64 8.97 Favored Glycine 0 N--CA 1.445 -0.765 0 CA-C-N 115.208 -0.906 . . . . 0.0 113.117 179.091 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.453 ' O ' HG22 ' A' ' 72' ' ' ILE . 35.8 mm -91.77 5.9 5.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.808 0.813 . . . . 0.0 110.119 -179.044 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 22.5 tpt180 -60.21 -84.35 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.259 177.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 11.1 m -91.69 -33.43 15.06 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.5 t70 . . . . . 0 N--CA 1.473 0.701 0 O-C-N 124.649 1.218 . . . . 0.0 112.767 178.955 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.613 ' HA3' ' O ' ' A' ' 57' ' ' PRO . . . . . . . . 0 N--CA 1.441 -0.997 0 N-CA-C 111.325 -0.71 . . . . 0.0 111.325 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -73.33 132.92 18.45 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 121.494 1.462 . . . . 0.0 110.66 174.394 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 34.8 p90 -104.97 -171.7 1.96 Allowed 'General case' 0 C--N 1.31 -1.137 0 CA-C-O 121.703 0.763 . . . . 0.0 112.452 -173.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.89 156.44 36.26 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.924 -1.035 . . . . 0.0 109.2 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 22.5 ttt85 -61.6 -49.27 77.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.057 0.456 . . . . 0.0 110.346 -179.039 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.419 HH11 ' HD2' ' A' ' 15' ' ' ARG . 30.7 mtp180 -52.22 -47.97 65.36 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.338 -0.847 . . . . 0.0 111.2 175.63 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.595 ' O ' HG23 ' A' ' 20' ' ' VAL . 84.1 mm-40 -58.0 -48.73 79.15 Favored 'General case' 0 C--O 1.226 -0.173 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.374 176.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -55.45 -46.09 76.8 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.319 -179.344 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 27.2 mm-40 -56.79 -41.65 78.07 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.529 -178.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.17 -23.26 67.06 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-O 121.181 0.515 . . . . 0.0 111.55 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.595 HG23 ' O ' ' A' ' 16' ' ' GLN . 5.0 t -90.6 -20.98 6.74 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.803 0 N-CA-C 107.227 -1.398 . . . . 0.0 107.227 -175.52 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.2 m -83.8 -31.73 25.73 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 114.084 -1.416 . . . . 0.0 110.243 179.446 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 15.6 p -70.41 -32.29 69.85 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 173.183 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 16.7 m -79.91 -49.06 12.45 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.756 175.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.707 ' O ' HG13 ' A' ' 27' ' ' ILE . 33.6 m-85 -115.12 96.9 5.91 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 175.322 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 37.9 m -83.33 16.17 2.63 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.035 0.445 . . . . 0.0 111.628 -174.285 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.44 ' OD1' ' HB3' ' A' ' 24' ' ' TYR . 21.5 p-10 -91.29 -17.4 26.0 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 169.543 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.707 HG13 ' O ' ' A' ' 24' ' ' TYR . 2.5 mt -72.55 147.46 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 CA-C-N 115.182 -0.917 . . . . 0.0 108.542 175.689 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.518 ' O ' ' HA ' ' A' ' 39' ' ' LEU . 14.5 p -141.95 144.45 33.74 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.712 -175.635 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.5 tt -101.15 108.62 20.34 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -113.77 162.5 16.22 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.83 179.054 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.578 ' O ' ' HA ' ' A' ' 37' ' ' PHE . 3.2 m-20 57.26 70.72 0.63 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.999 -1.001 . . . . 0.0 112.062 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -77.18 75.58 3.74 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.147 174.146 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.529 ' HB2' ' HB2' ' A' ' 36' ' ' HIS . 16.2 mm-40 -103.61 21.21 16.53 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.133 0.492 . . . . 0.0 109.981 -179.659 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.72 -93.06 1.64 Allowed Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 121.08 -0.581 . . . . 0.0 112.296 178.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 27.2 t -75.4 -29.55 59.84 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.397 0.617 . . . . 0.0 109.883 178.064 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.529 ' HB2' ' HB2' ' A' ' 33' ' ' GLN . 26.8 m-70 -101.84 107.54 18.75 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.79 177.6 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.578 ' HA ' ' O ' ' A' ' 31' ' ' ASP . 45.9 p90 -148.62 146.66 28.31 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 173.54 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 37.5 ptt85 -127.92 152.1 48.28 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.316 0.579 . . . . 0.0 112.314 -173.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.518 ' HA ' ' O ' ' A' ' 28' ' ' THR . 86.2 mt -108.88 132.6 53.88 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.891 175.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.439 ' HB ' ' OG1' ' A' ' 28' ' ' THR . 41.2 t -114.53 118.81 59.72 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.717 -179.032 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 93.5 t -89.46 114.83 28.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.654 176.515 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.469 ' HA ' ' O ' ' A' ' 47' ' ' ARG . 49.2 mtp180 -104.15 164.2 11.88 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.932 177.657 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.452 ' CG ' ' H ' ' A' ' 45' ' ' GLU . 1.7 p-10 -102.9 -166.04 1.23 Allowed 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 110.325 -0.25 . . . . 0.0 110.325 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 25.6 p -66.62 -22.96 66.11 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 120.92 0.39 . . . . 0.0 111.893 179.353 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.452 ' H ' ' CG ' ' A' ' 43' ' ' ASP . 8.6 tp10 -86.98 -21.61 26.07 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.239 0.543 . . . . 0.0 109.574 178.159 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 101.17 5.23 53.11 Favored Glycine 0 N--CA 1.444 -0.808 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.08 179.409 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.469 ' O ' ' HA ' ' A' ' 42' ' ' ARG . 88.0 mtt180 -72.23 146.87 47.0 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 -178.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -74.06 103.09 4.4 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 176.317 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 57.4 t -77.96 -40.67 26.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.991 179.602 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 76.1 t-105 -164.17 142.13 7.08 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.819 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.417 HH11 ' HD3' ' A' ' 51' ' ' ARG . 14.9 ptt-85 -141.78 138.68 32.44 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 177.477 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -143.97 156.47 44.42 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.354 -177.416 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 92.8 m95 -88.52 -161.6 0.76 Allowed 'General case' 0 N--CA 1.447 -0.615 0 CA-C-O 121.423 0.63 . . . . 0.0 110.474 -179.297 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -106.23 -33.93 7.66 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.274 -176.364 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -81.45 3.53 24.32 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 -173.577 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.523 ' HB2' ' HB2' ' A' ' 59' ' ' ALA . 37.1 mt-10 -80.19 129.22 70.58 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.463 -178.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.613 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 31.3 Cg_exo -62.16 -10.37 17.94 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 123.396 2.731 . . . . 0.0 114.009 -172.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.519 ' HA ' ' CA ' ' A' ' 10' ' ' GLY . 24.0 p-10 -143.01 34.02 1.36 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.761 0.315 . . . . 0.0 110.794 177.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.523 ' HB2' ' HB2' ' A' ' 56' ' ' GLU . . . -55.75 -40.96 73.25 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.994 -178.839 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -62.8 -39.33 97.85 Favored Glycine 0 N--CA 1.443 -0.878 0 CA-C-N 115.826 -0.624 . . . . 0.0 112.381 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -66.02 -23.1 66.49 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.886 0.343 . . . . 0.0 111.721 -177.321 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -75.5 -49.23 9.39 Favored Glycine 0 C--O 1.24 0.477 0 C-N-CA 120.286 -0.959 . . . . 0.0 111.085 175.035 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.427 ' O ' HG13 ' A' ' 67' ' ' ILE . 50.0 mt -63.24 -43.35 98.29 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.273 0.559 . . . . 0.0 109.833 177.625 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 8.8 m-20 -69.16 -20.43 64.02 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.189 178.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 6.8 tmm_? -65.93 -41.36 91.48 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 173.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.438 ' CE1' ' HA2' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -67.97 -42.9 80.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.425 175.018 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.427 HG13 ' O ' ' A' ' 63' ' ' LEU . 62.9 mt -67.74 -26.75 35.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.257 -178.837 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -59.9 -33.37 71.76 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.138 -178.257 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.449 ' O ' ' HB2' ' A' ' 70' ' ' SER . 4.5 t -101.73 66.48 1.06 Allowed 'General case' 0 N--CA 1.442 -0.838 0 CA-C-O 121.825 0.822 . . . . 0.0 109.526 179.015 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.449 ' HB2' ' O ' ' A' ' 69' ' ' THR . 63.2 m 80.37 -51.7 0.35 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 114.211 -1.359 . . . . 0.0 112.808 171.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.438 ' HA2' ' CE1' ' A' ' 66' ' ' TYR . . . 79.15 -174.04 55.29 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.633 -0.794 . . . . 0.0 111.271 -170.596 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.487 ' O ' HG22 ' A' ' 72' ' ' ILE . 47.5 mm -101.35 7.0 9.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-O 121.896 0.855 . . . . 0.0 110.341 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.54 ' HB3' ' CE2' ' A' ' 24' ' ' TYR . 14.6 ptm180 -55.43 -11.02 0.72 Allowed 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.423 -0.808 . . . . 0.0 113.103 -178.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 2.8 m -61.3 -10.03 6.3 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.955 0.407 . . . . 0.0 110.439 176.452 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 9.1 t0 . . . . . 0 CA--C 1.515 -0.393 0 CA-C-O 121.3 0.571 . . . . 0.0 109.75 -178.959 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.425 ' HA3' ' HD3' ' A' ' 11' ' ' PRO . . . . . . . . 0 N--CA 1.463 0.473 0 N-CA-C 113.966 0.346 . . . . 0.0 113.966 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.425 ' HD3' ' HA3' ' A' ' 10' ' ' GLY . 7.7 Cg_exo -70.53 139.09 36.79 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.775 2.317 . . . . 0.0 111.053 176.411 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -104.9 -175.15 2.71 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.493 0.663 . . . . 0.0 112.134 -173.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.46 ' H ' ' HB2' ' A' ' 16' ' ' GLN . 1.7 m -126.05 164.22 21.33 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-N 114.342 -1.299 . . . . 0.0 109.742 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.543 ' HA ' ' CZ ' ' A' ' 37' ' ' PHE . 48.3 ttt85 -51.49 -55.78 17.0 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 122.64 0.376 . . . . 0.0 111.351 -179.038 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 43.5 mtp180 -56.53 -45.57 81.08 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.464 177.453 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.572 ' O ' HG23 ' A' ' 20' ' ' VAL . 1.9 mp0 -59.2 -46.92 87.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.943 -179.69 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.505 ' HB1' HD11 ' A' ' 39' ' ' LEU . . . -57.44 -44.18 84.5 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 121.086 0.47 . . . . 0.0 111.17 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 58.2 mt-30 -55.28 -41.75 72.69 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.024 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.49 -23.96 66.33 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.739 -178.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.572 HG23 ' O ' ' A' ' 16' ' ' GLN . 10.4 t -90.83 -19.76 7.07 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.687 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 -172.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.526 HG23 ' HB ' ' A' ' 27' ' ' ILE . 10.8 m -95.86 -28.79 14.54 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 114.055 -1.429 . . . . 0.0 108.417 -176.036 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 54.8 m -63.45 -36.63 84.4 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 114.083 -1.417 . . . . 0.0 108.939 167.097 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.585 HG23 HH11 ' A' ' 73' ' ' ARG . 90.8 m -76.21 -54.4 6.85 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.376 175.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.569 ' HB2' HG13 ' A' ' 27' ' ' ILE . 51.1 m-85 -110.64 102.7 11.25 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-O 121.087 0.47 . . . . 0.0 109.796 179.144 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 6.1 p -75.62 2.17 12.56 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.376 -177.517 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.453 ' OD1' ' HB3' ' A' ' 24' ' ' TYR . 6.1 p-10 -87.71 -8.3 56.25 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.572 173.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.569 HG13 ' HB2' ' A' ' 24' ' ' TYR . 2.9 mt -83.08 150.27 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 172.55 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.409 ' O ' ' HA ' ' A' ' 39' ' ' LEU . 1.1 p -141.43 135.94 30.85 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 120.912 -0.315 . . . . 0.0 110.785 -178.011 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 5.0 tt -94.64 107.16 19.16 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -178.032 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -119.07 164.66 15.18 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.753 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.482 ' HB2' ' HG2' ' A' ' 38' ' ' ARG . 90.5 m-20 56.71 42.39 26.92 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.6 0.715 . . . . 0.0 110.462 -175.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -74.6 103.38 4.89 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.913 -177.448 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -103.43 -19.73 14.31 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 173.397 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 126.03 -80.54 0.36 Allowed Glycine 0 N--CA 1.449 -0.469 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.405 -177.293 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.8 t -72.21 -35.6 68.94 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.262 0.553 . . . . 0.0 109.623 174.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 40.0 m80 -109.34 139.26 44.51 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.783 178.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.543 ' CZ ' ' HA ' ' A' ' 14' ' ' ARG . 55.6 p90 -174.23 164.04 3.91 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 176.748 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.482 ' HG2' ' HB2' ' A' ' 31' ' ' ASP . 29.3 ptt85 -128.68 144.83 51.25 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.205 0.526 . . . . 0.0 111.191 177.539 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.505 HD11 ' HB1' ' A' ' 17' ' ' ALA . 86.0 mt -99.18 127.1 45.1 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.934 176.322 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 27.5 t -103.7 119.93 53.05 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.529 177.041 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.409 HG11 ' CD2' ' A' ' 66' ' ' TYR . 16.3 t -91.19 108.76 20.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.214 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 33.9 mtt85 -105.19 168.15 9.26 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.038 -177.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.628 ' OD1' ' HG2' ' A' ' 47' ' ' ARG . 7.6 p-10 -104.02 -164.57 1.07 Allowed 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.616 179.182 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -66.17 -17.11 64.51 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -91.98 -24.32 19.28 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.477 0.656 . . . . 0.0 109.821 179.263 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 99.32 7.78 53.93 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.745 -0.741 . . . . 0.0 111.575 -179.062 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.628 ' HG2' ' OD1' ' A' ' 43' ' ' ASP . 15.9 ptt180 -78.35 150.46 33.21 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 177.565 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 23.3 ptp -79.12 116.86 19.67 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.309 0.576 . . . . 0.0 110.01 178.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 41.4 t -98.26 -31.94 3.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-O 121.478 0.656 . . . . 0.0 109.322 176.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 75.2 t-105 -155.11 155.76 34.59 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.53 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 16.7 ptt180 -158.5 142.66 15.67 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 175.618 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -150.55 147.92 28.04 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.214 -179.4 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.561 ' HB2' ' HG2' ' A' ' 56' ' ' GLU . 65.0 m95 -80.92 -176.73 6.05 Favored 'General case' 0 CA--C 1.509 -0.627 0 CA-C-O 122.15 0.976 . . . . 0.0 111.371 177.788 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -82.82 -31.54 28.06 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 113.465 -1.698 . . . . 0.0 110.079 -178.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -97.04 8.65 44.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.58 -0.737 . . . . 0.0 112.325 -173.407 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.664 ' HB2' ' HB2' ' A' ' 59' ' ' ALA . 38.9 mm-40 -71.02 128.14 90.9 Favored Pre-proline 0 C--N 1.328 -0.354 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 179.118 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -49.28 -37.45 40.04 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 124.074 3.182 . . . . 0.0 113.904 -173.276 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -131.15 43.82 3.04 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.143 0.497 . . . . 0.0 110.248 178.667 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.664 ' HB2' ' HB2' ' A' ' 56' ' ' GLU . . . -51.4 -45.36 62.48 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.545 -177.234 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -59.04 -38.63 93.25 Favored Glycine 0 N--CA 1.446 -0.646 0 CA-C-N 115.433 -0.803 . . . . 0.0 113.163 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 22.1 tp10 -60.06 -38.78 83.84 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.873 0.337 . . . . 0.0 110.996 -175.414 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -68.84 -43.54 73.79 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.33 -0.938 . . . . 0.0 111.021 177.399 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.438 ' O ' HG13 ' A' ' 67' ' ' ILE . 57.5 mt -58.52 -47.6 83.61 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.324 -0.438 . . . . 0.0 109.867 176.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 64.7 m-20 -59.72 -33.34 71.5 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.698 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.419 HH11 ' HD2' ' A' ' 65' ' ' ARG . 9.5 tpp85 -70.07 -29.58 66.61 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.059 -175.718 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.409 ' CD2' HG11 ' A' ' 41' ' ' VAL . 80.0 t80 -87.45 -42.58 12.7 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.177 -0.609 . . . . 0.0 110.546 172.515 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.696 HG22 ' H ' ' A' ' 69' ' ' THR . 86.1 mt -57.04 -59.89 2.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.884 -179.411 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.516 ' O ' HG22 ' A' ' 69' ' ' THR . 57.1 mtm-85 51.85 30.28 6.9 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.242 0.544 . . . . 0.0 111.213 177.339 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.696 ' H ' HG22 ' A' ' 67' ' ' ILE . 13.2 t 61.55 21.12 11.83 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 126.102 1.761 . . . . 0.0 111.736 174.369 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 55.3 p -112.57 -62.18 1.62 Allowed 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.233 171.146 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 65.26 -175.83 14.02 Favored Glycine 0 N--CA 1.446 -0.69 0 CA-C-N 115.152 -0.931 . . . . 0.0 112.721 177.01 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.455 ' O ' HG22 ' A' ' 72' ' ' ILE . 40.9 mm -101.34 5.82 10.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-O 121.876 0.846 . . . . 0.0 109.35 178.486 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.585 HH11 HG23 ' A' ' 23' ' ' THR . 51.3 ttt180 -58.6 -70.4 0.15 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.376 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 10.0 t -97.06 4.14 51.51 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 178.588 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 32.9 t0 . . . . . 0 N--CA 1.466 0.35 0 CA-C-N 114.304 -1.316 . . . . 0.0 111.543 -176.868 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.612 ' HA2' ' HA ' ' A' ' 58' ' ' ASP . . . . . . . . 0 CA--C 1.523 0.559 0 N-CA-C 113.554 0.181 . . . . 0.0 113.554 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.474 ' HD3' ' HA3' ' A' ' 10' ' ' GLY . 3.3 Cg_exo -81.31 170.85 14.38 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 123.371 2.714 . . . . 0.0 112.29 177.246 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 15.2 p90 -122.27 -173.85 2.77 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.015 0.436 . . . . 0.0 111.48 -176.505 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.48 ' H ' ' HB2' ' A' ' 16' ' ' GLN . 62.5 p -125.16 179.64 4.97 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.896 178.416 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 29.3 ttt180 -63.99 -41.32 97.55 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 174.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 25.7 ttm180 -58.72 -53.43 58.48 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.625 177.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.584 ' O ' HG23 ' A' ' 20' ' ' VAL . 2.0 mp0 -60.78 -48.61 81.02 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.541 178.192 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -50.26 -54.59 20.17 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.534 179.462 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -57.79 -36.77 72.64 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.191 -0.458 . . . . 0.0 112.11 -179.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.66 -29.48 70.05 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.027 0.441 . . . . 0.0 111.565 -179.164 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.584 HG23 ' O ' ' A' ' 16' ' ' GLN . 11.5 t -88.95 -25.31 5.77 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.827 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 -173.567 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.418 HG23 ' HB ' ' A' ' 27' ' ' ILE . 9.7 m -83.14 -33.51 26.25 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-N 113.909 -1.496 . . . . 0.0 110.994 -179.49 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.1 t -70.44 -25.34 63.16 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 173.126 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 33.6 m -76.0 -56.99 4.15 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.682 169.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.675 ' CE1' ' HA3' ' A' ' 71' ' ' GLY . 34.1 m-85 -113.14 105.72 13.79 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.282 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 31.5 m -86.71 11.6 12.65 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.59 0.709 . . . . 0.0 110.23 -176.476 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.559 ' OD1' ' HB3' ' A' ' 24' ' ' TYR . 7.5 p-10 -88.73 -6.98 57.06 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.917 -1.038 . . . . 0.0 108.748 170.44 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.613 HG13 ' O ' ' A' ' 24' ' ' TYR . 3.6 mt -82.45 142.32 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 172.721 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.0 p -136.05 130.13 33.0 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.748 -0.381 . . . . 0.0 111.095 -174.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.546 ' HA ' HD23 ' A' ' 39' ' ' LEU . 5.4 tt -86.08 117.3 24.83 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.335 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 70.7 mt-10 -123.4 173.3 8.08 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.295 -178.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.493 ' O ' ' HA ' ' A' ' 37' ' ' PHE . 0.4 OUTLIER 55.56 63.62 2.01 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.703 -1.135 . . . . 0.0 111.364 176.747 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -80.8 97.45 7.35 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.022 -179.07 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -106.94 -10.56 15.94 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 171.019 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 111.92 -81.97 0.3 Allowed Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.895 -0.669 . . . . 0.0 111.601 -177.279 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.7 m -76.74 -18.64 58.36 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.32 0.581 . . . . 0.0 110.18 177.375 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 38.3 m-70 -115.84 137.72 51.83 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.949 176.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.493 ' HA ' ' O ' ' A' ' 31' ' ' ASP . 48.6 p90 -167.17 156.94 10.84 Favored 'General case' 0 C--N 1.328 -0.337 0 O-C-N 123.824 0.703 . . . . 0.0 109.334 175.342 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 22.4 ptt180 -128.97 158.13 39.71 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.705 0.288 . . . . 0.0 111.056 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.546 HD23 ' HA ' ' A' ' 29' ' ' LEU . 75.0 mt -113.73 125.02 53.65 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.235 0.541 . . . . 0.0 109.978 174.077 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.51 HG22 ' CB ' ' A' ' 51' ' ' ARG . 61.9 t -103.37 123.97 57.25 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.823 177.03 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.452 HG11 ' CD1' ' A' ' 66' ' ' TYR . 3.1 t -93.92 111.0 24.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -104.47 168.24 9.22 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.963 -178.064 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -97.16 -166.72 1.43 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.637 0.256 . . . . 0.0 110.316 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 12.4 p -70.15 -17.18 63.17 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 111.99 0.366 . . . . 0.0 111.99 -176.148 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.434 ' HB3' ' HG2' ' A' ' 47' ' ' ARG . 23.5 tt0 -93.11 -22.69 18.95 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.002 0.43 . . . . 0.0 109.92 179.149 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 105.81 14.01 22.32 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.807 -0.711 . . . . 0.0 111.769 -178.043 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.434 ' HG2' ' HB3' ' A' ' 45' ' ' GLU . 14.9 mmt180 -76.74 124.93 28.41 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 178.535 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -69.09 106.07 2.67 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.133 0.492 . . . . 0.0 109.984 176.183 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 41.2 t -92.55 -33.11 5.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.444 -177.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 69.1 t-105 -156.4 149.17 23.84 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.893 -175.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.51 ' CB ' HG22 ' A' ' 40' ' ' VAL . 14.5 ptp180 -146.69 143.48 28.77 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 172.758 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -143.56 147.44 34.44 Favored 'General case' 0 C--N 1.319 -0.717 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 82.8 m95 -82.37 -171.26 3.35 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-O 121.594 0.711 . . . . 0.0 110.637 178.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -98.72 -16.78 18.85 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 114.417 -1.265 . . . . 0.0 110.294 -176.341 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -104.26 4.17 33.48 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.622 -177.111 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.58 ' HB2' ' HB2' ' A' ' 59' ' ' ALA . 20.7 mm-40 -61.26 131.93 92.4 Favored Pre-proline 0 C--O 1.235 0.316 0 CA-C-N 116.641 -0.254 . . . . 0.0 110.525 178.757 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_exo -40.01 -47.65 3.9 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 124.264 3.309 . . . . 0.0 113.243 -176.077 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.612 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . 5.0 t0 -140.22 70.03 1.36 Allowed 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 171.74 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.58 ' HB2' ' HB2' ' A' ' 56' ' ' GLU . . . -55.47 -35.98 66.09 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.823 178.786 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -58.16 -43.1 95.49 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.416 -0.811 . . . . 0.0 112.5 178.533 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.654 ' O ' ' HG3' ' A' ' 65' ' ' ARG . 5.3 tm-20 -58.65 -39.71 81.36 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.696 0.248 . . . . 0.0 111.003 -177.289 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.63 ' O ' ' HB2' ' A' ' 65' ' ' ARG . . . -76.4 -40.61 27.7 Favored Glycine 0 C--N 1.331 0.264 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.126 -178.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.484 ' O ' HG13 ' A' ' 67' ' ' ILE . 77.3 mt -66.26 -40.55 90.25 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 177.152 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -65.6 -26.42 67.83 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.822 177.056 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.654 ' HG3' ' O ' ' A' ' 61' ' ' GLU . 87.7 mtt180 -58.26 -48.91 78.93 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 121.112 0.482 . . . . 0.0 109.804 171.503 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.452 ' CD1' HG11 ' A' ' 41' ' ' VAL . 29.3 t80 -69.44 -48.36 61.13 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.378 178.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.484 HG13 ' O ' ' A' ' 63' ' ' LEU . 80.3 mt -56.86 -58.07 7.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.848 -178.211 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.454 ' O ' HG22 ' A' ' 69' ' ' THR . 13.7 mtm180 57.42 28.2 15.06 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-O 121.045 0.45 . . . . 0.0 110.611 178.003 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.454 HG22 ' O ' ' A' ' 68' ' ' ARG . 11.5 t 52.51 22.76 2.26 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.266 1.427 . . . . 0.0 112.001 -177.521 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 17.0 t -108.25 -64.73 1.19 Allowed 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 172.352 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.675 ' HA3' ' CE1' ' A' ' 24' ' ' TYR . . . 75.38 166.93 20.38 Favored Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.998 176.182 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.559 ' HB ' ' OD1' ' A' ' 26' ' ' ASN . 40.8 mm -87.74 -11.19 10.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 120.664 0.269 . . . . 0.0 111.164 -179.203 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.406 HH11 ' HD3' ' A' ' 73' ' ' ARG . 7.9 ttm180 -49.81 -74.16 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.931 0.396 . . . . 0.0 111.899 -178.323 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.8 m -83.32 2.15 37.61 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.76 0.791 . . . . 0.0 109.472 -177.26 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.556 ' HB3' ' HA ' ' A' ' 72' ' ' ILE . 17.2 t70 . . . . . 0 C--N 1.325 -0.486 0 CA-C-N 115.091 -0.958 . . . . 0.0 110.282 -178.586 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.421 ' HA3' ' HD3' ' A' ' 11' ' ' PRO . . . . . . . . 0 CA--C 1.516 0.127 0 CA-C-O 120.147 -0.252 . . . . 0.0 113.201 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.421 ' HD3' ' HA3' ' A' ' 10' ' ' GLY . 20.8 Cg_exo -64.75 153.05 79.71 Favored 'Trans proline' 0 C--O 1.234 0.314 0 C-N-CA 122.88 2.387 . . . . 0.0 111.704 177.633 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 16.8 p90 -120.32 -171.69 2.21 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.053 -176.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.484 ' H ' ' HB2' ' A' ' 16' ' ' GLN . 46.1 p -125.02 171.65 10.07 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.84 179.225 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.479 ' O ' ' HG3' ' A' ' 18' ' ' GLN . 43.1 ttt180 -55.8 -45.86 78.15 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.651 0.739 . . . . 0.0 109.773 174.385 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -63.5 -50.27 70.29 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.765 -1.107 . . . . 0.0 111.772 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.586 ' O ' HG23 ' A' ' 20' ' ' VAL . 1.5 mp0 -58.78 -44.59 90.71 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.692 -0.231 . . . . 0.0 110.689 179.188 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -52.29 -49.0 65.03 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.256 178.245 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.479 ' HG3' ' O ' ' A' ' 14' ' ' ARG . 98.3 mt-30 -56.04 -45.1 79.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.374 -178.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.12 -31.15 70.86 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.079 -176.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.586 HG23 ' O ' ' A' ' 16' ' ' GLN . 8.2 t -87.55 -24.31 6.33 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.881 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 -171.278 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.52 HG23 ' HB ' ' A' ' 27' ' ' ILE . 10.3 m -86.4 -30.94 21.73 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 113.597 -1.638 . . . . 0.0 110.698 -178.389 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.6 p -68.56 -28.25 66.8 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 170.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 20.7 m -76.95 -56.79 4.28 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.089 172.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.627 ' HB3' ' OD1' ' A' ' 26' ' ' ASN . 79.0 m-85 -109.59 103.41 12.27 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 121.259 0.552 . . . . 0.0 109.948 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 6.0 p -71.72 -3.9 24.51 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.492 -0.776 . . . . 0.0 112.134 -178.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.627 ' OD1' ' HB3' ' A' ' 24' ' ' TYR . 25.6 p-10 -80.05 -16.68 54.54 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 174.405 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.548 HG13 ' O ' ' A' ' 24' ' ' TYR . 2.4 mt -76.72 146.63 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 173.793 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.535 ' OG1' ' HB ' ' A' ' 40' ' ' VAL . 1.6 p -141.59 123.26 15.16 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.013 0.435 . . . . 0.0 111.007 -177.798 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.465 ' CD2' ' HB3' ' A' ' 32' ' ' ASP . 6.5 tt -80.69 99.73 8.34 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 178.742 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 52.7 mm-40 -118.81 166.96 12.16 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.561 -177.119 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 58.97 34.63 23.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.347 -175.539 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.55 ' HA ' ' HB3' ' A' ' 37' ' ' PHE . 5.7 p-10 -68.03 99.8 0.91 Allowed 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.274 -0.876 . . . . 0.0 111.514 -178.152 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -104.97 9.21 34.61 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.018 176.548 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 125.06 -94.37 0.46 Allowed Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.409 -177.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.3 t -101.45 -13.38 17.97 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 173.304 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 13.9 m-70 -94.27 111.69 23.45 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.298 174.301 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.55 ' HB3' ' HA ' ' A' ' 32' ' ' ASP . 47.4 p90 -163.83 171.56 15.3 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -179.239 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.527 ' HA ' ' HA ' ' A' ' 53' ' ' TRP . 16.6 ptt-85 -130.79 144.63 51.58 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.083 0.468 . . . . 0.0 110.539 175.153 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.463 HD23 ' HA ' ' A' ' 29' ' ' LEU . 95.1 mt -95.33 117.12 29.75 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.532 176.346 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.535 ' HB ' ' OG1' ' A' ' 28' ' ' THR . 38.3 t -92.14 119.99 40.57 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.832 178.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.462 HG11 ' CD1' ' A' ' 66' ' ' TYR . 4.9 t -92.2 116.45 33.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 178.336 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 59.2 mtm180 -99.32 166.74 11.06 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.435 -178.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.639 ' OD1' ' HG2' ' A' ' 47' ' ' ARG . 9.7 p-10 -100.28 -166.71 1.36 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.23 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.83 -17.94 64.99 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.792 -179.185 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -89.32 -29.03 19.45 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -179.225 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 102.42 16.69 21.91 Favored Glycine 0 N--CA 1.444 -0.821 0 CA-C-N 115.276 -0.874 . . . . 0.0 112.309 -178.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.639 ' HG2' ' OD1' ' A' ' 43' ' ' ASP . 25.4 ptt180 -93.69 153.1 18.54 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 178.392 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 49.4 mtt -73.33 113.38 10.34 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.397 -178.522 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.455 HG21 ' HB3' ' A' ' 43' ' ' ASP . 46.1 t -97.84 -33.21 4.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 121.105 0.479 . . . . 0.0 110.264 178.114 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 74.0 t-105 -157.02 154.64 29.91 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.087 -177.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.412 ' HB2' ' HD2' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -151.13 140.46 21.38 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 174.366 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -141.51 143.75 33.96 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 177.401 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.531 ' HB2' ' HG2' ' A' ' 56' ' ' GLU . 69.2 m95 -80.23 -173.82 4.21 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 121.721 0.772 . . . . 0.0 111.069 -179.122 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -90.22 -28.32 18.93 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 114.008 -1.451 . . . . 0.0 110.089 -175.227 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 13.5 p90 -101.55 15.85 27.57 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.21 -0.904 . . . . 0.0 112.075 -173.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.531 ' HG2' ' HB2' ' A' ' 53' ' ' TRP . 19.3 mm-40 -77.87 135.23 63.62 Favored Pre-proline 0 C--N 1.323 -0.571 0 C-N-CA 121.232 -0.187 . . . . 0.0 110.828 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_exo -38.77 -46.67 2.66 Favored 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 124.637 3.558 . . . . 0.0 113.966 -173.417 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -145.33 67.8 1.23 Allowed 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 172.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.53 ' HB2' ' HB2' ' A' ' 56' ' ' GLU . . . -56.2 -36.12 68.06 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 115.263 -0.881 . . . . 0.0 111.232 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -57.0 -36.23 72.8 Favored Glycine 0 N--CA 1.447 -0.633 0 CA-C-N 115.486 -0.779 . . . . 0.0 113.78 -178.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.416 ' CD ' HH21 ' A' ' 65' ' ' ARG . 1.2 tm-20 -56.73 -49.15 76.07 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 117.211 0.505 . . . . 0.0 110.83 -176.472 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -70.21 -43.26 64.23 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.341 -177.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.546 ' O ' HG13 ' A' ' 67' ' ' ILE . 52.6 mt -66.39 -52.3 48.22 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.866 -0.167 . . . . 0.0 110.766 -178.418 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.666 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 87.9 m-20 -58.72 -40.76 84.65 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.717 -179.481 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.416 HH21 ' CD ' ' A' ' 61' ' ' GLU . 19.0 ttm180 -51.63 -50.99 59.2 Favored 'General case' 0 C--O 1.233 0.192 0 O-C-N 123.643 0.589 . . . . 0.0 110.446 178.504 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.462 ' CD1' HG11 ' A' ' 41' ' ' VAL . 44.5 t80 -63.36 -43.25 98.2 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.352 179.07 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.546 HG13 ' O ' ' A' ' 63' ' ' LEU . 87.4 mt -57.6 -31.49 39.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.927 -0.579 . . . . 0.0 112.329 -177.498 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.666 ' HG2' ' O ' ' A' ' 64' ' ' ASN . 10.7 mmm180 -65.02 -62.08 1.77 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.972 0.415 . . . . 0.0 111.257 -175.852 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 17.7 p -81.57 -26.21 35.18 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.327 -177.192 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 24.7 m -125.91 31.14 5.53 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -169.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.15 116.41 9.05 Favored Glycine 0 CA--C 1.522 0.528 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.099 170.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.455 ' O ' HG22 ' A' ' 72' ' ' ILE . 37.5 mm -93.99 2.6 9.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-O 121.029 0.442 . . . . 0.0 111.339 -171.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.429 ' HG3' ' N ' ' A' ' 74' ' ' THR . 45.0 ptt85 -68.63 -39.85 80.57 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 121.976 -0.453 . . . . 0.0 111.691 -175.598 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.429 ' N ' ' HG3' ' A' ' 73' ' ' ARG . 9.2 t -84.17 -2.63 57.18 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 178.439 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.34 0.188 0 O-C-N 124.894 1.371 . . . . 0.0 113.167 -179.192 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.571 ' HA3' ' HA ' ' A' ' 58' ' ' ASP . . . . . . . . 0 N--CA 1.442 -0.907 0 N-CA-C 111.52 -0.632 . . . . 0.0 111.52 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -76.45 131.67 12.86 Favored 'Trans proline' 0 N--CA 1.45 -1.034 0 C-N-CA 121.776 1.651 . . . . 0.0 111.031 173.264 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 19.8 p90 -98.39 -169.54 1.82 Allowed 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.73 -173.093 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.424 ' HB ' ' OE1' ' A' ' 16' ' ' GLN . 0.2 OUTLIER -122.82 156.51 34.4 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.401 179.425 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 32.1 ttt85 -56.4 -46.19 80.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.331 0.586 . . . . 0.0 110.477 178.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 26.2 ttm180 -53.07 -59.29 4.73 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.981 -1.008 . . . . 0.0 110.842 176.237 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.629 ' O ' HG23 ' A' ' 20' ' ' VAL . 15.9 mp0 -57.4 -44.09 84.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.456 -179.19 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.482 ' HB1' HD11 ' A' ' 39' ' ' LEU . . . -53.54 -45.83 69.96 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 121.248 0.547 . . . . 0.0 111.114 179.542 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -59.91 -36.84 77.83 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.912 179.097 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.74 -24.43 64.45 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.017 177.625 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.629 HG23 ' O ' ' A' ' 16' ' ' GLN . 2.9 t -83.97 -18.68 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 -178.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.623 HG23 ' HB ' ' A' ' 27' ' ' ILE . 0.0 OUTLIER -90.89 -32.15 16.13 Favored 'General case' 0 CA--C 1.506 -0.734 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 177.581 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 76.4 m -56.65 -34.42 67.31 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 113.623 -1.626 . . . . 0.0 109.46 168.432 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.583 HG23 HH11 ' A' ' 73' ' ' ARG . 59.8 m -87.51 -49.31 7.28 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.399 -0.818 . . . . 0.0 111.684 177.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.658 ' HB3' ' OD1' ' A' ' 26' ' ' ASN . 63.7 m-85 -118.71 109.7 16.41 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 121.018 0.437 . . . . 0.0 110.352 -178.828 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 11.8 p -78.72 0.59 26.12 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.663 -177.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.658 ' OD1' ' HB3' ' A' ' 24' ' ' TYR . 25.0 p-10 -82.76 -19.79 37.17 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 175.473 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.623 ' HB ' HG23 ' A' ' 21' ' ' THR . 1.1 mt -77.68 151.32 5.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 177.155 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.562 ' OG1' ' HB ' ' A' ' 40' ' ' VAL . 19.7 p -138.33 128.08 25.15 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.904 0.383 . . . . 0.0 111.119 179.589 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.533 ' HA ' HD23 ' A' ' 39' ' ' LEU . 6.5 tt -86.63 103.24 14.92 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 175.474 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.421 ' O ' ' HB3' ' A' ' 31' ' ' ASP . 53.2 mt-10 -121.74 174.12 7.03 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.929 -176.214 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.421 ' HB3' ' O ' ' A' ' 30' ' ' GLU . 12.4 t70 77.48 -62.9 0.37 Allowed 'General case' 0 N--CA 1.466 0.341 0 O-C-N 124.28 0.987 . . . . 0.0 110.242 -176.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.517 ' HA ' ' HB3' ' A' ' 37' ' ' PHE . 54.1 t0 38.7 78.56 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.554 -1.203 . . . . 0.0 112.99 -177.592 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -105.01 37.01 2.27 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 170.459 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.2 -102.13 2.75 Favored Glycine 0 N--CA 1.448 -0.558 0 CA-C-N 115.142 -0.936 . . . . 0.0 112.126 179.496 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.3 m -82.84 -15.05 53.07 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.229 0.538 . . . . 0.0 110.547 177.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 55.6 m170 -108.33 109.51 20.85 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.901 177.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.517 ' HB3' ' HA ' ' A' ' 32' ' ' ASP . 53.3 p90 -152.92 169.45 22.81 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 177.133 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.471 ' HA ' ' HA ' ' A' ' 53' ' ' TRP . 25.6 ptt-85 -128.45 147.98 50.69 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.181 -0.608 . . . . 0.0 111.556 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.537 ' HA ' ' O ' ' A' ' 28' ' ' THR . 90.5 mt -107.0 117.66 34.65 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.403 173.809 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.562 ' HB ' ' OG1' ' A' ' 28' ' ' THR . 53.0 t -95.11 119.02 42.6 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.135 178.34 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.476 ' HB ' ' HB3' ' A' ' 50' ' ' TRP . 61.4 t -88.79 110.88 21.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 121.106 0.479 . . . . 0.0 109.888 177.828 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.432 ' HA ' ' O ' ' A' ' 47' ' ' ARG . 33.4 mtm180 -98.77 176.66 5.54 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.214 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -94.76 -171.14 2.39 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 173.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.1 t -60.76 -24.08 65.48 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.64 -176.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -91.59 -31.59 15.84 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.924 0.393 . . . . 0.0 110.663 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 120.73 10.36 7.07 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.929 -177.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.432 ' O ' ' HA ' ' A' ' 42' ' ' ARG . 28.9 mmm180 -74.54 133.59 42.26 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 177.49 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.448 ' SD ' HG11 ' A' ' 40' ' ' VAL . 50.8 mtt -79.96 104.06 10.27 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.065 0.46 . . . . 0.0 110.622 -174.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 35.0 t -90.18 -31.62 5.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.339 -177.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.476 ' HB3' ' HB ' ' A' ' 41' ' ' VAL . 76.6 t-105 -151.65 161.12 43.2 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.774 -176.632 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 4.3 ptp180 -159.24 132.81 7.29 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 176.505 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -138.62 141.72 39.12 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.698 -0.228 . . . . 0.0 110.742 -178.319 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.596 ' HB2' ' HG3' ' A' ' 56' ' ' GLU . 84.1 m95 -83.44 -166.05 1.27 Allowed 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 121.54 0.686 . . . . 0.0 110.226 178.654 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.422 HD22 ' C ' ' A' ' 54' ' ' ASN . 0.2 OUTLIER -99.51 -33.05 10.82 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.86 -178.501 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -88.98 10.17 22.45 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.893 -173.548 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.596 ' HG3' ' HB2' ' A' ' 53' ' ' TRP . 26.5 mt-10 -82.29 131.89 54.62 Favored Pre-proline 0 C--N 1.325 -0.489 0 C-N-CA 120.971 -0.292 . . . . 0.0 110.976 -177.811 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_exo -36.17 -53.71 0.95 Allowed 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 124.816 3.677 . . . . 0.0 114.109 -173.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.571 ' HA ' ' HA3' ' A' ' 10' ' ' GLY . 3.3 t70 -137.37 67.02 1.44 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.104 0.478 . . . . 0.0 110.129 174.573 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.0 -33.76 65.17 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.201 176.474 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -61.4 -33.74 85.74 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 121.223 -0.513 . . . . 0.0 113.284 -178.516 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -64.61 -34.97 79.51 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.586 0.232 . . . . 0.0 110.944 -178.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -69.84 -45.74 56.34 Favored Glycine 0 C--O 1.236 0.25 0 C-N-CA 120.396 -0.907 . . . . 0.0 111.201 178.5 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 43.3 mt -61.97 -43.44 98.84 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.381 -0.41 . . . . 0.0 109.932 177.258 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -61.26 -38.33 86.32 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.073 177.489 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 23.3 tpt85 -56.09 -38.95 71.41 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.356 177.334 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.503 ' O ' HG22 ' A' ' 69' ' ' THR . 46.2 t80 -79.04 -49.42 12.71 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.229 177.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 94.6 mt -56.51 -30.5 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -177.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.431 HH11 ' HD2' ' A' ' 68' ' ' ARG . 33.2 ttm180 -59.0 -30.27 67.87 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.433 -179.571 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.503 HG22 ' O ' ' A' ' 66' ' ' TYR . 10.0 t -91.84 62.35 4.33 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 122.003 0.906 . . . . 0.0 110.058 179.141 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.405 ' HB3' ' O ' ' A' ' 69' ' ' THR . 25.3 t 84.35 -37.41 0.06 Allowed 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 114.363 -1.29 . . . . 0.0 112.718 167.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 76.59 164.35 18.83 Favored Glycine 0 CA--C 1.522 0.526 0 C-N-CA 120.285 -0.96 . . . . 0.0 111.977 -174.58 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.483 ' O ' HG22 ' A' ' 72' ' ' ILE . 46.2 mm -101.07 6.0 10.0 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-O 121.79 0.805 . . . . 0.0 111.025 -175.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.583 HH11 HG23 ' A' ' 23' ' ' THR . 21.2 ttt180 -71.35 -29.82 65.43 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 121.257 -0.902 . . . . 0.0 110.881 178.636 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 2.9 m -79.1 11.69 2.65 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.109 178.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 12.1 t70 . . . . . 0 C--O 1.233 0.231 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.028 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.427 ' HA3' ' HD3' ' A' ' 11' ' ' PRO . . . . . . . . 0 CA--C 1.519 0.332 0 CA-C-O 119.936 -0.369 . . . . 0.0 112.94 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.442 ' HG3' ' HA ' ' A' ' 57' ' ' PRO . 16.5 Cg_exo -66.65 142.13 63.01 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.655 2.236 . . . . 0.0 111.812 175.683 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.439 ' HE1' ' HB1' ' A' ' 59' ' ' ALA . 42.9 p90 -112.39 151.46 29.78 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.707 0.765 . . . . 0.0 112.521 -174.755 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.654 ' HB ' ' HG2' ' A' ' 16' ' ' GLN . 0.3 OUTLIER -76.94 156.34 32.07 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 114.422 -1.263 . . . . 0.0 110.788 178.66 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 25.8 ttt180 -61.32 -46.73 89.05 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.796 0.331 . . . . 0.0 110.578 -178.65 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 84.3 mtt-85 -61.29 -36.75 80.94 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.368 176.698 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.654 ' HG2' ' HB ' ' A' ' 13' ' ' THR . 76.3 mm-40 -61.75 -48.84 78.91 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 178.44 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.499 ' HB1' HD21 ' A' ' 39' ' ' LEU . . . -53.58 -44.12 69.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.943 178.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.407 ' HA ' ' OE1' ' A' ' 18' ' ' GLN . 14.7 mm-40 -58.82 -38.05 77.78 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.778 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.43 ' HA ' HG22 ' A' ' 22' ' ' THR . . . -72.68 -25.28 61.2 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.448 -178.34 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.618 HG23 ' O ' ' A' ' 16' ' ' GLN . 10.6 t -87.18 -30.07 5.75 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.96 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 -173.392 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 23.4 m -79.51 -32.3 42.35 Favored 'General case' 0 N--CA 1.435 -1.217 0 CA-C-N 113.478 -1.692 . . . . 0.0 110.935 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.43 HG22 ' HA ' ' A' ' 19' ' ' ALA . 6.5 t -73.33 -23.31 60.23 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 174.237 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 26.9 m -78.93 -57.23 3.85 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.368 171.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.603 ' HB2' HG13 ' A' ' 27' ' ' ILE . 38.5 m-85 -107.9 96.34 6.31 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 178.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 4.6 p -65.4 -5.16 6.83 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.516 -179.09 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.558 ' OD1' ' HB3' ' A' ' 24' ' ' TYR . 28.2 p-10 -79.02 -16.89 56.24 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 173.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.603 HG13 ' HB2' ' A' ' 24' ' ' TYR . 2.6 mt -80.24 150.71 4.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 171.438 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 6.6 p -143.91 124.71 14.21 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.003 178.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.558 ' HA ' HD23 ' A' ' 39' ' ' LEU . 5.8 tt -81.87 98.43 8.51 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 176.546 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -119.48 169.37 10.1 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.129 -0.942 . . . . 0.0 109.659 -174.403 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.0 t70 62.28 26.07 15.6 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.287 0.565 . . . . 0.0 109.982 176.59 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.563 ' HA ' ' HB3' ' A' ' 37' ' ' PHE . 17.8 t70 -68.28 119.9 13.57 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.152 -173.377 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -146.57 52.6 1.11 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.42 177.25 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.25 -101.56 2.22 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.462 177.077 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.9 m -91.43 -3.02 57.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.312 0.577 . . . . 0.0 110.367 178.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 47.8 m80 -115.84 108.09 15.86 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.739 177.256 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.563 ' HB3' ' HA ' ' A' ' 32' ' ' ASP . 53.5 p90 -160.94 160.81 31.27 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.036 178.764 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 68.3 mtm180 -134.03 138.01 45.09 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.26 0.552 . . . . 0.0 111.696 -178.131 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.558 HD23 ' HA ' ' A' ' 29' ' ' LEU . 91.1 mt -92.66 114.27 26.77 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.303 173.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 31.5 t -94.8 111.57 25.77 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.958 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.416 HG11 ' CD1' ' A' ' 66' ' ' TYR . 39.0 t -85.19 117.62 30.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 178.115 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.467 ' O ' ' HB2' ' A' ' 26' ' ' ASN . 63.2 mtp180 -110.35 161.45 15.63 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.258 -177.453 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.489 ' HB3' ' HG3' ' A' ' 47' ' ' ARG . 7.7 t70 -92.56 177.83 6.0 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.572 -177.758 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.427 ' N ' ' CG ' ' A' ' 43' ' ' ASP . 7.0 p -61.28 -22.36 64.78 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 122.59 0.356 . . . . 0.0 111.862 -177.559 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -88.84 -9.74 50.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.427 0.632 . . . . 0.0 109.967 178.193 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 93.79 4.62 63.42 Favored Glycine 0 N--CA 1.451 -0.305 0 CA-C-N 115.767 -0.652 . . . . 0.0 112.994 177.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.489 ' HG3' ' HB3' ' A' ' 43' ' ' ASP . 14.1 ptt180 -73.74 140.75 46.16 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 110.321 -0.252 . . . . 0.0 110.321 177.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 69.1 mtm -71.88 122.16 20.3 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 178.149 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 20.3 t -107.2 -29.84 2.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.611 -178.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.403 ' HB3' ' HB ' ' A' ' 41' ' ' VAL . 73.7 t-105 -157.99 151.54 23.57 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.573 -175.728 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 11.2 ptp180 -152.67 132.87 13.54 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 173.124 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -134.27 149.71 50.95 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.561 -0.291 . . . . 0.0 111.058 -178.299 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.884 ' HB2' ' HG3' ' A' ' 56' ' ' GLU . 86.5 m95 -75.74 -170.11 1.23 Allowed 'General case' 0 CA--C 1.514 -0.434 0 CA-C-O 121.905 0.859 . . . . 0.0 111.498 177.724 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -101.52 -37.76 8.27 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 114.223 -1.353 . . . . 0.0 110.74 178.144 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -88.02 3.69 47.88 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.052 -173.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.884 ' HG3' ' HB2' ' A' ' 53' ' ' TRP . 35.7 mt-10 -74.43 128.91 85.05 Favored Pre-proline 0 N--CA 1.452 -0.372 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.179 178.039 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.442 ' HA ' ' HG3' ' A' ' 11' ' ' PRO . 32.5 Cg_exo -59.25 -14.44 24.34 Favored 'Trans proline' 0 N--CA 1.475 0.414 0 C-N-CA 123.293 2.662 . . . . 0.0 113.668 -175.159 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -133.6 24.95 4.06 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.756 -0.202 . . . . 0.0 111.46 -177.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.599 ' HB2' ' HB2' ' A' ' 56' ' ' GLU . . . -58.66 -48.08 82.28 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.015 0.436 . . . . 0.0 111.209 -174.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -65.14 -28.51 73.63 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.926 -179.128 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -68.02 -40.79 82.89 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.623 0.249 . . . . 0.0 110.532 -177.677 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -66.99 -39.77 93.27 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.51 -0.852 . . . . 0.0 111.291 178.403 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.443 ' O ' HG13 ' A' ' 67' ' ' ILE . 68.9 mt -63.91 -48.85 74.95 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.387 -0.407 . . . . 0.0 110.779 177.855 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.506 ' O ' ' HG3' ' A' ' 68' ' ' ARG . 96.0 m-20 -61.55 -36.71 81.37 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.748 0.309 . . . . 0.0 110.66 178.656 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.418 HH11 ' HD2' ' A' ' 65' ' ' ARG . 20.4 ttt85 -53.59 -42.2 67.37 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.499 176.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.416 ' CD1' HG11 ' A' ' 41' ' ' VAL . 43.3 t80 -72.57 -50.5 25.1 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.382 175.207 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.443 HG13 ' O ' ' A' ' 63' ' ' LEU . 97.1 mt -48.38 -47.67 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 -176.116 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.506 ' HG3' ' O ' ' A' ' 64' ' ' ASN . 15.5 mtp180 -56.78 -54.08 50.48 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -173.759 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.6 t -90.96 10.97 24.34 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 120.691 -0.404 . . . . 0.0 111.175 -174.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 17.1 m -120.44 -61.83 1.53 Allowed 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.208 -0.597 . . . . 0.0 111.12 177.408 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 43.55 74.48 0.2 Allowed Glycine 0 CA--C 1.525 0.701 0 CA-C-N 115.281 -0.872 . . . . 0.0 113.41 -173.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.465 ' O ' HG22 ' A' ' 72' ' ' ILE . 30.2 mm -89.2 6.9 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-O 121.355 0.597 . . . . 0.0 110.973 -174.306 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 35.0 ptt180 -64.2 -35.03 79.47 Favored 'General case' 0 C--N 1.329 -0.298 0 O-C-N 122.068 -0.395 . . . . 0.0 111.814 -175.433 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 15.3 t -77.65 -5.6 50.93 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 177.202 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 17.6 t0 . . . . . 0 CA--C 1.518 -0.266 0 CA-C-O 122.299 1.047 . . . . 0.0 111.679 -172.992 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.48 ' HA2' ' HA ' ' A' ' 58' ' ' ASP . . . . . . . . 0 CA--C 1.519 0.293 0 CA-C-O 120.132 -0.26 . . . . 0.0 112.979 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.453 ' HD3' ' HA3' ' A' ' 10' ' ' GLY . 6.1 Cg_exo -72.03 162.23 42.44 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.597 2.198 . . . . 0.0 111.2 178.36 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -123.75 151.54 43.13 Favored 'General case' 0 CA--C 1.505 -0.783 0 CA-C-O 121.756 0.789 . . . . 0.0 112.096 -176.244 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -91.8 165.64 13.16 Favored 'General case' 0 N--CA 1.433 -1.275 0 CA-C-N 113.993 -1.458 . . . . 0.0 109.431 176.789 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.401 ' O ' ' HG3' ' A' ' 18' ' ' GLN . 47.8 ttt180 -61.97 -51.04 69.68 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 120.737 0.303 . . . . 0.0 110.693 -177.581 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 37.2 ttp180 -54.4 -40.17 67.98 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.481 177.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.609 ' O ' HG23 ' A' ' 20' ' ' VAL . 85.6 mm-40 -62.97 -47.86 81.36 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.305 177.5 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.71 -42.88 84.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.301 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.401 ' HG3' ' O ' ' A' ' 14' ' ' ARG . 97.9 mt-30 -61.04 -44.4 97.46 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.856 -178.506 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.1 -37.8 86.48 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.195 0.521 . . . . 0.0 111.202 -179.407 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.609 HG23 ' O ' ' A' ' 16' ' ' GLN . 10.2 t -77.8 -22.87 13.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.405 -175.613 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.474 HG23 ' HB ' ' A' ' 27' ' ' ILE . 0.0 OUTLIER -83.35 -33.23 25.89 Favored 'General case' 0 CA--C 1.516 -0.362 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.481 176.168 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.3 p -68.04 -19.68 64.91 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 174.126 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.3 m -89.74 -53.46 4.5 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.211 171.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.618 ' O ' HG13 ' A' ' 27' ' ' ILE . 47.3 m-85 -113.92 102.26 10.04 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 177.488 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 11.6 p -80.78 5.0 17.16 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.96 0.41 . . . . 0.0 111.469 -178.018 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.525 ' OD1' ' HB3' ' A' ' 24' ' ' TYR . 25.7 p-10 -82.34 -21.64 35.9 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 171.432 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.618 HG13 ' O ' ' A' ' 24' ' ' TYR . 1.0 OUTLIER -74.69 147.46 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 170.991 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.479 ' O ' ' HA ' ' A' ' 39' ' ' LEU . 2.5 p -142.05 134.51 28.06 Favored 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 120.571 -0.452 . . . . 0.0 110.881 -176.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.591 HD22 ' HB3' ' A' ' 32' ' ' ASP . 1.5 tt -90.29 97.17 11.03 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.67 0.747 . . . . 0.0 109.367 -179.087 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.478 ' HB2' ' HG3' ' A' ' 38' ' ' ARG . 14.5 mm-40 -104.05 161.96 13.56 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 114.482 -1.236 . . . . 0.0 109.481 -174.313 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.482 ' HB2' ' HG2' ' A' ' 38' ' ' ARG . 1.0 OUTLIER 56.25 30.72 17.16 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 123.541 0.526 . . . . 0.0 111.692 179.411 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.591 ' HB3' HD22 ' A' ' 29' ' ' LEU . 16.2 p-10 -71.35 90.58 0.95 Allowed 'General case' 0 N--CA 1.446 -0.674 0 CA-C-O 122.045 0.926 . . . . 0.0 111.385 -176.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 14.4 tm0? -111.77 -15.49 13.39 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.649 -1.16 . . . . 0.0 109.442 178.028 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 113.41 -79.02 0.26 Allowed Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.468 -175.409 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 11.7 m -63.17 -33.0 74.52 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.442 0.639 . . . . 0.0 109.732 175.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 68.2 m170 -115.61 141.62 47.82 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.929 173.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 55.6 p90 -176.31 145.13 0.58 Allowed 'General case' 0 C--N 1.326 -0.432 0 O-C-N 124.077 0.861 . . . . 0.0 109.318 169.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.482 ' HG2' ' HB2' ' A' ' 31' ' ' ASP . 16.1 ptt180 -132.75 150.2 52.19 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.87 0.367 . . . . 0.0 111.145 -178.244 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.479 ' HA ' ' O ' ' A' ' 28' ' ' THR . 84.0 mt -103.31 115.75 31.15 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 174.123 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.473 HG22 ' HB3' ' A' ' 51' ' ' ARG . 48.6 t -99.33 115.39 39.94 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.836 177.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.476 HG11 ' CD1' ' A' ' 66' ' ' TYR . 50.2 t -82.92 104.64 11.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 175.85 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.487 ' O ' ' HB2' ' A' ' 26' ' ' ASN . 50.3 mtt180 -102.16 163.74 12.07 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.592 0.711 . . . . 0.0 111.27 -177.38 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.702 ' HB3' ' HB2' ' A' ' 47' ' ' ARG . 4.3 t70 -89.45 176.08 7.05 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 114.514 -1.221 . . . . 0.0 109.444 177.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.414 ' N ' ' CG ' ' A' ' 43' ' ' ASP . 0.3 OUTLIER -67.35 -18.99 65.37 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 120.855 0.36 . . . . 0.0 111.298 -174.741 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -93.37 -0.2 56.65 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 121.46 0.647 . . . . 0.0 110.044 175.451 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 89.14 8.46 68.76 Favored Glycine 0 N--CA 1.452 -0.275 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.431 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.702 ' HB2' ' HB3' ' A' ' 43' ' ' ASP . 39.4 mtt180 -61.03 132.97 55.53 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 122.278 0.231 . . . . 0.0 110.775 177.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 10.0 mmt -75.65 97.36 3.78 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.31 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.2 t -84.45 -38.83 13.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.033 0.444 . . . . 0.0 110.551 -175.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 69.8 t-105 -166.17 153.8 10.16 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.711 -178.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.473 ' HB3' HG22 ' A' ' 40' ' ' VAL . 9.0 ptt180 -152.14 148.02 27.14 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.034 0.445 . . . . 0.0 111.14 177.025 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -148.79 143.09 26.13 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.17 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.468 ' H ' ' HG3' ' A' ' 56' ' ' GLU . 72.0 m95 -87.98 -171.34 3.36 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 122.208 1.004 . . . . 0.0 111.539 -178.775 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -82.28 -35.63 27.84 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 113.481 -1.69 . . . . 0.0 109.83 178.535 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 32.2 p90 -87.98 17.88 4.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.65 -178.004 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.586 ' HB2' ' HB2' ' A' ' 59' ' ' ALA . 11.8 mm-40 -85.23 116.75 66.83 Favored Pre-proline 0 C--N 1.327 -0.401 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 175.753 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.445 ' HD2' ' HA ' ' A' ' 56' ' ' GLU . 3.6 Cg_endo -46.34 -39.92 21.95 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 124.269 3.312 . . . . 0.0 114.163 -172.487 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.48 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . 4.6 t0 -138.1 55.89 1.75 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.088 0.47 . . . . 0.0 110.14 178.324 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.586 ' HB2' ' HB2' ' A' ' 56' ' ' GLU . . . -56.4 -39.89 73.76 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.277 -179.452 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -59.45 -33.0 74.37 Favored Glycine 0 N--CA 1.45 -0.387 0 CA-C-N 115.384 -0.825 . . . . 0.0 114.071 -177.168 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.468 ' HB2' ' OD1' ' A' ' 58' ' ' ASP . 35.7 tt0 -62.52 -43.07 99.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 117.608 0.704 . . . . 0.0 110.96 -176.421 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -73.28 -41.2 47.01 Favored Glycine 0 C--O 1.237 0.288 0 C-N-CA 120.539 -0.838 . . . . 0.0 111.557 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 72.6 mt -64.73 -51.97 59.56 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.547 -0.326 . . . . 0.0 110.851 -179.461 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.452 ' HA ' ' HB ' ' A' ' 67' ' ' ILE . 93.2 m-20 -60.56 -32.64 71.71 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.608 0.242 . . . . 0.0 111.006 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 11.2 tpt180 -55.45 -50.75 69.03 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.262 176.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.476 ' CD1' HG11 ' A' ' 41' ' ' VAL . 38.9 t80 -72.53 -43.27 63.75 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.447 179.356 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.538 HG23 ' CZ ' ' A' ' 24' ' ' TYR . 59.9 mt -49.61 -44.84 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-N 115.617 -0.72 . . . . 0.0 112.262 -178.507 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 61.9 ttt180 -68.37 -53.77 21.73 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -175.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 8.8 t -76.34 -35.65 58.65 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 112.37 0.508 . . . . 0.0 112.37 -169.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 25.1 m -90.21 -50.84 5.75 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.69 -177.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 48.25 85.14 0.02 OUTLIER Glycine 0 CA--C 1.525 0.667 0 CA-C-N 115.515 -0.766 . . . . 0.0 114.632 179.466 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.516 HG21 ' HB3' ' A' ' 26' ' ' ASN . 1.8 mp -80.74 5.37 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 CA-C-O 122.369 1.08 . . . . 0.0 109.63 177.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.499 ' HB3' ' CE2' ' A' ' 24' ' ' TYR . 52.3 ptt85 -57.89 -16.92 13.58 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 114.833 -1.076 . . . . 0.0 112.036 178.795 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 7.2 t -75.26 9.26 2.16 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.272 0.558 . . . . 0.0 109.961 176.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.8 t70 . . . . . 0 N--CA 1.467 0.408 0 CA-C-N 114.886 -1.052 . . . . 0.0 112.543 169.095 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.525 ' HA3' ' O ' ' A' ' 57' ' ' PRO . . . . . . . . 0 N--CA 1.441 -0.998 0 N-CA-C 110.991 -0.844 . . . . 0.0 110.991 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -75.7 130.39 12.54 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 121.623 1.548 . . . . 0.0 110.958 172.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -102.58 -178.46 3.69 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 121.806 0.812 . . . . 0.0 111.923 -172.39 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.98 151.49 32.28 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 114.705 -1.134 . . . . 0.0 108.988 176.308 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.544 ' O ' ' HG3' ' A' ' 18' ' ' GLN . 43.7 ttt-85 -59.36 -48.98 79.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.033 0.444 . . . . 0.0 109.944 -178.684 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 72.5 mtp85 -56.7 -45.69 81.66 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.241 177.589 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.519 ' O ' HG23 ' A' ' 20' ' ' VAL . 73.7 mm-40 -63.31 -39.87 95.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.489 179.255 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.456 ' HB1' HD21 ' A' ' 39' ' ' LEU . . . -62.06 -43.38 98.96 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.685 177.03 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.544 ' HG3' ' O ' ' A' ' 14' ' ' ARG . 79.7 mt-30 -51.71 -44.37 63.16 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.022 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.79 -27.04 68.91 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.107 -179.259 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.519 HG23 ' O ' ' A' ' 16' ' ' GLN . 14.1 t -92.46 -16.13 7.92 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.752 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 -172.619 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 12.0 m -93.31 -31.42 14.69 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-N 113.972 -1.467 . . . . 0.0 107.588 -176.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 99.0 m -61.65 -38.1 86.46 Favored 'General case' 0 N--CA 1.436 -1.175 0 CA-C-N 113.628 -1.624 . . . . 0.0 109.299 166.709 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.575 HG23 ' HE ' ' A' ' 73' ' ' ARG . 36.7 m -75.03 -53.86 8.18 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.992 177.139 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.67 ' O ' HG13 ' A' ' 27' ' ' ILE . 89.9 m-85 -117.45 96.88 5.6 Favored 'General case' 0 N--CA 1.44 -0.975 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 178.548 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 48.3 m -76.12 5.72 6.37 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.865 0.364 . . . . 0.0 111.506 -177.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.473 ' HB3' HG21 ' A' ' 72' ' ' ILE . 11.9 p-10 -76.84 -16.43 59.42 Favored 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 108.598 -0.889 . . . . 0.0 108.598 167.803 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.67 HG13 ' O ' ' A' ' 24' ' ' TYR . 2.2 mt -84.4 151.45 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 171.371 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.564 ' OG1' ' HB ' ' A' ' 40' ' ' VAL . 11.1 p -138.14 117.41 12.73 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 119.954 -0.698 . . . . 0.0 111.068 178.713 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.593 ' HA ' HD23 ' A' ' 39' ' ' LEU . 4.8 tt -83.23 99.03 9.71 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 174.239 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.532 ' HG2' ' HB ' ' A' ' 28' ' ' THR . 74.2 mm-40 -132.9 -173.55 3.22 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.957 -173.697 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.7 t70 69.53 17.25 8.01 Favored 'General case' 0 CA--C 1.531 0.214 0 O-C-N 124.072 0.857 . . . . 0.0 110.505 177.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -57.59 95.54 0.02 OUTLIER 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.659 178.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 33.0 tp60 -122.79 10.11 9.56 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.206 0.527 . . . . 0.0 110.206 -178.141 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 119.31 -88.98 0.45 Allowed Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.583 178.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 9.8 t -89.36 -17.04 29.63 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 120.702 0.286 . . . . 0.0 110.569 -176.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 30.1 p80 -124.41 145.79 49.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.153 0.501 . . . . 0.0 111.424 178.291 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -166.67 167.91 14.87 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.298 -1.319 . . . . 0.0 107.608 174.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.429 ' HB3' ' HA ' ' A' ' 53' ' ' TRP . 30.9 ptt180 -153.0 156.29 38.54 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.115 0.484 . . . . 0.0 112.076 -175.285 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.593 HD23 ' HA ' ' A' ' 29' ' ' LEU . 89.2 mt -102.03 117.95 35.89 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.961 178.22 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.564 ' HB ' ' OG1' ' A' ' 28' ' ' THR . 37.7 t -100.89 113.91 38.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 116.278 -0.419 . . . . 0.0 109.983 178.54 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 46.5 t -90.04 122.4 41.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.022 0.439 . . . . 0.0 110.051 178.152 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 57.9 mtp180 -105.06 163.88 12.22 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.476 -178.441 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -88.66 -171.74 3.45 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 177.697 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.1 p -62.31 -22.26 65.92 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.918 -176.544 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -91.71 -31.46 15.8 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.891 0.377 . . . . 0.0 110.54 179.092 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 119.6 10.0 8.08 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.418 -0.896 . . . . 0.0 112.541 -177.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 92.4 mtt180 -82.57 127.56 33.47 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 177.589 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.13 118.62 10.13 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.264 0.554 . . . . 0.0 110.785 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 41.9 t -97.23 -35.78 5.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.07 -179.368 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 68.8 t-105 -158.14 119.32 3.49 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.177 -178.191 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.473 ' HB3' HG13 ' A' ' 40' ' ' VAL . 36.4 ptt180 -112.68 129.02 56.54 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.817 174.089 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -122.76 142.09 51.1 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.555 -177.065 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.547 ' HB2' ' HG3' ' A' ' 56' ' ' GLU . 95.0 m95 -79.36 -169.13 1.76 Allowed 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 121.709 0.766 . . . . 0.0 110.923 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -101.32 -30.41 11.5 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 114.701 -1.136 . . . . 0.0 110.932 -176.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 40.6 p90 -90.29 3.69 52.89 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.557 -174.611 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.547 ' HG3' ' HB2' ' A' ' 53' ' ' TRP . 40.0 mt-10 -75.42 132.51 75.72 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 120.752 0.31 . . . . 0.0 110.275 179.476 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.525 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 39.8 Cg_endo -66.5 -11.65 32.54 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 123.225 2.617 . . . . 0.0 113.394 -173.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -137.57 28.39 2.72 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.648 -0.251 . . . . 0.0 110.561 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.563 ' O ' ' HG ' ' A' ' 63' ' ' LEU . . . -53.03 -49.61 65.93 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.847 -176.787 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -69.82 -30.45 70.39 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.653 -178.53 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -70.53 -34.06 71.85 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.841 0.321 . . . . 0.0 110.279 -175.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.484 ' O ' ' HB3' ' A' ' 65' ' ' ARG . . . -74.24 -39.22 44.67 Favored Glycine 0 C--O 1.238 0.354 0 C-N-CA 120.382 -0.913 . . . . 0.0 111.583 177.158 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.563 ' HG ' ' O ' ' A' ' 59' ' ' ALA . 70.2 mt -67.51 -45.31 76.15 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.539 -0.33 . . . . 0.0 110.513 178.594 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -61.25 -32.34 72.14 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.557 176.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.484 ' HB3' ' O ' ' A' ' 62' ' ' GLY . 0.4 OUTLIER -57.32 -44.83 84.53 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.301 -0.409 . . . . 0.0 109.922 175.473 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 14.1 t80 -67.11 -53.19 33.16 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.079 176.232 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 97.3 mt -50.92 -51.37 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.847 -178.398 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 45.9 ttm105 -55.99 -32.41 63.92 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.274 -173.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 5.1 t -111.38 15.01 21.53 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.449 -0.501 . . . . 0.0 111.705 -174.415 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 16.2 m -134.66 -54.98 0.83 Allowed 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.849 -0.341 . . . . 0.0 111.15 -179.278 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.52 ' HA2' ' CE1' ' A' ' 24' ' ' TYR . . . 47.15 75.82 0.17 Allowed Glycine 0 CA--C 1.527 0.812 0 CA-C-N 115.552 -0.749 . . . . 0.0 114.114 -177.601 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.473 HG21 ' HB3' ' A' ' 26' ' ' ASN . 1.8 mp -72.94 -20.65 19.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-N 117.132 0.466 . . . . 0.0 111.912 -174.707 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.575 ' HE ' HG23 ' A' ' 23' ' ' THR . 0.0 OUTLIER -57.78 -65.39 0.64 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.237 0.541 . . . . 0.0 111.525 -178.403 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 2.8 t -72.6 -0.8 13.91 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.355 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 35.0 t70 . . . . . 0 N--CA 1.47 0.53 0 CA-C-N 113.719 -1.582 . . . . 0.0 112.644 174.026 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.56 ' HA2' ' HA ' ' A' ' 58' ' ' ASP . . . . . . . . 0 CA--C 1.52 0.358 0 N-CA-C 114.584 0.594 . . . . 0.0 114.584 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.466 ' HD3' ' HA3' ' A' ' 10' ' ' GLY . 6.6 Cg_exo -72.16 144.2 41.53 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 123.159 2.573 . . . . 0.0 112.515 -177.478 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -112.12 -173.3 2.22 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.143 -178.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.447 ' OG1' ' HG2' ' A' ' 16' ' ' GLN . 28.8 p -125.07 176.31 6.77 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 175.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.412 HH11 ' HD2' ' A' ' 14' ' ' ARG . 22.8 ttt180 -61.67 -46.7 88.6 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.488 0.661 . . . . 0.0 109.489 175.655 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 36.1 mmt180 -55.02 -48.79 72.91 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.558 -1.201 . . . . 0.0 110.675 178.303 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.61 ' O ' HG23 ' A' ' 20' ' ' VAL . 84.9 mm-40 -62.7 -49.15 76.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.211 178.193 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -52.76 -49.26 65.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.684 179.261 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.405 ' HG2' ' O ' ' A' ' 14' ' ' ARG . 15.2 mm100 -55.65 -41.82 74.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.312 -179.37 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.44 -29.11 70.45 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.982 -179.273 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.61 HG23 ' O ' ' A' ' 16' ' ' GLN . 3.3 t -91.33 -26.05 5.17 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.958 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 -171.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 16.2 m -79.55 -32.97 42.2 Favored 'General case' 0 N--CA 1.437 -1.117 0 CA-C-N 113.95 -1.477 . . . . 0.0 110.655 179.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.8 p -73.54 -26.08 60.69 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 121.082 0.467 . . . . 0.0 109.742 172.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.534 HG23 ' HD2' ' A' ' 73' ' ' ARG . 89.8 m -76.2 -55.09 5.9 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.783 172.689 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.606 ' O ' HG13 ' A' ' 27' ' ' ILE . 70.1 m-85 -116.63 101.53 8.68 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 175.61 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 45.0 m -82.16 17.39 1.65 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.207 0.527 . . . . 0.0 111.747 -176.566 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.547 ' OD1' ' HB3' ' A' ' 24' ' ' TYR . 25.1 p-10 -87.91 -20.37 26.04 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 167.238 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.606 HG13 ' O ' ' A' ' 24' ' ' TYR . 2.4 mt -73.57 146.92 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 171.763 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -149.46 130.3 14.23 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 120.225 -0.59 . . . . 0.0 111.566 -179.094 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.528 ' HA ' HD23 ' A' ' 39' ' ' LEU . 5.9 tt -79.3 103.12 9.01 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.229 178.778 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -112.76 166.41 11.39 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.497 -176.548 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.6 t70 66.39 46.37 1.96 Allowed 'General case' 0 N--CA 1.465 0.304 0 O-C-N 123.65 0.594 . . . . 0.0 110.542 176.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -64.95 99.93 0.38 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.454 -179.354 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 21.8 tt0 -129.63 57.56 1.67 Allowed 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.494 0.664 . . . . 0.0 109.422 175.485 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 74.52 -112.81 3.85 Favored Glycine 0 N--CA 1.45 -0.372 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.741 -178.362 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 30.2 t -87.67 -1.5 57.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.092 0.472 . . . . 0.0 110.119 177.279 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -101.44 124.85 47.77 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 176.164 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -173.8 170.49 3.94 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 178.477 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 30.1 ptt-85 -145.18 145.39 31.33 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.217 0.532 . . . . 0.0 111.433 178.293 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.528 HD23 ' HA ' ' A' ' 29' ' ' LEU . 93.9 mt -90.67 110.75 21.91 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.284 177.642 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 84.2 t -89.93 115.05 28.72 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.049 173.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.5 t -91.82 108.73 20.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.453 ' O ' ' HB2' ' A' ' 26' ' ' ASN . 60.3 mtt85 -95.93 170.21 9.45 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.868 -178.488 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.438 ' CG ' ' H ' ' A' ' 45' ' ' GLU . 1.2 p-10 -96.65 -171.19 2.21 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.974 0.416 . . . . 0.0 110.002 179.54 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.46 -19.99 66.17 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.687 -176.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.438 ' H ' ' CG ' ' A' ' 43' ' ' ASP . 9.5 tp10 -91.08 -28.67 17.78 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.24 0.543 . . . . 0.0 109.944 177.663 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 114.18 12.19 11.28 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.798 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.445 ' O ' ' HA ' ' A' ' 42' ' ' ARG . 40.5 mtt-85 -80.33 137.67 36.61 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.081 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -76.72 96.87 4.32 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.42 0.629 . . . . 0.0 110.599 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 15.8 t -83.54 -31.27 8.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.523 -177.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.442 ' CD1' HD23 ' A' ' 63' ' ' LEU . 75.4 t-105 -150.38 159.15 44.67 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.261 -177.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 27.5 ptt-85 -158.4 131.4 7.3 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 178.5 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -140.94 140.75 34.49 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 110.463 -0.199 . . . . 0.0 110.463 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.635 ' HB2' ' HG3' ' A' ' 56' ' ' GLU . 72.4 m95 -77.27 -173.89 3.02 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-O 121.764 0.793 . . . . 0.0 110.752 -179.177 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -94.18 -26.37 16.71 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 114.254 -1.339 . . . . 0.0 109.837 -178.534 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -98.33 6.16 47.58 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.802 -174.066 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.635 ' HG3' ' HB2' ' A' ' 53' ' ' TRP . 38.2 mt-10 -76.45 129.97 78.37 Favored Pre-proline 0 C--N 1.326 -0.43 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.195 178.618 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.428 ' HA ' ' HG3' ' A' ' 11' ' ' PRO . 31.7 Cg_exo -59.2 -20.07 52.99 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 123.431 2.754 . . . . 0.0 113.136 -175.155 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.56 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . 13.2 m-20 -133.6 37.92 3.28 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.541 179.599 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.407 ' O ' ' HG ' ' A' ' 63' ' ' LEU . . . -54.95 -50.18 69.54 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 120.925 0.393 . . . . 0.0 111.141 -178.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -63.33 -30.28 77.07 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.789 179.525 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.42 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 23.5 tp10 -60.79 -42.18 97.07 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.784 0.325 . . . . 0.0 110.367 -178.826 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.477 ' O ' ' HB3' ' A' ' 65' ' ' ARG . . . -77.05 -38.64 29.62 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.093 179.354 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.519 ' O ' HG13 ' A' ' 67' ' ' ILE . 85.5 mt -63.17 -52.76 61.08 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.723 0.297 . . . . 0.0 110.357 179.492 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -61.99 -32.13 72.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.632 178.428 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.477 ' HB3' ' O ' ' A' ' 62' ' ' GLY . 7.0 tpt85 -54.29 -46.74 72.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.669 177.384 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -74.86 -44.14 50.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.985 178.116 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.519 HG13 ' O ' ' A' ' 63' ' ' LEU . 89.5 mt -52.65 -44.57 46.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-O 120.897 0.379 . . . . 0.0 111.083 -179.119 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 23.6 ttt180 -58.83 -24.24 61.73 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.432 -0.803 . . . . 0.0 112.425 -176.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 11.3 t -118.1 22.21 12.33 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.402 0.62 . . . . 0.0 111.601 -175.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 29.2 p -144.91 -55.44 0.32 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.349 178.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 44.98 78.13 0.08 OUTLIER Glycine 0 CA--C 1.52 0.353 0 CA-C-N 115.325 -0.852 . . . . 0.0 113.333 -177.105 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.7 mp -72.46 -19.93 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-N 117.196 0.498 . . . . 0.0 111.642 -174.18 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.534 ' HD2' HG23 ' A' ' 23' ' ' THR . 72.2 ttt180 -64.33 -49.63 70.94 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-O 121.259 0.552 . . . . 0.0 111.273 -175.796 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 14.1 t -80.72 17.41 1.15 Allowed 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.247 -178.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.474 ' H ' ' C ' ' A' ' 73' ' ' ARG . 21.9 t70 . . . . . 0 C--O 1.231 0.122 0 CA-C-N 114.395 -1.275 . . . . 0.0 112.104 -178.397 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.537 ' HA2' ' HA ' ' A' ' 58' ' ' ASP . . . . . . . . 0 CA--C 1.519 0.301 0 CA-C-O 120.086 -0.286 . . . . 0.0 113.689 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -72.49 165.2 33.39 Favored 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 122.873 2.382 . . . . 0.0 111.82 179.176 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -132.74 169.58 16.49 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.741 0.781 . . . . 0.0 111.997 -176.732 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.5 m -112.85 166.86 10.99 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 114.441 -1.254 . . . . 0.0 110.048 -176.663 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 45.5 ttt-85 -62.36 -47.56 83.67 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.683 0.277 . . . . 0.0 110.877 -175.515 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.428 HH11 ' HD3' ' A' ' 15' ' ' ARG . 27.0 ttm-85 -53.08 -47.13 68.77 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.612 174.76 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.605 ' O ' HG23 ' A' ' 20' ' ' VAL . 77.6 mt-30 -59.98 -47.83 84.22 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.657 178.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.404 ' HB1' HD21 ' A' ' 39' ' ' LEU . . . -55.28 -47.98 74.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.165 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 56.9 mm-40 -59.25 -36.16 74.97 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.934 -179.428 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.1 -29.32 68.23 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.036 0.446 . . . . 0.0 111.415 -178.229 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.605 HG23 ' O ' ' A' ' 16' ' ' GLN . 11.1 t -89.83 -27.42 5.18 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.826 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 -172.068 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.477 HG23 ' HB ' ' A' ' 27' ' ' ILE . 15.6 m -83.64 -27.47 29.09 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-N 113.795 -1.548 . . . . 0.0 111.119 -179.273 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.2 p -73.4 -30.68 63.42 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 171.73 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 34.7 m -77.09 -47.03 21.59 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.275 173.694 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.636 ' HB2' HG13 ' A' ' 27' ' ' ILE . 40.0 m-85 -114.54 96.35 5.71 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 177.656 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 37.8 p -64.9 -7.61 12.09 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 111.906 0.335 . . . . 0.0 111.906 -179.549 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.586 ' OD1' ' HB3' ' A' ' 24' ' ' TYR . 5.4 p-10 -78.81 -11.49 59.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.999 0.428 . . . . 0.0 110.192 177.137 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.636 HG13 ' HB2' ' A' ' 24' ' ' TYR . 2.5 mt -83.08 146.59 6.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 174.21 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.525 ' OG1' ' HB ' ' A' ' 40' ' ' VAL . 10.3 p -133.12 120.23 20.98 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.398 -0.521 . . . . 0.0 110.786 -177.81 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.561 HD22 ' HB2' ' A' ' 32' ' ' ASP . 2.8 tt -88.36 105.15 17.39 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 -179.171 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.22 161.85 18.35 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.71 -176.242 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 61.26 30.56 19.24 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.032 -177.627 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.561 ' HB2' HD22 ' A' ' 29' ' ' LEU . 32.7 t0 -73.98 95.97 2.58 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.004 -178.194 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -115.29 1.96 13.9 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.564 178.138 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 119.88 -85.22 0.38 Allowed Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.463 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.1 t -89.32 -1.14 57.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.997 0.427 . . . . 0.0 110.496 -178.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 12.3 m170 -132.66 135.72 46.02 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 173.001 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.436 ' HB3' ' HA ' ' A' ' 32' ' ' ASP . 43.2 p90 -174.66 156.83 2.43 Favored 'General case' 0 C--O 1.234 0.285 0 O-C-N 123.858 0.724 . . . . 0.0 109.558 178.869 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 15.1 ptt180 -136.08 153.03 51.44 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.937 0.399 . . . . 0.0 111.513 176.541 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.526 HD23 ' HA ' ' A' ' 29' ' ' LEU . 71.5 mt -108.66 125.76 52.23 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.171 0.51 . . . . 0.0 110.558 177.049 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.525 ' HB ' ' OG1' ' A' ' 28' ' ' THR . 45.1 t -100.13 114.83 39.87 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.351 171.762 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 16.9 t -87.6 114.99 27.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.243 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.421 ' HA ' ' O ' ' A' ' 47' ' ' ARG . 3.8 mtt85 -101.24 160.87 14.04 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.398 0.618 . . . . 0.0 111.402 -176.883 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.421 ' CG ' ' N ' ' A' ' 44' ' ' THR . 4.1 t70 -91.57 178.23 5.99 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.487 -1.233 . . . . 0.0 109.979 -178.823 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.421 ' N ' ' CG ' ' A' ' 43' ' ' ASP . 19.1 p -59.01 -22.39 60.59 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 123.201 0.6 . . . . 0.0 111.718 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -92.63 -5.07 52.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.138 0.494 . . . . 0.0 110.536 178.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 89.29 9.49 67.11 Favored Glycine 0 N--CA 1.453 -0.173 0 C-N-CA 120.807 -0.711 . . . . 0.0 111.946 -177.043 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.421 ' O ' ' HA ' ' A' ' 42' ' ' ARG . 38.0 mtp180 -70.96 130.66 42.17 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 122.533 0.333 . . . . 0.0 110.364 179.359 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.15 90.52 2.54 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.599 0.714 . . . . 0.0 110.283 176.037 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 24.7 t -75.16 -38.45 41.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.621 -176.662 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 75.5 t-105 -150.14 152.61 34.98 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.248 -175.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 13.7 ptt-85 -150.14 137.19 19.46 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 177.145 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -145.97 146.54 31.06 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.407 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.463 ' HB2' ' HG3' ' A' ' 56' ' ' GLU . 96.5 m95 -80.44 -171.23 2.94 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-O 121.387 0.613 . . . . 0.0 109.587 175.199 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -99.81 -21.34 15.79 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.551 -176.226 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -100.46 11.73 38.81 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.58 -174.538 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.463 ' HG3' ' HB2' ' A' ' 53' ' ' TRP . 42.7 mt-10 -80.88 135.8 51.57 Favored Pre-proline 0 C--N 1.329 -0.308 0 C-N-CA 121.025 -0.27 . . . . 0.0 110.432 179.419 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -36.78 -47.23 1.39 Allowed 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 125.071 3.847 . . . . 0.0 114.31 -172.608 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.537 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . 4.2 t70 -144.58 63.35 1.31 Allowed 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 176.424 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.436 ' HB2' ' HB2' ' A' ' 56' ' ' GLU . . . -58.69 -31.55 68.33 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.041 179.714 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -61.7 -34.07 87.33 Favored Glycine 0 N--CA 1.447 -0.604 0 CA-C-N 115.582 -0.735 . . . . 0.0 113.56 -178.558 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.52 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 2.1 tm-20 -57.34 -50.47 72.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 117.074 0.437 . . . . 0.0 110.351 -177.61 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -67.56 -43.25 86.69 Favored Glycine 0 C--O 1.237 0.334 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.287 -177.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.458 ' O ' HG13 ' A' ' 67' ' ' ILE . 53.2 mt -60.34 -55.61 31.58 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 110.331 -0.248 . . . . 0.0 110.331 178.62 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.569 ' HA ' ' HB ' ' A' ' 67' ' ' ILE . 94.4 m-20 -62.69 -31.46 72.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.933 -179.02 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.52 ' HB2' ' O ' ' A' ' 61' ' ' GLU . 7.1 tpt180 -52.86 -46.06 67.68 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.362 0.601 . . . . 0.0 109.66 177.315 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 75.8 t80 -81.35 -41.82 21.44 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.986 178.447 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.569 ' HB ' ' HA ' ' A' ' 64' ' ' ASN . 95.2 mt -55.37 -48.88 76.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -178.415 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 59.9 ttt-85 -63.42 -48.98 75.56 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.376 -176.352 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 38.7 p -79.4 -41.12 28.44 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.035 -0.53 . . . . 0.0 112.179 -172.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.436 ' O ' HD12 ' A' ' 72' ' ' ILE . 3.3 m -127.85 20.19 6.53 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 112.681 0.622 . . . . 0.0 112.681 -166.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -48.33 134.24 19.15 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 121.346 -0.454 . . . . 0.0 113.927 178.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.478 ' HB ' ' OD1' ' A' ' 26' ' ' ASN . 2.5 mp -89.2 7.68 3.44 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 C-N-CA 123.258 0.623 . . . . 0.0 109.935 -176.722 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.633 ' HB3' ' CE1' ' A' ' 24' ' ' TYR . 30.7 ptt180 -48.79 -6.25 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 115.135 1.531 . . . . 0.0 115.135 -173.004 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.417 ' N ' ' O ' ' A' ' 72' ' ' ILE . 10.1 t -68.87 5.73 1.06 Allowed 'General case' 0 C--N 1.321 -0.641 0 O-C-N 122.017 -0.427 . . . . 0.0 110.223 173.491 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.422 ' H ' ' C ' ' A' ' 73' ' ' ARG . 12.5 p-10 . . . . . 0 N--CA 1.45 -0.473 0 CA-C-O 122.476 1.131 . . . . 0.0 109.52 176.091 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.464 ' HA2' ' HA ' ' A' ' 58' ' ' ASP . . . . . . . . 0 CA--C 1.518 0.251 0 CA-C-O 120.04 -0.311 . . . . 0.0 113.157 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.489 ' HD3' ' O ' ' A' ' 57' ' ' PRO . 19.4 Cg_exo -66.69 169.22 14.89 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.716 2.277 . . . . 0.0 111.856 176.732 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.488 ' CD2' ' HB2' ' A' ' 17' ' ' ALA . 41.2 p90 -140.33 165.27 27.86 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.189 -179.053 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.8 p -103.72 178.17 4.63 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.27 -178.35 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.563 ' HA ' ' CZ ' ' A' ' 37' ' ' PHE . 47.2 ttt180 -60.8 -54.85 40.19 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.212 178.22 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 57.9 mtt-85 -62.84 -37.31 86.3 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.683 -178.082 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.581 ' O ' HG23 ' A' ' 20' ' ' VAL . 77.5 mm-40 -62.97 -53.07 59.76 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.222 177.495 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.488 ' HB2' ' CD2' ' A' ' 12' ' ' PHE . . . -52.85 -44.27 66.66 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.492 178.156 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -58.8 -39.2 80.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.767 -178.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.02 -27.29 65.55 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-O 121.392 0.615 . . . . 0.0 110.945 179.684 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.581 HG23 ' O ' ' A' ' 16' ' ' GLN . 3.6 t -76.71 -25.71 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 -179.169 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.545 HG23 ' HB ' ' A' ' 27' ' ' ILE . 0.0 OUTLIER -80.61 -28.01 37.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.841 175.542 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.9 p -75.99 -14.52 60.23 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.434 0.635 . . . . 0.0 109.552 173.17 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 18.9 m -92.4 -50.18 5.77 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.753 170.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.587 ' HB3' ' OD1' ' A' ' 26' ' ' ASN . 48.3 m-85 -118.85 105.31 11.38 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 177.273 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 17.7 p -76.94 -1.76 30.23 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.079 0.466 . . . . 0.0 111.093 -179.63 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.587 ' OD1' ' HB3' ' A' ' 24' ' ' TYR . 6.1 p-10 -81.6 -9.84 59.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.649 175.897 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.584 HG13 ' O ' ' A' ' 24' ' ' TYR . 1.8 mt -86.03 155.62 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 174.235 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.517 ' OG1' ' HB ' ' A' ' 40' ' ' VAL . 1.2 p -142.35 123.27 14.42 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.888 0.375 . . . . 0.0 111.251 -179.529 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.45 ' HA ' HD23 ' A' ' 39' ' ' LEU . 6.1 tt -88.44 105.78 17.83 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 178.697 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -126.79 169.09 13.56 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.524 179.243 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.549 ' HB2' ' HG2' ' A' ' 38' ' ' ARG . 1.1 m-20 66.06 37.67 5.14 Favored 'General case' 0 C--N 1.329 -0.309 0 O-C-N 123.528 0.517 . . . . 0.0 110.761 179.572 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.502 ' HA ' ' HB3' ' A' ' 37' ' ' PHE . 11.3 p-10 -67.6 102.56 1.19 Allowed 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 121.878 0.847 . . . . 0.0 110.334 179.216 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -116.93 30.31 7.41 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.435 -177.553 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 96.44 -106.41 3.36 Favored Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.807 -179.388 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.6 m -81.94 -1.87 49.47 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.911 0.386 . . . . 0.0 110.784 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.42 ' HA ' ' OD1' ' A' ' 54' ' ' ASN . 20.7 m-70 -129.37 143.42 50.83 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.652 179.504 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.563 ' CZ ' ' HA ' ' A' ' 14' ' ' ARG . 36.8 p90 -173.95 170.96 3.76 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 -178.683 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.549 ' HG2' ' HB2' ' A' ' 31' ' ' ASP . 16.5 ptt180 -127.33 152.61 47.24 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.133 0.492 . . . . 0.0 111.004 179.03 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.47 HD11 ' HB1' ' A' ' 17' ' ' ALA . 96.3 mt -111.56 115.78 29.75 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.713 173.779 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.558 HG13 ' HB3' ' A' ' 51' ' ' ARG . 3.1 t -92.2 113.79 28.07 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.152 178.253 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.406 HG11 ' CD2' ' A' ' 66' ' ' TYR . 21.8 t -87.12 111.51 21.85 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.428 HH11 HG21 ' A' ' 28' ' ' THR . 23.7 mtp180 -100.42 164.02 12.11 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.23 -178.423 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.558 ' HB2' ' CG2' ' A' ' 49' ' ' VAL . 10.1 t70 -97.38 -169.2 1.81 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.605 -175.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.417 ' H ' ' CG ' ' A' ' 43' ' ' ASP . 40.3 p -67.91 -21.81 65.11 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.064 0.459 . . . . 0.0 110.727 -178.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -84.74 -10.58 57.12 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.665 0.745 . . . . 0.0 109.224 178.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 86.36 3.04 84.85 Favored Glycine 0 N--CA 1.444 -0.797 0 CA-C-N 115.289 -0.869 . . . . 0.0 112.75 -179.376 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 8.9 ptp180 -82.72 147.91 28.19 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 117.103 0.451 . . . . 0.0 110.212 177.277 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 21.2 ptt? -75.06 123.23 24.81 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.321 0.582 . . . . 0.0 110.749 -179.173 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.558 ' CG2' ' HB2' ' A' ' 43' ' ' ASP . 6.5 t -103.31 -33.93 3.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.085 -177.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 75.0 t-105 -152.23 152.0 31.66 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.494 -178.387 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.558 ' HB3' HG13 ' A' ' 40' ' ' VAL . 1.9 ppt_? -150.97 139.88 20.92 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 178.392 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -150.59 157.76 43.36 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.054 179.213 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.521 ' HA ' ' HA ' ' A' ' 38' ' ' ARG . 69.1 m95 -88.31 -164.67 1.15 Allowed 'General case' 0 N--CA 1.444 -0.764 0 CA-C-O 121.081 0.467 . . . . 0.0 110.229 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.42 ' OD1' ' HA ' ' A' ' 36' ' ' HIS . 0.4 OUTLIER -104.18 -21.93 13.47 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.301 -175.012 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -95.28 0.93 54.3 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -171.111 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.585 ' HB2' ' HB2' ' A' ' 59' ' ' ALA . 48.4 mt-10 -74.14 141.57 77.91 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 116.808 -0.178 . . . . 0.0 110.526 -179.147 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.489 ' O ' ' HD3' ' A' ' 11' ' ' PRO . 80.4 Cg_exo -45.95 -38.78 18.94 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 123.956 3.104 . . . . 0.0 114.163 -172.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.464 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . 9.1 m-20 -136.21 48.44 2.16 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 177.606 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.585 ' HB2' ' HB2' ' A' ' 56' ' ' GLU . . . -56.77 -48.43 77.89 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.723 -0.672 . . . . 0.0 111.292 -175.311 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.405 ' HA2' HD12 ' A' ' 63' ' ' LEU . . . -70.77 -25.65 75.38 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.45 -178.416 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.59 -33.25 66.6 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 -177.082 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.55 ' O ' ' HB2' ' A' ' 65' ' ' ARG . . . -71.81 -41.02 56.99 Favored Glycine 0 C--O 1.239 0.459 0 C-N-CA 120.684 -0.77 . . . . 0.0 111.273 176.223 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.515 ' HG ' ' O ' ' A' ' 59' ' ' ALA . 55.1 mt -58.24 -44.48 88.3 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.112 0.482 . . . . 0.0 109.711 175.461 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.569 ' HA ' ' HB ' ' A' ' 67' ' ' ILE . 33.2 m-80 -73.32 -18.42 61.19 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.756 -0.657 . . . . 0.0 111.636 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.55 ' HB2' ' O ' ' A' ' 62' ' ' GLY . 9.7 mmt180 -60.76 -47.88 84.3 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 172.041 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.406 ' CD2' HG11 ' A' ' 41' ' ' VAL . 83.8 t80 -67.99 -47.27 68.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.434 176.213 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.569 ' HB ' ' HA ' ' A' ' 64' ' ' ASN . 97.0 mt -59.16 -39.87 79.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -177.301 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 47.1 ttt180 -54.54 -43.2 71.75 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.633 0.254 . . . . 0.0 111.253 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.3 t -98.7 -9.99 23.82 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.746 0.308 . . . . 0.0 111.484 -177.119 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 33.1 t -159.09 66.72 0.41 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.331 0.586 . . . . 0.0 111.328 -177.377 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -89.29 127.61 8.77 Favored Glycine 0 N--CA 1.447 -0.619 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 171.015 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.521 ' HB ' ' OD1' ' A' ' 26' ' ' ASN . 2.0 mp -83.82 -0.85 5.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 CA-C-O 121.433 0.635 . . . . 0.0 110.714 -172.834 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.523 ' HB3' ' CE1' ' A' ' 24' ' ' TYR . 4.7 ptm180 -64.17 -7.71 9.93 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -176.063 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.1 m -59.26 -10.18 2.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.88 0.848 . . . . 0.0 109.253 172.774 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.401 ' N ' ' C ' ' A' ' 73' ' ' ARG . 17.5 t0 . . . . . 0 N--CA 1.449 -0.494 0 CA-C-N 114.402 -1.272 . . . . 0.0 109.252 171.262 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.409 ' HA3' ' HD3' ' A' ' 11' ' ' PRO . . . . . . . . 0 N--CA 1.453 -0.215 0 CA-C-O 119.957 -0.357 . . . . 0.0 112.506 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.409 ' HD3' ' HA3' ' A' ' 10' ' ' GLY . 2.8 Cg_exo -74.96 175.1 11.67 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 122.696 2.264 . . . . 0.0 111.872 178.475 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.453 ' HE1' ' HE2' ' A' ' 37' ' ' PHE . 51.3 p90 -128.19 161.5 29.15 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.386 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 43.0 p -102.08 170.31 8.2 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.677 178.182 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 32.6 ttt85 -59.22 -44.0 92.31 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.09 0.472 . . . . 0.0 109.814 176.269 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.435 HH11 ' HD2' ' A' ' 15' ' ' ARG . 4.8 tpp180 -65.5 -45.07 85.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.1 179.505 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.669 ' O ' HG23 ' A' ' 20' ' ' VAL . 0.9 OUTLIER -62.36 -48.13 81.14 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.911 178.961 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.411 ' HB2' ' CD1' ' A' ' 12' ' ' PHE . . . -51.76 -53.48 39.17 Favored 'General case' 0 C--N 1.328 -0.359 0 O-C-N 123.339 0.399 . . . . 0.0 111.56 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 18.7 mm-40 -56.59 -42.57 78.9 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.826 -177.121 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.96 -28.41 70.06 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.491 -179.269 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.669 HG23 ' O ' ' A' ' 16' ' ' GLN . 15.4 t -90.77 -15.14 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -172.723 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.37 -29.04 37.87 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.26 174.066 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -80.24 -15.75 56.29 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-O 121.132 0.492 . . . . 0.0 109.758 172.688 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 7.0 m -85.78 -55.12 4.12 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.759 171.305 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.547 ' HB3' ' OD1' ' A' ' 26' ' ' ASN . 34.3 m-85 -117.67 105.95 12.56 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 174.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -76.7 -2.2 31.68 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 120.962 -0.295 . . . . 0.0 111.309 -176.03 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.547 ' OD1' ' HB3' ' A' ' 24' ' ' TYR . 24.7 p-10 -75.87 -17.4 59.82 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 174.582 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.544 HG13 ' O ' ' A' ' 24' ' ' TYR . 4.2 mt -76.04 148.12 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 174.277 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 6.7 p -144.1 132.33 21.87 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 117.842 0.292 . . . . 0.0 111.05 -179.494 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.527 ' HA ' HD23 ' A' ' 39' ' ' LEU . 3.8 tt -86.53 105.65 16.97 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 176.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -118.93 163.74 16.47 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.329 -178.016 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 63.8 30.64 14.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.034 175.484 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.503 ' HA ' ' HB3' ' A' ' 37' ' ' PHE . 17.8 t0 -65.56 107.87 1.85 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.487 -178.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.418 ' HB3' ' HB2' ' A' ' 36' ' ' HIS . 60.9 tt0 -129.09 34.57 4.41 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.264 -0.88 . . . . 0.0 108.662 179.068 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 85.24 -95.48 1.98 Allowed Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.638 -178.315 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 17.4 p -80.39 -30.09 37.78 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.332 0.587 . . . . 0.0 110.453 178.378 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.418 ' HB2' ' HB3' ' A' ' 33' ' ' GLN . 9.0 m-70 -92.87 121.57 34.37 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.769 177.523 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.503 ' HB3' ' HA ' ' A' ' 32' ' ' ASP . 38.2 p90 -170.33 157.05 5.95 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 176.155 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.447 ' NH1' ' HD3' ' A' ' 51' ' ' ARG . 38.3 ptt180 -139.72 150.09 44.42 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.216 0.531 . . . . 0.0 111.709 179.176 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.527 HD23 ' HA ' ' A' ' 29' ' ' LEU . 94.4 mt -98.27 124.09 42.69 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.941 177.085 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 46.7 t -101.8 121.24 52.51 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-N 115.329 -0.851 . . . . 0.0 109.716 177.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.402 HG23 HD22 ' A' ' 63' ' ' LEU . 15.4 t -99.03 115.01 38.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-O 121.04 0.448 . . . . 0.0 110.02 -179.51 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.521 ' HD2' ' O ' ' A' ' 46' ' ' GLY . 56.0 mtm180 -100.31 167.12 10.62 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.259 179.699 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -88.84 -169.49 2.55 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.781 0.324 . . . . 0.0 110.47 -178.66 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.485 HG23 HD12 ' A' ' 72' ' ' ILE . 0.5 OUTLIER -61.53 -26.75 68.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.827 -178.528 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 18.5 tp10 -86.41 -31.47 21.42 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 120.95 0.405 . . . . 0.0 110.247 179.55 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.521 ' O ' ' HD2' ' A' ' 42' ' ' ARG . . . 112.7 20.99 6.23 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.394 -176.108 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 89.0 mtm180 -87.81 129.32 35.23 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 176.616 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 12.5 ptt? -62.79 112.54 2.58 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.125 0.488 . . . . 0.0 110.909 176.458 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.403 HG11 ' CE1' ' A' ' 66' ' ' TYR . 40.1 t -99.84 -36.65 5.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.498 179.462 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.526 ' CD1' HD23 ' A' ' 63' ' ' LEU . 58.2 t-105 -157.27 156.68 32.87 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.851 -174.404 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.447 ' HD3' ' NH1' ' A' ' 38' ' ' ARG . 7.6 ptp85 -155.79 143.32 19.47 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.139 -178.883 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -146.93 143.46 28.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.632 -0.258 . . . . 0.0 110.413 179.333 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 70.2 m95 -82.75 -168.03 1.87 Allowed 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 121.808 0.813 . . . . 0.0 111.439 -177.289 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -93.54 -35.24 13.02 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.152 -1.386 . . . . 0.0 110.622 -179.483 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 26.6 p90 -83.67 12.01 6.46 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.481 -178.369 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.664 ' HB2' ' HB2' ' A' ' 59' ' ' ALA . 10.2 mm-40 -82.1 124.07 79.09 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.37 177.779 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -45.73 -50.95 8.85 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 124.303 3.335 . . . . 0.0 113.193 -175.171 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -126.96 57.65 1.45 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.082 0.468 . . . . 0.0 109.887 176.078 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.664 ' HB2' ' HB2' ' A' ' 56' ' ' GLU . . . -54.48 -45.46 73.2 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.428 -178.864 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -63.2 -32.36 83.89 Favored Glycine 0 N--CA 1.441 -1.026 0 CA-C-N 115.135 -0.939 . . . . 0.0 112.779 -177.439 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.428 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 18.0 tp10 -59.66 -41.94 91.71 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.969 0.384 . . . . 0.0 110.623 -176.556 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -73.62 -43.19 37.3 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.456 -0.878 . . . . 0.0 112.007 179.658 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.526 HD23 ' CD1' ' A' ' 50' ' ' TRP . 65.7 mt -66.27 -46.98 75.2 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.681 0.277 . . . . 0.0 110.43 -179.308 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.472 ' HA ' HD12 ' A' ' 67' ' ' ILE . 87.2 m-20 -65.75 -25.51 67.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.477 178.781 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.428 ' HB2' ' O ' ' A' ' 61' ' ' GLU . 42.4 ttp180 -63.84 -45.25 90.38 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 178.152 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.403 ' CE1' HG11 ' A' ' 49' ' ' VAL . 85.3 t80 -69.47 -42.63 74.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.953 0.406 . . . . 0.0 110.219 175.826 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.472 HD12 ' HA ' ' A' ' 64' ' ' ASN . 97.0 mt -55.09 -37.57 43.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.476 177.15 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 47.1 ttt180 -60.27 -46.75 88.73 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.84 -178.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 16.9 p -87.57 -17.68 31.45 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -172.772 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 24.7 m -108.46 -50.17 3.07 Favored 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.447 -176.491 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 47.7 81.92 0.04 OUTLIER Glycine 0 CA--C 1.522 0.519 0 CA-C-N 115.868 -0.605 . . . . 0.0 112.948 -174.704 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.485 HD12 HG23 ' A' ' 44' ' ' THR . 35.2 mm -90.88 6.58 4.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-O 121.697 0.76 . . . . 0.0 110.304 -173.515 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.461 ' HB3' ' CE2' ' A' ' 24' ' ' TYR . 15.0 ptt180 -64.1 -1.94 1.79 Allowed 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.767 179.395 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 8.9 t -71.25 6.53 1.65 Allowed 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.266 177.612 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 . . . . . 0 N--CA 1.45 -0.437 0 CA-C-O 122.878 1.323 . . . . 0.0 109.977 178.77 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.461 ' HA3' ' HD3' ' A' ' 11' ' ' PRO . . . . . . . . 0 CA--C 1.522 0.49 0 CA-C-O 120.14 -0.255 . . . . 0.0 113.626 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.461 ' HD3' ' HA3' ' A' ' 10' ' ' GLY . 14.4 Cg_exo -67.86 142.49 57.53 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.778 2.319 . . . . 0.0 111.841 176.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.535 ' CD2' ' HB2' ' A' ' 17' ' ' ALA . 12.9 p90 -108.79 -171.8 1.92 Allowed 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.804 -175.474 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.455 ' OG1' ' HG2' ' A' ' 16' ' ' GLN . 21.5 p -125.49 175.71 7.33 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 172.807 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.498 ' HG2' HD11 ' A' ' 29' ' ' LEU . 67.9 mtm180 -65.4 -43.94 89.05 Favored 'General case' 0 C--O 1.22 -0.462 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.128 175.129 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -54.93 -50.77 68.02 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 178.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.488 ' O ' HG23 ' A' ' 20' ' ' VAL . 65.0 mm-40 -60.81 -52.78 63.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.072 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.535 ' HB2' ' CD2' ' A' ' 12' ' ' PHE . . . -56.71 -46.45 81.24 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.304 -179.156 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.475 ' HG3' ' O ' ' A' ' 14' ' ' ARG . 91.9 mt-30 -58.95 -38.52 79.24 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.492 -176.787 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.52 -26.06 68.26 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-O 121.205 0.526 . . . . 0.0 111.535 178.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 16' ' ' GLN . 3.2 t -85.49 -22.88 7.29 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.903 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 -175.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 17.8 m -85.69 -33.73 21.46 Favored 'General case' 0 N--CA 1.434 -1.267 0 CA-C-N 113.315 -1.766 . . . . 0.0 110.814 -178.061 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.0 p -67.48 -29.35 68.77 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 173.012 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 23.3 m -80.73 -53.46 6.49 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.305 173.178 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.631 ' O ' HG13 ' A' ' 27' ' ' ILE . 62.3 m-85 -106.49 98.94 8.55 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 178.572 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 37.3 p -69.51 -3.8 16.18 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.225 -0.443 . . . . 0.0 112.142 -178.019 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.627 ' OD1' ' HB3' ' A' ' 24' ' ' TYR . 24.1 p-10 -82.48 -14.18 55.45 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.986 0.422 . . . . 0.0 109.877 176.141 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.631 HG13 ' O ' ' A' ' 24' ' ' TYR . 1.2 mt -81.12 146.17 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 N-CA-C 108.372 -0.974 . . . . 0.0 108.372 173.396 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.482 ' O ' ' HA ' ' A' ' 39' ' ' LEU . 3.0 p -144.12 136.42 26.62 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.853 -0.339 . . . . 0.0 111.204 -179.238 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.498 HD11 ' HG2' ' A' ' 14' ' ' ARG . 5.1 tt -95.71 105.12 17.08 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 177.277 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -115.84 166.59 11.79 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.224 -178.555 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.504 ' HB2' ' HG2' ' A' ' 38' ' ' ARG . 0.3 OUTLIER 60.95 31.59 19.96 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.256 177.493 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -70.77 102.47 2.34 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 121.612 0.72 . . . . 0.0 111.184 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 19.5 tm0? -100.53 -30.73 11.63 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.038 175.246 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 146.11 -80.02 0.22 Allowed Glycine 0 N--CA 1.445 -0.731 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 -175.647 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 44.5 p -82.12 -31.41 30.66 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 172.642 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 60.4 m80 -96.72 126.1 41.64 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.269 177.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.453 ' HB2' HD21 ' A' ' 29' ' ' LEU . 49.7 p90 -168.21 147.19 4.53 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.485 -0.779 . . . . 0.0 109.032 177.241 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.504 ' HG2' ' HB2' ' A' ' 31' ' ' ASP . 49.2 ptt85 -129.59 149.23 51.44 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.843 0.354 . . . . 0.0 110.785 -176.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.564 ' O ' ' HA ' ' A' ' 51' ' ' ARG . 75.9 mt -106.26 144.42 32.98 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.139 0.495 . . . . 0.0 110.188 178.434 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.575 HG13 ' HB3' ' A' ' 51' ' ' ARG . 38.2 t -123.48 110.04 24.97 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.066 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.316 174.845 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.2 t -88.84 104.37 14.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 173.445 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.403 ' HA ' ' O ' ' A' ' 47' ' ' ARG . 67.2 mtt85 -94.98 171.2 8.9 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.325 -177.822 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.427 ' CG ' ' H ' ' A' ' 45' ' ' GLU . 1.5 p-10 -96.73 -169.73 1.94 Allowed 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 175.667 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.97 -17.28 62.66 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.548 -175.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.444 ' OE1' ' HD3' ' A' ' 47' ' ' ARG . 37.9 tt0 -89.18 -24.73 22.1 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 176.347 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 105.0 18.55 12.07 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.329 178.521 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.444 ' HD3' ' OE1' ' A' ' 45' ' ' GLU . 41.6 mtm-85 -85.65 142.07 29.33 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 177.452 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 11.0 ptp -77.86 105.38 9.01 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.46 0.648 . . . . 0.0 111.104 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.2 t -87.7 -36.22 9.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.69 177.46 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.518 ' CZ2' ' HB3' ' A' ' 52' ' ' ALA . 31.4 t90 -137.62 123.27 19.82 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 177.661 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.575 ' HB3' HG13 ' A' ' 40' ' ' VAL . 0.0 OUTLIER -149.47 120.1 7.5 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.518 0.675 . . . . 0.0 110.006 172.706 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.518 ' HB3' ' CZ2' ' A' ' 50' ' ' TRP . . . -155.3 174.38 15.3 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.322 -174.883 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 78.9 m95 -93.9 -158.95 0.66 Allowed 'General case' 0 N--CA 1.445 -0.698 0 CA-C-O 121.258 0.551 . . . . 0.0 110.799 -174.226 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -110.09 -32.41 7.02 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.619 -0.718 . . . . 0.0 111.25 -175.461 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -79.34 34.73 0.26 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.982 -175.452 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.557 ' HB2' ' HB2' ' A' ' 59' ' ' ALA . 51.1 mt-10 -111.04 135.19 20.87 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.058 179.633 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -51.69 -32.83 46.88 Favored 'Trans proline' 0 N--CA 1.477 0.513 0 C-N-CA 123.879 3.052 . . . . 0.0 114.375 -170.15 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.47 ' HB2' ' HB3' ' A' ' 61' ' ' GLU . 2.3 p30 -136.36 44.18 2.43 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.017 0.436 . . . . 0.0 110.617 179.419 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.557 ' HB2' ' HB2' ' A' ' 56' ' ' GLU . . . -58.74 -41.35 86.25 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.904 -178.649 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.44 ' HA2' HD12 ' A' ' 63' ' ' LEU . . . -69.2 -27.52 73.67 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.588 178.846 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.47 ' HB3' ' HB2' ' A' ' 58' ' ' ASP . 31.2 tt0 -73.46 -34.63 65.48 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.592 ' HA2' ' HD3' ' A' ' 65' ' ' ARG . . . -63.49 -41.27 99.32 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.71 -0.757 . . . . 0.0 111.487 173.747 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.46 ' O ' HG13 ' A' ' 67' ' ' ILE . 6.6 mt -64.1 -41.08 97.41 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 110.31 -0.255 . . . . 0.0 110.31 175.141 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -56.17 -33.95 65.73 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.146 0.498 . . . . 0.0 110.497 173.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.592 ' HD3' ' HA2' ' A' ' 62' ' ' GLY . 45.6 mtp85 -71.31 -28.67 64.27 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.153 179.46 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.562 ' O ' HG22 ' A' ' 69' ' ' THR . 36.9 t80 -76.24 -51.62 11.69 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.49 -0.484 . . . . 0.0 109.795 171.658 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.46 HG13 ' O ' ' A' ' 63' ' ' LEU . 46.2 mt -62.05 -13.19 9.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.172 -178.612 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 8.8 tpt180 -49.36 -32.87 12.2 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.632 172.555 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.562 HG22 ' O ' ' A' ' 66' ' ' TYR . 12.1 t -92.96 29.29 1.86 Allowed 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 121.322 0.582 . . . . 0.0 110.291 -177.312 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 7.9 t 80.22 -27.05 0.15 Allowed 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.967 0.907 . . . . 0.0 111.351 176.434 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.12 -172.27 51.17 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.468 -0.873 . . . . 0.0 111.894 -177.697 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.481 ' O ' HG22 ' A' ' 72' ' ' ILE . 32.3 mm -101.02 7.73 9.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 121.768 0.794 . . . . 0.0 110.626 -174.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -50.17 -21.24 1.24 Allowed 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.64 178.571 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 10.0 t -63.88 -1.49 1.44 Allowed 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 120.772 0.32 . . . . 0.0 110.569 176.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 19.9 t70 . . . . . 0 C--N 1.331 -0.238 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.428 177.371 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.559 ' HA2' ' HA ' ' A' ' 58' ' ' ASP . . . . . . . . 0 N--CA 1.45 -0.397 0 CA-C-O 120.147 -0.252 . . . . 0.0 112.778 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.405 ' HD3' ' HA3' ' A' ' 10' ' ' GLY . 8.0 Cg_exo -72.7 168.56 24.18 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.956 2.437 . . . . 0.0 111.856 177.004 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -125.74 -170.61 2.21 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.379 -176.597 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.473 ' H ' ' HB2' ' A' ' 16' ' ' GLN . 41.6 p -125.4 173.41 8.89 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.149 178.579 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 4.4 tmt_? -58.42 -43.91 88.86 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.548 0.689 . . . . 0.0 109.261 172.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 41.5 ttm105 -60.77 -54.13 48.96 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.525 -1.216 . . . . 0.0 111.306 178.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.634 ' O ' HG23 ' A' ' 20' ' ' VAL . 73.5 mm-40 -56.71 -49.86 73.88 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.918 179.538 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.457 ' HB1' HD21 ' A' ' 39' ' ' LEU . . . -48.84 -51.9 27.06 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.576 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 9.1 mm100 -58.68 -38.0 77.27 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.664 -177.69 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.98 -27.87 66.1 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.969 0.414 . . . . 0.0 111.446 -178.531 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.634 HG23 ' O ' ' A' ' 16' ' ' GLN . 18.7 t -89.16 -18.9 7.68 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.816 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 -172.432 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 21.1 m -93.41 -31.25 14.69 Favored 'General case' 0 N--CA 1.432 -1.328 0 CA-C-N 114.004 -1.453 . . . . 0.0 108.149 -175.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 52.9 m -61.4 -36.58 80.7 Favored 'General case' 0 N--CA 1.435 -1.187 0 CA-C-N 113.93 -1.486 . . . . 0.0 109.047 168.503 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 25.9 m -78.97 -51.4 9.67 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.592 177.403 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.63 ' O ' HG13 ' A' ' 27' ' ' ILE . 47.6 m-85 -113.37 94.81 5.04 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 177.228 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 13.7 m -73.25 1.53 9.22 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.987 0.423 . . . . 0.0 111.204 -176.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.567 ' OD1' ' HB3' ' A' ' 24' ' ' TYR . 4.4 p-10 -78.55 -18.08 55.2 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 172.323 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.63 HG13 ' O ' ' A' ' 24' ' ' TYR . 2.0 mt -79.72 152.18 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 170.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.474 ' O ' ' HA ' ' A' ' 39' ' ' LEU . 17.2 p -141.0 123.64 16.04 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.91 -178.68 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.56 ' HA ' HD23 ' A' ' 39' ' ' LEU . 6.7 tt -83.85 95.68 8.55 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 176.114 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -114.95 171.31 7.73 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.628 -175.024 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.468 ' OD2' ' HZ3' ' A' ' 53' ' ' TRP . 38.3 t70 66.39 18.34 10.84 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 123.652 0.595 . . . . 0.0 110.639 177.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.568 ' HA ' ' HB3' ' A' ' 37' ' ' PHE . 7.6 p-10 -64.78 95.97 0.17 Allowed 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 121.826 0.822 . . . . 0.0 110.752 -179.793 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -128.13 45.17 2.8 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.133 -0.939 . . . . 0.0 109.471 -179.328 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.25 -88.24 1.44 Allowed Glycine 0 N--CA 1.444 -0.815 0 CA-C-N 114.55 -1.205 . . . . 0.0 112.6 176.558 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 49.0 m -81.63 -14.4 56.75 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -173.654 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 25.7 p80 -136.74 148.95 47.57 Favored 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 119.912 -0.715 . . . . 0.0 110.953 176.669 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.568 ' HB3' ' HA ' ' A' ' 32' ' ' ASP . 45.1 p90 -170.0 161.44 8.74 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.79 -1.095 . . . . 0.0 108.474 178.708 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.421 ' HG2' ' HB3' ' A' ' 31' ' ' ASP . 32.9 ptt180 -144.05 155.57 44.04 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.052 0.453 . . . . 0.0 112.119 -178.86 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.56 HD23 ' HA ' ' A' ' 29' ' ' LEU . 95.8 mt -103.18 112.38 25.21 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.285 176.651 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 47.8 t -94.21 122.38 45.63 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.944 175.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.507 HG11 ' CD2' ' A' ' 66' ' ' TYR . 80.4 t -90.09 115.28 29.26 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 178.201 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.536 ' HA ' ' O ' ' A' ' 47' ' ' ARG . 59.1 mtp180 -110.52 161.04 16.09 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.37 -176.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -95.56 -165.81 1.35 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.18 -178.28 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 17.6 p -63.46 -27.23 69.14 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.859 0.361 . . . . 0.0 111.427 -177.228 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -82.87 -33.82 26.9 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.217 0.532 . . . . 0.0 109.788 177.511 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 110.28 18.49 8.62 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.817 -0.706 . . . . 0.0 111.584 -175.263 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.536 ' O ' ' HA ' ' A' ' 42' ' ' ARG . 52.0 mtt180 -80.53 145.57 31.74 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 179.101 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.404 ' N ' ' SD ' ' A' ' 48' ' ' MET . 1.8 mpt? -72.49 108.46 5.57 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 177.42 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 42.6 t -95.14 -31.03 4.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.459 0.647 . . . . 0.0 109.592 177.18 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.457 ' CD1' HD23 ' A' ' 63' ' ' LEU . 69.3 t-105 -159.12 157.87 31.79 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.35 -178.352 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 15.3 ptt180 -160.66 138.73 9.77 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.887 0.375 . . . . 0.0 110.114 178.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -143.12 145.76 33.13 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.043 178.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.537 ' HB2' ' OE1' ' A' ' 56' ' ' GLU . 42.4 m95 -84.71 -160.44 0.48 Allowed 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 176.736 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -107.55 0.86 22.95 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.928 -174.684 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 22.9 p90 -117.56 2.98 12.42 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -173.632 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.569 ' HB2' ' HB2' ' A' ' 59' ' ' ALA . 3.1 mp0 -66.16 132.18 94.49 Favored Pre-proline 0 C--O 1.237 0.398 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.119 173.13 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -46.65 -32.62 12.09 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 123.86 3.04 . . . . 0.0 113.358 -176.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.559 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . 4.4 t0 -146.29 62.9 1.22 Allowed 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 174.389 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.569 ' HB2' ' HB2' ' A' ' 56' ' ' GLU . . . -58.17 -35.51 71.68 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-O 121.286 0.565 . . . . 0.0 111.011 -179.054 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -59.01 -37.75 91.98 Favored Glycine 0 N--CA 1.446 -0.673 0 CA-C-N 115.281 -0.872 . . . . 0.0 113.554 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -60.5 -38.72 85.23 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 117.386 0.593 . . . . 0.0 111.182 -174.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.527 ' O ' ' HB3' ' A' ' 65' ' ' ARG . . . -72.32 -44.49 42.6 Favored Glycine 0 C--O 1.237 0.308 0 C-N-CA 120.823 -0.703 . . . . 0.0 111.99 179.078 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.457 HD23 ' CD1' ' A' ' 50' ' ' TRP . 65.6 mt -62.36 -50.24 72.36 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.705 0.288 . . . . 0.0 110.244 178.21 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.414 ' HA ' ' HB ' ' A' ' 67' ' ' ILE . 92.8 m-20 -63.43 -28.33 69.9 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.923 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.527 ' HB3' ' O ' ' A' ' 62' ' ' GLY . 10.9 ttt180 -57.02 -51.0 71.0 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.009 175.293 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.507 ' CD2' HG11 ' A' ' 41' ' ' VAL . 77.5 t80 -72.06 -38.8 69.39 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.622 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.414 ' HB ' ' HA ' ' A' ' 64' ' ' ASN . 96.4 mt -57.21 -43.97 82.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.007 0.432 . . . . 0.0 110.896 177.868 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 5.9 ttp85 -65.76 -41.85 91.61 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.89 -179.444 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 30.9 p -79.3 -44.7 21.15 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -176.7 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.427 ' O ' HD12 ' A' ' 72' ' ' ILE . 31.0 m -147.68 56.48 1.09 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.618 -173.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -64.46 130.51 37.61 Favored Glycine 0 CA--C 1.52 0.4 0 C-N-CA 120.284 -0.96 . . . . 0.0 111.9 173.205 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.533 ' HB ' ' OD1' ' A' ' 26' ' ' ASN . 1.9 mp -81.29 2.31 2.77 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 CA-C-O 121.66 0.743 . . . . 0.0 111.059 -174.758 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 15.5 ttt180 -57.48 -18.51 19.0 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 121.644 -0.66 . . . . 0.0 111.639 177.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 8.9 m -55.43 -15.42 2.66 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 121.378 0.608 . . . . 0.0 110.282 172.749 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 17.0 t70 . . . . . 0 CA--C 1.508 -0.652 0 CA-C-O 122.404 1.097 . . . . 0.0 110.144 178.676 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.446 ' HA2' ' OD1' ' A' ' 58' ' ' ASP . . . . . . . . 0 CA--C 1.519 0.311 0 CA-C-O 120.239 -0.2 . . . . 0.0 113.499 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -70.69 153.48 64.64 Favored 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 122.662 2.242 . . . . 0.0 111.577 178.539 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 16.4 p90 -115.98 -175.93 2.84 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.773 0.797 . . . . 0.0 112.134 -174.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -125.68 159.35 32.47 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-N 114.862 -1.063 . . . . 0.0 109.344 179.774 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.424 HH11 ' HD2' ' A' ' 14' ' ' ARG . 24.5 ttt85 -57.63 -48.46 79.37 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 120.895 0.379 . . . . 0.0 110.424 -179.774 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 21.4 tpp180 -46.22 -55.78 6.66 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.041 175.417 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.685 ' O ' HG23 ' A' ' 20' ' ' VAL . 1.7 mp0 -62.04 -49.45 75.94 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.857 179.22 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -53.29 -49.19 67.49 Favored 'General case' 0 N--CA 1.464 0.225 0 O-C-N 123.279 0.362 . . . . 0.0 111.557 -177.511 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -58.82 -40.14 83.27 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.433 -178.745 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.44 -24.26 66.42 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.856 179.327 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.685 HG23 ' O ' ' A' ' 16' ' ' GLN . 15.3 t -88.49 -22.75 6.58 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.794 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 -174.679 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.534 HG23 ' HB ' ' A' ' 27' ' ' ILE . 11.0 m -86.73 -31.03 21.19 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-N 113.768 -1.56 . . . . 0.0 110.575 -178.035 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.5 p -68.5 -31.34 70.53 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 170.163 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 41.0 m -75.67 -50.92 13.97 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.34 174.067 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.599 ' HB2' HG13 ' A' ' 27' ' ' ILE . 61.6 m-85 -113.16 102.26 10.21 Favored 'General case' 0 N--CA 1.447 -0.594 0 O-C-N 121.883 -0.511 . . . . 0.0 109.97 177.54 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 76.0 p -67.2 -9.25 38.33 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.06 -0.518 . . . . 0.0 112.056 -179.351 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.56 ' OD1' ' HB3' ' A' ' 24' ' ' TYR . 24.8 p-10 -79.01 -12.25 60.03 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.995 0.426 . . . . 0.0 110.035 177.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.599 HG13 ' HB2' ' A' ' 24' ' ' TYR . 2.2 mt -83.8 147.12 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 173.793 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.583 ' OG1' ' HB ' ' A' ' 40' ' ' VAL . 1.4 p -139.81 127.88 22.32 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 120.477 -0.489 . . . . 0.0 111.26 -179.07 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.521 ' HA ' HD23 ' A' ' 39' ' ' LEU . 5.6 tt -83.48 102.92 12.43 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 177.203 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -113.68 159.06 20.1 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.765 -175.632 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.8 t70 59.84 47.69 9.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.735 -179.682 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -72.27 96.54 1.85 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.976 -175.461 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -112.97 24.13 12.68 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.866 175.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 77.8 -79.99 1.38 Allowed Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.705 -0.68 . . . . 0.0 112.241 179.459 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 38.8 m -82.97 -16.69 46.26 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.077 0.465 . . . . 0.0 110.672 179.567 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 24.8 m170 -119.43 137.92 53.45 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 174.291 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -170.62 156.47 5.34 Favored 'General case' 0 C--N 1.323 -0.583 0 O-C-N 123.518 0.511 . . . . 0.0 109.769 177.803 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 11.9 ptt180 -128.53 153.28 47.35 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.136 176.17 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.546 ' O ' ' HA ' ' A' ' 51' ' ' ARG . 91.6 mt -111.21 132.54 54.25 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.177 0.513 . . . . 0.0 110.223 178.902 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.583 ' HB ' ' OG1' ' A' ' 28' ' ' THR . 38.6 t -108.99 109.23 27.56 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.624 176.849 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.468 HG11 ' CD2' ' A' ' 66' ' ' TYR . 10.9 t -85.1 118.44 32.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 173.267 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.407 ' O ' ' HB2' ' A' ' 26' ' ' ASN . 16.5 mtp180 -113.21 158.79 20.02 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 -178.097 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.448 ' CG ' ' H ' ' A' ' 45' ' ' GLU . 2.6 p-10 -89.77 -168.7 2.21 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 177.379 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 9.2 t -71.42 -14.32 62.12 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.099 -177.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.448 ' H ' ' CG ' ' A' ' 43' ' ' ASP . 32.5 tt0 -93.15 -16.02 25.36 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.34 0.591 . . . . 0.0 109.592 177.122 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 95.51 13.04 52.71 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.963 177.584 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 15.5 mtp180 -79.32 127.94 32.71 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 178.657 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.7 102.79 2.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.223 0.535 . . . . 0.0 111.213 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 43.9 t -86.72 -40.39 14.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.349 -0.842 . . . . 0.0 110.286 -179.155 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.598 ' CH2' ' HB3' ' A' ' 52' ' ' ALA . 22.6 t90 -135.48 106.57 6.7 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -178.719 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.546 ' HA ' ' O ' ' A' ' 39' ' ' LEU . 29.9 ptt180 -130.95 109.19 10.36 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 173.673 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.598 ' HB3' ' CH2' ' A' ' 50' ' ' TRP . . . -149.33 166.44 28.98 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.796 -177.456 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 44.1 m95 -85.53 -162.8 0.76 Allowed 'General case' 0 N--CA 1.445 -0.705 0 CA-C-O 121.468 0.651 . . . . 0.0 111.162 -175.139 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 61.8 t30 -105.17 -20.39 13.52 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.816 -176.035 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -83.45 14.67 3.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.15 0.5 . . . . 0.0 111.305 -178.017 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.54 ' HB2' ' HB2' ' A' ' 59' ' ' ALA . 9.4 mm-40 -80.33 129.57 68.85 Favored Pre-proline 0 C--N 1.325 -0.459 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 174.532 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -44.89 -39.1 13.85 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.867 3.045 . . . . 0.0 114.067 -172.39 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.446 ' OD1' ' HA2' ' A' ' 10' ' ' GLY . 12.7 t0 -142.11 59.02 1.47 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 178.021 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.54 ' HB2' ' HB2' ' A' ' 56' ' ' GLU . . . -56.38 -35.25 67.52 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.204 -179.636 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -62.22 -37.46 94.58 Favored Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.698 -0.683 . . . . 0.0 113.51 -177.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.404 ' CD ' HH21 ' A' ' 65' ' ' ARG . 1.4 tm-20 -59.75 -50.94 71.86 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 117.176 0.488 . . . . 0.0 110.384 -175.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -59.46 -43.05 97.8 Favored Glycine 0 CA--C 1.52 0.374 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.098 178.673 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 17.7 mt -59.31 -48.54 81.25 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.691 0.281 . . . . 0.0 111.074 176.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -65.05 -34.94 79.63 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.444 -178.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.404 HH21 ' CD ' ' A' ' 61' ' ' GLU . 14.2 ttm180 -63.63 -32.55 74.07 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.978 -178.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.468 ' CD2' HG11 ' A' ' 41' ' ' VAL . 68.6 t80 -82.45 -45.69 14.44 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 120.028 -0.669 . . . . 0.0 110.448 176.107 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 86.8 mt -55.22 -42.55 66.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.19 -178.567 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 56.8 ttp180 -55.87 -36.93 68.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.524 -178.664 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 13.6 t -105.34 25.56 10.5 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.179 0.514 . . . . 0.0 111.553 -173.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 54.0 m -149.59 -55.59 0.18 Allowed 'General case' 0 C--N 1.324 -0.534 0 O-C-N 122.126 -0.359 . . . . 0.0 111.266 177.075 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 45.03 75.64 0.16 Allowed Glycine 0 CA--C 1.524 0.632 0 CA-C-N 115.51 -0.768 . . . . 0.0 113.227 -175.082 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.475 HG21 ' HB3' ' A' ' 26' ' ' ASN . 45.9 mm -79.86 6.41 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-O 121.62 0.724 . . . . 0.0 111.118 -172.895 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.439 ' C ' ' H ' ' A' ' 75' ' ' ASP . 9.3 ptm180 -69.31 -2.82 11.73 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.193 178.848 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.4 t -72.26 8.48 1.31 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.971 175.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.439 ' H ' ' C ' ' A' ' 73' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.445 -0.675 0 CA-C-O 123.061 1.41 . . . . 0.0 110.896 -177.305 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.447 ' HA3' ' HD3' ' A' ' 11' ' ' PRO . . . . . . . . 0 CA--C 1.518 0.277 0 CA-C-O 120.117 -0.268 . . . . 0.0 113.404 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.447 ' HD3' ' HA3' ' A' ' 10' ' ' GLY . 17.7 Cg_exo -66.87 170.85 12.0 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.915 2.41 . . . . 0.0 112.531 178.44 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -136.25 -173.48 3.41 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.084 -177.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.435 ' H ' ' HB2' ' A' ' 16' ' ' GLN . 27.5 p -122.21 178.17 5.04 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.227 175.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.639 ' O ' ' HG2' ' A' ' 18' ' ' GLN . 36.4 ttt-85 -63.0 -46.99 85.08 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 176.695 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 70.6 mtp180 -57.01 -48.36 78.67 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.133 178.342 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.58 ' O ' HG23 ' A' ' 20' ' ' VAL . 81.2 mm-40 -60.4 -46.9 88.33 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 178.548 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.434 ' HB1' HD11 ' A' ' 39' ' ' LEU . . . -52.32 -47.1 66.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.565 177.576 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.639 ' HG2' ' O ' ' A' ' 14' ' ' ARG . 86.7 mm-40 -55.07 -48.06 74.03 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.504 -178.55 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.67 -28.53 69.99 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -175.664 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.58 HG23 ' O ' ' A' ' 16' ' ' GLN . 11.3 t -86.91 -25.57 6.18 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.787 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 -171.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.516 HG23 ' HB ' ' A' ' 27' ' ' ILE . 17.7 m -86.36 -31.25 21.61 Favored 'General case' 0 N--CA 1.435 -1.222 0 CA-C-N 113.735 -1.575 . . . . 0.0 111.211 -177.803 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.7 p -69.16 -29.01 66.93 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 172.263 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 19.5 m -77.34 -56.0 4.92 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.222 171.655 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.646 ' HB3' ' OD1' ' A' ' 26' ' ' ASN . 58.0 m-85 -105.13 98.07 7.83 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 -179.811 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.9 p -70.24 1.12 5.18 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 120.728 0.299 . . . . 0.0 111.759 178.68 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.646 ' OD1' ' HB3' ' A' ' 24' ' ' TYR . 4.5 p-10 -83.26 -10.87 58.3 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 174.205 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.622 HG13 ' O ' ' A' ' 24' ' ' TYR . 1.7 mt -85.25 138.02 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 173.058 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.503 ' OG1' ' HB ' ' A' ' 40' ' ' VAL . 2.3 p -130.62 126.43 36.62 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 120.641 -0.424 . . . . 0.0 111.043 -176.318 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.416 ' HA ' HD23 ' A' ' 39' ' ' LEU . 5.4 tt -91.26 108.05 19.62 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -122.97 167.9 13.0 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.719 178.767 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.571 ' HB2' HH11 ' A' ' 38' ' ' ARG . 0.7 OUTLIER 62.59 67.66 0.7 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.618 -177.88 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -81.38 100.25 9.14 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.657 -175.273 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -114.08 6.96 16.58 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.534 0.683 . . . . 0.0 109.553 174.261 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.62 -79.71 1.28 Allowed Glycine 0 N--CA 1.45 -0.419 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.948 -179.112 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 17.1 m -86.36 -18.63 31.38 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.156 0.503 . . . . 0.0 110.359 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 29.7 m170 -114.25 132.07 56.27 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.73 173.12 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.501 ' HA ' ' O ' ' A' ' 31' ' ' ASP . 52.9 p90 -164.59 157.37 16.89 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 178.812 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.607 ' HA ' ' HA ' ' A' ' 53' ' ' TRP . 27.0 ptt-85 -124.47 142.42 51.34 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 119.567 -0.853 . . . . 0.0 111.31 177.766 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.506 ' O ' ' HA ' ' A' ' 51' ' ' ARG . 63.0 mt -104.05 134.74 46.81 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.589 176.133 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.541 HG13 ' HB3' ' A' ' 51' ' ' ARG . 40.6 t -112.83 116.41 52.53 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.959 175.408 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.552 ' HB ' ' HB3' ' A' ' 50' ' ' TRP . 97.1 t -86.36 107.97 17.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.239 173.727 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.43 HH11 ' HD2' ' A' ' 42' ' ' ARG . 14.7 mtp180 -101.48 156.57 17.39 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.543 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.443 ' HA ' ' OH ' ' A' ' 66' ' ' TYR . 1.9 p-10 -88.91 -171.06 3.14 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 120.793 0.33 . . . . 0.0 110.947 -175.605 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 12.2 t -64.1 -22.53 66.97 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.878 -177.287 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -87.14 -31.52 20.36 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 178.478 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 114.01 14.07 9.56 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.339 -179.579 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 72.3 mtp180 -91.01 140.98 29.33 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 179.348 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 22.3 ptt? -74.91 118.79 18.26 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.227 0.537 . . . . 0.0 111.459 -177.201 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 34.0 t -101.6 -32.41 3.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.002 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.552 ' HB3' ' HB ' ' A' ' 41' ' ' VAL . 49.3 t90 -144.77 136.58 25.74 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.973 -1.012 . . . . 0.0 108.542 -179.76 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.573 ' O ' ' HD2' ' A' ' 51' ' ' ARG . 0.0 OUTLIER -158.01 119.99 3.67 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 121.448 0.642 . . . . 0.0 110.354 174.772 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.519 ' HB3' ' CZ2' ' A' ' 50' ' ' TRP . . . -151.83 171.3 17.95 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.091 -177.747 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.607 ' HA ' ' HA ' ' A' ' 38' ' ' ARG . 87.7 m95 -80.26 -95.25 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -172.333 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -162.1 -35.8 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.123 0.487 . . . . 0.0 110.607 -176.249 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -84.67 14.86 4.23 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.396 -177.027 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.526 ' HB2' ' HB2' ' A' ' 59' ' ' ALA . 1.9 mm-40 -66.52 128.02 93.64 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.1 -178.008 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_exo -38.19 -49.6 2.25 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 124.338 3.359 . . . . 0.0 113.541 -176.214 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -138.92 69.16 1.37 Allowed 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 172.191 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.526 ' HB2' ' HB2' ' A' ' 56' ' ' GLU . . . -57.75 -33.86 68.92 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.898 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -55.16 -41.84 79.85 Favored Glycine 0 N--CA 1.446 -0.694 0 CA-C-N 115.241 -0.89 . . . . 0.0 112.963 178.542 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.616 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 9.0 tp10 -49.02 -54.76 14.37 Favored 'General case' 0 C--O 1.223 -0.332 0 CA-C-N 116.974 0.387 . . . . 0.0 111.059 -178.143 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.498 ' HA3' ' CD1' ' A' ' 50' ' ' TRP . . . -65.22 -40.94 97.03 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.777 -178.157 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.478 HD23 HG21 ' A' ' 41' ' ' VAL . 49.3 mt -62.82 -51.04 68.61 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.609 0.242 . . . . 0.0 110.943 179.669 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 51.8 m-80 -69.15 -24.78 64.12 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.941 0.4 . . . . 0.0 110.28 179.775 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.616 ' HB2' ' O ' ' A' ' 61' ' ' GLU . 12.6 ttt85 -61.91 -37.64 85.41 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.961 177.277 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.443 ' OH ' ' HA ' ' A' ' 43' ' ' ASP . 91.4 t80 -82.32 -47.92 11.79 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.992 176.753 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.422 HG13 ' O ' ' A' ' 63' ' ' LEU . 72.2 mt -56.52 -21.85 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 CA-C-O 120.992 0.425 . . . . 0.0 111.404 179.718 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 49.6 ttp180 -50.24 -34.04 21.69 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.455 175.214 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.417 ' O ' ' HB2' ' A' ' 70' ' ' SER . 6.9 t -102.89 61.85 0.8 Allowed 'General case' 0 N--CA 1.443 -0.779 0 CA-C-O 122.062 0.934 . . . . 0.0 109.217 179.464 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.417 ' HB2' ' O ' ' A' ' 69' ' ' THR . 63.2 m 78.18 -51.63 0.49 Allowed 'General case' 0 C--O 1.236 0.356 0 CA-C-N 114.224 -1.353 . . . . 0.0 112.978 172.491 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.06 175.71 51.16 Favored Glycine 0 CA--C 1.52 0.38 0 N-CA-C 111.585 -0.606 . . . . 0.0 111.585 -172.248 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.592 ' HB ' ' OD1' ' A' ' 26' ' ' ASN . 1.1 mp -83.29 -5.62 9.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.458 0.647 . . . . 0.0 111.061 -177.313 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 23.7 ptt180 -59.34 -20.94 58.65 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.408 175.811 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.6 m -68.66 -1.54 7.12 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.058 177.664 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.7 t0 . . . . . 0 C--N 1.326 -0.415 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 177.654 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.578 ' HA3' ' O ' ' A' ' 57' ' ' PRO . . . . . . . . 0 N--CA 1.445 -0.766 0 N-CA-C 111.776 -0.53 . . . . 0.0 111.776 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.583 ' HG3' ' HA ' ' A' ' 57' ' ' PRO . 3.4 Cg_exo -78.86 133.67 11.46 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 121.547 1.498 . . . . 0.0 111.659 175.526 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 26.7 p90 -100.89 -170.78 1.9 Allowed 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.525 -0.762 . . . . 0.0 111.139 -178.12 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.438 ' OG1' ' HG2' ' A' ' 16' ' ' GLN . 21.2 p -125.73 172.53 9.73 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 176.24 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.529 ' O ' ' HG3' ' A' ' 18' ' ' GLN . 1.9 tmt_? -61.03 -49.1 78.76 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 174.365 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' A' ' 15' ' ' ARG . 13.7 ttp85 -52.56 -52.57 54.31 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.823 -1.08 . . . . 0.0 111.376 176.428 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.617 ' O ' HG23 ' A' ' 20' ' ' VAL . 15.6 mm100 -59.27 -47.34 85.75 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.587 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -52.11 -48.31 64.86 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.719 179.214 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.529 ' HG3' ' O ' ' A' ' 14' ' ' ARG . 44.9 mt-30 -54.94 -48.58 72.99 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.446 -179.321 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.98 -35.14 76.02 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.181 0.515 . . . . 0.0 111.175 -178.673 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.617 HG23 ' O ' ' A' ' 16' ' ' GLN . 16.4 t -82.29 -13.14 12.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.756 -175.08 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.472 HG23 ' HB ' ' A' ' 27' ' ' ILE . 0.0 OUTLIER -91.87 -34.72 14.41 Favored 'General case' 0 CA--C 1.507 -0.674 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 176.349 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 22.1 m -56.24 -30.87 62.96 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 114.294 -1.321 . . . . 0.0 109.665 167.39 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.406 ' O ' ' HA ' ' A' ' 73' ' ' ARG . 28.0 m -89.38 -46.99 8.32 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.794 178.257 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.625 ' O ' HG13 ' A' ' 27' ' ' ILE . 36.9 m-85 -122.29 104.81 9.69 Favored 'General case' 0 N--CA 1.447 -0.611 0 O-C-N 121.767 -0.583 . . . . 0.0 109.481 177.639 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 7.2 p -77.09 -6.07 51.4 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -177.216 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.454 ' ND2' ' HB3' ' A' ' 24' ' ' TYR . 6.4 p30 -71.71 -19.36 62.06 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 173.466 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.625 HG13 ' O ' ' A' ' 24' ' ' TYR . 1.9 mt -77.01 138.95 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 CA-C-N 115.258 -0.883 . . . . 0.0 108.622 177.433 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.545 ' OG1' ' HB ' ' A' ' 40' ' ' VAL . 1.3 p -137.0 146.4 45.28 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 121.18 -0.208 . . . . 0.0 110.534 -175.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.493 ' HA ' HD23 ' A' ' 39' ' ' LEU . 4.5 tt -100.31 122.98 43.96 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.962 0.411 . . . . 0.0 110.193 -176.32 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.551 ' HB2' ' HG3' ' A' ' 38' ' ' ARG . 24.0 mt-10 -116.82 155.15 29.47 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.679 175.63 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 59.92 52.88 5.01 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.205 171.728 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.454 ' OD2' HD22 ' A' ' 29' ' ' LEU . 2.0 m-20 -62.3 83.51 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.762 178.551 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -119.46 71.31 0.87 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.333 0.587 . . . . 0.0 111.088 -177.657 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 66.11 -106.88 1.73 Allowed Glycine 0 N--CA 1.445 -0.73 0 CA-C-N 115.094 -0.957 . . . . 0.0 112.966 174.69 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 39.7 t -85.49 -14.24 46.63 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 111.667 0.247 . . . . 0.0 111.667 -175.558 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 34.4 p-80 -129.7 143.02 50.62 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.071 -0.651 . . . . 0.0 111.598 -177.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -163.88 179.35 7.11 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 179.481 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.551 ' HG3' ' HB2' ' A' ' 30' ' ' GLU . 13.6 ptt180 -127.41 154.26 45.25 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.015 -0.674 . . . . 0.0 110.866 176.072 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.493 HD23 ' HA ' ' A' ' 29' ' ' LEU . 95.5 mt -115.93 136.15 53.3 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.024 0.44 . . . . 0.0 110.392 178.336 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.545 ' HB ' ' OG1' ' A' ' 28' ' ' THR . 21.4 t -107.21 120.85 59.23 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.556 178.319 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 63.5 t -89.28 122.63 40.84 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 173.019 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 42' ' ' ARG . 24.8 mtp85 -111.39 159.61 17.85 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.344 0.593 . . . . 0.0 110.558 -178.741 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -90.97 176.83 6.46 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.295 178.736 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 17.8 p -68.96 -15.69 63.55 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.757 0.313 . . . . 0.0 111.303 -177.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -83.88 -17.08 42.04 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.491 0.662 . . . . 0.0 109.363 172.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 91.14 11.04 61.78 Favored Glycine 0 N--CA 1.447 -0.61 0 CA-C-N 115.291 -0.868 . . . . 0.0 112.517 -178.643 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 31.8 ptt85 -81.19 138.22 35.84 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 175.505 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 14.4 ptm -61.22 127.47 31.69 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.049 0.452 . . . . 0.0 110.839 177.625 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 13.5 t -102.68 -39.11 5.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.86 177.768 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 75.6 t-105 -166.54 121.69 1.16 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.991 -175.645 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.407 ' HB3' HG22 ' A' ' 40' ' ' VAL . 4.8 ptp85 -120.39 125.14 47.23 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 174.158 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -134.67 157.59 46.25 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.155 -176.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.563 ' HB2' ' HG3' ' A' ' 56' ' ' GLU . 81.7 m95 -85.6 -174.45 5.17 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 122.203 1.001 . . . . 0.0 111.988 -177.392 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.461 HD22 ' C ' ' A' ' 54' ' ' ASN . 0.2 OUTLIER -96.34 -33.52 11.91 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 113.692 -1.595 . . . . 0.0 110.158 -176.59 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 17.8 p90 -85.84 10.56 13.42 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.625 -174.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.563 ' HG3' ' HB2' ' A' ' 53' ' ' TRP . 25.5 mt-10 -88.19 128.59 52.96 Favored Pre-proline 0 C--N 1.322 -0.593 0 C-N-CA 121.007 -0.277 . . . . 0.0 110.406 -178.651 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.583 ' HA ' ' HG3' ' A' ' 11' ' ' PRO . 21.9 Cg_exo -65.14 -5.22 10.56 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.46 2.774 . . . . 0.0 114.094 -171.893 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -141.03 25.93 2.07 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.365 0.126 . . . . 0.0 111.132 -179.161 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.544 ' O ' ' HG ' ' A' ' 63' ' ' LEU . . . -57.06 -46.6 82.33 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.166 0.508 . . . . 0.0 110.997 -176.888 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -74.0 -22.05 78.41 Favored Glycine 0 N--CA 1.443 -0.843 0 CA-C-N 115.775 -0.648 . . . . 0.0 113.303 -176.307 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -70.87 -33.43 70.6 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 117.182 0.491 . . . . 0.0 109.905 -177.023 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.52 ' O ' ' HB3' ' A' ' 65' ' ' ARG . . . -79.43 -38.27 21.77 Favored Glycine 0 N--CA 1.45 -0.399 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 175.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.544 ' HG ' ' O ' ' A' ' 59' ' ' ALA . 92.4 mt -61.77 -44.73 96.31 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.381 -0.409 . . . . 0.0 110.024 176.581 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.558 ' HA ' ' HB ' ' A' ' 67' ' ' ILE . 90.4 m-20 -62.96 -33.59 75.7 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.896 177.788 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.52 ' HB3' ' O ' ' A' ' 62' ' ' GLY . 9.5 tpt180 -54.39 -40.4 68.15 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.833 0.349 . . . . 0.0 110.439 173.72 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -77.33 -48.56 17.03 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.905 0.384 . . . . 0.0 110.545 174.581 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.558 ' HB ' ' HA ' ' A' ' 64' ' ' ASN . 84.2 mt -52.83 -56.15 8.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -174.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -71.86 -32.89 67.95 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.705 0.288 . . . . 0.0 111.656 -169.549 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.03 28.71 7.98 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -176.079 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 62.4 m -148.77 -53.75 0.18 Allowed 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 172.33 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 53.84 89.13 0.01 OUTLIER Glycine 0 CA--C 1.522 0.529 0 CA-C-N 115.422 -0.808 . . . . 0.0 114.373 176.381 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.451 ' O ' HG22 ' A' ' 72' ' ' ILE . 38.2 mm -86.37 7.02 2.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.749 0.785 . . . . 0.0 109.89 178.612 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.409 ' C ' ' H ' ' A' ' 75' ' ' ASP . 4.6 ptm180 -63.95 -13.5 46.42 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.646 -178.59 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 14.3 t -75.52 5.69 5.62 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 174.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.409 ' H ' ' C ' ' A' ' 73' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.466 0.342 0 C-N-CA 124.939 1.295 . . . . 0.0 112.499 176.501 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.482 ' HA3' ' HD3' ' A' ' 11' ' ' PRO . . . . . . . . 0 CA--C 1.522 0.527 0 N-CA-C 114.812 0.685 . . . . 0.0 114.812 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.514 ' HG3' ' HA ' ' A' ' 57' ' ' PRO . 1.3 Cg_endo -80.53 142.64 14.71 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 122.852 2.368 . . . . 0.0 112.409 -179.216 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.445 ' CZ ' ' HA ' ' A' ' 54' ' ' ASN . 9.8 p90 -111.46 -171.39 1.83 Allowed 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.002 -179.275 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.436 ' OG1' ' HG2' ' A' ' 16' ' ' GLN . 16.7 p -124.61 179.94 4.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.186 178.868 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.409 ' O ' ' HG3' ' A' ' 18' ' ' GLN . 5.6 ttm180 -65.8 -53.58 38.37 Favored 'General case' 0 N--CA 1.427 -1.591 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.705 -178.887 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.429 HH11 ' HD2' ' A' ' 15' ' ' ARG . 20.6 ptt85 -62.37 -36.46 82.34 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.204 178.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.618 ' O ' HG23 ' A' ' 20' ' ' VAL . 87.7 mm-40 -62.31 -48.18 81.0 Favored 'General case' 0 CA--C 1.519 -0.246 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 176.516 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -55.0 -47.9 74.05 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.99 175.602 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.409 ' HG3' ' O ' ' A' ' 14' ' ' ARG . 99.1 mt-30 -57.59 -42.54 83.36 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.401 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.454 ' O ' ' HB ' ' A' ' 22' ' ' THR . . . -62.59 -34.59 77.29 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.985 178.31 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.618 HG23 ' O ' ' A' ' 16' ' ' GLN . 24.3 t -79.18 -16.33 13.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.808 0.337 . . . . 0.0 110.362 -178.034 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.555 HG23 ' HB ' ' A' ' 27' ' ' ILE . 0.0 OUTLIER -92.24 -26.42 18.18 Favored 'General case' 0 CA--C 1.503 -0.83 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 177.624 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.454 ' HB ' ' O ' ' A' ' 19' ' ' ALA . 98.0 m -61.12 -32.97 72.65 Favored 'General case' 0 N--CA 1.437 -1.122 0 CA-C-N 113.612 -1.631 . . . . 0.0 109.419 167.859 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.8 m -87.45 -50.66 6.4 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.968 178.264 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.637 ' O ' HG13 ' A' ' 27' ' ' ILE . 35.0 m-85 -116.64 102.37 9.39 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 -179.469 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 15.6 p -81.21 5.34 17.3 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.942 0.401 . . . . 0.0 111.419 -177.638 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.538 ' OD1' ' HB3' ' A' ' 24' ' ' TYR . 25.5 p-10 -83.53 -17.31 42.28 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 172.221 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.637 HG13 ' O ' ' A' ' 24' ' ' TYR . 1.1 mt -78.22 148.48 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 N-CA-C 108.183 -1.044 . . . . 0.0 108.183 173.5 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.504 ' O ' ' HA ' ' A' ' 39' ' ' LEU . 1.7 p -141.68 133.94 27.91 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.498 -0.481 . . . . 0.0 111.465 -178.029 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.518 ' HA ' HD23 ' A' ' 39' ' ' LEU . 6.5 tt -87.88 100.6 13.0 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 179.623 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -115.75 166.5 11.87 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.848 -174.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 60.6 37.22 19.49 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 123.388 0.43 . . . . 0.0 111.462 171.871 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -74.95 125.11 28.19 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.135 0.493 . . . . 0.0 111.305 -175.278 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -126.69 25.2 6.45 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.526 173.204 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.0 -90.87 1.6 Allowed Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.038 -177.794 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.0 t -78.27 -7.13 56.83 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.262 0.553 . . . . 0.0 110.863 -178.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 57.2 m80 -131.42 138.56 49.13 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.647 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.41 ' O ' ' HA ' ' A' ' 53' ' ' TRP . 52.8 p90 -168.81 166.39 11.49 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.306 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.502 ' HA ' ' HA ' ' A' ' 53' ' ' TRP . 70.2 mtm180 -128.28 132.98 48.69 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.518 HD23 ' HA ' ' A' ' 29' ' ' LEU . 64.4 mt -95.45 107.65 19.81 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.348 0.594 . . . . 0.0 109.661 174.244 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 60.7 t -89.48 116.87 31.71 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.896 177.826 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.465 HG22 HG23 ' A' ' 27' ' ' ILE . 25.4 t -89.4 110.58 21.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 178.057 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.415 ' HA ' ' O ' ' A' ' 47' ' ' ARG . 33.7 mtt85 -97.03 171.82 8.24 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.806 -178.685 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.437 ' CG ' ' H ' ' A' ' 45' ' ' GLU . 1.3 p-10 -104.17 -168.91 1.55 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.602 -178.752 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.1 p -63.01 -22.74 67.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.108 -179.202 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.437 ' H ' ' CG ' ' A' ' 43' ' ' ASP . 9.9 tp10 -89.81 -28.56 19.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.057 0.456 . . . . 0.0 110.073 178.42 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 107.19 19.36 9.51 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.055 -178.151 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.415 ' O ' ' HA ' ' A' ' 42' ' ' ARG . 51.0 mtp180 -89.79 143.99 26.34 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 178.227 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.8 113.74 8.17 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.227 0.537 . . . . 0.0 110.709 178.391 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 58.0 t -98.83 -33.46 4.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.135 178.459 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 73.3 t-105 -153.0 157.44 40.55 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.989 -176.361 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.417 HH11 ' HD2' ' A' ' 51' ' ' ARG . 20.6 ptt85 -156.93 146.19 20.33 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 177.917 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -152.95 153.42 32.95 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 177.388 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.633 ' HB2' ' OE1' ' A' ' 56' ' ' GLU . 80.4 m95 -77.39 -92.66 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.05 0.452 . . . . 0.0 110.857 -179.048 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.445 ' HA ' ' CZ ' ' A' ' 12' ' ' PHE . 26.7 t-20 -175.58 -37.78 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.385 -177.889 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -86.0 -15.04 42.72 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -169.136 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.633 ' OE1' ' HB2' ' A' ' 53' ' ' TRP . 2.4 mp0 -62.88 137.16 96.8 Favored Pre-proline 0 C--N 1.327 -0.408 0 N-CA-C 110.321 -0.251 . . . . 0.0 110.321 -179.236 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.514 ' HA ' ' HG3' ' A' ' 11' ' ' PRO . 43.2 Cg_endo -68.59 5.35 1.31 Allowed 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.879 2.386 . . . . 0.0 112.917 -177.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -138.6 12.24 2.73 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.465 177.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.52 ' HB2' ' HB2' ' A' ' 56' ' ' GLU . . . -62.31 -43.35 99.02 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-O 121.239 0.542 . . . . 0.0 110.738 -172.773 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -68.03 -29.72 73.63 Favored Glycine 0 N--CA 1.442 -0.936 0 CA-C-N 115.346 -0.843 . . . . 0.0 112.301 179.215 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -72.44 -29.51 63.76 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 120.494 -0.483 . . . . 0.0 109.719 -178.421 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -68.57 -41.87 82.8 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.573 -0.822 . . . . 0.0 111.077 176.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 57.7 mt -64.16 -47.8 78.46 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.906 0.384 . . . . 0.0 110.143 176.363 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 9.5 m-20 -61.9 -29.2 70.05 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.953 177.067 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 36.0 ttm180 -65.73 -37.99 87.94 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.191 179.41 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -70.39 -50.3 40.17 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 174.203 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 99.0 mt -53.83 -35.97 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.068 179.097 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 50.0 ttt180 -49.72 -32.44 13.5 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -176.548 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.408 ' O ' ' HB2' ' A' ' 70' ' ' SER . 41.0 p -56.26 -38.37 71.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.038 0.447 . . . . 0.0 111.147 -178.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.408 ' HB2' ' O ' ' A' ' 69' ' ' THR . 37.2 t 167.32 -38.13 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 114.914 -1.039 . . . . 0.0 108.997 -174.838 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 84.12 147.34 8.05 Favored Glycine 0 N--CA 1.447 -0.628 0 CA-C-N 115.416 -0.811 . . . . 0.0 112.264 -178.59 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.466 ' O ' HG22 ' A' ' 72' ' ' ILE . 38.9 mm -83.29 6.7 1.69 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-O 121.672 0.749 . . . . 0.0 110.161 -178.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.476 ' HB3' ' CE2' ' A' ' 24' ' ' TYR . 16.1 ptt-85 -62.86 -24.28 67.72 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.74 178.061 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 20.0 m -60.95 -20.69 62.59 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.433 0.635 . . . . 0.0 109.548 173.725 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 29.5 t0 . . . . . 0 CA--C 1.517 -0.309 0 CA-C-N 114.036 -1.438 . . . . 0.0 112.914 -175.621 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.555 ' HA2' ' HA ' ' A' ' 58' ' ' ASP . . . . . . . . 0 N--CA 1.451 -0.304 0 CA-C-O 119.795 -0.447 . . . . 0.0 113.024 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -67.59 154.66 72.87 Favored 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 122.512 2.141 . . . . 0.0 112.396 177.662 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.479 ' CD2' ' HB2' ' A' ' 17' ' ' ALA . 15.9 p90 -126.79 -172.14 2.57 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.968 -176.682 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.52 ' OG1' ' HG2' ' A' ' 16' ' ' GLN . 31.9 p -125.47 176.13 7.03 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 172.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.524 ' HG2' HD11 ' A' ' 29' ' ' LEU . 45.1 mtm180 -65.38 -43.83 89.45 Favored 'General case' 0 C--O 1.219 -0.52 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.332 173.53 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 16.7 mtp180 -56.94 -46.97 81.71 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.933 179.174 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.554 ' O ' HG23 ' A' ' 20' ' ' VAL . 10.6 mm100 -64.37 -49.89 69.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.962 178.499 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.479 ' HB2' ' CD2' ' A' ' 12' ' ' PHE . . . -56.24 -49.05 75.26 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.768 179.339 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.443 ' HG2' ' O ' ' A' ' 14' ' ' ARG . 15.2 mm100 -55.28 -38.6 68.83 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.432 -178.54 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.11 -25.67 66.32 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.656 178.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 16' ' ' GLN . 31.3 t -91.61 -16.88 7.85 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.721 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 -173.731 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.537 HG23 ' HB ' ' A' ' 27' ' ' ILE . 6.2 m -93.74 -27.02 16.74 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-N 113.839 -1.528 . . . . 0.0 107.612 -177.623 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.9 m -65.07 -35.55 81.51 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 113.636 -1.62 . . . . 0.0 108.943 165.097 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 41.6 m -74.57 -55.93 5.38 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.559 177.073 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.66 ' HB3' ' OD1' ' A' ' 26' ' ' ASN . 63.9 m-85 -114.21 104.13 11.79 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-O 121.097 0.475 . . . . 0.0 109.839 178.71 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.3 p -69.72 -6.52 32.37 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.309 -179.629 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.66 ' OD1' ' HB3' ' A' ' 24' ' ' TYR . 7.6 p-10 -79.5 -8.83 59.42 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.167 0.508 . . . . 0.0 109.723 175.459 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.561 HG13 ' HB2' ' A' ' 24' ' ' TYR . 4.2 mt -88.19 157.42 3.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 172.834 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -153.37 130.82 11.36 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.639 -0.424 . . . . 0.0 111.298 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.526 ' HA ' HD23 ' A' ' 39' ' ' LEU . 6.5 tt -90.01 111.11 22.09 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -178.334 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -123.97 170.94 10.12 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.141 -178.552 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.8 t70 61.85 30.17 18.13 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.432 -0.803 . . . . 0.0 110.061 -178.319 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -63.18 99.33 0.17 Allowed 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.505 -177.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -112.74 -6.98 13.83 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.242 176.461 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.419 ' HA2' ' NH1' ' A' ' 14' ' ' ARG . . . 129.74 -102.42 0.55 Allowed Glycine 0 N--CA 1.448 -0.518 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.036 -177.399 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 37.2 m -79.3 -19.68 49.87 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 172.309 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -93.13 120.38 33.37 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.715 173.352 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.429 ' HE2' ' HE2' ' A' ' 12' ' ' PHE . 35.6 p90 -174.8 165.93 3.66 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 176.007 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.427 HH11 ' HD3' ' A' ' 38' ' ' ARG . 13.8 ptt180 -142.17 142.95 32.75 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.093 0.473 . . . . 0.0 110.774 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.526 HD23 ' HA ' ' A' ' 29' ' ' LEU . 82.0 mt -95.68 121.65 37.61 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.193 0.52 . . . . 0.0 110.375 179.819 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 41.4 t -98.46 115.14 37.98 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.632 178.021 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.0 t -96.69 118.63 43.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 121.122 0.487 . . . . 0.0 110.11 -177.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.478 ' HA ' ' O ' ' A' ' 47' ' ' ARG . 39.1 mtm105 -103.08 168.8 8.95 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.485 -178.466 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.475 ' CG ' ' H ' ' A' ' 45' ' ' GLU . 0.5 OUTLIER -96.09 -167.91 1.66 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.037 -0.528 . . . . 0.0 109.986 178.505 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 23.2 p -64.01 -26.17 68.45 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.317 -178.581 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.554 ' HB3' ' HD2' ' A' ' 47' ' ' ARG . 9.1 tp10 -95.84 -13.0 24.37 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 121.18 0.515 . . . . 0.0 110.433 -177.044 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 104.63 15.28 21.24 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.575 179.278 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.554 ' HD2' ' HB3' ' A' ' 45' ' ' GLU . 0.0 OUTLIER -78.0 128.54 34.04 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 178.448 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 63.1 mtm -74.27 99.89 3.58 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 177.019 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 23.7 t -86.92 -33.45 6.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.641 -174.741 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.424 ' CD1' HD23 ' A' ' 63' ' ' LEU . 75.5 t-105 -153.72 150.78 28.89 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.486 -173.838 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 16.0 ptt180 -156.09 141.24 17.42 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 174.811 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -142.92 153.49 43.14 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.415 -178.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.515 ' HB2' ' HG2' ' A' ' 56' ' ' GLU . 98.0 m95 -75.62 -167.41 0.68 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.643 0.735 . . . . 0.0 111.73 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -103.98 -40.88 6.04 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.746 -1.115 . . . . 0.0 111.413 -177.755 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 13.8 p90 -83.24 10.27 8.82 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.82 -174.319 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.642 ' HB2' ' HB2' ' A' ' 59' ' ' ALA . 11.9 mm-40 -77.55 131.75 70.56 Favored Pre-proline 0 C--N 1.324 -0.538 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 177.676 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 56' ' ' GLU . 52.1 Cg_exo -55.39 -21.26 28.99 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 123.493 2.795 . . . . 0.0 113.217 -176.487 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.555 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . 4.2 p30 -136.86 38.34 2.59 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.77 0.319 . . . . 0.0 110.621 177.476 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.642 ' HB2' ' HB2' ' A' ' 56' ' ' GLU . . . -55.0 -52.75 62.16 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 121.22 0.533 . . . . 0.0 111.36 -174.344 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.424 ' HA2' HD12 ' A' ' 63' ' ' LEU . . . -67.7 -28.62 73.51 Favored Glycine 0 N--CA 1.44 -1.091 0 CA-C-N 115.422 -0.808 . . . . 0.0 112.729 -178.024 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -68.15 -35.88 78.77 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 117.139 0.469 . . . . 0.0 110.407 -176.605 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -68.49 -42.46 81.38 Favored Glycine 0 CA--C 1.519 0.299 0 C-N-CA 120.645 -0.788 . . . . 0.0 111.305 175.072 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.462 ' O ' HG13 ' A' ' 67' ' ' ILE . 49.7 mt -61.05 -47.47 86.21 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.994 -0.372 . . . . 0.0 109.994 176.014 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.508 ' HA ' ' HB ' ' A' ' 67' ' ' ILE . 94.0 m-20 -63.57 -29.29 70.57 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.791 177.679 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 6.4 ttt180 -58.93 -39.66 82.25 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 177.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -76.88 -46.59 24.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.505 173.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.508 ' HB ' ' HA ' ' A' ' 64' ' ' ASN . 93.7 mt -53.41 -46.16 58.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.681 -178.378 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 47.6 ttt85 -57.69 -36.56 72.12 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.948 -176.759 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.5 p -105.4 20.81 18.26 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -176.148 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 15.0 m -139.16 -57.31 0.6 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.688 0.28 . . . . 0.0 110.841 178.545 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 40.1 77.71 0.07 OUTLIER Glycine 0 CA--C 1.521 0.461 0 CA-C-N 115.189 -0.914 . . . . 0.0 113.512 -175.673 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.513 ' HB ' ' OD1' ' A' ' 26' ' ' ASN . 37.8 mm -82.55 5.73 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 CA-C-O 121.465 0.65 . . . . 0.0 111.317 -171.383 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 30.7 ttt-85 -75.84 -65.95 0.84 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.072 0.463 . . . . 0.0 111.839 -179.498 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 61.5 m -66.04 -8.32 22.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.127 -178.538 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 16.4 t70 . . . . . 0 C--N 1.326 -0.418 0 CA-C-N 114.29 -1.323 . . . . 0.0 111.705 -170.982 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.356 0 CA-C-O 120.257 -0.19 . . . . 0.0 113.007 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.575 ' HD3' ' O ' ' A' ' 57' ' ' PRO . 53.2 Cg_endo -76.07 174.85 12.13 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.443 2.095 . . . . 0.0 112.17 176.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.439 ' CE1' ' HA ' ' A' ' 54' ' ' ASN . 16.5 p90 -126.96 -175.13 3.33 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.089 -177.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.517 ' H ' ' HB2' ' A' ' 16' ' ' GLN . 40.6 p -122.27 170.36 9.99 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.891 178.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 25.0 ttt85 -59.33 -39.55 83.49 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.246 0.546 . . . . 0.0 110.16 175.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 32.2 mtm180 -66.38 -52.36 47.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.106 177.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.623 ' O ' HG23 ' A' ' 20' ' ' VAL . 57.8 mm-40 -56.07 -48.0 76.9 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.862 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.427 ' HB1' HD21 ' A' ' 39' ' ' LEU . . . -49.12 -51.06 34.29 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.994 177.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -54.65 -40.31 68.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.455 179.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.17 -25.97 63.7 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.706 0.289 . . . . 0.0 111.745 -176.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.623 HG23 ' O ' ' A' ' 16' ' ' GLN . 15.9 t -89.44 -19.47 7.43 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.734 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 -173.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.525 HG23 ' HB ' ' A' ' 27' ' ' ILE . 13.2 m -97.11 -27.89 14.37 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-N 113.826 -1.534 . . . . 0.0 108.619 -175.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.8 m -63.63 -37.89 89.06 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 114.356 -1.293 . . . . 0.0 108.963 168.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 34.1 m -75.88 -56.68 4.44 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.645 175.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.572 ' O ' HG13 ' A' ' 27' ' ' ILE . 65.1 m-85 -105.78 99.81 9.39 Favored 'General case' 0 N--CA 1.439 -1.019 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 -179.054 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 4.0 p -70.01 -4.6 21.64 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.216 -178.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.531 ' OD1' ' HB3' ' A' ' 24' ' ' TYR . 6.3 p-10 -82.25 -7.42 59.63 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.702 176.123 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.572 HG13 ' O ' ' A' ' 24' ' ' TYR . 1.8 mt -90.25 158.74 2.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 173.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -153.39 135.41 14.72 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.721 0.296 . . . . 0.0 111.317 178.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.401 ' HA ' HD23 ' A' ' 39' ' ' LEU . 7.0 tt -90.66 109.76 20.93 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -131.17 176.73 8.02 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.384 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.446 ' HB2' ' HG2' ' A' ' 38' ' ' ARG . 11.9 m-20 61.85 30.82 18.34 Favored 'General case' 0 N--CA 1.467 0.376 0 O-C-N 123.735 0.647 . . . . 0.0 110.908 -178.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.585 ' HA ' ' HB3' ' A' ' 37' ' ' PHE . 25.9 t0 -71.13 122.85 20.88 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.619 -175.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.541 ' HB3' ' HB2' ' A' ' 36' ' ' HIS . 35.0 tt0 -133.78 18.31 3.87 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.034 178.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 113.14 -91.99 0.6 Allowed Glycine 0 N--CA 1.45 -0.393 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.688 -177.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.6 t -100.63 -15.33 17.81 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 174.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.541 ' HB2' ' HB3' ' A' ' 33' ' ' GLN . 35.5 m170 -93.1 107.7 19.44 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.417 175.051 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.585 ' HB3' ' HA ' ' A' ' 32' ' ' ASP . 55.3 p90 -163.81 162.17 23.62 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.049 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.544 ' HB3' ' HA ' ' A' ' 53' ' ' TRP . 30.7 ptt180 -138.62 146.15 41.39 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.29 0.567 . . . . 0.0 111.814 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.427 HD21 ' HB1' ' A' ' 17' ' ' ALA . 97.0 mt -91.77 126.15 36.75 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.072 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.466 HG11 ' SD ' ' A' ' 48' ' ' MET . 28.7 t -96.31 109.71 23.35 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.948 178.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 91.1 t -81.01 114.54 22.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.536 175.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.463 ' HB3' ' HA2' ' A' ' 46' ' ' GLY . 10.7 mtt180 -106.02 173.02 6.49 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.216 178.134 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.438 ' CG ' ' H ' ' A' ' 45' ' ' GLU . 1.0 OUTLIER -95.65 -167.9 1.68 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.244 -0.434 . . . . 0.0 109.933 177.647 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 10.2 p -60.7 -26.81 67.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.58 -178.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.438 ' H ' ' CG ' ' A' ' 43' ' ' ASP . 36.1 tt0 -91.56 -27.39 18.23 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.337 -179.555 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.463 ' HA2' ' HB3' ' A' ' 42' ' ' ARG . . . 108.39 19.6 8.75 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.526 -0.845 . . . . 0.0 112.836 -178.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.429 ' O ' ' HA ' ' A' ' 42' ' ' ARG . 79.3 mtt180 -78.64 143.95 35.87 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 176.142 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.466 ' SD ' HG11 ' A' ' 40' ' ' VAL . 14.3 mmt -66.22 114.28 5.2 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.245 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 43.8 t -103.33 -35.1 3.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 120.741 0.305 . . . . 0.0 110.536 178.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 68.4 t-105 -172.3 125.54 0.52 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.968 -174.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 12.3 ptp180 -120.03 125.23 47.82 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.92 0.39 . . . . 0.0 110.232 175.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -125.89 143.25 51.15 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.572 -178.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.698 ' HB2' ' HG2' ' A' ' 56' ' ' GLU . 96.9 m95 -72.13 -174.12 1.2 Allowed 'General case' 0 CA--C 1.513 -0.464 0 CA-C-O 122.079 0.942 . . . . 0.0 112.13 -177.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.439 ' HA ' ' CE1' ' A' ' 12' ' ' PHE . 18.9 t-20 -101.9 -43.43 5.8 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 113.825 -1.534 . . . . 0.0 110.879 -176.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -83.68 10.64 8.84 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.941 -173.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.698 ' HG2' ' HB2' ' A' ' 53' ' ' TRP . 12.8 mm-40 -75.83 131.12 77.04 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.192 178.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.575 ' O ' ' HD3' ' A' ' 11' ' ' PRO . 4.2 Cg_endo -46.74 -37.01 20.39 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 124.01 3.14 . . . . 0.0 113.304 -174.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.566 ' HB3' ' HB2' ' A' ' 61' ' ' GLU . 11.5 m-20 -140.14 63.25 1.48 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.727 0.298 . . . . 0.0 110.249 174.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.539 ' HB2' ' HB2' ' A' ' 56' ' ' GLU . . . -61.77 -38.31 87.52 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-O 121.352 0.596 . . . . 0.0 110.572 177.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -62.51 -23.68 65.09 Favored Glycine 0 C--O 1.221 -0.691 0 CA-C-N 115.389 -0.823 . . . . 0.0 113.112 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.566 ' HB2' ' HB3' ' A' ' 58' ' ' ASP . 2.5 tm-20 -58.14 -51.9 67.8 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.159 0.504 . . . . 0.0 110.21 -178.297 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -71.84 -39.34 59.71 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.678 -0.772 . . . . 0.0 111.847 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.511 ' O ' HG13 ' A' ' 67' ' ' ILE . 80.4 mt -61.73 -46.46 89.55 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.593 0.235 . . . . 0.0 110.97 179.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -65.44 -29.53 70.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.14 -179.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.509 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 25.3 ttm105 -66.03 -33.76 76.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.027 176.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -73.07 -46.56 50.91 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 119.979 -0.688 . . . . 0.0 109.739 172.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.511 HG13 ' O ' ' A' ' 63' ' ' LEU . 80.3 mt -55.46 -55.59 16.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.342 -178.094 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.607 ' O ' HG22 ' A' ' 69' ' ' THR . 26.0 mmm-85 54.93 27.79 9.65 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 123.119 0.262 . . . . 0.0 111.55 177.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.607 HG22 ' O ' ' A' ' 68' ' ' ARG . 9.8 t 61.29 16.69 7.57 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.222 1.409 . . . . 0.0 111.042 176.165 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 13.2 p -113.72 -66.14 1.12 Allowed 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.438 175.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.535 ' HA3' ' CE1' ' A' ' 24' ' ' TYR . . . 65.65 179.64 8.97 Favored Glycine 0 N--CA 1.445 -0.765 0 CA-C-N 115.208 -0.906 . . . . 0.0 113.117 179.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.453 ' O ' HG22 ' A' ' 72' ' ' ILE . 35.8 mm -91.77 5.9 5.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.808 0.813 . . . . 0.0 110.119 -179.044 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 22.5 tpt180 . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.259 177.84 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.613 ' HA3' ' O ' ' A' ' 57' ' ' PRO . . . . . . . . 0 N--CA 1.441 -0.997 0 N-CA-C 111.325 -0.71 . . . . 0.0 111.325 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -73.33 132.92 18.45 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 121.494 1.462 . . . . 0.0 110.66 174.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 34.8 p90 -104.97 -171.7 1.96 Allowed 'General case' 0 C--N 1.31 -1.137 0 CA-C-O 121.703 0.763 . . . . 0.0 112.452 -173.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.89 156.44 36.26 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.924 -1.035 . . . . 0.0 109.2 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 22.5 ttt85 -61.6 -49.27 77.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.057 0.456 . . . . 0.0 110.346 -179.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.419 HH11 ' HD2' ' A' ' 15' ' ' ARG . 30.7 mtp180 -52.22 -47.97 65.36 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.338 -0.847 . . . . 0.0 111.2 175.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.595 ' O ' HG23 ' A' ' 20' ' ' VAL . 13.4 mm100 -58.0 -48.73 79.15 Favored 'General case' 0 C--O 1.226 -0.173 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.374 176.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -55.45 -46.09 76.8 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.319 -179.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 27.2 mm-40 -56.79 -41.65 78.07 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.529 -178.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.17 -23.26 67.06 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-O 121.181 0.515 . . . . 0.0 111.55 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.595 HG23 ' O ' ' A' ' 16' ' ' GLN . 5.0 t -90.6 -20.98 6.74 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.803 0 N-CA-C 107.227 -1.398 . . . . 0.0 107.227 -175.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.2 m -83.8 -31.73 25.73 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 114.084 -1.416 . . . . 0.0 110.243 179.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 15.6 p -70.41 -32.29 69.85 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 173.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 16.7 m -79.91 -49.06 12.45 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.756 175.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.707 ' O ' HG13 ' A' ' 27' ' ' ILE . 33.6 m-85 -115.12 96.9 5.91 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 175.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 37.9 m -83.33 16.17 2.63 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.035 0.445 . . . . 0.0 111.628 -174.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.44 ' OD1' ' HB3' ' A' ' 24' ' ' TYR . 21.5 p-10 -91.29 -17.4 26.0 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 169.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.707 HG13 ' O ' ' A' ' 24' ' ' TYR . 2.5 mt -72.55 147.46 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 CA-C-N 115.182 -0.917 . . . . 0.0 108.542 175.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.518 ' O ' ' HA ' ' A' ' 39' ' ' LEU . 14.5 p -141.95 144.45 33.74 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.712 -175.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.5 tt -101.15 108.62 20.34 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -113.77 162.5 16.22 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.83 179.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.578 ' O ' ' HA ' ' A' ' 37' ' ' PHE . 3.2 m-20 57.26 70.72 0.63 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.999 -1.001 . . . . 0.0 112.062 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -77.18 75.58 3.74 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.147 174.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.529 ' HB2' ' HB2' ' A' ' 36' ' ' HIS . 16.2 mm-40 -103.61 21.21 16.53 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.133 0.492 . . . . 0.0 109.981 -179.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.72 -93.06 1.64 Allowed Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 121.08 -0.581 . . . . 0.0 112.296 178.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 27.2 t -75.4 -29.55 59.84 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.397 0.617 . . . . 0.0 109.883 178.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.529 ' HB2' ' HB2' ' A' ' 33' ' ' GLN . 26.8 m-70 -101.84 107.54 18.75 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.79 177.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.578 ' HA ' ' O ' ' A' ' 31' ' ' ASP . 45.9 p90 -148.62 146.66 28.31 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 173.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 37.5 ptt85 -127.92 152.1 48.28 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.316 0.579 . . . . 0.0 112.314 -173.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.518 ' HA ' ' O ' ' A' ' 28' ' ' THR . 86.2 mt -108.88 132.6 53.88 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.891 175.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.439 ' HB ' ' OG1' ' A' ' 28' ' ' THR . 41.2 t -114.53 118.81 59.72 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.717 -179.032 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 93.5 t -89.46 114.83 28.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.654 176.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.469 ' HA ' ' O ' ' A' ' 47' ' ' ARG . 49.2 mtp180 -104.15 164.2 11.88 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.932 177.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.452 ' CG ' ' H ' ' A' ' 45' ' ' GLU . 1.7 p-10 -102.9 -166.04 1.23 Allowed 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 110.325 -0.25 . . . . 0.0 110.325 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 25.6 p -66.62 -22.96 66.11 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 120.92 0.39 . . . . 0.0 111.893 179.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.452 ' H ' ' CG ' ' A' ' 43' ' ' ASP . 8.6 tp10 -86.98 -21.61 26.07 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.239 0.543 . . . . 0.0 109.574 178.159 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 101.17 5.23 53.11 Favored Glycine 0 N--CA 1.444 -0.808 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.08 179.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.469 ' O ' ' HA ' ' A' ' 42' ' ' ARG . 88.0 mtt180 -72.23 146.87 47.0 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 -178.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -74.06 103.09 4.4 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 176.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 57.4 t -77.96 -40.67 26.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.991 179.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 76.1 t-105 -164.17 142.13 7.08 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.819 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.417 HH11 ' HD3' ' A' ' 51' ' ' ARG . 14.9 ptt-85 -141.78 138.68 32.44 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 177.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -143.97 156.47 44.42 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.354 -177.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 92.8 m95 -88.52 -161.6 0.76 Allowed 'General case' 0 N--CA 1.447 -0.615 0 CA-C-O 121.423 0.63 . . . . 0.0 110.474 -179.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -106.23 -33.93 7.66 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.274 -176.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -81.45 3.53 24.32 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 -173.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.523 ' HB2' ' HB2' ' A' ' 59' ' ' ALA . 37.1 mt-10 -80.19 129.22 70.58 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.463 -178.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.613 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 31.3 Cg_exo -62.16 -10.37 17.94 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 123.396 2.731 . . . . 0.0 114.009 -172.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.519 ' HA ' ' CA ' ' A' ' 10' ' ' GLY . 24.0 p-10 -143.01 34.02 1.36 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.761 0.315 . . . . 0.0 110.794 177.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.523 ' HB2' ' HB2' ' A' ' 56' ' ' GLU . . . -55.75 -40.96 73.25 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.994 -178.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -62.8 -39.33 97.85 Favored Glycine 0 N--CA 1.443 -0.878 0 CA-C-N 115.826 -0.624 . . . . 0.0 112.381 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -66.02 -23.1 66.49 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.886 0.343 . . . . 0.0 111.721 -177.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -75.5 -49.23 9.39 Favored Glycine 0 C--O 1.24 0.477 0 C-N-CA 120.286 -0.959 . . . . 0.0 111.085 175.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.427 ' O ' HG13 ' A' ' 67' ' ' ILE . 50.0 mt -63.24 -43.35 98.29 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.273 0.559 . . . . 0.0 109.833 177.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 8.8 m-20 -69.16 -20.43 64.02 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.189 178.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 6.8 tmm_? -65.93 -41.36 91.48 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 173.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.438 ' CE1' ' HA2' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -67.97 -42.9 80.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.425 175.018 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.427 HG13 ' O ' ' A' ' 63' ' ' LEU . 62.9 mt -67.74 -26.75 35.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.257 -178.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -59.9 -33.37 71.76 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.138 -178.257 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.449 ' O ' ' HB2' ' A' ' 70' ' ' SER . 4.5 t -101.73 66.48 1.06 Allowed 'General case' 0 N--CA 1.442 -0.838 0 CA-C-O 121.825 0.822 . . . . 0.0 109.526 179.015 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.449 ' HB2' ' O ' ' A' ' 69' ' ' THR . 63.2 m 80.37 -51.7 0.35 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 114.211 -1.359 . . . . 0.0 112.808 171.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.438 ' HA2' ' CE1' ' A' ' 66' ' ' TYR . . . 79.15 -174.04 55.29 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.633 -0.794 . . . . 0.0 111.271 -170.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.487 ' O ' HG22 ' A' ' 72' ' ' ILE . 47.5 mm -101.35 7.0 9.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-O 121.896 0.855 . . . . 0.0 110.341 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.54 ' HB3' ' CE2' ' A' ' 24' ' ' TYR . 14.6 ptm180 . . . . . 0 N--CA 1.474 0.726 0 CA-C-N 115.423 -0.808 . . . . 0.0 113.103 -178.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.425 ' HA3' ' HD3' ' A' ' 11' ' ' PRO . . . . . . . . 0 N--CA 1.463 0.473 0 N-CA-C 113.966 0.346 . . . . 0.0 113.966 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.425 ' HD3' ' HA3' ' A' ' 10' ' ' GLY . 7.7 Cg_exo -70.53 139.09 36.79 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.775 2.317 . . . . 0.0 111.053 176.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -104.9 -175.15 2.71 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.493 0.663 . . . . 0.0 112.134 -173.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.46 ' H ' ' HB2' ' A' ' 16' ' ' GLN . 1.7 m -126.05 164.22 21.33 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-N 114.342 -1.299 . . . . 0.0 109.742 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.543 ' HA ' ' CZ ' ' A' ' 37' ' ' PHE . 48.3 ttt85 -51.49 -55.78 17.0 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 122.64 0.376 . . . . 0.0 111.351 -179.038 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 43.5 mtp180 -56.53 -45.57 81.08 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.464 177.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.572 ' O ' HG23 ' A' ' 20' ' ' VAL . 1.9 mp0 -59.2 -46.92 87.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.943 -179.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.505 ' HB1' HD11 ' A' ' 39' ' ' LEU . . . -57.44 -44.18 84.5 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 121.086 0.47 . . . . 0.0 111.17 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 58.2 mt-30 -55.28 -41.75 72.69 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.024 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.49 -23.96 66.33 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.739 -178.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.572 HG23 ' O ' ' A' ' 16' ' ' GLN . 10.4 t -90.83 -19.76 7.07 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.687 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 -172.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.526 HG23 ' HB ' ' A' ' 27' ' ' ILE . 10.8 m -95.86 -28.79 14.54 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 114.055 -1.429 . . . . 0.0 108.417 -176.036 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 54.8 m -63.45 -36.63 84.4 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 114.083 -1.417 . . . . 0.0 108.939 167.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.585 HG23 HH11 ' A' ' 73' ' ' ARG . 90.8 m -76.21 -54.4 6.85 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.376 175.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.569 ' HB2' HG13 ' A' ' 27' ' ' ILE . 51.1 m-85 -110.64 102.7 11.25 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-O 121.087 0.47 . . . . 0.0 109.796 179.144 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 6.1 p -75.62 2.17 12.56 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.376 -177.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.453 ' OD1' ' HB3' ' A' ' 24' ' ' TYR . 6.1 p-10 -87.71 -8.3 56.25 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.572 173.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.569 HG13 ' HB2' ' A' ' 24' ' ' TYR . 2.9 mt -83.08 150.27 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 172.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.409 ' O ' ' HA ' ' A' ' 39' ' ' LEU . 1.1 p -141.43 135.94 30.85 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 120.912 -0.315 . . . . 0.0 110.785 -178.011 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 5.0 tt -94.64 107.16 19.16 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -178.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -119.07 164.66 15.18 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.753 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.482 ' HB2' ' HG2' ' A' ' 38' ' ' ARG . 90.5 m-20 56.71 42.39 26.92 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.6 0.715 . . . . 0.0 110.462 -175.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -74.6 103.38 4.89 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.913 -177.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -103.43 -19.73 14.31 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 173.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 126.03 -80.54 0.36 Allowed Glycine 0 N--CA 1.449 -0.469 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.405 -177.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.8 t -72.21 -35.6 68.94 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.262 0.553 . . . . 0.0 109.623 174.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 40.0 m80 -109.34 139.26 44.51 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.783 178.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.543 ' CZ ' ' HA ' ' A' ' 14' ' ' ARG . 55.6 p90 -174.23 164.04 3.91 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 176.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.482 ' HG2' ' HB2' ' A' ' 31' ' ' ASP . 29.3 ptt85 -128.68 144.83 51.25 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.205 0.526 . . . . 0.0 111.191 177.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.505 HD11 ' HB1' ' A' ' 17' ' ' ALA . 86.0 mt -99.18 127.1 45.1 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.934 176.322 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 27.5 t -103.7 119.93 53.05 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.529 177.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.409 HG11 ' CD2' ' A' ' 66' ' ' TYR . 16.3 t -91.19 108.76 20.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.214 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 33.9 mtt85 -105.19 168.15 9.26 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.038 -177.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.628 ' OD1' ' HG2' ' A' ' 47' ' ' ARG . 7.6 p-10 -104.02 -164.57 1.07 Allowed 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.616 179.182 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -66.17 -17.11 64.51 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -91.98 -24.32 19.28 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.477 0.656 . . . . 0.0 109.821 179.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 99.32 7.78 53.93 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.745 -0.741 . . . . 0.0 111.575 -179.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.628 ' HG2' ' OD1' ' A' ' 43' ' ' ASP . 15.9 ptt180 -78.35 150.46 33.21 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 177.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 23.3 ptp -79.12 116.86 19.67 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.309 0.576 . . . . 0.0 110.01 178.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 41.4 t -98.26 -31.94 3.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-O 121.478 0.656 . . . . 0.0 109.322 176.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 75.2 t-105 -155.11 155.76 34.59 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.53 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 16.7 ptt180 -158.5 142.66 15.67 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 175.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -150.55 147.92 28.04 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.214 -179.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.561 ' HB2' ' HG2' ' A' ' 56' ' ' GLU . 65.0 m95 -80.92 -176.73 6.05 Favored 'General case' 0 CA--C 1.509 -0.627 0 CA-C-O 122.15 0.976 . . . . 0.0 111.371 177.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -82.82 -31.54 28.06 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 113.465 -1.698 . . . . 0.0 110.079 -178.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -97.04 8.65 44.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.58 -0.737 . . . . 0.0 112.325 -173.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.664 ' HB2' ' HB2' ' A' ' 59' ' ' ALA . 38.9 mm-40 -71.02 128.14 90.9 Favored Pre-proline 0 C--N 1.328 -0.354 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 179.118 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -49.28 -37.45 40.04 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 124.074 3.182 . . . . 0.0 113.904 -173.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -131.15 43.82 3.04 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.143 0.497 . . . . 0.0 110.248 178.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.664 ' HB2' ' HB2' ' A' ' 56' ' ' GLU . . . -51.4 -45.36 62.48 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.545 -177.234 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -59.04 -38.63 93.25 Favored Glycine 0 N--CA 1.446 -0.646 0 CA-C-N 115.433 -0.803 . . . . 0.0 113.163 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 22.1 tp10 -60.06 -38.78 83.84 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.873 0.337 . . . . 0.0 110.996 -175.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -68.84 -43.54 73.79 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.33 -0.938 . . . . 0.0 111.021 177.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.438 ' O ' HG13 ' A' ' 67' ' ' ILE . 57.5 mt -58.52 -47.6 83.61 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.324 -0.438 . . . . 0.0 109.867 176.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -59.72 -33.34 71.5 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.698 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.419 HH11 ' HD2' ' A' ' 65' ' ' ARG . 9.5 tpp85 -70.07 -29.58 66.61 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.059 -175.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.409 ' CD2' HG11 ' A' ' 41' ' ' VAL . 80.0 t80 -87.45 -42.58 12.7 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.177 -0.609 . . . . 0.0 110.546 172.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.696 HG22 ' H ' ' A' ' 69' ' ' THR . 86.1 mt -57.04 -59.89 2.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.884 -179.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.516 ' O ' HG22 ' A' ' 69' ' ' THR . 57.1 mtm-85 51.85 30.28 6.9 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.242 0.544 . . . . 0.0 111.213 177.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.696 ' H ' HG22 ' A' ' 67' ' ' ILE . 13.2 t 61.55 21.12 11.83 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 126.102 1.761 . . . . 0.0 111.736 174.369 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 55.3 p -112.57 -62.18 1.62 Allowed 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.233 171.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 65.26 -175.83 14.02 Favored Glycine 0 N--CA 1.446 -0.69 0 CA-C-N 115.152 -0.931 . . . . 0.0 112.721 177.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.455 ' O ' HG22 ' A' ' 72' ' ' ILE . 40.9 mm -101.34 5.82 10.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-O 121.876 0.846 . . . . 0.0 109.35 178.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.585 HH11 HG23 ' A' ' 23' ' ' THR . 51.3 ttt180 . . . . . 0 C--N 1.33 -0.24 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.376 179.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.612 ' HA2' ' HA ' ' A' ' 58' ' ' ASP . . . . . . . . 0 CA--C 1.523 0.559 0 N-CA-C 113.554 0.181 . . . . 0.0 113.554 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.474 ' HD3' ' HA3' ' A' ' 10' ' ' GLY . 3.3 Cg_exo -81.31 170.85 14.38 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 123.371 2.714 . . . . 0.0 112.29 177.246 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 15.2 p90 -122.27 -173.85 2.77 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.015 0.436 . . . . 0.0 111.48 -176.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.48 ' H ' ' HB2' ' A' ' 16' ' ' GLN . 62.5 p -125.16 179.64 4.97 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.896 178.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 29.3 ttt180 -63.99 -41.32 97.55 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 174.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 25.7 ttm180 -58.72 -53.43 58.48 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.625 177.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.584 ' O ' HG23 ' A' ' 20' ' ' VAL . 2.0 mp0 -60.78 -48.61 81.02 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.541 178.192 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -50.26 -54.59 20.17 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.534 179.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -57.79 -36.77 72.64 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.191 -0.458 . . . . 0.0 112.11 -179.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.66 -29.48 70.05 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.027 0.441 . . . . 0.0 111.565 -179.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.584 HG23 ' O ' ' A' ' 16' ' ' GLN . 11.5 t -88.95 -25.31 5.77 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.827 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 -173.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.418 HG23 ' HB ' ' A' ' 27' ' ' ILE . 9.7 m -83.14 -33.51 26.25 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-N 113.909 -1.496 . . . . 0.0 110.994 -179.49 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.1 t -70.44 -25.34 63.16 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 173.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 33.6 m -76.0 -56.99 4.15 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.682 169.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.675 ' CE1' ' HA3' ' A' ' 71' ' ' GLY . 34.1 m-85 -113.14 105.72 13.79 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.282 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 31.5 m -86.71 11.6 12.65 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.59 0.709 . . . . 0.0 110.23 -176.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.559 ' OD1' ' HB3' ' A' ' 24' ' ' TYR . 7.5 p-10 -88.73 -6.98 57.06 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.917 -1.038 . . . . 0.0 108.748 170.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.613 HG13 ' O ' ' A' ' 24' ' ' TYR . 3.6 mt -82.45 142.32 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 172.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.0 p -136.05 130.13 33.0 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.748 -0.381 . . . . 0.0 111.095 -174.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.546 ' HA ' HD23 ' A' ' 39' ' ' LEU . 5.4 tt -86.08 117.3 24.83 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 70.7 mt-10 -123.4 173.3 8.08 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.295 -178.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.493 ' O ' ' HA ' ' A' ' 37' ' ' PHE . 0.4 OUTLIER 55.56 63.62 2.01 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.703 -1.135 . . . . 0.0 111.364 176.747 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -80.8 97.45 7.35 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.022 -179.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -106.94 -10.56 15.94 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 171.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 111.92 -81.97 0.3 Allowed Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.895 -0.669 . . . . 0.0 111.601 -177.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.7 m -76.74 -18.64 58.36 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.32 0.581 . . . . 0.0 110.18 177.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 38.3 m-70 -115.84 137.72 51.83 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.949 176.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.493 ' HA ' ' O ' ' A' ' 31' ' ' ASP . 48.6 p90 -167.17 156.94 10.84 Favored 'General case' 0 C--N 1.328 -0.337 0 O-C-N 123.824 0.703 . . . . 0.0 109.334 175.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 22.4 ptt180 -128.97 158.13 39.71 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.705 0.288 . . . . 0.0 111.056 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.546 HD23 ' HA ' ' A' ' 29' ' ' LEU . 75.0 mt -113.73 125.02 53.65 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.235 0.541 . . . . 0.0 109.978 174.077 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.51 HG22 ' CB ' ' A' ' 51' ' ' ARG . 61.9 t -103.37 123.97 57.25 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.823 177.03 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.452 HG11 ' CD1' ' A' ' 66' ' ' TYR . 3.1 t -93.92 111.0 24.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -104.47 168.24 9.22 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.963 -178.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -97.16 -166.72 1.43 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.637 0.256 . . . . 0.0 110.316 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 12.4 p -70.15 -17.18 63.17 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 111.99 0.366 . . . . 0.0 111.99 -176.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.434 ' HB3' ' HG2' ' A' ' 47' ' ' ARG . 23.5 tt0 -93.11 -22.69 18.95 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.002 0.43 . . . . 0.0 109.92 179.149 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 105.81 14.01 22.32 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.807 -0.711 . . . . 0.0 111.769 -178.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.434 ' HG2' ' HB3' ' A' ' 45' ' ' GLU . 14.9 mmt180 -76.74 124.93 28.41 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 178.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -69.09 106.07 2.67 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.133 0.492 . . . . 0.0 109.984 176.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 41.2 t -92.55 -33.11 5.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.444 -177.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 69.1 t-105 -156.4 149.17 23.84 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.893 -175.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.51 ' CB ' HG22 ' A' ' 40' ' ' VAL . 14.5 ptp180 -146.69 143.48 28.77 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 172.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -143.56 147.44 34.44 Favored 'General case' 0 C--N 1.319 -0.717 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 82.8 m95 -82.37 -171.26 3.35 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-O 121.594 0.711 . . . . 0.0 110.637 178.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -98.72 -16.78 18.85 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 114.417 -1.265 . . . . 0.0 110.294 -176.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -104.26 4.17 33.48 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.622 -177.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.58 ' HB2' ' HB2' ' A' ' 59' ' ' ALA . 20.7 mm-40 -61.26 131.93 92.4 Favored Pre-proline 0 C--O 1.235 0.316 0 CA-C-N 116.641 -0.254 . . . . 0.0 110.525 178.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_exo -40.01 -47.65 3.9 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 124.264 3.309 . . . . 0.0 113.243 -176.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.612 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . 5.0 t0 -140.22 70.03 1.36 Allowed 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 171.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.58 ' HB2' ' HB2' ' A' ' 56' ' ' GLU . . . -55.47 -35.98 66.09 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.823 178.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -58.16 -43.1 95.49 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.416 -0.811 . . . . 0.0 112.5 178.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.654 ' O ' ' HG3' ' A' ' 65' ' ' ARG . 5.3 tm-20 -58.65 -39.71 81.36 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.696 0.248 . . . . 0.0 111.003 -177.289 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.63 ' O ' ' HB2' ' A' ' 65' ' ' ARG . . . -76.4 -40.61 27.7 Favored Glycine 0 C--N 1.331 0.264 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.126 -178.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.484 ' O ' HG13 ' A' ' 67' ' ' ILE . 77.3 mt -66.26 -40.55 90.25 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 177.152 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -65.6 -26.42 67.83 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.822 177.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.654 ' HG3' ' O ' ' A' ' 61' ' ' GLU . 87.7 mtt180 -58.26 -48.91 78.93 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 121.112 0.482 . . . . 0.0 109.804 171.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.452 ' CD1' HG11 ' A' ' 41' ' ' VAL . 29.3 t80 -69.44 -48.36 61.13 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.378 178.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.484 HG13 ' O ' ' A' ' 63' ' ' LEU . 80.3 mt -56.86 -58.07 7.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.848 -178.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.454 ' O ' HG22 ' A' ' 69' ' ' THR . 13.7 mtm180 57.42 28.2 15.06 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-O 121.045 0.45 . . . . 0.0 110.611 178.003 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.454 HG22 ' O ' ' A' ' 68' ' ' ARG . 11.5 t 52.51 22.76 2.26 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.266 1.427 . . . . 0.0 112.001 -177.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 17.0 t -108.25 -64.73 1.19 Allowed 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 172.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.675 ' HA3' ' CE1' ' A' ' 24' ' ' TYR . . . 75.38 166.93 20.38 Favored Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.998 176.182 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.559 ' HB ' ' OD1' ' A' ' 26' ' ' ASN . 40.8 mm -87.74 -11.19 10.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 120.664 0.269 . . . . 0.0 111.164 -179.203 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.406 HH11 ' HD3' ' A' ' 73' ' ' ARG . 7.9 ttm180 . . . . . 0 N--CA 1.468 0.445 0 CA-C-O 120.931 0.396 . . . . 0.0 111.899 -178.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.421 ' HA3' ' HD3' ' A' ' 11' ' ' PRO . . . . . . . . 0 CA--C 1.516 0.127 0 CA-C-O 120.147 -0.252 . . . . 0.0 113.201 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.421 ' HD3' ' HA3' ' A' ' 10' ' ' GLY . 20.8 Cg_exo -64.75 153.05 79.71 Favored 'Trans proline' 0 C--O 1.234 0.314 0 C-N-CA 122.88 2.387 . . . . 0.0 111.704 177.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 16.8 p90 -120.32 -171.69 2.21 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.053 -176.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.484 ' H ' ' HB2' ' A' ' 16' ' ' GLN . 46.1 p -125.02 171.65 10.07 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.84 179.225 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.479 ' O ' ' HG3' ' A' ' 18' ' ' GLN . 43.1 ttt180 -55.8 -45.86 78.15 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.651 0.739 . . . . 0.0 109.773 174.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -63.5 -50.27 70.29 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.765 -1.107 . . . . 0.0 111.772 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.586 ' O ' HG23 ' A' ' 20' ' ' VAL . 1.5 mp0 -58.78 -44.59 90.71 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.692 -0.231 . . . . 0.0 110.689 179.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -52.29 -49.0 65.03 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.256 178.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.479 ' HG3' ' O ' ' A' ' 14' ' ' ARG . 98.3 mt-30 -56.04 -45.1 79.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.374 -178.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.12 -31.15 70.86 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.079 -176.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.586 HG23 ' O ' ' A' ' 16' ' ' GLN . 8.2 t -87.55 -24.31 6.33 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.881 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 -171.278 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.52 HG23 ' HB ' ' A' ' 27' ' ' ILE . 10.3 m -86.4 -30.94 21.73 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 113.597 -1.638 . . . . 0.0 110.698 -178.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.6 p -68.56 -28.25 66.8 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 170.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 20.7 m -76.95 -56.79 4.28 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.089 172.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.627 ' HB3' ' OD1' ' A' ' 26' ' ' ASN . 79.0 m-85 -109.59 103.41 12.27 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 121.259 0.552 . . . . 0.0 109.948 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 6.0 p -71.72 -3.9 24.51 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.492 -0.776 . . . . 0.0 112.134 -178.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.627 ' OD1' ' HB3' ' A' ' 24' ' ' TYR . 25.6 p-10 -80.05 -16.68 54.54 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 174.405 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.548 HG13 ' O ' ' A' ' 24' ' ' TYR . 2.4 mt -76.72 146.63 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 173.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.535 ' OG1' ' HB ' ' A' ' 40' ' ' VAL . 1.6 p -141.59 123.26 15.16 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.013 0.435 . . . . 0.0 111.007 -177.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.465 ' CD2' ' HB3' ' A' ' 32' ' ' ASP . 6.5 tt -80.69 99.73 8.34 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 178.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 52.7 mm-40 -118.81 166.96 12.16 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.561 -177.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 58.97 34.63 23.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.347 -175.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.55 ' HA ' ' HB3' ' A' ' 37' ' ' PHE . 5.7 p-10 -68.03 99.8 0.91 Allowed 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.274 -0.876 . . . . 0.0 111.514 -178.152 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -104.97 9.21 34.61 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.018 176.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 125.06 -94.37 0.46 Allowed Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.409 -177.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.3 t -101.45 -13.38 17.97 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 173.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 13.9 m-70 -94.27 111.69 23.45 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.298 174.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.55 ' HB3' ' HA ' ' A' ' 32' ' ' ASP . 47.4 p90 -163.83 171.56 15.3 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -179.239 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.527 ' HA ' ' HA ' ' A' ' 53' ' ' TRP . 16.6 ptt-85 -130.79 144.63 51.58 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.083 0.468 . . . . 0.0 110.539 175.153 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.463 HD23 ' HA ' ' A' ' 29' ' ' LEU . 95.1 mt -95.33 117.12 29.75 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.532 176.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.535 ' HB ' ' OG1' ' A' ' 28' ' ' THR . 38.3 t -92.14 119.99 40.57 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.832 178.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.462 HG11 ' CD1' ' A' ' 66' ' ' TYR . 4.9 t -92.2 116.45 33.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 178.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 59.2 mtm180 -99.32 166.74 11.06 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.435 -178.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.639 ' OD1' ' HG2' ' A' ' 47' ' ' ARG . 9.7 p-10 -100.28 -166.71 1.36 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.23 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.83 -17.94 64.99 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.792 -179.185 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -89.32 -29.03 19.45 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -179.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 102.42 16.69 21.91 Favored Glycine 0 N--CA 1.444 -0.821 0 CA-C-N 115.276 -0.874 . . . . 0.0 112.309 -178.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.639 ' HG2' ' OD1' ' A' ' 43' ' ' ASP . 25.4 ptt180 -93.69 153.1 18.54 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 178.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 49.4 mtt -73.33 113.38 10.34 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.397 -178.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.455 HG21 ' HB3' ' A' ' 43' ' ' ASP . 46.1 t -97.84 -33.21 4.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 121.105 0.479 . . . . 0.0 110.264 178.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 74.0 t-105 -157.02 154.64 29.91 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.087 -177.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.412 ' HB2' ' HD2' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -151.13 140.46 21.38 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 174.366 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -141.51 143.75 33.96 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 177.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.531 ' HB2' ' HG2' ' A' ' 56' ' ' GLU . 69.2 m95 -80.23 -173.82 4.21 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 121.721 0.772 . . . . 0.0 111.069 -179.122 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -90.22 -28.32 18.93 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 114.008 -1.451 . . . . 0.0 110.089 -175.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 13.5 p90 -101.55 15.85 27.57 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.21 -0.904 . . . . 0.0 112.075 -173.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.531 ' HG2' ' HB2' ' A' ' 53' ' ' TRP . 19.3 mm-40 -77.87 135.23 63.62 Favored Pre-proline 0 C--N 1.323 -0.571 0 C-N-CA 121.232 -0.187 . . . . 0.0 110.828 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_exo -38.77 -46.67 2.66 Favored 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 124.637 3.558 . . . . 0.0 113.966 -173.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -145.33 67.8 1.23 Allowed 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 172.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.53 ' HB2' ' HB2' ' A' ' 56' ' ' GLU . . . -56.2 -36.12 68.06 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 115.263 -0.881 . . . . 0.0 111.232 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -57.0 -36.23 72.8 Favored Glycine 0 N--CA 1.447 -0.633 0 CA-C-N 115.486 -0.779 . . . . 0.0 113.78 -178.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.416 ' CD ' HH21 ' A' ' 65' ' ' ARG . 1.2 tm-20 -56.73 -49.15 76.07 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 117.211 0.505 . . . . 0.0 110.83 -176.472 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -70.21 -43.26 64.23 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.341 -177.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.546 ' O ' HG13 ' A' ' 67' ' ' ILE . 52.6 mt -66.39 -52.3 48.22 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.866 -0.167 . . . . 0.0 110.766 -178.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.666 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 87.9 m-20 -58.72 -40.76 84.65 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.717 -179.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.416 HH21 ' CD ' ' A' ' 61' ' ' GLU . 19.0 ttm180 -51.63 -50.99 59.2 Favored 'General case' 0 C--O 1.233 0.192 0 O-C-N 123.643 0.589 . . . . 0.0 110.446 178.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.462 ' CD1' HG11 ' A' ' 41' ' ' VAL . 44.5 t80 -63.36 -43.25 98.2 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.352 179.07 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.546 HG13 ' O ' ' A' ' 63' ' ' LEU . 87.4 mt -57.6 -31.49 39.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.927 -0.579 . . . . 0.0 112.329 -177.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.666 ' HG2' ' O ' ' A' ' 64' ' ' ASN . 10.7 mmm180 -65.02 -62.08 1.77 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.972 0.415 . . . . 0.0 111.257 -175.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 17.7 p -81.57 -26.21 35.18 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.327 -177.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 24.7 m -125.91 31.14 5.53 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -169.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.15 116.41 9.05 Favored Glycine 0 CA--C 1.522 0.528 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.099 170.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.455 ' O ' HG22 ' A' ' 72' ' ' ILE . 37.5 mm -93.99 2.6 9.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-O 121.029 0.442 . . . . 0.0 111.339 -171.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 45.0 ptt85 . . . . . 0 C--N 1.328 -0.34 0 O-C-N 121.976 -0.453 . . . . 0.0 111.691 -175.598 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.571 ' HA3' ' HA ' ' A' ' 58' ' ' ASP . . . . . . . . 0 N--CA 1.442 -0.907 0 N-CA-C 111.52 -0.632 . . . . 0.0 111.52 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -76.45 131.67 12.86 Favored 'Trans proline' 0 N--CA 1.45 -1.034 0 C-N-CA 121.776 1.651 . . . . 0.0 111.031 173.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 19.8 p90 -98.39 -169.54 1.82 Allowed 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.73 -173.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.424 ' HB ' ' OE1' ' A' ' 16' ' ' GLN . 0.2 OUTLIER -122.82 156.51 34.4 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.401 179.425 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 32.1 ttt85 -56.4 -46.19 80.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.331 0.586 . . . . 0.0 110.477 178.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 26.2 ttm180 -53.07 -59.29 4.73 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.981 -1.008 . . . . 0.0 110.842 176.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.629 ' O ' HG23 ' A' ' 20' ' ' VAL . 15.9 mp0 -57.4 -44.09 84.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.456 -179.19 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.482 ' HB1' HD11 ' A' ' 39' ' ' LEU . . . -53.54 -45.83 69.96 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 121.248 0.547 . . . . 0.0 111.114 179.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -59.91 -36.84 77.83 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.912 179.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.74 -24.43 64.45 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.017 177.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.629 HG23 ' O ' ' A' ' 16' ' ' GLN . 2.9 t -83.97 -18.68 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 -178.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.623 HG23 ' HB ' ' A' ' 27' ' ' ILE . 0.0 OUTLIER -90.89 -32.15 16.13 Favored 'General case' 0 CA--C 1.506 -0.734 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 177.581 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 76.4 m -56.65 -34.42 67.31 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 113.623 -1.626 . . . . 0.0 109.46 168.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.583 HG23 HH11 ' A' ' 73' ' ' ARG . 59.8 m -87.51 -49.31 7.28 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.399 -0.818 . . . . 0.0 111.684 177.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.658 ' HB3' ' OD1' ' A' ' 26' ' ' ASN . 63.7 m-85 -118.71 109.7 16.41 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 121.018 0.437 . . . . 0.0 110.352 -178.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 11.8 p -78.72 0.59 26.12 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.663 -177.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.658 ' OD1' ' HB3' ' A' ' 24' ' ' TYR . 25.0 p-10 -82.76 -19.79 37.17 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 175.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.623 ' HB ' HG23 ' A' ' 21' ' ' THR . 1.1 mt -77.68 151.32 5.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 177.155 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.562 ' OG1' ' HB ' ' A' ' 40' ' ' VAL . 19.7 p -138.33 128.08 25.15 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.904 0.383 . . . . 0.0 111.119 179.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.533 ' HA ' HD23 ' A' ' 39' ' ' LEU . 6.5 tt -86.63 103.24 14.92 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 175.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.421 ' O ' ' HB3' ' A' ' 31' ' ' ASP . 53.2 mt-10 -121.74 174.12 7.03 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.929 -176.214 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.421 ' HB3' ' O ' ' A' ' 30' ' ' GLU . 12.4 t70 77.48 -62.9 0.37 Allowed 'General case' 0 N--CA 1.466 0.341 0 O-C-N 124.28 0.987 . . . . 0.0 110.242 -176.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.517 ' HA ' ' HB3' ' A' ' 37' ' ' PHE . 54.1 t0 38.7 78.56 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.554 -1.203 . . . . 0.0 112.99 -177.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -105.01 37.01 2.27 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 170.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.2 -102.13 2.75 Favored Glycine 0 N--CA 1.448 -0.558 0 CA-C-N 115.142 -0.936 . . . . 0.0 112.126 179.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.3 m -82.84 -15.05 53.07 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.229 0.538 . . . . 0.0 110.547 177.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 55.6 m170 -108.33 109.51 20.85 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.901 177.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.517 ' HB3' ' HA ' ' A' ' 32' ' ' ASP . 53.3 p90 -152.92 169.45 22.81 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 177.133 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.471 ' HA ' ' HA ' ' A' ' 53' ' ' TRP . 25.6 ptt-85 -128.45 147.98 50.69 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.181 -0.608 . . . . 0.0 111.556 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.537 ' HA ' ' O ' ' A' ' 28' ' ' THR . 90.5 mt -107.0 117.66 34.65 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.403 173.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.562 ' HB ' ' OG1' ' A' ' 28' ' ' THR . 53.0 t -95.11 119.02 42.6 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.135 178.34 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.476 ' HB ' ' HB3' ' A' ' 50' ' ' TRP . 61.4 t -88.79 110.88 21.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 121.106 0.479 . . . . 0.0 109.888 177.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.432 ' HA ' ' O ' ' A' ' 47' ' ' ARG . 33.4 mtm180 -98.77 176.66 5.54 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.214 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -94.76 -171.14 2.39 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 173.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.1 t -60.76 -24.08 65.48 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.64 -176.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -91.59 -31.59 15.84 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.924 0.393 . . . . 0.0 110.663 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 120.73 10.36 7.07 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.929 -177.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.432 ' O ' ' HA ' ' A' ' 42' ' ' ARG . 28.9 mmm180 -74.54 133.59 42.26 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 177.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.448 ' SD ' HG11 ' A' ' 40' ' ' VAL . 50.8 mtt -79.96 104.06 10.27 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.065 0.46 . . . . 0.0 110.622 -174.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 35.0 t -90.18 -31.62 5.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.339 -177.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.476 ' HB3' ' HB ' ' A' ' 41' ' ' VAL . 76.6 t-105 -151.65 161.12 43.2 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.774 -176.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 4.3 ptp180 -159.24 132.81 7.29 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 176.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -138.62 141.72 39.12 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.698 -0.228 . . . . 0.0 110.742 -178.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.596 ' HB2' ' HG3' ' A' ' 56' ' ' GLU . 84.1 m95 -83.44 -166.05 1.27 Allowed 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 121.54 0.686 . . . . 0.0 110.226 178.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.422 HD22 ' C ' ' A' ' 54' ' ' ASN . 0.2 OUTLIER -99.51 -33.05 10.82 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.86 -178.501 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -88.98 10.17 22.45 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.893 -173.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.596 ' HG3' ' HB2' ' A' ' 53' ' ' TRP . 26.5 mt-10 -82.29 131.89 54.62 Favored Pre-proline 0 C--N 1.325 -0.489 0 C-N-CA 120.971 -0.292 . . . . 0.0 110.976 -177.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_exo -36.17 -53.71 0.95 Allowed 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 124.816 3.677 . . . . 0.0 114.109 -173.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.571 ' HA ' ' HA3' ' A' ' 10' ' ' GLY . 3.3 t70 -137.37 67.02 1.44 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.104 0.478 . . . . 0.0 110.129 174.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.0 -33.76 65.17 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.201 176.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -61.4 -33.74 85.74 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 121.223 -0.513 . . . . 0.0 113.284 -178.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -64.61 -34.97 79.51 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.586 0.232 . . . . 0.0 110.944 -178.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -69.84 -45.74 56.34 Favored Glycine 0 C--O 1.236 0.25 0 C-N-CA 120.396 -0.907 . . . . 0.0 111.201 178.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 43.3 mt -61.97 -43.44 98.84 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.381 -0.41 . . . . 0.0 109.932 177.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -61.26 -38.33 86.32 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.073 177.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 23.3 tpt85 -56.09 -38.95 71.41 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.356 177.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.503 ' O ' HG22 ' A' ' 69' ' ' THR . 46.2 t80 -79.04 -49.42 12.71 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.229 177.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 94.6 mt -56.51 -30.5 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -177.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.431 HH11 ' HD2' ' A' ' 68' ' ' ARG . 33.2 ttm180 -59.0 -30.27 67.87 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.433 -179.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.503 HG22 ' O ' ' A' ' 66' ' ' TYR . 10.0 t -91.84 62.35 4.33 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 122.003 0.906 . . . . 0.0 110.058 179.141 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.405 ' HB3' ' O ' ' A' ' 69' ' ' THR . 25.3 t 84.35 -37.41 0.06 Allowed 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 114.363 -1.29 . . . . 0.0 112.718 167.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 76.59 164.35 18.83 Favored Glycine 0 CA--C 1.522 0.526 0 C-N-CA 120.285 -0.96 . . . . 0.0 111.977 -174.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.483 ' O ' HG22 ' A' ' 72' ' ' ILE . 46.2 mm -101.07 6.0 10.0 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-O 121.79 0.805 . . . . 0.0 111.025 -175.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.583 HH11 HG23 ' A' ' 23' ' ' THR . 21.2 ttt180 . . . . . 0 C--N 1.324 -0.506 0 O-C-N 121.257 -0.902 . . . . 0.0 110.881 178.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.427 ' HA3' ' HD3' ' A' ' 11' ' ' PRO . . . . . . . . 0 CA--C 1.519 0.332 0 CA-C-O 119.936 -0.369 . . . . 0.0 112.94 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.442 ' HG3' ' HA ' ' A' ' 57' ' ' PRO . 16.5 Cg_exo -66.65 142.13 63.01 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.655 2.236 . . . . 0.0 111.812 175.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.439 ' HE1' ' HB1' ' A' ' 59' ' ' ALA . 42.9 p90 -112.39 151.46 29.78 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.707 0.765 . . . . 0.0 112.521 -174.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.654 ' HB ' ' HG2' ' A' ' 16' ' ' GLN . 0.3 OUTLIER -76.94 156.34 32.07 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 114.422 -1.263 . . . . 0.0 110.788 178.66 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 25.8 ttt180 -61.32 -46.73 89.05 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.796 0.331 . . . . 0.0 110.578 -178.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 84.3 mtt-85 -61.29 -36.75 80.94 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.368 176.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.654 ' HG2' ' HB ' ' A' ' 13' ' ' THR . 76.3 mm-40 -61.75 -48.84 78.91 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 178.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.499 ' HB1' HD21 ' A' ' 39' ' ' LEU . . . -53.58 -44.12 69.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.943 178.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.407 ' HA ' ' OE1' ' A' ' 18' ' ' GLN . 14.7 mm-40 -58.82 -38.05 77.78 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.778 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.43 ' HA ' HG22 ' A' ' 22' ' ' THR . . . -72.68 -25.28 61.2 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.448 -178.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.618 HG23 ' O ' ' A' ' 16' ' ' GLN . 10.6 t -87.18 -30.07 5.75 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.96 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 -173.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 23.4 m -79.51 -32.3 42.35 Favored 'General case' 0 N--CA 1.435 -1.217 0 CA-C-N 113.478 -1.692 . . . . 0.0 110.935 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.43 HG22 ' HA ' ' A' ' 19' ' ' ALA . 6.5 t -73.33 -23.31 60.23 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 174.237 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 26.9 m -78.93 -57.23 3.85 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.368 171.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.603 ' HB2' HG13 ' A' ' 27' ' ' ILE . 38.5 m-85 -107.9 96.34 6.31 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 178.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 4.6 p -65.4 -5.16 6.83 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.516 -179.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.558 ' OD1' ' HB3' ' A' ' 24' ' ' TYR . 28.2 p-10 -79.02 -16.89 56.24 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 173.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.603 HG13 ' HB2' ' A' ' 24' ' ' TYR . 2.6 mt -80.24 150.71 4.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 171.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 6.6 p -143.91 124.71 14.21 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.003 178.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.558 ' HA ' HD23 ' A' ' 39' ' ' LEU . 5.8 tt -81.87 98.43 8.51 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 176.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -119.48 169.37 10.1 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.129 -0.942 . . . . 0.0 109.659 -174.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.0 t70 62.28 26.07 15.6 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.287 0.565 . . . . 0.0 109.982 176.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.563 ' HA ' ' HB3' ' A' ' 37' ' ' PHE . 17.8 t70 -68.28 119.9 13.57 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.152 -173.377 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -146.57 52.6 1.11 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.42 177.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.25 -101.56 2.22 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.462 177.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.9 m -91.43 -3.02 57.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.312 0.577 . . . . 0.0 110.367 178.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 47.8 m80 -115.84 108.09 15.86 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.739 177.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.563 ' HB3' ' HA ' ' A' ' 32' ' ' ASP . 53.5 p90 -160.94 160.81 31.27 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.036 178.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 68.3 mtm180 -134.03 138.01 45.09 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.26 0.552 . . . . 0.0 111.696 -178.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.558 HD23 ' HA ' ' A' ' 29' ' ' LEU . 91.1 mt -92.66 114.27 26.77 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.303 173.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 31.5 t -94.8 111.57 25.77 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.958 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.416 HG11 ' CD1' ' A' ' 66' ' ' TYR . 39.0 t -85.19 117.62 30.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 178.115 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.467 ' O ' ' HB2' ' A' ' 26' ' ' ASN . 63.2 mtp180 -110.35 161.45 15.63 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.258 -177.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.489 ' HB3' ' HG3' ' A' ' 47' ' ' ARG . 7.7 t70 -92.56 177.83 6.0 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.572 -177.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.427 ' N ' ' CG ' ' A' ' 43' ' ' ASP . 7.0 p -61.28 -22.36 64.78 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 122.59 0.356 . . . . 0.0 111.862 -177.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -88.84 -9.74 50.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.427 0.632 . . . . 0.0 109.967 178.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 93.79 4.62 63.42 Favored Glycine 0 N--CA 1.451 -0.305 0 CA-C-N 115.767 -0.652 . . . . 0.0 112.994 177.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.489 ' HG3' ' HB3' ' A' ' 43' ' ' ASP . 14.1 ptt180 -73.74 140.75 46.16 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 110.321 -0.252 . . . . 0.0 110.321 177.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 69.1 mtm -71.88 122.16 20.3 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 178.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 20.3 t -107.2 -29.84 2.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.611 -178.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.403 ' HB3' ' HB ' ' A' ' 41' ' ' VAL . 73.7 t-105 -157.99 151.54 23.57 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.573 -175.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 11.2 ptp180 -152.67 132.87 13.54 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 173.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -134.27 149.71 50.95 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.561 -0.291 . . . . 0.0 111.058 -178.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.884 ' HB2' ' HG3' ' A' ' 56' ' ' GLU . 86.5 m95 -75.74 -170.11 1.23 Allowed 'General case' 0 CA--C 1.514 -0.434 0 CA-C-O 121.905 0.859 . . . . 0.0 111.498 177.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -101.52 -37.76 8.27 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 114.223 -1.353 . . . . 0.0 110.74 178.144 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -88.02 3.69 47.88 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.052 -173.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.884 ' HG3' ' HB2' ' A' ' 53' ' ' TRP . 35.7 mt-10 -74.43 128.91 85.05 Favored Pre-proline 0 N--CA 1.452 -0.372 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.179 178.039 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.442 ' HA ' ' HG3' ' A' ' 11' ' ' PRO . 32.5 Cg_exo -59.25 -14.44 24.34 Favored 'Trans proline' 0 N--CA 1.475 0.414 0 C-N-CA 123.293 2.662 . . . . 0.0 113.668 -175.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -133.6 24.95 4.06 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.756 -0.202 . . . . 0.0 111.46 -177.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.599 ' HB2' ' HB2' ' A' ' 56' ' ' GLU . . . -58.66 -48.08 82.28 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.015 0.436 . . . . 0.0 111.209 -174.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -65.14 -28.51 73.63 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.926 -179.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -68.02 -40.79 82.89 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.623 0.249 . . . . 0.0 110.532 -177.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -66.99 -39.77 93.27 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.51 -0.852 . . . . 0.0 111.291 178.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.443 ' O ' HG13 ' A' ' 67' ' ' ILE . 68.9 mt -63.91 -48.85 74.95 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.387 -0.407 . . . . 0.0 110.779 177.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.506 ' O ' ' HG3' ' A' ' 68' ' ' ARG . 96.0 m-20 -61.55 -36.71 81.37 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.748 0.309 . . . . 0.0 110.66 178.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.418 HH11 ' HD2' ' A' ' 65' ' ' ARG . 20.4 ttt85 -53.59 -42.2 67.37 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.499 176.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.416 ' CD1' HG11 ' A' ' 41' ' ' VAL . 43.3 t80 -72.57 -50.5 25.1 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.382 175.207 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.443 HG13 ' O ' ' A' ' 63' ' ' LEU . 97.1 mt -48.38 -47.67 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 -176.116 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.506 ' HG3' ' O ' ' A' ' 64' ' ' ASN . 15.5 mtp180 -56.78 -54.08 50.48 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -173.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.6 t -90.96 10.97 24.34 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 120.691 -0.404 . . . . 0.0 111.175 -174.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 17.1 m -120.44 -61.83 1.53 Allowed 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.208 -0.597 . . . . 0.0 111.12 177.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 43.55 74.48 0.2 Allowed Glycine 0 CA--C 1.525 0.701 0 CA-C-N 115.281 -0.872 . . . . 0.0 113.41 -173.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.465 ' O ' HG22 ' A' ' 72' ' ' ILE . 30.2 mm -89.2 6.9 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-O 121.355 0.597 . . . . 0.0 110.973 -174.306 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 35.0 ptt180 . . . . . 0 C--N 1.329 -0.298 0 O-C-N 122.068 -0.395 . . . . 0.0 111.814 -175.433 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.48 ' HA2' ' HA ' ' A' ' 58' ' ' ASP . . . . . . . . 0 CA--C 1.519 0.293 0 CA-C-O 120.132 -0.26 . . . . 0.0 112.979 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.453 ' HD3' ' HA3' ' A' ' 10' ' ' GLY . 6.1 Cg_exo -72.03 162.23 42.44 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.597 2.198 . . . . 0.0 111.2 178.36 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -123.75 151.54 43.13 Favored 'General case' 0 CA--C 1.505 -0.783 0 CA-C-O 121.756 0.789 . . . . 0.0 112.096 -176.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -91.8 165.64 13.16 Favored 'General case' 0 N--CA 1.433 -1.275 0 CA-C-N 113.993 -1.458 . . . . 0.0 109.431 176.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.401 ' O ' ' HG3' ' A' ' 18' ' ' GLN . 47.8 ttt180 -61.97 -51.04 69.68 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 120.737 0.303 . . . . 0.0 110.693 -177.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 37.2 ttp180 -54.4 -40.17 67.98 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.481 177.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.609 ' O ' HG23 ' A' ' 20' ' ' VAL . 85.6 mm-40 -62.97 -47.86 81.36 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.305 177.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.71 -42.88 84.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.301 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.401 ' HG3' ' O ' ' A' ' 14' ' ' ARG . 24.4 mt-30 -61.04 -44.4 97.46 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.856 -178.506 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.1 -37.8 86.48 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.195 0.521 . . . . 0.0 111.202 -179.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.609 HG23 ' O ' ' A' ' 16' ' ' GLN . 10.2 t -77.8 -22.87 13.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.405 -175.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.474 HG23 ' HB ' ' A' ' 27' ' ' ILE . 0.0 OUTLIER -83.35 -33.23 25.89 Favored 'General case' 0 CA--C 1.516 -0.362 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.481 176.168 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.3 p -68.04 -19.68 64.91 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 174.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.3 m -89.74 -53.46 4.5 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.211 171.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.618 ' O ' HG13 ' A' ' 27' ' ' ILE . 47.3 m-85 -113.92 102.26 10.04 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 177.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 11.6 p -80.78 5.0 17.16 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.96 0.41 . . . . 0.0 111.469 -178.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.525 ' OD1' ' HB3' ' A' ' 24' ' ' TYR . 25.7 p-10 -82.34 -21.64 35.9 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 171.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.618 HG13 ' O ' ' A' ' 24' ' ' TYR . 1.0 OUTLIER -74.69 147.46 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 170.991 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.479 ' O ' ' HA ' ' A' ' 39' ' ' LEU . 2.5 p -142.05 134.51 28.06 Favored 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 120.571 -0.452 . . . . 0.0 110.881 -176.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.591 HD22 ' HB3' ' A' ' 32' ' ' ASP . 1.5 tt -90.29 97.17 11.03 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.67 0.747 . . . . 0.0 109.367 -179.087 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.478 ' HB2' ' HG3' ' A' ' 38' ' ' ARG . 14.5 mm-40 -104.05 161.96 13.56 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 114.482 -1.236 . . . . 0.0 109.481 -174.313 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.482 ' HB2' ' HG2' ' A' ' 38' ' ' ARG . 1.0 OUTLIER 56.25 30.72 17.16 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 123.541 0.526 . . . . 0.0 111.692 179.411 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.591 ' HB3' HD22 ' A' ' 29' ' ' LEU . 16.2 p-10 -71.35 90.58 0.95 Allowed 'General case' 0 N--CA 1.446 -0.674 0 CA-C-O 122.045 0.926 . . . . 0.0 111.385 -176.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 14.4 tm0? -111.77 -15.49 13.39 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.649 -1.16 . . . . 0.0 109.442 178.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 113.41 -79.02 0.26 Allowed Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.468 -175.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 11.7 m -63.17 -33.0 74.52 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.442 0.639 . . . . 0.0 109.732 175.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 68.2 m170 -115.61 141.62 47.82 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.929 173.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 55.6 p90 -176.31 145.13 0.58 Allowed 'General case' 0 C--N 1.326 -0.432 0 O-C-N 124.077 0.861 . . . . 0.0 109.318 169.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.482 ' HG2' ' HB2' ' A' ' 31' ' ' ASP . 16.1 ptt180 -132.75 150.2 52.19 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.87 0.367 . . . . 0.0 111.145 -178.244 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.479 ' HA ' ' O ' ' A' ' 28' ' ' THR . 84.0 mt -103.31 115.75 31.15 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 174.123 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.473 HG22 ' HB3' ' A' ' 51' ' ' ARG . 48.6 t -99.33 115.39 39.94 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.836 177.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.476 HG11 ' CD1' ' A' ' 66' ' ' TYR . 50.2 t -82.92 104.64 11.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 175.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.487 ' O ' ' HB2' ' A' ' 26' ' ' ASN . 50.3 mtt180 -102.16 163.74 12.07 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.592 0.711 . . . . 0.0 111.27 -177.38 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.702 ' HB3' ' HB2' ' A' ' 47' ' ' ARG . 4.3 t70 -89.45 176.08 7.05 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 114.514 -1.221 . . . . 0.0 109.444 177.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.414 ' N ' ' CG ' ' A' ' 43' ' ' ASP . 0.3 OUTLIER -67.35 -18.99 65.37 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 120.855 0.36 . . . . 0.0 111.298 -174.741 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -93.37 -0.2 56.65 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 121.46 0.647 . . . . 0.0 110.044 175.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 89.14 8.46 68.76 Favored Glycine 0 N--CA 1.452 -0.275 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.431 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.702 ' HB2' ' HB3' ' A' ' 43' ' ' ASP . 39.4 mtt180 -61.03 132.97 55.53 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 122.278 0.231 . . . . 0.0 110.775 177.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 10.0 mmt -75.65 97.36 3.78 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.2 t -84.45 -38.83 13.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.033 0.444 . . . . 0.0 110.551 -175.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 69.8 t-105 -166.17 153.8 10.16 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.711 -178.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.473 ' HB3' HG22 ' A' ' 40' ' ' VAL . 9.0 ptt180 -152.14 148.02 27.14 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.034 0.445 . . . . 0.0 111.14 177.025 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -148.79 143.09 26.13 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.17 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.468 ' H ' ' HG3' ' A' ' 56' ' ' GLU . 72.0 m95 -87.98 -171.34 3.36 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 122.208 1.004 . . . . 0.0 111.539 -178.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -82.28 -35.63 27.84 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 113.481 -1.69 . . . . 0.0 109.83 178.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 32.2 p90 -87.98 17.88 4.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.65 -178.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.586 ' HB2' ' HB2' ' A' ' 59' ' ' ALA . 11.8 mm-40 -85.23 116.75 66.83 Favored Pre-proline 0 C--N 1.327 -0.401 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 175.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.445 ' HD2' ' HA ' ' A' ' 56' ' ' GLU . 3.6 Cg_endo -46.34 -39.92 21.95 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 124.269 3.312 . . . . 0.0 114.163 -172.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.48 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . 4.6 t0 -138.1 55.89 1.75 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.088 0.47 . . . . 0.0 110.14 178.324 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.586 ' HB2' ' HB2' ' A' ' 56' ' ' GLU . . . -56.4 -39.89 73.76 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.277 -179.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -59.45 -33.0 74.37 Favored Glycine 0 N--CA 1.45 -0.387 0 CA-C-N 115.384 -0.825 . . . . 0.0 114.071 -177.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.468 ' HB2' ' OD1' ' A' ' 58' ' ' ASP . 35.7 tt0 -62.52 -43.07 99.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 117.608 0.704 . . . . 0.0 110.96 -176.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -73.28 -41.2 47.01 Favored Glycine 0 C--O 1.237 0.288 0 C-N-CA 120.539 -0.838 . . . . 0.0 111.557 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 72.6 mt -64.73 -51.97 59.56 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.547 -0.326 . . . . 0.0 110.851 -179.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.452 ' HA ' ' HB ' ' A' ' 67' ' ' ILE . 93.2 m-20 -60.56 -32.64 71.71 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.608 0.242 . . . . 0.0 111.006 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 11.2 tpt180 -55.45 -50.75 69.03 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.262 176.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.476 ' CD1' HG11 ' A' ' 41' ' ' VAL . 38.9 t80 -72.53 -43.27 63.75 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.447 179.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.538 HG23 ' CZ ' ' A' ' 24' ' ' TYR . 59.9 mt -49.61 -44.84 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-N 115.617 -0.72 . . . . 0.0 112.262 -178.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 61.9 ttt180 -68.37 -53.77 21.73 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -175.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 8.8 t -76.34 -35.65 58.65 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 112.37 0.508 . . . . 0.0 112.37 -169.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 25.1 m -90.21 -50.84 5.75 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.69 -177.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 48.25 85.14 0.02 OUTLIER Glycine 0 CA--C 1.525 0.667 0 CA-C-N 115.515 -0.766 . . . . 0.0 114.632 179.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.516 HG21 ' HB3' ' A' ' 26' ' ' ASN . 1.8 mp -80.74 5.37 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 CA-C-O 122.369 1.08 . . . . 0.0 109.63 177.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.499 ' HB3' ' CE2' ' A' ' 24' ' ' TYR . 52.3 ptt85 . . . . . 0 N--CA 1.468 0.47 0 CA-C-N 114.833 -1.076 . . . . 0.0 112.036 178.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.525 ' HA3' ' O ' ' A' ' 57' ' ' PRO . . . . . . . . 0 N--CA 1.441 -0.998 0 N-CA-C 110.991 -0.844 . . . . 0.0 110.991 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -75.7 130.39 12.54 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 121.623 1.548 . . . . 0.0 110.958 172.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -102.58 -178.46 3.69 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 121.806 0.812 . . . . 0.0 111.923 -172.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.98 151.49 32.28 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 114.705 -1.134 . . . . 0.0 108.988 176.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.544 ' O ' ' HG3' ' A' ' 18' ' ' GLN . 43.7 ttt-85 -59.36 -48.98 79.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.033 0.444 . . . . 0.0 109.944 -178.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 72.5 mtp85 -56.7 -45.69 81.66 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.241 177.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.519 ' O ' HG23 ' A' ' 20' ' ' VAL . 12.4 mm100 -63.31 -39.87 95.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.489 179.255 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.456 ' HB1' HD21 ' A' ' 39' ' ' LEU . . . -62.06 -43.38 98.96 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.685 177.03 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.544 ' HG3' ' O ' ' A' ' 14' ' ' ARG . 28.0 mt-30 -51.71 -44.37 63.16 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.022 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.79 -27.04 68.91 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.107 -179.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.519 HG23 ' O ' ' A' ' 16' ' ' GLN . 14.1 t -92.46 -16.13 7.92 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.752 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 -172.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 12.0 m -93.31 -31.42 14.69 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-N 113.972 -1.467 . . . . 0.0 107.588 -176.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 99.0 m -61.65 -38.1 86.46 Favored 'General case' 0 N--CA 1.436 -1.175 0 CA-C-N 113.628 -1.624 . . . . 0.0 109.299 166.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.575 HG23 ' HE ' ' A' ' 73' ' ' ARG . 36.7 m -75.03 -53.86 8.18 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.992 177.139 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.67 ' O ' HG13 ' A' ' 27' ' ' ILE . 89.9 m-85 -117.45 96.88 5.6 Favored 'General case' 0 N--CA 1.44 -0.975 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 178.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 48.3 m -76.12 5.72 6.37 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.865 0.364 . . . . 0.0 111.506 -177.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.563 ' ND2' ' HB3' ' A' ' 24' ' ' TYR . 0.1 OUTLIER -76.84 -16.43 59.42 Favored 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 108.598 -0.889 . . . . 0.0 108.598 167.803 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.67 HG13 ' O ' ' A' ' 24' ' ' TYR . 2.2 mt -84.4 151.45 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 171.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.564 ' OG1' ' HB ' ' A' ' 40' ' ' VAL . 11.1 p -138.14 117.41 12.73 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 119.954 -0.698 . . . . 0.0 111.068 178.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.593 ' HA ' HD23 ' A' ' 39' ' ' LEU . 4.8 tt -83.23 99.03 9.71 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 174.239 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.532 ' HG2' ' HB ' ' A' ' 28' ' ' THR . 74.2 mm-40 -132.9 -173.55 3.22 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.957 -173.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.7 t70 69.53 17.25 8.01 Favored 'General case' 0 CA--C 1.531 0.214 0 O-C-N 124.072 0.857 . . . . 0.0 110.505 177.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -57.59 95.54 0.02 OUTLIER 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.659 178.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -122.79 10.11 9.56 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.206 0.527 . . . . 0.0 110.206 -178.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 119.31 -88.98 0.45 Allowed Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.583 178.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 9.8 t -89.36 -17.04 29.63 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 120.702 0.286 . . . . 0.0 110.569 -176.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 30.1 p80 -124.41 145.79 49.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.153 0.501 . . . . 0.0 111.424 178.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -166.67 167.91 14.87 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.298 -1.319 . . . . 0.0 107.608 174.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.429 ' HB3' ' HA ' ' A' ' 53' ' ' TRP . 30.9 ptt180 -153.0 156.29 38.54 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.115 0.484 . . . . 0.0 112.076 -175.285 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.593 HD23 ' HA ' ' A' ' 29' ' ' LEU . 89.2 mt -102.03 117.95 35.89 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.961 178.22 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.564 ' HB ' ' OG1' ' A' ' 28' ' ' THR . 37.7 t -100.89 113.91 38.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 116.278 -0.419 . . . . 0.0 109.983 178.54 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 46.5 t -90.04 122.4 41.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.022 0.439 . . . . 0.0 110.051 178.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 57.9 mtp180 -105.06 163.88 12.22 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.476 -178.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -88.66 -171.74 3.45 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 177.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.1 p -62.31 -22.26 65.92 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.918 -176.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -91.71 -31.46 15.8 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.891 0.377 . . . . 0.0 110.54 179.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 119.6 10.0 8.08 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.418 -0.896 . . . . 0.0 112.541 -177.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 92.4 mtt180 -82.57 127.56 33.47 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 177.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.13 118.62 10.13 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.264 0.554 . . . . 0.0 110.785 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 41.9 t -97.23 -35.78 5.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.07 -179.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 68.8 t-105 -158.14 119.32 3.49 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.177 -178.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.473 ' HB3' HG13 ' A' ' 40' ' ' VAL . 36.4 ptt180 -112.68 129.02 56.54 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.817 174.089 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -122.76 142.09 51.1 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.555 -177.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.547 ' HB2' ' HG3' ' A' ' 56' ' ' GLU . 95.0 m95 -79.36 -169.13 1.76 Allowed 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 121.709 0.766 . . . . 0.0 110.923 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -101.32 -30.41 11.5 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 114.701 -1.136 . . . . 0.0 110.932 -176.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 40.6 p90 -90.29 3.69 52.89 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.557 -174.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.547 ' HG3' ' HB2' ' A' ' 53' ' ' TRP . 40.0 mt-10 -75.42 132.51 75.72 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 120.752 0.31 . . . . 0.0 110.275 179.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.525 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 39.8 Cg_endo -66.5 -11.65 32.54 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 123.225 2.617 . . . . 0.0 113.394 -173.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -137.57 28.39 2.72 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.648 -0.251 . . . . 0.0 110.561 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.563 ' O ' ' HG ' ' A' ' 63' ' ' LEU . . . -53.03 -49.61 65.93 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.847 -176.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -69.82 -30.45 70.39 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.653 -178.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -70.53 -34.06 71.85 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.841 0.321 . . . . 0.0 110.279 -175.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.484 ' O ' ' HB3' ' A' ' 65' ' ' ARG . . . -74.24 -39.22 44.67 Favored Glycine 0 C--O 1.238 0.354 0 C-N-CA 120.382 -0.913 . . . . 0.0 111.583 177.158 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.563 ' HG ' ' O ' ' A' ' 59' ' ' ALA . 70.2 mt -67.51 -45.31 76.15 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.539 -0.33 . . . . 0.0 110.513 178.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -61.25 -32.34 72.14 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.557 176.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.484 ' HB3' ' O ' ' A' ' 62' ' ' GLY . 0.4 OUTLIER -57.32 -44.83 84.53 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.301 -0.409 . . . . 0.0 109.922 175.473 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 14.1 t80 -67.11 -53.19 33.16 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.079 176.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 97.3 mt -50.92 -51.37 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.847 -178.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 45.9 ttm105 -55.99 -32.41 63.92 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.274 -173.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 5.1 t -111.38 15.01 21.53 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.449 -0.501 . . . . 0.0 111.705 -174.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 16.2 m -134.66 -54.98 0.83 Allowed 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.849 -0.341 . . . . 0.0 111.15 -179.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.52 ' HA2' ' CE1' ' A' ' 24' ' ' TYR . . . 47.15 75.82 0.17 Allowed Glycine 0 CA--C 1.527 0.812 0 CA-C-N 115.552 -0.749 . . . . 0.0 114.114 -177.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.473 HG21 ' HB3' ' A' ' 26' ' ' ASN . 1.8 mp -72.94 -20.65 19.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-N 117.132 0.466 . . . . 0.0 111.912 -174.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.575 ' HE ' HG23 ' A' ' 23' ' ' THR . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.261 0 CA-C-O 121.237 0.541 . . . . 0.0 111.525 -178.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.56 ' HA2' ' HA ' ' A' ' 58' ' ' ASP . . . . . . . . 0 CA--C 1.52 0.358 0 N-CA-C 114.584 0.594 . . . . 0.0 114.584 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.466 ' HD3' ' HA3' ' A' ' 10' ' ' GLY . 6.6 Cg_exo -72.16 144.2 41.53 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 123.159 2.573 . . . . 0.0 112.515 -177.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -112.12 -173.3 2.22 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.143 -178.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.447 ' OG1' ' HG2' ' A' ' 16' ' ' GLN . 28.8 p -125.07 176.31 6.77 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 175.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.412 HH11 ' HD2' ' A' ' 14' ' ' ARG . 22.8 ttt180 -61.67 -46.7 88.6 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.488 0.661 . . . . 0.0 109.489 175.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 36.1 mmt180 -55.02 -48.79 72.91 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.558 -1.201 . . . . 0.0 110.675 178.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.61 ' O ' HG23 ' A' ' 20' ' ' VAL . 15.7 mm100 -62.7 -49.15 76.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.211 178.193 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -52.76 -49.26 65.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.684 179.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.405 ' HG2' ' O ' ' A' ' 14' ' ' ARG . 15.2 mm100 -55.65 -41.82 74.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.312 -179.37 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.44 -29.11 70.45 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.982 -179.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.61 HG23 ' O ' ' A' ' 16' ' ' GLN . 3.3 t -91.33 -26.05 5.17 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.958 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 -171.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 16.2 m -79.55 -32.97 42.2 Favored 'General case' 0 N--CA 1.437 -1.117 0 CA-C-N 113.95 -1.477 . . . . 0.0 110.655 179.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.8 p -73.54 -26.08 60.69 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 121.082 0.467 . . . . 0.0 109.742 172.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.534 HG23 ' HD2' ' A' ' 73' ' ' ARG . 89.8 m -76.2 -55.09 5.9 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.783 172.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.606 ' O ' HG13 ' A' ' 27' ' ' ILE . 70.1 m-85 -116.63 101.53 8.68 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 175.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 45.0 m -82.16 17.39 1.65 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.207 0.527 . . . . 0.0 111.747 -176.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.547 ' OD1' ' HB3' ' A' ' 24' ' ' TYR . 25.1 p-10 -87.91 -20.37 26.04 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 167.238 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.606 HG13 ' O ' ' A' ' 24' ' ' TYR . 2.4 mt -73.57 146.92 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 171.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -149.46 130.3 14.23 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 120.225 -0.59 . . . . 0.0 111.566 -179.094 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.528 ' HA ' HD23 ' A' ' 39' ' ' LEU . 5.9 tt -79.3 103.12 9.01 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.229 178.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -112.76 166.41 11.39 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.497 -176.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.6 t70 66.39 46.37 1.96 Allowed 'General case' 0 N--CA 1.465 0.304 0 O-C-N 123.65 0.594 . . . . 0.0 110.542 176.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -64.95 99.93 0.38 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.454 -179.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 21.8 tt0 -129.63 57.56 1.67 Allowed 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.494 0.664 . . . . 0.0 109.422 175.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 74.52 -112.81 3.85 Favored Glycine 0 N--CA 1.45 -0.372 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.741 -178.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 30.2 t -87.67 -1.5 57.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.092 0.472 . . . . 0.0 110.119 177.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -101.44 124.85 47.77 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 176.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -173.8 170.49 3.94 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 178.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 30.1 ptt-85 -145.18 145.39 31.33 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.217 0.532 . . . . 0.0 111.433 178.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.528 HD23 ' HA ' ' A' ' 29' ' ' LEU . 93.9 mt -90.67 110.75 21.91 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.284 177.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 84.2 t -89.93 115.05 28.72 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.049 173.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.5 t -91.82 108.73 20.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.453 ' O ' ' HB2' ' A' ' 26' ' ' ASN . 60.3 mtt85 -95.93 170.21 9.45 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.868 -178.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.438 ' CG ' ' H ' ' A' ' 45' ' ' GLU . 1.2 p-10 -96.65 -171.19 2.21 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.974 0.416 . . . . 0.0 110.002 179.54 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.46 -19.99 66.17 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.687 -176.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.438 ' H ' ' CG ' ' A' ' 43' ' ' ASP . 9.5 tp10 -91.08 -28.67 17.78 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.24 0.543 . . . . 0.0 109.944 177.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 114.18 12.19 11.28 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.798 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.445 ' O ' ' HA ' ' A' ' 42' ' ' ARG . 40.5 mtt-85 -80.33 137.67 36.61 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -76.72 96.87 4.32 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.42 0.629 . . . . 0.0 110.599 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 15.8 t -83.54 -31.27 8.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.523 -177.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.442 ' CD1' HD23 ' A' ' 63' ' ' LEU . 75.4 t-105 -150.38 159.15 44.67 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.261 -177.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 27.5 ptt-85 -158.4 131.4 7.3 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 178.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -140.94 140.75 34.49 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 110.463 -0.199 . . . . 0.0 110.463 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.635 ' HB2' ' HG3' ' A' ' 56' ' ' GLU . 72.4 m95 -77.27 -173.89 3.02 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-O 121.764 0.793 . . . . 0.0 110.752 -179.177 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -94.18 -26.37 16.71 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 114.254 -1.339 . . . . 0.0 109.837 -178.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -98.33 6.16 47.58 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.802 -174.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.635 ' HG3' ' HB2' ' A' ' 53' ' ' TRP . 38.2 mt-10 -76.45 129.97 78.37 Favored Pre-proline 0 C--N 1.326 -0.43 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.195 178.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.428 ' HA ' ' HG3' ' A' ' 11' ' ' PRO . 31.7 Cg_exo -59.2 -20.07 52.99 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 123.431 2.754 . . . . 0.0 113.136 -175.155 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.56 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . 13.2 m-20 -133.6 37.92 3.28 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.541 179.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.407 ' O ' ' HG ' ' A' ' 63' ' ' LEU . . . -54.95 -50.18 69.54 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 120.925 0.393 . . . . 0.0 111.141 -178.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -63.33 -30.28 77.07 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.789 179.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.42 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 23.5 tp10 -60.79 -42.18 97.07 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.784 0.325 . . . . 0.0 110.367 -178.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.477 ' O ' ' HB3' ' A' ' 65' ' ' ARG . . . -77.05 -38.64 29.62 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.093 179.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.519 ' O ' HG13 ' A' ' 67' ' ' ILE . 85.5 mt -63.17 -52.76 61.08 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.723 0.297 . . . . 0.0 110.357 179.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -61.99 -32.13 72.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.632 178.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.477 ' HB3' ' O ' ' A' ' 62' ' ' GLY . 7.0 tpt85 -54.29 -46.74 72.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.669 177.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -74.86 -44.14 50.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.985 178.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.519 HG13 ' O ' ' A' ' 63' ' ' LEU . 89.5 mt -52.65 -44.57 46.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-O 120.897 0.379 . . . . 0.0 111.083 -179.119 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 23.6 ttt180 -58.83 -24.24 61.73 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.432 -0.803 . . . . 0.0 112.425 -176.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 11.3 t -118.1 22.21 12.33 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.402 0.62 . . . . 0.0 111.601 -175.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 29.2 p -144.91 -55.44 0.32 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.349 178.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 44.98 78.13 0.08 OUTLIER Glycine 0 CA--C 1.52 0.353 0 CA-C-N 115.325 -0.852 . . . . 0.0 113.333 -177.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.7 mp -72.46 -19.93 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-N 117.196 0.498 . . . . 0.0 111.642 -174.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.534 ' HD2' HG23 ' A' ' 23' ' ' THR . 72.2 ttt180 . . . . . 0 CA--C 1.515 -0.398 0 CA-C-O 121.259 0.552 . . . . 0.0 111.273 -175.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.537 ' HA2' ' HA ' ' A' ' 58' ' ' ASP . . . . . . . . 0 CA--C 1.519 0.301 0 CA-C-O 120.086 -0.286 . . . . 0.0 113.689 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -72.49 165.2 33.39 Favored 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 122.873 2.382 . . . . 0.0 111.82 179.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -132.74 169.58 16.49 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.741 0.781 . . . . 0.0 111.997 -176.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.5 m -112.85 166.86 10.99 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 114.441 -1.254 . . . . 0.0 110.048 -176.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 45.5 ttt-85 -62.36 -47.56 83.67 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.683 0.277 . . . . 0.0 110.877 -175.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.428 HH11 ' HD3' ' A' ' 15' ' ' ARG . 27.0 ttm-85 -53.08 -47.13 68.77 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.612 174.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.605 ' O ' HG23 ' A' ' 20' ' ' VAL . 77.6 mt-30 -59.98 -47.83 84.22 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.657 178.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.404 ' HB1' HD21 ' A' ' 39' ' ' LEU . . . -55.28 -47.98 74.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.165 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 56.9 mm-40 -59.25 -36.16 74.97 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.934 -179.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.1 -29.32 68.23 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.036 0.446 . . . . 0.0 111.415 -178.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.605 HG23 ' O ' ' A' ' 16' ' ' GLN . 11.1 t -89.83 -27.42 5.18 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.826 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 -172.068 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.477 HG23 ' HB ' ' A' ' 27' ' ' ILE . 15.6 m -83.64 -27.47 29.09 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-N 113.795 -1.548 . . . . 0.0 111.119 -179.273 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.2 p -73.4 -30.68 63.42 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 171.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 34.7 m -77.09 -47.03 21.59 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.275 173.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.636 ' HB2' HG13 ' A' ' 27' ' ' ILE . 40.0 m-85 -114.54 96.35 5.71 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 177.656 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 37.8 p -64.9 -7.61 12.09 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 111.906 0.335 . . . . 0.0 111.906 -179.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.586 ' OD1' ' HB3' ' A' ' 24' ' ' TYR . 5.4 p-10 -78.81 -11.49 59.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.999 0.428 . . . . 0.0 110.192 177.137 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.636 HG13 ' HB2' ' A' ' 24' ' ' TYR . 2.5 mt -83.08 146.59 6.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 174.21 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.525 ' OG1' ' HB ' ' A' ' 40' ' ' VAL . 10.3 p -133.12 120.23 20.98 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.398 -0.521 . . . . 0.0 110.786 -177.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.561 HD22 ' HB2' ' A' ' 32' ' ' ASP . 2.8 tt -88.36 105.15 17.39 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 -179.171 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.22 161.85 18.35 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.71 -176.242 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 61.26 30.56 19.24 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.032 -177.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.561 ' HB2' HD22 ' A' ' 29' ' ' LEU . 32.7 t0 -73.98 95.97 2.58 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.004 -178.194 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -115.29 1.96 13.9 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.564 178.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 119.88 -85.22 0.38 Allowed Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.463 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.1 t -89.32 -1.14 57.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.997 0.427 . . . . 0.0 110.496 -178.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 12.3 m170 -132.66 135.72 46.02 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 173.001 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.436 ' HB3' ' HA ' ' A' ' 32' ' ' ASP . 43.2 p90 -174.66 156.83 2.43 Favored 'General case' 0 C--O 1.234 0.285 0 O-C-N 123.858 0.724 . . . . 0.0 109.558 178.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 15.1 ptt180 -136.08 153.03 51.44 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.937 0.399 . . . . 0.0 111.513 176.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.526 HD23 ' HA ' ' A' ' 29' ' ' LEU . 71.5 mt -108.66 125.76 52.23 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.171 0.51 . . . . 0.0 110.558 177.049 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.525 ' HB ' ' OG1' ' A' ' 28' ' ' THR . 45.1 t -100.13 114.83 39.87 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.351 171.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 16.9 t -87.6 114.99 27.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.421 ' HA ' ' O ' ' A' ' 47' ' ' ARG . 3.8 mtt85 -101.24 160.87 14.04 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.398 0.618 . . . . 0.0 111.402 -176.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.421 ' CG ' ' N ' ' A' ' 44' ' ' THR . 4.1 t70 -91.57 178.23 5.99 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.487 -1.233 . . . . 0.0 109.979 -178.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.421 ' N ' ' CG ' ' A' ' 43' ' ' ASP . 19.1 p -59.01 -22.39 60.59 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 123.201 0.6 . . . . 0.0 111.718 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -92.63 -5.07 52.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.138 0.494 . . . . 0.0 110.536 178.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 89.29 9.49 67.11 Favored Glycine 0 N--CA 1.453 -0.173 0 C-N-CA 120.807 -0.711 . . . . 0.0 111.946 -177.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.421 ' O ' ' HA ' ' A' ' 42' ' ' ARG . 38.0 mtp180 -70.96 130.66 42.17 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 122.533 0.333 . . . . 0.0 110.364 179.359 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.15 90.52 2.54 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.599 0.714 . . . . 0.0 110.283 176.037 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 24.7 t -75.16 -38.45 41.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.621 -176.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 75.5 t-105 -150.14 152.61 34.98 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.248 -175.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 13.7 ptt-85 -150.14 137.19 19.46 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 177.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -145.97 146.54 31.06 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.407 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.463 ' HB2' ' HG3' ' A' ' 56' ' ' GLU . 96.5 m95 -80.44 -171.23 2.94 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-O 121.387 0.613 . . . . 0.0 109.587 175.199 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -99.81 -21.34 15.79 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.551 -176.226 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -100.46 11.73 38.81 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.58 -174.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.463 ' HG3' ' HB2' ' A' ' 53' ' ' TRP . 42.7 mt-10 -80.88 135.8 51.57 Favored Pre-proline 0 C--N 1.329 -0.308 0 C-N-CA 121.025 -0.27 . . . . 0.0 110.432 179.419 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -36.78 -47.23 1.39 Allowed 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 125.071 3.847 . . . . 0.0 114.31 -172.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.537 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . 4.2 t70 -144.58 63.35 1.31 Allowed 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 176.424 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.436 ' HB2' ' HB2' ' A' ' 56' ' ' GLU . . . -58.69 -31.55 68.33 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.041 179.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -61.7 -34.07 87.33 Favored Glycine 0 N--CA 1.447 -0.604 0 CA-C-N 115.582 -0.735 . . . . 0.0 113.56 -178.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.52 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 2.1 tm-20 -57.34 -50.47 72.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 117.074 0.437 . . . . 0.0 110.351 -177.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -67.56 -43.25 86.69 Favored Glycine 0 C--O 1.237 0.334 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.287 -177.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.458 ' O ' HG13 ' A' ' 67' ' ' ILE . 53.2 mt -60.34 -55.61 31.58 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 110.331 -0.248 . . . . 0.0 110.331 178.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.569 ' HA ' ' HB ' ' A' ' 67' ' ' ILE . 94.4 m-20 -62.69 -31.46 72.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.933 -179.02 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.52 ' HB2' ' O ' ' A' ' 61' ' ' GLU . 7.1 tpt180 -52.86 -46.06 67.68 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.362 0.601 . . . . 0.0 109.66 177.315 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 75.8 t80 -81.35 -41.82 21.44 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.986 178.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.569 ' HB ' ' HA ' ' A' ' 64' ' ' ASN . 95.2 mt -55.37 -48.88 76.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -178.415 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 59.9 ttt-85 -63.42 -48.98 75.56 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.376 -176.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 38.7 p -79.4 -41.12 28.44 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.035 -0.53 . . . . 0.0 112.179 -172.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.436 ' O ' HD12 ' A' ' 72' ' ' ILE . 3.3 m -127.85 20.19 6.53 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 112.681 0.622 . . . . 0.0 112.681 -166.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -48.33 134.24 19.15 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 121.346 -0.454 . . . . 0.0 113.927 178.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.478 ' HB ' ' OD1' ' A' ' 26' ' ' ASN . 2.5 mp -89.2 7.68 3.44 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 C-N-CA 123.258 0.623 . . . . 0.0 109.935 -176.722 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.633 ' HB3' ' CE1' ' A' ' 24' ' ' TYR . 30.7 ptt180 . . . . . 0 N--CA 1.484 1.265 0 N-CA-C 115.135 1.531 . . . . 0.0 115.135 -173.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.464 ' HA2' ' HA ' ' A' ' 58' ' ' ASP . . . . . . . . 0 CA--C 1.518 0.251 0 CA-C-O 120.04 -0.311 . . . . 0.0 113.157 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.489 ' HD3' ' O ' ' A' ' 57' ' ' PRO . 19.4 Cg_exo -66.69 169.22 14.89 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.716 2.277 . . . . 0.0 111.856 176.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.488 ' CD2' ' HB2' ' A' ' 17' ' ' ALA . 41.2 p90 -140.33 165.27 27.86 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.189 -179.053 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.8 p -103.72 178.17 4.63 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.27 -178.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.563 ' HA ' ' CZ ' ' A' ' 37' ' ' PHE . 47.2 ttt180 -60.8 -54.85 40.19 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.212 178.22 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 57.9 mtt-85 -62.84 -37.31 86.3 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.683 -178.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.581 ' O ' HG23 ' A' ' 20' ' ' VAL . 77.5 mm-40 -62.97 -53.07 59.76 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.222 177.495 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.488 ' HB2' ' CD2' ' A' ' 12' ' ' PHE . . . -52.85 -44.27 66.66 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.492 178.156 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -58.8 -39.2 80.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.767 -178.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.02 -27.29 65.55 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-O 121.392 0.615 . . . . 0.0 110.945 179.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.581 HG23 ' O ' ' A' ' 16' ' ' GLN . 3.6 t -76.71 -25.71 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 -179.169 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.545 HG23 ' HB ' ' A' ' 27' ' ' ILE . 0.0 OUTLIER -80.61 -28.01 37.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.841 175.542 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.9 p -75.99 -14.52 60.23 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.434 0.635 . . . . 0.0 109.552 173.17 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 18.9 m -92.4 -50.18 5.77 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.753 170.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.587 ' HB3' ' OD1' ' A' ' 26' ' ' ASN . 48.3 m-85 -118.85 105.31 11.38 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 177.273 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 17.7 p -76.94 -1.76 30.23 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.079 0.466 . . . . 0.0 111.093 -179.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.587 ' OD1' ' HB3' ' A' ' 24' ' ' TYR . 6.1 p-10 -81.6 -9.84 59.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.649 175.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.584 HG13 ' O ' ' A' ' 24' ' ' TYR . 1.8 mt -86.03 155.62 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 174.235 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.517 ' OG1' ' HB ' ' A' ' 40' ' ' VAL . 1.2 p -142.35 123.27 14.42 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.888 0.375 . . . . 0.0 111.251 -179.529 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.45 ' HA ' HD23 ' A' ' 39' ' ' LEU . 6.1 tt -88.44 105.78 17.83 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 178.697 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -126.79 169.09 13.56 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.524 179.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.549 ' HB2' ' HG2' ' A' ' 38' ' ' ARG . 1.1 m-20 66.06 37.67 5.14 Favored 'General case' 0 C--N 1.329 -0.309 0 O-C-N 123.528 0.517 . . . . 0.0 110.761 179.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.502 ' HA ' ' HB3' ' A' ' 37' ' ' PHE . 11.3 p-10 -67.6 102.56 1.19 Allowed 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 121.878 0.847 . . . . 0.0 110.334 179.216 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -116.93 30.31 7.41 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.435 -177.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 96.44 -106.41 3.36 Favored Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.807 -179.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.6 m -81.94 -1.87 49.47 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.911 0.386 . . . . 0.0 110.784 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.42 ' HA ' ' OD1' ' A' ' 54' ' ' ASN . 20.7 m-70 -129.37 143.42 50.83 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.652 179.504 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.563 ' CZ ' ' HA ' ' A' ' 14' ' ' ARG . 36.8 p90 -173.95 170.96 3.76 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 -178.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.549 ' HG2' ' HB2' ' A' ' 31' ' ' ASP . 16.5 ptt180 -127.33 152.61 47.24 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.133 0.492 . . . . 0.0 111.004 179.03 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.47 HD11 ' HB1' ' A' ' 17' ' ' ALA . 96.3 mt -111.56 115.78 29.75 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.713 173.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.558 HG13 ' HB3' ' A' ' 51' ' ' ARG . 3.1 t -92.2 113.79 28.07 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.152 178.253 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.406 HG11 ' CD2' ' A' ' 66' ' ' TYR . 21.8 t -87.12 111.51 21.85 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.428 HH11 HG21 ' A' ' 28' ' ' THR . 23.7 mtp180 -100.42 164.02 12.11 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.23 -178.423 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.558 ' HB2' ' CG2' ' A' ' 49' ' ' VAL . 10.1 t70 -97.38 -169.2 1.81 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.605 -175.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.417 ' H ' ' CG ' ' A' ' 43' ' ' ASP . 40.3 p -67.91 -21.81 65.11 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.064 0.459 . . . . 0.0 110.727 -178.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -84.74 -10.58 57.12 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.665 0.745 . . . . 0.0 109.224 178.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 86.36 3.04 84.85 Favored Glycine 0 N--CA 1.444 -0.797 0 CA-C-N 115.289 -0.869 . . . . 0.0 112.75 -179.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 8.9 ptp180 -82.72 147.91 28.19 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 117.103 0.451 . . . . 0.0 110.212 177.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 21.2 ptt? -75.06 123.23 24.81 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.321 0.582 . . . . 0.0 110.749 -179.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.558 ' CG2' ' HB2' ' A' ' 43' ' ' ASP . 6.5 t -103.31 -33.93 3.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.085 -177.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 75.0 t-105 -152.23 152.0 31.66 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.494 -178.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.558 ' HB3' HG13 ' A' ' 40' ' ' VAL . 1.9 ppt_? -150.97 139.88 20.92 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 178.392 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -150.59 157.76 43.36 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.054 179.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.521 ' HA ' ' HA ' ' A' ' 38' ' ' ARG . 69.1 m95 -88.31 -164.67 1.15 Allowed 'General case' 0 N--CA 1.444 -0.764 0 CA-C-O 121.081 0.467 . . . . 0.0 110.229 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.42 ' OD1' ' HA ' ' A' ' 36' ' ' HIS . 0.4 OUTLIER -104.18 -21.93 13.47 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.301 -175.012 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -95.28 0.93 54.3 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -171.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.585 ' HB2' ' HB2' ' A' ' 59' ' ' ALA . 48.4 mt-10 -74.14 141.57 77.91 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 116.808 -0.178 . . . . 0.0 110.526 -179.147 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.489 ' O ' ' HD3' ' A' ' 11' ' ' PRO . 80.4 Cg_exo -45.95 -38.78 18.94 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 123.956 3.104 . . . . 0.0 114.163 -172.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.464 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . 9.1 m-20 -136.21 48.44 2.16 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 177.606 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.585 ' HB2' ' HB2' ' A' ' 56' ' ' GLU . . . -56.77 -48.43 77.89 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.723 -0.672 . . . . 0.0 111.292 -175.311 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.405 ' HA2' HD12 ' A' ' 63' ' ' LEU . . . -70.77 -25.65 75.38 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.45 -178.416 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.59 -33.25 66.6 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 -177.082 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.55 ' O ' ' HB2' ' A' ' 65' ' ' ARG . . . -71.81 -41.02 56.99 Favored Glycine 0 C--O 1.239 0.459 0 C-N-CA 120.684 -0.77 . . . . 0.0 111.273 176.223 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.515 ' HG ' ' O ' ' A' ' 59' ' ' ALA . 55.1 mt -58.24 -44.48 88.3 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.112 0.482 . . . . 0.0 109.711 175.461 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.569 ' HA ' ' HB ' ' A' ' 67' ' ' ILE . 33.2 m-80 -73.32 -18.42 61.19 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.756 -0.657 . . . . 0.0 111.636 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.55 ' HB2' ' O ' ' A' ' 62' ' ' GLY . 9.7 mmt180 -60.76 -47.88 84.3 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 172.041 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.406 ' CD2' HG11 ' A' ' 41' ' ' VAL . 83.8 t80 -67.99 -47.27 68.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.434 176.213 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.569 ' HB ' ' HA ' ' A' ' 64' ' ' ASN . 97.0 mt -59.16 -39.87 79.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -177.301 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 47.1 ttt180 -54.54 -43.2 71.75 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.633 0.254 . . . . 0.0 111.253 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.3 t -98.7 -9.99 23.82 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.746 0.308 . . . . 0.0 111.484 -177.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 33.1 t -159.09 66.72 0.41 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.331 0.586 . . . . 0.0 111.328 -177.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -89.29 127.61 8.77 Favored Glycine 0 N--CA 1.447 -0.619 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 171.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.521 ' HB ' ' OD1' ' A' ' 26' ' ' ASN . 2.0 mp -83.82 -0.85 5.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 CA-C-O 121.433 0.635 . . . . 0.0 110.714 -172.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.523 ' HB3' ' CE1' ' A' ' 24' ' ' TYR . 4.7 ptm180 . . . . . 0 N--CA 1.47 0.571 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -176.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.409 ' HA3' ' HD3' ' A' ' 11' ' ' PRO . . . . . . . . 0 N--CA 1.453 -0.215 0 CA-C-O 119.957 -0.357 . . . . 0.0 112.506 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.409 ' HD3' ' HA3' ' A' ' 10' ' ' GLY . 2.8 Cg_exo -74.96 175.1 11.67 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 122.696 2.264 . . . . 0.0 111.872 178.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.453 ' HE1' ' HE2' ' A' ' 37' ' ' PHE . 51.3 p90 -128.19 161.5 29.15 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.386 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 43.0 p -102.08 170.31 8.2 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.677 178.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 32.6 ttt85 -59.22 -44.0 92.31 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.09 0.472 . . . . 0.0 109.814 176.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.435 HH11 ' HD2' ' A' ' 15' ' ' ARG . 4.8 tpp180 -65.5 -45.07 85.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.1 179.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.669 ' O ' HG23 ' A' ' 20' ' ' VAL . 2.1 mp0 -62.36 -48.13 81.14 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.911 178.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.411 ' HB2' ' CD1' ' A' ' 12' ' ' PHE . . . -51.76 -53.48 39.17 Favored 'General case' 0 C--N 1.328 -0.359 0 O-C-N 123.339 0.399 . . . . 0.0 111.56 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.865 ' HA ' HE21 ' A' ' 18' ' ' GLN . 0.0 OUTLIER -56.59 -42.57 78.9 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.826 -177.121 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.96 -28.41 70.06 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.491 -179.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.669 HG23 ' O ' ' A' ' 16' ' ' GLN . 15.4 t -90.77 -15.14 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -172.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.37 -29.04 37.87 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.26 174.066 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -80.24 -15.75 56.29 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-O 121.132 0.492 . . . . 0.0 109.758 172.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 7.0 m -85.78 -55.12 4.12 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.759 171.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.547 ' HB3' ' OD1' ' A' ' 26' ' ' ASN . 34.3 m-85 -117.67 105.95 12.56 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 174.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -76.7 -2.2 31.68 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 120.962 -0.295 . . . . 0.0 111.309 -176.03 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.547 ' OD1' ' HB3' ' A' ' 24' ' ' TYR . 24.7 p-10 -75.87 -17.4 59.82 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 174.582 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.544 HG13 ' O ' ' A' ' 24' ' ' TYR . 4.2 mt -76.04 148.12 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 174.277 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 6.7 p -144.1 132.33 21.87 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 117.842 0.292 . . . . 0.0 111.05 -179.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.527 ' HA ' HD23 ' A' ' 39' ' ' LEU . 3.8 tt -86.53 105.65 16.97 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 176.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -118.93 163.74 16.47 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.329 -178.016 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 63.8 30.64 14.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.034 175.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.503 ' HA ' ' HB3' ' A' ' 37' ' ' PHE . 17.8 t0 -65.56 107.87 1.85 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.487 -178.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.418 ' HB3' ' HB2' ' A' ' 36' ' ' HIS . 9.2 tt0 -129.09 34.57 4.41 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.264 -0.88 . . . . 0.0 108.662 179.068 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 85.24 -95.48 1.98 Allowed Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.638 -178.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 17.4 p -80.39 -30.09 37.78 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.332 0.587 . . . . 0.0 110.453 178.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.418 ' HB2' ' HB3' ' A' ' 33' ' ' GLN . 9.0 m-70 -92.87 121.57 34.37 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.769 177.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.503 ' HB3' ' HA ' ' A' ' 32' ' ' ASP . 38.2 p90 -170.33 157.05 5.95 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 176.155 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.447 ' NH1' ' HD3' ' A' ' 51' ' ' ARG . 38.3 ptt180 -139.72 150.09 44.42 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.216 0.531 . . . . 0.0 111.709 179.176 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.527 HD23 ' HA ' ' A' ' 29' ' ' LEU . 94.4 mt -98.27 124.09 42.69 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.941 177.085 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 46.7 t -101.8 121.24 52.51 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-N 115.329 -0.851 . . . . 0.0 109.716 177.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.402 HG23 HD22 ' A' ' 63' ' ' LEU . 15.4 t -99.03 115.01 38.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-O 121.04 0.448 . . . . 0.0 110.02 -179.51 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.521 ' HD2' ' O ' ' A' ' 46' ' ' GLY . 56.0 mtm180 -100.31 167.12 10.62 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.259 179.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -88.84 -169.49 2.55 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.781 0.324 . . . . 0.0 110.47 -178.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.485 HG23 HD12 ' A' ' 72' ' ' ILE . 0.5 OUTLIER -61.53 -26.75 68.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.827 -178.528 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 18.5 tp10 -86.41 -31.47 21.42 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 120.95 0.405 . . . . 0.0 110.247 179.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.521 ' O ' ' HD2' ' A' ' 42' ' ' ARG . . . 112.7 20.99 6.23 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.394 -176.108 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 89.0 mtm180 -87.81 129.32 35.23 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 176.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 12.5 ptt? -62.79 112.54 2.58 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.125 0.488 . . . . 0.0 110.909 176.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.403 HG11 ' CE1' ' A' ' 66' ' ' TYR . 40.1 t -99.84 -36.65 5.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.498 179.462 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.526 ' CD1' HD23 ' A' ' 63' ' ' LEU . 58.2 t-105 -157.27 156.68 32.87 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.851 -174.404 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.447 ' HD3' ' NH1' ' A' ' 38' ' ' ARG . 7.6 ptp85 -155.79 143.32 19.47 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.139 -178.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -146.93 143.46 28.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.632 -0.258 . . . . 0.0 110.413 179.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 70.2 m95 -82.75 -168.03 1.87 Allowed 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 121.808 0.813 . . . . 0.0 111.439 -177.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -93.54 -35.24 13.02 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.152 -1.386 . . . . 0.0 110.622 -179.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 26.6 p90 -83.67 12.01 6.46 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.481 -178.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.664 ' HB2' ' HB2' ' A' ' 59' ' ' ALA . 10.2 mm-40 -82.1 124.07 79.09 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.37 177.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -45.73 -50.95 8.85 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 124.303 3.335 . . . . 0.0 113.193 -175.171 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -126.96 57.65 1.45 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.082 0.468 . . . . 0.0 109.887 176.078 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.664 ' HB2' ' HB2' ' A' ' 56' ' ' GLU . . . -54.48 -45.46 73.2 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.428 -178.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -63.2 -32.36 83.89 Favored Glycine 0 N--CA 1.441 -1.026 0 CA-C-N 115.135 -0.939 . . . . 0.0 112.779 -177.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.428 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 18.0 tp10 -59.66 -41.94 91.71 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.969 0.384 . . . . 0.0 110.623 -176.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -73.62 -43.19 37.3 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.456 -0.878 . . . . 0.0 112.007 179.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.526 HD23 ' CD1' ' A' ' 50' ' ' TRP . 65.7 mt -66.27 -46.98 75.2 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.681 0.277 . . . . 0.0 110.43 -179.308 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.472 ' HA ' HD12 ' A' ' 67' ' ' ILE . 87.2 m-20 -65.75 -25.51 67.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.477 178.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.428 ' HB2' ' O ' ' A' ' 61' ' ' GLU . 42.4 ttp180 -63.84 -45.25 90.38 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 178.152 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.403 ' CE1' HG11 ' A' ' 49' ' ' VAL . 85.3 t80 -69.47 -42.63 74.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.953 0.406 . . . . 0.0 110.219 175.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.472 HD12 ' HA ' ' A' ' 64' ' ' ASN . 97.0 mt -55.09 -37.57 43.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.476 177.15 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 47.1 ttt180 -60.27 -46.75 88.73 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.84 -178.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 16.9 p -87.57 -17.68 31.45 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -172.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 24.7 m -108.46 -50.17 3.07 Favored 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.447 -176.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 47.7 81.92 0.04 OUTLIER Glycine 0 CA--C 1.522 0.519 0 CA-C-N 115.868 -0.605 . . . . 0.0 112.948 -174.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.485 HD12 HG23 ' A' ' 44' ' ' THR . 35.2 mm -90.88 6.58 4.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-O 121.697 0.76 . . . . 0.0 110.304 -173.515 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.461 ' HB3' ' CE2' ' A' ' 24' ' ' TYR . 15.0 ptt180 . . . . . 0 N--CA 1.471 0.577 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.767 179.395 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.461 ' HA3' ' HD3' ' A' ' 11' ' ' PRO . . . . . . . . 0 CA--C 1.522 0.49 0 CA-C-O 120.14 -0.255 . . . . 0.0 113.626 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.461 ' HD3' ' HA3' ' A' ' 10' ' ' GLY . 14.4 Cg_exo -67.86 142.49 57.53 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.778 2.319 . . . . 0.0 111.841 176.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.535 ' CD2' ' HB2' ' A' ' 17' ' ' ALA . 12.9 p90 -108.79 -171.8 1.92 Allowed 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.804 -175.474 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.455 ' OG1' ' HG2' ' A' ' 16' ' ' GLN . 21.5 p -125.49 175.71 7.33 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 172.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.498 ' HG2' HD11 ' A' ' 29' ' ' LEU . 67.9 mtm180 -65.4 -43.94 89.05 Favored 'General case' 0 C--O 1.22 -0.462 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.128 175.129 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -54.93 -50.77 68.02 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 178.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.488 ' O ' HG23 ' A' ' 20' ' ' VAL . 65.0 mm-40 -60.81 -52.78 63.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.072 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.535 ' HB2' ' CD2' ' A' ' 12' ' ' PHE . . . -56.71 -46.45 81.24 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.304 -179.156 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.475 ' HG3' ' O ' ' A' ' 14' ' ' ARG . 91.9 mt-30 -58.95 -38.52 79.24 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.492 -176.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.52 -26.06 68.26 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-O 121.205 0.526 . . . . 0.0 111.535 178.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 16' ' ' GLN . 3.2 t -85.49 -22.88 7.29 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.903 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 -175.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 17.8 m -85.69 -33.73 21.46 Favored 'General case' 0 N--CA 1.434 -1.267 0 CA-C-N 113.315 -1.766 . . . . 0.0 110.814 -178.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.0 p -67.48 -29.35 68.77 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 173.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 23.3 m -80.73 -53.46 6.49 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.305 173.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.631 ' O ' HG13 ' A' ' 27' ' ' ILE . 62.3 m-85 -106.49 98.94 8.55 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 178.572 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 37.3 p -69.51 -3.8 16.18 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.225 -0.443 . . . . 0.0 112.142 -178.019 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.627 ' OD1' ' HB3' ' A' ' 24' ' ' TYR . 24.1 p-10 -82.48 -14.18 55.45 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.986 0.422 . . . . 0.0 109.877 176.141 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.631 HG13 ' O ' ' A' ' 24' ' ' TYR . 1.2 mt -81.12 146.17 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 N-CA-C 108.372 -0.974 . . . . 0.0 108.372 173.396 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.482 ' O ' ' HA ' ' A' ' 39' ' ' LEU . 3.0 p -144.12 136.42 26.62 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.853 -0.339 . . . . 0.0 111.204 -179.238 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.498 HD11 ' HG2' ' A' ' 14' ' ' ARG . 5.1 tt -95.71 105.12 17.08 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 177.277 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -115.84 166.59 11.79 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.224 -178.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.504 ' HB2' ' HG2' ' A' ' 38' ' ' ARG . 0.3 OUTLIER 60.95 31.59 19.96 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.256 177.493 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -70.77 102.47 2.34 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 121.612 0.72 . . . . 0.0 111.184 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 19.5 tm0? -100.53 -30.73 11.63 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.038 175.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 146.11 -80.02 0.22 Allowed Glycine 0 N--CA 1.445 -0.731 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 -175.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 44.5 p -82.12 -31.41 30.66 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 172.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 60.4 m80 -96.72 126.1 41.64 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.269 177.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.453 ' HB2' HD21 ' A' ' 29' ' ' LEU . 49.7 p90 -168.21 147.19 4.53 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.485 -0.779 . . . . 0.0 109.032 177.241 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.504 ' HG2' ' HB2' ' A' ' 31' ' ' ASP . 49.2 ptt85 -129.59 149.23 51.44 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.843 0.354 . . . . 0.0 110.785 -176.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.564 ' O ' ' HA ' ' A' ' 51' ' ' ARG . 75.9 mt -106.26 144.42 32.98 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.139 0.495 . . . . 0.0 110.188 178.434 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.575 HG13 ' HB3' ' A' ' 51' ' ' ARG . 38.2 t -123.48 110.04 24.97 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.066 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.316 174.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.2 t -88.84 104.37 14.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 173.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.403 ' HA ' ' O ' ' A' ' 47' ' ' ARG . 67.2 mtt85 -94.98 171.2 8.9 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.325 -177.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.427 ' CG ' ' H ' ' A' ' 45' ' ' GLU . 1.5 p-10 -96.73 -169.73 1.94 Allowed 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 175.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.97 -17.28 62.66 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.548 -175.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.444 ' OE1' ' HD3' ' A' ' 47' ' ' ARG . 37.9 tt0 -89.18 -24.73 22.1 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 176.347 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 105.0 18.55 12.07 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.329 178.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.444 ' HD3' ' OE1' ' A' ' 45' ' ' GLU . 41.6 mtm-85 -85.65 142.07 29.33 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 177.452 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 11.0 ptp -77.86 105.38 9.01 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.46 0.648 . . . . 0.0 111.104 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.2 t -87.7 -36.22 9.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.69 177.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.518 ' CZ2' ' HB3' ' A' ' 52' ' ' ALA . 31.4 t90 -137.62 123.27 19.82 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 177.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.575 ' HB3' HG13 ' A' ' 40' ' ' VAL . 0.0 OUTLIER -149.47 120.1 7.5 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.518 0.675 . . . . 0.0 110.006 172.706 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.518 ' HB3' ' CZ2' ' A' ' 50' ' ' TRP . . . -155.3 174.38 15.3 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.322 -174.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 78.9 m95 -93.9 -158.95 0.66 Allowed 'General case' 0 N--CA 1.445 -0.698 0 CA-C-O 121.258 0.551 . . . . 0.0 110.799 -174.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -110.09 -32.41 7.02 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.619 -0.718 . . . . 0.0 111.25 -175.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -79.34 34.73 0.26 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.982 -175.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.557 ' HB2' ' HB2' ' A' ' 59' ' ' ALA . 51.1 mt-10 -111.04 135.19 20.87 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.058 179.633 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -51.69 -32.83 46.88 Favored 'Trans proline' 0 N--CA 1.477 0.513 0 C-N-CA 123.879 3.052 . . . . 0.0 114.375 -170.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.47 ' HB2' ' HB3' ' A' ' 61' ' ' GLU . 2.3 p30 -136.36 44.18 2.43 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.017 0.436 . . . . 0.0 110.617 179.419 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.557 ' HB2' ' HB2' ' A' ' 56' ' ' GLU . . . -58.74 -41.35 86.25 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.904 -178.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.44 ' HA2' HD12 ' A' ' 63' ' ' LEU . . . -69.2 -27.52 73.67 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.588 178.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.47 ' HB3' ' HB2' ' A' ' 58' ' ' ASP . 31.2 tt0 -73.46 -34.63 65.48 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.592 ' HA2' ' HD3' ' A' ' 65' ' ' ARG . . . -63.49 -41.27 99.32 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.71 -0.757 . . . . 0.0 111.487 173.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.46 ' O ' HG13 ' A' ' 67' ' ' ILE . 6.6 mt -64.1 -41.08 97.41 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 110.31 -0.255 . . . . 0.0 110.31 175.141 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -56.17 -33.95 65.73 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.146 0.498 . . . . 0.0 110.497 173.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.592 ' HD3' ' HA2' ' A' ' 62' ' ' GLY . 45.6 mtp85 -71.31 -28.67 64.27 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.153 179.46 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.562 ' O ' HG22 ' A' ' 69' ' ' THR . 36.9 t80 -76.24 -51.62 11.69 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.49 -0.484 . . . . 0.0 109.795 171.658 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.46 HG13 ' O ' ' A' ' 63' ' ' LEU . 46.2 mt -62.05 -13.19 9.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.172 -178.612 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 8.8 tpt180 -49.36 -32.87 12.2 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.632 172.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.562 HG22 ' O ' ' A' ' 66' ' ' TYR . 12.1 t -92.96 29.29 1.86 Allowed 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 121.322 0.582 . . . . 0.0 110.291 -177.312 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 7.9 t 80.22 -27.05 0.15 Allowed 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.967 0.907 . . . . 0.0 111.351 176.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.12 -172.27 51.17 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.468 -0.873 . . . . 0.0 111.894 -177.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.481 ' O ' HG22 ' A' ' 72' ' ' ILE . 32.3 mm -101.02 7.73 9.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 121.768 0.794 . . . . 0.0 110.626 -174.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 . . . . . 0 N--CA 1.474 0.765 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.64 178.571 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.559 ' HA2' ' HA ' ' A' ' 58' ' ' ASP . . . . . . . . 0 N--CA 1.45 -0.397 0 CA-C-O 120.147 -0.252 . . . . 0.0 112.778 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.405 ' HD3' ' HA3' ' A' ' 10' ' ' GLY . 8.0 Cg_exo -72.7 168.56 24.18 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.956 2.437 . . . . 0.0 111.856 177.004 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -125.74 -170.61 2.21 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.379 -176.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.473 ' H ' ' HB2' ' A' ' 16' ' ' GLN . 41.6 p -125.4 173.41 8.89 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.149 178.579 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 4.4 tmt_? -58.42 -43.91 88.86 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.548 0.689 . . . . 0.0 109.261 172.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 41.5 ttm105 -60.77 -54.13 48.96 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.525 -1.216 . . . . 0.0 111.306 178.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.634 ' O ' HG23 ' A' ' 20' ' ' VAL . 73.5 mm-40 -56.71 -49.86 73.88 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.918 179.538 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.457 ' HB1' HD21 ' A' ' 39' ' ' LEU . . . -48.84 -51.9 27.06 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.576 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.467 HE21 HD13 ' A' ' 29' ' ' LEU . 55.4 mm-40 -58.68 -38.0 77.27 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.664 -177.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.98 -27.87 66.1 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.969 0.414 . . . . 0.0 111.446 -178.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.634 HG23 ' O ' ' A' ' 16' ' ' GLN . 18.7 t -89.16 -18.9 7.68 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.816 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 -172.432 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 21.1 m -93.41 -31.25 14.69 Favored 'General case' 0 N--CA 1.432 -1.328 0 CA-C-N 114.004 -1.453 . . . . 0.0 108.149 -175.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 52.9 m -61.4 -36.58 80.7 Favored 'General case' 0 N--CA 1.435 -1.187 0 CA-C-N 113.93 -1.486 . . . . 0.0 109.047 168.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 25.9 m -78.97 -51.4 9.67 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.592 177.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.63 ' O ' HG13 ' A' ' 27' ' ' ILE . 47.6 m-85 -113.37 94.81 5.04 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 177.228 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 13.7 m -73.25 1.53 9.22 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.987 0.423 . . . . 0.0 111.204 -176.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.567 ' OD1' ' HB3' ' A' ' 24' ' ' TYR . 4.4 p-10 -78.55 -18.08 55.2 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 172.323 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.63 HG13 ' O ' ' A' ' 24' ' ' TYR . 2.0 mt -79.72 152.18 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 170.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.474 ' O ' ' HA ' ' A' ' 39' ' ' LEU . 17.2 p -141.0 123.64 16.04 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.91 -178.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.56 ' HA ' HD23 ' A' ' 39' ' ' LEU . 6.7 tt -83.85 95.68 8.55 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 176.114 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -114.95 171.31 7.73 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.628 -175.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.468 ' OD2' ' HZ3' ' A' ' 53' ' ' TRP . 38.3 t70 66.39 18.34 10.84 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 123.652 0.595 . . . . 0.0 110.639 177.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.568 ' HA ' ' HB3' ' A' ' 37' ' ' PHE . 7.6 p-10 -64.78 95.97 0.17 Allowed 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 121.826 0.822 . . . . 0.0 110.752 -179.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.429 ' NE2' ' HE1' ' A' ' 36' ' ' HIS . 45.1 mt-30 -128.13 45.17 2.8 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.133 -0.939 . . . . 0.0 109.471 -179.328 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.25 -88.24 1.44 Allowed Glycine 0 N--CA 1.444 -0.815 0 CA-C-N 114.55 -1.205 . . . . 0.0 112.6 176.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 49.0 m -81.63 -14.4 56.75 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -173.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.429 ' HE1' ' NE2' ' A' ' 33' ' ' GLN . 25.7 p80 -136.74 148.95 47.57 Favored 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 119.912 -0.715 . . . . 0.0 110.953 176.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.568 ' HB3' ' HA ' ' A' ' 32' ' ' ASP . 45.1 p90 -170.0 161.44 8.74 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.79 -1.095 . . . . 0.0 108.474 178.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.421 ' HG2' ' HB3' ' A' ' 31' ' ' ASP . 32.9 ptt180 -144.05 155.57 44.04 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.052 0.453 . . . . 0.0 112.119 -178.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.56 HD23 ' HA ' ' A' ' 29' ' ' LEU . 95.8 mt -103.18 112.38 25.21 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.285 176.651 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 47.8 t -94.21 122.38 45.63 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.944 175.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.507 HG11 ' CD2' ' A' ' 66' ' ' TYR . 80.4 t -90.09 115.28 29.26 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 178.201 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.536 ' HA ' ' O ' ' A' ' 47' ' ' ARG . 59.1 mtp180 -110.52 161.04 16.09 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.37 -176.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -95.56 -165.81 1.35 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.18 -178.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 17.6 p -63.46 -27.23 69.14 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.859 0.361 . . . . 0.0 111.427 -177.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -82.87 -33.82 26.9 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.217 0.532 . . . . 0.0 109.788 177.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 110.28 18.49 8.62 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.817 -0.706 . . . . 0.0 111.584 -175.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.536 ' O ' ' HA ' ' A' ' 42' ' ' ARG . 52.0 mtt180 -80.53 145.57 31.74 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 179.101 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.404 ' N ' ' SD ' ' A' ' 48' ' ' MET . 1.8 mpt? -72.49 108.46 5.57 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 177.42 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 42.6 t -95.14 -31.03 4.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.459 0.647 . . . . 0.0 109.592 177.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.457 ' CD1' HD23 ' A' ' 63' ' ' LEU . 69.3 t-105 -159.12 157.87 31.79 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.35 -178.352 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 15.3 ptt180 -160.66 138.73 9.77 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.887 0.375 . . . . 0.0 110.114 178.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -143.12 145.76 33.13 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.043 178.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.537 ' HB2' ' OE1' ' A' ' 56' ' ' GLU . 42.4 m95 -84.71 -160.44 0.48 Allowed 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 176.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -107.55 0.86 22.95 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.928 -174.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 22.9 p90 -117.56 2.98 12.42 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -173.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.569 ' HB2' ' HB2' ' A' ' 59' ' ' ALA . 3.1 mp0 -66.16 132.18 94.49 Favored Pre-proline 0 C--O 1.237 0.398 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.119 173.13 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -46.65 -32.62 12.09 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 123.86 3.04 . . . . 0.0 113.358 -176.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.559 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . 4.4 t0 -146.29 62.9 1.22 Allowed 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 174.389 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.569 ' HB2' ' HB2' ' A' ' 56' ' ' GLU . . . -58.17 -35.51 71.68 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-O 121.286 0.565 . . . . 0.0 111.011 -179.054 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -59.01 -37.75 91.98 Favored Glycine 0 N--CA 1.446 -0.673 0 CA-C-N 115.281 -0.872 . . . . 0.0 113.554 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -60.5 -38.72 85.23 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 117.386 0.593 . . . . 0.0 111.182 -174.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.527 ' O ' ' HB3' ' A' ' 65' ' ' ARG . . . -72.32 -44.49 42.6 Favored Glycine 0 C--O 1.237 0.308 0 C-N-CA 120.823 -0.703 . . . . 0.0 111.99 179.078 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.457 HD23 ' CD1' ' A' ' 50' ' ' TRP . 65.6 mt -62.36 -50.24 72.36 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.705 0.288 . . . . 0.0 110.244 178.21 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.414 ' HA ' ' HB ' ' A' ' 67' ' ' ILE . 92.8 m-20 -63.43 -28.33 69.9 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.923 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.527 ' HB3' ' O ' ' A' ' 62' ' ' GLY . 10.9 ttt180 -57.02 -51.0 71.0 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.009 175.293 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.507 ' CD2' HG11 ' A' ' 41' ' ' VAL . 77.5 t80 -72.06 -38.8 69.39 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.622 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.414 ' HB ' ' HA ' ' A' ' 64' ' ' ASN . 96.4 mt -57.21 -43.97 82.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.007 0.432 . . . . 0.0 110.896 177.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 5.9 ttp85 -65.76 -41.85 91.61 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.89 -179.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 30.9 p -79.3 -44.7 21.15 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -176.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.427 ' O ' HD12 ' A' ' 72' ' ' ILE . 31.0 m -147.68 56.48 1.09 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.618 -173.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -64.46 130.51 37.61 Favored Glycine 0 CA--C 1.52 0.4 0 C-N-CA 120.284 -0.96 . . . . 0.0 111.9 173.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.533 ' HB ' ' OD1' ' A' ' 26' ' ' ASN . 1.9 mp -81.29 2.31 2.77 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 CA-C-O 121.66 0.743 . . . . 0.0 111.059 -174.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 15.5 ttt180 . . . . . 0 N--CA 1.469 0.524 0 O-C-N 121.644 -0.66 . . . . 0.0 111.639 177.917 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.446 ' HA2' ' OD1' ' A' ' 58' ' ' ASP . . . . . . . . 0 CA--C 1.519 0.311 0 CA-C-O 120.239 -0.2 . . . . 0.0 113.499 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -70.69 153.48 64.64 Favored 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 122.662 2.242 . . . . 0.0 111.577 178.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 16.4 p90 -115.98 -175.93 2.84 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.773 0.797 . . . . 0.0 112.134 -174.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -125.68 159.35 32.47 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-N 114.862 -1.063 . . . . 0.0 109.344 179.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.424 HH11 ' HD2' ' A' ' 14' ' ' ARG . 24.5 ttt85 -57.63 -48.46 79.37 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 120.895 0.379 . . . . 0.0 110.424 -179.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 21.4 tpp180 -46.22 -55.78 6.66 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.041 175.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.685 ' O ' HG23 ' A' ' 20' ' ' VAL . 2.1 mp0 -62.04 -49.45 75.94 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.857 179.22 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -53.29 -49.19 67.49 Favored 'General case' 0 N--CA 1.464 0.225 0 O-C-N 123.279 0.362 . . . . 0.0 111.557 -177.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -58.82 -40.14 83.27 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.433 -178.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.44 -24.26 66.42 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.856 179.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.685 HG23 ' O ' ' A' ' 16' ' ' GLN . 15.3 t -88.49 -22.75 6.58 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.794 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 -174.679 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.534 HG23 ' HB ' ' A' ' 27' ' ' ILE . 11.0 m -86.73 -31.03 21.19 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-N 113.768 -1.56 . . . . 0.0 110.575 -178.035 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.5 p -68.5 -31.34 70.53 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 170.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 41.0 m -75.67 -50.92 13.97 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.34 174.067 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.599 ' HB2' HG13 ' A' ' 27' ' ' ILE . 61.6 m-85 -113.16 102.26 10.21 Favored 'General case' 0 N--CA 1.447 -0.594 0 O-C-N 121.883 -0.511 . . . . 0.0 109.97 177.54 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 76.0 p -67.2 -9.25 38.33 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.06 -0.518 . . . . 0.0 112.056 -179.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.56 ' OD1' ' HB3' ' A' ' 24' ' ' TYR . 24.8 p-10 -79.01 -12.25 60.03 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.995 0.426 . . . . 0.0 110.035 177.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.599 HG13 ' HB2' ' A' ' 24' ' ' TYR . 2.2 mt -83.8 147.12 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 173.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.583 ' OG1' ' HB ' ' A' ' 40' ' ' VAL . 1.4 p -139.81 127.88 22.32 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 120.477 -0.489 . . . . 0.0 111.26 -179.07 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.521 ' HA ' HD23 ' A' ' 39' ' ' LEU . 5.6 tt -83.48 102.92 12.43 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 177.203 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -113.68 159.06 20.1 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.765 -175.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.8 t70 59.84 47.69 9.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.735 -179.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -72.27 96.54 1.85 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.976 -175.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -112.97 24.13 12.68 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.866 175.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 77.8 -79.99 1.38 Allowed Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.705 -0.68 . . . . 0.0 112.241 179.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 38.8 m -82.97 -16.69 46.26 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.077 0.465 . . . . 0.0 110.672 179.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 24.8 m170 -119.43 137.92 53.45 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 174.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -170.62 156.47 5.34 Favored 'General case' 0 C--N 1.323 -0.583 0 O-C-N 123.518 0.511 . . . . 0.0 109.769 177.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 11.9 ptt180 -128.53 153.28 47.35 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.136 176.17 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.546 ' O ' ' HA ' ' A' ' 51' ' ' ARG . 91.6 mt -111.21 132.54 54.25 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.177 0.513 . . . . 0.0 110.223 178.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.583 ' HB ' ' OG1' ' A' ' 28' ' ' THR . 38.6 t -108.99 109.23 27.56 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.624 176.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.468 HG11 ' CD2' ' A' ' 66' ' ' TYR . 10.9 t -85.1 118.44 32.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 173.267 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.407 ' O ' ' HB2' ' A' ' 26' ' ' ASN . 16.5 mtp180 -113.21 158.79 20.02 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 -178.097 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.448 ' CG ' ' H ' ' A' ' 45' ' ' GLU . 2.6 p-10 -89.77 -168.7 2.21 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 177.379 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 9.2 t -71.42 -14.32 62.12 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.099 -177.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.448 ' H ' ' CG ' ' A' ' 43' ' ' ASP . 32.5 tt0 -93.15 -16.02 25.36 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.34 0.591 . . . . 0.0 109.592 177.122 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 95.51 13.04 52.71 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.963 177.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 15.5 mtp180 -79.32 127.94 32.71 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 178.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.7 102.79 2.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.223 0.535 . . . . 0.0 111.213 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 43.9 t -86.72 -40.39 14.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.349 -0.842 . . . . 0.0 110.286 -179.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.598 ' CH2' ' HB3' ' A' ' 52' ' ' ALA . 22.6 t90 -135.48 106.57 6.7 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -178.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.546 ' HA ' ' O ' ' A' ' 39' ' ' LEU . 29.9 ptt180 -130.95 109.19 10.36 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 173.673 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.598 ' HB3' ' CH2' ' A' ' 50' ' ' TRP . . . -149.33 166.44 28.98 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.796 -177.456 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 44.1 m95 -85.53 -162.8 0.76 Allowed 'General case' 0 N--CA 1.445 -0.705 0 CA-C-O 121.468 0.651 . . . . 0.0 111.162 -175.139 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 61.8 t30 -105.17 -20.39 13.52 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.816 -176.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -83.45 14.67 3.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.15 0.5 . . . . 0.0 111.305 -178.017 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.54 ' HB2' ' HB2' ' A' ' 59' ' ' ALA . 9.4 mm-40 -80.33 129.57 68.85 Favored Pre-proline 0 C--N 1.325 -0.459 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 174.532 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -44.89 -39.1 13.85 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.867 3.045 . . . . 0.0 114.067 -172.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.446 ' OD1' ' HA2' ' A' ' 10' ' ' GLY . 12.7 t0 -142.11 59.02 1.47 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 178.021 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.54 ' HB2' ' HB2' ' A' ' 56' ' ' GLU . . . -56.38 -35.25 67.52 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.204 -179.636 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -62.22 -37.46 94.58 Favored Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.698 -0.683 . . . . 0.0 113.51 -177.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.404 ' CD ' HH21 ' A' ' 65' ' ' ARG . 1.4 tm-20 -59.75 -50.94 71.86 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 117.176 0.488 . . . . 0.0 110.384 -175.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -59.46 -43.05 97.8 Favored Glycine 0 CA--C 1.52 0.374 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.098 178.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 17.7 mt -59.31 -48.54 81.25 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.691 0.281 . . . . 0.0 111.074 176.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.45 HD22 ' N ' ' A' ' 64' ' ' ASN . 0.9 OUTLIER -65.05 -34.94 79.63 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.444 -178.948 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.404 HH21 ' CD ' ' A' ' 61' ' ' GLU . 14.2 ttm180 -63.63 -32.55 74.07 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.978 -178.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.468 ' CD2' HG11 ' A' ' 41' ' ' VAL . 68.6 t80 -82.45 -45.69 14.44 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 120.028 -0.669 . . . . 0.0 110.448 176.107 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 86.8 mt -55.22 -42.55 66.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.19 -178.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 56.8 ttp180 -55.87 -36.93 68.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.524 -178.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 13.6 t -105.34 25.56 10.5 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.179 0.514 . . . . 0.0 111.553 -173.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 54.0 m -149.59 -55.59 0.18 Allowed 'General case' 0 C--N 1.324 -0.534 0 O-C-N 122.126 -0.359 . . . . 0.0 111.266 177.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 45.03 75.64 0.16 Allowed Glycine 0 CA--C 1.524 0.632 0 CA-C-N 115.51 -0.768 . . . . 0.0 113.227 -175.082 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.475 HG21 ' HB3' ' A' ' 26' ' ' ASN . 45.9 mm -79.86 6.41 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-O 121.62 0.724 . . . . 0.0 111.118 -172.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 . . . . . 0 N--CA 1.469 0.495 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.193 178.848 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.447 ' HA3' ' HD3' ' A' ' 11' ' ' PRO . . . . . . . . 0 CA--C 1.518 0.277 0 CA-C-O 120.117 -0.268 . . . . 0.0 113.404 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.447 ' HD3' ' HA3' ' A' ' 10' ' ' GLY . 17.7 Cg_exo -66.87 170.85 12.0 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.915 2.41 . . . . 0.0 112.531 178.44 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -136.25 -173.48 3.41 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.084 -177.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.435 ' H ' ' HB2' ' A' ' 16' ' ' GLN . 27.5 p -122.21 178.17 5.04 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.227 175.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.639 ' O ' ' HG2' ' A' ' 18' ' ' GLN . 36.4 ttt-85 -63.0 -46.99 85.08 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 176.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 70.6 mtp180 -57.01 -48.36 78.67 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.133 178.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.58 ' O ' HG23 ' A' ' 20' ' ' VAL . 81.2 mm-40 -60.4 -46.9 88.33 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 178.548 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.434 ' HB1' HD11 ' A' ' 39' ' ' LEU . . . -52.32 -47.1 66.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.565 177.576 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.639 ' HG2' ' O ' ' A' ' 14' ' ' ARG . 16.4 mm100 -55.07 -48.06 74.03 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.504 -178.55 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.67 -28.53 69.99 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -175.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.58 HG23 ' O ' ' A' ' 16' ' ' GLN . 11.3 t -86.91 -25.57 6.18 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.787 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 -171.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.516 HG23 ' HB ' ' A' ' 27' ' ' ILE . 17.7 m -86.36 -31.25 21.61 Favored 'General case' 0 N--CA 1.435 -1.222 0 CA-C-N 113.735 -1.575 . . . . 0.0 111.211 -177.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.7 p -69.16 -29.01 66.93 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 172.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 19.5 m -77.34 -56.0 4.92 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.222 171.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.646 ' HB3' ' OD1' ' A' ' 26' ' ' ASN . 58.0 m-85 -105.13 98.07 7.83 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 -179.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.9 p -70.24 1.12 5.18 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 120.728 0.299 . . . . 0.0 111.759 178.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.646 ' OD1' ' HB3' ' A' ' 24' ' ' TYR . 4.5 p-10 -83.26 -10.87 58.3 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 174.205 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.622 HG13 ' O ' ' A' ' 24' ' ' TYR . 1.7 mt -85.25 138.02 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 173.058 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.503 ' OG1' ' HB ' ' A' ' 40' ' ' VAL . 2.3 p -130.62 126.43 36.62 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 120.641 -0.424 . . . . 0.0 111.043 -176.318 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.416 ' HA ' HD23 ' A' ' 39' ' ' LEU . 5.4 tt -91.26 108.05 19.62 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -122.97 167.9 13.0 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.719 178.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.571 ' HB2' HH11 ' A' ' 38' ' ' ARG . 0.7 OUTLIER 62.59 67.66 0.7 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.618 -177.88 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -81.38 100.25 9.14 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.657 -175.273 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -114.08 6.96 16.58 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.534 0.683 . . . . 0.0 109.553 174.261 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.62 -79.71 1.28 Allowed Glycine 0 N--CA 1.45 -0.419 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.948 -179.112 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 17.1 m -86.36 -18.63 31.38 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.156 0.503 . . . . 0.0 110.359 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 29.7 m170 -114.25 132.07 56.27 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.73 173.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.501 ' HA ' ' O ' ' A' ' 31' ' ' ASP . 52.9 p90 -164.59 157.37 16.89 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 178.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.607 ' HA ' ' HA ' ' A' ' 53' ' ' TRP . 27.0 ptt-85 -124.47 142.42 51.34 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 119.567 -0.853 . . . . 0.0 111.31 177.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.506 ' O ' ' HA ' ' A' ' 51' ' ' ARG . 63.0 mt -104.05 134.74 46.81 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.589 176.133 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.541 HG13 ' HB3' ' A' ' 51' ' ' ARG . 40.6 t -112.83 116.41 52.53 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.959 175.408 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.552 ' HB ' ' HB3' ' A' ' 50' ' ' TRP . 97.1 t -86.36 107.97 17.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.239 173.727 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.43 HH11 ' HD2' ' A' ' 42' ' ' ARG . 14.7 mtp180 -101.48 156.57 17.39 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.543 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.443 ' HA ' ' OH ' ' A' ' 66' ' ' TYR . 1.9 p-10 -88.91 -171.06 3.14 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 120.793 0.33 . . . . 0.0 110.947 -175.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 12.2 t -64.1 -22.53 66.97 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.878 -177.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -87.14 -31.52 20.36 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 178.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 114.01 14.07 9.56 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.339 -179.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 72.3 mtp180 -91.01 140.98 29.33 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 179.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 22.3 ptt? -74.91 118.79 18.26 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.227 0.537 . . . . 0.0 111.459 -177.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 34.0 t -101.6 -32.41 3.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.002 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.552 ' HB3' ' HB ' ' A' ' 41' ' ' VAL . 49.3 t90 -144.77 136.58 25.74 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.973 -1.012 . . . . 0.0 108.542 -179.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.573 ' O ' ' HD2' ' A' ' 51' ' ' ARG . 0.0 OUTLIER -158.01 119.99 3.67 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 121.448 0.642 . . . . 0.0 110.354 174.772 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.519 ' HB3' ' CZ2' ' A' ' 50' ' ' TRP . . . -151.83 171.3 17.95 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.091 -177.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.607 ' HA ' ' HA ' ' A' ' 38' ' ' ARG . 87.7 m95 -80.26 -95.25 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -172.333 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -162.1 -35.8 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.123 0.487 . . . . 0.0 110.607 -176.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -84.67 14.86 4.23 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.396 -177.027 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.526 ' HB2' ' HB2' ' A' ' 59' ' ' ALA . 1.9 mm-40 -66.52 128.02 93.64 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.1 -178.008 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_exo -38.19 -49.6 2.25 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 124.338 3.359 . . . . 0.0 113.541 -176.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -138.92 69.16 1.37 Allowed 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 172.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.526 ' HB2' ' HB2' ' A' ' 56' ' ' GLU . . . -57.75 -33.86 68.92 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.898 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -55.16 -41.84 79.85 Favored Glycine 0 N--CA 1.446 -0.694 0 CA-C-N 115.241 -0.89 . . . . 0.0 112.963 178.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.616 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 9.0 tp10 -49.02 -54.76 14.37 Favored 'General case' 0 C--O 1.223 -0.332 0 CA-C-N 116.974 0.387 . . . . 0.0 111.059 -178.143 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.498 ' HA3' ' CD1' ' A' ' 50' ' ' TRP . . . -65.22 -40.94 97.03 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.777 -178.157 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.478 HD23 HG21 ' A' ' 41' ' ' VAL . 49.3 mt -62.82 -51.04 68.61 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.609 0.242 . . . . 0.0 110.943 179.669 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 51.8 m-80 -69.15 -24.78 64.12 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.941 0.4 . . . . 0.0 110.28 179.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.616 ' HB2' ' O ' ' A' ' 61' ' ' GLU . 12.6 ttt85 -61.91 -37.64 85.41 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.961 177.277 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.443 ' OH ' ' HA ' ' A' ' 43' ' ' ASP . 91.4 t80 -82.32 -47.92 11.79 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.992 176.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.422 HG13 ' O ' ' A' ' 63' ' ' LEU . 72.2 mt -56.52 -21.85 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 CA-C-O 120.992 0.425 . . . . 0.0 111.404 179.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 49.6 ttp180 -50.24 -34.04 21.69 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.455 175.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.417 ' O ' ' HB2' ' A' ' 70' ' ' SER . 6.9 t -102.89 61.85 0.8 Allowed 'General case' 0 N--CA 1.443 -0.779 0 CA-C-O 122.062 0.934 . . . . 0.0 109.217 179.464 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.417 ' HB2' ' O ' ' A' ' 69' ' ' THR . 63.2 m 78.18 -51.63 0.49 Allowed 'General case' 0 C--O 1.236 0.356 0 CA-C-N 114.224 -1.353 . . . . 0.0 112.978 172.491 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.06 175.71 51.16 Favored Glycine 0 CA--C 1.52 0.38 0 N-CA-C 111.585 -0.606 . . . . 0.0 111.585 -172.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.592 ' HB ' ' OD1' ' A' ' 26' ' ' ASN . 1.1 mp -83.29 -5.62 9.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.458 0.647 . . . . 0.0 111.061 -177.313 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 23.7 ptt180 . . . . . 0 C--N 1.327 -0.398 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.408 175.811 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.578 ' HA3' ' O ' ' A' ' 57' ' ' PRO . . . . . . . . 0 N--CA 1.445 -0.766 0 N-CA-C 111.776 -0.53 . . . . 0.0 111.776 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.583 ' HG3' ' HA ' ' A' ' 57' ' ' PRO . 3.4 Cg_exo -78.86 133.67 11.46 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 121.547 1.498 . . . . 0.0 111.659 175.526 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 26.7 p90 -100.89 -170.78 1.9 Allowed 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.525 -0.762 . . . . 0.0 111.139 -178.12 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.438 ' OG1' ' HG2' ' A' ' 16' ' ' GLN . 21.2 p -125.73 172.53 9.73 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 176.24 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.529 ' O ' ' HG3' ' A' ' 18' ' ' GLN . 1.9 tmt_? -61.03 -49.1 78.76 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 174.365 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' A' ' 15' ' ' ARG . 13.7 ttp85 -52.56 -52.57 54.31 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.823 -1.08 . . . . 0.0 111.376 176.428 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.617 ' O ' HG23 ' A' ' 20' ' ' VAL . 15.6 mm100 -59.27 -47.34 85.75 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.587 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -52.11 -48.31 64.86 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.719 179.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.529 ' HG3' ' O ' ' A' ' 14' ' ' ARG . 44.9 mt-30 -54.94 -48.58 72.99 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.446 -179.321 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.98 -35.14 76.02 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.181 0.515 . . . . 0.0 111.175 -178.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.617 HG23 ' O ' ' A' ' 16' ' ' GLN . 16.4 t -82.29 -13.14 12.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.756 -175.08 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.472 HG23 ' HB ' ' A' ' 27' ' ' ILE . 0.0 OUTLIER -91.87 -34.72 14.41 Favored 'General case' 0 CA--C 1.507 -0.674 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 176.349 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 22.1 m -56.24 -30.87 62.96 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 114.294 -1.321 . . . . 0.0 109.665 167.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.406 ' O ' ' HA ' ' A' ' 73' ' ' ARG . 28.0 m -89.38 -46.99 8.32 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.794 178.257 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.625 ' O ' HG13 ' A' ' 27' ' ' ILE . 36.9 m-85 -122.29 104.81 9.69 Favored 'General case' 0 N--CA 1.447 -0.611 0 O-C-N 121.767 -0.583 . . . . 0.0 109.481 177.639 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 7.2 p -77.09 -6.07 51.4 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -177.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.454 ' ND2' ' HB3' ' A' ' 24' ' ' TYR . 6.4 p30 -71.71 -19.36 62.06 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 173.466 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.625 HG13 ' O ' ' A' ' 24' ' ' TYR . 1.9 mt -77.01 138.95 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 CA-C-N 115.258 -0.883 . . . . 0.0 108.622 177.433 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.545 ' OG1' ' HB ' ' A' ' 40' ' ' VAL . 1.3 p -137.0 146.4 45.28 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 121.18 -0.208 . . . . 0.0 110.534 -175.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.493 ' HA ' HD23 ' A' ' 39' ' ' LEU . 4.5 tt -100.31 122.98 43.96 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.962 0.411 . . . . 0.0 110.193 -176.32 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.551 ' HB2' ' HG3' ' A' ' 38' ' ' ARG . 24.0 mt-10 -116.82 155.15 29.47 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.679 175.63 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 59.92 52.88 5.01 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.205 171.728 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.454 ' OD2' HD22 ' A' ' 29' ' ' LEU . 2.0 m-20 -62.3 83.51 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.762 178.551 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -119.46 71.31 0.87 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.333 0.587 . . . . 0.0 111.088 -177.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 66.11 -106.88 1.73 Allowed Glycine 0 N--CA 1.445 -0.73 0 CA-C-N 115.094 -0.957 . . . . 0.0 112.966 174.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 39.7 t -85.49 -14.24 46.63 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 111.667 0.247 . . . . 0.0 111.667 -175.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 34.4 p-80 -129.7 143.02 50.62 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.071 -0.651 . . . . 0.0 111.598 -177.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -163.88 179.35 7.11 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 179.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.551 ' HG3' ' HB2' ' A' ' 30' ' ' GLU . 13.6 ptt180 -127.41 154.26 45.25 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.015 -0.674 . . . . 0.0 110.866 176.072 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.493 HD23 ' HA ' ' A' ' 29' ' ' LEU . 95.5 mt -115.93 136.15 53.3 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.024 0.44 . . . . 0.0 110.392 178.336 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.545 ' HB ' ' OG1' ' A' ' 28' ' ' THR . 21.4 t -107.21 120.85 59.23 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.556 178.319 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 63.5 t -89.28 122.63 40.84 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 173.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 42' ' ' ARG . 24.8 mtp85 -111.39 159.61 17.85 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.344 0.593 . . . . 0.0 110.558 -178.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -90.97 176.83 6.46 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.295 178.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 17.8 p -68.96 -15.69 63.55 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.757 0.313 . . . . 0.0 111.303 -177.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -83.88 -17.08 42.04 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.491 0.662 . . . . 0.0 109.363 172.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 91.14 11.04 61.78 Favored Glycine 0 N--CA 1.447 -0.61 0 CA-C-N 115.291 -0.868 . . . . 0.0 112.517 -178.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 31.8 ptt85 -81.19 138.22 35.84 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 175.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 14.4 ptm -61.22 127.47 31.69 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.049 0.452 . . . . 0.0 110.839 177.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 13.5 t -102.68 -39.11 5.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.86 177.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 75.6 t-105 -166.54 121.69 1.16 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.991 -175.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.407 ' HB3' HG22 ' A' ' 40' ' ' VAL . 4.8 ptp85 -120.39 125.14 47.23 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 174.158 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -134.67 157.59 46.25 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.155 -176.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.563 ' HB2' ' HG3' ' A' ' 56' ' ' GLU . 81.7 m95 -85.6 -174.45 5.17 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 122.203 1.001 . . . . 0.0 111.988 -177.392 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.461 HD22 ' C ' ' A' ' 54' ' ' ASN . 0.2 OUTLIER -96.34 -33.52 11.91 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 113.692 -1.595 . . . . 0.0 110.158 -176.59 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 17.8 p90 -85.84 10.56 13.42 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.625 -174.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.563 ' HG3' ' HB2' ' A' ' 53' ' ' TRP . 25.5 mt-10 -88.19 128.59 52.96 Favored Pre-proline 0 C--N 1.322 -0.593 0 C-N-CA 121.007 -0.277 . . . . 0.0 110.406 -178.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.583 ' HA ' ' HG3' ' A' ' 11' ' ' PRO . 21.9 Cg_exo -65.14 -5.22 10.56 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.46 2.774 . . . . 0.0 114.094 -171.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -141.03 25.93 2.07 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.365 0.126 . . . . 0.0 111.132 -179.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.544 ' O ' ' HG ' ' A' ' 63' ' ' LEU . . . -57.06 -46.6 82.33 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.166 0.508 . . . . 0.0 110.997 -176.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -74.0 -22.05 78.41 Favored Glycine 0 N--CA 1.443 -0.843 0 CA-C-N 115.775 -0.648 . . . . 0.0 113.303 -176.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -70.87 -33.43 70.6 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 117.182 0.491 . . . . 0.0 109.905 -177.023 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.52 ' O ' ' HB3' ' A' ' 65' ' ' ARG . . . -79.43 -38.27 21.77 Favored Glycine 0 N--CA 1.45 -0.399 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 175.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.544 ' HG ' ' O ' ' A' ' 59' ' ' ALA . 92.4 mt -61.77 -44.73 96.31 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.381 -0.409 . . . . 0.0 110.024 176.581 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.558 ' HA ' ' HB ' ' A' ' 67' ' ' ILE . 90.4 m-20 -62.96 -33.59 75.7 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.896 177.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.52 ' HB3' ' O ' ' A' ' 62' ' ' GLY . 9.5 tpt180 -54.39 -40.4 68.15 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.833 0.349 . . . . 0.0 110.439 173.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -77.33 -48.56 17.03 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.905 0.384 . . . . 0.0 110.545 174.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.558 ' HB ' ' HA ' ' A' ' 64' ' ' ASN . 84.2 mt -52.83 -56.15 8.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -174.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -71.86 -32.89 67.95 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.705 0.288 . . . . 0.0 111.656 -169.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.03 28.71 7.98 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -176.079 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 62.4 m -148.77 -53.75 0.18 Allowed 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 172.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 53.84 89.13 0.01 OUTLIER Glycine 0 CA--C 1.522 0.529 0 CA-C-N 115.422 -0.808 . . . . 0.0 114.373 176.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.451 ' O ' HG22 ' A' ' 72' ' ' ILE . 38.2 mm -86.37 7.02 2.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.749 0.785 . . . . 0.0 109.89 178.612 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.406 ' HA ' ' O ' ' A' ' 23' ' ' THR . 4.6 ptm180 . . . . . 0 N--CA 1.466 0.327 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.646 -178.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.482 ' HA3' ' HD3' ' A' ' 11' ' ' PRO . . . . . . . . 0 CA--C 1.522 0.527 0 N-CA-C 114.812 0.685 . . . . 0.0 114.812 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.514 ' HG3' ' HA ' ' A' ' 57' ' ' PRO . 1.3 Cg_endo -80.53 142.64 14.71 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 122.852 2.368 . . . . 0.0 112.409 -179.216 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.445 ' CZ ' ' HA ' ' A' ' 54' ' ' ASN . 9.8 p90 -111.46 -171.39 1.83 Allowed 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.002 -179.275 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.436 ' OG1' ' HG2' ' A' ' 16' ' ' GLN . 16.7 p -124.61 179.94 4.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.186 178.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.409 ' O ' ' HG3' ' A' ' 18' ' ' GLN . 5.6 ttm180 -65.8 -53.58 38.37 Favored 'General case' 0 N--CA 1.427 -1.591 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.705 -178.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.429 HH11 ' HD2' ' A' ' 15' ' ' ARG . 20.6 ptt85 -62.37 -36.46 82.34 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.204 178.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.618 ' O ' HG23 ' A' ' 20' ' ' VAL . 15.7 mm100 -62.31 -48.18 81.0 Favored 'General case' 0 CA--C 1.519 -0.246 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 176.516 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -55.0 -47.9 74.05 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.99 175.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.409 ' HG3' ' O ' ' A' ' 14' ' ' ARG . 99.1 mt-30 -57.59 -42.54 83.36 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.401 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.454 ' O ' ' HB ' ' A' ' 22' ' ' THR . . . -62.59 -34.59 77.29 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.985 178.31 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.618 HG23 ' O ' ' A' ' 16' ' ' GLN . 24.3 t -79.18 -16.33 13.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.808 0.337 . . . . 0.0 110.362 -178.034 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.555 HG23 ' HB ' ' A' ' 27' ' ' ILE . 0.0 OUTLIER -92.24 -26.42 18.18 Favored 'General case' 0 CA--C 1.503 -0.83 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 177.624 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.454 ' HB ' ' O ' ' A' ' 19' ' ' ALA . 98.0 m -61.12 -32.97 72.65 Favored 'General case' 0 N--CA 1.437 -1.122 0 CA-C-N 113.612 -1.631 . . . . 0.0 109.419 167.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.8 m -87.45 -50.66 6.4 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.968 178.264 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.637 ' O ' HG13 ' A' ' 27' ' ' ILE . 35.0 m-85 -116.64 102.37 9.39 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 -179.469 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 15.6 p -81.21 5.34 17.3 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.942 0.401 . . . . 0.0 111.419 -177.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.538 ' OD1' ' HB3' ' A' ' 24' ' ' TYR . 25.5 p-10 -83.53 -17.31 42.28 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 172.221 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.637 HG13 ' O ' ' A' ' 24' ' ' TYR . 1.1 mt -78.22 148.48 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 N-CA-C 108.183 -1.044 . . . . 0.0 108.183 173.5 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.504 ' O ' ' HA ' ' A' ' 39' ' ' LEU . 1.7 p -141.68 133.94 27.91 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.498 -0.481 . . . . 0.0 111.465 -178.029 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.518 ' HA ' HD23 ' A' ' 39' ' ' LEU . 6.5 tt -87.88 100.6 13.0 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 179.623 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -115.75 166.5 11.87 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.848 -174.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 60.6 37.22 19.49 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 123.388 0.43 . . . . 0.0 111.462 171.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -74.95 125.11 28.19 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.135 0.493 . . . . 0.0 111.305 -175.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -126.69 25.2 6.45 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.526 173.204 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.0 -90.87 1.6 Allowed Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.038 -177.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.0 t -78.27 -7.13 56.83 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.262 0.553 . . . . 0.0 110.863 -178.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 57.2 m80 -131.42 138.56 49.13 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.41 ' O ' ' HA ' ' A' ' 53' ' ' TRP . 52.8 p90 -168.81 166.39 11.49 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.306 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.502 ' HA ' ' HA ' ' A' ' 53' ' ' TRP . 70.2 mtm180 -128.28 132.98 48.69 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.518 HD23 ' HA ' ' A' ' 29' ' ' LEU . 64.4 mt -95.45 107.65 19.81 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.348 0.594 . . . . 0.0 109.661 174.244 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 60.7 t -89.48 116.87 31.71 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.896 177.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.465 HG22 HG23 ' A' ' 27' ' ' ILE . 25.4 t -89.4 110.58 21.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 178.057 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.415 ' HA ' ' O ' ' A' ' 47' ' ' ARG . 33.7 mtt85 -97.03 171.82 8.24 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.806 -178.685 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.437 ' CG ' ' H ' ' A' ' 45' ' ' GLU . 1.3 p-10 -104.17 -168.91 1.55 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.602 -178.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.1 p -63.01 -22.74 67.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.108 -179.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.437 ' H ' ' CG ' ' A' ' 43' ' ' ASP . 9.9 tp10 -89.81 -28.56 19.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.057 0.456 . . . . 0.0 110.073 178.42 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 107.19 19.36 9.51 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.055 -178.151 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.415 ' O ' ' HA ' ' A' ' 42' ' ' ARG . 51.0 mtp180 -89.79 143.99 26.34 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 178.227 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.8 113.74 8.17 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.227 0.537 . . . . 0.0 110.709 178.391 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 58.0 t -98.83 -33.46 4.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.135 178.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 73.3 t-105 -153.0 157.44 40.55 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.989 -176.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.417 HH11 ' HD2' ' A' ' 51' ' ' ARG . 20.6 ptt85 -156.93 146.19 20.33 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 177.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -152.95 153.42 32.95 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 177.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.633 ' HB2' ' OE1' ' A' ' 56' ' ' GLU . 80.4 m95 -77.39 -92.66 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.05 0.452 . . . . 0.0 110.857 -179.048 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.445 ' HA ' ' CZ ' ' A' ' 12' ' ' PHE . 6.6 t30 -175.58 -37.78 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.385 -177.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -86.0 -15.04 42.72 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -169.136 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.633 ' OE1' ' HB2' ' A' ' 53' ' ' TRP . 2.4 mp0 -62.88 137.16 96.8 Favored Pre-proline 0 C--N 1.327 -0.408 0 N-CA-C 110.321 -0.251 . . . . 0.0 110.321 -179.236 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.514 ' HA ' ' HG3' ' A' ' 11' ' ' PRO . 43.2 Cg_endo -68.59 5.35 1.31 Allowed 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.879 2.386 . . . . 0.0 112.917 -177.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -138.6 12.24 2.73 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.465 177.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.52 ' HB2' ' HB2' ' A' ' 56' ' ' GLU . . . -62.31 -43.35 99.02 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-O 121.239 0.542 . . . . 0.0 110.738 -172.773 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -68.03 -29.72 73.63 Favored Glycine 0 N--CA 1.442 -0.936 0 CA-C-N 115.346 -0.843 . . . . 0.0 112.301 179.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -72.44 -29.51 63.76 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 120.494 -0.483 . . . . 0.0 109.719 -178.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -68.57 -41.87 82.8 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.573 -0.822 . . . . 0.0 111.077 176.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 57.7 mt -64.16 -47.8 78.46 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.906 0.384 . . . . 0.0 110.143 176.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 9.5 m-20 -61.9 -29.2 70.05 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.953 177.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 36.0 ttm180 -65.73 -37.99 87.94 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.191 179.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -70.39 -50.3 40.17 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 174.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 99.0 mt -53.83 -35.97 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.068 179.097 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 50.0 ttt180 -49.72 -32.44 13.5 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -176.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.408 ' O ' ' HB2' ' A' ' 70' ' ' SER . 41.0 p -56.26 -38.37 71.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.038 0.447 . . . . 0.0 111.147 -178.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.408 ' HB2' ' O ' ' A' ' 69' ' ' THR . 37.2 t 167.32 -38.13 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 114.914 -1.039 . . . . 0.0 108.997 -174.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 84.12 147.34 8.05 Favored Glycine 0 N--CA 1.447 -0.628 0 CA-C-N 115.416 -0.811 . . . . 0.0 112.264 -178.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.466 ' O ' HG22 ' A' ' 72' ' ' ILE . 38.9 mm -83.29 6.7 1.69 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-O 121.672 0.749 . . . . 0.0 110.161 -178.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.476 ' HB3' ' CE2' ' A' ' 24' ' ' TYR . 16.1 ptt-85 . . . . . 0 N--CA 1.466 0.359 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.74 178.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.555 ' HA2' ' HA ' ' A' ' 58' ' ' ASP . . . . . . . . 0 N--CA 1.451 -0.304 0 CA-C-O 119.795 -0.447 . . . . 0.0 113.024 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -67.59 154.66 72.87 Favored 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 122.512 2.141 . . . . 0.0 112.396 177.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.479 ' CD2' ' HB2' ' A' ' 17' ' ' ALA . 15.9 p90 -126.79 -172.14 2.57 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.968 -176.682 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.52 ' OG1' ' HG2' ' A' ' 16' ' ' GLN . 31.9 p -125.47 176.13 7.03 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 172.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.524 ' HG2' HD11 ' A' ' 29' ' ' LEU . 45.1 mtm180 -65.38 -43.83 89.45 Favored 'General case' 0 C--O 1.219 -0.52 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.332 173.53 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 16.7 mtp180 -56.94 -46.97 81.71 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.933 179.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.554 ' O ' HG23 ' A' ' 20' ' ' VAL . 10.6 mm100 -64.37 -49.89 69.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.962 178.499 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.479 ' HB2' ' CD2' ' A' ' 12' ' ' PHE . . . -56.24 -49.05 75.26 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.768 179.339 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.443 ' HG2' ' O ' ' A' ' 14' ' ' ARG . 15.2 mm100 -55.28 -38.6 68.83 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.432 -178.54 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.11 -25.67 66.32 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.656 178.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 16' ' ' GLN . 31.3 t -91.61 -16.88 7.85 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.721 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 -173.731 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.537 HG23 ' HB ' ' A' ' 27' ' ' ILE . 6.2 m -93.74 -27.02 16.74 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-N 113.839 -1.528 . . . . 0.0 107.612 -177.623 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.9 m -65.07 -35.55 81.51 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 113.636 -1.62 . . . . 0.0 108.943 165.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 41.6 m -74.57 -55.93 5.38 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.559 177.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.66 ' HB3' ' OD1' ' A' ' 26' ' ' ASN . 63.9 m-85 -114.21 104.13 11.79 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-O 121.097 0.475 . . . . 0.0 109.839 178.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.3 p -69.72 -6.52 32.37 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.309 -179.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.66 ' OD1' ' HB3' ' A' ' 24' ' ' TYR . 7.6 p-10 -79.5 -8.83 59.42 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.167 0.508 . . . . 0.0 109.723 175.459 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.561 HG13 ' HB2' ' A' ' 24' ' ' TYR . 4.2 mt -88.19 157.42 3.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 172.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -153.37 130.82 11.36 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.639 -0.424 . . . . 0.0 111.298 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.526 ' HA ' HD23 ' A' ' 39' ' ' LEU . 6.5 tt -90.01 111.11 22.09 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -178.334 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -123.97 170.94 10.12 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.141 -178.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.8 t70 61.85 30.17 18.13 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.432 -0.803 . . . . 0.0 110.061 -178.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -63.18 99.33 0.17 Allowed 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.505 -177.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -112.74 -6.98 13.83 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.242 176.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.419 ' HA2' ' NH1' ' A' ' 14' ' ' ARG . . . 129.74 -102.42 0.55 Allowed Glycine 0 N--CA 1.448 -0.518 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.036 -177.399 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 37.2 m -79.3 -19.68 49.87 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 172.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -93.13 120.38 33.37 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.715 173.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.429 ' HE2' ' HE2' ' A' ' 12' ' ' PHE . 35.6 p90 -174.8 165.93 3.66 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 176.007 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.427 HH11 ' HD3' ' A' ' 38' ' ' ARG . 13.8 ptt180 -142.17 142.95 32.75 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.093 0.473 . . . . 0.0 110.774 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.526 HD23 ' HA ' ' A' ' 29' ' ' LEU . 82.0 mt -95.68 121.65 37.61 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.193 0.52 . . . . 0.0 110.375 179.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 41.4 t -98.46 115.14 37.98 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.632 178.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.0 t -96.69 118.63 43.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 121.122 0.487 . . . . 0.0 110.11 -177.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.478 ' HA ' ' O ' ' A' ' 47' ' ' ARG . 39.1 mtm105 -103.08 168.8 8.95 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.485 -178.466 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.475 ' CG ' ' H ' ' A' ' 45' ' ' GLU . 0.5 OUTLIER -96.09 -167.91 1.66 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.037 -0.528 . . . . 0.0 109.986 178.505 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 23.2 p -64.01 -26.17 68.45 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.317 -178.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.554 ' HB3' ' HD2' ' A' ' 47' ' ' ARG . 9.1 tp10 -95.84 -13.0 24.37 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 121.18 0.515 . . . . 0.0 110.433 -177.044 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 104.63 15.28 21.24 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.575 179.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.554 ' HD2' ' HB3' ' A' ' 45' ' ' GLU . 0.0 OUTLIER -78.0 128.54 34.04 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 178.448 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 63.1 mtm -74.27 99.89 3.58 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 177.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 23.7 t -86.92 -33.45 6.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.641 -174.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.424 ' CD1' HD23 ' A' ' 63' ' ' LEU . 75.5 t-105 -153.72 150.78 28.89 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.486 -173.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 16.0 ptt180 -156.09 141.24 17.42 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 174.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -142.92 153.49 43.14 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.415 -178.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.515 ' HB2' ' HG2' ' A' ' 56' ' ' GLU . 98.0 m95 -75.62 -167.41 0.68 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.643 0.735 . . . . 0.0 111.73 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -103.98 -40.88 6.04 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.746 -1.115 . . . . 0.0 111.413 -177.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 13.8 p90 -83.24 10.27 8.82 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.82 -174.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.642 ' HB2' ' HB2' ' A' ' 59' ' ' ALA . 11.9 mm-40 -77.55 131.75 70.56 Favored Pre-proline 0 C--N 1.324 -0.538 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 177.676 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 56' ' ' GLU . 52.1 Cg_exo -55.39 -21.26 28.99 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 123.493 2.795 . . . . 0.0 113.217 -176.487 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.555 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . 4.2 p30 -136.86 38.34 2.59 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.77 0.319 . . . . 0.0 110.621 177.476 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.642 ' HB2' ' HB2' ' A' ' 56' ' ' GLU . . . -55.0 -52.75 62.16 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 121.22 0.533 . . . . 0.0 111.36 -174.344 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.424 ' HA2' HD12 ' A' ' 63' ' ' LEU . . . -67.7 -28.62 73.51 Favored Glycine 0 N--CA 1.44 -1.091 0 CA-C-N 115.422 -0.808 . . . . 0.0 112.729 -178.024 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -68.15 -35.88 78.77 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 117.139 0.469 . . . . 0.0 110.407 -176.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -68.49 -42.46 81.38 Favored Glycine 0 CA--C 1.519 0.299 0 C-N-CA 120.645 -0.788 . . . . 0.0 111.305 175.072 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.462 ' O ' HG13 ' A' ' 67' ' ' ILE . 49.7 mt -61.05 -47.47 86.21 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.994 -0.372 . . . . 0.0 109.994 176.014 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.508 ' HA ' ' HB ' ' A' ' 67' ' ' ILE . 94.0 m-20 -63.57 -29.29 70.57 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.791 177.679 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 6.4 ttt180 -58.93 -39.66 82.25 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 177.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -76.88 -46.59 24.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.505 173.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.508 ' HB ' ' HA ' ' A' ' 64' ' ' ASN . 93.7 mt -53.41 -46.16 58.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.681 -178.378 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 47.6 ttt85 -57.69 -36.56 72.12 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.948 -176.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.5 p -105.4 20.81 18.26 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -176.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 15.0 m -139.16 -57.31 0.6 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.688 0.28 . . . . 0.0 110.841 178.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 40.1 77.71 0.07 OUTLIER Glycine 0 CA--C 1.521 0.461 0 CA-C-N 115.189 -0.914 . . . . 0.0 113.512 -175.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.513 ' HB ' ' OD1' ' A' ' 26' ' ' ASN . 37.8 mm -82.55 5.73 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 CA-C-O 121.465 0.65 . . . . 0.0 111.317 -171.383 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 30.7 ttt-85 . . . . . 0 C--N 1.328 -0.36 0 CA-C-O 121.072 0.463 . . . . 0.0 111.839 -179.498 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.356 0 CA-C-O 120.257 -0.19 . . . . 0.0 113.007 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.575 ' HD3' ' O ' ' A' ' 57' ' ' PRO . 53.2 Cg_endo -76.07 174.85 12.13 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.443 2.095 . . . . 0.0 112.17 176.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.439 ' CE1' ' HA ' ' A' ' 54' ' ' ASN . 16.5 p90 -126.96 -175.13 3.33 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.089 -177.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.517 ' H ' ' HB2' ' A' ' 16' ' ' GLN . 40.6 p -122.27 170.36 9.99 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.891 178.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 25.0 ttt85 -59.33 -39.55 83.49 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.246 0.546 . . . . 0.0 110.16 175.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 32.2 mtm180 -66.38 -52.36 47.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.106 177.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.623 ' O ' HG23 ' A' ' 20' ' ' VAL . 57.8 mm-40 -56.07 -48.0 76.9 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.862 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.427 ' HB1' HD21 ' A' ' 39' ' ' LEU . . . -49.12 -51.06 34.29 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.994 177.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -54.65 -40.31 68.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.455 179.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.17 -25.97 63.7 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.706 0.289 . . . . 0.0 111.745 -176.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.623 HG23 ' O ' ' A' ' 16' ' ' GLN . 15.9 t -89.44 -19.47 7.43 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.734 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 -173.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.525 HG23 ' HB ' ' A' ' 27' ' ' ILE . 13.2 m -97.11 -27.89 14.37 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-N 113.826 -1.534 . . . . 0.0 108.619 -175.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.8 m -63.63 -37.89 89.06 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 114.356 -1.293 . . . . 0.0 108.963 168.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 34.1 m -75.88 -56.68 4.44 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.645 175.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.572 ' O ' HG13 ' A' ' 27' ' ' ILE . 65.1 m-85 -105.78 99.81 9.39 Favored 'General case' 0 N--CA 1.439 -1.019 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 -179.054 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 4.0 p -70.01 -4.6 21.64 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.216 -178.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.531 ' OD1' ' HB3' ' A' ' 24' ' ' TYR . 6.3 p-10 -82.25 -7.42 59.63 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.702 176.123 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.572 HG13 ' O ' ' A' ' 24' ' ' TYR . 1.8 mt -90.25 158.74 2.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 173.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -153.39 135.41 14.72 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.721 0.296 . . . . 0.0 111.317 178.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.401 ' HA ' HD23 ' A' ' 39' ' ' LEU . 7.0 tt -90.66 109.76 20.93 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -131.17 176.73 8.02 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.384 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.446 ' HB2' ' HG2' ' A' ' 38' ' ' ARG . 11.9 m-20 61.85 30.82 18.34 Favored 'General case' 0 N--CA 1.467 0.376 0 O-C-N 123.735 0.647 . . . . 0.0 110.908 -178.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.585 ' HA ' ' HB3' ' A' ' 37' ' ' PHE . 25.9 t0 -71.13 122.85 20.88 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.619 -175.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.541 ' HB3' ' HB2' ' A' ' 36' ' ' HIS . 35.0 tt0 -133.78 18.31 3.87 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.034 178.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 113.14 -91.99 0.6 Allowed Glycine 0 N--CA 1.45 -0.393 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.688 -177.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.6 t -100.63 -15.33 17.81 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 174.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.541 ' HB2' ' HB3' ' A' ' 33' ' ' GLN . 35.5 m170 -93.1 107.7 19.44 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.417 175.051 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.585 ' HB3' ' HA ' ' A' ' 32' ' ' ASP . 55.3 p90 -163.81 162.17 23.62 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.049 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.544 ' HB3' ' HA ' ' A' ' 53' ' ' TRP . 30.7 ptt180 -138.62 146.15 41.39 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.29 0.567 . . . . 0.0 111.814 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.427 HD21 ' HB1' ' A' ' 17' ' ' ALA . 97.0 mt -91.77 126.15 36.75 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.072 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.466 HG11 ' SD ' ' A' ' 48' ' ' MET . 28.7 t -96.31 109.71 23.35 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.102 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.948 178.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 91.1 t -81.01 114.54 22.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.536 175.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.463 ' HB3' ' HA2' ' A' ' 46' ' ' GLY . 10.7 mtt180 -106.02 173.02 6.49 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.216 178.134 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.438 ' CG ' ' H ' ' A' ' 45' ' ' GLU . 1.0 OUTLIER -95.65 -167.9 1.68 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.244 -0.434 . . . . 0.0 109.933 177.647 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 10.2 p -60.7 -26.81 67.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.58 -178.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.438 ' H ' ' CG ' ' A' ' 43' ' ' ASP . 36.1 tt0 -91.56 -27.39 18.23 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.337 -179.555 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.463 ' HA2' ' HB3' ' A' ' 42' ' ' ARG . . . 108.39 19.6 8.75 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.526 -0.845 . . . . 0.0 112.836 -178.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.429 ' O ' ' HA ' ' A' ' 42' ' ' ARG . 79.3 mtt180 -78.64 143.95 35.87 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 176.142 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.466 ' SD ' HG11 ' A' ' 40' ' ' VAL . 14.3 mmt -66.22 114.28 5.2 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.245 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 43.8 t -103.33 -35.1 3.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 120.741 0.305 . . . . 0.0 110.536 178.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 68.4 t-105 -172.3 125.54 0.52 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.968 -174.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 12.3 ptp180 -120.03 125.23 47.82 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.92 0.39 . . . . 0.0 110.232 175.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -125.89 143.25 51.15 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.572 -178.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.698 ' HB2' ' HG2' ' A' ' 56' ' ' GLU . 96.9 m95 -72.13 -174.12 1.2 Allowed 'General case' 0 CA--C 1.513 -0.464 0 CA-C-O 122.079 0.942 . . . . 0.0 112.13 -177.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.439 ' HA ' ' CE1' ' A' ' 12' ' ' PHE . 18.9 t-20 -101.9 -43.43 5.8 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 113.825 -1.534 . . . . 0.0 110.879 -176.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -83.68 10.64 8.84 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.941 -173.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.698 ' HG2' ' HB2' ' A' ' 53' ' ' TRP . 12.8 mm-40 -75.83 131.12 77.04 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.192 178.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.575 ' O ' ' HD3' ' A' ' 11' ' ' PRO . 4.2 Cg_endo -46.74 -37.01 20.39 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 124.01 3.14 . . . . 0.0 113.304 -174.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.566 ' HB3' ' HB2' ' A' ' 61' ' ' GLU . 11.5 m-20 -140.14 63.25 1.48 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.727 0.298 . . . . 0.0 110.249 174.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.539 ' HB2' ' HB2' ' A' ' 56' ' ' GLU . . . -61.77 -38.31 87.52 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-O 121.352 0.596 . . . . 0.0 110.572 177.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -62.51 -23.68 65.09 Favored Glycine 0 C--O 1.221 -0.691 0 CA-C-N 115.389 -0.823 . . . . 0.0 113.112 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.566 ' HB2' ' HB3' ' A' ' 58' ' ' ASP . 2.5 tm-20 -58.14 -51.9 67.8 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.159 0.504 . . . . 0.0 110.21 -178.297 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -71.84 -39.34 59.71 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.678 -0.772 . . . . 0.0 111.847 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.511 ' O ' HG13 ' A' ' 67' ' ' ILE . 80.4 mt -61.73 -46.46 89.55 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.593 0.235 . . . . 0.0 110.97 179.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -65.44 -29.53 70.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.14 -179.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.509 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 25.3 ttm105 -66.03 -33.76 76.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.027 176.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -73.07 -46.56 50.91 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 119.979 -0.688 . . . . 0.0 109.739 172.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.511 HG13 ' O ' ' A' ' 63' ' ' LEU . 80.3 mt -55.46 -55.59 16.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.342 -178.094 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.607 ' O ' HG22 ' A' ' 69' ' ' THR . 26.0 mmm-85 54.93 27.79 9.65 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 123.119 0.262 . . . . 0.0 111.55 177.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.607 HG22 ' O ' ' A' ' 68' ' ' ARG . 9.8 t 61.29 16.69 7.57 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.222 1.409 . . . . 0.0 111.042 176.165 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 13.2 p -113.72 -66.14 1.12 Allowed 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.438 175.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.535 ' HA3' ' CE1' ' A' ' 24' ' ' TYR . . . 65.65 179.64 8.97 Favored Glycine 0 N--CA 1.445 -0.765 0 CA-C-N 115.208 -0.906 . . . . 0.0 113.117 179.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.453 ' O ' HG22 ' A' ' 72' ' ' ILE . 35.8 mm -91.77 5.9 5.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.808 0.813 . . . . 0.0 110.119 -179.044 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 22.5 tpt180 -60.21 -84.35 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.259 177.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 11.1 m -91.69 -33.43 15.06 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.5 t70 . . . . . 0 N--CA 1.473 0.701 0 O-C-N 124.649 1.218 . . . . 0.0 112.767 178.955 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.613 ' HA3' ' O ' ' A' ' 57' ' ' PRO . . . . . . . . 0 N--CA 1.441 -0.997 0 N-CA-C 111.325 -0.71 . . . . 0.0 111.325 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -73.33 132.92 18.45 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 121.494 1.462 . . . . 0.0 110.66 174.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 34.8 p90 -104.97 -171.7 1.96 Allowed 'General case' 0 C--N 1.31 -1.137 0 CA-C-O 121.703 0.763 . . . . 0.0 112.452 -173.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.89 156.44 36.26 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 114.924 -1.035 . . . . 0.0 109.2 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 22.5 ttt85 -61.6 -49.27 77.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.057 0.456 . . . . 0.0 110.346 -179.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.419 HH11 ' HD2' ' A' ' 15' ' ' ARG . 30.7 mtp180 -52.22 -47.97 65.36 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.338 -0.847 . . . . 0.0 111.2 175.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.595 ' O ' HG23 ' A' ' 20' ' ' VAL . 13.4 mm100 -58.0 -48.73 79.15 Favored 'General case' 0 C--O 1.226 -0.173 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.374 176.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -55.45 -46.09 76.8 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.319 -179.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 27.2 mm-40 -56.79 -41.65 78.07 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.529 -178.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.17 -23.26 67.06 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-O 121.181 0.515 . . . . 0.0 111.55 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.595 HG23 ' O ' ' A' ' 16' ' ' GLN . 5.0 t -90.6 -20.98 6.74 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.803 0 N-CA-C 107.227 -1.398 . . . . 0.0 107.227 -175.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.2 m -83.8 -31.73 25.73 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 114.084 -1.416 . . . . 0.0 110.243 179.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 15.6 p -70.41 -32.29 69.85 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 173.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 16.7 m -79.91 -49.06 12.45 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.756 175.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.707 ' O ' HG13 ' A' ' 27' ' ' ILE . 33.6 m-85 -115.12 96.9 5.91 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 175.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 37.9 m -83.33 16.17 2.63 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.035 0.445 . . . . 0.0 111.628 -174.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.44 ' OD1' ' HB3' ' A' ' 24' ' ' TYR . 21.5 p-10 -91.29 -17.4 26.0 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 169.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.707 HG13 ' O ' ' A' ' 24' ' ' TYR . 2.5 mt -72.55 147.46 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 CA-C-N 115.182 -0.917 . . . . 0.0 108.542 175.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.518 ' O ' ' HA ' ' A' ' 39' ' ' LEU . 14.5 p -141.95 144.45 33.74 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.712 -175.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.5 tt -101.15 108.62 20.34 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -113.77 162.5 16.22 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.83 179.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.578 ' O ' ' HA ' ' A' ' 37' ' ' PHE . 3.2 m-20 57.26 70.72 0.63 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.999 -1.001 . . . . 0.0 112.062 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -77.18 75.58 3.74 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.147 174.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.529 ' HB2' ' HB2' ' A' ' 36' ' ' HIS . 16.2 mm-40 -103.61 21.21 16.53 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.133 0.492 . . . . 0.0 109.981 -179.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.72 -93.06 1.64 Allowed Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 121.08 -0.581 . . . . 0.0 112.296 178.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 27.2 t -75.4 -29.55 59.84 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.397 0.617 . . . . 0.0 109.883 178.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.529 ' HB2' ' HB2' ' A' ' 33' ' ' GLN . 26.8 m-70 -101.84 107.54 18.75 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.79 177.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.578 ' HA ' ' O ' ' A' ' 31' ' ' ASP . 45.9 p90 -148.62 146.66 28.31 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 173.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 37.5 ptt85 -127.92 152.1 48.28 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.316 0.579 . . . . 0.0 112.314 -173.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.518 ' HA ' ' O ' ' A' ' 28' ' ' THR . 86.2 mt -108.88 132.6 53.88 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.891 175.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.439 ' HB ' ' OG1' ' A' ' 28' ' ' THR . 41.2 t -114.53 118.81 59.72 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.717 -179.032 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 93.5 t -89.46 114.83 28.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.654 176.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.469 ' HA ' ' O ' ' A' ' 47' ' ' ARG . 49.2 mtp180 -104.15 164.2 11.88 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.932 177.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.452 ' CG ' ' H ' ' A' ' 45' ' ' GLU . 1.7 p-10 -102.9 -166.04 1.23 Allowed 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 110.325 -0.25 . . . . 0.0 110.325 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 25.6 p -66.62 -22.96 66.11 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 120.92 0.39 . . . . 0.0 111.893 179.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.452 ' H ' ' CG ' ' A' ' 43' ' ' ASP . 8.6 tp10 -86.98 -21.61 26.07 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.239 0.543 . . . . 0.0 109.574 178.159 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 101.17 5.23 53.11 Favored Glycine 0 N--CA 1.444 -0.808 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.08 179.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.469 ' O ' ' HA ' ' A' ' 42' ' ' ARG . 88.0 mtt180 -72.23 146.87 47.0 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 -178.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -74.06 103.09 4.4 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 176.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 57.4 t -77.96 -40.67 26.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.991 179.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 76.1 t-105 -164.17 142.13 7.08 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.819 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.417 HH11 ' HD3' ' A' ' 51' ' ' ARG . 14.9 ptt-85 -141.78 138.68 32.44 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 177.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -143.97 156.47 44.42 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.354 -177.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 92.8 m95 -88.52 -161.6 0.76 Allowed 'General case' 0 N--CA 1.447 -0.615 0 CA-C-O 121.423 0.63 . . . . 0.0 110.474 -179.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -106.23 -33.93 7.66 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.274 -176.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -81.45 3.53 24.32 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 -173.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.523 ' HB2' ' HB2' ' A' ' 59' ' ' ALA . 37.1 mt-10 -80.19 129.22 70.58 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.463 -178.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.613 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 31.3 Cg_exo -62.16 -10.37 17.94 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 123.396 2.731 . . . . 0.0 114.009 -172.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.519 ' HA ' ' CA ' ' A' ' 10' ' ' GLY . 24.0 p-10 -143.01 34.02 1.36 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.761 0.315 . . . . 0.0 110.794 177.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.523 ' HB2' ' HB2' ' A' ' 56' ' ' GLU . . . -55.75 -40.96 73.25 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.994 -178.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -62.8 -39.33 97.85 Favored Glycine 0 N--CA 1.443 -0.878 0 CA-C-N 115.826 -0.624 . . . . 0.0 112.381 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -66.02 -23.1 66.49 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.886 0.343 . . . . 0.0 111.721 -177.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -75.5 -49.23 9.39 Favored Glycine 0 C--O 1.24 0.477 0 C-N-CA 120.286 -0.959 . . . . 0.0 111.085 175.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.427 ' O ' HG13 ' A' ' 67' ' ' ILE . 50.0 mt -63.24 -43.35 98.29 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.273 0.559 . . . . 0.0 109.833 177.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 8.8 m-20 -69.16 -20.43 64.02 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.189 178.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 6.8 tmm_? -65.93 -41.36 91.48 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 173.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.438 ' CE1' ' HA2' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -67.97 -42.9 80.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.425 175.018 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.427 HG13 ' O ' ' A' ' 63' ' ' LEU . 62.9 mt -67.74 -26.75 35.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.257 -178.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -59.9 -33.37 71.76 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.138 -178.257 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.449 ' O ' ' HB2' ' A' ' 70' ' ' SER . 4.5 t -101.73 66.48 1.06 Allowed 'General case' 0 N--CA 1.442 -0.838 0 CA-C-O 121.825 0.822 . . . . 0.0 109.526 179.015 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.449 ' HB2' ' O ' ' A' ' 69' ' ' THR . 63.2 m 80.37 -51.7 0.35 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 114.211 -1.359 . . . . 0.0 112.808 171.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.438 ' HA2' ' CE1' ' A' ' 66' ' ' TYR . . . 79.15 -174.04 55.29 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.633 -0.794 . . . . 0.0 111.271 -170.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.487 ' O ' HG22 ' A' ' 72' ' ' ILE . 47.5 mm -101.35 7.0 9.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-O 121.896 0.855 . . . . 0.0 110.341 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.54 ' HB3' ' CE2' ' A' ' 24' ' ' TYR . 14.6 ptm180 -55.43 -11.02 0.72 Allowed 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.423 -0.808 . . . . 0.0 113.103 -178.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 2.8 m -61.3 -10.03 6.3 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.955 0.407 . . . . 0.0 110.439 176.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 9.1 t0 . . . . . 0 CA--C 1.515 -0.393 0 CA-C-O 121.3 0.571 . . . . 0.0 109.75 -178.959 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.425 ' HA3' ' HD3' ' A' ' 11' ' ' PRO . . . . . . . . 0 N--CA 1.463 0.473 0 N-CA-C 113.966 0.346 . . . . 0.0 113.966 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.425 ' HD3' ' HA3' ' A' ' 10' ' ' GLY . 7.7 Cg_exo -70.53 139.09 36.79 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.775 2.317 . . . . 0.0 111.053 176.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -104.9 -175.15 2.71 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.493 0.663 . . . . 0.0 112.134 -173.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.46 ' H ' ' HB2' ' A' ' 16' ' ' GLN . 1.7 m -126.05 164.22 21.33 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-N 114.342 -1.299 . . . . 0.0 109.742 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.543 ' HA ' ' CZ ' ' A' ' 37' ' ' PHE . 48.3 ttt85 -51.49 -55.78 17.0 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 122.64 0.376 . . . . 0.0 111.351 -179.038 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 43.5 mtp180 -56.53 -45.57 81.08 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.464 177.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.572 ' O ' HG23 ' A' ' 20' ' ' VAL . 1.9 mp0 -59.2 -46.92 87.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.943 -179.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.505 ' HB1' HD11 ' A' ' 39' ' ' LEU . . . -57.44 -44.18 84.5 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 121.086 0.47 . . . . 0.0 111.17 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 58.2 mt-30 -55.28 -41.75 72.69 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.024 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.49 -23.96 66.33 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.739 -178.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.572 HG23 ' O ' ' A' ' 16' ' ' GLN . 10.4 t -90.83 -19.76 7.07 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.687 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 -172.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.526 HG23 ' HB ' ' A' ' 27' ' ' ILE . 10.8 m -95.86 -28.79 14.54 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 114.055 -1.429 . . . . 0.0 108.417 -176.036 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 54.8 m -63.45 -36.63 84.4 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 114.083 -1.417 . . . . 0.0 108.939 167.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.585 HG23 HH11 ' A' ' 73' ' ' ARG . 90.8 m -76.21 -54.4 6.85 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.376 175.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.569 ' HB2' HG13 ' A' ' 27' ' ' ILE . 51.1 m-85 -110.64 102.7 11.25 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-O 121.087 0.47 . . . . 0.0 109.796 179.144 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 6.1 p -75.62 2.17 12.56 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.376 -177.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.453 ' OD1' ' HB3' ' A' ' 24' ' ' TYR . 6.1 p-10 -87.71 -8.3 56.25 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.572 173.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.569 HG13 ' HB2' ' A' ' 24' ' ' TYR . 2.9 mt -83.08 150.27 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 172.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.409 ' O ' ' HA ' ' A' ' 39' ' ' LEU . 1.1 p -141.43 135.94 30.85 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 120.912 -0.315 . . . . 0.0 110.785 -178.011 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 5.0 tt -94.64 107.16 19.16 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -178.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -119.07 164.66 15.18 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.753 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.482 ' HB2' ' HG2' ' A' ' 38' ' ' ARG . 90.5 m-20 56.71 42.39 26.92 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.6 0.715 . . . . 0.0 110.462 -175.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -74.6 103.38 4.89 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.913 -177.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -103.43 -19.73 14.31 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 173.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 126.03 -80.54 0.36 Allowed Glycine 0 N--CA 1.449 -0.469 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.405 -177.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.8 t -72.21 -35.6 68.94 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.262 0.553 . . . . 0.0 109.623 174.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 40.0 m80 -109.34 139.26 44.51 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.783 178.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.543 ' CZ ' ' HA ' ' A' ' 14' ' ' ARG . 55.6 p90 -174.23 164.04 3.91 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 176.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.482 ' HG2' ' HB2' ' A' ' 31' ' ' ASP . 29.3 ptt85 -128.68 144.83 51.25 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.205 0.526 . . . . 0.0 111.191 177.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.505 HD11 ' HB1' ' A' ' 17' ' ' ALA . 86.0 mt -99.18 127.1 45.1 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.934 176.322 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 27.5 t -103.7 119.93 53.05 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.529 177.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.409 HG11 ' CD2' ' A' ' 66' ' ' TYR . 16.3 t -91.19 108.76 20.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.214 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 33.9 mtt85 -105.19 168.15 9.26 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.038 -177.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.628 ' OD1' ' HG2' ' A' ' 47' ' ' ARG . 7.6 p-10 -104.02 -164.57 1.07 Allowed 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.616 179.182 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -66.17 -17.11 64.51 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -91.98 -24.32 19.28 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.477 0.656 . . . . 0.0 109.821 179.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 99.32 7.78 53.93 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.745 -0.741 . . . . 0.0 111.575 -179.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.628 ' HG2' ' OD1' ' A' ' 43' ' ' ASP . 15.9 ptt180 -78.35 150.46 33.21 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 177.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 23.3 ptp -79.12 116.86 19.67 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.309 0.576 . . . . 0.0 110.01 178.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 41.4 t -98.26 -31.94 3.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-O 121.478 0.656 . . . . 0.0 109.322 176.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 75.2 t-105 -155.11 155.76 34.59 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.53 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 16.7 ptt180 -158.5 142.66 15.67 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 175.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -150.55 147.92 28.04 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.214 -179.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.561 ' HB2' ' HG2' ' A' ' 56' ' ' GLU . 65.0 m95 -80.92 -176.73 6.05 Favored 'General case' 0 CA--C 1.509 -0.627 0 CA-C-O 122.15 0.976 . . . . 0.0 111.371 177.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -82.82 -31.54 28.06 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 113.465 -1.698 . . . . 0.0 110.079 -178.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -97.04 8.65 44.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.58 -0.737 . . . . 0.0 112.325 -173.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.664 ' HB2' ' HB2' ' A' ' 59' ' ' ALA . 38.9 mm-40 -71.02 128.14 90.9 Favored Pre-proline 0 C--N 1.328 -0.354 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 179.118 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -49.28 -37.45 40.04 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 124.074 3.182 . . . . 0.0 113.904 -173.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -131.15 43.82 3.04 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.143 0.497 . . . . 0.0 110.248 178.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.664 ' HB2' ' HB2' ' A' ' 56' ' ' GLU . . . -51.4 -45.36 62.48 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.545 -177.234 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -59.04 -38.63 93.25 Favored Glycine 0 N--CA 1.446 -0.646 0 CA-C-N 115.433 -0.803 . . . . 0.0 113.163 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 22.1 tp10 -60.06 -38.78 83.84 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.873 0.337 . . . . 0.0 110.996 -175.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -68.84 -43.54 73.79 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.33 -0.938 . . . . 0.0 111.021 177.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.438 ' O ' HG13 ' A' ' 67' ' ' ILE . 57.5 mt -58.52 -47.6 83.61 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.324 -0.438 . . . . 0.0 109.867 176.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -59.72 -33.34 71.5 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.698 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.419 HH11 ' HD2' ' A' ' 65' ' ' ARG . 9.5 tpp85 -70.07 -29.58 66.61 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.059 -175.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.409 ' CD2' HG11 ' A' ' 41' ' ' VAL . 80.0 t80 -87.45 -42.58 12.7 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.177 -0.609 . . . . 0.0 110.546 172.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.696 HG22 ' H ' ' A' ' 69' ' ' THR . 86.1 mt -57.04 -59.89 2.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.884 -179.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.516 ' O ' HG22 ' A' ' 69' ' ' THR . 57.1 mtm-85 51.85 30.28 6.9 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.242 0.544 . . . . 0.0 111.213 177.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.696 ' H ' HG22 ' A' ' 67' ' ' ILE . 13.2 t 61.55 21.12 11.83 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 126.102 1.761 . . . . 0.0 111.736 174.369 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 55.3 p -112.57 -62.18 1.62 Allowed 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.233 171.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 65.26 -175.83 14.02 Favored Glycine 0 N--CA 1.446 -0.69 0 CA-C-N 115.152 -0.931 . . . . 0.0 112.721 177.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.455 ' O ' HG22 ' A' ' 72' ' ' ILE . 40.9 mm -101.34 5.82 10.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-O 121.876 0.846 . . . . 0.0 109.35 178.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.585 HH11 HG23 ' A' ' 23' ' ' THR . 51.3 ttt180 -58.6 -70.4 0.15 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.376 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 10.0 t -97.06 4.14 51.51 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 178.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 32.9 t0 . . . . . 0 N--CA 1.466 0.35 0 CA-C-N 114.304 -1.316 . . . . 0.0 111.543 -176.868 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.612 ' HA2' ' HA ' ' A' ' 58' ' ' ASP . . . . . . . . 0 CA--C 1.523 0.559 0 N-CA-C 113.554 0.181 . . . . 0.0 113.554 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.474 ' HD3' ' HA3' ' A' ' 10' ' ' GLY . 3.3 Cg_exo -81.31 170.85 14.38 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 123.371 2.714 . . . . 0.0 112.29 177.246 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 15.2 p90 -122.27 -173.85 2.77 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.015 0.436 . . . . 0.0 111.48 -176.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.48 ' H ' ' HB2' ' A' ' 16' ' ' GLN . 62.5 p -125.16 179.64 4.97 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.896 178.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 29.3 ttt180 -63.99 -41.32 97.55 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 174.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 25.7 ttm180 -58.72 -53.43 58.48 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.625 177.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.584 ' O ' HG23 ' A' ' 20' ' ' VAL . 2.0 mp0 -60.78 -48.61 81.02 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.541 178.192 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -50.26 -54.59 20.17 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.534 179.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -57.79 -36.77 72.64 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.191 -0.458 . . . . 0.0 112.11 -179.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.66 -29.48 70.05 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.027 0.441 . . . . 0.0 111.565 -179.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.584 HG23 ' O ' ' A' ' 16' ' ' GLN . 11.5 t -88.95 -25.31 5.77 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.827 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 -173.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.418 HG23 ' HB ' ' A' ' 27' ' ' ILE . 9.7 m -83.14 -33.51 26.25 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-N 113.909 -1.496 . . . . 0.0 110.994 -179.49 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.1 t -70.44 -25.34 63.16 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 173.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 33.6 m -76.0 -56.99 4.15 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.682 169.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.675 ' CE1' ' HA3' ' A' ' 71' ' ' GLY . 34.1 m-85 -113.14 105.72 13.79 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.282 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 31.5 m -86.71 11.6 12.65 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.59 0.709 . . . . 0.0 110.23 -176.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.559 ' OD1' ' HB3' ' A' ' 24' ' ' TYR . 7.5 p-10 -88.73 -6.98 57.06 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.917 -1.038 . . . . 0.0 108.748 170.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.613 HG13 ' O ' ' A' ' 24' ' ' TYR . 3.6 mt -82.45 142.32 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 172.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.0 p -136.05 130.13 33.0 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.748 -0.381 . . . . 0.0 111.095 -174.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.546 ' HA ' HD23 ' A' ' 39' ' ' LEU . 5.4 tt -86.08 117.3 24.83 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 70.7 mt-10 -123.4 173.3 8.08 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.295 -178.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.493 ' O ' ' HA ' ' A' ' 37' ' ' PHE . 0.4 OUTLIER 55.56 63.62 2.01 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.703 -1.135 . . . . 0.0 111.364 176.747 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -80.8 97.45 7.35 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.022 -179.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -106.94 -10.56 15.94 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 171.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 111.92 -81.97 0.3 Allowed Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.895 -0.669 . . . . 0.0 111.601 -177.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.7 m -76.74 -18.64 58.36 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.32 0.581 . . . . 0.0 110.18 177.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 38.3 m-70 -115.84 137.72 51.83 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.949 176.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.493 ' HA ' ' O ' ' A' ' 31' ' ' ASP . 48.6 p90 -167.17 156.94 10.84 Favored 'General case' 0 C--N 1.328 -0.337 0 O-C-N 123.824 0.703 . . . . 0.0 109.334 175.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 22.4 ptt180 -128.97 158.13 39.71 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.705 0.288 . . . . 0.0 111.056 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.546 HD23 ' HA ' ' A' ' 29' ' ' LEU . 75.0 mt -113.73 125.02 53.65 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.235 0.541 . . . . 0.0 109.978 174.077 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.51 HG22 ' CB ' ' A' ' 51' ' ' ARG . 61.9 t -103.37 123.97 57.25 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.823 177.03 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.452 HG11 ' CD1' ' A' ' 66' ' ' TYR . 3.1 t -93.92 111.0 24.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 91.9 mtt180 -104.47 168.24 9.22 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.963 -178.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -97.16 -166.72 1.43 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.637 0.256 . . . . 0.0 110.316 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 12.4 p -70.15 -17.18 63.17 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 111.99 0.366 . . . . 0.0 111.99 -176.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.434 ' HB3' ' HG2' ' A' ' 47' ' ' ARG . 23.5 tt0 -93.11 -22.69 18.95 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.002 0.43 . . . . 0.0 109.92 179.149 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 105.81 14.01 22.32 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.807 -0.711 . . . . 0.0 111.769 -178.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.434 ' HG2' ' HB3' ' A' ' 45' ' ' GLU . 14.9 mmt180 -76.74 124.93 28.41 Favored 'General case' 0 N--CA 1.446 -0.63 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 178.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -69.09 106.07 2.67 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.133 0.492 . . . . 0.0 109.984 176.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 41.2 t -92.55 -33.11 5.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.444 -177.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 69.1 t-105 -156.4 149.17 23.84 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.893 -175.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.51 ' CB ' HG22 ' A' ' 40' ' ' VAL . 14.5 ptp180 -146.69 143.48 28.77 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 172.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -143.56 147.44 34.44 Favored 'General case' 0 C--N 1.319 -0.717 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 82.8 m95 -82.37 -171.26 3.35 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-O 121.594 0.711 . . . . 0.0 110.637 178.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -98.72 -16.78 18.85 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 114.417 -1.265 . . . . 0.0 110.294 -176.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -104.26 4.17 33.48 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.622 -177.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.58 ' HB2' ' HB2' ' A' ' 59' ' ' ALA . 20.7 mm-40 -61.26 131.93 92.4 Favored Pre-proline 0 C--O 1.235 0.316 0 CA-C-N 116.641 -0.254 . . . . 0.0 110.525 178.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_exo -40.01 -47.65 3.9 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 124.264 3.309 . . . . 0.0 113.243 -176.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.612 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . 5.0 t0 -140.22 70.03 1.36 Allowed 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 171.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.58 ' HB2' ' HB2' ' A' ' 56' ' ' GLU . . . -55.47 -35.98 66.09 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.823 178.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -58.16 -43.1 95.49 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.416 -0.811 . . . . 0.0 112.5 178.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.654 ' O ' ' HG3' ' A' ' 65' ' ' ARG . 5.3 tm-20 -58.65 -39.71 81.36 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.696 0.248 . . . . 0.0 111.003 -177.289 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.63 ' O ' ' HB2' ' A' ' 65' ' ' ARG . . . -76.4 -40.61 27.7 Favored Glycine 0 C--N 1.331 0.264 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.126 -178.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.484 ' O ' HG13 ' A' ' 67' ' ' ILE . 77.3 mt -66.26 -40.55 90.25 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 177.152 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -65.6 -26.42 67.83 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.822 177.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.654 ' HG3' ' O ' ' A' ' 61' ' ' GLU . 87.7 mtt180 -58.26 -48.91 78.93 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 121.112 0.482 . . . . 0.0 109.804 171.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.452 ' CD1' HG11 ' A' ' 41' ' ' VAL . 29.3 t80 -69.44 -48.36 61.13 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.378 178.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.484 HG13 ' O ' ' A' ' 63' ' ' LEU . 80.3 mt -56.86 -58.07 7.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.848 -178.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.454 ' O ' HG22 ' A' ' 69' ' ' THR . 13.7 mtm180 57.42 28.2 15.06 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-O 121.045 0.45 . . . . 0.0 110.611 178.003 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.454 HG22 ' O ' ' A' ' 68' ' ' ARG . 11.5 t 52.51 22.76 2.26 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.266 1.427 . . . . 0.0 112.001 -177.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 17.0 t -108.25 -64.73 1.19 Allowed 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 172.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.675 ' HA3' ' CE1' ' A' ' 24' ' ' TYR . . . 75.38 166.93 20.38 Favored Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.998 176.182 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.559 ' HB ' ' OD1' ' A' ' 26' ' ' ASN . 40.8 mm -87.74 -11.19 10.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 120.664 0.269 . . . . 0.0 111.164 -179.203 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.406 HH11 ' HD3' ' A' ' 73' ' ' ARG . 7.9 ttm180 -49.81 -74.16 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.931 0.396 . . . . 0.0 111.899 -178.323 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.8 m -83.32 2.15 37.61 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.76 0.791 . . . . 0.0 109.472 -177.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.556 ' HB3' ' HA ' ' A' ' 72' ' ' ILE . 17.2 t70 . . . . . 0 C--N 1.325 -0.486 0 CA-C-N 115.091 -0.958 . . . . 0.0 110.282 -178.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.421 ' HA3' ' HD3' ' A' ' 11' ' ' PRO . . . . . . . . 0 CA--C 1.516 0.127 0 CA-C-O 120.147 -0.252 . . . . 0.0 113.201 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.421 ' HD3' ' HA3' ' A' ' 10' ' ' GLY . 20.8 Cg_exo -64.75 153.05 79.71 Favored 'Trans proline' 0 C--O 1.234 0.314 0 C-N-CA 122.88 2.387 . . . . 0.0 111.704 177.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 16.8 p90 -120.32 -171.69 2.21 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.053 -176.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.484 ' H ' ' HB2' ' A' ' 16' ' ' GLN . 46.1 p -125.02 171.65 10.07 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.84 179.225 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.479 ' O ' ' HG3' ' A' ' 18' ' ' GLN . 43.1 ttt180 -55.8 -45.86 78.15 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.651 0.739 . . . . 0.0 109.773 174.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -63.5 -50.27 70.29 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.765 -1.107 . . . . 0.0 111.772 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.586 ' O ' HG23 ' A' ' 20' ' ' VAL . 1.5 mp0 -58.78 -44.59 90.71 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.692 -0.231 . . . . 0.0 110.689 179.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -52.29 -49.0 65.03 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.256 178.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.479 ' HG3' ' O ' ' A' ' 14' ' ' ARG . 98.3 mt-30 -56.04 -45.1 79.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.374 -178.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.12 -31.15 70.86 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.079 -176.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.586 HG23 ' O ' ' A' ' 16' ' ' GLN . 8.2 t -87.55 -24.31 6.33 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.881 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 -171.278 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.52 HG23 ' HB ' ' A' ' 27' ' ' ILE . 10.3 m -86.4 -30.94 21.73 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 113.597 -1.638 . . . . 0.0 110.698 -178.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.6 p -68.56 -28.25 66.8 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 170.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 20.7 m -76.95 -56.79 4.28 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.089 172.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.627 ' HB3' ' OD1' ' A' ' 26' ' ' ASN . 79.0 m-85 -109.59 103.41 12.27 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 121.259 0.552 . . . . 0.0 109.948 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 6.0 p -71.72 -3.9 24.51 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.492 -0.776 . . . . 0.0 112.134 -178.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.627 ' OD1' ' HB3' ' A' ' 24' ' ' TYR . 25.6 p-10 -80.05 -16.68 54.54 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 174.405 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.548 HG13 ' O ' ' A' ' 24' ' ' TYR . 2.4 mt -76.72 146.63 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 173.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.535 ' OG1' ' HB ' ' A' ' 40' ' ' VAL . 1.6 p -141.59 123.26 15.16 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.013 0.435 . . . . 0.0 111.007 -177.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.465 ' CD2' ' HB3' ' A' ' 32' ' ' ASP . 6.5 tt -80.69 99.73 8.34 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 178.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 52.7 mm-40 -118.81 166.96 12.16 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.561 -177.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 58.97 34.63 23.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.347 -175.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.55 ' HA ' ' HB3' ' A' ' 37' ' ' PHE . 5.7 p-10 -68.03 99.8 0.91 Allowed 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.274 -0.876 . . . . 0.0 111.514 -178.152 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -104.97 9.21 34.61 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.018 176.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 125.06 -94.37 0.46 Allowed Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.409 -177.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.3 t -101.45 -13.38 17.97 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 173.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 13.9 m-70 -94.27 111.69 23.45 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.298 174.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.55 ' HB3' ' HA ' ' A' ' 32' ' ' ASP . 47.4 p90 -163.83 171.56 15.3 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -179.239 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.527 ' HA ' ' HA ' ' A' ' 53' ' ' TRP . 16.6 ptt-85 -130.79 144.63 51.58 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.083 0.468 . . . . 0.0 110.539 175.153 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.463 HD23 ' HA ' ' A' ' 29' ' ' LEU . 95.1 mt -95.33 117.12 29.75 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.532 176.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.535 ' HB ' ' OG1' ' A' ' 28' ' ' THR . 38.3 t -92.14 119.99 40.57 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.832 178.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.462 HG11 ' CD1' ' A' ' 66' ' ' TYR . 4.9 t -92.2 116.45 33.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 178.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 59.2 mtm180 -99.32 166.74 11.06 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.435 -178.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.639 ' OD1' ' HG2' ' A' ' 47' ' ' ARG . 9.7 p-10 -100.28 -166.71 1.36 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.23 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.83 -17.94 64.99 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.792 -179.185 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -89.32 -29.03 19.45 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -179.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 102.42 16.69 21.91 Favored Glycine 0 N--CA 1.444 -0.821 0 CA-C-N 115.276 -0.874 . . . . 0.0 112.309 -178.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.639 ' HG2' ' OD1' ' A' ' 43' ' ' ASP . 25.4 ptt180 -93.69 153.1 18.54 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 178.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 49.4 mtt -73.33 113.38 10.34 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.397 -178.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.455 HG21 ' HB3' ' A' ' 43' ' ' ASP . 46.1 t -97.84 -33.21 4.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 121.105 0.479 . . . . 0.0 110.264 178.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 74.0 t-105 -157.02 154.64 29.91 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.087 -177.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.412 ' HB2' ' HD2' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -151.13 140.46 21.38 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 174.366 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -141.51 143.75 33.96 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 177.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.531 ' HB2' ' HG2' ' A' ' 56' ' ' GLU . 69.2 m95 -80.23 -173.82 4.21 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 121.721 0.772 . . . . 0.0 111.069 -179.122 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -90.22 -28.32 18.93 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 114.008 -1.451 . . . . 0.0 110.089 -175.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 13.5 p90 -101.55 15.85 27.57 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.21 -0.904 . . . . 0.0 112.075 -173.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.531 ' HG2' ' HB2' ' A' ' 53' ' ' TRP . 19.3 mm-40 -77.87 135.23 63.62 Favored Pre-proline 0 C--N 1.323 -0.571 0 C-N-CA 121.232 -0.187 . . . . 0.0 110.828 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_exo -38.77 -46.67 2.66 Favored 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 124.637 3.558 . . . . 0.0 113.966 -173.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -145.33 67.8 1.23 Allowed 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 172.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.53 ' HB2' ' HB2' ' A' ' 56' ' ' GLU . . . -56.2 -36.12 68.06 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 115.263 -0.881 . . . . 0.0 111.232 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -57.0 -36.23 72.8 Favored Glycine 0 N--CA 1.447 -0.633 0 CA-C-N 115.486 -0.779 . . . . 0.0 113.78 -178.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.416 ' CD ' HH21 ' A' ' 65' ' ' ARG . 1.2 tm-20 -56.73 -49.15 76.07 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 117.211 0.505 . . . . 0.0 110.83 -176.472 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -70.21 -43.26 64.23 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.341 -177.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.546 ' O ' HG13 ' A' ' 67' ' ' ILE . 52.6 mt -66.39 -52.3 48.22 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.866 -0.167 . . . . 0.0 110.766 -178.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.666 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 87.9 m-20 -58.72 -40.76 84.65 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.717 -179.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.416 HH21 ' CD ' ' A' ' 61' ' ' GLU . 19.0 ttm180 -51.63 -50.99 59.2 Favored 'General case' 0 C--O 1.233 0.192 0 O-C-N 123.643 0.589 . . . . 0.0 110.446 178.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.462 ' CD1' HG11 ' A' ' 41' ' ' VAL . 44.5 t80 -63.36 -43.25 98.2 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.352 179.07 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.546 HG13 ' O ' ' A' ' 63' ' ' LEU . 87.4 mt -57.6 -31.49 39.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.927 -0.579 . . . . 0.0 112.329 -177.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.666 ' HG2' ' O ' ' A' ' 64' ' ' ASN . 10.7 mmm180 -65.02 -62.08 1.77 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.972 0.415 . . . . 0.0 111.257 -175.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 17.7 p -81.57 -26.21 35.18 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.327 -177.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 24.7 m -125.91 31.14 5.53 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -169.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.15 116.41 9.05 Favored Glycine 0 CA--C 1.522 0.528 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.099 170.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.455 ' O ' HG22 ' A' ' 72' ' ' ILE . 37.5 mm -93.99 2.6 9.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-O 121.029 0.442 . . . . 0.0 111.339 -171.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.429 ' HG3' ' N ' ' A' ' 74' ' ' THR . 45.0 ptt85 -68.63 -39.85 80.57 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 121.976 -0.453 . . . . 0.0 111.691 -175.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.429 ' N ' ' HG3' ' A' ' 73' ' ' ARG . 9.2 t -84.17 -2.63 57.18 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 178.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.34 0.188 0 O-C-N 124.894 1.371 . . . . 0.0 113.167 -179.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.571 ' HA3' ' HA ' ' A' ' 58' ' ' ASP . . . . . . . . 0 N--CA 1.442 -0.907 0 N-CA-C 111.52 -0.632 . . . . 0.0 111.52 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -76.45 131.67 12.86 Favored 'Trans proline' 0 N--CA 1.45 -1.034 0 C-N-CA 121.776 1.651 . . . . 0.0 111.031 173.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 19.8 p90 -98.39 -169.54 1.82 Allowed 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.73 -173.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.424 ' HB ' ' OE1' ' A' ' 16' ' ' GLN . 0.2 OUTLIER -122.82 156.51 34.4 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.401 179.425 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 32.1 ttt85 -56.4 -46.19 80.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.331 0.586 . . . . 0.0 110.477 178.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 26.2 ttm180 -53.07 -59.29 4.73 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.981 -1.008 . . . . 0.0 110.842 176.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.629 ' O ' HG23 ' A' ' 20' ' ' VAL . 15.9 mp0 -57.4 -44.09 84.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.456 -179.19 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.482 ' HB1' HD11 ' A' ' 39' ' ' LEU . . . -53.54 -45.83 69.96 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 121.248 0.547 . . . . 0.0 111.114 179.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -59.91 -36.84 77.83 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.912 179.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.74 -24.43 64.45 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.017 177.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.629 HG23 ' O ' ' A' ' 16' ' ' GLN . 2.9 t -83.97 -18.68 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 -178.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.623 HG23 ' HB ' ' A' ' 27' ' ' ILE . 0.0 OUTLIER -90.89 -32.15 16.13 Favored 'General case' 0 CA--C 1.506 -0.734 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 177.581 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 76.4 m -56.65 -34.42 67.31 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 113.623 -1.626 . . . . 0.0 109.46 168.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.583 HG23 HH11 ' A' ' 73' ' ' ARG . 59.8 m -87.51 -49.31 7.28 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.399 -0.818 . . . . 0.0 111.684 177.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.658 ' HB3' ' OD1' ' A' ' 26' ' ' ASN . 63.7 m-85 -118.71 109.7 16.41 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 121.018 0.437 . . . . 0.0 110.352 -178.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 11.8 p -78.72 0.59 26.12 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.663 -177.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.658 ' OD1' ' HB3' ' A' ' 24' ' ' TYR . 25.0 p-10 -82.76 -19.79 37.17 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 175.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.623 ' HB ' HG23 ' A' ' 21' ' ' THR . 1.1 mt -77.68 151.32 5.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 177.155 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.562 ' OG1' ' HB ' ' A' ' 40' ' ' VAL . 19.7 p -138.33 128.08 25.15 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.904 0.383 . . . . 0.0 111.119 179.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.533 ' HA ' HD23 ' A' ' 39' ' ' LEU . 6.5 tt -86.63 103.24 14.92 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 175.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.421 ' O ' ' HB3' ' A' ' 31' ' ' ASP . 53.2 mt-10 -121.74 174.12 7.03 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.929 -176.214 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.421 ' HB3' ' O ' ' A' ' 30' ' ' GLU . 12.4 t70 77.48 -62.9 0.37 Allowed 'General case' 0 N--CA 1.466 0.341 0 O-C-N 124.28 0.987 . . . . 0.0 110.242 -176.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.517 ' HA ' ' HB3' ' A' ' 37' ' ' PHE . 54.1 t0 38.7 78.56 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.554 -1.203 . . . . 0.0 112.99 -177.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -105.01 37.01 2.27 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 170.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.2 -102.13 2.75 Favored Glycine 0 N--CA 1.448 -0.558 0 CA-C-N 115.142 -0.936 . . . . 0.0 112.126 179.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.3 m -82.84 -15.05 53.07 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.229 0.538 . . . . 0.0 110.547 177.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 55.6 m170 -108.33 109.51 20.85 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.901 177.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.517 ' HB3' ' HA ' ' A' ' 32' ' ' ASP . 53.3 p90 -152.92 169.45 22.81 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 177.133 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.471 ' HA ' ' HA ' ' A' ' 53' ' ' TRP . 25.6 ptt-85 -128.45 147.98 50.69 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.181 -0.608 . . . . 0.0 111.556 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.537 ' HA ' ' O ' ' A' ' 28' ' ' THR . 90.5 mt -107.0 117.66 34.65 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.403 173.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.562 ' HB ' ' OG1' ' A' ' 28' ' ' THR . 53.0 t -95.11 119.02 42.6 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.135 178.34 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.476 ' HB ' ' HB3' ' A' ' 50' ' ' TRP . 61.4 t -88.79 110.88 21.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 121.106 0.479 . . . . 0.0 109.888 177.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.432 ' HA ' ' O ' ' A' ' 47' ' ' ARG . 33.4 mtm180 -98.77 176.66 5.54 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.214 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -94.76 -171.14 2.39 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 173.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.1 t -60.76 -24.08 65.48 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.64 -176.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -91.59 -31.59 15.84 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.924 0.393 . . . . 0.0 110.663 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 120.73 10.36 7.07 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.929 -177.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.432 ' O ' ' HA ' ' A' ' 42' ' ' ARG . 28.9 mmm180 -74.54 133.59 42.26 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 177.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.448 ' SD ' HG11 ' A' ' 40' ' ' VAL . 50.8 mtt -79.96 104.06 10.27 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.065 0.46 . . . . 0.0 110.622 -174.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 35.0 t -90.18 -31.62 5.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.339 -177.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.476 ' HB3' ' HB ' ' A' ' 41' ' ' VAL . 76.6 t-105 -151.65 161.12 43.2 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.774 -176.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 4.3 ptp180 -159.24 132.81 7.29 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 176.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -138.62 141.72 39.12 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.698 -0.228 . . . . 0.0 110.742 -178.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.596 ' HB2' ' HG3' ' A' ' 56' ' ' GLU . 84.1 m95 -83.44 -166.05 1.27 Allowed 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 121.54 0.686 . . . . 0.0 110.226 178.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.422 HD22 ' C ' ' A' ' 54' ' ' ASN . 0.2 OUTLIER -99.51 -33.05 10.82 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.86 -178.501 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -88.98 10.17 22.45 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.893 -173.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.596 ' HG3' ' HB2' ' A' ' 53' ' ' TRP . 26.5 mt-10 -82.29 131.89 54.62 Favored Pre-proline 0 C--N 1.325 -0.489 0 C-N-CA 120.971 -0.292 . . . . 0.0 110.976 -177.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_exo -36.17 -53.71 0.95 Allowed 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 124.816 3.677 . . . . 0.0 114.109 -173.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.571 ' HA ' ' HA3' ' A' ' 10' ' ' GLY . 3.3 t70 -137.37 67.02 1.44 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.104 0.478 . . . . 0.0 110.129 174.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.0 -33.76 65.17 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.201 176.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -61.4 -33.74 85.74 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 121.223 -0.513 . . . . 0.0 113.284 -178.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -64.61 -34.97 79.51 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.586 0.232 . . . . 0.0 110.944 -178.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -69.84 -45.74 56.34 Favored Glycine 0 C--O 1.236 0.25 0 C-N-CA 120.396 -0.907 . . . . 0.0 111.201 178.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 43.3 mt -61.97 -43.44 98.84 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.381 -0.41 . . . . 0.0 109.932 177.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -61.26 -38.33 86.32 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.073 177.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 23.3 tpt85 -56.09 -38.95 71.41 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.356 177.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.503 ' O ' HG22 ' A' ' 69' ' ' THR . 46.2 t80 -79.04 -49.42 12.71 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.229 177.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 94.6 mt -56.51 -30.5 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -177.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.431 HH11 ' HD2' ' A' ' 68' ' ' ARG . 33.2 ttm180 -59.0 -30.27 67.87 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.433 -179.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.503 HG22 ' O ' ' A' ' 66' ' ' TYR . 10.0 t -91.84 62.35 4.33 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 122.003 0.906 . . . . 0.0 110.058 179.141 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.405 ' HB3' ' O ' ' A' ' 69' ' ' THR . 25.3 t 84.35 -37.41 0.06 Allowed 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 114.363 -1.29 . . . . 0.0 112.718 167.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 76.59 164.35 18.83 Favored Glycine 0 CA--C 1.522 0.526 0 C-N-CA 120.285 -0.96 . . . . 0.0 111.977 -174.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.483 ' O ' HG22 ' A' ' 72' ' ' ILE . 46.2 mm -101.07 6.0 10.0 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-O 121.79 0.805 . . . . 0.0 111.025 -175.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.583 HH11 HG23 ' A' ' 23' ' ' THR . 21.2 ttt180 -71.35 -29.82 65.43 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 121.257 -0.902 . . . . 0.0 110.881 178.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 2.9 m -79.1 11.69 2.65 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.109 178.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 12.1 t70 . . . . . 0 C--O 1.233 0.231 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.028 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.427 ' HA3' ' HD3' ' A' ' 11' ' ' PRO . . . . . . . . 0 CA--C 1.519 0.332 0 CA-C-O 119.936 -0.369 . . . . 0.0 112.94 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.442 ' HG3' ' HA ' ' A' ' 57' ' ' PRO . 16.5 Cg_exo -66.65 142.13 63.01 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.655 2.236 . . . . 0.0 111.812 175.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.439 ' HE1' ' HB1' ' A' ' 59' ' ' ALA . 42.9 p90 -112.39 151.46 29.78 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.707 0.765 . . . . 0.0 112.521 -174.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.654 ' HB ' ' HG2' ' A' ' 16' ' ' GLN . 0.3 OUTLIER -76.94 156.34 32.07 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 114.422 -1.263 . . . . 0.0 110.788 178.66 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 25.8 ttt180 -61.32 -46.73 89.05 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.796 0.331 . . . . 0.0 110.578 -178.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 84.3 mtt-85 -61.29 -36.75 80.94 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.368 176.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.654 ' HG2' ' HB ' ' A' ' 13' ' ' THR . 76.3 mm-40 -61.75 -48.84 78.91 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 178.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.499 ' HB1' HD21 ' A' ' 39' ' ' LEU . . . -53.58 -44.12 69.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.943 178.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.407 ' HA ' ' OE1' ' A' ' 18' ' ' GLN . 14.7 mm-40 -58.82 -38.05 77.78 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.778 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.43 ' HA ' HG22 ' A' ' 22' ' ' THR . . . -72.68 -25.28 61.2 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.448 -178.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.618 HG23 ' O ' ' A' ' 16' ' ' GLN . 10.6 t -87.18 -30.07 5.75 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.96 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 -173.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 23.4 m -79.51 -32.3 42.35 Favored 'General case' 0 N--CA 1.435 -1.217 0 CA-C-N 113.478 -1.692 . . . . 0.0 110.935 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.43 HG22 ' HA ' ' A' ' 19' ' ' ALA . 6.5 t -73.33 -23.31 60.23 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 174.237 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 26.9 m -78.93 -57.23 3.85 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.368 171.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.603 ' HB2' HG13 ' A' ' 27' ' ' ILE . 38.5 m-85 -107.9 96.34 6.31 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 178.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 4.6 p -65.4 -5.16 6.83 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.516 -179.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.558 ' OD1' ' HB3' ' A' ' 24' ' ' TYR . 28.2 p-10 -79.02 -16.89 56.24 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 173.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.603 HG13 ' HB2' ' A' ' 24' ' ' TYR . 2.6 mt -80.24 150.71 4.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 171.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 6.6 p -143.91 124.71 14.21 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.003 178.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.558 ' HA ' HD23 ' A' ' 39' ' ' LEU . 5.8 tt -81.87 98.43 8.51 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 176.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -119.48 169.37 10.1 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.129 -0.942 . . . . 0.0 109.659 -174.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.0 t70 62.28 26.07 15.6 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.287 0.565 . . . . 0.0 109.982 176.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.563 ' HA ' ' HB3' ' A' ' 37' ' ' PHE . 17.8 t70 -68.28 119.9 13.57 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.152 -173.377 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -146.57 52.6 1.11 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.42 177.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.25 -101.56 2.22 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.462 177.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.9 m -91.43 -3.02 57.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.312 0.577 . . . . 0.0 110.367 178.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 47.8 m80 -115.84 108.09 15.86 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.739 177.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.563 ' HB3' ' HA ' ' A' ' 32' ' ' ASP . 53.5 p90 -160.94 160.81 31.27 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.036 178.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 68.3 mtm180 -134.03 138.01 45.09 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.26 0.552 . . . . 0.0 111.696 -178.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.558 HD23 ' HA ' ' A' ' 29' ' ' LEU . 91.1 mt -92.66 114.27 26.77 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.303 173.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 31.5 t -94.8 111.57 25.77 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.958 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.416 HG11 ' CD1' ' A' ' 66' ' ' TYR . 39.0 t -85.19 117.62 30.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 178.115 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.467 ' O ' ' HB2' ' A' ' 26' ' ' ASN . 63.2 mtp180 -110.35 161.45 15.63 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.258 -177.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.489 ' HB3' ' HG3' ' A' ' 47' ' ' ARG . 7.7 t70 -92.56 177.83 6.0 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.572 -177.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.427 ' N ' ' CG ' ' A' ' 43' ' ' ASP . 7.0 p -61.28 -22.36 64.78 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 122.59 0.356 . . . . 0.0 111.862 -177.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -88.84 -9.74 50.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.427 0.632 . . . . 0.0 109.967 178.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 93.79 4.62 63.42 Favored Glycine 0 N--CA 1.451 -0.305 0 CA-C-N 115.767 -0.652 . . . . 0.0 112.994 177.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.489 ' HG3' ' HB3' ' A' ' 43' ' ' ASP . 14.1 ptt180 -73.74 140.75 46.16 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 110.321 -0.252 . . . . 0.0 110.321 177.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 69.1 mtm -71.88 122.16 20.3 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 178.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 20.3 t -107.2 -29.84 2.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.611 -178.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.403 ' HB3' ' HB ' ' A' ' 41' ' ' VAL . 73.7 t-105 -157.99 151.54 23.57 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.573 -175.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 11.2 ptp180 -152.67 132.87 13.54 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 173.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -134.27 149.71 50.95 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.561 -0.291 . . . . 0.0 111.058 -178.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.884 ' HB2' ' HG3' ' A' ' 56' ' ' GLU . 86.5 m95 -75.74 -170.11 1.23 Allowed 'General case' 0 CA--C 1.514 -0.434 0 CA-C-O 121.905 0.859 . . . . 0.0 111.498 177.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -101.52 -37.76 8.27 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 114.223 -1.353 . . . . 0.0 110.74 178.144 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -88.02 3.69 47.88 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.052 -173.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.884 ' HG3' ' HB2' ' A' ' 53' ' ' TRP . 35.7 mt-10 -74.43 128.91 85.05 Favored Pre-proline 0 N--CA 1.452 -0.372 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.179 178.039 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.442 ' HA ' ' HG3' ' A' ' 11' ' ' PRO . 32.5 Cg_exo -59.25 -14.44 24.34 Favored 'Trans proline' 0 N--CA 1.475 0.414 0 C-N-CA 123.293 2.662 . . . . 0.0 113.668 -175.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -133.6 24.95 4.06 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.756 -0.202 . . . . 0.0 111.46 -177.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.599 ' HB2' ' HB2' ' A' ' 56' ' ' GLU . . . -58.66 -48.08 82.28 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.015 0.436 . . . . 0.0 111.209 -174.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -65.14 -28.51 73.63 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.926 -179.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -68.02 -40.79 82.89 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.623 0.249 . . . . 0.0 110.532 -177.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -66.99 -39.77 93.27 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.51 -0.852 . . . . 0.0 111.291 178.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.443 ' O ' HG13 ' A' ' 67' ' ' ILE . 68.9 mt -63.91 -48.85 74.95 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.387 -0.407 . . . . 0.0 110.779 177.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.506 ' O ' ' HG3' ' A' ' 68' ' ' ARG . 96.0 m-20 -61.55 -36.71 81.37 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.748 0.309 . . . . 0.0 110.66 178.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.418 HH11 ' HD2' ' A' ' 65' ' ' ARG . 20.4 ttt85 -53.59 -42.2 67.37 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.499 176.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.416 ' CD1' HG11 ' A' ' 41' ' ' VAL . 43.3 t80 -72.57 -50.5 25.1 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.382 175.207 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.443 HG13 ' O ' ' A' ' 63' ' ' LEU . 97.1 mt -48.38 -47.67 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 -176.116 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.506 ' HG3' ' O ' ' A' ' 64' ' ' ASN . 15.5 mtp180 -56.78 -54.08 50.48 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -173.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.6 t -90.96 10.97 24.34 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 120.691 -0.404 . . . . 0.0 111.175 -174.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 17.1 m -120.44 -61.83 1.53 Allowed 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.208 -0.597 . . . . 0.0 111.12 177.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 43.55 74.48 0.2 Allowed Glycine 0 CA--C 1.525 0.701 0 CA-C-N 115.281 -0.872 . . . . 0.0 113.41 -173.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.465 ' O ' HG22 ' A' ' 72' ' ' ILE . 30.2 mm -89.2 6.9 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-O 121.355 0.597 . . . . 0.0 110.973 -174.306 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 35.0 ptt180 -64.2 -35.03 79.47 Favored 'General case' 0 C--N 1.329 -0.298 0 O-C-N 122.068 -0.395 . . . . 0.0 111.814 -175.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 15.3 t -77.65 -5.6 50.93 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 177.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 17.6 t0 . . . . . 0 CA--C 1.518 -0.266 0 CA-C-O 122.299 1.047 . . . . 0.0 111.679 -172.992 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.48 ' HA2' ' HA ' ' A' ' 58' ' ' ASP . . . . . . . . 0 CA--C 1.519 0.293 0 CA-C-O 120.132 -0.26 . . . . 0.0 112.979 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.453 ' HD3' ' HA3' ' A' ' 10' ' ' GLY . 6.1 Cg_exo -72.03 162.23 42.44 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.597 2.198 . . . . 0.0 111.2 178.36 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -123.75 151.54 43.13 Favored 'General case' 0 CA--C 1.505 -0.783 0 CA-C-O 121.756 0.789 . . . . 0.0 112.096 -176.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -91.8 165.64 13.16 Favored 'General case' 0 N--CA 1.433 -1.275 0 CA-C-N 113.993 -1.458 . . . . 0.0 109.431 176.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.401 ' O ' ' HG3' ' A' ' 18' ' ' GLN . 47.8 ttt180 -61.97 -51.04 69.68 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-O 120.737 0.303 . . . . 0.0 110.693 -177.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 37.2 ttp180 -54.4 -40.17 67.98 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.481 177.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.609 ' O ' HG23 ' A' ' 20' ' ' VAL . 85.6 mm-40 -62.97 -47.86 81.36 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.305 177.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.71 -42.88 84.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.301 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.401 ' HG3' ' O ' ' A' ' 14' ' ' ARG . 24.4 mt-30 -61.04 -44.4 97.46 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.856 -178.506 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.1 -37.8 86.48 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.195 0.521 . . . . 0.0 111.202 -179.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.609 HG23 ' O ' ' A' ' 16' ' ' GLN . 10.2 t -77.8 -22.87 13.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.405 -175.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.474 HG23 ' HB ' ' A' ' 27' ' ' ILE . 0.0 OUTLIER -83.35 -33.23 25.89 Favored 'General case' 0 CA--C 1.516 -0.362 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.481 176.168 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.3 p -68.04 -19.68 64.91 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 174.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 11.3 m -89.74 -53.46 4.5 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.211 171.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.618 ' O ' HG13 ' A' ' 27' ' ' ILE . 47.3 m-85 -113.92 102.26 10.04 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 177.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 11.6 p -80.78 5.0 17.16 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.96 0.41 . . . . 0.0 111.469 -178.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.525 ' OD1' ' HB3' ' A' ' 24' ' ' TYR . 25.7 p-10 -82.34 -21.64 35.9 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 171.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.618 HG13 ' O ' ' A' ' 24' ' ' TYR . 1.0 OUTLIER -74.69 147.46 8.63 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 170.991 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.479 ' O ' ' HA ' ' A' ' 39' ' ' LEU . 2.5 p -142.05 134.51 28.06 Favored 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 120.571 -0.452 . . . . 0.0 110.881 -176.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.591 HD22 ' HB3' ' A' ' 32' ' ' ASP . 1.5 tt -90.29 97.17 11.03 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.67 0.747 . . . . 0.0 109.367 -179.087 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.478 ' HB2' ' HG3' ' A' ' 38' ' ' ARG . 14.5 mm-40 -104.05 161.96 13.56 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 114.482 -1.236 . . . . 0.0 109.481 -174.313 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.482 ' HB2' ' HG2' ' A' ' 38' ' ' ARG . 1.0 OUTLIER 56.25 30.72 17.16 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 123.541 0.526 . . . . 0.0 111.692 179.411 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.591 ' HB3' HD22 ' A' ' 29' ' ' LEU . 16.2 p-10 -71.35 90.58 0.95 Allowed 'General case' 0 N--CA 1.446 -0.674 0 CA-C-O 122.045 0.926 . . . . 0.0 111.385 -176.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 14.4 tm0? -111.77 -15.49 13.39 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.649 -1.16 . . . . 0.0 109.442 178.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 113.41 -79.02 0.26 Allowed Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.468 -175.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 11.7 m -63.17 -33.0 74.52 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.442 0.639 . . . . 0.0 109.732 175.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 68.2 m170 -115.61 141.62 47.82 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.929 173.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 55.6 p90 -176.31 145.13 0.58 Allowed 'General case' 0 C--N 1.326 -0.432 0 O-C-N 124.077 0.861 . . . . 0.0 109.318 169.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.482 ' HG2' ' HB2' ' A' ' 31' ' ' ASP . 16.1 ptt180 -132.75 150.2 52.19 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.87 0.367 . . . . 0.0 111.145 -178.244 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.479 ' HA ' ' O ' ' A' ' 28' ' ' THR . 84.0 mt -103.31 115.75 31.15 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 174.123 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.473 HG22 ' HB3' ' A' ' 51' ' ' ARG . 48.6 t -99.33 115.39 39.94 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.836 177.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.476 HG11 ' CD1' ' A' ' 66' ' ' TYR . 50.2 t -82.92 104.64 11.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 175.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.487 ' O ' ' HB2' ' A' ' 26' ' ' ASN . 50.3 mtt180 -102.16 163.74 12.07 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.592 0.711 . . . . 0.0 111.27 -177.38 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.702 ' HB3' ' HB2' ' A' ' 47' ' ' ARG . 4.3 t70 -89.45 176.08 7.05 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 114.514 -1.221 . . . . 0.0 109.444 177.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.414 ' N ' ' CG ' ' A' ' 43' ' ' ASP . 0.3 OUTLIER -67.35 -18.99 65.37 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 120.855 0.36 . . . . 0.0 111.298 -174.741 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -93.37 -0.2 56.65 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 121.46 0.647 . . . . 0.0 110.044 175.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 89.14 8.46 68.76 Favored Glycine 0 N--CA 1.452 -0.275 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.431 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.702 ' HB2' ' HB3' ' A' ' 43' ' ' ASP . 39.4 mtt180 -61.03 132.97 55.53 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 122.278 0.231 . . . . 0.0 110.775 177.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 10.0 mmt -75.65 97.36 3.78 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.2 t -84.45 -38.83 13.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.033 0.444 . . . . 0.0 110.551 -175.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 69.8 t-105 -166.17 153.8 10.16 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.711 -178.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.473 ' HB3' HG22 ' A' ' 40' ' ' VAL . 9.0 ptt180 -152.14 148.02 27.14 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.034 0.445 . . . . 0.0 111.14 177.025 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -148.79 143.09 26.13 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.17 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.468 ' H ' ' HG3' ' A' ' 56' ' ' GLU . 72.0 m95 -87.98 -171.34 3.36 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 122.208 1.004 . . . . 0.0 111.539 -178.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -82.28 -35.63 27.84 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 113.481 -1.69 . . . . 0.0 109.83 178.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 32.2 p90 -87.98 17.88 4.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.65 -178.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.586 ' HB2' ' HB2' ' A' ' 59' ' ' ALA . 11.8 mm-40 -85.23 116.75 66.83 Favored Pre-proline 0 C--N 1.327 -0.401 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 175.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.445 ' HD2' ' HA ' ' A' ' 56' ' ' GLU . 3.6 Cg_endo -46.34 -39.92 21.95 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 124.269 3.312 . . . . 0.0 114.163 -172.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.48 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . 4.6 t0 -138.1 55.89 1.75 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.088 0.47 . . . . 0.0 110.14 178.324 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.586 ' HB2' ' HB2' ' A' ' 56' ' ' GLU . . . -56.4 -39.89 73.76 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.277 -179.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -59.45 -33.0 74.37 Favored Glycine 0 N--CA 1.45 -0.387 0 CA-C-N 115.384 -0.825 . . . . 0.0 114.071 -177.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.468 ' HB2' ' OD1' ' A' ' 58' ' ' ASP . 35.7 tt0 -62.52 -43.07 99.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 117.608 0.704 . . . . 0.0 110.96 -176.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -73.28 -41.2 47.01 Favored Glycine 0 C--O 1.237 0.288 0 C-N-CA 120.539 -0.838 . . . . 0.0 111.557 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 72.6 mt -64.73 -51.97 59.56 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.547 -0.326 . . . . 0.0 110.851 -179.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.452 ' HA ' ' HB ' ' A' ' 67' ' ' ILE . 93.2 m-20 -60.56 -32.64 71.71 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.608 0.242 . . . . 0.0 111.006 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 11.2 tpt180 -55.45 -50.75 69.03 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.262 176.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.476 ' CD1' HG11 ' A' ' 41' ' ' VAL . 38.9 t80 -72.53 -43.27 63.75 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.447 179.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.538 HG23 ' CZ ' ' A' ' 24' ' ' TYR . 59.9 mt -49.61 -44.84 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-N 115.617 -0.72 . . . . 0.0 112.262 -178.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 61.9 ttt180 -68.37 -53.77 21.73 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -175.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 8.8 t -76.34 -35.65 58.65 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 112.37 0.508 . . . . 0.0 112.37 -169.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 25.1 m -90.21 -50.84 5.75 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.69 -177.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 48.25 85.14 0.02 OUTLIER Glycine 0 CA--C 1.525 0.667 0 CA-C-N 115.515 -0.766 . . . . 0.0 114.632 179.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.516 HG21 ' HB3' ' A' ' 26' ' ' ASN . 1.8 mp -80.74 5.37 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 CA-C-O 122.369 1.08 . . . . 0.0 109.63 177.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.499 ' HB3' ' CE2' ' A' ' 24' ' ' TYR . 52.3 ptt85 -57.89 -16.92 13.58 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 114.833 -1.076 . . . . 0.0 112.036 178.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 7.2 t -75.26 9.26 2.16 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.272 0.558 . . . . 0.0 109.961 176.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.8 t70 . . . . . 0 N--CA 1.467 0.408 0 CA-C-N 114.886 -1.052 . . . . 0.0 112.543 169.095 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.525 ' HA3' ' O ' ' A' ' 57' ' ' PRO . . . . . . . . 0 N--CA 1.441 -0.998 0 N-CA-C 110.991 -0.844 . . . . 0.0 110.991 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -75.7 130.39 12.54 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 121.623 1.548 . . . . 0.0 110.958 172.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -102.58 -178.46 3.69 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 121.806 0.812 . . . . 0.0 111.923 -172.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.98 151.49 32.28 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 114.705 -1.134 . . . . 0.0 108.988 176.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.544 ' O ' ' HG3' ' A' ' 18' ' ' GLN . 43.7 ttt-85 -59.36 -48.98 79.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.033 0.444 . . . . 0.0 109.944 -178.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 72.5 mtp85 -56.7 -45.69 81.66 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.241 177.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.519 ' O ' HG23 ' A' ' 20' ' ' VAL . 12.4 mm100 -63.31 -39.87 95.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.489 179.255 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.456 ' HB1' HD21 ' A' ' 39' ' ' LEU . . . -62.06 -43.38 98.96 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.685 177.03 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.544 ' HG3' ' O ' ' A' ' 14' ' ' ARG . 28.0 mt-30 -51.71 -44.37 63.16 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.022 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.79 -27.04 68.91 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.107 -179.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.519 HG23 ' O ' ' A' ' 16' ' ' GLN . 14.1 t -92.46 -16.13 7.92 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.752 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 -172.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 12.0 m -93.31 -31.42 14.69 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-N 113.972 -1.467 . . . . 0.0 107.588 -176.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 99.0 m -61.65 -38.1 86.46 Favored 'General case' 0 N--CA 1.436 -1.175 0 CA-C-N 113.628 -1.624 . . . . 0.0 109.299 166.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.575 HG23 ' HE ' ' A' ' 73' ' ' ARG . 36.7 m -75.03 -53.86 8.18 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.992 177.139 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.67 ' O ' HG13 ' A' ' 27' ' ' ILE . 89.9 m-85 -117.45 96.88 5.6 Favored 'General case' 0 N--CA 1.44 -0.975 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 178.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 48.3 m -76.12 5.72 6.37 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.865 0.364 . . . . 0.0 111.506 -177.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.563 ' ND2' ' HB3' ' A' ' 24' ' ' TYR . 0.1 OUTLIER -76.84 -16.43 59.42 Favored 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 108.598 -0.889 . . . . 0.0 108.598 167.803 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.67 HG13 ' O ' ' A' ' 24' ' ' TYR . 2.2 mt -84.4 151.45 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 171.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.564 ' OG1' ' HB ' ' A' ' 40' ' ' VAL . 11.1 p -138.14 117.41 12.73 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 119.954 -0.698 . . . . 0.0 111.068 178.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.593 ' HA ' HD23 ' A' ' 39' ' ' LEU . 4.8 tt -83.23 99.03 9.71 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 174.239 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.532 ' HG2' ' HB ' ' A' ' 28' ' ' THR . 74.2 mm-40 -132.9 -173.55 3.22 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.957 -173.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.7 t70 69.53 17.25 8.01 Favored 'General case' 0 CA--C 1.531 0.214 0 O-C-N 124.072 0.857 . . . . 0.0 110.505 177.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -57.59 95.54 0.02 OUTLIER 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.659 178.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -122.79 10.11 9.56 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.206 0.527 . . . . 0.0 110.206 -178.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 119.31 -88.98 0.45 Allowed Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.583 178.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 9.8 t -89.36 -17.04 29.63 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 120.702 0.286 . . . . 0.0 110.569 -176.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 30.1 p80 -124.41 145.79 49.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.153 0.501 . . . . 0.0 111.424 178.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -166.67 167.91 14.87 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.298 -1.319 . . . . 0.0 107.608 174.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.429 ' HB3' ' HA ' ' A' ' 53' ' ' TRP . 30.9 ptt180 -153.0 156.29 38.54 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.115 0.484 . . . . 0.0 112.076 -175.285 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.593 HD23 ' HA ' ' A' ' 29' ' ' LEU . 89.2 mt -102.03 117.95 35.89 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.961 178.22 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.564 ' HB ' ' OG1' ' A' ' 28' ' ' THR . 37.7 t -100.89 113.91 38.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 116.278 -0.419 . . . . 0.0 109.983 178.54 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 46.5 t -90.04 122.4 41.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.022 0.439 . . . . 0.0 110.051 178.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 57.9 mtp180 -105.06 163.88 12.22 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.476 -178.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -88.66 -171.74 3.45 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 177.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.1 p -62.31 -22.26 65.92 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.918 -176.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -91.71 -31.46 15.8 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.891 0.377 . . . . 0.0 110.54 179.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 119.6 10.0 8.08 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.418 -0.896 . . . . 0.0 112.541 -177.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 92.4 mtt180 -82.57 127.56 33.47 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 177.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.13 118.62 10.13 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.264 0.554 . . . . 0.0 110.785 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 41.9 t -97.23 -35.78 5.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.07 -179.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 68.8 t-105 -158.14 119.32 3.49 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.177 -178.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.473 ' HB3' HG13 ' A' ' 40' ' ' VAL . 36.4 ptt180 -112.68 129.02 56.54 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.817 174.089 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -122.76 142.09 51.1 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.555 -177.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.547 ' HB2' ' HG3' ' A' ' 56' ' ' GLU . 95.0 m95 -79.36 -169.13 1.76 Allowed 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 121.709 0.766 . . . . 0.0 110.923 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -101.32 -30.41 11.5 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 114.701 -1.136 . . . . 0.0 110.932 -176.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 40.6 p90 -90.29 3.69 52.89 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.557 -174.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.547 ' HG3' ' HB2' ' A' ' 53' ' ' TRP . 40.0 mt-10 -75.42 132.51 75.72 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 120.752 0.31 . . . . 0.0 110.275 179.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.525 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 39.8 Cg_endo -66.5 -11.65 32.54 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 123.225 2.617 . . . . 0.0 113.394 -173.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -137.57 28.39 2.72 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.648 -0.251 . . . . 0.0 110.561 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.563 ' O ' ' HG ' ' A' ' 63' ' ' LEU . . . -53.03 -49.61 65.93 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.847 -176.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -69.82 -30.45 70.39 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.653 -178.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -70.53 -34.06 71.85 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.841 0.321 . . . . 0.0 110.279 -175.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.484 ' O ' ' HB3' ' A' ' 65' ' ' ARG . . . -74.24 -39.22 44.67 Favored Glycine 0 C--O 1.238 0.354 0 C-N-CA 120.382 -0.913 . . . . 0.0 111.583 177.158 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.563 ' HG ' ' O ' ' A' ' 59' ' ' ALA . 70.2 mt -67.51 -45.31 76.15 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.539 -0.33 . . . . 0.0 110.513 178.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -61.25 -32.34 72.14 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.557 176.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.484 ' HB3' ' O ' ' A' ' 62' ' ' GLY . 0.4 OUTLIER -57.32 -44.83 84.53 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.301 -0.409 . . . . 0.0 109.922 175.473 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 14.1 t80 -67.11 -53.19 33.16 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.079 176.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 97.3 mt -50.92 -51.37 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.847 -178.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 45.9 ttm105 -55.99 -32.41 63.92 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.274 -173.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 5.1 t -111.38 15.01 21.53 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.449 -0.501 . . . . 0.0 111.705 -174.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 16.2 m -134.66 -54.98 0.83 Allowed 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.849 -0.341 . . . . 0.0 111.15 -179.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.52 ' HA2' ' CE1' ' A' ' 24' ' ' TYR . . . 47.15 75.82 0.17 Allowed Glycine 0 CA--C 1.527 0.812 0 CA-C-N 115.552 -0.749 . . . . 0.0 114.114 -177.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.473 HG21 ' HB3' ' A' ' 26' ' ' ASN . 1.8 mp -72.94 -20.65 19.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-N 117.132 0.466 . . . . 0.0 111.912 -174.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.575 ' HE ' HG23 ' A' ' 23' ' ' THR . 0.0 OUTLIER -57.78 -65.39 0.64 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.237 0.541 . . . . 0.0 111.525 -178.403 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 2.8 t -72.6 -0.8 13.91 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.355 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 35.0 t70 . . . . . 0 N--CA 1.47 0.53 0 CA-C-N 113.719 -1.582 . . . . 0.0 112.644 174.026 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.56 ' HA2' ' HA ' ' A' ' 58' ' ' ASP . . . . . . . . 0 CA--C 1.52 0.358 0 N-CA-C 114.584 0.594 . . . . 0.0 114.584 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.466 ' HD3' ' HA3' ' A' ' 10' ' ' GLY . 6.6 Cg_exo -72.16 144.2 41.53 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 123.159 2.573 . . . . 0.0 112.515 -177.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -112.12 -173.3 2.22 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.143 -178.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.447 ' OG1' ' HG2' ' A' ' 16' ' ' GLN . 28.8 p -125.07 176.31 6.77 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 175.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.412 HH11 ' HD2' ' A' ' 14' ' ' ARG . 22.8 ttt180 -61.67 -46.7 88.6 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.488 0.661 . . . . 0.0 109.489 175.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 36.1 mmt180 -55.02 -48.79 72.91 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.558 -1.201 . . . . 0.0 110.675 178.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.61 ' O ' HG23 ' A' ' 20' ' ' VAL . 15.7 mm100 -62.7 -49.15 76.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.211 178.193 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -52.76 -49.26 65.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.684 179.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.405 ' HG2' ' O ' ' A' ' 14' ' ' ARG . 15.2 mm100 -55.65 -41.82 74.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.312 -179.37 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.44 -29.11 70.45 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.982 -179.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.61 HG23 ' O ' ' A' ' 16' ' ' GLN . 3.3 t -91.33 -26.05 5.17 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.958 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 -171.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 16.2 m -79.55 -32.97 42.2 Favored 'General case' 0 N--CA 1.437 -1.117 0 CA-C-N 113.95 -1.477 . . . . 0.0 110.655 179.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.8 p -73.54 -26.08 60.69 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 121.082 0.467 . . . . 0.0 109.742 172.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.534 HG23 ' HD2' ' A' ' 73' ' ' ARG . 89.8 m -76.2 -55.09 5.9 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.783 172.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.606 ' O ' HG13 ' A' ' 27' ' ' ILE . 70.1 m-85 -116.63 101.53 8.68 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 175.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 45.0 m -82.16 17.39 1.65 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.207 0.527 . . . . 0.0 111.747 -176.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.547 ' OD1' ' HB3' ' A' ' 24' ' ' TYR . 25.1 p-10 -87.91 -20.37 26.04 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 167.238 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.606 HG13 ' O ' ' A' ' 24' ' ' TYR . 2.4 mt -73.57 146.92 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 171.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -149.46 130.3 14.23 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 120.225 -0.59 . . . . 0.0 111.566 -179.094 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.528 ' HA ' HD23 ' A' ' 39' ' ' LEU . 5.9 tt -79.3 103.12 9.01 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.229 178.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -112.76 166.41 11.39 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.497 -176.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.6 t70 66.39 46.37 1.96 Allowed 'General case' 0 N--CA 1.465 0.304 0 O-C-N 123.65 0.594 . . . . 0.0 110.542 176.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -64.95 99.93 0.38 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.454 -179.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 21.8 tt0 -129.63 57.56 1.67 Allowed 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.494 0.664 . . . . 0.0 109.422 175.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 74.52 -112.81 3.85 Favored Glycine 0 N--CA 1.45 -0.372 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.741 -178.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 30.2 t -87.67 -1.5 57.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.092 0.472 . . . . 0.0 110.119 177.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -101.44 124.85 47.77 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 176.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -173.8 170.49 3.94 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 178.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 30.1 ptt-85 -145.18 145.39 31.33 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.217 0.532 . . . . 0.0 111.433 178.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.528 HD23 ' HA ' ' A' ' 29' ' ' LEU . 93.9 mt -90.67 110.75 21.91 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.284 177.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 84.2 t -89.93 115.05 28.72 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.049 173.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.5 t -91.82 108.73 20.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.453 ' O ' ' HB2' ' A' ' 26' ' ' ASN . 60.3 mtt85 -95.93 170.21 9.45 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.868 -178.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.438 ' CG ' ' H ' ' A' ' 45' ' ' GLU . 1.2 p-10 -96.65 -171.19 2.21 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.974 0.416 . . . . 0.0 110.002 179.54 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.46 -19.99 66.17 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.687 -176.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.438 ' H ' ' CG ' ' A' ' 43' ' ' ASP . 9.5 tp10 -91.08 -28.67 17.78 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.24 0.543 . . . . 0.0 109.944 177.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 114.18 12.19 11.28 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.798 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.445 ' O ' ' HA ' ' A' ' 42' ' ' ARG . 40.5 mtt-85 -80.33 137.67 36.61 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -76.72 96.87 4.32 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.42 0.629 . . . . 0.0 110.599 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 15.8 t -83.54 -31.27 8.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.523 -177.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.442 ' CD1' HD23 ' A' ' 63' ' ' LEU . 75.4 t-105 -150.38 159.15 44.67 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.261 -177.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 27.5 ptt-85 -158.4 131.4 7.3 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 178.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -140.94 140.75 34.49 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 110.463 -0.199 . . . . 0.0 110.463 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.635 ' HB2' ' HG3' ' A' ' 56' ' ' GLU . 72.4 m95 -77.27 -173.89 3.02 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-O 121.764 0.793 . . . . 0.0 110.752 -179.177 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -94.18 -26.37 16.71 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 114.254 -1.339 . . . . 0.0 109.837 -178.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -98.33 6.16 47.58 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.802 -174.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.635 ' HG3' ' HB2' ' A' ' 53' ' ' TRP . 38.2 mt-10 -76.45 129.97 78.37 Favored Pre-proline 0 C--N 1.326 -0.43 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.195 178.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.428 ' HA ' ' HG3' ' A' ' 11' ' ' PRO . 31.7 Cg_exo -59.2 -20.07 52.99 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 123.431 2.754 . . . . 0.0 113.136 -175.155 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.56 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . 13.2 m-20 -133.6 37.92 3.28 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.541 179.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.407 ' O ' ' HG ' ' A' ' 63' ' ' LEU . . . -54.95 -50.18 69.54 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 120.925 0.393 . . . . 0.0 111.141 -178.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -63.33 -30.28 77.07 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.789 179.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.42 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 23.5 tp10 -60.79 -42.18 97.07 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.784 0.325 . . . . 0.0 110.367 -178.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.477 ' O ' ' HB3' ' A' ' 65' ' ' ARG . . . -77.05 -38.64 29.62 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.093 179.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.519 ' O ' HG13 ' A' ' 67' ' ' ILE . 85.5 mt -63.17 -52.76 61.08 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.723 0.297 . . . . 0.0 110.357 179.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -61.99 -32.13 72.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.632 178.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.477 ' HB3' ' O ' ' A' ' 62' ' ' GLY . 7.0 tpt85 -54.29 -46.74 72.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.669 177.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -74.86 -44.14 50.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.985 178.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.519 HG13 ' O ' ' A' ' 63' ' ' LEU . 89.5 mt -52.65 -44.57 46.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-O 120.897 0.379 . . . . 0.0 111.083 -179.119 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 23.6 ttt180 -58.83 -24.24 61.73 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.432 -0.803 . . . . 0.0 112.425 -176.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 11.3 t -118.1 22.21 12.33 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.402 0.62 . . . . 0.0 111.601 -175.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 29.2 p -144.91 -55.44 0.32 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.349 178.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 44.98 78.13 0.08 OUTLIER Glycine 0 CA--C 1.52 0.353 0 CA-C-N 115.325 -0.852 . . . . 0.0 113.333 -177.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.7 mp -72.46 -19.93 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-N 117.196 0.498 . . . . 0.0 111.642 -174.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.534 ' HD2' HG23 ' A' ' 23' ' ' THR . 72.2 ttt180 -64.33 -49.63 70.94 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-O 121.259 0.552 . . . . 0.0 111.273 -175.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 14.1 t -80.72 17.41 1.15 Allowed 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.247 -178.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.474 ' H ' ' C ' ' A' ' 73' ' ' ARG . 21.9 t70 . . . . . 0 C--O 1.231 0.122 0 CA-C-N 114.395 -1.275 . . . . 0.0 112.104 -178.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.537 ' HA2' ' HA ' ' A' ' 58' ' ' ASP . . . . . . . . 0 CA--C 1.519 0.301 0 CA-C-O 120.086 -0.286 . . . . 0.0 113.689 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -72.49 165.2 33.39 Favored 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 122.873 2.382 . . . . 0.0 111.82 179.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -132.74 169.58 16.49 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.741 0.781 . . . . 0.0 111.997 -176.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.5 m -112.85 166.86 10.99 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 114.441 -1.254 . . . . 0.0 110.048 -176.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 45.5 ttt-85 -62.36 -47.56 83.67 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.683 0.277 . . . . 0.0 110.877 -175.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.428 HH11 ' HD3' ' A' ' 15' ' ' ARG . 27.0 ttm-85 -53.08 -47.13 68.77 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.612 174.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.605 ' O ' HG23 ' A' ' 20' ' ' VAL . 77.6 mt-30 -59.98 -47.83 84.22 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.657 178.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.404 ' HB1' HD21 ' A' ' 39' ' ' LEU . . . -55.28 -47.98 74.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.165 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 56.9 mm-40 -59.25 -36.16 74.97 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.934 -179.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.1 -29.32 68.23 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.036 0.446 . . . . 0.0 111.415 -178.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.605 HG23 ' O ' ' A' ' 16' ' ' GLN . 11.1 t -89.83 -27.42 5.18 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.826 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 -172.068 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.477 HG23 ' HB ' ' A' ' 27' ' ' ILE . 15.6 m -83.64 -27.47 29.09 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-N 113.795 -1.548 . . . . 0.0 111.119 -179.273 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.2 p -73.4 -30.68 63.42 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 171.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 34.7 m -77.09 -47.03 21.59 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.275 173.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.636 ' HB2' HG13 ' A' ' 27' ' ' ILE . 40.0 m-85 -114.54 96.35 5.71 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 177.656 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 37.8 p -64.9 -7.61 12.09 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 111.906 0.335 . . . . 0.0 111.906 -179.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.586 ' OD1' ' HB3' ' A' ' 24' ' ' TYR . 5.4 p-10 -78.81 -11.49 59.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.999 0.428 . . . . 0.0 110.192 177.137 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.636 HG13 ' HB2' ' A' ' 24' ' ' TYR . 2.5 mt -83.08 146.59 6.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 174.21 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.525 ' OG1' ' HB ' ' A' ' 40' ' ' VAL . 10.3 p -133.12 120.23 20.98 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.398 -0.521 . . . . 0.0 110.786 -177.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.561 HD22 ' HB2' ' A' ' 32' ' ' ASP . 2.8 tt -88.36 105.15 17.39 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 -179.171 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.22 161.85 18.35 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.71 -176.242 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 61.26 30.56 19.24 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.032 -177.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.561 ' HB2' HD22 ' A' ' 29' ' ' LEU . 32.7 t0 -73.98 95.97 2.58 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.004 -178.194 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -115.29 1.96 13.9 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.564 178.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 119.88 -85.22 0.38 Allowed Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.463 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.1 t -89.32 -1.14 57.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.997 0.427 . . . . 0.0 110.496 -178.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 12.3 m170 -132.66 135.72 46.02 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 173.001 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.436 ' HB3' ' HA ' ' A' ' 32' ' ' ASP . 43.2 p90 -174.66 156.83 2.43 Favored 'General case' 0 C--O 1.234 0.285 0 O-C-N 123.858 0.724 . . . . 0.0 109.558 178.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 15.1 ptt180 -136.08 153.03 51.44 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.937 0.399 . . . . 0.0 111.513 176.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.526 HD23 ' HA ' ' A' ' 29' ' ' LEU . 71.5 mt -108.66 125.76 52.23 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.171 0.51 . . . . 0.0 110.558 177.049 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.525 ' HB ' ' OG1' ' A' ' 28' ' ' THR . 45.1 t -100.13 114.83 39.87 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.351 171.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 16.9 t -87.6 114.99 27.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.421 ' HA ' ' O ' ' A' ' 47' ' ' ARG . 3.8 mtt85 -101.24 160.87 14.04 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.398 0.618 . . . . 0.0 111.402 -176.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.421 ' CG ' ' N ' ' A' ' 44' ' ' THR . 4.1 t70 -91.57 178.23 5.99 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 114.487 -1.233 . . . . 0.0 109.979 -178.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.421 ' N ' ' CG ' ' A' ' 43' ' ' ASP . 19.1 p -59.01 -22.39 60.59 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 123.201 0.6 . . . . 0.0 111.718 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -92.63 -5.07 52.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.138 0.494 . . . . 0.0 110.536 178.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 89.29 9.49 67.11 Favored Glycine 0 N--CA 1.453 -0.173 0 C-N-CA 120.807 -0.711 . . . . 0.0 111.946 -177.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.421 ' O ' ' HA ' ' A' ' 42' ' ' ARG . 38.0 mtp180 -70.96 130.66 42.17 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 122.533 0.333 . . . . 0.0 110.364 179.359 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.15 90.52 2.54 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.599 0.714 . . . . 0.0 110.283 176.037 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 24.7 t -75.16 -38.45 41.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.621 -176.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 75.5 t-105 -150.14 152.61 34.98 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.248 -175.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 13.7 ptt-85 -150.14 137.19 19.46 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 177.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -145.97 146.54 31.06 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.407 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.463 ' HB2' ' HG3' ' A' ' 56' ' ' GLU . 96.5 m95 -80.44 -171.23 2.94 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-O 121.387 0.613 . . . . 0.0 109.587 175.199 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -99.81 -21.34 15.79 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.551 -176.226 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -100.46 11.73 38.81 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.58 -174.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.463 ' HG3' ' HB2' ' A' ' 53' ' ' TRP . 42.7 mt-10 -80.88 135.8 51.57 Favored Pre-proline 0 C--N 1.329 -0.308 0 C-N-CA 121.025 -0.27 . . . . 0.0 110.432 179.419 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -36.78 -47.23 1.39 Allowed 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 125.071 3.847 . . . . 0.0 114.31 -172.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.537 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . 4.2 t70 -144.58 63.35 1.31 Allowed 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 176.424 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.436 ' HB2' ' HB2' ' A' ' 56' ' ' GLU . . . -58.69 -31.55 68.33 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.041 179.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -61.7 -34.07 87.33 Favored Glycine 0 N--CA 1.447 -0.604 0 CA-C-N 115.582 -0.735 . . . . 0.0 113.56 -178.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.52 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 2.1 tm-20 -57.34 -50.47 72.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 117.074 0.437 . . . . 0.0 110.351 -177.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -67.56 -43.25 86.69 Favored Glycine 0 C--O 1.237 0.334 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.287 -177.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.458 ' O ' HG13 ' A' ' 67' ' ' ILE . 53.2 mt -60.34 -55.61 31.58 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 110.331 -0.248 . . . . 0.0 110.331 178.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.569 ' HA ' ' HB ' ' A' ' 67' ' ' ILE . 94.4 m-20 -62.69 -31.46 72.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.933 -179.02 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.52 ' HB2' ' O ' ' A' ' 61' ' ' GLU . 7.1 tpt180 -52.86 -46.06 67.68 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.362 0.601 . . . . 0.0 109.66 177.315 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 75.8 t80 -81.35 -41.82 21.44 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.986 178.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.569 ' HB ' ' HA ' ' A' ' 64' ' ' ASN . 95.2 mt -55.37 -48.88 76.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -178.415 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 59.9 ttt-85 -63.42 -48.98 75.56 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.376 -176.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 38.7 p -79.4 -41.12 28.44 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.035 -0.53 . . . . 0.0 112.179 -172.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.436 ' O ' HD12 ' A' ' 72' ' ' ILE . 3.3 m -127.85 20.19 6.53 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 112.681 0.622 . . . . 0.0 112.681 -166.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -48.33 134.24 19.15 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 121.346 -0.454 . . . . 0.0 113.927 178.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.478 ' HB ' ' OD1' ' A' ' 26' ' ' ASN . 2.5 mp -89.2 7.68 3.44 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 C-N-CA 123.258 0.623 . . . . 0.0 109.935 -176.722 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.633 ' HB3' ' CE1' ' A' ' 24' ' ' TYR . 30.7 ptt180 -48.79 -6.25 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 115.135 1.531 . . . . 0.0 115.135 -173.004 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.417 ' N ' ' O ' ' A' ' 72' ' ' ILE . 10.1 t -68.87 5.73 1.06 Allowed 'General case' 0 C--N 1.321 -0.641 0 O-C-N 122.017 -0.427 . . . . 0.0 110.223 173.491 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.422 ' H ' ' C ' ' A' ' 73' ' ' ARG . 12.5 p-10 . . . . . 0 N--CA 1.45 -0.473 0 CA-C-O 122.476 1.131 . . . . 0.0 109.52 176.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.464 ' HA2' ' HA ' ' A' ' 58' ' ' ASP . . . . . . . . 0 CA--C 1.518 0.251 0 CA-C-O 120.04 -0.311 . . . . 0.0 113.157 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.489 ' HD3' ' O ' ' A' ' 57' ' ' PRO . 19.4 Cg_exo -66.69 169.22 14.89 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.716 2.277 . . . . 0.0 111.856 176.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.488 ' CD2' ' HB2' ' A' ' 17' ' ' ALA . 41.2 p90 -140.33 165.27 27.86 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.189 -179.053 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.8 p -103.72 178.17 4.63 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.27 -178.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.563 ' HA ' ' CZ ' ' A' ' 37' ' ' PHE . 47.2 ttt180 -60.8 -54.85 40.19 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.212 178.22 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 57.9 mtt-85 -62.84 -37.31 86.3 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.683 -178.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.581 ' O ' HG23 ' A' ' 20' ' ' VAL . 77.5 mm-40 -62.97 -53.07 59.76 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.222 177.495 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.488 ' HB2' ' CD2' ' A' ' 12' ' ' PHE . . . -52.85 -44.27 66.66 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.492 178.156 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -58.8 -39.2 80.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.767 -178.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.02 -27.29 65.55 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-O 121.392 0.615 . . . . 0.0 110.945 179.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.581 HG23 ' O ' ' A' ' 16' ' ' GLN . 3.6 t -76.71 -25.71 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 -179.169 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.545 HG23 ' HB ' ' A' ' 27' ' ' ILE . 0.0 OUTLIER -80.61 -28.01 37.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.841 175.542 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.9 p -75.99 -14.52 60.23 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.434 0.635 . . . . 0.0 109.552 173.17 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 18.9 m -92.4 -50.18 5.77 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.753 170.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.587 ' HB3' ' OD1' ' A' ' 26' ' ' ASN . 48.3 m-85 -118.85 105.31 11.38 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 177.273 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 17.7 p -76.94 -1.76 30.23 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.079 0.466 . . . . 0.0 111.093 -179.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.587 ' OD1' ' HB3' ' A' ' 24' ' ' TYR . 6.1 p-10 -81.6 -9.84 59.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.649 175.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.584 HG13 ' O ' ' A' ' 24' ' ' TYR . 1.8 mt -86.03 155.62 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 174.235 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.517 ' OG1' ' HB ' ' A' ' 40' ' ' VAL . 1.2 p -142.35 123.27 14.42 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.888 0.375 . . . . 0.0 111.251 -179.529 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.45 ' HA ' HD23 ' A' ' 39' ' ' LEU . 6.1 tt -88.44 105.78 17.83 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 178.697 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -126.79 169.09 13.56 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.524 179.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.549 ' HB2' ' HG2' ' A' ' 38' ' ' ARG . 1.1 m-20 66.06 37.67 5.14 Favored 'General case' 0 C--N 1.329 -0.309 0 O-C-N 123.528 0.517 . . . . 0.0 110.761 179.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.502 ' HA ' ' HB3' ' A' ' 37' ' ' PHE . 11.3 p-10 -67.6 102.56 1.19 Allowed 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 121.878 0.847 . . . . 0.0 110.334 179.216 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -116.93 30.31 7.41 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.435 -177.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 96.44 -106.41 3.36 Favored Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.807 -179.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.6 m -81.94 -1.87 49.47 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.911 0.386 . . . . 0.0 110.784 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.42 ' HA ' ' OD1' ' A' ' 54' ' ' ASN . 20.7 m-70 -129.37 143.42 50.83 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.652 179.504 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.563 ' CZ ' ' HA ' ' A' ' 14' ' ' ARG . 36.8 p90 -173.95 170.96 3.76 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 -178.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.549 ' HG2' ' HB2' ' A' ' 31' ' ' ASP . 16.5 ptt180 -127.33 152.61 47.24 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.133 0.492 . . . . 0.0 111.004 179.03 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.47 HD11 ' HB1' ' A' ' 17' ' ' ALA . 96.3 mt -111.56 115.78 29.75 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.713 173.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.558 HG13 ' HB3' ' A' ' 51' ' ' ARG . 3.1 t -92.2 113.79 28.07 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.152 178.253 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.406 HG11 ' CD2' ' A' ' 66' ' ' TYR . 21.8 t -87.12 111.51 21.85 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.428 HH11 HG21 ' A' ' 28' ' ' THR . 23.7 mtp180 -100.42 164.02 12.11 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.23 -178.423 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.558 ' HB2' ' CG2' ' A' ' 49' ' ' VAL . 10.1 t70 -97.38 -169.2 1.81 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.605 -175.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.417 ' H ' ' CG ' ' A' ' 43' ' ' ASP . 40.3 p -67.91 -21.81 65.11 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.064 0.459 . . . . 0.0 110.727 -178.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -84.74 -10.58 57.12 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.665 0.745 . . . . 0.0 109.224 178.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 86.36 3.04 84.85 Favored Glycine 0 N--CA 1.444 -0.797 0 CA-C-N 115.289 -0.869 . . . . 0.0 112.75 -179.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 8.9 ptp180 -82.72 147.91 28.19 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 117.103 0.451 . . . . 0.0 110.212 177.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 21.2 ptt? -75.06 123.23 24.81 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.321 0.582 . . . . 0.0 110.749 -179.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.558 ' CG2' ' HB2' ' A' ' 43' ' ' ASP . 6.5 t -103.31 -33.93 3.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.085 -177.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 75.0 t-105 -152.23 152.0 31.66 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.494 -178.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.558 ' HB3' HG13 ' A' ' 40' ' ' VAL . 1.9 ppt_? -150.97 139.88 20.92 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 178.392 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -150.59 157.76 43.36 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.054 179.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.521 ' HA ' ' HA ' ' A' ' 38' ' ' ARG . 69.1 m95 -88.31 -164.67 1.15 Allowed 'General case' 0 N--CA 1.444 -0.764 0 CA-C-O 121.081 0.467 . . . . 0.0 110.229 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.42 ' OD1' ' HA ' ' A' ' 36' ' ' HIS . 0.4 OUTLIER -104.18 -21.93 13.47 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.301 -175.012 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -95.28 0.93 54.3 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -171.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.585 ' HB2' ' HB2' ' A' ' 59' ' ' ALA . 48.4 mt-10 -74.14 141.57 77.91 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 116.808 -0.178 . . . . 0.0 110.526 -179.147 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.489 ' O ' ' HD3' ' A' ' 11' ' ' PRO . 80.4 Cg_exo -45.95 -38.78 18.94 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 123.956 3.104 . . . . 0.0 114.163 -172.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.464 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . 9.1 m-20 -136.21 48.44 2.16 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 177.606 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.585 ' HB2' ' HB2' ' A' ' 56' ' ' GLU . . . -56.77 -48.43 77.89 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.723 -0.672 . . . . 0.0 111.292 -175.311 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.405 ' HA2' HD12 ' A' ' 63' ' ' LEU . . . -70.77 -25.65 75.38 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.45 -178.416 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.59 -33.25 66.6 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 -177.082 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.55 ' O ' ' HB2' ' A' ' 65' ' ' ARG . . . -71.81 -41.02 56.99 Favored Glycine 0 C--O 1.239 0.459 0 C-N-CA 120.684 -0.77 . . . . 0.0 111.273 176.223 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.515 ' HG ' ' O ' ' A' ' 59' ' ' ALA . 55.1 mt -58.24 -44.48 88.3 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.112 0.482 . . . . 0.0 109.711 175.461 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.569 ' HA ' ' HB ' ' A' ' 67' ' ' ILE . 33.2 m-80 -73.32 -18.42 61.19 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.756 -0.657 . . . . 0.0 111.636 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.55 ' HB2' ' O ' ' A' ' 62' ' ' GLY . 9.7 mmt180 -60.76 -47.88 84.3 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 172.041 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.406 ' CD2' HG11 ' A' ' 41' ' ' VAL . 83.8 t80 -67.99 -47.27 68.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.434 176.213 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.569 ' HB ' ' HA ' ' A' ' 64' ' ' ASN . 97.0 mt -59.16 -39.87 79.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -177.301 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 47.1 ttt180 -54.54 -43.2 71.75 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.633 0.254 . . . . 0.0 111.253 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.3 t -98.7 -9.99 23.82 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.746 0.308 . . . . 0.0 111.484 -177.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 33.1 t -159.09 66.72 0.41 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.331 0.586 . . . . 0.0 111.328 -177.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -89.29 127.61 8.77 Favored Glycine 0 N--CA 1.447 -0.619 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 171.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.521 ' HB ' ' OD1' ' A' ' 26' ' ' ASN . 2.0 mp -83.82 -0.85 5.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 CA-C-O 121.433 0.635 . . . . 0.0 110.714 -172.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.523 ' HB3' ' CE1' ' A' ' 24' ' ' TYR . 4.7 ptm180 -64.17 -7.71 9.93 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -176.063 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.1 m -59.26 -10.18 2.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.88 0.848 . . . . 0.0 109.253 172.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.401 ' N ' ' C ' ' A' ' 73' ' ' ARG . 17.5 t0 . . . . . 0 N--CA 1.449 -0.494 0 CA-C-N 114.402 -1.272 . . . . 0.0 109.252 171.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.409 ' HA3' ' HD3' ' A' ' 11' ' ' PRO . . . . . . . . 0 N--CA 1.453 -0.215 0 CA-C-O 119.957 -0.357 . . . . 0.0 112.506 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.409 ' HD3' ' HA3' ' A' ' 10' ' ' GLY . 2.8 Cg_exo -74.96 175.1 11.67 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 122.696 2.264 . . . . 0.0 111.872 178.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.453 ' HE1' ' HE2' ' A' ' 37' ' ' PHE . 51.3 p90 -128.19 161.5 29.15 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.386 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 43.0 p -102.08 170.31 8.2 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.677 178.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 32.6 ttt85 -59.22 -44.0 92.31 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.09 0.472 . . . . 0.0 109.814 176.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.435 HH11 ' HD2' ' A' ' 15' ' ' ARG . 4.8 tpp180 -65.5 -45.07 85.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.1 179.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.669 ' O ' HG23 ' A' ' 20' ' ' VAL . 2.1 mp0 -62.36 -48.13 81.14 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.911 178.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.411 ' HB2' ' CD1' ' A' ' 12' ' ' PHE . . . -51.76 -53.48 39.17 Favored 'General case' 0 C--N 1.328 -0.359 0 O-C-N 123.339 0.399 . . . . 0.0 111.56 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.865 ' HA ' HE21 ' A' ' 18' ' ' GLN . 0.0 OUTLIER -56.59 -42.57 78.9 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.826 -177.121 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.96 -28.41 70.06 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.491 -179.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.669 HG23 ' O ' ' A' ' 16' ' ' GLN . 15.4 t -90.77 -15.14 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -172.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.37 -29.04 37.87 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.26 174.066 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -80.24 -15.75 56.29 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-O 121.132 0.492 . . . . 0.0 109.758 172.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 7.0 m -85.78 -55.12 4.12 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.759 171.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.547 ' HB3' ' OD1' ' A' ' 26' ' ' ASN . 34.3 m-85 -117.67 105.95 12.56 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 174.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -76.7 -2.2 31.68 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 120.962 -0.295 . . . . 0.0 111.309 -176.03 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.547 ' OD1' ' HB3' ' A' ' 24' ' ' TYR . 24.7 p-10 -75.87 -17.4 59.82 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 174.582 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.544 HG13 ' O ' ' A' ' 24' ' ' TYR . 4.2 mt -76.04 148.12 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 174.277 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 6.7 p -144.1 132.33 21.87 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 117.842 0.292 . . . . 0.0 111.05 -179.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.527 ' HA ' HD23 ' A' ' 39' ' ' LEU . 3.8 tt -86.53 105.65 16.97 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 176.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -118.93 163.74 16.47 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.329 -178.016 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 63.8 30.64 14.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.034 175.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.503 ' HA ' ' HB3' ' A' ' 37' ' ' PHE . 17.8 t0 -65.56 107.87 1.85 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.487 -178.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.418 ' HB3' ' HB2' ' A' ' 36' ' ' HIS . 9.2 tt0 -129.09 34.57 4.41 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.264 -0.88 . . . . 0.0 108.662 179.068 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 85.24 -95.48 1.98 Allowed Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.638 -178.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 17.4 p -80.39 -30.09 37.78 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.332 0.587 . . . . 0.0 110.453 178.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.418 ' HB2' ' HB3' ' A' ' 33' ' ' GLN . 9.0 m-70 -92.87 121.57 34.37 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.769 177.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.503 ' HB3' ' HA ' ' A' ' 32' ' ' ASP . 38.2 p90 -170.33 157.05 5.95 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 176.155 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.447 ' NH1' ' HD3' ' A' ' 51' ' ' ARG . 38.3 ptt180 -139.72 150.09 44.42 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.216 0.531 . . . . 0.0 111.709 179.176 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.527 HD23 ' HA ' ' A' ' 29' ' ' LEU . 94.4 mt -98.27 124.09 42.69 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.941 177.085 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 46.7 t -101.8 121.24 52.51 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-N 115.329 -0.851 . . . . 0.0 109.716 177.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.402 HG23 HD22 ' A' ' 63' ' ' LEU . 15.4 t -99.03 115.01 38.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-O 121.04 0.448 . . . . 0.0 110.02 -179.51 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.521 ' HD2' ' O ' ' A' ' 46' ' ' GLY . 56.0 mtm180 -100.31 167.12 10.62 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.259 179.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -88.84 -169.49 2.55 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.781 0.324 . . . . 0.0 110.47 -178.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.485 HG23 HD12 ' A' ' 72' ' ' ILE . 0.5 OUTLIER -61.53 -26.75 68.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.827 -178.528 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 18.5 tp10 -86.41 -31.47 21.42 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 120.95 0.405 . . . . 0.0 110.247 179.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.521 ' O ' ' HD2' ' A' ' 42' ' ' ARG . . . 112.7 20.99 6.23 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.394 -176.108 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 89.0 mtm180 -87.81 129.32 35.23 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 176.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 12.5 ptt? -62.79 112.54 2.58 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.125 0.488 . . . . 0.0 110.909 176.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.403 HG11 ' CE1' ' A' ' 66' ' ' TYR . 40.1 t -99.84 -36.65 5.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.498 179.462 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.526 ' CD1' HD23 ' A' ' 63' ' ' LEU . 58.2 t-105 -157.27 156.68 32.87 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.851 -174.404 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.447 ' HD3' ' NH1' ' A' ' 38' ' ' ARG . 7.6 ptp85 -155.79 143.32 19.47 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.139 -178.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -146.93 143.46 28.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.632 -0.258 . . . . 0.0 110.413 179.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 70.2 m95 -82.75 -168.03 1.87 Allowed 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 121.808 0.813 . . . . 0.0 111.439 -177.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -93.54 -35.24 13.02 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.152 -1.386 . . . . 0.0 110.622 -179.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 26.6 p90 -83.67 12.01 6.46 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.481 -178.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.664 ' HB2' ' HB2' ' A' ' 59' ' ' ALA . 10.2 mm-40 -82.1 124.07 79.09 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.37 177.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -45.73 -50.95 8.85 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 124.303 3.335 . . . . 0.0 113.193 -175.171 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -126.96 57.65 1.45 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.082 0.468 . . . . 0.0 109.887 176.078 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.664 ' HB2' ' HB2' ' A' ' 56' ' ' GLU . . . -54.48 -45.46 73.2 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.428 -178.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -63.2 -32.36 83.89 Favored Glycine 0 N--CA 1.441 -1.026 0 CA-C-N 115.135 -0.939 . . . . 0.0 112.779 -177.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.428 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 18.0 tp10 -59.66 -41.94 91.71 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.969 0.384 . . . . 0.0 110.623 -176.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -73.62 -43.19 37.3 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.456 -0.878 . . . . 0.0 112.007 179.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.526 HD23 ' CD1' ' A' ' 50' ' ' TRP . 65.7 mt -66.27 -46.98 75.2 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.681 0.277 . . . . 0.0 110.43 -179.308 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.472 ' HA ' HD12 ' A' ' 67' ' ' ILE . 87.2 m-20 -65.75 -25.51 67.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.477 178.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.428 ' HB2' ' O ' ' A' ' 61' ' ' GLU . 42.4 ttp180 -63.84 -45.25 90.38 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 178.152 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.403 ' CE1' HG11 ' A' ' 49' ' ' VAL . 85.3 t80 -69.47 -42.63 74.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.953 0.406 . . . . 0.0 110.219 175.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.472 HD12 ' HA ' ' A' ' 64' ' ' ASN . 97.0 mt -55.09 -37.57 43.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.476 177.15 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 47.1 ttt180 -60.27 -46.75 88.73 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.84 -178.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 16.9 p -87.57 -17.68 31.45 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -172.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 24.7 m -108.46 -50.17 3.07 Favored 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.447 -176.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 47.7 81.92 0.04 OUTLIER Glycine 0 CA--C 1.522 0.519 0 CA-C-N 115.868 -0.605 . . . . 0.0 112.948 -174.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.485 HD12 HG23 ' A' ' 44' ' ' THR . 35.2 mm -90.88 6.58 4.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-O 121.697 0.76 . . . . 0.0 110.304 -173.515 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.461 ' HB3' ' CE2' ' A' ' 24' ' ' TYR . 15.0 ptt180 -64.1 -1.94 1.79 Allowed 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.767 179.395 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 8.9 t -71.25 6.53 1.65 Allowed 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.266 177.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 . . . . . 0 N--CA 1.45 -0.437 0 CA-C-O 122.878 1.323 . . . . 0.0 109.977 178.77 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.461 ' HA3' ' HD3' ' A' ' 11' ' ' PRO . . . . . . . . 0 CA--C 1.522 0.49 0 CA-C-O 120.14 -0.255 . . . . 0.0 113.626 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.461 ' HD3' ' HA3' ' A' ' 10' ' ' GLY . 14.4 Cg_exo -67.86 142.49 57.53 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.778 2.319 . . . . 0.0 111.841 176.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.535 ' CD2' ' HB2' ' A' ' 17' ' ' ALA . 12.9 p90 -108.79 -171.8 1.92 Allowed 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.804 -175.474 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.455 ' OG1' ' HG2' ' A' ' 16' ' ' GLN . 21.5 p -125.49 175.71 7.33 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 172.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.498 ' HG2' HD11 ' A' ' 29' ' ' LEU . 67.9 mtm180 -65.4 -43.94 89.05 Favored 'General case' 0 C--O 1.22 -0.462 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.128 175.129 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -54.93 -50.77 68.02 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 178.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.488 ' O ' HG23 ' A' ' 20' ' ' VAL . 65.0 mm-40 -60.81 -52.78 63.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.072 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.535 ' HB2' ' CD2' ' A' ' 12' ' ' PHE . . . -56.71 -46.45 81.24 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.304 -179.156 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.475 ' HG3' ' O ' ' A' ' 14' ' ' ARG . 91.9 mt-30 -58.95 -38.52 79.24 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.492 -176.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.52 -26.06 68.26 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-O 121.205 0.526 . . . . 0.0 111.535 178.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 16' ' ' GLN . 3.2 t -85.49 -22.88 7.29 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.903 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 -175.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 17.8 m -85.69 -33.73 21.46 Favored 'General case' 0 N--CA 1.434 -1.267 0 CA-C-N 113.315 -1.766 . . . . 0.0 110.814 -178.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.0 p -67.48 -29.35 68.77 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 173.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 23.3 m -80.73 -53.46 6.49 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.305 173.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.631 ' O ' HG13 ' A' ' 27' ' ' ILE . 62.3 m-85 -106.49 98.94 8.55 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 178.572 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 37.3 p -69.51 -3.8 16.18 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.225 -0.443 . . . . 0.0 112.142 -178.019 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.627 ' OD1' ' HB3' ' A' ' 24' ' ' TYR . 24.1 p-10 -82.48 -14.18 55.45 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.986 0.422 . . . . 0.0 109.877 176.141 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.631 HG13 ' O ' ' A' ' 24' ' ' TYR . 1.2 mt -81.12 146.17 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 N-CA-C 108.372 -0.974 . . . . 0.0 108.372 173.396 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.482 ' O ' ' HA ' ' A' ' 39' ' ' LEU . 3.0 p -144.12 136.42 26.62 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.853 -0.339 . . . . 0.0 111.204 -179.238 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.498 HD11 ' HG2' ' A' ' 14' ' ' ARG . 5.1 tt -95.71 105.12 17.08 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 177.277 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -115.84 166.59 11.79 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.224 -178.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.504 ' HB2' ' HG2' ' A' ' 38' ' ' ARG . 0.3 OUTLIER 60.95 31.59 19.96 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.256 177.493 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -70.77 102.47 2.34 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 121.612 0.72 . . . . 0.0 111.184 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 19.5 tm0? -100.53 -30.73 11.63 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.038 175.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 146.11 -80.02 0.22 Allowed Glycine 0 N--CA 1.445 -0.731 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 -175.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 44.5 p -82.12 -31.41 30.66 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 172.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 60.4 m80 -96.72 126.1 41.64 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.269 177.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.453 ' HB2' HD21 ' A' ' 29' ' ' LEU . 49.7 p90 -168.21 147.19 4.53 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.485 -0.779 . . . . 0.0 109.032 177.241 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.504 ' HG2' ' HB2' ' A' ' 31' ' ' ASP . 49.2 ptt85 -129.59 149.23 51.44 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.843 0.354 . . . . 0.0 110.785 -176.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.564 ' O ' ' HA ' ' A' ' 51' ' ' ARG . 75.9 mt -106.26 144.42 32.98 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.139 0.495 . . . . 0.0 110.188 178.434 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.575 HG13 ' HB3' ' A' ' 51' ' ' ARG . 38.2 t -123.48 110.04 24.97 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.066 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.316 174.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.2 t -88.84 104.37 14.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 173.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.403 ' HA ' ' O ' ' A' ' 47' ' ' ARG . 67.2 mtt85 -94.98 171.2 8.9 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.325 -177.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.427 ' CG ' ' H ' ' A' ' 45' ' ' GLU . 1.5 p-10 -96.73 -169.73 1.94 Allowed 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 175.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.97 -17.28 62.66 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.548 -175.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.444 ' OE1' ' HD3' ' A' ' 47' ' ' ARG . 37.9 tt0 -89.18 -24.73 22.1 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 176.347 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 105.0 18.55 12.07 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.329 178.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.444 ' HD3' ' OE1' ' A' ' 45' ' ' GLU . 41.6 mtm-85 -85.65 142.07 29.33 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 177.452 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 11.0 ptp -77.86 105.38 9.01 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.46 0.648 . . . . 0.0 111.104 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 21.2 t -87.7 -36.22 9.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.69 177.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.518 ' CZ2' ' HB3' ' A' ' 52' ' ' ALA . 31.4 t90 -137.62 123.27 19.82 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 177.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.575 ' HB3' HG13 ' A' ' 40' ' ' VAL . 0.0 OUTLIER -149.47 120.1 7.5 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.518 0.675 . . . . 0.0 110.006 172.706 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.518 ' HB3' ' CZ2' ' A' ' 50' ' ' TRP . . . -155.3 174.38 15.3 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.322 -174.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 78.9 m95 -93.9 -158.95 0.66 Allowed 'General case' 0 N--CA 1.445 -0.698 0 CA-C-O 121.258 0.551 . . . . 0.0 110.799 -174.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -110.09 -32.41 7.02 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.619 -0.718 . . . . 0.0 111.25 -175.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -79.34 34.73 0.26 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.982 -175.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.557 ' HB2' ' HB2' ' A' ' 59' ' ' ALA . 51.1 mt-10 -111.04 135.19 20.87 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.058 179.633 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -51.69 -32.83 46.88 Favored 'Trans proline' 0 N--CA 1.477 0.513 0 C-N-CA 123.879 3.052 . . . . 0.0 114.375 -170.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.47 ' HB2' ' HB3' ' A' ' 61' ' ' GLU . 2.3 p30 -136.36 44.18 2.43 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.017 0.436 . . . . 0.0 110.617 179.419 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.557 ' HB2' ' HB2' ' A' ' 56' ' ' GLU . . . -58.74 -41.35 86.25 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.904 -178.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.44 ' HA2' HD12 ' A' ' 63' ' ' LEU . . . -69.2 -27.52 73.67 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.588 178.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.47 ' HB3' ' HB2' ' A' ' 58' ' ' ASP . 31.2 tt0 -73.46 -34.63 65.48 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.592 ' HA2' ' HD3' ' A' ' 65' ' ' ARG . . . -63.49 -41.27 99.32 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.71 -0.757 . . . . 0.0 111.487 173.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.46 ' O ' HG13 ' A' ' 67' ' ' ILE . 6.6 mt -64.1 -41.08 97.41 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 110.31 -0.255 . . . . 0.0 110.31 175.141 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -56.17 -33.95 65.73 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.146 0.498 . . . . 0.0 110.497 173.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.592 ' HD3' ' HA2' ' A' ' 62' ' ' GLY . 45.6 mtp85 -71.31 -28.67 64.27 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.153 179.46 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.562 ' O ' HG22 ' A' ' 69' ' ' THR . 36.9 t80 -76.24 -51.62 11.69 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.49 -0.484 . . . . 0.0 109.795 171.658 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.46 HG13 ' O ' ' A' ' 63' ' ' LEU . 46.2 mt -62.05 -13.19 9.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.172 -178.612 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 8.8 tpt180 -49.36 -32.87 12.2 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.632 172.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.562 HG22 ' O ' ' A' ' 66' ' ' TYR . 12.1 t -92.96 29.29 1.86 Allowed 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 121.322 0.582 . . . . 0.0 110.291 -177.312 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 7.9 t 80.22 -27.05 0.15 Allowed 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.967 0.907 . . . . 0.0 111.351 176.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.12 -172.27 51.17 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.468 -0.873 . . . . 0.0 111.894 -177.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.481 ' O ' HG22 ' A' ' 72' ' ' ILE . 32.3 mm -101.02 7.73 9.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 121.768 0.794 . . . . 0.0 110.626 -174.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -50.17 -21.24 1.24 Allowed 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.64 178.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 10.0 t -63.88 -1.49 1.44 Allowed 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 120.772 0.32 . . . . 0.0 110.569 176.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 19.9 t70 . . . . . 0 C--N 1.331 -0.238 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.428 177.371 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.559 ' HA2' ' HA ' ' A' ' 58' ' ' ASP . . . . . . . . 0 N--CA 1.45 -0.397 0 CA-C-O 120.147 -0.252 . . . . 0.0 112.778 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.405 ' HD3' ' HA3' ' A' ' 10' ' ' GLY . 8.0 Cg_exo -72.7 168.56 24.18 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.956 2.437 . . . . 0.0 111.856 177.004 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -125.74 -170.61 2.21 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.379 -176.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.473 ' H ' ' HB2' ' A' ' 16' ' ' GLN . 41.6 p -125.4 173.41 8.89 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.149 178.579 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 4.4 tmt_? -58.42 -43.91 88.86 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.548 0.689 . . . . 0.0 109.261 172.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 41.5 ttm105 -60.77 -54.13 48.96 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.525 -1.216 . . . . 0.0 111.306 178.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.634 ' O ' HG23 ' A' ' 20' ' ' VAL . 73.5 mm-40 -56.71 -49.86 73.88 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.918 179.538 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.457 ' HB1' HD21 ' A' ' 39' ' ' LEU . . . -48.84 -51.9 27.06 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.576 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.467 HE21 HD13 ' A' ' 29' ' ' LEU . 55.4 mm-40 -58.68 -38.0 77.27 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.664 -177.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.98 -27.87 66.1 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.969 0.414 . . . . 0.0 111.446 -178.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.634 HG23 ' O ' ' A' ' 16' ' ' GLN . 18.7 t -89.16 -18.9 7.68 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.816 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 -172.432 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 21.1 m -93.41 -31.25 14.69 Favored 'General case' 0 N--CA 1.432 -1.328 0 CA-C-N 114.004 -1.453 . . . . 0.0 108.149 -175.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 52.9 m -61.4 -36.58 80.7 Favored 'General case' 0 N--CA 1.435 -1.187 0 CA-C-N 113.93 -1.486 . . . . 0.0 109.047 168.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 25.9 m -78.97 -51.4 9.67 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.592 177.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.63 ' O ' HG13 ' A' ' 27' ' ' ILE . 47.6 m-85 -113.37 94.81 5.04 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 177.228 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 13.7 m -73.25 1.53 9.22 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.987 0.423 . . . . 0.0 111.204 -176.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.567 ' OD1' ' HB3' ' A' ' 24' ' ' TYR . 4.4 p-10 -78.55 -18.08 55.2 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 172.323 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.63 HG13 ' O ' ' A' ' 24' ' ' TYR . 2.0 mt -79.72 152.18 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 170.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.474 ' O ' ' HA ' ' A' ' 39' ' ' LEU . 17.2 p -141.0 123.64 16.04 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.91 -178.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.56 ' HA ' HD23 ' A' ' 39' ' ' LEU . 6.7 tt -83.85 95.68 8.55 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 176.114 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -114.95 171.31 7.73 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.628 -175.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.468 ' OD2' ' HZ3' ' A' ' 53' ' ' TRP . 38.3 t70 66.39 18.34 10.84 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 123.652 0.595 . . . . 0.0 110.639 177.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.568 ' HA ' ' HB3' ' A' ' 37' ' ' PHE . 7.6 p-10 -64.78 95.97 0.17 Allowed 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 121.826 0.822 . . . . 0.0 110.752 -179.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.429 ' NE2' ' HE1' ' A' ' 36' ' ' HIS . 45.1 mt-30 -128.13 45.17 2.8 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.133 -0.939 . . . . 0.0 109.471 -179.328 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.25 -88.24 1.44 Allowed Glycine 0 N--CA 1.444 -0.815 0 CA-C-N 114.55 -1.205 . . . . 0.0 112.6 176.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 49.0 m -81.63 -14.4 56.75 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -173.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.429 ' HE1' ' NE2' ' A' ' 33' ' ' GLN . 25.7 p80 -136.74 148.95 47.57 Favored 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 119.912 -0.715 . . . . 0.0 110.953 176.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.568 ' HB3' ' HA ' ' A' ' 32' ' ' ASP . 45.1 p90 -170.0 161.44 8.74 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.79 -1.095 . . . . 0.0 108.474 178.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.421 ' HG2' ' HB3' ' A' ' 31' ' ' ASP . 32.9 ptt180 -144.05 155.57 44.04 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.052 0.453 . . . . 0.0 112.119 -178.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.56 HD23 ' HA ' ' A' ' 29' ' ' LEU . 95.8 mt -103.18 112.38 25.21 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.285 176.651 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 47.8 t -94.21 122.38 45.63 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.944 175.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.507 HG11 ' CD2' ' A' ' 66' ' ' TYR . 80.4 t -90.09 115.28 29.26 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 178.201 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.536 ' HA ' ' O ' ' A' ' 47' ' ' ARG . 59.1 mtp180 -110.52 161.04 16.09 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.37 -176.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -95.56 -165.81 1.35 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.18 -178.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 17.6 p -63.46 -27.23 69.14 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.859 0.361 . . . . 0.0 111.427 -177.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -82.87 -33.82 26.9 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.217 0.532 . . . . 0.0 109.788 177.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 110.28 18.49 8.62 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.817 -0.706 . . . . 0.0 111.584 -175.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.536 ' O ' ' HA ' ' A' ' 42' ' ' ARG . 52.0 mtt180 -80.53 145.57 31.74 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 179.101 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.404 ' N ' ' SD ' ' A' ' 48' ' ' MET . 1.8 mpt? -72.49 108.46 5.57 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 177.42 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 42.6 t -95.14 -31.03 4.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.459 0.647 . . . . 0.0 109.592 177.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.457 ' CD1' HD23 ' A' ' 63' ' ' LEU . 69.3 t-105 -159.12 157.87 31.79 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.35 -178.352 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 15.3 ptt180 -160.66 138.73 9.77 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.887 0.375 . . . . 0.0 110.114 178.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -143.12 145.76 33.13 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.043 178.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.537 ' HB2' ' OE1' ' A' ' 56' ' ' GLU . 42.4 m95 -84.71 -160.44 0.48 Allowed 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 176.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -107.55 0.86 22.95 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.928 -174.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 22.9 p90 -117.56 2.98 12.42 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -173.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.569 ' HB2' ' HB2' ' A' ' 59' ' ' ALA . 3.1 mp0 -66.16 132.18 94.49 Favored Pre-proline 0 C--O 1.237 0.398 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.119 173.13 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -46.65 -32.62 12.09 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 123.86 3.04 . . . . 0.0 113.358 -176.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.559 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . 4.4 t0 -146.29 62.9 1.22 Allowed 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 174.389 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.569 ' HB2' ' HB2' ' A' ' 56' ' ' GLU . . . -58.17 -35.51 71.68 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-O 121.286 0.565 . . . . 0.0 111.011 -179.054 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -59.01 -37.75 91.98 Favored Glycine 0 N--CA 1.446 -0.673 0 CA-C-N 115.281 -0.872 . . . . 0.0 113.554 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -60.5 -38.72 85.23 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 117.386 0.593 . . . . 0.0 111.182 -174.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.527 ' O ' ' HB3' ' A' ' 65' ' ' ARG . . . -72.32 -44.49 42.6 Favored Glycine 0 C--O 1.237 0.308 0 C-N-CA 120.823 -0.703 . . . . 0.0 111.99 179.078 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.457 HD23 ' CD1' ' A' ' 50' ' ' TRP . 65.6 mt -62.36 -50.24 72.36 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.705 0.288 . . . . 0.0 110.244 178.21 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.414 ' HA ' ' HB ' ' A' ' 67' ' ' ILE . 92.8 m-20 -63.43 -28.33 69.9 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.923 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.527 ' HB3' ' O ' ' A' ' 62' ' ' GLY . 10.9 ttt180 -57.02 -51.0 71.0 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.009 175.293 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.507 ' CD2' HG11 ' A' ' 41' ' ' VAL . 77.5 t80 -72.06 -38.8 69.39 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.622 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.414 ' HB ' ' HA ' ' A' ' 64' ' ' ASN . 96.4 mt -57.21 -43.97 82.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.007 0.432 . . . . 0.0 110.896 177.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 5.9 ttp85 -65.76 -41.85 91.61 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.89 -179.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 30.9 p -79.3 -44.7 21.15 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -176.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.427 ' O ' HD12 ' A' ' 72' ' ' ILE . 31.0 m -147.68 56.48 1.09 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.618 -173.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -64.46 130.51 37.61 Favored Glycine 0 CA--C 1.52 0.4 0 C-N-CA 120.284 -0.96 . . . . 0.0 111.9 173.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.533 ' HB ' ' OD1' ' A' ' 26' ' ' ASN . 1.9 mp -81.29 2.31 2.77 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 CA-C-O 121.66 0.743 . . . . 0.0 111.059 -174.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 15.5 ttt180 -57.48 -18.51 19.0 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 121.644 -0.66 . . . . 0.0 111.639 177.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 8.9 m -55.43 -15.42 2.66 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 121.378 0.608 . . . . 0.0 110.282 172.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 17.0 t70 . . . . . 0 CA--C 1.508 -0.652 0 CA-C-O 122.404 1.097 . . . . 0.0 110.144 178.676 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.446 ' HA2' ' OD1' ' A' ' 58' ' ' ASP . . . . . . . . 0 CA--C 1.519 0.311 0 CA-C-O 120.239 -0.2 . . . . 0.0 113.499 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -70.69 153.48 64.64 Favored 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 122.662 2.242 . . . . 0.0 111.577 178.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 16.4 p90 -115.98 -175.93 2.84 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.773 0.797 . . . . 0.0 112.134 -174.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -125.68 159.35 32.47 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-N 114.862 -1.063 . . . . 0.0 109.344 179.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.424 HH11 ' HD2' ' A' ' 14' ' ' ARG . 24.5 ttt85 -57.63 -48.46 79.37 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 120.895 0.379 . . . . 0.0 110.424 -179.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 21.4 tpp180 -46.22 -55.78 6.66 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.041 175.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.685 ' O ' HG23 ' A' ' 20' ' ' VAL . 2.1 mp0 -62.04 -49.45 75.94 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.857 179.22 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -53.29 -49.19 67.49 Favored 'General case' 0 N--CA 1.464 0.225 0 O-C-N 123.279 0.362 . . . . 0.0 111.557 -177.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -58.82 -40.14 83.27 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.433 -178.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.44 -24.26 66.42 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.856 179.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.685 HG23 ' O ' ' A' ' 16' ' ' GLN . 15.3 t -88.49 -22.75 6.58 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.794 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 -174.679 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.534 HG23 ' HB ' ' A' ' 27' ' ' ILE . 11.0 m -86.73 -31.03 21.19 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-N 113.768 -1.56 . . . . 0.0 110.575 -178.035 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.5 p -68.5 -31.34 70.53 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 170.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 41.0 m -75.67 -50.92 13.97 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.34 174.067 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.599 ' HB2' HG13 ' A' ' 27' ' ' ILE . 61.6 m-85 -113.16 102.26 10.21 Favored 'General case' 0 N--CA 1.447 -0.594 0 O-C-N 121.883 -0.511 . . . . 0.0 109.97 177.54 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 76.0 p -67.2 -9.25 38.33 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.06 -0.518 . . . . 0.0 112.056 -179.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.56 ' OD1' ' HB3' ' A' ' 24' ' ' TYR . 24.8 p-10 -79.01 -12.25 60.03 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.995 0.426 . . . . 0.0 110.035 177.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.599 HG13 ' HB2' ' A' ' 24' ' ' TYR . 2.2 mt -83.8 147.12 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 173.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.583 ' OG1' ' HB ' ' A' ' 40' ' ' VAL . 1.4 p -139.81 127.88 22.32 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 120.477 -0.489 . . . . 0.0 111.26 -179.07 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.521 ' HA ' HD23 ' A' ' 39' ' ' LEU . 5.6 tt -83.48 102.92 12.43 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 177.203 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -113.68 159.06 20.1 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.765 -175.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.8 t70 59.84 47.69 9.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.735 -179.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -72.27 96.54 1.85 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.976 -175.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -112.97 24.13 12.68 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.866 175.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 77.8 -79.99 1.38 Allowed Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.705 -0.68 . . . . 0.0 112.241 179.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 38.8 m -82.97 -16.69 46.26 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.077 0.465 . . . . 0.0 110.672 179.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 24.8 m170 -119.43 137.92 53.45 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 174.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -170.62 156.47 5.34 Favored 'General case' 0 C--N 1.323 -0.583 0 O-C-N 123.518 0.511 . . . . 0.0 109.769 177.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 11.9 ptt180 -128.53 153.28 47.35 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.136 176.17 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.546 ' O ' ' HA ' ' A' ' 51' ' ' ARG . 91.6 mt -111.21 132.54 54.25 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.177 0.513 . . . . 0.0 110.223 178.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.583 ' HB ' ' OG1' ' A' ' 28' ' ' THR . 38.6 t -108.99 109.23 27.56 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.624 176.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.468 HG11 ' CD2' ' A' ' 66' ' ' TYR . 10.9 t -85.1 118.44 32.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 173.267 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.407 ' O ' ' HB2' ' A' ' 26' ' ' ASN . 16.5 mtp180 -113.21 158.79 20.02 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 -178.097 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.448 ' CG ' ' H ' ' A' ' 45' ' ' GLU . 2.6 p-10 -89.77 -168.7 2.21 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 177.379 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 9.2 t -71.42 -14.32 62.12 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.099 -177.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.448 ' H ' ' CG ' ' A' ' 43' ' ' ASP . 32.5 tt0 -93.15 -16.02 25.36 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.34 0.591 . . . . 0.0 109.592 177.122 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 95.51 13.04 52.71 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.963 177.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 15.5 mtp180 -79.32 127.94 32.71 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 178.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.7 102.79 2.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.223 0.535 . . . . 0.0 111.213 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 43.9 t -86.72 -40.39 14.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.349 -0.842 . . . . 0.0 110.286 -179.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.598 ' CH2' ' HB3' ' A' ' 52' ' ' ALA . 22.6 t90 -135.48 106.57 6.7 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -178.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.546 ' HA ' ' O ' ' A' ' 39' ' ' LEU . 29.9 ptt180 -130.95 109.19 10.36 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 173.673 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.598 ' HB3' ' CH2' ' A' ' 50' ' ' TRP . . . -149.33 166.44 28.98 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.796 -177.456 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 44.1 m95 -85.53 -162.8 0.76 Allowed 'General case' 0 N--CA 1.445 -0.705 0 CA-C-O 121.468 0.651 . . . . 0.0 111.162 -175.139 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 61.8 t30 -105.17 -20.39 13.52 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.816 -176.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -83.45 14.67 3.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.15 0.5 . . . . 0.0 111.305 -178.017 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.54 ' HB2' ' HB2' ' A' ' 59' ' ' ALA . 9.4 mm-40 -80.33 129.57 68.85 Favored Pre-proline 0 C--N 1.325 -0.459 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 174.532 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -44.89 -39.1 13.85 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.867 3.045 . . . . 0.0 114.067 -172.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.446 ' OD1' ' HA2' ' A' ' 10' ' ' GLY . 12.7 t0 -142.11 59.02 1.47 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 178.021 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.54 ' HB2' ' HB2' ' A' ' 56' ' ' GLU . . . -56.38 -35.25 67.52 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.204 -179.636 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -62.22 -37.46 94.58 Favored Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.698 -0.683 . . . . 0.0 113.51 -177.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.404 ' CD ' HH21 ' A' ' 65' ' ' ARG . 1.4 tm-20 -59.75 -50.94 71.86 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 117.176 0.488 . . . . 0.0 110.384 -175.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -59.46 -43.05 97.8 Favored Glycine 0 CA--C 1.52 0.374 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.098 178.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 17.7 mt -59.31 -48.54 81.25 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.691 0.281 . . . . 0.0 111.074 176.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.45 HD22 ' N ' ' A' ' 64' ' ' ASN . 0.9 OUTLIER -65.05 -34.94 79.63 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.444 -178.948 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.404 HH21 ' CD ' ' A' ' 61' ' ' GLU . 14.2 ttm180 -63.63 -32.55 74.07 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.978 -178.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.468 ' CD2' HG11 ' A' ' 41' ' ' VAL . 68.6 t80 -82.45 -45.69 14.44 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 120.028 -0.669 . . . . 0.0 110.448 176.107 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 86.8 mt -55.22 -42.55 66.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.19 -178.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 56.8 ttp180 -55.87 -36.93 68.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.524 -178.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 13.6 t -105.34 25.56 10.5 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.179 0.514 . . . . 0.0 111.553 -173.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 54.0 m -149.59 -55.59 0.18 Allowed 'General case' 0 C--N 1.324 -0.534 0 O-C-N 122.126 -0.359 . . . . 0.0 111.266 177.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 45.03 75.64 0.16 Allowed Glycine 0 CA--C 1.524 0.632 0 CA-C-N 115.51 -0.768 . . . . 0.0 113.227 -175.082 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.475 HG21 ' HB3' ' A' ' 26' ' ' ASN . 45.9 mm -79.86 6.41 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-O 121.62 0.724 . . . . 0.0 111.118 -172.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.439 ' C ' ' H ' ' A' ' 75' ' ' ASP . 9.3 ptm180 -69.31 -2.82 11.73 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.193 178.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.4 t -72.26 8.48 1.31 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.971 175.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.439 ' H ' ' C ' ' A' ' 73' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.445 -0.675 0 CA-C-O 123.061 1.41 . . . . 0.0 110.896 -177.305 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.447 ' HA3' ' HD3' ' A' ' 11' ' ' PRO . . . . . . . . 0 CA--C 1.518 0.277 0 CA-C-O 120.117 -0.268 . . . . 0.0 113.404 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.447 ' HD3' ' HA3' ' A' ' 10' ' ' GLY . 17.7 Cg_exo -66.87 170.85 12.0 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.915 2.41 . . . . 0.0 112.531 178.44 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -136.25 -173.48 3.41 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.084 -177.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.435 ' H ' ' HB2' ' A' ' 16' ' ' GLN . 27.5 p -122.21 178.17 5.04 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.227 175.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.639 ' O ' ' HG2' ' A' ' 18' ' ' GLN . 36.4 ttt-85 -63.0 -46.99 85.08 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 176.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 70.6 mtp180 -57.01 -48.36 78.67 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.133 178.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.58 ' O ' HG23 ' A' ' 20' ' ' VAL . 81.2 mm-40 -60.4 -46.9 88.33 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 178.548 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.434 ' HB1' HD11 ' A' ' 39' ' ' LEU . . . -52.32 -47.1 66.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.565 177.576 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.639 ' HG2' ' O ' ' A' ' 14' ' ' ARG . 16.4 mm100 -55.07 -48.06 74.03 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.504 -178.55 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.67 -28.53 69.99 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -175.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.58 HG23 ' O ' ' A' ' 16' ' ' GLN . 11.3 t -86.91 -25.57 6.18 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.787 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 -171.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.516 HG23 ' HB ' ' A' ' 27' ' ' ILE . 17.7 m -86.36 -31.25 21.61 Favored 'General case' 0 N--CA 1.435 -1.222 0 CA-C-N 113.735 -1.575 . . . . 0.0 111.211 -177.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.7 p -69.16 -29.01 66.93 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 172.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 19.5 m -77.34 -56.0 4.92 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.222 171.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.646 ' HB3' ' OD1' ' A' ' 26' ' ' ASN . 58.0 m-85 -105.13 98.07 7.83 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 -179.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.9 p -70.24 1.12 5.18 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 120.728 0.299 . . . . 0.0 111.759 178.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.646 ' OD1' ' HB3' ' A' ' 24' ' ' TYR . 4.5 p-10 -83.26 -10.87 58.3 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 174.205 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.622 HG13 ' O ' ' A' ' 24' ' ' TYR . 1.7 mt -85.25 138.02 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 173.058 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.503 ' OG1' ' HB ' ' A' ' 40' ' ' VAL . 2.3 p -130.62 126.43 36.62 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 120.641 -0.424 . . . . 0.0 111.043 -176.318 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.416 ' HA ' HD23 ' A' ' 39' ' ' LEU . 5.4 tt -91.26 108.05 19.62 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -122.97 167.9 13.0 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.719 178.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.571 ' HB2' HH11 ' A' ' 38' ' ' ARG . 0.7 OUTLIER 62.59 67.66 0.7 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.618 -177.88 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -81.38 100.25 9.14 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.657 -175.273 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -114.08 6.96 16.58 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.534 0.683 . . . . 0.0 109.553 174.261 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.62 -79.71 1.28 Allowed Glycine 0 N--CA 1.45 -0.419 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.948 -179.112 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 17.1 m -86.36 -18.63 31.38 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.156 0.503 . . . . 0.0 110.359 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 29.7 m170 -114.25 132.07 56.27 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.73 173.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.501 ' HA ' ' O ' ' A' ' 31' ' ' ASP . 52.9 p90 -164.59 157.37 16.89 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 178.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.607 ' HA ' ' HA ' ' A' ' 53' ' ' TRP . 27.0 ptt-85 -124.47 142.42 51.34 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 119.567 -0.853 . . . . 0.0 111.31 177.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.506 ' O ' ' HA ' ' A' ' 51' ' ' ARG . 63.0 mt -104.05 134.74 46.81 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.589 176.133 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.541 HG13 ' HB3' ' A' ' 51' ' ' ARG . 40.6 t -112.83 116.41 52.53 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.959 175.408 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.552 ' HB ' ' HB3' ' A' ' 50' ' ' TRP . 97.1 t -86.36 107.97 17.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.239 173.727 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.43 HH11 ' HD2' ' A' ' 42' ' ' ARG . 14.7 mtp180 -101.48 156.57 17.39 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.543 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.443 ' HA ' ' OH ' ' A' ' 66' ' ' TYR . 1.9 p-10 -88.91 -171.06 3.14 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 120.793 0.33 . . . . 0.0 110.947 -175.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 12.2 t -64.1 -22.53 66.97 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.878 -177.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -87.14 -31.52 20.36 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 178.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 114.01 14.07 9.56 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.339 -179.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 72.3 mtp180 -91.01 140.98 29.33 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 179.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 22.3 ptt? -74.91 118.79 18.26 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.227 0.537 . . . . 0.0 111.459 -177.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 34.0 t -101.6 -32.41 3.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.002 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.552 ' HB3' ' HB ' ' A' ' 41' ' ' VAL . 49.3 t90 -144.77 136.58 25.74 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.973 -1.012 . . . . 0.0 108.542 -179.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.573 ' O ' ' HD2' ' A' ' 51' ' ' ARG . 0.0 OUTLIER -158.01 119.99 3.67 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 121.448 0.642 . . . . 0.0 110.354 174.772 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.519 ' HB3' ' CZ2' ' A' ' 50' ' ' TRP . . . -151.83 171.3 17.95 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.091 -177.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.607 ' HA ' ' HA ' ' A' ' 38' ' ' ARG . 87.7 m95 -80.26 -95.25 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -172.333 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -162.1 -35.8 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.123 0.487 . . . . 0.0 110.607 -176.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -84.67 14.86 4.23 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.396 -177.027 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.526 ' HB2' ' HB2' ' A' ' 59' ' ' ALA . 1.9 mm-40 -66.52 128.02 93.64 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.1 -178.008 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_exo -38.19 -49.6 2.25 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 124.338 3.359 . . . . 0.0 113.541 -176.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -138.92 69.16 1.37 Allowed 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 172.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.526 ' HB2' ' HB2' ' A' ' 56' ' ' GLU . . . -57.75 -33.86 68.92 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.898 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -55.16 -41.84 79.85 Favored Glycine 0 N--CA 1.446 -0.694 0 CA-C-N 115.241 -0.89 . . . . 0.0 112.963 178.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.616 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 9.0 tp10 -49.02 -54.76 14.37 Favored 'General case' 0 C--O 1.223 -0.332 0 CA-C-N 116.974 0.387 . . . . 0.0 111.059 -178.143 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.498 ' HA3' ' CD1' ' A' ' 50' ' ' TRP . . . -65.22 -40.94 97.03 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.777 -178.157 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.478 HD23 HG21 ' A' ' 41' ' ' VAL . 49.3 mt -62.82 -51.04 68.61 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.609 0.242 . . . . 0.0 110.943 179.669 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 51.8 m-80 -69.15 -24.78 64.12 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.941 0.4 . . . . 0.0 110.28 179.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.616 ' HB2' ' O ' ' A' ' 61' ' ' GLU . 12.6 ttt85 -61.91 -37.64 85.41 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.961 177.277 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.443 ' OH ' ' HA ' ' A' ' 43' ' ' ASP . 91.4 t80 -82.32 -47.92 11.79 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.992 176.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.422 HG13 ' O ' ' A' ' 63' ' ' LEU . 72.2 mt -56.52 -21.85 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 CA-C-O 120.992 0.425 . . . . 0.0 111.404 179.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 49.6 ttp180 -50.24 -34.04 21.69 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.455 175.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.417 ' O ' ' HB2' ' A' ' 70' ' ' SER . 6.9 t -102.89 61.85 0.8 Allowed 'General case' 0 N--CA 1.443 -0.779 0 CA-C-O 122.062 0.934 . . . . 0.0 109.217 179.464 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.417 ' HB2' ' O ' ' A' ' 69' ' ' THR . 63.2 m 78.18 -51.63 0.49 Allowed 'General case' 0 C--O 1.236 0.356 0 CA-C-N 114.224 -1.353 . . . . 0.0 112.978 172.491 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.06 175.71 51.16 Favored Glycine 0 CA--C 1.52 0.38 0 N-CA-C 111.585 -0.606 . . . . 0.0 111.585 -172.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.592 ' HB ' ' OD1' ' A' ' 26' ' ' ASN . 1.1 mp -83.29 -5.62 9.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.458 0.647 . . . . 0.0 111.061 -177.313 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 23.7 ptt180 -59.34 -20.94 58.65 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.408 175.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.6 m -68.66 -1.54 7.12 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.058 177.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.7 t0 . . . . . 0 C--N 1.326 -0.415 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 177.654 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.578 ' HA3' ' O ' ' A' ' 57' ' ' PRO . . . . . . . . 0 N--CA 1.445 -0.766 0 N-CA-C 111.776 -0.53 . . . . 0.0 111.776 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.583 ' HG3' ' HA ' ' A' ' 57' ' ' PRO . 3.4 Cg_exo -78.86 133.67 11.46 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 121.547 1.498 . . . . 0.0 111.659 175.526 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 26.7 p90 -100.89 -170.78 1.9 Allowed 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.525 -0.762 . . . . 0.0 111.139 -178.12 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.438 ' OG1' ' HG2' ' A' ' 16' ' ' GLN . 21.2 p -125.73 172.53 9.73 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 176.24 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.529 ' O ' ' HG3' ' A' ' 18' ' ' GLN . 1.9 tmt_? -61.03 -49.1 78.76 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 174.365 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' A' ' 15' ' ' ARG . 13.7 ttp85 -52.56 -52.57 54.31 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.823 -1.08 . . . . 0.0 111.376 176.428 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.617 ' O ' HG23 ' A' ' 20' ' ' VAL . 15.6 mm100 -59.27 -47.34 85.75 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.587 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -52.11 -48.31 64.86 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.719 179.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.529 ' HG3' ' O ' ' A' ' 14' ' ' ARG . 44.9 mt-30 -54.94 -48.58 72.99 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.446 -179.321 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.98 -35.14 76.02 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.181 0.515 . . . . 0.0 111.175 -178.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.617 HG23 ' O ' ' A' ' 16' ' ' GLN . 16.4 t -82.29 -13.14 12.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.756 -175.08 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.472 HG23 ' HB ' ' A' ' 27' ' ' ILE . 0.0 OUTLIER -91.87 -34.72 14.41 Favored 'General case' 0 CA--C 1.507 -0.674 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 176.349 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 22.1 m -56.24 -30.87 62.96 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 114.294 -1.321 . . . . 0.0 109.665 167.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.406 ' O ' ' HA ' ' A' ' 73' ' ' ARG . 28.0 m -89.38 -46.99 8.32 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.794 178.257 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.625 ' O ' HG13 ' A' ' 27' ' ' ILE . 36.9 m-85 -122.29 104.81 9.69 Favored 'General case' 0 N--CA 1.447 -0.611 0 O-C-N 121.767 -0.583 . . . . 0.0 109.481 177.639 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 7.2 p -77.09 -6.07 51.4 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -177.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.454 ' ND2' ' HB3' ' A' ' 24' ' ' TYR . 6.4 p30 -71.71 -19.36 62.06 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 173.466 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.625 HG13 ' O ' ' A' ' 24' ' ' TYR . 1.9 mt -77.01 138.95 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 CA-C-N 115.258 -0.883 . . . . 0.0 108.622 177.433 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.545 ' OG1' ' HB ' ' A' ' 40' ' ' VAL . 1.3 p -137.0 146.4 45.28 Favored 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 121.18 -0.208 . . . . 0.0 110.534 -175.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.493 ' HA ' HD23 ' A' ' 39' ' ' LEU . 4.5 tt -100.31 122.98 43.96 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.962 0.411 . . . . 0.0 110.193 -176.32 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.551 ' HB2' ' HG3' ' A' ' 38' ' ' ARG . 24.0 mt-10 -116.82 155.15 29.47 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.679 175.63 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 59.92 52.88 5.01 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.205 171.728 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.454 ' OD2' HD22 ' A' ' 29' ' ' LEU . 2.0 m-20 -62.3 83.51 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.762 178.551 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -119.46 71.31 0.87 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.333 0.587 . . . . 0.0 111.088 -177.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 66.11 -106.88 1.73 Allowed Glycine 0 N--CA 1.445 -0.73 0 CA-C-N 115.094 -0.957 . . . . 0.0 112.966 174.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 39.7 t -85.49 -14.24 46.63 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 111.667 0.247 . . . . 0.0 111.667 -175.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 34.4 p-80 -129.7 143.02 50.62 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.071 -0.651 . . . . 0.0 111.598 -177.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -163.88 179.35 7.11 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 179.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.551 ' HG3' ' HB2' ' A' ' 30' ' ' GLU . 13.6 ptt180 -127.41 154.26 45.25 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.015 -0.674 . . . . 0.0 110.866 176.072 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.493 HD23 ' HA ' ' A' ' 29' ' ' LEU . 95.5 mt -115.93 136.15 53.3 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.024 0.44 . . . . 0.0 110.392 178.336 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.545 ' HB ' ' OG1' ' A' ' 28' ' ' THR . 21.4 t -107.21 120.85 59.23 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.556 178.319 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 63.5 t -89.28 122.63 40.84 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 173.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 42' ' ' ARG . 24.8 mtp85 -111.39 159.61 17.85 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.344 0.593 . . . . 0.0 110.558 -178.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -90.97 176.83 6.46 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.295 178.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 17.8 p -68.96 -15.69 63.55 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.757 0.313 . . . . 0.0 111.303 -177.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -83.88 -17.08 42.04 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.491 0.662 . . . . 0.0 109.363 172.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 91.14 11.04 61.78 Favored Glycine 0 N--CA 1.447 -0.61 0 CA-C-N 115.291 -0.868 . . . . 0.0 112.517 -178.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 31.8 ptt85 -81.19 138.22 35.84 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 175.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 14.4 ptm -61.22 127.47 31.69 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.049 0.452 . . . . 0.0 110.839 177.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 13.5 t -102.68 -39.11 5.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.86 177.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 75.6 t-105 -166.54 121.69 1.16 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.991 -175.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.407 ' HB3' HG22 ' A' ' 40' ' ' VAL . 4.8 ptp85 -120.39 125.14 47.23 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 174.158 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -134.67 157.59 46.25 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.155 -176.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.563 ' HB2' ' HG3' ' A' ' 56' ' ' GLU . 81.7 m95 -85.6 -174.45 5.17 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 122.203 1.001 . . . . 0.0 111.988 -177.392 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.461 HD22 ' C ' ' A' ' 54' ' ' ASN . 0.2 OUTLIER -96.34 -33.52 11.91 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 113.692 -1.595 . . . . 0.0 110.158 -176.59 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 17.8 p90 -85.84 10.56 13.42 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.625 -174.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.563 ' HG3' ' HB2' ' A' ' 53' ' ' TRP . 25.5 mt-10 -88.19 128.59 52.96 Favored Pre-proline 0 C--N 1.322 -0.593 0 C-N-CA 121.007 -0.277 . . . . 0.0 110.406 -178.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.583 ' HA ' ' HG3' ' A' ' 11' ' ' PRO . 21.9 Cg_exo -65.14 -5.22 10.56 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.46 2.774 . . . . 0.0 114.094 -171.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -141.03 25.93 2.07 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.365 0.126 . . . . 0.0 111.132 -179.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.544 ' O ' ' HG ' ' A' ' 63' ' ' LEU . . . -57.06 -46.6 82.33 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.166 0.508 . . . . 0.0 110.997 -176.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -74.0 -22.05 78.41 Favored Glycine 0 N--CA 1.443 -0.843 0 CA-C-N 115.775 -0.648 . . . . 0.0 113.303 -176.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 17.9 tt0 -70.87 -33.43 70.6 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 117.182 0.491 . . . . 0.0 109.905 -177.023 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.52 ' O ' ' HB3' ' A' ' 65' ' ' ARG . . . -79.43 -38.27 21.77 Favored Glycine 0 N--CA 1.45 -0.399 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 175.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.544 ' HG ' ' O ' ' A' ' 59' ' ' ALA . 92.4 mt -61.77 -44.73 96.31 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.381 -0.409 . . . . 0.0 110.024 176.581 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.558 ' HA ' ' HB ' ' A' ' 67' ' ' ILE . 90.4 m-20 -62.96 -33.59 75.7 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.896 177.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.52 ' HB3' ' O ' ' A' ' 62' ' ' GLY . 9.5 tpt180 -54.39 -40.4 68.15 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.833 0.349 . . . . 0.0 110.439 173.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -77.33 -48.56 17.03 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.905 0.384 . . . . 0.0 110.545 174.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.558 ' HB ' ' HA ' ' A' ' 64' ' ' ASN . 84.2 mt -52.83 -56.15 8.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -174.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -71.86 -32.89 67.95 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.705 0.288 . . . . 0.0 111.656 -169.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.03 28.71 7.98 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -176.079 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 62.4 m -148.77 -53.75 0.18 Allowed 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 172.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 53.84 89.13 0.01 OUTLIER Glycine 0 CA--C 1.522 0.529 0 CA-C-N 115.422 -0.808 . . . . 0.0 114.373 176.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.451 ' O ' HG22 ' A' ' 72' ' ' ILE . 38.2 mm -86.37 7.02 2.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.749 0.785 . . . . 0.0 109.89 178.612 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.409 ' C ' ' H ' ' A' ' 75' ' ' ASP . 4.6 ptm180 -63.95 -13.5 46.42 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.646 -178.59 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 14.3 t -75.52 5.69 5.62 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 174.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.409 ' H ' ' C ' ' A' ' 73' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.466 0.342 0 C-N-CA 124.939 1.295 . . . . 0.0 112.499 176.501 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.482 ' HA3' ' HD3' ' A' ' 11' ' ' PRO . . . . . . . . 0 CA--C 1.522 0.527 0 N-CA-C 114.812 0.685 . . . . 0.0 114.812 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.514 ' HG3' ' HA ' ' A' ' 57' ' ' PRO . 1.3 Cg_endo -80.53 142.64 14.71 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 122.852 2.368 . . . . 0.0 112.409 -179.216 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.445 ' CZ ' ' HA ' ' A' ' 54' ' ' ASN . 9.8 p90 -111.46 -171.39 1.83 Allowed 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.002 -179.275 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.436 ' OG1' ' HG2' ' A' ' 16' ' ' GLN . 16.7 p -124.61 179.94 4.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.186 178.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.409 ' O ' ' HG3' ' A' ' 18' ' ' GLN . 5.6 ttm180 -65.8 -53.58 38.37 Favored 'General case' 0 N--CA 1.427 -1.591 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.705 -178.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.429 HH11 ' HD2' ' A' ' 15' ' ' ARG . 20.6 ptt85 -62.37 -36.46 82.34 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.204 178.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.618 ' O ' HG23 ' A' ' 20' ' ' VAL . 15.7 mm100 -62.31 -48.18 81.0 Favored 'General case' 0 CA--C 1.519 -0.246 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 176.516 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -55.0 -47.9 74.05 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.99 175.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.409 ' HG3' ' O ' ' A' ' 14' ' ' ARG . 99.1 mt-30 -57.59 -42.54 83.36 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.401 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.454 ' O ' ' HB ' ' A' ' 22' ' ' THR . . . -62.59 -34.59 77.29 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.985 178.31 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.618 HG23 ' O ' ' A' ' 16' ' ' GLN . 24.3 t -79.18 -16.33 13.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.808 0.337 . . . . 0.0 110.362 -178.034 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.555 HG23 ' HB ' ' A' ' 27' ' ' ILE . 0.0 OUTLIER -92.24 -26.42 18.18 Favored 'General case' 0 CA--C 1.503 -0.83 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 177.624 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.454 ' HB ' ' O ' ' A' ' 19' ' ' ALA . 98.0 m -61.12 -32.97 72.65 Favored 'General case' 0 N--CA 1.437 -1.122 0 CA-C-N 113.612 -1.631 . . . . 0.0 109.419 167.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.8 m -87.45 -50.66 6.4 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.968 178.264 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.637 ' O ' HG13 ' A' ' 27' ' ' ILE . 35.0 m-85 -116.64 102.37 9.39 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 -179.469 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 15.6 p -81.21 5.34 17.3 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.942 0.401 . . . . 0.0 111.419 -177.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.538 ' OD1' ' HB3' ' A' ' 24' ' ' TYR . 25.5 p-10 -83.53 -17.31 42.28 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 172.221 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.637 HG13 ' O ' ' A' ' 24' ' ' TYR . 1.1 mt -78.22 148.48 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 N-CA-C 108.183 -1.044 . . . . 0.0 108.183 173.5 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.504 ' O ' ' HA ' ' A' ' 39' ' ' LEU . 1.7 p -141.68 133.94 27.91 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.498 -0.481 . . . . 0.0 111.465 -178.029 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.518 ' HA ' HD23 ' A' ' 39' ' ' LEU . 6.5 tt -87.88 100.6 13.0 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 179.623 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -115.75 166.5 11.87 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.848 -174.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 60.6 37.22 19.49 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 123.388 0.43 . . . . 0.0 111.462 171.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -74.95 125.11 28.19 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.135 0.493 . . . . 0.0 111.305 -175.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -126.69 25.2 6.45 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.526 173.204 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.0 -90.87 1.6 Allowed Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.038 -177.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.0 t -78.27 -7.13 56.83 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.262 0.553 . . . . 0.0 110.863 -178.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 57.2 m80 -131.42 138.56 49.13 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.41 ' O ' ' HA ' ' A' ' 53' ' ' TRP . 52.8 p90 -168.81 166.39 11.49 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.306 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.502 ' HA ' ' HA ' ' A' ' 53' ' ' TRP . 70.2 mtm180 -128.28 132.98 48.69 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.518 HD23 ' HA ' ' A' ' 29' ' ' LEU . 64.4 mt -95.45 107.65 19.81 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.348 0.594 . . . . 0.0 109.661 174.244 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 60.7 t -89.48 116.87 31.71 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.896 177.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.465 HG22 HG23 ' A' ' 27' ' ' ILE . 25.4 t -89.4 110.58 21.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 178.057 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.415 ' HA ' ' O ' ' A' ' 47' ' ' ARG . 33.7 mtt85 -97.03 171.82 8.24 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.806 -178.685 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.437 ' CG ' ' H ' ' A' ' 45' ' ' GLU . 1.3 p-10 -104.17 -168.91 1.55 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.602 -178.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.1 p -63.01 -22.74 67.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.108 -179.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.437 ' H ' ' CG ' ' A' ' 43' ' ' ASP . 9.9 tp10 -89.81 -28.56 19.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.057 0.456 . . . . 0.0 110.073 178.42 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 107.19 19.36 9.51 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.055 -178.151 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.415 ' O ' ' HA ' ' A' ' 42' ' ' ARG . 51.0 mtp180 -89.79 143.99 26.34 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 178.227 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.8 113.74 8.17 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.227 0.537 . . . . 0.0 110.709 178.391 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 58.0 t -98.83 -33.46 4.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.135 178.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 73.3 t-105 -153.0 157.44 40.55 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.989 -176.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.417 HH11 ' HD2' ' A' ' 51' ' ' ARG . 20.6 ptt85 -156.93 146.19 20.33 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 177.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -152.95 153.42 32.95 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 177.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.633 ' HB2' ' OE1' ' A' ' 56' ' ' GLU . 80.4 m95 -77.39 -92.66 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.05 0.452 . . . . 0.0 110.857 -179.048 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.445 ' HA ' ' CZ ' ' A' ' 12' ' ' PHE . 6.6 t30 -175.58 -37.78 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.385 -177.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -86.0 -15.04 42.72 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -169.136 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.633 ' OE1' ' HB2' ' A' ' 53' ' ' TRP . 2.4 mp0 -62.88 137.16 96.8 Favored Pre-proline 0 C--N 1.327 -0.408 0 N-CA-C 110.321 -0.251 . . . . 0.0 110.321 -179.236 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.514 ' HA ' ' HG3' ' A' ' 11' ' ' PRO . 43.2 Cg_endo -68.59 5.35 1.31 Allowed 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.879 2.386 . . . . 0.0 112.917 -177.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -138.6 12.24 2.73 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.465 177.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.52 ' HB2' ' HB2' ' A' ' 56' ' ' GLU . . . -62.31 -43.35 99.02 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-O 121.239 0.542 . . . . 0.0 110.738 -172.773 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -68.03 -29.72 73.63 Favored Glycine 0 N--CA 1.442 -0.936 0 CA-C-N 115.346 -0.843 . . . . 0.0 112.301 179.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -72.44 -29.51 63.76 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 120.494 -0.483 . . . . 0.0 109.719 -178.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -68.57 -41.87 82.8 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.573 -0.822 . . . . 0.0 111.077 176.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 57.7 mt -64.16 -47.8 78.46 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.906 0.384 . . . . 0.0 110.143 176.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 9.5 m-20 -61.9 -29.2 70.05 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.953 177.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 36.0 ttm180 -65.73 -37.99 87.94 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.191 179.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 42.5 t80 -70.39 -50.3 40.17 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 174.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 99.0 mt -53.83 -35.97 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.068 179.097 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 50.0 ttt180 -49.72 -32.44 13.5 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -176.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.408 ' O ' ' HB2' ' A' ' 70' ' ' SER . 41.0 p -56.26 -38.37 71.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.038 0.447 . . . . 0.0 111.147 -178.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.408 ' HB2' ' O ' ' A' ' 69' ' ' THR . 37.2 t 167.32 -38.13 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 114.914 -1.039 . . . . 0.0 108.997 -174.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 84.12 147.34 8.05 Favored Glycine 0 N--CA 1.447 -0.628 0 CA-C-N 115.416 -0.811 . . . . 0.0 112.264 -178.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.466 ' O ' HG22 ' A' ' 72' ' ' ILE . 38.9 mm -83.29 6.7 1.69 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-O 121.672 0.749 . . . . 0.0 110.161 -178.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.476 ' HB3' ' CE2' ' A' ' 24' ' ' TYR . 16.1 ptt-85 -62.86 -24.28 67.72 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.74 178.061 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 20.0 m -60.95 -20.69 62.59 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.433 0.635 . . . . 0.0 109.548 173.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 29.5 t0 . . . . . 0 CA--C 1.517 -0.309 0 CA-C-N 114.036 -1.438 . . . . 0.0 112.914 -175.621 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.555 ' HA2' ' HA ' ' A' ' 58' ' ' ASP . . . . . . . . 0 N--CA 1.451 -0.304 0 CA-C-O 119.795 -0.447 . . . . 0.0 113.024 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -67.59 154.66 72.87 Favored 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 122.512 2.141 . . . . 0.0 112.396 177.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.479 ' CD2' ' HB2' ' A' ' 17' ' ' ALA . 15.9 p90 -126.79 -172.14 2.57 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.968 -176.682 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.52 ' OG1' ' HG2' ' A' ' 16' ' ' GLN . 31.9 p -125.47 176.13 7.03 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 172.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.524 ' HG2' HD11 ' A' ' 29' ' ' LEU . 45.1 mtm180 -65.38 -43.83 89.45 Favored 'General case' 0 C--O 1.219 -0.52 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.332 173.53 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 16.7 mtp180 -56.94 -46.97 81.71 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.933 179.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.554 ' O ' HG23 ' A' ' 20' ' ' VAL . 10.6 mm100 -64.37 -49.89 69.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.962 178.499 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.479 ' HB2' ' CD2' ' A' ' 12' ' ' PHE . . . -56.24 -49.05 75.26 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.768 179.339 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.443 ' HG2' ' O ' ' A' ' 14' ' ' ARG . 15.2 mm100 -55.28 -38.6 68.83 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.432 -178.54 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -67.11 -25.67 66.32 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.656 178.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 16' ' ' GLN . 31.3 t -91.61 -16.88 7.85 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.721 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 -173.731 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.537 HG23 ' HB ' ' A' ' 27' ' ' ILE . 6.2 m -93.74 -27.02 16.74 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-N 113.839 -1.528 . . . . 0.0 107.612 -177.623 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.9 m -65.07 -35.55 81.51 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 113.636 -1.62 . . . . 0.0 108.943 165.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 41.6 m -74.57 -55.93 5.38 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.559 177.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.66 ' HB3' ' OD1' ' A' ' 26' ' ' ASN . 63.9 m-85 -114.21 104.13 11.79 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-O 121.097 0.475 . . . . 0.0 109.839 178.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.3 p -69.72 -6.52 32.37 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.309 -179.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.66 ' OD1' ' HB3' ' A' ' 24' ' ' TYR . 7.6 p-10 -79.5 -8.83 59.42 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.167 0.508 . . . . 0.0 109.723 175.459 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.561 HG13 ' HB2' ' A' ' 24' ' ' TYR . 4.2 mt -88.19 157.42 3.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 172.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -153.37 130.82 11.36 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.639 -0.424 . . . . 0.0 111.298 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.526 ' HA ' HD23 ' A' ' 39' ' ' LEU . 6.5 tt -90.01 111.11 22.09 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -178.334 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -123.97 170.94 10.12 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.141 -178.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 5.8 t70 61.85 30.17 18.13 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.432 -0.803 . . . . 0.0 110.061 -178.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -63.18 99.33 0.17 Allowed 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.505 -177.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -112.74 -6.98 13.83 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.242 176.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.419 ' HA2' ' NH1' ' A' ' 14' ' ' ARG . . . 129.74 -102.42 0.55 Allowed Glycine 0 N--CA 1.448 -0.518 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.036 -177.399 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 37.2 m -79.3 -19.68 49.87 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 172.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -93.13 120.38 33.37 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.715 173.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.429 ' HE2' ' HE2' ' A' ' 12' ' ' PHE . 35.6 p90 -174.8 165.93 3.66 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 176.007 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.427 HH11 ' HD3' ' A' ' 38' ' ' ARG . 13.8 ptt180 -142.17 142.95 32.75 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.093 0.473 . . . . 0.0 110.774 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.526 HD23 ' HA ' ' A' ' 29' ' ' LEU . 82.0 mt -95.68 121.65 37.61 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.193 0.52 . . . . 0.0 110.375 179.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 41.4 t -98.46 115.14 37.98 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.632 178.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.0 t -96.69 118.63 43.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 121.122 0.487 . . . . 0.0 110.11 -177.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.478 ' HA ' ' O ' ' A' ' 47' ' ' ARG . 39.1 mtm105 -103.08 168.8 8.95 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.485 -178.466 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.475 ' CG ' ' H ' ' A' ' 45' ' ' GLU . 0.5 OUTLIER -96.09 -167.91 1.66 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.037 -0.528 . . . . 0.0 109.986 178.505 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 23.2 p -64.01 -26.17 68.45 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.317 -178.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.554 ' HB3' ' HD2' ' A' ' 47' ' ' ARG . 9.1 tp10 -95.84 -13.0 24.37 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 121.18 0.515 . . . . 0.0 110.433 -177.044 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 104.63 15.28 21.24 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.575 179.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.554 ' HD2' ' HB3' ' A' ' 45' ' ' GLU . 0.0 OUTLIER -78.0 128.54 34.04 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 178.448 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 63.1 mtm -74.27 99.89 3.58 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 177.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 23.7 t -86.92 -33.45 6.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.641 -174.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.424 ' CD1' HD23 ' A' ' 63' ' ' LEU . 75.5 t-105 -153.72 150.78 28.89 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.486 -173.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 16.0 ptt180 -156.09 141.24 17.42 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 174.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -142.92 153.49 43.14 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.415 -178.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.515 ' HB2' ' HG2' ' A' ' 56' ' ' GLU . 98.0 m95 -75.62 -167.41 0.68 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.643 0.735 . . . . 0.0 111.73 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -103.98 -40.88 6.04 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.746 -1.115 . . . . 0.0 111.413 -177.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 13.8 p90 -83.24 10.27 8.82 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.82 -174.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.642 ' HB2' ' HB2' ' A' ' 59' ' ' ALA . 11.9 mm-40 -77.55 131.75 70.56 Favored Pre-proline 0 C--N 1.324 -0.538 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 177.676 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 56' ' ' GLU . 52.1 Cg_exo -55.39 -21.26 28.99 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 123.493 2.795 . . . . 0.0 113.217 -176.487 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.555 ' HA ' ' HA2' ' A' ' 10' ' ' GLY . 4.2 p30 -136.86 38.34 2.59 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.77 0.319 . . . . 0.0 110.621 177.476 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.642 ' HB2' ' HB2' ' A' ' 56' ' ' GLU . . . -55.0 -52.75 62.16 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 121.22 0.533 . . . . 0.0 111.36 -174.344 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.424 ' HA2' HD12 ' A' ' 63' ' ' LEU . . . -67.7 -28.62 73.51 Favored Glycine 0 N--CA 1.44 -1.091 0 CA-C-N 115.422 -0.808 . . . . 0.0 112.729 -178.024 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -68.15 -35.88 78.77 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 117.139 0.469 . . . . 0.0 110.407 -176.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -68.49 -42.46 81.38 Favored Glycine 0 CA--C 1.519 0.299 0 C-N-CA 120.645 -0.788 . . . . 0.0 111.305 175.072 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.462 ' O ' HG13 ' A' ' 67' ' ' ILE . 49.7 mt -61.05 -47.47 86.21 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.994 -0.372 . . . . 0.0 109.994 176.014 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.508 ' HA ' ' HB ' ' A' ' 67' ' ' ILE . 94.0 m-20 -63.57 -29.29 70.57 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.791 177.679 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 6.4 ttt180 -58.93 -39.66 82.25 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 177.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -76.88 -46.59 24.01 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.505 173.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.508 ' HB ' ' HA ' ' A' ' 64' ' ' ASN . 93.7 mt -53.41 -46.16 58.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.681 -178.378 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 47.6 ttt85 -57.69 -36.56 72.12 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.948 -176.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.5 p -105.4 20.81 18.26 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -176.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 15.0 m -139.16 -57.31 0.6 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.688 0.28 . . . . 0.0 110.841 178.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 40.1 77.71 0.07 OUTLIER Glycine 0 CA--C 1.521 0.461 0 CA-C-N 115.189 -0.914 . . . . 0.0 113.512 -175.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.513 ' HB ' ' OD1' ' A' ' 26' ' ' ASN . 37.8 mm -82.55 5.73 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 CA-C-O 121.465 0.65 . . . . 0.0 111.317 -171.383 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 30.7 ttt-85 -75.84 -65.95 0.84 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.072 0.463 . . . . 0.0 111.839 -179.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 61.5 m -66.04 -8.32 22.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.127 -178.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 16.4 t70 . . . . . 0 C--N 1.326 -0.418 0 CA-C-N 114.29 -1.323 . . . . 0.0 111.705 -170.982 . . . . . . . . 0 0 . 1 stop_ save_